PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hinchley, G; Patrick, K				Hinchley, Geoff; Patrick, Kirsten			Is infant male circumcision an abuse of the rights of the child?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barnet & Chase Farm NHS Trust, Enfield EN2 8JL, Middx, England; BMJ, London WC1H 9JR, England		Hinchley, G (corresponding author), Barnet & Chase Farm NHS Trust, Enfield EN2 8JL, Middx, England.	geoff.hinchley@bcf.nhs.uk; Kpatrick@bmj.com		Patrick, Kirsten/0000-0003-4525-8323					0	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1180	1181		10.1136/bmj.39406.520498.AD	http://dx.doi.org/10.1136/bmj.39406.520498.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242ER	18063641	Green Published			2022-12-28	WOS:000251707800027
J	Moellering, RC				Moellering, Robert C., Jr.			A 39-year-old man with a skin infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; SOFT-TISSUE INFECTIONS; INDUCIBLE CLINDAMYCIN RESISTANCE; COMMUNITY-ACQUIRED PNEUMONIA; GRAM-POSITIVE BACTERIA; COMPLICATED SKIN; UNITED-STATES; TRIMETHOPRIM-SULFAMETHOXAZOLE; MUPIROCIN PROPHYLAXIS	The case of Mr M, a previously healthy 39-year-old man with erythema and swelling of his finger, illustrates the issues involved in treating community-acquired skin and soft tissue infections since the emergence of methicillin-resistant Staphylococcus aureus (MRSA) in the community. Most community-acquired infections of the skin and soft tissues are caused by S aureus or Streptococcus pyogenes. Until recently, infections due to such organisms in the United States could safely be treated with an oral antistaphylococcal penicillin or an oral first-generation cephalosporin. However, the emergence of methicillin-resistant staphylococci as community-acquired pathogens has changed the picture as far as empirical therapy is concerned. Not only do communityacquired MRSA bacteria cause furunculitis and cellulitis, they have also been involved in a variety of more serious and life-threatening infections. Most of these organisms are susceptible to trimethoprim-sulfamethoxazole, minocycline, doxycycline, and rifampin, and these agents, along with clindamycin, have been used in the therapy of such infections, even though no clinical trials have proven their efficacy. For more serious, life-threatening infections, linezolid or parenteral agents such as vancomycin or daptomycin should be considered.	[Moellering, Robert C., Jr.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Moellering, RC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 110 Francis St,Ste 6A, Boston, MA 02215 USA.	rmoeller@bidmc.harvard.edu						Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Allen NE, 2003, FEMS MICROBIOL REV, V26, P511, DOI 10.1111/j.1574-6976.2003.tb00628.x; Annigeri R, 2001, PERITON DIALYSIS INT, V21, P554; Arbeit RD, 2004, CLIN INFECT DIS, V38, P1673, DOI 10.1086/420818; Baker AS, 1998, CLIN INFECT DIS, V27, P1168, DOI 10.1086/514980; Banthia S, 2005, INFECT DIS CLIN PRAC, V13, P132, DOI 10.1097/01.idc.0000161523.66158.25; BERGER RS, 1990, CUTIS, V45, P97; Breedt J, 2005, ANTIMICROB AGENTS CH, V49, P4658, DOI 10.1128/AAC.49.11.4658-4666.2005; Brooke CJ, 1999, J MED MICROBIOL, V48, P789, DOI 10.1099/00222615-48-9-789; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Cenizal MJ, 2007, ANTIMICROB AGENTS CH, V51, P2628, DOI 10.1128/AAC.00206-07; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; CRAVEN DE, 1986, AM J MED, V80, P770, DOI 10.1016/0002-9343(86)90614-5; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Drinkovic D, 2001, J ANTIMICROB CHEMOTH, V48, P315, DOI 10.1093/jac/48.2.315; Eron L J, 2006, Eur J Clin Microbiol Infect Dis, V25, P615, DOI 10.1007/s10096-006-0187-y; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gilbert DN, 2007, SANFORD GUIDE ANTIMI; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; GOLDSTEIN EJC, 1988, ANTIMICROB AGENTS CH, V32, P213, DOI 10.1128/AAC.32.2.213; GOLDSTEIN EJC, 2005, PRINCIPLES PRACTICE, P3552; Gorwitz RJ, 2007, CLIN INFECT DIS, V44, P785, DOI 10.1086/511884; HACKBARTH CJ, 1989, ANTIMICROB AGENTS CH, V33, P991, DOI 10.1128/AAC.33.7.991; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Holland S.M., 2005, PRINCIPLES PRACTICE, P149; HSU CCS, 1988, ARCH INTERN MED, V148, P569, DOI 10.1001/archinte.148.3.569; Jacquenline C, 2006, 46 INT C ANT AG CHEM; Jauregui LE, 2005, CLIN INFECT DIS, V41, P1407, DOI 10.1086/497271; Kaka AS, 2006, J ANTIMICROB CHEMOTH, V58, P680, DOI 10.1093/jac/dkl283; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Levin TP, 2005, ANTIMICROB AGENTS CH, V49, P1222, DOI 10.1128/AAC.49.3.1222-1224.2005; LEVINE DP, 1982, ANN INTERN MED, V97, P330, DOI 10.7326/0003-4819-97-3-330; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maguire GP, 1998, J HOSP INFECT, V38, P273, DOI 10.1016/S0195-6701(98)90076-7; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; MARKOWITZ N, 1992, ANN INTERN MED, V117, P390, DOI 10.7326/0003-4819-117-5-390; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Moellering RC, 1999, J ANTIMICROB CHEMOTH, V44, P251, DOI 10.1093/jac/44.2.251; Moellering RC, 2003, ANN INTERN MED, V138, P135, DOI 10.7326/0003-4819-138-2-200301210-00015; MOELLERING RC, 1979, GUIDELINES ANTIBIOTI, V5, P1; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Muller-Premru M, 2005, EUR J CLIN MICROBIOL, V24, P848, DOI 10.1007/s10096-005-0048-0; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Noel GJ, 2007, CLIN MICROBIOL INFEC, V13, P25, DOI 10.1111/j.1469-0691.2007.01725.x; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; REBOLI AC, 2005, PRINCIPLES PRACTICE, P2496; RIMLAND D, 1986, J CLIN MICROBIOL, V24, P137, DOI 10.1128/JCM.24.1.137-138.1986; Ruhe JJ, 2005, CLIN INFECT DIS, V40, P1429, DOI 10.1086/429628; Rybak MJ, 2006, CLIN MICROBIOL INFEC, V12, P24, DOI 10.1111/j.1469-0691.2006.01342.x; Sakoulas G, 2006, CLIN INFECT DIS, V42, pS40, DOI 10.1086/491713; SARAVOLATZ LD, 1982, ANN INTERN MED, V96, P11, DOI 10.7326/0003-4819-96-1-11; SCHAEFLER S, 1989, J CLIN MICROBIOL, V27, P335, DOI 10.1128/JCM.27.2.335-336.1989; Schneider-Lindner V, 2007, EMERG INFECT DIS, V13, P994, DOI 10.3201/eid1307.061561; SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1368, DOI 10.1056/NEJM198405243102107; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; Stryjewski ME, 2006, ANTIMICROB AGENTS CH, V50, P862, DOI 10.1128/AAC.50.3.862-867.2006; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Swartz MN, 2005, PRINCIPLES PRACTICE, V1, P1172; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Tacconelli E, 2003, CLIN INFECT DIS, V37, P1629, DOI 10.1086/379715; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; TENOVER FC, 2005, CLIN MICROBIOL NEWSL, V25, P33; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Weigelt J, 2004, AM J SURG, V188, P760, DOI 10.1016/j.amjsurg.2004.08.045; WHITE A, 1963, Antimicrob Agents Chemother (Bethesda), V161, P667; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204; 2006, MED LETT DRUGS THER, V48, P13	80	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					79	87		10.1001/jama.298.21.jrr70002	http://dx.doi.org/10.1001/jama.298.21.jrr70002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18056894				2022-12-28	WOS:000252052000019
J	Berridge, V				Berridge, Virginia			Public health activism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Berridge, V (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, Keppel St, London WC1E 7HT, England.	virginia.berridge@lshtm.ac.uk		berridge, virginia/0000-0001-8011-8348	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berridge V., 2007, MARKETING HLTH SMOKI; Berridge V., 1996, AIDS UK MAKING POLIC; Chadwick Edwin, 1965, REPORT SANITARY COND; DAUBE M, COMMUNICATION; *DEP HLTH HOM OFF, 2007, SAF SENS SOC NEXT ST; Greenaway J, 2003, DRINK AND BRITISH POLITICS SINCE 1830: A STUDY IN POLICY MAKING, P1; HAMLIN C, 1998, PUBLIC HLTH SOCIAL J, P249; HARRIS J, 2007, GUARDIAN        0726; HARRISON B, 1994, DRINK VICTORIANS TEM, P308; HARRISON B, 1994, DRINK VICTORIANS TEM, P350; Longmate Norman, 1968, WATERDRINKERS HIST T; PATERSON ROBERT G., 1948, BULL HISTORY MED, V22, P373; *ROYAL COLL PHYS, 1971, SMOK HLTH NOW; World Health Organization, 2003, WHO FRAM CONV TOB CO	14	17	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1310	1312		10.1136/bmj.39399.612454.AD	http://dx.doi.org/10.1136/bmj.39399.612454.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156243	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000252182700025
J	Knowles, TP; Fitzpatrick, AW; Meehan, S; Mott, HR; Vendruscolo, M; Dobson, CM; Welland, ME				Knowles, Tuomas P.; Fitzpatrick, Anthony W.; Meehan, Sarah; Mott, Helen R.; Vendruscolo, Michele; Dobson, Christopher M.; Welland, Mark E.			Role of intermolecular forces in defining material properties of protein nanofibrils	SCIENCE			English	Article							CROSS-BETA-SPINE; DYNAMICS; FIBRILS; FIBERS	Protein molecules have the ability to form a rich variety of natural and artificial structures and materials. We show that amyloid fibrils, ordered supramolecular nanostructures that are self- assembled from a wide range of polypeptide molecules, have rigidities varying over four orders of magnitude, and constitute a class of high- performance biomaterials. We elucidate the molecular origin of fibril material properties and show that the major contribution to their rigidity stems from a generic interbackbone hydrogen- bonding network that is modulated by variable side- chain interactions.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Nanosci Ctr, Cambridge, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; mew10@cam.ac.uk	Knowles, Tuomas/C-6663-2009; Mott, Helen/AAV-3873-2020; Vendruscolo, Michele/F-5901-2012	Knowles, Tuomas/0000-0002-7879-0140; Mott, Helen/0000-0002-7890-7097; Vendruscolo, Michele/0000-0002-3616-1610	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashby MF., 1980, ENG MAT INTRO THEIR; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n; Wang JC, 2002, J MOL BIOL, V315, P601, DOI 10.1006/jmbi.2001.5130; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	28	588	596	7	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1900	1903		10.1126/science.1150057	http://dx.doi.org/10.1126/science.1150057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096801				2022-12-28	WOS:000251786600052
J	Heneghan, C; Perera, R				Heneghan, Carl; Perera, Rafael			Prevention of hepatitis C in Japan: a lesson for us all	LANCET			English	Editorial Material							RISK		Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England	University of Oxford	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England.	carl.heneghan@dphpc.ox.ac.uk		Perera, Rafael/0000-0003-2418-2091				AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; ABOCAR A, 2002, CRIMINAL CHARGES LAI; Chalmers Iain, 2004, BMJ, V328, P475, DOI 10.1136/bmj.328.7438.475; Doust J, 2004, BRIT MED J, V328, P474, DOI 10.1136/bmj.328.7438.474; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; EVANS I, 2006, TESTING TREATMENTS B, P1; FRANCISCUS A, HCV ADVOCATE JAPANES; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; HOOFNAGLE JH, 1977, ANN INTERN MED, V87, P14, DOI 10.7326/0003-4819-87-1-14; *NIH CONS C STAT, 2007, MAN HEP C; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; VANDENBROUCKE JP, THALIDOMIDE UNANTICI; *WHO, 2000, 164 WHO; Yasunaga H, 2007, LANCET, V370, P2063, DOI 10.1016/S0140-6736(07)61867-4; 2005, DAILY RECORD    1031	15	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2007	370	9604					1982	1983		10.1016/S0140-6736(07)61842-X	http://dx.doi.org/10.1016/S0140-6736(07)61842-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242BD	18083387				2022-12-28	WOS:000251698600007
J	Srinivasan, K; Painter, O				Srinivasan, Kartik; Painter, Oskar			Linear and nonlinear optical spectroscopy of a strongly coupled microdisk-quantum dot system	NATURE			English	Article							CAVITY; PHOTONS; NANOCAVITY; ATOM	Cavity quantum electrodynamics(1), the study of coherent quantum interactions between the electromagnetic field and matter inside a resonator, has received attention as both a test bed for ideas in quantum mechanics and a building block for applications in the field of quantum information processing(2). The canonical experimental system studied in the optical domain is a single alkali atom coupled to a high-finesse Fabry-Perot cavity. Progress made in this system(1-5) has recently been complemented by research involving trapped ions(6), chip-based microtoroid cavities(7), integrated microcavity-atom-chips(8), nanocrystalline quantum dots coupled to microsphere cavities(9), and semiconductor quantum dots embedded in micropillars, photonic crystals and microdisks(10-12). The last system has been of particular interest owing to its relative simplicity and scalability. Here we use a fibre taper waveguide to perform direct optical spectroscopy of a system consisting of a quantum dot embedded in a microdisk. In contrast to earlier work with semiconductor systems, which has focused on photoluminescence measurements(10-14), we excite the system through the photonic ( light) channel rather than the excitonic ( matter) channel. Strong coupling, the regime of coherent quantum interactions, is demonstrated through observation of vacuum Rabi splitting in the transmitted and reflected signals from the cavity. The fibre coupling method also allows us to examine the system's steady-state nonlinear properties, where we see a saturation of the cavity-quantum dot response for less than one intracavity photon. The excitation of the cavity-quantum dot system through a fibre optic waveguide is central to applications such as high-efficiency single photon sources(15,16), and to more fundamental studies of the quantum character of the system(17).	CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA; CALTECH, Ctr Phys Informat, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Painter, O (corresponding author), CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA.	opainter@caltech.edu	Srinivasan, Kartik/D-6369-2010	Painter, Oskar/0000-0002-1581-9209				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Badolato A, 2005, SCIENCE, V308, P1158, DOI 10.1126/science.1109815; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Boca A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233603; COLOMBE Y, 2007, STRONG ATOM FIELD CO; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hennrich M, 2000, PHYS REV LETT, V85, P4872, DOI 10.1103/PhysRevLett.85.4872; Hood CJ, 1998, PHYS REV LETT, V80, P4157, DOI 10.1103/PhysRevLett.80.4157; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129; Kulakovskii VD, 1999, PHYS REV LETT, V82, P1780, DOI 10.1103/PhysRevLett.82.1780; Liu GT, 2000, IEEE J QUANTUM ELECT, V36, P1272, DOI 10.1109/3.890268; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Mosor S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2076435; Park YS, 2006, NANO LETT, V6, P2075, DOI 10.1021/nl061342r; Peter E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067401; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; SAVAGE CM, 1988, IEEE J QUANTUM ELECT, V24, P1495, DOI 10.1109/3.7075; Srinivasan K, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1901810; Srinivasan K, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.081306; Srinivasan K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775811; Srinivasan K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431719; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119	29	333	339	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					862	U15		10.1038/nature06274	http://dx.doi.org/10.1038/nature06274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064009	Green Submitted			2022-12-28	WOS:000251394900052
J	Lewington, S; Whitlock, G; Clarke, R; Sherliker, P; Emberson, J; Halsey, J; Qizilbash, N; Peto, R; Collins, R				Lewington, Sarah; Whitlock, Gary; Clarke, Robert; Sherliker, Paul; Emberson, Jonathan; Halsey, Jim; Qizilbash, Nawab; Peto, Richard; Collins, Rory		Prospective Studies Collaboration	Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; FLOATING ABSOLUTE RISK; ASIA-PACIFIC REGION; SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; STROKE; MEN	Background Age, sex, and blood pressure could modify the associations of total cholesterol (and its main two fractions, HDL and LDL cholesterol) with vascular mortality. This meta-analysis combined prospective studies of vascular mortality that recorded both blood pressure and total cholesterol at baseline, to determine the joint relevance of these two risk factors. Methods Information was obtained from 61 prospective observational studies, mostly in western Europe or North America, consisting of almost 900000 adults without previous disease and with baseline measurements of total cholesterol and blood pressure. During nearly 12 million person years at risk between the ages of 40 and 89 years, there were more than 55000 vascular deaths (34000 ischaemic heart disease [IHD], 12000 stroke, 10000 other). Information about HDL cholesterol was available for 150000 participants, among whom there were 5000 vascular deaths (3000 IHD, 1000 stroke, 1000 other). Reported associations are with usual cholesterol levels (ie, corrected for the regression dilution bias). Findings 1 mmol/L lower total cholesterol was associated with about a half (hazard ratio 0 . 44 [95% CI 0.42-0.48]), a third (0.66 [0.65-0.68]), and a sixth (0.83 [0.81-0.85]) lower IHD mortality in both sexes at ages 40-49, 50-69, and 70-89 years, respectively, throughout the main range of cholesterol in most developed countries, with no apparent threshold. The proportional risk reduction decreased with increasing blood pressure, since the absolute effects of cholesterol and blood pressure were approximately additive. Of various simple indices involving HDL cholesterol, the ratio total/HDL cholesterol was the strongest predictor of IHD mortality (40% more informative than non-HDL cholesterol and more than twice as informative as total cholesterol). Total cholesterol was weakly positively related to ischaemic and total stroke mortality in early middle age (40-59 years), but this finding could be largely or wholly accounted for by the association of cholesterol with blood pressure. Moreover, a positive relation was seen only in middle age and only in those with below-average blood pressure; at older ages (70-89 years) and, particularly, for those with systolic blood pressure over about 145 mm Hg, total cholesterol was negatively related to haemorrhagic and total stroke mortality. The results for other vascular mortality were intermediate between those for IHD and stroke. Interpretation Total cholesterol was positively associated with IHD mortality in both middle and old age and at all blood pressure levels. The absence of an independent positive association of cholesterol with stroke mortality, especially at older ages or higher blood pressures, is unexplained, and invites further research. Nevertheless, there is conclusive evidence from randomised trials that statins substantially reduce not only coronary event rates but also total stroke rates in patients with a wide range of ages and blood pressures.	Univ Oxford, Clin Trial Serv Unit, PSC Secretariat, Oxford OX3 7LF, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Lewington, S (corresponding author), Univ Oxford, Clin Trial Serv Unit, PSC Secretariat, Richard Doll Bldg, Oxford OX3 7LF, England.		; Marmot, Michael/Y-3920-2019; Davey Smith, George/A-7407-2013; Leon, David/G-2195-2010	Sutherland, Susan/0000-0001-7184-8920; Marmot, Michael/0000-0002-2431-6419; Thijs, Lutgarde/0000-0002-8108-2356; s, hema/0000-0002-3440-9475; Eberly, Lynn/0000-0003-4763-330X; Tverdal, Aage/0000-0002-2909-5678; Law, Matthew/0000-0002-3540-8837; Davey Smith, George/0000-0002-1407-8314; Emberson, Jonathan/0000-0001-7792-9422; Jacobs, David/0000-0002-7232-0543; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Leon, David/0000-0001-9747-1762; Carstensen, John/0000-0003-2256-8089; Rodgers, Anthony/0000-0003-1282-1896; Nakayama, Takeo/0000-0002-7918-6252; MacMahon, Stephen/0000-0003-2064-7699; Morris, Richard/0000-0001-7240-4563; Morris, Joan/0000-0002-7164-612X; Lewington, Sarah/0000-0002-4496-4771	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; MRC [MC_U137686857, MC_U137686851, MC_U137686853] Funding Source: UKRI; Medical Research Council [MC_U137686857, MC_U137686851, MC_U137686853] Funding Source: Medline; NIA NIH HHS [P01 AG17625-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Austin MA, 2000, AM J CARDIOL, V86, P412, DOI 10.1016/S0002-9149(00)00956-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ebrahim S, 2006, BMJ-BRIT MED J, V333, P22, DOI 10.1136/bmj.38855.610324.80; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Iso H, 1999, J CARDIOVASC RISK, V6, P315; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2005, CIRCULATION, V112, P3373, DOI 10.1161/CIRCULATIONAHA.105.581934; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Qizilbash N, 1995, LANCET, V346, P1647; QIZILBASH N, 1992, CEREBROVASC DIS, V2, P127, DOI 10.1159/000109004; Rodgers A, 2005, CIRCULATION, V112, P3384, DOI 10.1161/CIRCULATIONHA.105.537472; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shahar E, 2003, STROKE, V34, P623, DOI 10.1161/01.STR.0000057812.51734.FF; Tanne D, 1997, STROKE, V28, P83, DOI 10.1161/01.STR.28.1.83; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	25	1588	1654	5	122	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1829	1839						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061058				2022-12-28	WOS:000251588700029
J	Platell, C; Hall, J				Platell, Cameron; Hall, John			Mechanical bowel preparation before colorectal surgery?	LANCET			English	Editorial Material									[Platell, Cameron] St John God Hosp, Subiaco Colorectal Canc Unit, Perth, WA 6005, Australia; [Hall, John] Univ Western Australia, Perth, WA 6009, Australia	St John of God Health Care; University of Western Australia	Platell, C (corresponding author), St John God Hosp, Subiaco Colorectal Canc Unit, Perth, WA 6005, Australia.	cplatell@cyllene.uwa.edu.au						Bucher P, 2007, ANN SURG, V245, P662, DOI 10.1097/01.sla.0000259047.43665.04; Contant CME, 2007, LANCET, V370, P2112, DOI 10.1016/S0140-6736(07)61905-9; Jung B, 2007, BRIT J SURG, V94, P689, DOI 10.1002/bjs.5816; Platell C, 2007, COLORECTAL DIS, V9, P71, DOI 10.1111/j.1463-1318.2006.01002.x	4	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2073	2075		10.1016/S0140-6736(07)61875-3	http://dx.doi.org/10.1016/S0140-6736(07)61875-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156013				2022-12-28	WOS:000252058600005
J	Dorin, JR; Jackson, IJ				Dorin, Julia R.; Jackson, Ian J.			Genetics - beta-defensin repertoire expands	SCIENCE			English	Editorial Material							BETA-DEFENSIN-1; MICE		Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dorin, JR (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	ian.jackson@hgu.mrc.ac.uk		Jackson, Ian/0000-0001-6526-0688	MRC [MC_U127527200, MC_U127527201] Funding Source: UKRI; Medical Research Council [MC_U127527200, MC_U127527201] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Maaser C, 2006, ANN NY ACAD SCI, V1072, P123, DOI 10.1196/annals.1326.016; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520	10	11	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1395	1395		10.1126/science.1151370	http://dx.doi.org/10.1126/science.1151370			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048676				2022-12-28	WOS:000251246100030
J	Alber, F; Dokudovskaya, S; Veenhoff, LM; Zhang, WZ; Kipper, J; Devos, D; Suprapto, A; Karni-Schmidt, O; Williams, R; Chait, BT; Rout, MP; Sali, A				Alber, Frank; Dokudovskaya, Svetlana; Veenhoff, Liesbeth M.; Zhang, Wenzhu; Kipper, Julia; Devos, Damien; Suprapto, Adisetyantari; Karni-Schmidt, Orit; Williams, Rosemary; Chait, Brian T.; Rout, Michael P.; Sali, Andrej			Determining the architectures of macromolecular assemblies	NATURE			English	Article							NUCLEAR-PORE COMPLEX; PROTEIN; TRANSPORT; NUCLEOPORINS; IDENTIFICATION; PREDICTION; SUBUNIT; SHAPE	To understand the workings of a living cell, we need to know the architectures of its macromolecular assemblies. Here we show how proteomic data can be used to determine such structures. The process involves the collection of sufficient and diverse high-quality data, translation of these data into spatial restraints, and an optimization that uses the restraints to generate an ensemble of structures consistent with the data. Analysis of the ensemble produces a detailed architectural map of the assembly. We developed our approach on a challenging model system, the nuclear pore complex (NPC). The NPC acts as a dynamic barrier, controlling access to and from the nucleus, and in yeast is a 50 MDa assembly of 456 proteins. The resulting structure, presented in an accompanying paper, reveals the configuration of the proteins in the NPC, providing insights into its evolution and architectural principles. The present approach should be applicable to many other macromolecular assemblies.	Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University; Rockefeller University	Sali, A (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Byers Hall,Suite 503B,1700 4th St, San Francisco, CA 94158 USA.	chait@rockefeller.edu; rout@rockefeller.edu; sali@salilab.org	devos, damien/ABH-5348-2020; Rout, Michael/Y-7090-2018	Svetlana, Dokudovskaya/0000-0001-6032-622X; Veenhoff, Liesbeth/0000-0002-0158-4728; Devos, Damien/0000-0002-9453-4753; Rout, Michael/0000-0003-2010-706X	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062427, R01GM083960] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR022220] Funding Source: Medline; NIGMS NIH HHS [R01 GM062427, R01 GM083960] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Harding S E, 1994, Methods Mol Biol, V22, P61; HAVEL T, 1984, B MATH BIOL, V46, P673, DOI 10.1007/BF02459510; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MALHOTRA A, 1990, P NATL ACAD SCI USA, V87, P1950, DOI 10.1073/pnas.87.5.1950; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; STRAMBIODECASTILLIA C, 1995, J CELL BIOL, V131, P19, DOI 10.1083/jcb.131.1.19; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	44	412	419	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					683	694		10.1038/nature06404	http://dx.doi.org/10.1038/nature06404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046405				2022-12-28	WOS:000251209700047
J	Li, ZY; Young, NP; Di Vece, M; Palomba, S; Palmer, RE; Bleloch, AL; Curley, BC; Johnston, RL; Jiang, J; Yuan, J				Li, Z. Y.; Young, N. P.; Di Vece, M.; Palomba, S.; Palmer, R. E.; Bleloch, A. L.; Curley, B. C.; Johnston, R. L.; Jiang, J.; Yuan, J.			Three-dimensional atomic-scale structure of size-selected gold nanoclusters	NATURE			English	Article							OXIDATION; SURFACES; CLUSTER	An unambiguous determination of the three-dimensional structure of nanoparticles is challenging(1). Electron tomography requires a series of images taken for many different specimen orientations(2). This approach is ideal for stable and stationary structures(3). But ultrasmall nanoparticles are intrinsically structurally unstable and may interact with the incident electron beam(4-6), constraining the electron beam density that can be used and the duration of the observation. Here we use aberration-corrected scanning transmission electron microscopy(7), coupled with simple imaging simulation, to determine with atomic resolution the size, three- dimensional shape, orientation and atomic arrangement of size- selected gold nanoclusters that are preformed in the gas phase and soft- landed on an amorphous carbon substrate. The structures of gold nanoclusters containing 309 +/- 6 atoms can be identified with either Ino- decahedral, cuboctahedral or icosahedral geometries. Comparison with theoretical modelling of the system suggests that the structures are consistent with energetic considerations. The discovery that nanoscale gold particles function as active and selective catalysts for a variety of important chemical reactions has provoked much research interest in recent years(8-12). We believe that the detailed structure information we provide will help to unravel the role of these nanoclusters in size- and structure-specific catalytic reactions(11,12). We note that the technique will be of use in investigations of other supported ultrasmall metal cluster systems.	[Li, Z. Y.; Young, N. P.; Di Vece, M.; Palomba, S.; Palmer, R. E.] Univ Birmingham, Sch Phys & Astron, Nanoscale Phys Res Lab, Birmingham B15 2TT, W Midlands, England; [Curley, B. C.; Johnston, R. L.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Bleloch, A. L.] SERC, Daresbury Lab, UK SuperSTEM Lab, Daresbury WA4 4AD, England; [Jiang, J.; Yuan, J.] Tsinghua Univ, Beijing Electron Microscopy Ctr, Beijing 100084, Peoples R China; [Jiang, J.; Yuan, J.] Tsinghua Univ, Adv Mat Lab, Beijing 100084, Peoples R China; [Jiang, J.; Yuan, J.] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China	University of Birmingham; University of Birmingham; STFC Daresbury Laboratory; Tsinghua University; Tsinghua University; Tsinghua University	Li, ZY (corresponding author), Univ Birmingham, Sch Phys & Astron, Nanoscale Phys Res Lab, Birmingham B15 2TT, W Midlands, England.	ziyouli@nprl.ph.bham.ac.uk	Di Vece, Marcel/N-6957-2016; Bleloch, Andrew/A-1350-2009; yuan, jun/A-9726-2008; Palmer, Richard E/A-5366-2008; Yuan, Jun/J-2577-2012; Johnston, Roy L/H-2281-2014; Li, Ziyou/A-4100-2012	Di Vece, Marcel/0000-0002-0041-4348; yuan, jun/0000-0001-5833-4570; Palmer, Richard E/0000-0001-8728-8083; Yuan, Jun/0000-0001-5833-4570; Johnston, Roy L/0000-0003-4019-9280; Li, Ziyou/0000-0002-4652-9845; Yuan, Jun/0000-0002-6240-7151; palomba, stefano/0000-0003-2424-5160	Engineering and Physical Sciences Research Council [EP/E005918/1, EP/D056241/1, EP/D049245/1] Funding Source: researchfish; EPSRC [EP/E005918/1, EP/D056241/1, EP/D049245/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AJAYAN PM, 1989, PHYS REV LETT, V63, P279, DOI 10.1103/PhysRevLett.63.279; Arslan I, 2005, SCIENCE, V309, P2195, DOI 10.1126/science.1116745; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Bleloch A, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00570-X; BOVIN JO, 1985, NATURE, V317, P47, DOI 10.1038/317047a0; Chen MS, 2006, CATAL TODAY, V111, P22, DOI 10.1016/j.cattod.2005.10.007; CLERI F, 1993, PHYS REV B, V48, P22, DOI 10.1103/PhysRevB.48.22; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; IIJIMA S, 1986, PHYS REV LETT, V56, P616, DOI 10.1103/PhysRevLett.56.616; Jiang J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773745; Johnston RL, 2003, DALTON T, P4193, DOI 10.1039/b305686d; Kirkland E. J., 2020, ADV COMPUTING ELECT, V3, DOI 10.1007/978-1-4419-6533-2#; Koga K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.115507; Li ZY, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2139851; Li ZY, 2005, ADV MATER, V17, P2885, DOI 10.1002/adma.200500977; MARKS LD, 1994, REP PROG PHYS, V57, P603, DOI 10.1088/0034-4885/57/6/002; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Palmer RE, 2003, NAT MATER, V2, P443, DOI 10.1038/nmat897; Pratontep S, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1869332; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Schebarchov D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.116101; SMITH DJ, 1986, SCIENCE, V233, P872, DOI 10.1126/science.233.4766.872; Tsunoyama H, 2005, J AM CHEM SOC, V127, P9374, DOI 10.1021/ja052161e; von Issendorff B, 1999, REV SCI INSTRUM, V70, P4497, DOI 10.1063/1.1150102	27	348	350	11	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					46	U2		10.1038/nature06470	http://dx.doi.org/10.1038/nature06470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18066049				2022-12-28	WOS:000252079300029
J	[Anonymous]				[Anonymous]			Achieving a high-performance health care system with universal access: What the United States can learn from other countries	ANNALS OF INTERNAL MEDICINE			English	Review							REGIONAL-VARIATIONS; PART 2; QUALITY; MEDICARE; PHYSICIANS; OUTCOMES; ADULTS; COSTS	This position paper concerns improving health care in the United States. Unlike previous highly focused policy papers by the American College of Physicians, this article takes a comprehensive approach to improving access, quality, and efficiency of care. The first part describes health care in the United States. The second compares it with health care in other countries. The concluding section proposes lessons that the United States can learn from these countries and recommendations for achieving a high-performance health care system in the United States. The articles are based on a position paper developed by the American College of Physicians' Health and Public Policy Committee. This policy paper (not included in this article) also provides a detailed analysis of health care systems in 12 other industrialized countries. Although we can learn much from other health systems, the College recognizes that our political and social culture, demographics, and form of government will shape any solution for the United States. This caution notwithstanding, we have identified several approaches that have worked well for countries like ours and could probably be adapted to the unique circumstances in the United States.										*AAMC, 2005, AAMC MED ED COSTS ST; *AG HEALTHC RES QU, 2002, ROL MISS AG HEALTHC; *AG HEALTHC RES QU, 2005, AHRQ PUBL; *AM AC FAM PHYS AM, JOINT PRINC PAT CENT; *AM COLL PHYS, 2005, LINK PHYS PAYM QUAL; *AM COLL PHYS, 2003, CHANG FAC AMB MED RE; *AM COLL PHYS, 2004, MED PROF CHANG HLTH; *AM COLL PHYS, 2004, US PERF MEAS IMPR PH; *AM COLL PHYS, 2004, PAT CENT PHYS GUID C; *AM COLL PHYS, 2007, STAT EXP REF EXP ACC; *AM COLL PHYS, 2007, SYST NEED CHANG REST; *AM COLL PHYS, 2004, ENH QUAL PAT CAR INT; *AM COLL PHYS, 2005, COS DIR HLTH CAR HLT; *AM COLL PHYS, 2004, PAP MED OFF DIG TECH; *AM COLL PHYS AM S, 2000, TEL TRIAG; *AM COLL PHYS AM S, 2002, ACH AFF HLTH INS COV; *AM SOC INT MED, 1998, AM RED MAN CAR HASSL; *AM SOC INT MED, 1990, AM HLTH CAR SYST STR; Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American College of Physicians, 2006, CREAT NEW NAT WORKF; American College of Physicians, 2006, IMP COLL PRIM CAR ME; American College of Physicians, 2006, ADV MED HOM PAT CENT; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; Anell A, 2000, B WORLD HEALTH ORGAN, V78, P770; [Anonymous], 2007, US HLTH CARE SPENDIN; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Basu J, 2004, HEALTH SERV RES, V39, P489, DOI 10.1111/j.1475-6773.2004.00241.x; Betancourt JR, 2006, ACAD MED, V81, P788, DOI 10.1097/00001888-200609000-00004; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; *BNA, 2007, HLTH CAR DAIL REP; Bodenheimer T, 2005, ANN INTERN MED, V142, P932, DOI 10.7326/0003-4819-142-11-200506070-00012; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Borger C, 2006, HEALTH AFFAIR, V25, pW61, DOI 10.1377/hlthaff.25.w61; Braithwaite RS, 2007, ANN INTERN MED, V146, P133, DOI 10.7326/0003-4819-146-2-200701160-00008; *CDCP, 2007, LACK HLTH INS TYP CO; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT HIS; Clancy CM, 2006, HEALTH AFFAIR, V25, pW589, DOI 10.1377/hlthaff.25.w589; *COMM FUND COMM HI, 2006, FRAM HIGH PERF HLTH; CRIMMEL BL, 2006, 127 AG HEALTHC RES Q; *CTR MED MED SERV, 2008, MED YOU; *CTR MED MED SERV, 1960, OV NAT SCHIP POL SCH; *CTR MED MED SERV, NAT HTLH EXP AGGR PE; *CTR MED MED SERV, MED AT A GLAN 2005; *CTS MED MED SERV, NAT HLTH EXP ACC DEF; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Davis K, 2006, MIRROR MIRROR WALL U; Doty MM, 2005, SEEING RED AM DRIVEN; Dubay L, 2007, HEALTH AFFAIR, V26, pW22, DOI 10.1377/hlthaff.26.1.w22; *FAM US, 2007, FAM US PUBL; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; *I MED, 1983, MED ED SOC NEEDS PLA; *I MED, 2002, UN TREATM CONFR RAC; *I MED, 2004, NAT COMP INT ACH DIV; Iglehart JK, 1996, NEW ENGL J MED, V335, P1407, DOI 10.1056/NEJM199610313351821; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2005 A; LICHTENBERG FR, 2005, 2 CTR MED PROGR; Long JA, 2005, AM J PUBLIC HEALTH, V95, P2246, DOI 10.2105/AJPH.2004.061127; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; MERLIS M, 2006, COMMONWEALTH FUND PU, V887; *ORG EC COOP DEV, OECD HLTH DAT 2006; *ORG EC COOP DEV, JOINT OECD EUR WHO H; *ORG EC COOP DEV, 2006, TOT EXP PER CAP; PANANGALA SV, C RES SERVICE VETERA; PARCHMAN ML, 1994, J FAM PRACTICE, V39, P123; Powe NR, 2004, ANN INTERN MED, V141, P223, DOI 10.7326/0003-4819-141-3-200408030-00013; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; Rowland D, 2005, NEW ENGL J MED, V353, P1439, DOI 10.1056/NEJMp058063; SCHOEN C, 2005, HLTH AFF MILLWOOD S, DOI DOI 10.1377/HLTHAFF.W5.289; Schoen C, 2005, HLTH AFF MILLWOOD S; SCHOEN C, 2006, NATL SCORECARD US HL; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Shi L, 1992, J Health Care Poor Underserved, V3, P321; SHI LY, 1994, INT J HEALTH SERV, V24, P431, DOI 10.2190/BDUU-J0JD-BVEX-N90B; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; SOMMERS JP, 2007, 182 AG HEALTHC RES Q; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; The Commonwealth Fund Commission on a High Performance Health System, 2006, WHY NOT BEST RES NAT; *UN HLTH FDN, 2006, AM HLTH RANK CALL AC; *US BUR CENS, 2006, INC POV HLTH INS COV; *US DEP VET AFF, 2005, VA SPIN CORD INJ FAC; Vogel RL, 1998, INT J HEALTH SERV, V28, P183, DOI 10.2190/3B1X-EE5T-T7GR-KGUD; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; WILLIAMS B, 2004, WAITING MED EXPERIEN; Wilson JF, 2007, ANN INTERN MED, V146, P473, DOI 10.7326/0003-4819-146-6-200703200-00027; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Wu SY, 2000, PROJECTION CHRONIC I	98	91	93	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2008	148	1					55	75		10.7326/0003-4819-148-1-200801010-00196	http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00196			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	248JJ	18056654				2022-12-28	WOS:000252149300006
J	Schall, P; Weitz, DA; Spaepen, F				Schall, Peter; Weitz, David A.; Spaepen, Frans			Structural rearrangements that govern flow in colloidal glasses	SCIENCE			English	Article							METALLIC-GLASS; COMPUTER-SIMULATION; DEFORMATION; RELAXATION; TRANSITION; SUSPENSIONS; CRYSTALS; DYNAMICS	Structural rearrangements are an essential property of atomic and molecular glasses; they are critical in controlling resistance to flow and are central to the evolution of many properties of glasses, such as their heat capacity and dielectric constant. Despite their importance, these rearrangements cannot directly be visualized in atomic glasses. We used a colloidal glass to obtain direct three- dimensional images of thermally induced structural rearrangements in the presence of an applied shear. We identified localized irreversible shear transformation zones and determined their formation energy and topology. A transformation favored successive ones in its vicinity. Using continuum models, we elucidated the interplay between applied strain and thermal fluctuations that governs the formation of these zones in both colloidal and molecular glasses.	Univ Amsterdam, Van der Waals Zeeman Inst, NL-1018 XE Amsterdam, Netherlands; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	University of Amsterdam; Harvard University; Harvard University	Schall, P (corresponding author), Univ Amsterdam, Van der Waals Zeeman Inst, Valckenierstr 65, NL-1018 XE Amsterdam, Netherlands.	pschall@science.uva.nl						ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ARGON AS, 1979, MATER SCI ENG, V39, P101, DOI 10.1016/0025-5416(79)90174-5; Donati C, 1999, PHYS REV LETT, V82, P5064, DOI 10.1103/PhysRevLett.82.5064; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Heggen M, 2005, J APPL PHYS, V97, DOI 10.1063/1.1827344; KOBAYASHI S, 1980, ACTA METALL MATER, V28, P1641, DOI 10.1016/0001-6160(80)90017-6; Landau L. D., 1986, COURSE THEORETICAL P, V7; Lund AC, 2003, ACTA MATER, V51, P5399, DOI 10.1016/S1359-6454(03)00396-3; MAEDA K, 1981, PHILOS MAG A, V44, P643, DOI 10.1080/01418618108236167; MAEDA K, 1978, PHYS STATUS SOLIDI A, V49, P685, DOI 10.1002/pssa.2210490233; Maloney C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195501; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; Simeonova NB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035701; SOSHIRODA T, 1976, J NON-CRYST SOLIDS, V22, P173, DOI 10.1016/0022-3093(76)90017-X; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; SROLOVITZ D, 1983, ACTA METALL MATER, V31, P335, DOI 10.1016/0001-6160(83)90110-4; TAUB AI, 1980, ACTA METALL MATER, V28, P1781, DOI 10.1016/0001-6160(80)90031-0; van Megen W, 1998, PHYS REV E, V58, P6073, DOI 10.1103/PhysRevE.58.6073; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	24	442	456	7	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1895	1899		10.1126/science.1149308	http://dx.doi.org/10.1126/science.1149308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096800				2022-12-28	WOS:000251786600051
J	Kneller, EA; van Keken, PE				Kneller, Erik A.; van Keken, Peter E.			Trench-parallel flow and seismic anisotropy in the Mariana and Andean subduction systems	NATURE			English	Article							MANTLE FLOW; B-TYPE; PLATE; TEMPERATURE; BENEATH; CREEP	Shear- wave splitting measurements above the mantle wedge of the Mariana(1) and southern Andean(2,3) subduction zones show trench-parallel seismically fast directions close to the trench and abrupt rotations to trench- perpendicular anisotropy in the back arc. These patterns of seismic anisotropy may be caused by three-dimensional flow associated with along- strike variations in slab geometry(1-5). The Mariana and Andean subduction systems are associated with the largest along- strike variations of slab geometry observed on Earth(6,7) and are ideal for testing the link between slab geometry and solid- state creep processes in the mantle. Here we show, with fully three- dimensional non- newtonian subduction zone models, that the strong curvature of the Mariana slab and the transition to shallow slab dip in the Southern Andes give rise to strong trench- parallel stretching in the warm- arc and warm- back-arc mantle and to abrupt rotations in stretching directions that are accompanied by strong trench- parallel stretching. These models show that the patterns of shear- wave splitting observed in the Mariana and southern Andean systems may be caused by significant three- dimensional flow induced by along- strike variations in slab geometry.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kneller, EA (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	ekneller@umich.edu						ANDERSON M, UNPUB EARTH PLANET S; Anderson M, 2007, GEOPHYS J INT, V171, P419, DOI 10.1111/j.1365-246X.2007.03483.x; Anderson ML, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020906; Behn MD, 2007, SCIENCE, V317, P108, DOI 10.1126/science.1141269; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Cuvelier C., 1986, FINITE ELEMENT METHO; Fischer KM, 2000, J GEOPHYS RES-SOL EA, V105, P16181, DOI 10.1029/1999JB900441; Hall CE, 2000, J GEOPHYS RES-SOL EA, V105, P28009, DOI 10.1029/2000JB900297; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Honda S, 2003, EARTH PLANET SC LETT, V216, P703, DOI 10.1016/S0012-821X(03)00537-5; Kaminski E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000222; KANESHIMA S, 1995, PHYS EARTH PLANET IN, V88, P257, DOI 10.1016/0031-9201(94)02981-G; Karato SI, 2003, PHILOS MAG, V83, P401, DOI 10.1080/0141861021000025829; Katayama I, 2006, PHYS EARTH PLANET IN, V157, P33, DOI 10.1016/j.pepi.2006.03.005; Kendall JM, 2005, NATURE, V433, P146, DOI 10.1038/nature03161; Kneller EA, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004544; Kneller EA, 2005, EARTH PLANET SC LETT, V237, P781, DOI 10.1016/j.epsl.2005.06.049; KNELLER EA, IN PRESS GEOCHEM GEO; Lassak TM, 2006, EARTH PLANET SC LETT, V243, P632, DOI 10.1016/j.epsl.2006.01.022; Mehl L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002233; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; Park J, 2002, SCIENCE, V296, P485, DOI 10.1126/science.1067319; Pozgay SH, 2007, GEOPHYS J INT, V170, P371, DOI 10.1111/j.1365-246X.2007.03433.x; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; VANKEKEN PE, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI DOI 10.1029/2001DC000256; WIENS DA, 2003, GEOPHYS MONOGRAPH AM, V138, P8	27	106	107	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1222	U6		10.1038/nature06429	http://dx.doi.org/10.1038/nature06429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097407	Green Published			2022-12-28	WOS:000251786200048
J	Thewissen, JGM; Cooper, LN; Clementz, MT; Bajpai, S; Tiwari, BN				Thewissen, J. G. M.; Cooper, Lisa Noelle; Clementz, Mark T.; Bajpai, Sunil; Tiwari, B. N.			Whales originated from aquatic artiodactyls in the Eocene epoch of India	NATURE			English	Article							BONE-DENSITY; PHYLOGENETIC-RELATIONSHIPS; STABLE CARBON; TERRESTRIAL; MAMMALIA; CETACEANS; PAKISTAN; ANTHRACOTHERIIDAE; CETARTIODACTYLA; HIPPOPOTAMIDAE	Although the first ten million years of whale evolution are documented by a remarkable series of fossil skeletons, the link to the ancestor of cetaceans has been missing. It was known that whales are related to even- toed ungulates ( artiodactyls), but until now no artiodactyls were morphologically close to early whales. Here we show that the Eocene south Asian raoellid artiodactyls are the sister group to whales. The raoellid Indohyus is similar to whales, and unlike other artiodactyls, in the structure of its ears and premolars, in the density of its limb bones and in the stable- oxygen- isotope composition of its teeth. We also show that a major dietary change occurred during the transition from artiodactyls to whales and that raoellids were aquatic waders. This indicates that aquatic life in this lineage occurred before the origin of the order Cetacea.	Northeastern Ohio Univ Coll Med & Pharm, Dept Anat, Rootstown, OH 44272 USA; Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Wyoming; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG)	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu	Bajpai, Sunil/E-8416-2010	Thewissen, J. G. M./0000-0002-0973-4137				Bajpai Sunil, 2005, Journal of the Palaeontological Society of India, V50, P101; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Boisserie JR, 2005, ZOOL SCR, V34, P119, DOI 10.1111/j.1463-6409.2005.00183.x; Boisserie JR, 2005, P NATL ACAD SCI USA, V102, P1537, DOI 10.1073/pnas.0409518102; BRUNET M, 1968, CR ACAD SCI D NAT, V267, P835; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; COLBERT EH, 1938, AM MUS NAT HIST BULL, V74, P419; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; DOMNING DP, 1991, MAR MAMMAL SCI, V7, P331, DOI 10.1111/j.1748-7692.1991.tb00111.x; DUBOST G, 1978, MAMMALIA, V42, P1, DOI 10.1515/mamm.1978.42.1.1; Ducrocq Stephane, 1999, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V252, P93; Ducrocq Stephane, 1999, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V4, P199; FISH FE, 1991, ZOOMORPHOLOGY, V110, P339, DOI 10.1007/BF01668024; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Geisler JH, 2003, J VERTEBR PALEONTOL, V23, P991, DOI 10.1671/32; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; KAISER H.E., 1960, PALAEONTOGR ABT A, V114, P113; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kumar K., 1985, Journal of Vertebrate Paleontology, V5, P153; Lihoreau F, 2004, ZOOL SCR, V33, P97, DOI 10.1111/j.1463-6409.2004.00139.x; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Madar SI, 2007, J PALEONTOL, V81, P176, DOI 10.1666/0022-3360(2007)81[176:TPSOEE]2.0.CO;2; Milinkovitch MC, 1998, ADV VERT PALEOBIOL, P113; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nummela S, 2006, J VERTEBR PALEONTOL, V26, P746, DOI 10.1671/0272-4634(2006)26[746:CAOPCM]2.0.CO;2; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; Ranga Rao A., 1981, HIMAL GEOL, V11, P422; RAO AR, 1971, J GEOL SOC INDIA, V12, P125; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Suteethorn V., 1988, N JB GEOL PALAONT MH, V9, P563; Taylor Michael A., 2000, Historical Biology, V14, P15; Theodor Jessica M., 2005, Journal of Mammalian Evolution, V12, P161, DOI 10.1007/s10914-005-5706-6; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; WALL WP, 1983, J PALEONTOL, V57, P197; WEST RM, 1980, J PALEONTOL, V54, P508	48	217	241	13	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1190	U1		10.1038/nature06343	http://dx.doi.org/10.1038/nature06343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097400				2022-12-28	WOS:000251786200041
J	Lim, SS; Gaziano, TA; Gakidou, E; Reddy, KS; Farzadfar, F; Lozano, R; Rodgers, A				Lim, Stephen S.; Gaziano, Thomas A.; Gakidou, Emmanuela; Reddy, K. Srinath; Farzadfar, Farshad; Lozano, Rafael; Rodgers, Anthony			Chronic diseases 4 - Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs	LANCET			English	Article							CORONARY-HEART-DISEASE; LONG-TERM PERSISTENCE; MYOCARDIAL-INFARCTION; STATIN THERAPY; BLOOD-PRESSURE; ADHERENCE; INTERVENTIONS; SECONDARY; SURVIVAL; CHOLESTEROL	In 2005, a global goal of reducing chronic disease death rates by an additional 2% per year was established. Scaling up coverage of evidence-based interventions to prevent cardiovascular disease in high-risk individuals in low-income and middle-income countries could play a major part in reaching this goal. We aimed to estimate the number of deaths that could be averted and the financial cost of scaling up, above current coverage levels, a multidrug regimen for prevention of cardiovascular disease (a statin, aspirin, and two blood-pressure-lowering medicines) in 23 such countries. Identification of individuals was limited to those already accessing health services, and treatment eligibility was based on the presence of existing cardiovascular disease or absolute risk of cardiovascular disease by use of easily measurable risk factors. Over a 10-year period, scaling up this multidrug regimen could avert 17.9 million deaths from cardiovascular disease (95% uncertainty interval 7.4 million-25.7 million). 56% of deaths averted would be in those younger than 70 years, with more deaths averted in women than in men owing to larger absolute numbers of women at older ages. The 10-year financial cost would be US$47 billion ($33 billion-$61 billion) or an average yearly cost per head of $1.08 ($0.75-1.40), ranging from $0.43 to $0. 90 across low-income countries and from $0.54 to $2.93 across middle-income countries. This package could effectively meet three-quarters of the proposed global goal with a moderate increase in health expenditure.	Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA USA; Publ Hlth Fdn India, New Delhi, India; All India Inst Med Serv, Dept Cardiol, New Delhi, India; Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; Minist Hlth, Mexico City, DF, Mexico; Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Clin Trials Res Unit, Auckland 1, New Zealand	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Public Health Foundation of India; All India Institute of Medical Sciences (AIIMS) New Delhi; Harvard University; Harvard T.H. Chan School of Public Health; University of Auckland	Lim, SS (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98102 USA.	stevelim@u.washington.edu	Lozano, Rafael/T-5352-2018; Lim, Stephen S/B-4055-2012	Lozano, Rafael/0000-0002-7356-8823; Rodgers, Anthony/0000-0003-1282-1896; Farzadfar, Farshad/0000-0001-8288-4046				Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], WHO GLOB INFOBASE; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bovet P, 2002, B WORLD HEALTH ORGAN, V80, P33; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Egger M, 2005, INT J EPIDEMIOL, V34, P509, DOI 10.1093/ije/dyi110; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ezzati M., 2004, COMP QUANTIFICATION; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Gutierrez JP, 2004, LANCET, V364, P63, DOI 10.1016/S0140-6736(04)16590-2; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Kopjar B, 2003, AM J CARDIOL, V92, P1106, DOI 10.1016/j.amjcard.2003.07.008; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; LAWES C, 2004, COMP QUANTIFICATION, pCH7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; *MAN SCI HLTH, INT DRUG PRIC IND; Mantel-Teeuwisse AK, 2004, HEART, V90, P1065, DOI 10.1136/hrt.2003.026187; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; MENDIS S, 2007, B WORLD HEALTH ORGAN, V58, P279; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ranson MK, 2003, J INT DEV J DEV STUD, V15, P15, DOI DOI 10.1002/JID.964; Reddy KS, 2007, NEW ENGL J MED, V356, P212, DOI 10.1056/NEJMp068219; Rodgers A., 2004, COMP QUANTIFICATION; Schedlbauer A, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004371.PUB2; Schroeder K, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004804; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Turnbull F, 2003, LANCET, V362, P1527; UNAIDS, 2006, RES NEEDS EXP RESP A; *UNAIDS, 2005, RES NEEDS EXP RESP A; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; *WHO, 2005, HLTHH MILL DEV GOALS; *WHO, WORLD HLTH SURV RES; *WHO, 2002, GLOB BURD DIS; *WHO, CHOOS INT THHAT AR C; Williams B, 2006, LANCET, V368, P6, DOI 10.1016/S0140-6736(06)68943-5; Woodward M, 2003, DIABETES CARE, V26, P360; World Health Organization, 2006, GLOB PLAN STOP TB 20; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3	60	256	271	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2054	2062		10.1016/S0140-6736(07)61699-7	http://dx.doi.org/10.1016/S0140-6736(07)61699-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18063025				2022-12-28	WOS:000251698600032
J	Bieling, P; Laan, L; Schek, H; Munteanu, EL; Sandblad, L; Dogterom, M; Brunner, D; Surrey, T				Bieling, Peter; Laan, Liedewij; Schek, Henry; Munteanu, E. Laura; Sandblad, Linda; Dogterom, Marileen; Brunner, Damian; Surrey, Thomas			Reconstitution of a microtubule plus-end tracking system in vitro	NATURE			English	Article							FISSION YEAST; PROTEINS; DYNAMICS; EB1; KINESIN; BINDING; TIP1P; MECHANISMS; MOVEMENT; BEHAVIOR	The microtubule cytoskeleton is essential to cell morphogenesis. Growing microtubule plus ends have emerged as dynamic regulatory sites in which specialized proteins, called plus- end- binding proteins ( + TIPs), bind and regulate the proper functioning of microtubules(1-4). However, the molecular mechanism of plus- end association by + TIPs and their ability to track the growing end are not well understood. Here we report the in vitro reconstitution of a minimal plus- end tracking system consisting of the three fission yeast proteins Mal3, Tip1 and the kinesin Tea2. Using time- lapse total internal reflection fluorescence microscopy, we show that the EB1 homologue Mal3 has an enhanced affinity for growing microtubule end structures as opposed to the microtubule lattice. This allows it to track growing microtubule ends autonomously by an end recognition mechanism. In addition, Mal3 acts as a factor that mediates loading of the processive motor Tea2 and its cargo, the Clip170 homologue Tip1, onto the microtubule lattice. The interaction of all three proteins is required for the selective tracking of growing microtubule plus ends by both Tea2 and Tip1. Our results dissect the collective interactions of the constituents of this plus-end tracking system and show how these interactions lead to the emergence of its dynamic behaviour. We expect that such in vitro reconstitutions will also be essential for the mechanistic dissection of other plus- end tracking systems.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	European Molecular Biology Laboratory (EMBL); AMOLF	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dogterom@amolf.nl; brunner@embl.de; surrey@embl.de	Surrey, Thomas/AAC-4608-2021; Brunner, Damian/F-2024-2011	Laan, Liedewij/0000-0002-7138-9004; Surrey, Thomas/0000-0001-9082-1870; Bieling, Peter/0000-0002-7458-4358; Brunner, Damian/0000-0001-5250-492X				Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Brunner D, 2000, PHILOS T ROY SOC B, V355, P873, DOI 10.1098/rstb.2000.0622; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Ding DQ, 1998, J CELL SCI, V111, P701; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lata S, 2005, ANAL CHEM, V77, P1096, DOI 10.1021/ac048813j; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Ohkura H, 2001, J CELL SCI, V114, P3805; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2005, CURR BIOL, V15, pR126, DOI 10.1016/j.cub.2005.02.010	30	334	340	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1100	1105		10.1038/nature06386	http://dx.doi.org/10.1038/nature06386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18059460				2022-12-28	WOS:000251579900091
J	Enthoven, AC; van de Ven, WPMM				Enthoven, Alain C.; van de Ven, Wynand P. M. M.			Going dutch - Managed-competition health insurance in the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONSUMER-CHOICE; PROPOSAL; PLAN		Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; Erasmus Univ, Dept Hlth Policy & Management, Rotterdam, Netherlands	Stanford University; Erasmus University Rotterdam	Enthoven, AC (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.							*COMM EC DEV, 2007, QUAL AFF HLTH CAR AL; ENTHOVEN AC, 1978, NEW ENGL J MED, V298, P709, DOI 10.1056/NEJM197803302981304; ENTHOVEN AC, 1978, NEW ENGL J MED, V298, P650, DOI 10.1056/NEJM197803232981204; Palmisano DJ, 2004, JAMA-J AM MED ASSOC, V291, P2237, DOI 10.1001/jama.291.18.2237; Rittenhouse DR, 2004, HEALTH AFFAIR, V23, P51, DOI 10.1377/hlthaff.23.6.51; Shortell S. M., 2004, 21 CENTURY HLTH SYST	6	119	119	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2421	2423		10.1056/NEJMp078199	http://dx.doi.org/10.1056/NEJMp078199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240CK	18077805				2022-12-28	WOS:000251564400001
J	Ryan, R; Brophy, DP				Ryan, Ronan; Brophy, David P.			Occlusion and reperfusion of the middle cerebral artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Vincents Univ Hosp, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital	Ryan, R (corresponding author), St Vincents Univ Hosp, Dublin 4, Ireland.	ronan.ryan@st-vincents.ie							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2495	2495		10.1056/NEJMicm066750	http://dx.doi.org/10.1056/NEJMicm066750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077813				2022-12-28	WOS:000251564400011
J	Feng, L; Yan, HC; Wu, ZR; Yan, N; Wang, Z; Jeffrey, PD; Shi, YG				Feng, Liang; Yan, Hanchi; Wu, Zhuoru; Yan, Nieng; Wang, Zhe; Jeffrey, Philip D.; Shi, Yigong			Structure of a site-2 protease family intramembrane metalloprotease	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTEOLYSIS; CLEAVAGE; MECHANISM; SREBPS; THERMOLYSIN; PROTEINS	Regulated intramembrane proteolysis by members of the site- 2 protease (S2P) family is an important signaling mechanism conserved from bacteria to humans. Here we report the crystal structure of the transmembrane core domain of an S2P metalloprotease from Methanocaldococcus jannaschii. The protease consists of six transmembrane segments, with the catalytic zinc atom coordinated by two histidine residues and one aspartate residue similar to 14 angstroms into the lipid membrane surface. The protease exhibits two distinct conformations in the crystals. In the closed conformation, the active site is surrounded by transmembrane helices and is impermeable to substrate peptide; water molecules gain access to zinc through a polar, central channel that opens to the cytosolic side. In the open conformation, transmembrane helices alpha 1 and alpha 6 separate from each other by 10 to 12 angstroms, exposing the active site to substrate entry. The structure reveals how zinc embedded in an integral membrane protein can catalyze peptide cleavage.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada	Princeton University; University of British Columbia	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Yan, Hanchi/E-3639-2010	Yan, Hanchi/0000-0003-1055-5459; Jeffrey, Philip/0000-0002-4351-5341; Shi, Yigong/0000-0003-2030-168X				Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; English AC, 1999, PROTEINS, V37, P628, DOI 10.1002/(SICI)1097-0134(19991201)37:4<628::AID-PROT13>3.0.CO;2-G; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lewis AP, 1999, PROTEIN SCI, V8, P439; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2002, ESSAYS BIOCHEM, V38, P155, DOI 10.1042/bse0380155; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000	31	178	181	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1608	1612		10.1126/science.1150755	http://dx.doi.org/10.1126/science.1150755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063795				2022-12-28	WOS:000251421700041
J	O'Farrell, N; Moodley, P; Sturm, AW				O'Farrell, Nigel; Moodley, Prashini; Sturm, A. Wim			Genital herpes in Africa: time to rethink treatment	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLEX-VIRUS; WOMEN; ACYCLOVIR; INFECTION; REACTIVATION; PREVALENCE; THERAPY; IMPACT; SPREAD		[O'Farrell, Nigel] Ealing Gen Hosp, London UB1 3HW, England; [Moodley, Prashini; Sturm, A. Wim] Univ KwaZulu Natal, Nelson Mandela Sch Med, Dept Med Microbiol, Durban, South Africa	Imperial College London; University of Kwazulu Natal	O'Farrell, N (corresponding author), Ealing Gen Hosp, Pasteur Suite,Uxbridge Rd, London UB1 3HW, England.	nigel.ofarrell@lshtm.ac.uk						Aoki FY, 2006, CLIN INFECT DIS, V42, P8, DOI 10.1086/498521; Blower S, 2004, J INFECT DIS, V190, P1610, DOI 10.1086/424850; BROCK BV, 1990, JAMA-J AM MED ASSOC, V263, P418, DOI 10.1001/jama.263.3.418; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; COREY L, 1986, NEW ENGL J MED, V314, P686, DOI 10.1056/NEJM198603133141105; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; KOELLE DM, 1992, ANN INTERN MED, V116, P433, DOI 10.7326/0003-4819-116-6-433; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; LANGENBERG A, 1989, ANN INTERN MED, V110, P882, DOI 10.7326/0003-4819-110-11-882; Levin MJ, 2004, CLIN INFECT DIS, V39, pS248, DOI 10.1086/422364; MAYAUD P, 2006, ANRS SAT S TOR 15 AU; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; O'Farrell N, 1999, SEX TRANSM INFECT, V75, P377, DOI 10.1136/sti.75.6.377; O'Farrell N, 2006, SEX TRANSM DIS, V33, P558, DOI 10.1097/01.olq.0000216033.00860.1b; OFARRELL N, 2005, 16 BIENN M INT SOC S; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; REICHMAN RC, 1984, JAMA-J AM MED ASSOC, V251, P2103, DOI 10.1001/jama.251.16.2103; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Spruance SL, 1996, ARCH INTERN MED, V156, P1729, DOI 10.1001/archinte.156.15.1729; STIGMA, 2019, GUID MAN SEX TRANSM; Trollope-Kumar K, 2006, LANCET, V367, P1380, DOI 10.1016/S0140-6736(06)68593-0; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, CLIN INFECT DIS, V34, P944, DOI 10.1086/339325; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; White PJ, 1999, SEX TRANSM INFECT, V75, P49, DOI 10.1136/sti.75.1.49; Williams JR, 2007, SEX TRANSM DIS, V34, P123, DOI 10.1097/01.olq.0000258486.81492.a2	29	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2164	2166		10.1016/S0140-6736(07)61910-2	http://dx.doi.org/10.1016/S0140-6736(07)61910-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156037				2022-12-28	WOS:000252058600038
J	Trinkle-Mulcahy, L; Lamond, AI				Trinkle-Mulcahy, Laura; Lamond, Angus I.			Toward a high-resolution view of nuclear dynamics	SCIENCE			English	Review							IN-VIVO; PROTEOMIC ANALYSIS; PROTEIN DYNAMICS; GENE-EXPRESSION; PORE COMPLEX; LIVING CELLS; CHROMATIN; RNA; VISUALIZATION; STABILITY	The nucleus is the defining feature of eukaryotic cells. It is a highly dynamic, membrane-bound organelle that encloses chromatin and thereby partitions gene transcription from sites of protein translation in the cytoplasm. Major cellular events, including DNA replication, messenger RNA synthesis and processing, and ribosome subunit biogenesis, take place within the nucleus, resulting in a continuous flux of macromolecules into and out of the nucleus through dedicated nuclear pore complexes in the nuclear envelope. Here, we review the impact of new technologies, especially in areas of fluorescence microscopy and proteomics, which are providing major insights into dynamic processes affecting both structure and function within the nucleus.	Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Trinkle-Mulcahy, L (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	l.trinklemulcahy@dundee.ac.uk	Trinkle-Mulcahy, Laura/E-2197-2013	Lamond, Angus/0000-0001-6204-6045	Wellcome Trust [073980] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Angelier N, 2005, MOL BIOL CELL, V16, P2862, DOI 10.1091/mbc.e05-01-0041; Archambault V, 2005, EXPERT REV PROTEOMIC, V2, P615, DOI 10.1586/14789450.2.4.615; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Jackson Dean A., 2005, Briefings in Functional Genomics & Proteomics, V4, P143, DOI 10.1093/bfgp/4.2.143; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lamond AI, 2003, CURR BIOL, V13, pR825, DOI 10.1016/j.cub.2003.10.012; Le Guezennec X, 2005, BJU INT, V96, P16, DOI 10.1111/j.1464-410X.2005.05942.x; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Mone MJ, 2004, P NATL ACAD SCI USA, V101, P15933, DOI 10.1073/pnas.0403664101; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rodriguez Patrick, 2006, V338, P305; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Shav-Tal Y, 2006, EMBO J, V25, P3469, DOI 10.1038/sj.emboj.7601226; Sleeman J, 2007, J CELL SCI, V120, P1540, DOI 10.1242/jcs.001529; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Tyagi S, 2007, NAT METHODS, V4, P391, DOI 10.1038/nmeth0507-391; Yang WD, 2006, METHODS, V39, P316, DOI 10.1016/j.ymeth.2006.06.002	52	48	50	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1402	1407		10.1126/science.1142033	http://dx.doi.org/10.1126/science.1142033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048679				2022-12-28	WOS:000251246100033
J	Hayden, LA; Watson, EB				Hayden, Leslie A.; Watson, E. Bruce			A diffusion mechanism for core-mantle interaction	NATURE			English	Article							GRAIN-BOUNDARIES; CONSTRAINTS; EARTH	Understanding the geochemical behaviour of the siderophile elements - those tending to form alloys with iron in natural environments - is important in the search for a deep-mantle chemical 'fingerprint' in upper mantle rocks, and also in the evaluation of models of large-scale differentiation of the Earth and terrestrial planets. These elements are highly concentrated in the core relative to the silicate mantle, but their concentrations in upper mantle rocks are higher than predicted by most core-formation models(1,2). It has been suggested that mixing of outer-core material back into the mantle following core formation may be responsible for the siderophile element ratios observed in upper mantle rocks(3). Such re-mixing has been attributed to an unspecified metal - silicate interaction in the reactive D" layer just above the core - mantle boundary(4). The siderophile elements are excellent candidates as indicators of an outer-core contribution to the mantle, but the nature and existence of possible core - mantle interactions is controversial(5). In light of the recent findings that grain-boundary diffusion of oxygen through a dry intergranular medium may be effective over geologically significant length scales(6) and that grain boundaries can be primary storage sites for incompatible lithophile elements(7), the question arises as to whether siderophile elements might exhibit similar (or greater) grain-boundary mobility. Here we report experimental results from a study of grain-boundary diffusion of siderophile elements through polycrystalline MgO that were obtained by quantifying the extent of alloy formation between initially pure metals separated by similar to 1 mm of polycrystalline MgO. Grain-boundary diffusion resulted in significant alloying of sink and source particles, enabling calculation of grain-boundary fluxes. Our computed diffusivities were high enough to allow transport of a number of siderophile elements over geologically significant length scales (tens of kilometres) over the age of the Earth. This finding establishes grain-boundary diffusion as a potential fast pathway for chemical communication between the core and mantle.	Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Hayden, LA (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA.	haydel@rpi.edu						Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Brandon AD, 1998, SCIENCE, V280, P1570, DOI 10.1126/science.280.5369.1570; FARVER JR, 1991, GEOCHIM COSMOCHIM AC, V55, P1597, DOI 10.1016/0016-7037(91)90131-N; FISHER JC, 1951, J APPL PHYS, V22, P74, DOI 10.1063/1.1699825; HARRISON LG, 1961, T FARADAY SOC, V57, P1191, DOI 10.1039/tf9615701191; Hiraga T, 2004, NATURE, V427, P699, DOI 10.1038/nature02259; Hiraga T, 2003, AM MINERAL, V88, P1015, DOI 10.2138/am-2003-0709; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; Kingery WD, 1976, INTRO CERAMICS, P250; RICOULT DL, 1983, PHYS CHEM MINER, V9, P133, DOI 10.1007/BF00308370; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; SUTTON AP, 1995, INTERFACES CRYSTALLI, P305; Van Orman JA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016343; Walker R.J., 2005, EOS, V86, P237; WATSON EB, 2002, EOS S, V83	16	58	59	5	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					709	U6		10.1038/nature06380	http://dx.doi.org/10.1038/nature06380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046408				2022-12-28	WOS:000251209700051
J	Rensing, SA; Lang, D; Zimmer, AD; Terry, A; Salamov, A; Shapiro, H; Nishiyama, T; Perroud, PF; Lindquist, EA; Kamisugi, Y; Tanahashi, T; Sakakibara, K; Fujita, T; Oishi, K; Shin-I, T; Kuroki, Y; Toyoda, A; Suzuki, Y; Hashimoto, S; Yamaguchi, K; Sugano, S; Kohara, Y; Fujiyama, A; Anterola, A; Aoki, S; Ashton, N; Barbazuk, WB; Barker, E; Bennetzen, JL; Blankenship, R; Cho, SH; Dutcher, SK; Estelle, M; Fawcett, JA; Gundlach, H; Hanada, K; Heyl, A; Hicks, KA; Hughes, J; Lohr, M; Mayer, K; Melkozernov, A; Murata, T; Nelson, DR; Pils, B; Prigge, M; Reiss, B; Renner, T; Rombauts, S; Rushton, PJ; Sanderfoot, A; Schween, G; Shiu, SH; Stueber, K; Theodoulou, FL; Tu, H; Van de Peer, Y; Verrier, PJ; Waters, E; Wood, A; Yang, LX; Cove, D; Cuming, AC; Hasebe, M; Lucas, S; Mishler, BD; Reski, R; Grigoriev, IV; Quatrano, RS; Boore, JL				Rensing, Stefan A.; Lang, Daniel; Zimmer, Andreas D.; Terry, Astrid; Salamov, Asaf; Shapiro, Harris; Nishiyama, Tomoaki; Perroud, Pierre-Francois; Lindquist, Erika A.; Kamisugi, Yasuko; Tanahashi, Takako; Sakakibara, Keiko; Fujita, Tomomichi; Oishi, Kazuko; Shin-I, Tadasu; Kuroki, Yoko; Toyoda, Atsushi; Suzuki, Yutaka; Hashimoto, Shin-ichi; Yamaguchi, Kazuo; Sugano, Sumio; Kohara, Yuji; Fujiyama, Asao; Anterola, Aldwin; Aoki, Setsuyuki; Ashton, Neil; Barbazuk, W. Brad; Barker, Elizabeth; Bennetzen, Jeffrey L.; Blankenship, Robert; Cho, Sung Hyun; Dutcher, Susan K.; Estelle, Mark; Fawcett, Jeffrey A.; Gundlach, Heidrun; Hanada, Kousuke; Heyl, Alexander; Hicks, Karen A.; Hughes, Jon; Lohr, Martin; Mayer, Klaus; Melkozernov, Alexander; Murata, Takashi; Nelson, David R.; Pils, Birgit; Prigge, Michael; Reiss, Bernd; Renner, Tanya; Rombauts, Stephane; Rushton, Paul J.; Sanderfoot, Anton; Schween, Gabriele; Shiu, Shin-Han; Stueber, Kurt; Theodoulou, Frederica L.; Tu, Hank; Van de Peer, Yves; Verrier, Paul J.; Waters, Elizabeth; Wood, Andrew; Yang, Lixing; Cove, David; Cuming, Andrew C.; Hasebe, Mitsuyasu; Lucas, Susan; Mishler, Brent D.; Reski, Ralf; Grigoriev, Igor V.; Quatrano, Ralph S.; Boore, Jeffrey L.			The Physcomitrella genome reveals evolutionary insights into the conquest of land by plants	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; OSMOTIC-STRESS; ABSCISIC-ACID; PATENS; GENE; REPAIR; SALT; CONSEQUENCES; DUPLICATION; ARABIDOPSIS	We report the draft genome sequence of the model moss Physcomitrella patens and compare its features with those of flowering plants, from which it is separated by more than 400 million years, and unicellular aquatic algae. This comparison reveals genomic changes concomitant with the evolutionary movement to land, including a general increase in gene family complexity; loss of genes associated with aquatic environments ( e. g., flagellar arms); acquisition of genes for tolerating terrestrial stresses ( e. g., variation in temperature and water availability); and the development of the auxin and abscisic acid signaling pathways for coordinating multicellular growth and dehydration response. The Physcomitrella genome provides a resource for phylogenetic inferences about gene function and for experimental analysis of plant processes through this plant's unique facility for reverse genetics.	[Perroud, Pierre-Francois; Blankenship, Robert; Cho, Sung Hyun; Cove, David; Quatrano, Ralph S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Rensing, Stefan A.; Lang, Daniel; Zimmer, Andreas D.; Schween, Gabriele; Reski, Ralf] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Terry, Astrid; Lucas, Susan] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Terry, Astrid; Lucas, Susan] Lawrence Livermore Natl Lab, Walnut Creek, CA 94598 USA; [Salamov, Asaf; Shapiro, Harris; Lindquist, Erika A.; Tu, Hank; Grigoriev, Igor V.; Boore, Jeffrey L.] Lawrence Berkeley Lab, Walnut Creek, CA 94598 USA; [Nishiyama, Tomoaki; Yamaguchi, Kazuo] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9200934, Japan; [Kamisugi, Yasuko; Cove, David; Cuming, Andrew C.] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Tanahashi, Takako; Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Tanahashi, Takako; Murata, Takashi; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Sakakibara, Keiko] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Fujita, Tomomichi] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Oishi, Kazuko; Shin-I, Tadasu; Kohara, Yuji] Natl Inst Genet, Ctr Genet Resource Informat, Genome Biol Lab, Mishima, Shizuoka 4118540, Japan; [Kuroki, Yoko; Toyoda, Atsushi; Fujiyama, Asao] RIKEN, Genom Sci Ctr, Kanagawa 2300045, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Tokyo 1088639, Japan; [Hashimoto, Shin-ichi] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 1138654, Japan; [Yamaguchi, Kazuo] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Kohara, Yuji] Grad Univ Adv Studies, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Fujiyama, Asao] Natl Inst Informat, Tokyo 1018403, Japan; [Fujiyama, Asao] Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Informat, Tokyo 1018403, Japan; [Anterola, Aldwin; Wood, Andrew] So Illinois Univ, Dept Plant Biol, Carbondale, IL 62901 USA; [Aoki, Setsuyuki] Nagoya Univ, Grad Sch Informat Sci, Life Sci Informat Unit, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ashton, Neil; Barker, Elizabeth] Univ Regina, Regina, SK S4S 0A2, Canada; [Barbazuk, W. Brad] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Bennetzen, Jeffrey L.; Yang, Lixing] Univ Georgia, Dept Genet, Davison Life Sci Complex, Athens, GA 30602 USA; [Dutcher, Susan K.] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Estelle, Mark; Prigge, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Fawcett, Jeffrey A.; Rombauts, Stephane; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Gundlach, Heidrun; Mayer, Klaus] GSF Res Ctr Environm & Hlth, MIPS IBI Inst Bioinformat, D-85764 Neuherberg, Germany; [Hanada, Kousuke; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Hanada, Kousuke] RIKEN, Plant Sci Ctr, Kanagawa 2300045, Japan; [Heyl, Alexander] Free Univ Berlin, Inst Biol, Appl Genet Neubau, D-14195 Berlin, Germany; [Hicks, Karen A.; Reiss, Bernd; Stueber, Kurt] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Hicks, Karen A.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Hughes, Jon] Univ Giessen, D-35390 Giessen, Germany; [Lohr, Martin] Johannes Gutenberg Univ Mainz, Inst Gen Bot, D-55099 Mainz, Germany; [Melkozernov, Alexander] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Nelson, David R.] Univ Tennessee, Memphis, TN 38163 USA; [Pils, Birgit; Waters, Elizabeth] Univ Wurzburg, Biozentrum, Dept Bioinformat, D-97074 Wurzburg, Germany; [Renner, Tanya] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rushton, Paul J.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Sanderfoot, Anton] Univ Minnesota, Dept Plant Biol, Biol Sci Ctr 250, St Paul, MN 55108 USA; [Theodoulou, Frederica L.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England; [Verrier, Paul J.] Rothamsted Res, Biomath & Bioinformat Dept, Harpenden AL5 2JQ, Herts, England; [Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Mishler, Brent D.; Boore, Jeffrey L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA	Washington University (WUSTL); University of Freiburg; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Kanazawa University; University of Leeds; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Monash University; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; University of Tokyo; University of Tokyo; Kanazawa University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Graduate University for Advanced Studies - Japan; Southern Illinois University System; Southern Illinois University; Nagoya University; University of Regina; Donald Danforth Plant Science Center; University System of Georgia; University of Georgia; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Flanders Institute for Biotechnology (VIB); Ghent University; Michigan State University; RIKEN; Free University of Berlin; Max Planck Society; Kenyon College; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz; Arizona State University; Arizona State University-Tempe; University of Tennessee System; University of Tennessee Health Science Center; University of Wurzburg; California State University System; San Diego State University; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Japan Science & Technology Agency (JST); University of California System; University of California Berkeley	Quatrano, RS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	rsq@wustl.edu	Hanada, Kousuke/O-2954-2018; Rombauts, Stephane/P-2420-2019; Estelle, Mark/ABD-6742-2021; Terry, Astrid Y/A-2538-2011; Lang, Daniel/C-7238-2008; Schmutz, Jeremy/N-3173-2013; Van de Peer, Yves/D-4388-2009; Yang, Lixing/A-7073-2013; Fawcett, Jeffrey/B-4145-2008; Heyl, Alexander/ABD-2145-2020; Rombauts, Stephane M/D-7640-2014; Shiu, Shin-Han/R-6117-2016; Van de Peer, Yves/AAE-7666-2019; Lohr, Martin/A-1214-2009; Reski, Ralf/A-8817-2008; Lang, Daniel/M-5597-2019; Mayer, Klaus FX/M-7941-2015; Sakakibara, Keiko/Q-5748-2018	Hanada, Kousuke/0000-0001-8854-4261; Rombauts, Stephane/0000-0002-3985-4981; Terry, Astrid Y/0000-0002-5234-1224; Lang, Daniel/0000-0002-2166-0716; Schmutz, Jeremy/0000-0001-8062-9172; Van de Peer, Yves/0000-0003-4327-3730; Rombauts, Stephane M/0000-0002-3985-4981; Shiu, Shin-Han/0000-0001-6470-235X; Van de Peer, Yves/0000-0003-4327-3730; Lohr, Martin/0000-0002-4335-9887; Lang, Daniel/0000-0002-2166-0716; Mayer, Klaus FX/0000-0001-6484-1077; Sakakibara, Keiko/0000-0003-4420-9351; Fawcett, Jeffrey/0000-0003-3907-2135; Nelson, David/0000-0003-0583-5421; Hasebe, Mitsuyasu/0000-0001-7425-8758; Zimmer, Andreas/0000-0002-5595-9388; Prigge, Michael/0000-0003-0671-2538; Grigoriev, Igor/0000-0002-3136-8903; Murata, Takashi/0000-0002-1543-0439; Hicks, Karen/0000-0003-2785-0614; Barbazuk, William/0000-0002-0909-4563; Sanderfoot, Anton/0000-0003-3660-7632; Wood, Andrew/0000-0001-8113-4120; Gundlach, Heidrun/0000-0002-6757-0943; Reski, Ralf/0000-0002-5496-6711; Theodoulou, Frederica/0000-0002-8306-0716; Nishiyama, Tomoaki/0000-0003-1279-7806; Renner, Tanya/0000-0003-0442-0056	BBSRC [BBS/E/C/00004948] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004948] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Kamisugi Y, 2006, NUCLEIC ACIDS RES, V34, P6205, DOI 10.1093/nar/gkl832; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kelch DG, 2004, MONOG SYST BOTAN, V98, P3; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Liang L, 2006, PLANT MOL BIOL, V61, P345, DOI 10.1007/s11103-006-0016-9; Llorca O, 2007, CURR OPIN STRUC BIOL, V17, P215, DOI 10.1016/j.sbi.2007.03.009; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Markmann-Mulisch U, 2002, P NATL ACAD SCI USA, V99, P2959, DOI 10.1073/pnas.032668199; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Oliver MJ, 2005, INTEGR COMP BIOL, V45, P788, DOI 10.1093/icb/45.5.788; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Quatrano RS, 2007, CURR OPIN PLANT BIOL, V10, P182, DOI 10.1016/j.pbi.2007.01.005; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Sztein AE, 1999, AM J BOT, V86, P1544, DOI 10.2307/2656792; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vitte C, 2006, P NATL ACAD SCI USA, V103, P17638, DOI 10.1073/pnas.0605618103; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Zamora I, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-15; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	35	1349	1489	11	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					64	69		10.1126/science.1150646	http://dx.doi.org/10.1126/science.1150646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18079367	Green Submitted, Green Published			2022-12-28	WOS:000252084000030
J	Hilairet, N; Reynard, B; Wang, YB; Daniel, I; Merkel, S; Nishiyama, N; Petitgirard, S				Hilairet, Nadege; Reynard, Bruno; Wang, Yanbin; Daniel, Isabelle; Merkel, Sebastien; Nishiyama, Norimasa; Petitgirard, Sylvain			High-pressure creep of serpentine, interseismic deformation, and initiation of subduction	SCIENCE			English	Article							HYDROUS MINERALS; MANTLE; ZONE; EARTHQUAKE; OLIVINE; ROCKS; FLOW; LAW	The supposed low viscosity of serpentine may strongly influence subduction- zone dynamics at all time scales, but until now its role could not be quantified because measurements relevant to intermediate- depth settings were lacking. Deformation experiments on the serpentine antigorite at high pressures and temperatures ( 1 to 4 gigapascals, 200 degrees to 500 degrees C) showed that the viscosity of serpentine is much lower than that of the major mantle- forming minerals. Regardless of the temperature, low- viscosity serpentinized mantle at the slab surface can localize deformation, impede stress buildup, and limit the downdip propagation of large earthquakes at subduction zones. Antigorite enables viscous relaxation with characteristic times comparable to those of long- term postseismic deformations after large earthquakes and slow earthquakes. Antigorite viscosity is sufficiently low to make serpentinized faults in the oceanic lithosphere a site for subduction initiation.	Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Lab Sci Terre, F-69364 Lyon 07, France; Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; Univ Sci & Tech Lille Flandres Artois, Lab Struct & Proprietes Etat Solide, CNRS, UMR 8008, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Chicago; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Hilairet, N (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Lab Sci Terre, 46 Allee Italie, F-69364 Lyon 07, France.	nadege.hilairet@ens-lyon.fr	Merkel, Sébastien/E-5501-2011; Nishiyama, Norimasa/U-8670-2018; Daniel, Isabelle/D-2677-2012; Hilairet, Nadege/F-6245-2011; Nishiyama, Norimasa/A-7627-2016; Reynard, Bruno/C-8301-2012	Merkel, Sébastien/0000-0003-2767-581X; Nishiyama, Norimasa/0000-0001-6214-0875; Daniel, Isabelle/0000-0002-1448-7919; Hilairet, Nadege/0000-0002-5652-9128; Reynard, Bruno/0000-0002-4782-6163; Wang, Yanbin/0000-0001-5716-3183				Abers GA, 2005, PHYS EARTH PLANET IN, V149, P7, DOI 10.1016/j.pepi.2004.10.002; Auzende AL, 2002, EUR J MINERAL, V14, P905, DOI 10.1127/0935-1221/2002/0014-0905; Christensen NI, 2004, INT GEOL REV, V46, P795, DOI 10.2747/0020-6814.46.9.795; Conder JA, 2005, PHYS EARTH PLANET IN, V149, P155, DOI 10.1016/j.pepi.2004.08.018; Dimanov A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003431; Escartin J, 1997, J GEOPHYS RES-SOL EA, V102, P2897, DOI 10.1029/96JB02792; Freed AM, 2004, NATURE, V430, P548, DOI 10.1038/nature02784; FYFE WS, 1975, AM J SCI, VA275, P285; Gerya TV, 2002, TECTONICS, V21, DOI 10.1029/2002TC001406; Hilairet N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024728; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; KARATO S, 1993, J GEOPHYS RES-SOL EA, V98, P9761, DOI 10.1029/93JB00472; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; MURRELL SAF, 1976, TECTONOPHYSICS, V31, P207, DOI 10.1016/0040-1951(76)90120-7; Peacock SM, 1999, GEOPHYS RES LETT, V26, P2517, DOI 10.1029/1999GL900558; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Raterron P, 2004, PHYS EARTH PLANET IN, V145, P149, DOI 10.1016/j.pepi.2004.03.007; Regenauer-Lieb K, 2001, SCIENCE, V294, P578, DOI 10.1126/science.1063891; RUTTER EH, 1988, J GEOPHYS RES-SOLID, V93, P4907, DOI 10.1029/JB093iB05p04907; Rydelek PA, 2003, EARTH PLANET SC LETT, V206, P289, DOI 10.1016/S0012-821X(02)01095-6; Seno T, 2005, EARTH PLANET SC LETT, V231, P249, DOI 10.1016/j.epsl.2004.12.027; Simoes M, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002958; Subarya C, 2006, NATURE, V440, P46, DOI 10.1038/nature04522; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Uchida T, 1996, J APPL PHYS, V80, P739, DOI 10.1063/1.362920; Ueda H, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002067; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; Wang YB, 2003, REV SCI INSTRUM, V74, P3002, DOI 10.1063/1.1570948; Warren JM, 2006, EARTH PLANET SC LETT, V248, P438, DOI 10.1016/j.epsl.2006.06.006; Zweck C, 2002, PHYS EARTH PLANET IN, V132, P5, DOI 10.1016/S0031-9201(02)00041-9	30	298	306	8	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1910	1913		10.1126/science.1148494	http://dx.doi.org/10.1126/science.1148494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096804				2022-12-28	WOS:000251786600055
J	Nelson, JA				Nelson, Jay A.			Small RNAs and large DNA viruses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CYTOMEGALOVIRUS; APOPTOSIS; INHIBITOR		Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Oregon Health & Science University	Nelson, JA (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.							Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956	7	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2630	2632		10.1056/NEJMcibr0706718	http://dx.doi.org/10.1056/NEJMcibr0706718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094385				2022-12-28	WOS:000251728900016
J	Devroey, P; Fauser, BCJM				Devroey, Paul; Fauser, Bart C. J. M.			Preimplantation aneuploidy screening: a research tool for now	LANCET			English	Editorial Material							DIAGNOSIS		Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium; Univ Med Ctr, Dept Reprod Med & Gynaecol, Utrecht, Netherlands	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Utrecht University; Utrecht University Medical Center	Devroey, P (corresponding author), Free Univ Brussels, Ctr Reprod Med, 808 Route Lennik, B-1090 Brussels, Belgium.	paul.devroey@az.vub.ac.be						Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Cohen J, 2007, FERTIL STERIL, V87, P496, DOI 10.1016/j.fertnstert.2006.07.1516; Donoso P, 2007, HUM REPROD UPDATE, V13, P15, DOI 10.1093/humupd/dml043; Losi FJ, 2004, HUM REPROD UPDATE, V10, P79, DOI 10.1093/humupd/dmh005; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Munne S, 1999, HUM REPROD, V14, P2191, DOI 10.1093/humrep/14.9.2191; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Staessen C, 2007, HUM REPROD, V22, pI32; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030	9	9	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1985	1986		10.1016/S0140-6736(07)61843-1	http://dx.doi.org/10.1016/S0140-6736(07)61843-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083388				2022-12-28	WOS:000251698600009
J	Joensuu, H				Joensuu, Heikki			Cardiac toxicity of sunitinib	LANCET			English	Editorial Material							CARDIOTOXICITY; HYPOTHYROIDISM		Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland.	heikki.joensuu@hus.fi		Joensuu, Heikki/0000-0003-0281-2507				Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Fiedler W, 2005, BLOOD, V105, P986, DOI 10.1182/blood-2004-05-1846; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Gore ME, 2007, J CLIN ONCOL, V25; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Schmidinger M, 2007, J CLIN ONCOL S, V25, p262s; Strevel EL, 2007, J CLIN ONCOL, V25, P3362, DOI 10.1200/JCO.2006.09.6925; Telli ML, 2007, J CLIN ONCOL, V25, P3525, DOI 10.1200/JCO.2007.11.0106	11	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1978	1980		10.1016/S0140-6736(07)61840-6	http://dx.doi.org/10.1016/S0140-6736(07)61840-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083385				2022-12-28	WOS:000251698600005
J	Reitz, SR				Reitz, Stuart R.			Ecology - Invasion of the whiteflies	SCIENCE			English	Editorial Material							BEMISIA-TABACI HEMIPTERA; DISPLACEMENT; ALEYRODIDAE		ARS, USDA, Tallahassee, FL 32308 USA	United States Department of Agriculture (USDA)	Reitz, SR (corresponding author), ARS, USDA, Tallahassee, FL 32308 USA.	stuart.reitz@ars.usda.gov	Reitz, Stuart/B-7667-2008; Reitz, Stuart/AAC-4467-2019					Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Dame EA, 2006, ANIM BEHAV, V71, P1165, DOI 10.1016/j.anbehav.2005.10.009; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; *IUCN, 100 WORLDS WORST INV; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007	16	10	17	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1733	1734		10.1126/science.1152124	http://dx.doi.org/10.1126/science.1152124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079389				2022-12-28	WOS:000251616800026
J	Carollo, D; Beers, TC; Lee, YS; Chiba, M; Norris, JE; Wilhelm, R; Sivarani, T; Marsteller, B; Munn, JA; Bailer-Jones, CAL; Fiorentin, PR; York, DG				Carollo, Daniela; Beers, Timothy C.; Lee, Young Sun; Chiba, Masashi; Norris, John E.; Wilhelm, Ronald; Sivarani, Thirupathi; Marsteller, Brian; Munn, Jeffrey A.; Bailer-Jones, Coryn A. L.; Fiorentin, Paola Re; York, Donald G.			Two stellar components in the halo of the Milky Way	NATURE			English	Article							DIGITAL SKY SURVEY; HORIZONTAL-BRANCH STARS; ABSOLUTE PROPER MOTIONS; METAL-POOR STARS; GALACTIC HALO; GLOBULAR-CLUSTERS; GALAXY FORMATION; KINEMATICS; FIELD; DISK	The halo of the Milky Way provides unique elemental abundance and kinematic information on the first objects to form in the Universe, and this information can be used to tightly constrain models of galaxy formation and evolution. Although the halo was once considered a single component, evidence for its dichotomy has slowly emerged in recent years from inspection of small samples of halo objects. Here we show that the halo is indeed clearly divisible into two broadly overlapping structural components - an inner and an outer halo - that exhibit different spatial density profiles, stellar orbits and stellar metallicities ( abundances of elements heavier than helium). The inner halo has a modest net prograde rotation, whereas the outer halo exhibits a net retrograde rotation and a peak metallicity one- third that of the inner halo. These properties indicate that the individual halo components probably formed in fundamentally different ways, through successive dissipational ( inner) and dissipationless ( outer) mergers and tidal disruption of proto- Galactic clumps.	INAF, Osservatorio Astron Torino, I-10025 Pino Torinese, Italy; Michigan State Univ, Ctr Study Cosm Evolut, Dept Phys & Astron, E Lansing, MI 48824 USA; Michigan State Univ, Joint Inst Nucl Astrophys, E Lansing, MI 48824 USA; Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan; Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; Texas Tech Univ, Dept Phys, Lubbock, TX 79409 USA; USN Observ, Flagstaff, AZ 86002 USA; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Univ Ljubljana, Dept Phys, Ljubljana 1000, Slovenia; Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA	Istituto Nazionale Astrofisica (INAF); Michigan State University; Michigan State University; Tohoku University; Australian National University; Texas Tech University System; Texas Tech University; United States Department of Defense; United States Navy; Max Planck Society; University of Ljubljana; University of Chicago; University of Chicago	Carollo, D (corresponding author), INAF, Osservatorio Astron Torino, I-10025 Pino Torinese, Italy.	carollo@mso.anu.edu.au	Beers, Timothy/D-1193-2019	Re Fiorentin, Paola/0000-0002-4995-0475; Carollo, Daniela/0000-0002-0005-5787; Sivarani, Thirupathi/0000-0003-0891-8994; Lee, Young Sun/0000-0001-5297-4518				Abadi MG, 2006, MON NOT R ASTRON SOC, V365, P747, DOI 10.1111/j.1365-2966.2005.09789.x; Adelman-McCarthy JK, 2007, ASTROPHYS J SUPPL S, V172, P634, DOI 10.1086/518864; Bekki K, 2001, ASTROPHYS J, V558, P666, DOI 10.1086/322300; BELL EF, IN PRESS ASTROPHYS J; Belokurov V, 2007, ASTROPHYS J, V654, P897, DOI 10.1086/509718; Belokurov V, 2006, ASTROPHYS J, V642, pL137, DOI 10.1086/504797; BINNEY J, 1986, MON NOT R ASTRON SOC, V218, P743, DOI 10.1093/mnras/218.4.743; Bonifacio P, 2007, ASTRON ASTROPHYS, V462, P851, DOI 10.1051/0004-6361:20064834; Brook C, 2007, EAS PUBLICATIONS, V24, P269, DOI 10.1051/eas:2007036; Bullock JS, 2005, ASTROPHYS J, V635, P931, DOI 10.1086/497422; Carney BW, 1999, ASTR SOC P, V165, P230; Carney BW, 1996, ASTRON J, V112, P668, DOI 10.1086/118042; Chiba M, 2001, ASTROPHYS J, V549, P325, DOI 10.1086/319068; Chiba M, 2000, ASTRON J, V119, P2843, DOI 10.1086/301409; Dekel A, 2003, MON NOT R ASTRON SOC, V344, P1131, DOI 10.1046/j.1365-8711.2003.06923.x; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Frebel A, 2006, ASTROPHYS J, V652, P1585, DOI 10.1086/508506; FRENK CS, 1980, MON NOT R ASTRON SOC, V193, P295, DOI 10.1093/mnras/193.2.295; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Gunn JE, 1998, ASTRON J, V116, P3040, DOI 10.1086/300645; Hartwick F.D.A., 1987, NATO ASIC P, V207, P281; KINMAN TD, 1994, ASTRON J, V108, P1722, DOI 10.1086/117191; Lee YW, 2007, ASTROPHYS J, V661, pL49, DOI 10.1086/518653; MAJEWSKI SR, 1992, ASTROPHYS J SUPPL S, V78, P87, DOI 10.1086/191622; MAJEWSKI SR, 1994, ASTROPHYS J, V427, pL37, DOI 10.1086/187359; MAJEWSKI SR, 1993, ANNU REV ASTRON ASTR, V31, P575; MICELI A, IN PRESS ASTROPHYS J; NORRIS JE, 1989, ASTROPHYS J, V336, pL17, DOI 10.1086/185351; Norris JE, 2007, ASTROPHYS J, V670, P774, DOI 10.1086/521919; Pier JR, 2003, ASTRON J, V125, P1559, DOI 10.1086/346138; PRESTON GW, 1991, ASTROPHYS J, V375, P121, DOI 10.1086/170175; QUINN PJ, 1986, ASTROPHYS J, V309, P472, DOI 10.1086/164619; RYAN SG, 1991, ASTRON J, V101, P1835, DOI 10.1086/115811; SANDAGE A, 1987, ASTRON J, V93, P74, DOI 10.1086/114291; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; Sirko E, 2004, ASTRON J, V127, P899, DOI 10.1086/381483; SOMMERLARSEN J, 1990, MON NOT R ASTRON SOC, V242, P10, DOI 10.1093/mnras/242.1.10; TUMLINSON J, UNPUB ASTROPHYS J; Wilhelm R, 1996, ASTR SOC P, V92, P171; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; ZINN R, 1993, ASTR SOC P, V48, P38	48	484	488	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1020	1025		10.1038/nature06460	http://dx.doi.org/10.1038/nature06460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075581	Green Submitted			2022-12-28	WOS:000251579900074
J	Niestemski, FC; Kunwar, S; Zhou, S; Li, SL; Ding, H; Wang, ZQ; Dai, PC; Madhavan, V				Niestemski, F. C.; Kunwar, S.; Zhou, S.; Li, Shiliang; Ding, H.; Wang, Ziqiang; Dai, Pengcheng; Madhavan, V.			A distinct bosonic mode in an electron-doped high-transition-temperature superconductor	NATURE			English	Article							TUNNELING SPECTROSCOPY; NEUTRON-SCATTERING; DENSITY; STATES; BI2SR2CACU2O8+DELTA; ND1.85CE0.15CUO4; DISPERSION; PHONONS; GLUE	Despite recent advances in understanding high- transition-temperature ( high-T-c) superconductors, there is no consensus on the origin of the superconducting 'glue': that is, the mediator that binds electrons into superconducting pairs. The main contenders are lattice vibrations(1,2) ( phonons) and spin- excitations(3,4), with the additional possibility of pairing without mediators(5). In conventional superconductors, phonon- mediated pairing was unequivocally established by data from tunnelling experiments(6). Proponents of phonons as the high- T-c glue were therefore encouraged by the recent scanning tunnelling microscopy experiments on hole- doped Bi2Sr2CaCu2O8-delta ( BSCCO) that reveal an oxygen lattice vibrational mode whose energy is anticorrelated with the superconducting gap energy scale(7). Here we report high-resolution scanning tunnelling microscopy measurements of the electron- doped high- T-c superconductor Pr0.88LaCe0.12CuO4 ( PLCCO) ( T-c= 24 K) that reveal a bosonic excitation ( mode) at energies of 10.5 +/- 2.5 meV. This energy is consistent with both spin- excitations in PLCCO measured by inelastic neutron scattering ( resonance mode)(8) and a low- energy acoustic phonon mode(9), but differs substantially from the oxygen vibrational mode identified in BSCCO. Our analysis of the variation of the local mode energy and intensity with the local gap energy scale indicates an electronic origin of the mode consistent with spin- excitations rather than phonons.	Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Oak Ridge Natl Lab, Neutron Scattering Sci Div, Oak Ridge, TN 37831 USA	Boston College; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Madhavan, V (corresponding author), Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA.	madhavan@bc.edu	Li, Shiliang/B-9379-2009; Zhou, Sen/ABC-3859-2021; Dai, Pengcheng/C-9171-2012; Zhou, Sen/F-5667-2010	Li, Shiliang/0000-0001-7922-3730; Zhou, Sen/0000-0002-8744-8603; Dai, Pengcheng/0000-0002-6088-3170; Ding, Hong/0000-0003-4422-9248				Anderson PW, 2007, SCIENCE, V316, P1705, DOI 10.1126/science.1140970; CRAWFORD MK, 1990, SOLID STATE COMMUN, V73, P507, DOI 10.1016/0038-1098(90)90373-J; d'Astuto M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167002; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; Homes CC, 1997, PHYS REV B, V56, P5525, DOI 10.1103/PhysRevB.56.5525; Hwang J, 2007, NATURE, V446, pE3, DOI 10.1038/nature05709; Kashiwaya S, 1998, PHYS REV B, V57, P8680, DOI 10.1103/PhysRevB.57.8680; KIRTLEY JR, 1990, PHYS REV LETT, V65, P798, DOI 10.1103/PhysRevLett.65.798; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Lavrov AN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.227003; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973; LITTLEWOOD PB, 1992, PHYS REV B, V45, P12636, DOI 10.1103/PhysRevB.45.12636; LYNN JW, 1991, PHYS REV LETT, V66, P919, DOI 10.1103/PhysRevLett.66.919; Matsui H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017003; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; McQueeney RJ, 1999, PHYS REV LETT, V82, P628, DOI 10.1103/PhysRevLett.82.628; Norman MR, 1997, PHYS REV LETT, V79, P3506, DOI 10.1103/PhysRevLett.79.3506; PAN ZH, 2006, UNIVERSAL QUASIPARTI; PERSSON BNJ, 1987, PHYS REV LETT, V59, P339, DOI 10.1103/PhysRevLett.59.339; Pilgram S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.117003; PINTSCHOVIUS L, 1989, PROG HIGH TEMP SUPER, V21, P36; Pintschovius L., 1994, PHYS PROPERTIES HIGH, P295; RENKER B, 1992, PHYSICA B, V180, P450, DOI 10.1016/0921-4526(92)90788-T; ROSSATMIGNOD J, 1991, PHYSICA C, V185, P86, DOI 10.1016/0921-4534(91)91955-4; Scalapino DJ, 2006, NAT PHYS, V2, P593, DOI 10.1038/nphys398; SHAN L, IN PRESS PHYS REV B; Wilson SD, 2006, NATURE, V442, P59, DOI 10.1038/nature04857; Zhao J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017001; Zhu JX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014511	29	70	71	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1058	1061		10.1038/nature06430	http://dx.doi.org/10.1038/nature06430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075588	Green Submitted			2022-12-28	WOS:000251579900081
J	Stroebe, M; Schut, H; Stroebe, W				Stroebe, Margaret; Schut, Henk; Stroebe, Wolfgang			Health outcomes of bereavement	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; FOCUSED GRIEF THERAPY; COMPLICATED GRIEF; GROUP INTERVENTION; WIDOWED PERSONS; PSYCHOLOGICAL DISTRESS; CONJUGAL BEREAVEMENT; GENDER-DIFFERENCES; PARENTAL DEATH; VIOLENT DEATHS	In this Review, we look at the relation between bereavement and physical and mental health. Although grief is not a disease and most people adjust without professional psychological intervention, bereavement is associated with excess risk of mortality, particularly in the early weeks and months after loss. It is related to decrements in physical health, indicated by presence of symptoms and illnesses, and use of medical services. Furthermore, bereaved individuals report diverse psychological reactions. For a few people, mental disorders or complications in the grieving process ensue. We summarise research on risk factors that increase vulnerability of some bereaved individuals. Diverse factors (circumstances of death, intrapersonal and interpersonal variables, ways of coping) are likely to co-determine excesses in ill-health. We also assess the effectiveness of psychological intervention programmes. intervention should be targeted at high-risk people and those with complicated grief or bereavement-related depression and stress disorders.	Univ Utrecht, Res Inst Psychol & Hlth, NL-3508 TC Utrecht, Netherlands	Utrecht University	Stroebe, M (corresponding author), Univ Utrecht, Res Inst Psychol & Hlth, POB 80140, NL-3508 TC Utrecht, Netherlands.	M.S.Stroebe@UU.NL	Schut, Henk/E-7487-2013	Stroebe, Margaret/0000-0002-8468-3317				AARTSEN MJ, 2004, PSYCHOL MED, V34, P1; Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Aneshensel CS, 2004, J HEALTH SOC BEHAV, V45, P422, DOI 10.1177/002214650404500405; [Anonymous], 1994, DIAGN STAT MAN DIS; Archer J., 1999, NATURE GRIEF EVOLUTI; Averill James R, 1979, EMOTIONS PERSONALITY, P339; AVERILL JR, 1968, PSYCHOL BULL, V70, P721, DOI 10.1037/h0026824; Ayers T, 2004, DEATH STUD, V28, P491, DOI 10.1080/07481180490461188; Barr P, 2004, PSYCHOL PSYCHOTHER-T, V77, P493, DOI 10.1348/1476083042555442; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; Benore E. R., 2004, INT J PSYCHOL RELIG, V14, P1, DOI [10.1207/s15327582ijpr1401_1, DOI 10.1207/S15327582IJPR1401_1]; Bernard LL, 2003, GERONTOLOGIST, V43, P808, DOI 10.1093/geront/43.6.808; Bisconti TL, 2004, J GERONTOL B-PSYCHOL, V59, pP158, DOI 10.1093/geronb/59.4.P158; BLACK D, 1987, J CHILD PSYCHOL PSYC, V28, P467, DOI 10.1111/j.1469-7610.1987.tb01767.x; BOELEN PA, 2005, COMPLICATED GRIEF AS; Boerner K, 2005, J GERONTOL B-PSYCHOL, V60, pP67, DOI 10.1093/geronb/60.2.P67; Boerner K, 2004, PSYCHOL AGING, V19, P668, DOI 10.1037/0882-7974.19.4.668; Bonanno G. A., 2001, HDB BEREAVEMENT RES, P493, DOI [DOI 10.1037/10436-021, 10.1037/10436-021]; Bonanno GA, 2005, J CONSULT CLIN PSYCH, V73, P86, DOI 10.1037/0022-006X.73.1.86; Bower JE, 1998, J CONSULT CLIN PSYCH, V66, P979, DOI 10.1037/0022-006X.66.6.979; Bowlby J., 1980, LOSS SADNESS DEPRESS, V3; BOWLING A, 1994, INT J GERIATR PSYCH, V9, P445, DOI 10.1002/gps.930090603; Bradbeer M, 2003, CLIN J PAIN, V19, P247, DOI 10.1097/00002508-200307000-00008; BRADSHER JE, 1992, J GERONTOL, V47, pS261, DOI 10.1093/geronj/47.5.S261; Brown SL, 2004, PERS SOC PSYCHOL B, V30, P1165, DOI 10.1177/0146167204263752; Byrne GJA, 1997, INT J GERIATR PSYCH, V12, P241, DOI 10.1002/(SICI)1099-1166(199702)12:2<241::AID-GPS590>3.0.CO;2-0; Carr D, 2003, J HEALTH SOC BEHAV, V44, P215, DOI 10.2307/1519809; Carr D, 2000, J GERONTOL B-PSYCHOL, V55, pS197, DOI 10.1093/geronb/55.4.S197; Carr D, 2001, J GERONTOL B-PSYCHOL, V56, pS237, DOI 10.1093/geronb/56.4.S237; CARR D, 2005, LATE LIFE WIDOWHOOD; Carr DS, 2004, RES AGING, V26, P591, DOI 10.1177/0164027504268495; Cerel J, 1999, J AM ACAD CHILD PSY, V38, P672, DOI 10.1097/00004583-199906000-00013; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; CHRIST GH, 2005, JAMA-J AM MED ASSOC, V288, P1269; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Cleiren M.P., 1993, BEREAVEMENT ADAPTATI; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; DELEON CFM, 1993, J CLIN EPIDEMIOL, V46, P519, DOI 10.1016/0895-4356(93)90124-J; Duberstein PR, 1998, AM J GERIAT PSYCHIAT, V6, P328; Dyregrov K, 2003, DEATH STUD, V27, P143, DOI 10.1080/07481180302892; Elwert F, 2006, AM SOCIOL REV, V71, P16, DOI 10.1177/000312240607100102; Erlangsen A, 2004, AGE AGEING, V33, P378, DOI 10.1093/ageing/afh128; Ferrario SR, 2004, PALLIATIVE MED, V18, P129, DOI 10.1191/0269216304pm870oa; Folkman S., 2001, REVISED COPING THEOR, DOI DOI 10.1037/10436-024; FREUD S, 1957, EDITION COMPLETE WOR; Fristad MA, 2001, OMEGA-J DEATH DYING, V42, P321, DOI 10.2190/MC87-GQMC-VCDV-UL3U; Fry PS, 1997, OMEGA-J DEATH DYING, V35, P119, DOI 10.2190/4FMB-ELX3-JUUD-2RU0; Gerra G, 2003, PSYCHIAT RES, V121, P145, DOI 10.1016/S0165-1781(03)00255-5; Goodenough B, 2004, PSYCHO-ONCOLOGY, V13, P779, DOI 10.1002/pon.795; Goodkin K, 1999, ARCH GEN PSYCHIAT, V56, P52, DOI 10.1001/archpsyc.56.1.52; Gundel H, 2003, AM J PSYCHIAT, V160, P1946, DOI 10.1176/appi.ajp.160.11.1946; Haine RA, 2003, DEATH STUD, V27, P619, DOI 10.1080/07481180302894; Hansson R. O., 2003, ENCY PRIMARY PREVENT, P515, DOI DOI 10.1007/978-1-4615-0195-4_75; Hardison Heather Gaines, 2005, Behav Sleep Med, V3, P99, DOI 10.1207/s15402010bsm0302_4; Harwood D, 2002, J AFFECT DISORDERS, V72, P185, DOI 10.1016/S0165-0327(01)00462-1; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Horowitz MJ, 1997, AM J PSYCHIAT, V154, P904; Jacobs SC, 1993, PATHOLOGIC GRIEF MAL; Jordan JR, 2003, DEATH STUD, V27, P765, DOI 10.1080/713842360; Kaltman S, 2003, J ANXIETY DISORD, V17, P131, DOI 10.1016/S0887-6185(02)00184-6; KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283; Kato PM, 1999, CLIN PSYCHOL REV, V19, P275, DOI 10.1016/S0272-7358(98)00064-6; Kempson DA, 2001, OMEGA-J DEATH DYING, V42, P341, DOI 10.2190/T1U8-JWAU-3RXU-LY1L; Kirwin KM, 2005, J CHILD ADOL PS NURS, V18, P62, DOI 10.1111/j.1744-6171.2005.00002.x; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Kissane DW, 2003, PALLIATIVE MED, V17, P527, DOI 10.1191/0269216303pm808oa; Kleinman A., 1985, CULTURE DEPRESSION S; Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Lee GR, 2001, J GERONTOL B-PSYCHOL, V56, pS56, DOI 10.1093/geronb/56.1.S56; LI GH, 1995, SOC SCI MED, V40, P825, DOI 10.1016/0277-9536(94)00135-G; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Lin KK, 2004, J CLIN CHILD ADOLESC, V33, P673, DOI 10.1207/s15374424jccp3304_3; LITTERERALLUMBA.D, 1999, J COUNS PSYCHOL, V46, P370; Luecken LJ, 2000, J PSYCHOSOM RES, V49, P85, DOI 10.1016/S0022-3999(00)00151-3; Luecken LJ, 2006, DEV PSYCHOPATHOL, V18, P295, DOI 10.1017/S0954579406060160; LUND DA, 2004, BR SOC GERONTOL, V14, P9; Lund Dale A., 1993, P240, DOI 10.1017/CBO9780511664076.017; Mack KY, 2004, OMEGA-J DEATH DYING, V49, P131, DOI 10.2190/BTUQ-011V-ANEW-V7RT; Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1996, J EPIDEMIOL COMMUN H, V50, P264, DOI 10.1136/jech.50.3.264; Martikainen P, 1998, EPIDEMIOLOGY, V9, P530, DOI 10.1097/00001648-199809000-00010; McCrae Robert R., 1993, P196, DOI 10.1017/CBO9780511664076.014; Meij LWD, 2005, J CONSULT CLIN PSYCH, V73, P617, DOI 10.1037/0022-006X.73.4.617; Middleton W, 1996, BRIT J PSYCHIAT, V169, P167, DOI 10.1192/bjp.169.2.167; MIKULINCER M, IN PRESS HDB BEREAVE; Moskowitz JT, 2003, DEATH STUD, V27, P471, DOI 10.1080/07481180390197624; Murdock ME, 1998, J WOMEN AGING, V10, P3, DOI 10.1300/J074v10n02_02; Murphy SA, 1999, DEATH STUD, V23, P129, DOI 10.1080/074811899201118; Murphy SA, 1999, DEATH STUD, V23, P589, DOI 10.1080/074811899200795; Murphy SA, 1998, DEATH STUD, V22, P209; Murphy SA, 2003, J TRAUMA STRESS, V16, P17, DOI 10.1023/A:1022003126168; Murphy SA, 2003, DEATH STUD, V27, P39, DOI 10.1080/07481180302871; Murray JA, 2000, DEATH STUD, V24, P275, DOI 10.1080/074811800200469; Nicolson NA, 2004, PSYCHONEUROENDOCRINO, V29, P1012, DOI 10.1016/j.psyneuen.2003.09.005; NIEMEYER R, 2001, HDB BEREAVEMENT RES, P89; Nolen-Hoeksema S., 2001, HDB BEREAVEMENT RES, P545, DOI DOI 10.1037/10436-023; Nolen-Hoeksema S., 1999, COPING LOSS; O'Connor MF, 2002, J PSYCHOSOM RES, V52, P183, DOI 10.1016/S0022-3999(02)00292-1; Ogrodniczuk JS, 2003, CAN J PSYCHIAT, V48, P87, DOI 10.1177/070674370304800204; Ogrodniczuk JS, 2004, PSYCHOTHER RES, V14, P231, DOI 10.1093/ptr/kph019; Ong AD, 2005, PERS INDIV DIFFER, V38, P1057, DOI 10.1016/j.paid.2004.07.004; Parkes C. M., 1997, DEATH BEREAVEMENT CU; Parkes CM, 1998, BEREAVEMENT CARE, V17, P18; PARKES CM, 2005, OMEGA, V52; Parkes CM, 1983, RECOVERY BEREAVEMENT; Parkes CM, 1996, BEREAVEMENT STUDIES; Parkes Colin Murray, 2006, LOVE LOSS ROOTS GRIE; Pennebaker J.W., 2001, HDB BEREAVEMENT RES, P517, DOI [https://doi.org/10.1037/10436-022, DOI 10.1037/10436-022]; PERKINS HW, 1990, J MARRIAGE FAM, V52, P233, DOI 10.2307/352853; Pfeffer CR, 2002, J AM ACAD CHILD PSY, V41, P505, DOI 10.1097/00004583-200205000-00007; Piper WE, 2001, INT J GROUP PSYCHOTH, V51, P525, DOI 10.1521/ijgp.51.4.525.51307; Prigerson H., 2001, PRIMARY PSYCHIAT, V8, P61; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; PRIGERSON HG, 1995, AM J PSYCHIAT, V152, P22; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; Prigerson HG, 2000, GERONTOLOGIST, V40, P349, DOI 10.1093/geront/40.3.349; Prigerson HG, 2003, AM J GERIAT PSYCHIAT, V11, P309, DOI 10.1176/appi.ajgp.11.3.309; Prigerson HG, 2005, OMEGA-J DEATH DYING, V52, P9; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Range LM, 1997, DEATH STUD, V21, P25; RAPHAEL B, 2001, HDB BEREAVEMENT RES, P587; Raphael Beverley, 1997, P373; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Ringdal GI, 2001, J PAIN SYMPTOM MANAG, V22, P1016, DOI 10.1016/S0885-3924(01)00363-3; Rosenblatt PC., 2013, AFRICAN AM GRIEF; ROSENBLOOM CA, J GERONTOL, V48, pS223; Rosengard C, 1997, AIDS CARE, V9, P373, DOI 10.1080/713613168; Rotheram-Borus MJ, 2005, J CONSULT CLIN PSYCH, V73, P221, DOI 10.1037/0022-006X.73.2.221; Rubin S.S., 2001, HDB BEREAVEMENT RES, P219, DOI DOI 10.1037/10436-009; Rubin SS, 2004, OMEGA-J DEATH DYING, V49, P149, DOI 10.2190/5UNJ-BNBF-6PVT-L4RE; Sandler IN, 2003, J CONSULT CLIN PSYCH, V71, P587, DOI 10.1037/0022-006X.71.3.587; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schaefer J.A., 2001, HDB BEREAVEMENT RES, P145, DOI https://doi.org/10.1037/10436-006; SCHARLACH AE, 1991, AM J ORTHOPSYCHIAT, V61, P307, DOI 10.1037/h0079240; Schulz R, 2001, JAMA-J AM MED ASSOC, V285, P3123, DOI 10.1001/jama.285.24.3123; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schut H, 2001, HDB BEREAVEMENT RES, P705, DOI DOI 10.1037/10436-029; Schut H.E., 2001, HDB BEREAVEMENT RES; Schut HAW, 1997, BRIT J CLIN PSYCHOL, V36, P63, DOI 10.1111/j.2044-8260.1997.tb01231.x; Schut Henk, 2005, J Palliat Med, V8 Suppl 1, pS140; Segal NL, 2001, PERS INDIV DIFFER, V31, P445, DOI 10.1016/S0191-8869(00)00149-5; Seltzer MM, 2000, GERONTOLOGIST, V40, P165, DOI 10.1093/geront/40.2.165; Shahar DR, 2001, J AGING HEALTH, V13, P186, DOI 10.1177/089826430101300202; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Sikkema KJ, 2005, QUAL LIFE RES, V14, P991, DOI 10.1007/s11136-004-2959-0; Sikkema KJ, 2004, DEATH STUD, V28, P187, DOI 10.1080/07481180490276544; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; SIMONTON D, 1988, GREAT PSYCHOL THEIR; SKLAR FHS, 1991, OMEGA, V21, P103; Smith KR, 1996, SOC BIOL, V43, P59; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M, 2005, AM J PSYCHIAT, V162, P2178, DOI 10.1176/appi.ajp.162.11.2178; Stroebe M, 2005, REV GEN PSYCHOL, V9, P48, DOI 10.1037/1089-2680.9.1.48; Stroebe M., 2006, BEREAVEMENT LATE LIF; Stroebe M., 2001, REV GEN PSYCHOL, V5, P62, DOI [DOI 10.1037/1089-2680.5.1.62, 10.1037/1089-2680.5.1.62]; STROEBE M, IN PRESS HDB BEREAVE; Stroebe M. S., 2004, INT J PSYCHOL RELIG, V14, P23, DOI [10.1207/s15327582ijpr1401_2, DOI 10.1207/S15327582IJPR1401_2]; Stroebe M.S., 1993, HDB BEREAVEMENT THEO; Stroebe Margaret S., 1993, P175, DOI 10.1017/CBO9780511664076.013; Stroebe MS, 2006, SOC SCI MED, V63, P2440, DOI 10.1016/j.socscimed.2006.06.012; Stroebe W, 2005, CLIN PSYCHOL REV, V25, P395, DOI 10.1016/j.cpr.2005.01.004; Stroebe W., 2001, HDB BEREAVEMENT RES, P349, DOI DOI 10.1037/10436-015; SURTEES PG, 1995, BRIT J PSYCHIAT, V166, P583, DOI 10.1192/bjp.166.5.583; THOMPSON LW, 1984, J GERONTOL, V39, P309, DOI 10.1093/geronj/39.3.309; Tonkins S.A.M., 1996, CHILD ADOLESC SOC WO, V13, P3, DOI DOI 10.1007/BF01876592; Tsuchiya KJ, 2005, J AFFECT DISORDERS, V86, P151, DOI 10.1016/j.jad.2005.01.006; Utz RL, 2002, GERONTOLOGIST, V42, P522, DOI 10.1093/geront/42.4.522; VACHON MLS, 1980, AM J PSYCHIAT, V137, P1380; van Grootheest DS, 1999, SOC PSYCH PSYCH EPID, V34, P391, DOI 10.1007/s001270050160; VANBAARSEN B, 2001, OMEGA, V44, P4; Vance JC, 2002, J PAEDIATR CHILD H, V38, P368, DOI 10.1046/j.1440-1754.2002.00008.x; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385; WIKAN U, 1988, SOC SCI MED, V27, P451, DOI 10.1016/0277-9536(88)90368-1; WILLIAMS DR, 1992, J HEALTH SOC BEHAV, V33, P140, DOI 10.2307/2137252; Worden J., 2001, GRIEF COUNSELING GRI, V3rd; Wortman C., 2001, HDB BEREAVEMENT RES, P405, DOI [10.1037/10436-017., DOI 10.1037/10436-017]; Zettel LA, 2004, PSYCHOL AGING, V19, P433, DOI 10.1037/0882-7974.19.3.433	186	965	981	5	192	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1960	1973		10.1016/S0140-6736(07)61816-9	http://dx.doi.org/10.1016/S0140-6736(07)61816-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18068517	Green Submitted			2022-12-28	WOS:000251517600034
J	Wang, GY; Innes, JL; Lei, JF; Dai, SY; Wu, SW				Wang, Guangyu; Innes, John L.; Lei, Jiafu; Dai, Shuanyou; Wu, Sara W.			Ecology - China's forestry reforms	SCIENCE			English	Editorial Material									Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1Z4, Canada; State Forestry Adm, Beijing 100714, Peoples R China; World Forest Inst, Portland, OR 97221 USA	University of British Columbia	Innes, JL (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1Z4, Canada.	john.innes@ubc.ca	Innes, John L/E-4355-2013	Innes, John L/0000-0002-7076-1222				*CENTR COMM COMM P, 2003, DIR ENH FOR DEV; MA J, 2006, PATH ENV HARMONY CHI; *STAT FOR ADM, 2003, REP MON ASS SOC EC I; *STAT FOR ADM, 2005, CHIN FOR DEV REP; *STAT FOR ADM, 2005, 6 NAT SURV FOR RES P; *STAT FOR ADM, 2006, ENH FOR EC IMPR ACC; *STAT FOR ADM TASK, 2007, INV REP JIANGX FOR O; Sun X., 2007, CHINANEWS       0706, V15; *UNECE TIMB COMM, 2006, STAT FOR PROD MARK 2; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	10	224	245	17	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1556	1557		10.1126/science.1147247	http://dx.doi.org/10.1126/science.1147247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063773				2022-12-28	WOS:000251421700019
J	Ludwig, DS				Ludwig, David S.			Childhood obesity - The shape of things to come	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; OVERWEIGHT		Childrens Hosp, Optimal Weight Life Program, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Childrens Hosp, Optimal Weight Life Program, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544				Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006	5	189	207	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2325	2327		10.1056/NEJMp0706538	http://dx.doi.org/10.1056/NEJMp0706538			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057334	Bronze			2022-12-28	WOS:000251389200002
J	Klompas, M; Platt, R				Klompas, Michael; Platt, Richard			Ventilator-associated pneumonia-the wrong quality measure for Benchmarking	ANNALS OF INTERNAL MEDICINE			English	Article							DIAGNOSTIC-ACCURACY	Legislators, payers, and quality-of-care advocates across the United States are considering requiring hospitals to report ventilator-associated pneumonia rates as a way to benchmark and reward quality of care. Accurate diagnosis of ventilator-associated pneumonia, however, is notoriously difficult because several common complications of critical care can mimic the clinical appearance of ventilator-associated pneumonia. The challenge is compounded by substantial subjectivity inherent in the current surveillance definition. These sources of variability make ventilator-associated pneumonia rates difficult to acquire, interpret, and compare both within and among institutions. Ventilator-associated pneumonia should be excluded from compulsory reporting initiatives until we develop and validate more objective outcome measures that meaningfully reflect quality of care for ventilated patients.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Pilgrim Hlth Care, Boston, MA 02115 USA	Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Harvard Pilgrim Hlth Care, 133 Brookline Ave, 6th Fl, Boston, MA 02215 USA.		Klompas, Michael/Z-2415-2019					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bregeon F, 2000, EUR RESPIR J, V16, P969, DOI 10.1183/09031936.00.16596900; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; *HEALTHC INF CONTR, 2005, INFECT CONT HOSP EP, V26, P580; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Louthan F B, 1996, Semin Respir Infect, V11, P77; MARQUETTE CH, 1995, AM J RESP CRIT CARE, V151, P1878, DOI 10.1164/ajrccm.151.6.7767535; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221	14	92	92	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					803	235		10.7326/0003-4819-147-11-200712040-00013	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056666				2022-12-28	WOS:000251539100009
J	Juhasz, AL; Smith, E; Weber, J				Juhasz, Albert L.; Smith, Euan; Weber, John			Brominated flame retardants-safety at what cost?	LANCET			English	Editorial Material							POLYBROMINATED DIPHENYL ETHERS; HUMAN EXPOSURE; MARKET-BASKET; HOUSE-DUST; PBDES; FOOD		Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia	University of South Australia	Juhasz, AL (corresponding author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes Campus, Mawson Lakes, SA 5095, Australia.	Albert.Juhasz@unisa.edu.au	Juhasz, Albert/F-6600-2011	Juhasz, Albert/0000-0002-1164-4085				Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; Alm H, 2006, ENVIRON HEALTH PERSP, V114, P254, DOI 10.1289/ehp.8419; Birnbaum LS, 2006, ENVIRON HEALTH PERSP, V114, P1770, DOI 10.1289/ehp.9061; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Fischer D, 2006, ENVIRON HEALTH PERSP, V114, P1581, DOI 10.1289/ehp.8554; FOWLES JR, 1994, TOXICOLOGY, V86, P49, DOI 10.1016/0300-483X(94)90052-3; Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; LORBER M, 2007, J EXP SCI ENV E 0411; Meironyte D, 1999, J TOXICOL ENV HEAL A, V58, P329, DOI 10.1080/009841099157197; Schecter A, 2006, ENVIRON HEALTH PERSP, V114, P1515, DOI 10.1289/ehp.9121; Voorspoels S, 2007, ENVIRON INT, V33, P93, DOI 10.1016/j.envint.2006.08.003; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282	12	5	6	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1813	1814		10.1016/S0140-6736(07)61757-7	http://dx.doi.org/10.1016/S0140-6736(07)61757-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061044				2022-12-28	WOS:000251588700010
J	Kennedy, BM; van Soest, MC				Kennedy, B. Mack; van Soest, Matthijs C.			Flow of mantle fluids through the ductile lower crust: Helium isotope trends	SCIENCE			English	Article							SAN-ANDREAS FAULT; RANGE PROVINCE; BASIN; TECTONICS; NEVADA; ORIGIN; SYSTEM; FLUXES; RIFT	Heat and mass are injected into the shallow crust when mantle fluids are able to flow through the ductile lower crust. Minimum He-3/He-4 ratios in surface fluids from the northern Basin and Range Province, western North America, increase systematically from low crustal values in the east to high mantle values in the west, a regional trend that correlates with the rates of active crustal deformation. The highest ratios occur where the extension and shear strain rates are greatest. The correspondence of helium isotope ratios and active transtensional deformation indicates a deformation-enhanced permeability and that mantle fluids can penetrate the ductile lithosphere, even in regions where there is no substantial magmatism. Superimposed on the regional trend are local, high He-3/He-4 anomalies indicating hidden magmatic activity and/or deep fluid production with locally enhanced permeability, identifying zones with high resource potential, particularly for geothermal energy development.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Ctr Isotope Geochem, Berkeley, CA 94720 USA; Arizona State Univ, Sch Earth & Space Explorat, Noble Gas Geochem & Geochronol Lab, Tempe, AZ 85287 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe	Kennedy, BM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Ctr Isotope Geochem, Berkeley, CA 94720 USA.	bmkennedy@lbl.gov						Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P539, DOI 10.2138/rmg.2002.47.13; Bennett RA, 2003, TECTONICS, V22, DOI 10.1029/2001TC001355; Blackwell DD, 2000, GEOTHERM RESOUR COUN, V24, P223; BRADSHAW GA, 1988, GEOLOGY, V16, P271, DOI 10.1130/0091-7613(1988)016<0271:LNFSRA>2.3.CO;2; BYERLEE J, 1990, GEOPHYS RES LETT, V17, P2109, DOI 10.1029/GL017i012p02109; BYERLEE J, 1993, GEOLOGY, V21, P303, DOI 10.1130/0091-7613(1993)021<0303:MFEFOH>2.3.CO;2; Cox SF, 2002, EARTH PLANETS SPACE, V54, P1121, DOI 10.1186/BF03353312; Flesch LM, 2000, SCIENCE, V287, P834, DOI 10.1126/science.287.5454.834; Hammond WC, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002746; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; JONES CH, 1992, TECTONOPHYSICS, V213, P57, DOI 10.1016/0040-1951(92)90252-2; Kennedy BM, 2006, GEOTHERMICS, V35, P26, DOI 10.1016/j.geothermics.2005.09.004; Kennedy BM, 1997, SCIENCE, V278, P1278, DOI 10.1126/science.278.5341.1278; Kulongoski JT, 2005, GEOCHIM COSMOCHIM AC, V69, P3857, DOI 10.1016/j.gca.2005.03.001; MELOSH HJ, 1990, NATURE, V343, P331, DOI 10.1038/343331a0; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Newell DL, 2005, GSA TODAY, V15, P4, DOI [10.1130/1052-5173(2005)0152.0.CO;2, DOI 10.1130/1052-5173(2005)0152.0.CO;2, DOI 10.1130/1052-5173(2005)015[4:CSLBTM]2.0.CO;2]; NIELSON DL, 1979, GEOTHERM RESOUR COUN, V3, P503; PARSONS T, 1995, DEVEL GEOT, V25, P277; SLEEP NH, 1992, NATURE, V359, P687, DOI 10.1038/359687a0; SPERA FJ, 1984, CONTRIB MINERAL PETR, V88, P217, DOI 10.1007/BF00380167; TORGERSEN T, 1993, J GEOPHYS RES-SOL EA, V98, P16257, DOI 10.1029/93JB00891; WANNAMAKER PE, 2005, GEOL SOC AM ABSTR, V37, P495; ZOBACK ML, 1978, GEOLOGY, V6, P111, DOI 10.1130/0091-7613(1978)6<111:BARRIN>2.0.CO;2	25	155	161	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1433	1436		10.1126/science.1147537	http://dx.doi.org/10.1126/science.1147537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048684	Green Submitted			2022-12-28	WOS:000251246100040
J	Chabot, JR; Pedraza, JM; Luitel, P; van Oudenaarden, A				Chabot, Jeffrey R.; Pedraza, Juan M.; Luitel, Prashant; van Oudenaarden, Alexander			Stochastic gene expression out-of-steady-state in the cyanobacterial circadian clock	NATURE			English	Article							PROTEIN EXPRESSION; NOISE; RHYTHMS; VARIABILITY; LUCIFERASE; REPORTER; ORIGINS; CELLS	Recent advances in measuring gene expression at the single- cell level have highlighted the stochastic nature of messenger RNA and protein synthesis(1-3). Stochastic gene expression creates a source of variability in the abundance of cellular components, even among isogenic cells exposed to an identical environment. Recent integrated experimental and modelling studies(4-13) have shed light on the molecular sources of this variability. However, many of these studies focus on systems that have reached a steady state and therefore do not address a large class of dynamic phenomena including oscillatory gene expression. Here we develop a general protocol for analysing and predicting stochastic gene expression in systems that never reach steady states. We use this framework to analyse experimentally stochastic expression of genes driven by the Synechococcus elongatus circadian clock. We find that, although the average expression at two points in the circadian cycle separated by 12 hours is identical, the variability at these two time points can be different. We show that this is a general feature of out- of- steady- state systems. We demonstrate how intrinsic noise sources, owing to random births and deaths of mRNAs and proteins, or extrinsic noise sources, which introduce fluctuations in rate constants, affect the cell- to- cell variability. To distinguish experimentally between these sources, we measured how the correlation between expression fluctuations of two identical genes is modulated during the circadian cycle. This quantitative framework is generally applicable to any out- of steady state system and will be necessary for understanding the fidelity of dynamic cellular systems.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Pedraza, Juan/0000-0002-1802-3337				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Johnson CH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-217; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168	30	86	87	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1249	1252		10.1038/nature06395	http://dx.doi.org/10.1038/nature06395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097413				2022-12-28	WOS:000251786200054
J	Schumacher, MA; Glover, TC; Brzoska, AJ; Jensen, SO; Dunham, TD; Skurray, RA; Firth, N				Schumacher, Maria A.; Glover, Tiffany C.; Brzoska, Anthony J.; Jensen, Slade O.; Dunham, Thomas D.; Skurray, Ronald A.; Firth, Neville			Segrosome structure revealed by a complex of ParR with centromere DNA	NATURE			English	Article							CRYSTAL-STRUCTURE; PLASMID R1; ANGSTROM RESOLUTION; BETA-SHEETS; PROTEIN; SEGREGATION; ACTIN; RECOGNITION; HELIX; PARTITION	The stable inheritance of genetic material depends on accurate DNA partition. Plasmids serve as tractable model systems to study DNA segregation because they require only a DNA centromere, a centromere- binding protein and a force- generating ATPase. The centromeres of partition ( par) systems typically consist of a tandem arrangement of direct repeats(1-7). The best- characterized par system contains a centromere- binding protein called ParR and an ATPase called ParM. In the first step of segregation, multiple ParR proteins interact with the centromere repeats to form a large nucleoprotein complex of unknown structure called the segrosome, which binds ParM filaments(4,8-10). pSK41 ParR binds a centromere consisting of multiple 20- base- pair ( bp) tandem repeats to mediate both transcription autoregulation and segregation. Here we report the structure of the pSK41 segrosome revealed in the crystal structure of a ParR - DNA complex. In the crystals, the 20- mer tandem repeats stack pseudo- continuously to generate the full- length centromere with the ribbon - helix - helix ( RHH) fold of ParR binding successive DNA repeats as dimer- of- dimers. Remarkably, the dimer- of- dimers assemble in a continuous protein super- helical array, wrapping the DNA about its positive convex surface to form a large segrosome with an open, solenoid-shaped structure, suggesting a mechanism for ParM capture and subsequent plasmid segregation.	Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Sydney	Schumacher, MA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org		Firth, Neville/0000-0002-5791-7691; Jensen, Slade/0000-0003-4489-589X				BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DELANO WL, 2002, PYMOL MOL GRAPHCIS S, P33202; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HE YY, 1992, NATURE, V359, P431, DOI 10.1038/359431a0; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Kwong SM, 2004, MOL MICROBIOL, V51, P497, DOI 10.1046/j.1365-2958.2003.03843.x; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101	34	79	80	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1268	U15		10.1038/nature06392	http://dx.doi.org/10.1038/nature06392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097417				2022-12-28	WOS:000251786200058
J	Bower, M; Powles, T; Williams, S; Davis, TN; Atkins, M; Montoto, S; Orkin, C; Webb, A; Fisher, M; Nelson, M; Gazzard, B; Stebbing, J; Kelleher, P				Bower, Mark; Powles, Tom; Williams, Sarah; Davis, Tom Newsom; Atkins, Mark; Montoto, Silvia; Orkin, Chloe; Webb, Andy; Fisher, Martin; Nelson, Mark; Gazzard, Brian; Stebbing, Justin; Kelleher, Peter			Brief communication: Rituximab in HIV-associated multicentric Castleman disease	ANNALS OF INTERNAL MEDICINE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; PROLONGED REMISSION; THERAPY; CELLS; INTERLEUKIN-10; INFECTION; TRIAL; IL-6	Background: HIV-associated multicentric Castleman disease is a rare lymphoproliferative disorder with marked systemic symptoms attributed to cytokine disarray. Many therapeutic approaches in small series of patients have proved largely unsuccessful to date. Objective: To investigate the efficacy and clinicopathologic variables associated with first-line treatment for HIV-associated multicentric Castleman disease with the anti-CD20 monoclonal antibody rituximab. Design: Single-group, open-label, phase II trial. Setting: 3 teaching hospitals in England. Patients: Previously untreated patients with histologically proven HIV-associated multicentric Castleman disease. Intervention: 4 infusions of rituximab, 375 mg per m(2) of body surface area, at weekly intervals. Measurements: Response was evaluated clinically and radiologically and by measuring plasma Kaposi sarcoma-associated herpesvirus viral load. Results: 21 consecutive patients (18 men) with plasmablastic multicentric Castleman disease were recruited. The median follow-up was 12 months (range, 1 to 49 months). one patient died before completing therapy, 20 achieved remission of symptoms, and 14 (67%) achieved a radiologic response. The overall and disease-free survival rates at 2 years were 95% (95% Cl, 86% to 100%) and 79% (Cl, 49% to 100%), respectively. Plasma acute-phase proteins, immunoglobulins, and Kaposi sarcoma-associated herpesvirus viral load decreased after rituximab therapy. The main adverse effect was reactivation of Kaposi sarcoma. Limitation: The study had no comparison group. Conclusion: Rituximab may be clinically valuable as initial therapy for HIV-associated multicentric Castleman disease.	Chelsea & Westminster Hosp, Dept Oncol, London SW109NH, England; Queen Marys Univ, Chelsea & Westminster Hosp, Barts & London NHS Trust, London, England; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England	Barts Health NHS Trust; Imperial College London; University of London; Queen Mary University London; University of Brighton	Bower, M (corresponding author), Chelsea & Westminster Hosp, Dept Oncol, 369 Fulham Rd, London SW109NH, England.	m.bower@imperial.ac.uk	Montoto, Silvia/M-6812-2019	Montoto, Silvia/0000-0002-3006-9725; Stebbing, Justin/0000-0002-1117-6947; Bower, Mark/0000-0002-4077-6351				Casquero A, 2006, ANN HEMATOL, V85, P185, DOI 10.1007/s00277-005-0038-4; Corbellino M, 2001, BLOOD, V98, P3473, DOI 10.1182/blood.V98.12.3473; Drexler HG, 1999, LEUKEMIA, V13, P634, DOI 10.1038/sj.leu.2401371; Du MQ, 2001, BLOOD, V97, P2130, DOI 10.1182/blood.V97.7.2130; Dupin N, 2000, BLOOD, V95, P1406, DOI 10.1182/blood.V95.4.1406.004k26_1406_1412; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Gerard L, 2007, J CLIN ONCOL, V25, P3350, DOI 10.1200/JCO.2007.10.6732; Gill J, 2002, JAIDS-J ACQ IMM DEF, V31, P384, DOI 10.1097/00126334-200212010-00003; Jones KD, 1999, BLOOD, V94, P2871; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaplan LD, 2005, BLOOD, V106, P1538, DOI 10.1182/blood-2005-04-1437; Kofteridis DP, 2004, AIDS, V18, P585, DOI 10.1097/00002030-200402200-00037; Marcelin AG, 2003, BLOOD, V102, P2786, DOI 10.1182/blood-2003-03-0951; Marrache F, 2003, AIDS, V17, P1409, DOI 10.1097/00002030-200306130-00023; Neuville S, 2005, AM J HEMATOL, V79, P337, DOI 10.1002/ajh.20418; Newsom-Davis T, 2004, LEUKEMIA LYMPHOMA, V45, P1939, DOI 10.1080/10428190410001693533; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; PARRAVICINI C, 2000, AM J PATHOL, V96, P4546; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Stebbing J, 2004, INT J CANCER, V108, P473, DOI 10.1002/ijc.11601; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Waterston A, 2004, ACTA ONCOL, V43, P698, DOI 10.1080/02841860410002752	23	136	142	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					836	839		10.7326/0003-4819-147-12-200712180-00003	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00003			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087054				2022-12-28	WOS:000251787600003
J	Counsell, SR; Callahan, CM; Clark, DO; Tu, WZ; Buttar, AB; Stump, TE; Ricketts, GD				Counsell, Steven R.; Callahan, Christopher M.; Clark, Daniel O.; Tu, Wanzhu; Buttar, Amna B.; Stump, Timothy E.; Ricketts, Gretchen D.			Geriatric care management for low-income seniors - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Scientific Meeting of the American-Geriatrics-Society	MAY 02-06, 2007	Seattle, WA	Amer Geriat Soc			ALL-INCLUSIVE CARE; HEALTH OUTCOMES; OLDER PATIENTS; FUNCTIONAL DECLINE; MEDICARE BENEFICIARIES; COLLABORATIVE CARE; VULNERABLE ELDERS; CLINICAL-TRIAL; COMMUNITY; PROGRAM	Context Low- income seniors frequently have multiple chronic medical conditions for which they often fail to receive the recommended standard of care. Objectives To test the effectiveness of a geriatric care management model on improving the quality of care for low- income seniors in primary care. Design, Setting, and Patients Controlled clinical trial of 951 adults 65 years or older with an annual income less than 200% of the federal poverty level, whose primary care physicians were randomized from January 2002 through August 2004 to participate in the intervention ( 474 patients) or usual care ( 477 patients) in community-based health centers. Intervention Patients received 2 years of home- based care management by a nurse practitioner and social worker who collaborated with the primary care physician and a geriatrics interdisciplinary team and were guided by 12 care protocols for common geriatric conditions. Main Outcome Measures The Medical Outcomes 36- Item Short- Form ( SF- 36) scales and summary measures; instrumental and basic activities of daily living ( ADLs); and emergency department ( ED) visits not resulting in hospitalization and hospitalizations. Results Intention- to- treat analysis revealed significant improvements for intervention patients compared with usual care at 24 months in 4 of 8 SF- 36 scales: general health ( 0.2 vs - 2.3, P=. 045), vitality ( 2.6 vs - 2.6, P <. 001), social functioning ( 3.0 vs - 2.3, P=. 008), and mental health ( 3.6 vs - 0.3, P=. 001); and in the Mental Component Summary ( 2.1 vs - 0.3, P <. 001). No group differences were found for ADLs or death. The cumulative 2- year ED visit rate per 1000 was lower in the intervention group ( 1445 [ n= 474] vs 1748 [ n= 477], P=. 03) but hospital admission rates per 1000 were not significantly different between groups ( 700 [ n= 474] vs 740 [ n= 477], P=. 66). In a predefined group at high risk of hospitalization ( comprising 112 intervention and 114 usual- care patients), ED visit and hospital admission rates were lower for intervention patients in the second year ( 848 [ n= 106] vs 1314 [ n= 105]; P=. 03 and 396 [ n= 106] vs 705 [ n= 105]; P=. 03, respectively). Conclusions Integrated and home- based geriatric care management resulted in improved quality of care and reduced acute care utilization among a high- risk group. Improvements in health- related quality of life were mixed and physical function outcomes did not differ between groups. Future studies are needed to determine whether more specific targeting will improve the program's effectiveness and whether reductions in acute care utilization will offset program costs.	Indiana Univ, Sch Med, Ctr Aging Res, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Regenstrief Inst Inc, Indianapolis, IN USA; Univ Wisconsin, Sch Med, Dept Med, Madison, WI USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Wisconsin System; University of Wisconsin Madison	Counsell, SR (corresponding author), Indiana Univ, Sch Med, Ctr Aging Res, 1001 W 10th St,WOP-M200, Indianapolis, IN 46202 USA.	scounsel@iupui.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	NATIONAL INSTITUTE ON AGING [R01AG020175] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG20175, R01 AG020175] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen KR, 2003, J AM GERIATR SOC, V51, P1660, DOI 10.1046/j.1532-5415.2003.51521.x; *AM CANC SOC, 2006, AM CANC SOC BREAST C, P1; [Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Boult C, 1998, J AM GERIATR SOC, V46, P499, DOI 10.1111/j.1532-5415.1998.tb02474.x; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Burton LC, 2002, J AM GERIATR SOC, V50, P382, DOI 10.1046/j.1532-5415.2002.50074.x; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Callahan CM, 1998, J AM GERIATR SOC, V46, P1371, DOI 10.1111/j.1532-5415.1998.tb06003.x; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x; Covinsky KE, 1997, J AM GERIATR SOC, V45, P729, DOI 10.1111/j.1532-5415.1997.tb01478.x; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; GRAVELLE H, 2007, BRIT MED J, V334, P7583, DOI DOI 10.1136/BMJ.39020.413310.55; HAUSER RM, 2005, AGING HLTH PUBLIC PO, P208; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; *IMSL INC, 2006, US MAN FORTRAN SUBR; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kane RL, 2006, J AM GERIATR SOC, V54, P276, DOI 10.1111/j.1532-5415.2005.00581.x; Kane RL, 2004, J AM GERIATR SOC, V52, P2039, DOI 10.1111/j.1532-5415.2004.52558.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; *MED PAC, 2005, DAT BOOK HEALTHC SPE, P12; PACALA JT, 1995, J AM GERIATR SOC, V43, P374, DOI 10.1111/j.1532-5415.1995.tb05810.x; Palmer RM, 2003, DIS MANAG HEALTH OUT, V11, P507, DOI 10.2165/00115677-200311080-00004; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Reuben DB, 2002, MED CARE, V40, P416, DOI 10.1097/00005650-200205000-00007; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Streiner D, 2001, Evid Based Ment Health, V4, P70; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Vojta CL, 2001, J GEN INTERN MED, V16, P525, DOI 10.1046/j.1525-1497.2001.016008525.x; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Wieland D, 2000, J AM GERIATR SOC, V48, P1373, DOI 10.1111/j.1532-5415.2000.tb02625.x; Wolff JL, 2005, ANN INTERN MED, V143, P439, DOI 10.7326/0003-4819-143-6-200509200-00008	56	350	350	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2623	2633		10.1001/jama.298.22.2623	http://dx.doi.org/10.1001/jama.298.22.2623			11	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239VJ	18073358	Bronze			2022-12-28	WOS:000251546100014
J	Porco, CC; Thomas, PC; Weiss, JW; Richardson, DC				Porco, C. C.; Thomas, P. C.; Weiss, J. W.; Richardson, D. C.			Saturn's small inner satellites: Clues to their origins	SCIENCE			English	Article							CASSINI IMAGING SCIENCE; PLANETARY RINGS; ASTEROIDS; SIMULATIONS; COLLISIONS; PARTICLES; DYNAMICS; SHAPE	Cassini images of Saturn's small inner satellites ( radii of less than similar to 100 kilometers) have yielded their sizes, shapes, and in some cases, topographies and mean densities. This information and numerical N- body simulations of accretionary growth have provided clues to their internal structures and origins. The innermost ring- region satellites have likely grown to the maximum sizes possible by accreting material around a dense core about one- third to one- half the present size of the moon. The other small satellites outside the ring region either may be close to monolithic collisional shards, modified to varying degrees by accretion, or may have grown by accretion without the aid of a core. We derived viscosity values of 87 and 20 square centimeters per second, respectively, for the ring material surrounding ring- embedded Pan and Daphnis. These moons almost certainly opened their respective gaps and then grew to their present size early on, when the local ring environment was thicker than it is today.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Cornell University; University System of Maryland; University of Maryland College Park	Porco, CC (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St, Boulder, CO 80301 USA.	carolyn@ciclops.org	Richardson, Derek C/J-4257-2018	Richardson, Derek C/0000-0002-0054-6850				Asphaug E, 1998, NATURE, V393, P437, DOI 10.1038/30911; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; CANUP RM, 1995, ICARUS, V113, P331, DOI 10.1006/icar.1995.1026; Charnoz S, 2007, SCIENCE, V318, P1622, DOI 10.1126/science.1148631; Colwell JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025163; Danby J.M.A., 1992, FUNDAMENTALS CELESTI, V2nd ed.; DAVIS DR, 1984, SCIENCE, V224, P744, DOI 10.1126/science.224.4650.744; DOBROVOLSKIS AR, 1980, ICARUS, V42, P422, DOI 10.1016/0019-1035(80)90105-0; ESPOSITO LW, 1986, ICARUS, V67, P345, DOI 10.1016/0019-1035(86)90119-3; French RG, 2000, ICARUS, V145, P502, DOI 10.1006/icar.2000.6357; GOLDREICH P, 1982, ANNU REV ASTRON ASTR, V20, P249, DOI 10.1146/annurev.aa.20.090182.001341; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; PORCO CC, 2007, 8857 IAU; PORCO CC, 2004, 8432 IAU; Richardson DC, 2000, ICARUS, V143, P45, DOI 10.1006/icar.1999.6243; RICHARDSON DC, 1994, MON NOT R ASTRON SOC, V269, P493, DOI 10.1093/mnras/269.2.493; Sharma I, 2006, ICARUS, V183, P312, DOI 10.1016/j.icarus.2006.03.006; SIMONELLI DP, 1993, ICARUS, V103, P49, DOI 10.1006/icar.1993.1057; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; SMITH BA, 1982, SCIENCE, V215, P505; Spitale JN, 2006, ASTRON J, V132, P692, DOI 10.1086/505206; SUPULVER KD, 1995, ICARUS, V113, P188, DOI 10.1006/icar.1995.1015; THOMAS P, 1983, J GEOPHYS RES-SPACE, V88, P8743, DOI 10.1029/JA088iA11p08743; Thomas PC, 2007, NATURE, V448, P50, DOI 10.1038/nature05779; Thomas PC, 1998, ICARUS, V135, P175, DOI 10.1006/icar.1998.5987; THOMAS PC, 1993, ICARUS, V105, P326, DOI 10.1006/icar.1993.1130; Tiscareno MS, 2006, ASTROPHYS J, V651, pL65, DOI 10.1086/509120; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581; WEISS JW, 2005, B AM ASTRON SOC, V37, P767; [No title captured]	31	106	106	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1602	1607		10.1126/science.1143977	http://dx.doi.org/10.1126/science.1143977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063794				2022-12-28	WOS:000251421700040
J	McCreanor, J; Cullinan, P; Nieuwenhuijsen, MJ; Stewart-Evans, J; Malliarou, E; Jarup, L; Harrington, R; Svartengren, M; Han, I; Ohman-Strickland, P; Chung, KF; Zhang, JF				McCreanor, James; Cullinan, Paul; Nieuwenhuijsen, Mark J.; Stewart-Evans, James; Malliarou, Eleni; Jarup, Lars; Harrington, Robert; Svartengren, Magnus; Han, In-Kyu; Ohman-Strickland, Pamela; Chung, Kian Fan; Zhang, Junfeng			Respiratory effects of exposure to diesel traffic in persons with asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRWAY INFLAMMATION; LUNG-FUNCTION; EXHAUST; POLLUTION; SYMPTOMS; HEALTH	Background: Air pollution from road traffic is a serious health hazard, and people with preexisting respiratory disease may be at increased risk. We investigated the effects of short-term exposure to diesel traffic in people with asthma in an urban, roadside environment. Methods: We recruited 60 adults with either mild or moderate asthma to participate in a randomized, crossover study. Each participant walked for 2 hours along a London street (Oxford Street) and, on a separate occasion, through a nearby park (Hyde Park). We performed detailed real-time exposure, physiological, and immunologic measurements. Results: Participants had significantly higher exposures to fine particles (<2.5 mu m in aerodynamic diameter), ultrafine particles, elemental carbon, and nitrogen dioxide on Oxford Street than in Hyde Park. Walking for 2 hours on Oxford Street induced asymptomatic but consistent reductions in the forced expiratory volume in 1 second (FEV1) (up to 6.1%) and forced vital capacity (FVC) (up to 5.4%) that were significantly larger than the reductions in FEV1 and FVC after exposure in Hyde Park (P=0.04 and P=0.01, respectively, for the overall effect of exposure, and P<0.005 at some time points). The effects were greater in subjects with moderate asthma than in those with mild asthma. These changes were accompanied by increases in biomarkers of neutrophilic inflammation (sputum myeloperoxidase, 4.24 ng per milliliter after exposure in Hyde Park vs. 24.5 ng per milliliter after exposure on Oxford Street; P=0.05) and airway acidification (maximum decrease in pH, 0.04% after exposure in Hyde Park and 1.9% after exposure on Oxford Street; P=0.003). The changes were associated most consistently with exposures to ultrafine particles and elemental carbon. Conclusions: Our observations serve as a demonstration and explanation of the epidemiologic evidence that associates the degree of traffic exposure with lung function in asthma.	Imperial Coll, Dept Occupat & Environm Med, Natl Heart & Lung Inst, London SW3 6LR, England; Royal Brompton Hosp, London, England; Imperial Coll, Dept Epidemiol & Publ Hlth, London SW3 6LR, England; Univ Med & Dent New Jersey, Sch Publ Hlth, Piscataway, NJ USA; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Imperial College London; Royal Brompton Hospital; Imperial College London; Rutgers State University New Brunswick; Rutgers State University Medical Center; Karolinska Institutet	Cullinan, P (corresponding author), Imperial Coll, Dept Occupat & Environm Med, Natl Heart & Lung Inst, 1b Manresa Rd, London SW3 6LR, England.	p.cullinan@imperial.ac.uk	Zhang, Junfeng/AAJ-9183-2020; Nieuwenhuijsen, Mark J/C-3914-2017; Svartengren, Magnus/AAM-7777-2021; Chung, Kian Fan/B-1872-2012	Zhang, Junfeng/0000-0003-3759-6672; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Svartengren, Magnus/0000-0002-8165-7236; Chung, Kian Fan/0000-0001-7101-1426	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abe S, 2000, AM J RESP CELL MOL, V22, P296, DOI 10.1165/ajrcmb.22.3.3711; Air Quality Expert Group, 2005, PART MATT UK; Fischer H, 2002, AM J PHYSIOL-CELL PH, V282, pC736, DOI 10.1152/ajpcell.00369.2001; Goldsmith Carroll-Ann W., 1999, Reviews on Environmental Health, V14, P121; Gong Henry Jr, 2003, Res Rep Health Eff Inst, P1; HISHAM MWM, 1990, ATMOS ENVIRON A-GEN, V24, P2523, DOI 10.1016/0960-1686(90)90344-M; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Ising H, 2003, Noise Health, V5, P41; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; KAUFMAN DS, 1993, ARCH BIOCHEM BIOPHYS, V302, P245, DOI 10.1006/abbi.1993.1206; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Manchester-Neesvig JB, 2003, J AIR WASTE MANAGE, V53, P1065, DOI 10.1080/10473289.2003.10466265; Nel A, 2005, SCIENCE, V309, P1326; Nightingale JA, 2000, AM J RESP CRIT CARE, V162, P161, DOI 10.1164/ajrccm.162.1.9908092; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Penttinen P, 2001, EUR RESPIR J, V17, P428, DOI 10.1183/09031936.01.17304280; Peters A, 1997, AM J RESP CRIT CARE, V155, P1376, DOI 10.1164/ajrccm.155.4.9105082; Polosa R, 2002, ARCH ENVIRON HEALTH, V57, P188, DOI 10.1080/00039890209602935; RUDELL B, 1994, INT ARCH OCC ENV HEA, V66, P77, DOI 10.1007/BF00383361; Rudell B, 1999, OCCUP ENVIRON MED, V56, P527, DOI 10.1136/oem.56.8.527; Rudell B, 1996, OCCUP ENVIRON MED, V53, P658, DOI 10.1136/oem.53.10.658; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; *SAS I, 2006, SAS MIX MOD; Stenfors N, 2004, EUR RESPIR J, V23, P82, DOI 10.1183/09031936.03.00004603; Svartengren M, 2000, EUR RESPIR J, V15, P716, DOI 10.1034/j.1399-3003.2000.15d15.x	28	637	652	3	179	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2348	2358		10.1056/NEJMoa071535	http://dx.doi.org/10.1056/NEJMoa071535			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057337	Green Published			2022-12-28	WOS:000251389200005
J	Dixon-Mueller, R; Germain, A				Dixon-Mueller, Ruth; Germain, Adrienne			HIV testing: the mutual rights and responsibilities of partners	LANCET			English	Editorial Material									Int Womens Hlth Coalit, New York, NY 10001 USA		Germain, A (corresponding author), Int Womens Hlth Coalit, New York, NY 10001 USA.	agermain@iwhc.org						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2004, GEND DIM HIV STAT DI; Csete J, 2004, LANCET, V363, P493, DOI 10.1016/S0140-6736(04)15509-8; McGrath JW, 2007, AIDS CARE, V19, P418, DOI 10.1080/09540120600717668; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Tarantola D, 2007, LANCET, V370, P202, DOI 10.1016/S0140-6736(07)61102-7; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; *UN, 1996, 4 WORLD C WOM BEIJ S; *WHO, 2003, GEND HIV AIDS GEND H	9	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1808	1809		10.1016/S0140-6736(07)61754-1	http://dx.doi.org/10.1016/S0140-6736(07)61754-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061041				2022-12-28	WOS:000251588700007
J	Mateen, FJ				Mateen, Farrah Jasmine			Smoking the pipe of peace	LANCET			English	Editorial Material									Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Mateen, FJ (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	mateen.farrah@mayo.edu		Mateen, Farrah/0000-0002-4293-8115				CATLIN G, 1973, LETT NOTES MANNERS C, V2, P258	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2170	2171		10.1016/S0140-6736(07)61912-6	http://dx.doi.org/10.1016/S0140-6736(07)61912-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156039				2022-12-28	WOS:000252058600040
J	Hambley, TW				Hambley, Trevor W.			Chemistry - Metal-based therapeutics	SCIENCE			English	Editorial Material							COMPLEXES; CYTOTOXICITY; INHIBITORS		Univ Sydney, Sch Chem, Ctr Heavy Met Res, Sydney, NSW 2006, Australia	University of Sydney	Hambley, TW (corresponding author), Univ Sydney, Sch Chem, Ctr Heavy Met Res, Sydney, NSW 2006, Australia.	t.hambley@chem.usyd.edu.au						Ang WH, 2005, J AM CHEM SOC, V127, P1382, DOI 10.1021/ja0432618; Barnard PJ, 2007, COORDIN CHEM REV, V251, P1889, DOI 10.1016/j.ccr.2007.04.006; Barnes KR, 2004, CHEM BIOL, V11, P557, DOI 10.1016/j.chembiol.2004.03.024; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Davies NM, 2004, J PHARM PHARM SCI, V7, P332; *DURH U, 2007, DALT DISC, V10; Failes TW, 2007, CHEM-EUR J, V13, P2974, DOI 10.1002/chem.200601137; Grimley J, 2006, CHEM ENG NEWS, V84, P17, DOI 10.1021/cen-v084n049.p017; HAMBLEY TW, 2007, J CHEM SOC DA, P4929; Hutchinson E, 2006, NAT REV DRUG DISCOV, V5, P720, DOI 10.1038/nrd2142; Kabolizadeh P, 2007, BIOCHEM PHARMACOL, V73, P1270, DOI 10.1016/j.bcp.2006.12.016; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sessler J.L., 2003, MED INORGANIC CHEM; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Thompson KH, 2003, SCIENCE, V300, P936, DOI 10.1126/science.1083004; Ware DC, 2000, J CHEM SOC DALTON, P925, DOI 10.1039/a909447d; Weder JE, 2002, COORDIN CHEM REV, V232, P95, DOI 10.1016/S0010-8545(02)00086-3	17	180	183	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1392	1393		10.1126/science.1150504	http://dx.doi.org/10.1126/science.1150504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048674				2022-12-28	WOS:000251246100028
J	Romer, W; Berland, L; Chambon, V; Gaus, K; Windschiegl, B; Tenza, D; Aly, MRE; Fraisier, V; Florent, JC; Perrais, D; Lamaze, C; Raposo, G; Steinem, C; Sens, P; Bassereau, P; Johannes, L				Roemer, Winfried; Berland, Ludwig; Chambon, Valerie; Gaus, Katharina; Windschiegl, Barbara; Tenza, Daniele; Aly, Mohamed R. E.; Fraisier, Vincent; Florent, Jean-Claude; Perrais, David; Lamaze, Christophe; Raposo, Graca; Steinem, Claudia; Sens, Pierre; Bassereau, Patricia; Johannes, Ludger			Shiga toxin induces tubular membrane invaginations for its uptake into cells	NATURE			English	Article							RETROGRADE TRANSPORT; CRYSTAL-STRUCTURE; ENDOCYTOSIS; CURVATURE; DYNAMIN; PROTEINS; IDENTIFICATION; MECHANISMS; SEPARATION; CAVEOLAE	Clathrin seems to be dispensable for some endocytic processes and, in several instances, no cytosolic coat protein complexes could be detected at sites of membrane invagination. Hence, new principles must in these cases be invoked to account for the mechanical force driving membrane shape changes. Here we show that the Gb3 (glycolipid)-binding B-subunit of bacterial Shiga toxin induces narrow tubular membrane invaginations in human and mouse cells and model membranes. In cells, tubule occurrence increases on energy depletion and inhibition of dynamin or actin functions. Our data thus demonstrate that active cellular processes are needed for tubule scission rather than tubule formation. We conclude that the B-subunit induces lipid reorganization that favours negative membrane curvature, which drives the formation of inward membrane tubules. Our findings support a model in which the lateral growth of B-subunit-Gb3 microdomains is limited by the invagination process, which itself is regulated by membrane tension. The physical principles underlying this basic cargo-induced membrane uptake may also be relevant to other internalization processes, creating a rationale for conceptualizing the perplexing diversity of endocytic routes.	Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Physicochim, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Struct & Compartiments Membranaires, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Chim Organ Vectorisat, F-75248 Paris 05, France; Univ Paris 06, CNRS, UMR168, F-75252 Paris 05, France; CNRS, UMR176, F-75700 Paris, France; Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Hosp, Dept Haematol, Sydney, NSW 2031, Australia; Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Univ Bordeaux 2, Inst Francois Magendie, F-33077 Bordeaux, France; CNRS, ESPCI, UMR Gulliver 7083, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of New South Wales Sydney; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Johannes, L (corresponding author), Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, 26 Rue Ulm, F-75248 Paris 05, France.	johannes@curie.fr	Steinem, Claudia/O-4801-2019; Perrais, David/W-9360-2019; Johannes, Ludger/M-9778-2017; Wunder, Stephanie L/B-5066-2012; sens, pierre/C-3537-2011; Lamaze, Christophe/M-4912-2017; Johannes, Ludger/W-8593-2019; Steinem, Claudia/K-7534-2018; Zdilla, Michael J/B-4145-2011; Bassereau, Patricia/P-8657-2018	Steinem, Claudia/0000-0001-8778-9283; Perrais, David/0000-0002-5878-5408; Johannes, Ludger/0000-0002-2168-0004; sens, pierre/0000-0003-4523-3791; Johannes, Ludger/0000-0002-2168-0004; Gaus, Katharina/0000-0002-8009-9658; Bassereau, Patricia/0000-0002-8544-6778; LAMAZE, Christophe/0000-0001-5430-2707; florent, jean-claude/0000-0001-9837-5094; Raposo, graca/0000-0001-9590-1298				Aly MRE, 2006, CARBOHYD RES, V341, P2026, DOI 10.1016/j.carres.2006.03.044; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Figueroa-Perez S, 2000, CARBOHYD RES, V328, P95, DOI 10.1016/S0008-6215(00)00092-6; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hagnerelle X, 2002, J STRUCT BIOL, V139, P113, DOI 10.1016/S1047-8477(02)00504-X; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; ISRAELACHVILI J, 1991, INTRAMOLECULAR SUR 3; Jensen MH, 2007, LANGMUIR, V23, P8135, DOI 10.1021/la700647v; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manzoni L, 1998, J CARBOHYD CHEM, V17, P739, DOI 10.1080/07328309808002349; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; QIU DX, 1992, LIEBIGS ANN CHEM, P217; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sarasij RC, 2007, BIOPHYS J, V92, P3140, DOI 10.1529/biophysj.106.085662; Sarasij RC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.088101; SCHMIDT RR, 1986, TETRAHEDRON LETT, V27, P481, DOI 10.1016/S0040-4039(00)85510-0; Sens P, 2004, BIOPHYS J, V86, P2049, DOI 10.1016/S0006-3495(04)74266-6; Sens P, 2000, EUR PHYS J E, V1, P237, DOI 10.1007/s101890050026; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	50	444	446	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					670	U3		10.1038/nature05996	http://dx.doi.org/10.1038/nature05996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046403				2022-12-28	WOS:000251209700045
J	Berthe, M; Stiufiuc, R; Grandidier, B; Deresmes, D; Delerue, C; Stievenard, D				Berthe, M.; Stiufiuc, R.; Grandidier, B.; Deresmes, D.; Delerue, C.; Stievenard, D.			Probing the carrier capture rate of a single quantum level	SCIENCE			English	Article							SILICON SURFACES; ATOMIC-SCALE; INTERFACE; DEVICES; STATES; GAP	The performance of many semiconductor quantum- based structures is governed by the dynamics of charge carriers between a localized state and a band of electronic states. Using scanning tunneling spectroscopy, we studied the transport of inelastic tunneling electrons through a prototypical localized state: an isolated dangling- bond state on a Si( 111) surface. From the saturation of the current at an energy resonant with this state, the hole capture rate by the dangling bond was determined. By further mapping the spatial extension of its wave function, the localized nature of the level was found to be consistent with the small magnitude of its cross section. This approach illustrates how the microscopic environment of a single defect critically affects its carrier dynamics.	[Berthe, M.; Stiufiuc, R.; Grandidier, B.; Deresmes, D.; Delerue, C.; Stievenard, D.] Inst Elect Microelect & Nanotechnol, Dept ISEN, CNRS, UMR 8520, F-59046 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lille - ISITE; Centrale Lille; Universite de Lille; Universite Polytechnique Hauts-de-France	Grandidier, B (corresponding author), Inst Elect Microelect & Nanotechnol, Dept ISEN, CNRS, UMR 8520, 41 Blvd Vauban, F-59046 Lille, France.	bruno.grandidier@isen.fr	Stiufiuc, Rares/AAT-3101-2021; STIUFIUC, Rares Ionut/AAO-5177-2021; Berthe, Maxime/E-4124-2014; Delerue, Christophe/E-9949-2012	Stiufiuc, Rares/0000-0001-6769-1545; Berthe, Maxime/0000-0002-3918-7111; Delerue, Christophe/0000-0002-0427-3001				Berthe M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206801; Bourgoin J., 1983, POINT DEFECTS SEMICO; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; de la Broise X, 2000, PHYS REV B, V61, P2138, DOI 10.1103/PhysRevB.61.2138; DELERUE C, 1993, PHYS REV B, V48, P11024, DOI 10.1103/PhysRevB.48.11024; GOGUENHEIM D, 1990, J APPL PHYS, V68, P1059, DOI 10.1063/1.346745; GOGUENHEIM D, 1991, PHYS REV B, V44, P1724, DOI 10.1103/PhysRevB.44.1724; GRIMMEISS HG, 1981, J PHYS E SCI INSTRUM, V14, P1032, DOI 10.1088/0022-3735/14/9/002; HENRY CH, 1977, PHYS REV B, V15, P989, DOI 10.1103/PhysRevB.15.989; JOHNSON NM, 1979, J VAC SCI TECHNOL, V16, P1407, DOI 10.1116/1.570211; Limot L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.126102; LYO IW, 1989, SCIENCE, V245, P1369, DOI 10.1126/science.245.4924.1369; LYO IW, 1989, PHYS REV LETT, V63, P1261, DOI 10.1103/PhysRevLett.63.1261; LYO IW, 1991, SCIENCE, V253, P173, DOI 10.1126/science.253.5016.173; Mahieu G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026407; Neel N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.065502; Repp J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225503; Schmidt KH, 1996, PHYS REV B, V54, P11346, DOI 10.1103/PhysRevB.54.11346; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; WAGNER J, 1988, J APPL PHYS, V63, P425, DOI 10.1063/1.340257; WAGNER J, 1984, PHYS REV B, V29, P2002, DOI 10.1103/PhysRevB.29.2002	21	49	49	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					436	438		10.1126/science.1151186	http://dx.doi.org/10.1126/science.1151186			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18079365				2022-12-28	WOS:000252576600029
J	Hansen, AK; Wisborg, K; Uldbjerg, N; Henriksen, TB				Hansen, Anne Kirkeby; Wisborg, Kirsten; Uldbjerg, Niels; Henriksen, Tine Brink			Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTETRICIANS PERSONAL PREFERENCE; SPONTANEOUS LABOR; VAGINAL DELIVERY; LUNG LIQUID; DISTRESS; FETAL; ABSORPTION; PREGNANCY; REQUEST; HEALTH	Objective To investigate the association between elective Caesarean sections and neonatal respiratory morbidity and the importance of timing of elective Caesarean sections. Design Cohort study with prospectively collected data from the Aarhus birth cohort, Denmark. Setting Obstetric department and neonatal department of a university hospital in Denmark. Participants All liveborn babies without malformations, with gestational ages between 37 and 41 weeks, and delivered between 1 January 1998 and 31 December 2006 (34 458 pregnancies). Main outcome measures Respiratory morbidity (transitory tachypnoea of the newborn, respiratory distress syndrome, persistent pulmonary hypertension of the newborn) and serious respiratory morbidity (oxygen therapy for more than two days, nasal continuous positive airway pressure, or need for mechanical ventilation). Results 2687 infants were delivered by elective caesarean section. Compared with newborns intended for vaginal delivery, an increased risk of respiratory morbidity was found for infants delivered by elective Caesarean section at 37 weeks' gestation (odds ratio 3.9, 95% confidence interval 2.4 to 6.5), 38 weeks' gestation (3.0, 2.1 to 4.3), and 39 weeks' gestation (1.9, 1.2 to 3.0). The increased risks of serious respiratory morbidity showed the same pattern but with higher odds ratios: a fivefold increase was found at 37 weeks (5.0, 1.6 to16.0). These results remained essentially unchanged after exclusion of pregnancies complicated by diabetes, pre-eclampsia, and intrauterine growth retardation, or by breech presentation. Conclusion Compared with newborns delivered vaginally or by emergency caesarean sections, those delivered by elective Caesarean section around term have an increased risk of overall and serious respiratory morbidity. The relative risk increased with decreasing gestational age.	[Hansen, Anne Kirkeby] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; [Wisborg, Kirsten; Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus N, Denmark; [Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8200 Aarhus N, Denmark	Aarhus University; Aarhus University; Aarhus University	Hansen, AK (corresponding author), Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	AKH@svf.au.dk	Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426				*ACOB COMM, 2003, OBSTET GYNECOL 1, V102, P1101; AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Bergholt T, 2004, ACTA OBSTET GYN SCAN, V83, P262, DOI 10.1111/j.0001-6349.2004.0312.x; BOWERS SK, 1982, AM J OBSTET GYNECOL, V143, P186, DOI 10.1016/0002-9378(82)90653-6; BROWN MJ, 1983, J PHYSIOL-LONDON, V344, P137, DOI 10.1113/jphysiol.1983.sp014929; COHEN M, 1985, OBSTET GYNECOL, V65, P818; FAXELIUS G, 1983, ARCH DIS CHILD, V58, P262, DOI 10.1136/adc.58.4.262; Hannah ME, 2004, CAN MED ASSOC J, V170, P813, DOI 10.1503/cmaj.1032002; Hansen AK, 2007, ACTA OBSTET GYN SCAN, V86, P389, DOI 10.1080/00016340601159256; IRESTEDT L, 1982, AM J OBSTET GYNECOL, V142, P1004, DOI 10.1016/0002-9378(82)90783-9; Jackson Nikki V., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P115; Kolas T, 2003, AM J OBSTET GYNECOL, V188, P864, DOI 10.1067/mob.2003.217; LAWSON EE, 1978, AM REV RESPIR DIS, V118, P1023; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Madar J, 1999, ACTA PAEDIATR, V88, P1244, DOI 10.1080/080352599750030365; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Scott JR, 2006, OBSTET GYNECOL, V107, P1222, DOI 10.1097/01.AOG.0000221482.51250.3c; Steer PJ, 2005, BMJ-BRIT MED J, V331, P645, DOI 10.1136/bmj.331.7518.645; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WALTERS DV, 1978, PEDIATR RES, V12, P239, DOI 10.1203/00006450-197803000-00017; WENNERGREN M, 1986, BRIT J OBSTET GYNAEC, V93, P799; Wisborg K, 2003, BRIT MED J, V326, P420, DOI 10.1136/bmj.326.7386.420	24	366	391	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					85	87		10.1136/bmj.39405.539282.BE	http://dx.doi.org/10.1136/bmj.39405.539282.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18077440	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000252494800030
J	Kleiven, HF; Kissel, C; Laj, C; Ninnemann, US; Richter, TO; Cortijo, E				Kleiven, Helga (Kikki) Flesche; Kissel, Catherine; Laj, Carlo; Ninnemann, Ulysses S.; Richter, Thomas O.; Cortijo, Elsa			Reduced North Atlantic Deep Water coeval with the glacial Lake Agassiz freshwater outburst	SCIENCE			English	Article							RAPID CLIMATIC VARIATIONS; KA BP EVENT; LABRADOR SEA; NORDIC SEAS; CATASTROPHIC DRAINAGE; MAGNETIC SIGNATURE; COLD EVENT; OCEAN; CIRCULATION; VARIABILITY	An outstanding climate anomaly 8200 years before the present ( B. P.) in the North Atlantic is commonly postulated to be the result of weakened overturning circulation triggered by a freshwater outburst. New stable isotopic and sedimentological records from a northwest Atlantic sediment core reveal that the most prominent Holocene anomaly in bottom- water chemistry and flow speed in the deep limb of the Atlantic overturning circulation begins at similar to 8.38 thousand years B. P., coeval with the catastrophic drainage of Lake Agassiz. The influence of Lower North Atlantic Deep Water was strongly reduced at our site for similar to 100 years after the outburst, confirming the ocean's sensitivity to freshwater forcing. The similarities between the timing and duration of the pronounced deep circulation changes and regional climate anomalies support a causal link.	[Kleiven, Helga (Kikki) Flesche; Ninnemann, Ulysses S.] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Kissel, Catherine; Laj, Carlo; Cortijo, Elsa] Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; [Kleiven, Helga (Kikki) Flesche; Ninnemann, Ulysses S.] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Richter, Thomas O.] Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands	Bjerknes Centre for Climate Research; University of Bergen; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Bergen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Kleiven, HF (corresponding author), Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway.	kikki@uib.no	Catherine, Kissel/AAH-1647-2019	Catherine, Kissel/0000-0002-2572-2742				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bauer E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001030; Biastoch A, 2003, J PHYS OCEANOGR, V33, P2307, DOI 10.1175/1520-0485(2003)033<2307:TSOTGR>2.0.CO;2; Came RE, 2007, GEOLOGY, V35, P315, DOI 10.1130/G23455A.1; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Ellison CRW, 2006, SCIENCE, V312, P1929, DOI 10.1126/science.1127213; Hall IR, 2004, QUATERNARY SCI REV, V23, P1529, DOI 10.1016/j.quascirev.2004.04.004; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Hillaire-Marcel C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030396; HILLAIREMARCEL C, 1994, CAN J EARTH SCI, V31, P63, DOI 10.1139/e94-007; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Keigwin LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001074; Kissel C, 1999, EARTH PLANET SC LETT, V171, P489, DOI 10.1016/S0012-821X(99)00162-4; Kissel C, 2005, CR GEOSCI, V337, P908, DOI 10.1016/j.crte.2005.04.009; Klitgaard-Kristensen D, 1998, J QUATERNARY SCI, V13, P165, DOI 10.1002/(SICI)1099-1417(199803/04)13:2<165::AID-JQS365>3.0.CO;2-#; Latif M, 2006, J CLIMATE, V19, P4631, DOI 10.1175/JCLI3876.1; LeGrande AN, 2006, P NATL ACAD SCI USA, V103, P837, DOI 10.1073/pnas.0510095103; Leverington DW, 2002, QUATERNARY RES, V57, P244, DOI 10.1006/qres.2001.2311; MCCARTNEY MS, 1992, PROG OCEANOGR, V29, P283, DOI 10.1016/0079-6611(92)90006-L; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Oppo DW, 2003, NATURE, V422, P277, DOI 10.1038/422277b; Rasmussen SO, 2007, QUATERNARY SCI REV, V26, P1907, DOI 10.1016/j.quascirev.2007.06.015; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Renssen H, 2001, GEOPHYS RES LETT, V28, P1567, DOI 10.1029/2000GL012602; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; Stoner JS, 1996, PALEOCEANOGRAPHY, V11, P309, DOI 10.1029/96PA00583; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7; Thomas ER, 2007, QUATERNARY SCI REV, V26, P70, DOI 10.1016/j.quascirev.2006.07.017; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Wiersma AP, 2006, CLIM DYNAM, V27, P831, DOI 10.1007/s00382-006-0166-0; Wiersma AP, 2006, QUATERNARY SCI REV, V25, P63, DOI 10.1016/j.quascirev.2005.07.009; WOLD CN, 1994, PALEOCEANOGRAPHY, V9, P917, DOI 10.1029/94PA01438	39	183	193	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					60	64		10.1126/science.1148924	http://dx.doi.org/10.1126/science.1148924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18063758	Green Submitted			2022-12-28	WOS:000252084000029
J	Triunfol, ML				Triunfol, Marcia L.			Latin American science moves into the spotlight	CELL			English	Editorial Material														Triunfol, Marcia/0000-0003-4485-6380					0	8	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1213	1216		10.1016/j.cell.2007.12.008	http://dx.doi.org/10.1016/j.cell.2007.12.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160028	Bronze			2022-12-28	WOS:000252217200006
J	McWilliams, JM; Meara, E; Zaslavsky, AM; Ayanian, JZ				McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.			Health of previously uninsured adults after acquiring medicare coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; INSURANCE-COVERAGE; SURVEY SF-36; CARDIOVASCULAR EVENTS; CARE; AGE; SERVICES; RISK; BENEFICIARIES; HYPERTENSION	Context Uninsured near- elderly adults, particularly those with cardiovascular disease or diabetes, experience worse health outcomes than insured adults. However, the health benefits of providing insurance coverage for uninsured adults have not been clearly demonstrated. Objective To assess the effect of acquiring Medicare coverage on the health of previously uninsured adults. Design and Setting We conducted quasi- experimental analyses of longitudinal survey data from 1992 through 2004 from the nationally representative Health and Retirement Study. We compared changes in health trends reported by previously uninsured and insured adults after they acquired Medicare coverage at age 65 years. Participants Five thousand six adults who were continuously insured and 2227 adults who were persistently or intermittently uninsured from ages 55 to 64 years. Main Outcome Measures Differential changes in self- reported trends after age 65 years in general health, change in general health, mobility, agility, pain, depressive symptoms, and a summary measure of these 6 domains; and adverse cardiovascular outcomes ( all trend changes reported in health scores per year). Results Compared with previously insured adults, previously uninsured adults reported significantly improved health trends after age 65 years for the summary measure ( differential change in annual trend, + 0.20; P =. 002) and several component measures. Relative to previously insured adults with cardiovascular disease or diabetes, previously uninsured adults with these conditions reported significantly improved trends in summary health ( differential change in annual trend, + 0.26; P=. 006), change in general health ( + 0.02; P=. 03), mobility ( + 0.04; P=. 05), agility ( + 0.08; P=. 003), and adverse cardiovascular outcomes (- 0.015; P=. 02) but not in depressive symptoms ( + 0.04; P=. 32). Previously uninsured adults without these conditions reported differential improvement in depressive symptoms ( + 0.08; P=. 002) but not in summary health ( + 0.10; P=. 17) or any other measure. By age 70 years, the expected difference in summary health between previously uninsured and insured adults with cardiovascular disease or diabetes was reduced by 50%. Conclusion In this study, acquisition of Medicare coverage was associated with improved trends in self- reported health for previously uninsured adults, particularly those with cardiovascular disease or diabetes.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med & Primary Care, Dept Med, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Bureau of Economic Research; Harvard University; Harvard T.H. Chan School of Public Health	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM COLL PHYS, 2006, DEV MED BUY IN PROGR; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Baker DW, 2006, J GEN INTERN MED, V21, P1144, DOI 10.1111/j.1525-1497.2006.00576.x; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2005, ARCH INTERN MED, V165, P770, DOI 10.1001/archinte.165.7.770; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Balding DJ, 2004, APPL LONGITUDINAL AN; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown ME, 1998, MED CARE RES REV, V55, P177, DOI 10.1177/107755879805500203; CARD D, 2004, IMPACT NEARLY UNIVER; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; COLLINS SR, 2005, WILL YOU STILL NEED, P840; Cutler DM, 2007, HEALTH AFFAIR, V26, P97, DOI 10.1377/hlthaff.26.1.97; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; DiMassa G, 2007, ANN INTERN MED, V146, P814, DOI 10.7326/0003-4819-146-11-200706050-00010; Dor A, 2006, HEALTH SERV RES, V41, P759, DOI 10.1111/j.1475-6773.2006.00513.x; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; FINKELSTEIN A, 2005, WHAT DID MEDICARE DO, P11609; Fowler-Brown A, 2007, J GEN INTERN MED, V22, P502, DOI 10.1007/s11606-007-0127-2; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; HEERINGA SG, TECHNICAL DESCRIPTIO; HELSLER M, 2007, ARCH INTERN MED, V167, P1853; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; *I MED, 2003, HIDD COSTS AL LOST; Institute of Medicine, 2002, CAR COV TOO LITTL TO; *KAIS FAM FDN HLTH, 2004, EMPL HLTH BEN 2004 A; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Levy H., 2004, WHAT WE REALLY KNOW; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LICHTENBERG FR, 2002, FRONTIERS HLTH POLIC, V5; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; MILLER W, 2004, HLTH AFF MILLWOOD; *NAT CTR HLTH STAT, 2005, DHHS PUBL; POLSKY D, 2006, HLTH EFFECTS MEDICAR; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rice T, 2004, MED CARE RES REV, V61, P415, DOI 10.1177/1077558704269498; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Rosen AB, 2007, HEALTH AFFAIR, V26, P111, DOI 10.1377/hlthaff.26.1.111; Sherman SE, 1998, J GEN INTERN MED, V13, P817, DOI 10.1046/j.1525-1497.1998.00245.x; Simantov E, 2001, HEALTH AFFAIR, V20, P139, DOI 10.1377/hlthaff.20.4.139; STUART B, 2003, HLTH AFF MILLWOOD; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *U MICH, 2006, HLTH RET STUD 1992 2; Wallace RB, 1995, J HUM RESOUR, V30, pS84, DOI 10.2307/146279; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yusuf S, 2000, NEW ENGL J MED, V342, P145	62	135	136	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2886	2894		10.1001/jama.298.24.2886	http://dx.doi.org/10.1001/jama.298.24.2886			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243RW	18159058	Bronze			2022-12-28	WOS:000251816000021
J	Sharma, S; Kandpal, H				Sharma, Sanjay; Kandpal, Harsh			Images in clinical medicine: Chronic Budd-Chiari syndrome and abdominal varices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, S (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	drssharma@hotmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					E29	E29		10.1056/NEJMicm067852	http://dx.doi.org/10.1056/NEJMicm067852			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094370				2022-12-28	WOS:000251728900012
J	Berry, DL; Baehrecke, EH				Berry, Deborah L.; Baehrecke, Eric H.			Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila	CELL			English	Article							STEROID REGULATION; DEATH; APOPTOSIS; INDUCTION; SIZE; CASPASES; SURVIVAL; MUTANTS; PATHWAY; DISEASE	Autophagy is a catabolic process that is negatively regulated by growth and has been implicated in cell death. We find that autophagy is induced following growth arrest and precedes developmental autophagic cell death of Drosophila salivary glands. Maintaining growth by expression of either activated Ras or positive regulators of the class I phosphoinositide 3-kinase (PI3K) pathway inhibits autophagy and blocks salivary gland cell degradation. Developmental degradation of salivary glands is also inhibited in autophagy gene (atg) mutants. Caspases are active in PI3K-expressing and atg mutant salivary glands, and combined inhibition of both autophagy and caspases increases suppression of gland degradation. Further, induction of autophagy is sufficient to induce premature cell death in a caspase-independent manner. Our results provide in vivo evidence that growth arrest, autophagy, and atg genes are required for physiological autophagic cell death and that multiple degradation pathways cooperate in the efficient clearance of cells during development.	[Berry, Deborah L.; Baehrecke, Eric H.] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA.	eric.baehrecke@umassmed.edu			NIGMS NIH HHS [R56 GM059136, R01 GM059136-09, R01 GM059136-10, R01 GM079431-01, R01 GM079431, GM59136, R01 GM059136-06, GM079431, R01 GM059136-08, R01 GM059136, R01 GM059136-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059136, R01GM079431, R56GM059136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FOX H, 1975, J EMBRYOL EXP MORPH, V34, P191; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Lee CY, 2001, DEVELOPMENT, V128, P1443; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Martin DN, 2007, CELL DEATH DIFFER, V14, P916, DOI 10.1038/sj.cdd.4402098; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schreiber AM, 2003, P NATL ACAD SCI USA, V100, P1769, DOI 10.1073/pnas.252774999; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	48	461	476	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1137	1148		10.1016/j.cell.2007.10.048	http://dx.doi.org/10.1016/j.cell.2007.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083103	Green Accepted, Bronze			2022-12-28	WOS:000252217100021
J	Hoegh-Guldberg, O; Mumby, PJ; Hooten, AJ; Steneck, RS; Greenfield, P; Gomez, E; Harvell, CD; Sale, PF; Edwards, AJ; Caldeira, K; Knowlton, N; Eakin, CM; Iglesias-Prieto, R; Muthiga, N; Bradbury, RH; Dubi, A; Hatziolos, ME				Hoegh-Guldberg, O.; Mumby, P. J.; Hooten, A. J.; Steneck, R. S.; Greenfield, P.; Gomez, E.; Harvell, C. D.; Sale, P. F.; Edwards, A. J.; Caldeira, K.; Knowlton, N.; Eakin, C. M.; Iglesias-Prieto, R.; Muthiga, N.; Bradbury, R. H.; Dubi, A.; Hatziolos, M. E.			Coral reefs under rapid climate change and ocean acidification	SCIENCE			English	Review							ATMOSPHERIC CO2; MARINE; ECOLOGY; RECRUITMENT; THRESHOLDS; RESILIENCE; INTENSITY; DYNAMICS; RECOVERY; FUTURE	Atmospheric carbon dioxide concentration is expected to exceed 500 parts per million and global temperatures to rise by at least 2 degrees C by 2050 to 2100, values that significantly exceed those of at least the past 420,000 years during which most extant marine organisms evolved. Under conditions expected in the 21st century, global warming and ocean acidification will compromise carbonate accretion, with corals becoming increasingly rare on reef systems. The result will be less diverse reef communities and carbonate reef structures that fail to be maintained. Climate change also exacerbates local stresses from declining water quality and overexploitation of key species, driving reefs increasingly toward the tipping point for functional collapse. This review presents future scenarios for coral reefs that predict increasingly serious consequences for reef- associated fisheries, tourism, coastal protection, and people. As the International Year of the Reef 2008 begins, scaled- up management intervention and decisive action on global emissions are required if the loss of coral- dominated ecosystems is to be avoided.	Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia; Univ Exeter, Sch Biosci, Marine Spatial Ecol Lab, Exeter EX4 4PS, Devon, England; AJH Environm Serv, Bethesda, MD 20814 USA; Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA; Univ Queensland, The Chancellery, St Lucia, Qld 4072, Australia; Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines; Cornell Univ, Ithaca, NY 14853 USA; United Nations Univ, Int Network Water Environm & Hlth, Hamilton, ON L8N 1E9, Canada; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; NOAA, Coral Reef Watch, Silver Spring, MD 20910 USA; Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Puerto Morelos, Cancun 77500, QR, Mexico; Wildlife Conservat Soc, Bronx, NY 10460 USA; Australian Natl Univ, Resource Management Asia Pacific Program, Canberra, ACT 0200, Australia; Univ Dar Es Salaam, Inst Marine Sci, Dar Es Salaam, Tanzania; World Bank, Dept Environm, Washington, DC 20433 USA	University of Queensland; University of Exeter; University of Maine System; University of Maine Orono; University of Queensland; University of the Philippines System; University of the Philippines Diliman; Cornell University; Newcastle University - UK; Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History; National Oceanic Atmospheric Admin (NOAA) - USA; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Wildlife Conservation Society; Australian National University; University of Dar es Salaam; The World Bank	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia.	oveh@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Edwards, Alasdair J/C-9558-2009; Iglesias-Prieto, Roberto/E-4921-2011; Hoegh-Guldberg, Ove/H-6169-2011; Caldeira, Ken/E-7914-2011; Mumby, Peter/F-9914-2010; Eakin, C. Mark/F-5585-2010	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Edwards, Alasdair J/0000-0002-2979-7389; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Caldeira, Ken/0000-0002-4591-643X; Mumby, Peter/0000-0002-6297-9053; Dubi, Alfonse/0000-0002-7003-3591; Eakin, C. Mark/0000-0002-5987-0858; Bradbury, Roger/0000-0002-0940-3493	Natural Environment Research Council [NE/E00606X/1] Funding Source: researchfish; NERC [NE/E00606X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2006, MARINE COASTAL ECOSY; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bryant D., 1998, REEFS RISK MAP BASED; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Done T., 2003, GLOBAL CLIMATE CHANG; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Fernando H., 2005, EOS T AM GEOPHYS UN, V86, P301, DOI [10.1029/2005EO330002, DOI 10.1029/2005EO330002]; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Grigg RW, 2002, CORAL REEFS, V21, P73, DOI 10.1007/s00338-001-0203-8; Hansen JE, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024002; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hoegh-Guldberg H., 2004, BIOL EC SOCIAL IMPAC; Hoegh-Guldberg O, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002528; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IPCC, 2001, ADV CLIM CHANG RES; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kleypas JA, 1999, AM ZOOL, V39, P146; KLEYPAS JA, 2003, EARTH-SCI REV, V60, P195; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; KNOWLTON N, 1992, AM ZOOL, V32, P674; Lewis E., 1998, ORNLCDIAC105 US DEP; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Raven J., 2005, 1205 ROYAL SOC; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; SADD JL, 1984, B MAR SCI, V35, P221; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Steneck R. S, 1994, P C GLOB ASP COR REE; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; UNEP-WCMC, 2006, FRONT LIN SHOR PROT, P33; Williams EH, 1999, GLOBAL CHANGE BIOL, V5, P839, DOI 10.1046/j.1365-2486.1999.00272.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; WRAY JL, 1969, P N AM PALEONTOL CON, P1358	52	3638	3741	572	11105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1737	1742		10.1126/science.1152509	http://dx.doi.org/10.1126/science.1152509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079392	Green Published			2022-12-28	WOS:000251616800029
J	Schieber, J; Southard, J; Thaisen, K				Schieber, Juergen; Southard, John; Thaisen, Kevin			Accretion of mudstone beds from migrating floccule ripples	SCIENCE			English	Article							AMAZON SUBAQUEOUS DELTA; SEDIMENTARY STRUCTURES; FLUME EXPERIMENTS; ORIGIN; DEPOSITION; SHALES; FACIES	Mudstones make up the majority of the geological record. However, it is difficult to reconstruct the complex processes of mud deposition in the laboratory, such as the clumping of particles into floccules. Using flume experiments, we have investigated the bedload transport and deposition of clay floccules and find that this occurs at flow velocities that transport and deposit sand. Deposition- prone floccules form over a wide range of experimental conditions, which suggests an underlying universal process. Floccule ripples develop into low- angle foresets and mud beds that appear laminated after postdepositional compaction, but the layers retain signs of floccule ripple bedding that would be detectable in the rock record. Because mudstones were long thought to record low- energy conditions of offshore and deeper water environments, our results call for reevaluation of published interpretations of ancient mudstone successions and derived paleoceanographic conditions.	Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; MIT, Dept Earth & Planetary Sci, Cambridge, MA 02139 USA	Indiana University System; Indiana University Bloomington; Massachusetts Institute of Technology (MIT)	Schieber, J (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	jschiebe@indiana.edu	Schieber, Juergen Schieber/A-3001-2013					Allen JRL., 1985, PRINCIPLES PHYS SEDI; Baas JH, 2002, J SEDIMENT RES, V72, P336, DOI 10.1306/120601720336; BERLAMONT J, 1993, COAST ENG, V21, P105, DOI 10.1016/0378-3839(93)90047-C; EINSTEIN HA, 1961, P J HYDR DIV, V12, P51; HAWLEY N, 1981, SEDIMENTOLOGY, V28, P699, DOI 10.1111/j.1365-3091.1981.tb01930.x; KUEHL SA, 1986, CONT SHELF RES, V6, P311, DOI 10.1016/0278-4343(86)90066-X; KUEHL SA, 1988, J SEDIMENT PETROL, V58, P12; KUEHL SA, 1991, FRONT SED, P33; MCCAVE IN, 1984, FINE GRAINED SEDIMEN, P35; OBRIEN NR, 1990, ARGILLACEOUS ROCK AT; PARTHENIADES E, 1965, P AM SOC CIVIL ENG, V91, P105; Pasierbiewicz KW, 1997, J SEDIMENT RES, V67, P510; Potter P.E., 2005, MUD AND MUDSTONES; Potter P.E., 1980, SEDIMENTOLOGY SHALE; Schieber J, 1999, J SEDIMENT RES, V69, P909, DOI 10.2110/jsr.69.909; SCHIEBER J, 1986, SEDIMENTOLOGY, V33, P521, DOI 10.1111/j.1365-3091.1986.tb00758.x; SCHIEBER J, 1989, SEDIMENTOLOGY, V36, P203, DOI 10.1111/j.1365-3091.1989.tb00603.x; Schieber J., 1998, SHALES MUDSTONES, V1, P131; Schieber J., 1998, SHALES AND MUDSTONES, V1, P187; SEGALL MP, 1994, SEDIMENT GEOL, V93, P165, DOI 10.1016/0037-0738(94)90003-5; Sorby H.C., 1908, Q J GEOLOGICAL SOC, V64, P171, DOI [10.1144/GSL.JGS.1908.064.01-04.12, DOI 10.1144/GSL.JGS.1908.064.01-04.12]; Stokes W.L., 1953, PRIMARY SEDIMENTAR 1; WINTERWERP JC, 2002, P MAR SCI, V5	23	247	275	7	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1760	1763		10.1126/science.1147001	http://dx.doi.org/10.1126/science.1147001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079398				2022-12-28	WOS:000251616800036
J	Manis, JP				Manis, John P.			Knock out, knock in, knock down - Genetically manipulated mice and the Nobel Prize	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; GENE		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Manis, JP (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.							DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5	5	46	53	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2426	2429		10.1056/NEJMp0707712	http://dx.doi.org/10.1056/NEJMp0707712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077807				2022-12-28	WOS:000251564400003
J	Trefethen, LN				Trefethen, Lloyd N.			Gene H. Holub (1932-2007) - Obituary	NATURE			English	Biographical-Item									Univ Oxford, Comp Lab, Oxford OX1 3QD, England	University of Oxford	Trefethen, LN (corresponding author), Univ Oxford, Comp Lab, Oxford OX1 3QD, England.	lnt@comlab.ox.ac.uk							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					962	962		10.1038/450962a	http://dx.doi.org/10.1038/450962a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075573				2022-12-28	WOS:000251579900064
J	Kang, HJ; Coulibaly, F; Clow, F; Proft, T; Baker, EN				Kang, Hae Joo; Coulibaly, Fasseli; Clow, Fiona; Proft, Thomas; Baker, Edward N.			Stabilizing isopeptide bonds revealed in Gram-positive bacterial pilus structure	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN; PATHOGENESIS; ANTIGENS; ADHESION; COLLAGEN; BINDING; SURFACE; PILIN	Many bacterial pathogens have long, slender pili through which they adhere to host cells. The crystal structure of the major pilin subunit from the Gram- positive human pathogen Streptococcus pyogenes at 2.2 angstroms resolution reveals an extended structure comprising two all-beta domains. The molecules associate in columns through the crystal, with each carboxyl terminus adjacent to a conserved lysine of the next molecule. This lysine forms the isopeptide bonds that link the subunits in native pili, validating the relevance of the crystal assembly. Each subunit contains two lysine-asparagine isopeptide bonds generated by an intramolecular reaction, and we find evidence for similar isopeptide bonds in other cell surface proteins of Gram- positive bacteria. The present structure explains the strength and stability of such Gram- positive pili and could facilitate vaccine development.	Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; Univ Auckland, Sch Med Sci, Auckland 1023, New Zealand	University of Auckland; University of Auckland; University of Auckland	Proft, T (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand.	t.proft@auckland.ac.nz; ted.baker@auckland.ac.nz	Kang, H J/D-4845-2009; Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Coulibaly, Fasseli/0000-0003-3380-2117; Baker, Edward/0000-0003-2456-7661				Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LANCEFIELD RC, 1946, J EXP MED, V84, P449, DOI 10.1084/jem.84.5.449; Lancefield RC, 1940, J EXP MED, V71, P521, DOI 10.1084/jem.71.4.521; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	23	271	283	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1625	1628		10.1126/science.1145806	http://dx.doi.org/10.1126/science.1145806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063798				2022-12-28	WOS:000251421700046
J	Reale, F; Parenti, S; Reeves, KK; Weber, M; Bobra, MG; Barbera, M; Kano, R; Narukage, N; Shimojo, M; Sakao, T; Peres, G; Golub, L				Reale, Fabio; Parenti, Susanna; Reeves, Kathy K.; Weber, Mark; Bobra, Monica G.; Barbera, Marco; Kano, Ryouhei; Narukage, Noriyuki; Shimojo, Masumi; Sakao, Taro; Peres, Giovanni; Golub, Leon			Fine thermal structure of a coronal active region	SCIENCE			English	Article							X-RAY TELESCOPE; LOOPS	The determination of the fine thermal structure of the solar corona is fundamental to constraining the coronal heating mechanisms. The Hinode X-ray Telescope collected images of the solar corona in different passbands, thus providing temperature diagnostics through energy ratios. By combining different filters to optimize the signal-to-noise ratio, we observed a coronal active region in five filters, revealing a highly thermally structured corona: very fine structures in the core of the region and on a larger scale further away. We observed continuous thermal distribution along the coronal loops, as well as entangled structures, and variations of thermal structuring along the line of sight.	Univ Palermo, Sez Astron, Dipartimento Sci Fis & Astron, I-90134 Palermo, Italy; Ist Nazl AstroFis, Osservatorio Astron Palermo, I-90134 Palermo, Italy; Observ Royal Belgique, B-1180 Brussels, Belgium; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Natl Astron Observ, Tokyo 1818588, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Natl Astron Observ, Nobeyama Solar Radio Observ, Nagano 3841305, Japan	University of Palermo; Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Reale, F (corresponding author), Univ Palermo, Sez Astron, Dipartimento Sci Fis & Astron, Piazza Parlamento 1, I-90134 Palermo, Italy.	reale@astropa.unipa.it	Shimojo, Masumi/J-2605-2016; Reeves, Katharine/P-9163-2014	Shimojo, Masumi/0000-0002-2350-3749; PERES, Giovanni/0000-0002-6033-8180; Golub, Leon/0000-0001-9638-3082; Narukage, Noriyuki/0000-0002-6330-3944; Reeves, Katharine/0000-0002-6903-6832; Bobra, Monica/0000-0002-5662-9604; Reale, Fabio/0000-0002-1820-4824; Barbera, Marco/0000-0002-3188-7420	Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish; STFC [PP/D002907/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Cargill PJ, 2004, ASTROPHYS J, V605, P911, DOI 10.1086/382526; CARGILL PJ, 1994, ASTROPHYS J, V422, P381, DOI 10.1086/173733; DERE KP, 1993, SOL PHYS, V144, P217, DOI 10.1007/BF00627590; Fuentes MCL, 2006, ASTROPHYS J, V639, P459, DOI 10.1086/499155; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; SERIO S, 1981, ASTROPHYS J, V243, P288, DOI 10.1086/158597; TSUNETA S, 1992, PUBL ASTRON SOC JPN, V44, pL63; VAIANA GS, 1973, SOL PHYS, V32, P81, DOI 10.1007/BF00152731; VESECKY JF, 1979, ASTROPHYS J, V233, P987, DOI 10.1086/157462; Yoshida T, 1996, ASTROPHYS J, V459, P342, DOI 10.1086/176897	12	34	35	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1582	1585		10.1126/science.1146590	http://dx.doi.org/10.1126/science.1146590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063787				2022-12-28	WOS:000251421700033
J	Al-Amoudi, A; Diez, DC; Betts, MJ; Frangakis, AS				Al-Amoudi, Ashraf; Diez, Daniel Castano; Betts, Matthew J.; Frangakis, Achilleas S.			The molecular architecture of cadherins in native epidermal desmosomes	NATURE			English	Article							CELL-CELL ADHESION; CRYOELECTRON MICROSCOPY; VITREOUS SECTIONS; STRUCTURAL BASIS; HOMOPHILIC BINDING; IDENTIFICATION; ECTODOMAIN; DIMERIZATION; SPECIFICITY; DEPENDENCE	Desmosomes are cadherin- based adhesive intercellular junctions, which are present in tissues such as heart and skin. Despite considerable efforts, the molecular interfaces that mediate adhesion remain obscure. Here we apply cryo- electron tomography of vitreous sections from human epidermis to visualize the three- dimensional molecular architecture of desmosomal cadherins at close- to- native conditions. The three- dimensional reconstructions show a regular array of densities at similar to 70 angstrom intervals along the midline, with a curved shape resembling the X- ray structure of C- cadherin, a representative 'classical' cadherin. Model- independent three- dimensional image processing of extracted sub- tomograms reveals the cadherin organization. After fitting the C- cadherin atomic structure into the averaged sub- tomograms, we see a periodic arrangement of a trans W- like and a cis V- like interaction corresponding to molecules from opposing membranes and the same cell membrane, respectively. The resulting model of cadherin organization explains existing two- dimensional data and yields insights into a possible mechanism of cadherin- based cell adhesion.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Frangakis, AS (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	frangak@embl.de		Betts, Matthew/0000-0003-4583-9814; Castano-Diez, Daniel/0000-0002-0197-163X; Frangakis, Achilleas/0000-0002-8067-6611				Al-Amoudi A, 2005, J STRUCT BIOL, V150, P109, DOI 10.1016/j.jsb.2005.01.003; Al-Amoudi A, 2005, J INVEST DERMATOL, V124, P764, DOI 10.1111/j.0022-202X.2005.23630.x; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; FORSTER F, IN PRESS J STRUCT BI; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Franzen A, 2006, EUR SOCIOL REV, V22, P353, DOI 10.1093/esr/jcl001; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Hsieh CE, 2006, J STRUCT BIOL, V153, P1, DOI 10.1016/j.jsb.2005.10.004; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Masich S, 2006, J STRUCT BIOL, V156, P461, DOI 10.1016/j.jsb.2006.05.010; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Shaikh TR, 2003, J STRUCT BIOL, V142, P301, DOI 10.1016/S1047-8477(03)00029-7; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	38	211	212	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					832	U8		10.1038/nature05994	http://dx.doi.org/10.1038/nature05994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064004				2022-12-28	WOS:000251394900046
J	Peltier, WR; Liu, YG; Crowley, JW				Peltier, W. Richard; Liu, Yonggang; Crowley, John W.			Snowball Earth prevention by dissolved organic carbon remineralization	NATURE			English	Article							ENERGY-BALANCE; SURFACE-TEMPERATURE; GEOCHEMICAL CYCLE; CLIMATE DYNAMICS; SOUTH-AUSTRALIA; FIQ GLACIATION; SHEET MODEL; ICE-AGE; SUCCESSIONS; OMAN	The 'snowball Earth' hypothesis posits the occurrence of a sequence of glaciations in the Earth's history sufficiently deep that photosynthetic activity was essentially arrested. Because the time interval during which these events are believed to have occurred immediately preceded the Cambrian explosion of life, the issue as to whether such snowball states actually developed has important implications for our understanding of evolutionary biology. Here we couple an explicit model of the Neoproterozoic carbon cycle to a model of the physical climate system. We show that the drawdown of atmospheric oxygen into the ocean, as surface temperatures decline, operates so as to increase the rate of remineralization of a massive pool of dissolved organic carbon. This leads directly to an increase of atmospheric carbon dioxide, enhanced greenhouse warming of the surface of the Earth, and the prevention of a snowball state.	Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	University of Toronto	Peltier, WR (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	peltier@atmosp.physics.utoronto.ca	Peltier, William R./A-1102-2008	Liu, Yonggang/0000-0001-8844-2185; Crowley, John/0000-0001-8655-7907				Allen PA, 2004, BASIN RES, V16, P507, DOI 10.1111/j.1365-2117.2004.00249.x; BERNER R A, 2004, PHANEROZOIC CARBON C, P1; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; Butler SL, 2005, PHYS EARTH PLANET IN, V152, P22, DOI 10.1016/j.pepi.2005.05.005; Chandler MA, 2000, J GEOPHYS RES-ATMOS, V105, P20737, DOI 10.1029/2000JD900221; Christie-Blick N, 2001, J GEOL SOC LONDON, V158, P573, DOI 10.1144/jgs.158.3.573; CHRISTIEBLICK N, 1990, AM J SCI, V290A, P295; Condie K.C., 2008, EOS T AM GEOPHYS UN, V89, P112, DOI [DOI 10.1029/2006EO450005, 10.1029/2008EO110011, DOI 10.1029/2008EO110011]; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DEBLONDE G, 1992, GLOBAL PLANET CHANGE, V98, P37, DOI 10.1016/0921-8181(92)90021-2; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Eyles N, 2004, EARTH-SCI REV, V65, P1, DOI 10.1016/S0012-8252(03)00080-1; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Goodman JC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001471; Grey K, 1998, PRECAMBRIAN RES, V92, P65, DOI 10.1016/S0301-9268(98)00068-0; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hoffman PF, 2000, SCI AM, V282, P68, DOI 10.1038/scientificamerican0100-68; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hyde WT, 2006, GEOLOGY, V34, P421, DOI 10.1130/G22108.1; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Hyde WT, 1999, CLIM DYNAM, V15, P619, DOI 10.1007/s003820050305; Kaufman AJ, 1997, NATURE, V386, P227, DOI 10.1038/386227a0; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Knoll A., 2003, LIFE YOUNG PLANET 1, P1; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Le Guerroue E, 2006, PRECAMBRIAN RES, V146, P68, DOI 10.1016/j.precamres.2006.01.007; Leather J, 2002, GEOLOGY, V30, P891, DOI 10.1130/0091-7613(2002)030<0891:NSEUSE>2.0.CO;2; MARSHALL HG, 1988, J GEOPHYS RES-ATMOS, V93, P791, DOI 10.1029/JD093iD01p00791; MOCZYDLOWSKA M, 1995, STUD GEOPHYS GEOD, V39, P276, DOI 10.1007/BF02295819; NORTH GR, 1983, J GEOPHYS RES-OCEANS, V88, P6576, DOI 10.1029/JC088iC11p06576; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Peltier WR, 2004, GEOPHYS MONOGR SER, V146, P107, DOI 10.1029/146GM10; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Pierrehumbert RT, 2004, NATURE, V429, P646, DOI 10.1038/nature02640; PIERREHUMBERT RT, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2004JD0005162; Pollard D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002525; Poulsen CJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001056; Poulsen CJ, 2001, GEOPHYS RES LETT, V28, P1575, DOI 10.1029/2000GL012058; RAMANATHAN V, 1979, J GEOPHYS RES-OCEANS, V84, P4949, DOI 10.1029/JC084iC08p04949; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Runnegar B, 2000, NATURE, V405, P403, DOI 10.1038/35013168; Schrag DP, 2001, NATURE, V409, P306, DOI 10.1038/35053170; Tarasov L, 2005, NATURE, V435, P662, DOI 10.1038/nature03617; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776	48	77	78	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					813	U1		10.1038/nature06354	http://dx.doi.org/10.1038/nature06354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064001				2022-12-28	WOS:000251394900043
J	McInerney, JO; Pisani, D				McInerney, James O.; Pisani, Davide			Genetics - Paradigm for life	SCIENCE			English	Editorial Material							GENOMES; TREE		Natl Univ Ireland Univ Maynooth, Dept Biol, Maynooth, Kildare, Ireland	Maynooth University	McInerney, JO (corresponding author), Natl Univ Ireland Univ Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	james.o.mcinerney@nuim.ie	McInerney, James/B-5108-2012; Mcinerney, James/AAF-7234-2020; Pisani, Davide/ABD-5225-2021	McInerney, James/0000-0003-1885-2503; Pisani, Davide/0000-0003-0949-6682				Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Lake JA, 2007, NATURE, V446, P983, DOI 10.1038/446983a; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Pisani D, 2007, MOL BIOL EVOL, V24, P1752, DOI 10.1093/molbev/msm095; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	10	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1390	1391		10.1126/science.1151657	http://dx.doi.org/10.1126/science.1151657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048672				2022-12-28	WOS:000251246100026
J	Holtzman, NA				Holtzman, Neil A. (Tony)			The strange malady of Alessandro's uncle	BRITISH MEDICAL JOURNAL			English	Editorial Material									Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Holtzman, NA (corresponding author), Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	nholtzma@jhsph.edu						Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; POLLACK A, 2006, NY TIMES        0413	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1306	1307		10.1136/bmj.39407.647014.80	http://dx.doi.org/10.1136/bmj.39407.647014.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156241	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000252182700023
J	Halevy, I; Zuber, MT; Schrag, DP				Halevy, Itay; Zuber, Maria T.; Schrag, Daniel P.			A sulfur dioxide climate feedback on early Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; MARTIAN SURFACE; ATMOSPHERE; EVOLUTION; RADIATION; LIFE; SO2; CO2; CONDENSATION; ASSEMBLAGES	Ancient Mars had liquid water on its surface and a CO(2)-rich atmosphere. Despite the implication that massive carbonate deposits should have formed, these have not been detected. On the basis of fundamental chemical and physical principles, we propose that climatic conditions enabling the existence of liquid water were maintained by appreciable atmospheric concentrations of volcanically degassed SO(2) and H(2)S. The geochemistry resulting from equilibration of this atmosphere with the hydrological cycle is shown to inhibit the formation of carbonates. We propose an early martian climate feedback involving SO2, much like that maintained by CO(2) on Earth.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Halevy, I (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ihalevy@fas.harvard.edu	Halevy, Itay/W-9850-2019; HALEVY, ITAY/K-1364-2012	Halevy, Itay/0000-0002-7325-8139; HALEVY, ITAY/0000-0002-7325-8139				Andrews-Hanna JC, 2007, NATURE, V446, P163, DOI 10.1038/nature05594; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BLUTH GJS, 1993, NATURE, V366, P327, DOI 10.1038/366327a0; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CLARK BC, 1976, SCIENCE, V194, P1283, DOI 10.1126/science.194.4271.1283; Coombs ML, 2006, J VOLCANOL GEOTH RES, V151, P19, DOI 10.1016/j.jvolgeores.2005.07.037; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; FANALE FP, 1995, LUN PLAN SCI C 26, P391; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; HAFF LV, 1970, CHEM ANAL, V29, P183; Hanna JC, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002330; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Jakosky B. M., 1992, MARS, P969; JOHNSON SS, 2006, WORKSH MART SULF REC; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; Krasnopolsky VA, 2005, ICARUS, V178, P487, DOI 10.1016/j.icarus.2005.05.006; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Molina-Cuberos GJ, 2001, ICARUS, V154, P216, DOI 10.1006/icar.2001.6658; Morner NA, 2002, GLOBAL PLANET CHANGE, V33, P185, DOI 10.1016/S0921-8181(02)00070-X; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; RONOV AB, 1967, GEOCHEM INT, V4, P1041; Ryabinina AF, 1972, T URAL LESOTEKH I, V28, P182; SCHRAG DP, 2003, 6 INT C MARS PAS CA; Shuster DL, 2005, SCIENCE, V309, P594, DOI 10.1126/science.1113077; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALLACE PJ, 1994, AM MINERAL, V79, P161; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003; Yen AS, 2005, NATURE, V436, P881, DOI 10.1038/nature04042; Yung YL, 1997, ICARUS, V130, P222, DOI 10.1006/icar.1997.5808; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; ZAHNLE KJ, 2006, WORKSH MART SULF REC	48	151	152	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1903	1907		10.1126/science.1147039	http://dx.doi.org/10.1126/science.1147039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096802				2022-12-28	WOS:000251786600053
J	Lutz, S; Shankaranarayanan, A; Coco, C; Ridilla, M; Nance, MR; Vettel, C; Baltus, D; Evelyn, CR; Neubig, RR; Wieland, T; Tesmer, JJG				Lutz, Susanne; Shankaranarayanan, Aruna; Coco, Cassandra; Ridilla, Marc; Nance, Mark R.; Vettel, Christiane; Baltus, Doris; Evelyn, Chris R.; Neubig, Richard R.; Wieland, Thomas; Tesmer, John J. G.			Structure of G alpha(q)-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs	SCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLURIPOTENT STEM-CELLS; PLECKSTRIN HOMOLOGY; G-PROTEINS; GTPASES; TRIO; FIBROBLASTS; P63RHOGEF; DOMAINS; DISEASE	The guanine nucleotide exchange factor p63RhoGEF is an effector of the heterotrimeric guanine nucleotide- binding protein ( G protein) G alpha(q) and thereby links G alpha(q)- coupled receptors ( GPCRs) to the activation of the small- molecular- weight G protein RhoA. We determined the crystal structure of the G alpha(q)-p63RhoGEF- RhoA complex, detailing the interactions of G alpha(q) with the Dbl and pleckstrin homology ( DH and PH) domains of p63RhoGEF. These interactions involve the effector- binding site and the C- terminal region of G alpha(q) and appear to relieve autoinhibition of the catalytic DH domain by the PH domain. Trio, Duet, and p63RhoGEF are shown to constitute a family of G alpha(q) effectors that appear to activate RhoA both in vitro and in intact cells. We propose that this structure represents the crux of an ancient signal transduction pathway that is expected to be important in an array of physiological processes.	Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, D-68169 Mannheim, Germany; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	Ruprecht Karls University Heidelberg; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan	Wieland, T (corresponding author), Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Maybachstr 14, D-68169 Mannheim, Germany.	thomas.wieland@urz.uni-heidelberg.de; tesmerjj@umich.edu	Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Ridilla, Marc/0000-0002-0306-7097; Tesmer, John/0000-0003-1125-3727; Neubig, Richard/0000-0003-0501-0008	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NHLBI NIH HHS [HL071818, HL086865] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2004, N-S ARCH PHARMACOL, V369, P540, DOI 10.1007/s00210-004-0926-5; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McPherson CE, 2002, GENE, V284, P41, DOI 10.1016/S0378-1119(02)00386-4; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Souchet M, 2002, J CELL SCI, V115, P629; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Worthylake DK, 2004, STRUCTURE, V12, P1079, DOI 10.1016/j.str.2004.03.021; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	160	168	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1923	1927		10.1126/science.1147554	http://dx.doi.org/10.1126/science.1147554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096806				2022-12-28	WOS:000251786600059
J	Millum, J; Emanuel, EJ				Millum, Joseph; Emanuel, Ezekiel J.			Ethics - The ethics of international research with abandoned children	SCIENCE			English	Editorial Material							CLINICAL-RESEARCH; TRIALS; TRANSMISSION; CARE		NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov			Intramural NIH HHS [Z99 CL999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Annas GJ, 1998, AM J PUBLIC HEALTH, V88, P560, DOI 10.2105/AJPH.88.4.560; CHRISTAKIS NA, 1988, HASTINGS CENT REP, V18, P35; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Levine C, 2004, HASTINGS CENT REP, V34, P17, DOI 10.2307/3528172; Lie RK, 2004, J MED ETHICS, V30, P190, DOI 10.1136/jme.2003.006031; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; PACE C, 2003, SCIDEVNET       0828; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH GUID PR; Wertheimer Alan, 1999, EXPLOITATION, P10	14	58	58	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1874	1875		10.1126/science.1153822	http://dx.doi.org/10.1126/science.1153822			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096792	Green Accepted, Green Submitted			2022-12-28	WOS:000251786600041
J	Ramadan, K; Bruderer, R; Spiga, FM; Popp, O; Baur, T; Gotta, M; Meyer, HH				Ramadan, Kristijan; Bruderer, Roland; Spiga, Fabio M.; Popp, Oliver; Baur, Tina; Gotta, Monica; Meyer, Hemmo H.			Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin	NATURE			English	Article							CAENORHABDITIS-ELEGANS; AAA-ATPASE; MEMBRANE-FUSION; CONDENSIN-I; HISTONE H3; ENVELOPE; P97; PHOSPHORYLATION; ACTIVATION; UBIQUITIN	During division of metazoan cells, the nucleus disassembles to allow chromosome segregation, and then reforms in each daughter cell. Reformation of the nucleus involves chromatin decondensation and assembly of the double- membrane nuclear envelope around the chromatin; however, regulation of the process is still poorly understood(1,2). In vitro, nucleus formation requires p97 ( ref. 3), a hexameric ATPase implicated in membrane fusion and ubiquitin- dependent processes(4,5). However, the role and relevance of p97 in nucleus formation have remained controversial. Here we show that p97 stimulates nucleus reformation by inactivating the chromatin- associated kinase Aurora B. During mitosis, Aurora B inhibits nucleus reformation by preventing chromosome decondensation and formation of the nuclear envelope membrane. During exit from mitosis, p97 binds to Aurora B after its ubiquitylation and extracts it from chromatin. This leads to inactivation of Aurora B on chromatin, thus allowing chromatin decondensation and nuclear envelope formation. These data reveal an essential pathway that regulates reformation of the nucleus after mitosis and defines ubiquitin- dependent protein extraction as a common mechanism of Cdc48/p97 activity also during nucleus formation.	ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Meyer, HH (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	hemmo.meyer@bc.biol.ethz.ch	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Gotta, Monica/0000-0002-4336-7860; Spiga, Fabio/0000-0002-0541-3141; Bruderer, Roland/0000-0002-1049-5524				Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Lohka MJ, 1998, METHOD CELL BIOL, V53, P367; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Yamauchi S, 2006, BIOCHEM BIOPH RES CO, V345, P746, DOI 10.1016/j.bbrc.2006.04.160; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	33	204	211	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1258	U13		10.1038/nature06388	http://dx.doi.org/10.1038/nature06388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097415				2022-12-28	WOS:000251786200056
J	Chapman, RD; Heidemann, M; Albert, TK; Mailhammer, R; Flatley, A; Meisterernst, M; Kremmer, E; Eick, D				Chapman, Rob D.; Heidemann, Martin; Albert, Thomas K.; Mailhammer, Reinhard; Flatley, Andrew; Meisterernst, Michael; Kremmer, Elisabeth; Eick, Dirk			Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7	SCIENCE			English	Article							CARBOXYL-TERMINAL DOMAIN; LARGEST-SUBUNIT; TRANSCRIPTION; DELETION	RNA polymerase II is distinguished by its large carboxyl- terminal repeat domain ( CTD), composed of repeats of the consensus heptapeptide Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). Differential phosphorylation of serine-2 and serine-5 at the 5 ' and 3 ' regions of genes appears to coordinate the localization of transcription and RNA processing factors to the elongating polymerase complex. Using monoclonal antibodies, we reveal serine-7 phosphorylation on transcribed genes. This position does not appear to be phosphorylated in CTDs of less than 20 consensus repeats. The position of repeats where serine-7 is substituted influenced the appearance of distinct phosphorylated forms, suggesting functional differences between CTD regions. Our results indicate that restriction of serine-7 epitopes to the Linker- proximal region limits CTD phosphorylation patterns and is a requirement for optimal gene expression.	Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, D-81377 Munich, Germany; Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich	Eick, D (corresponding author), Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, Marchioninistr 25, D-81377 Munich, Germany.	eick@gsf.de		Albert, Thomas Karl/0000-0002-2488-0706				BARRONCASELLA E, 1992, J MOL EVOL, V35, P405, DOI 10.1007/BF00171818; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; WEST ML, 1995, GENETICS, V140, P1223	15	235	235	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1780	1782		10.1126/science.1145977	http://dx.doi.org/10.1126/science.1145977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079404				2022-12-28	WOS:000251616800043
J	Labrosse, S; Hernlund, JW; Coltice, N				Labrosse, S.; Hernlund, J. W.; Coltice, N.			A crystallizing dense magma ocean at the base of the Earth's mantle	NATURE			English	Article							CONTINENTAL-CRUST; SEISMIC EVIDENCE; CORE; BOUNDARY; DIFFERENTIATION; SYSTEMATICS; CONVECTION; EVOLUTION; MELT	The distribution of geochemical species in the Earth's interior is largely controlled by fractional melting and crystallization processes that are intimately linked to the thermal state and evolution of the mantle. The existence of patches of dense partial melt at the base of the Earth's mantle(1), together with estimates of melting temperatures for deep mantle phases(2) and the amount of cooling of the underlying core required to maintain a geodynamo throughout much of the Earth's history(3), suggest that more extensive deep melting occurred in the past. Here we show that a stable layer of dense melt formed at the base of the mantle early in the Earth's history would have undergone slow fractional crystallization, and would be an ideal candidate for an unsampled geochemical reservoir hosting a variety of incompatible species ( most notably the missing budget of heat-producing elements) for an initial basal magma ocean thickness of about 1,000 km. Differences in Nd-142/Nd-144 ratios between chondrites and terrestrial rocks(4) can be explained by fractional crystallization with a decay timescale of the order of 1 Gyr. These combined constraints yield thermal evolution models in which radiogenic heat production and latent heat exchange prevent early cooling of the core and possibly delay the onset of the geodynamo to 3.4-4 Gyr ago(5).	Univ Lyon, CNRS, Lab Sci Terre, Ecole Normale Super Lyon,UMR 5570, F-69364 Lyon 07, France; Inst Phys Globe, F-75252 Paris, France; Univ Lyon 1, Lab Sci Terres, CNRS, UMR 5570, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Labrosse, S (corresponding author), Univ Lyon, CNRS, Lab Sci Terre, Ecole Normale Super Lyon,UMR 5570, Allee Italie, F-69364 Lyon 07, France.	stephane.labrosse@ens-lyon.fr	Hernlund, John/A-8931-2014; Labrosse, Stéphane/M-5990-2019; Labrosse, Stéphane/C-8665-2012	Hernlund, John/0000-0003-1008-0182; Labrosse, Stéphane/0000-0002-7620-4363; Labrosse, Stéphane/0000-0002-7620-4363; Coltice, Nicolas/0000-0001-5444-414X				ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Braginsky SI, 1999, PHYS EARTH PLANET IN, V111, P21, DOI 10.1016/S0031-9201(98)00143-5; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; Coltice N, 1999, EARTH PLANET SC LETT, V174, P125, DOI 10.1016/S0012-821X(99)00258-7; Corgne A, 2005, GEOCHIM COSMOCHIM AC, V69, P485, DOI 10.1016/j.gca.2004.06.041; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Labrosse S, 2003, PHYS EARTH PLANET IN, V140, P127, DOI 10.1016/j.pepi.2003.07.006; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Mosenfelder JL, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004364; Ozima M, 2005, NATURE, V436, P655, DOI 10.1038/nature03929; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Stixrude L, 2005, SCIENCE, V310, P297, DOI 10.1126/science.1116952; SUN SS, 1989, SPECIAL PUBLICATIONS, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Tarduno JA, 2007, NATURE, V446, P657, DOI 10.1038/nature05667; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; Wen LX, 2001, EARTH PLANET SC LETT, V189, P141, DOI 10.1016/S0012-821X(01)00365-X; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243	28	509	516	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					866	869		10.1038/nature06355	http://dx.doi.org/10.1038/nature06355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064010				2022-12-28	WOS:000251394900053
J	Banatvala, N; Donaldson, L				Banatvala, Nicholas; Donaldson, Liam			Chronic diseases in developing countries	LANCET			English	Editorial Material									[Banatvala, Nicholas; Donaldson, Liam] Dept Hlth, London SE1 8UG, England		Banatvala, N (corresponding author), Dept Hlth, London SE1 8UG, England.	nick.banatvala@dh.gsi.gov.uk		Banatvala, Nick/0000-0001-8130-154X				[Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Fuster V, 2007, CIRCULATION, V116, P1966, DOI 10.1161/CIRCULATIONAHA.107.733444; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Kerry VB, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-3; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MUSUNGU SF, 2004, UTILISING TRIPS FLEX; Nishtar S, 2007, LANCET, V370, P1887, DOI 10.1016/S0140-6736(07)61791-7; *UK COLL DEV SCI, WELC UKCDS; 2007, LANCET, V370, P630	11	11	11	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2076	2078		10.1016/S0140-6736(07)61877-7	http://dx.doi.org/10.1016/S0140-6736(07)61877-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156015				2022-12-28	WOS:000252058600007
J	Beaglehole, R; Ebrahim, S; Reddy, S; Voute, J; Leeder, S				Beaglehole, Robert; Ebrahim, Shah; Reddy, Srinath; Voute, Janet; Leeder, Steve		Chronic Dis Action Grp	Chronic Diseases 5 - Prevention of chronic diseases: a call to action	LANCET			English	Article							HEALTH; DEATHS; RISK	Chronic (non-communicable) diseases-principally cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes-are leading causes of death and disability but are surprisingly neglected elements of the global-health agenda. They are underappreciated as development issues and underestimated as diseases with profound economic effects. Achievement of the global goal for prevention and control of chronic diseases would avert 36 million deaths by 2015 and would have major economic benefits. The main challenge for achievement of the global goal is to show that it can be reached in a cost-effective manner with existing interventions. This series of papers in The Lancet provides evidence that this goal is not only possible but also realistic with a small set of interventions directed towards whole populations and individuals who are at high risk. The total yearly cost of the interventions in 23 low-income and middle-income countries is about US$5.8 billion (as of 2005). In this final paper in the Series we call for a serious and sustained worldwide effort to prevent and control chronic diseases in the context of a general strengthening of health systems. Urgent action is needed by WHO, the World flank, regional banks and development agencies, foundations, national governments, civil society non-governmental organisations, the private sector including the pharmaceutical industry, and academics. We have established the Chronic Disease Action Group to encourage, support, and monitor action on the implementation of evidence-based efforts to promote global, regional, and national action to prevent and control chronic diseases.	[Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Voute, Janet] World Heart Federat, Geneva, Switzerland; [Leeder, Steve] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Auckland; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Sydney	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	Lim, Stephen S/B-4055-2012					Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], DIET PHYS ACT PUBL H; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; *AUSTR GOV AUSAID, 2006, HELP HLTH SYST DEL P; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; *DFID, 2007, WORK BETT HLTH DFID; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Nestle M, 2006, LANCET, V368, P564, DOI 10.1016/S0140-6736(06)69177-0; Nishtar S, 2006, BRIT MED J, V333, P820, DOI 10.1136/bmj.39003.517731.BE; *PRIM MIN OFF, 2002, 772002QDTTG PRIM MIN; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Raymond S., 2004, Development (London), V47, P97, DOI 10.1057/palgrave.development.1100035; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; World Health Organization, WHO FRAM CONV TOB CO; YACH D, 2004, WHO LONG TERM STRATE; 2006, LANCET, V367, P1549; 2007, LANCET, V369, P2133	31	197	206	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2152	2157		10.1016/S0140-6736(07)61700-0	http://dx.doi.org/10.1016/S0140-6736(07)61700-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18063026				2022-12-28	WOS:000252058600036
J	Kuijl, C; Savage, NDL; Marsman, M; Tuin, AW; Janssen, L; Egan, DA; Ketema, M; van den Nieuwendijk, R; van den Eeden, SJF; Geluk, A; Poot, A; van der Marel, G; Beijersbergen, RL; Overkleeft, H; Ottenhoff, THM; Neefjes, J				Kuijl, Coenraad; Savage, Nigel D. L.; Marsman, Marije; Tuin, Adriaan W.; Janssen, Lennert; Egan, David A.; Ketema, Mirjam; van den Nieuwendijk, Rian; van den Eeden, Susan J. F.; Geluk, Annemieke; Poot, Alex; van der Marel, Gijs; Beijersbergen, Roderick L.; Overkleeft, Hermen; Ottenhoff, Tom H. M.; Neefjes, Jacques			Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; ENTERICA SEROVAR TYPHIMURIUM; PROTEIN-KINASE; RNAI SCREEN; PHOSPHOINOSITIDE METABOLISM; GLUT4 TRANSLOCATION; MATURATION ARREST; EPITHELIAL-CELLS; GTPASE; INFECTION	With the emergence of multidrug resistant (MDR) bacteria, it is imperative to develop new intervention strategies. Current antibiotics typically target pathogen rather than host-specific biochemical pathways(1). Here we have developed kinase inhibitors that prevent intracellular growth of unrelated pathogens such as Salmonella typhimurium and Mycobacterium tuberculosis. An RNA interference screen of the human kinome using automated microscopy revealed several host kinases capable of inhibiting intracellular growth of S. typhimurium. The kinases identified clustered in one network around AKT1 (also known as PKB). Inhibitors of AKT1 prevent intracellular growth of various bacteria including MDR-M. tuberculosis. AKT1 is activated by the S. typhimurium effector SopB, which promotes intracellular survival by controlling actin dynamics through PAK4, and phagosome-lysosome fusion through the AS160 (also known as TBC1D4)-RAB14 pathway. AKT1 inhibitors counteract the bacterial manipulation of host signalling processes, thus controlling intracellular growth of bacteria. By using a reciprocal chemical genetics approach, we identified kinase inhibitors with antibiotic properties and their host targets, and we determined host signalling networks that are activated by intracellular bacteria for survival.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Leiden Med Univ Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; Leiden Med Univ Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Leiden Inst Chem, Bioorgan Chem Lab, NL-2300 RA Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Janssen, Lennert/0000-0001-9705-0204; Overkleeft, Herman/0000-0001-6976-7005; Beijersbergen, Roderick/0000-0003-0116-4130; Kuijl, Coen/0000-0003-4378-1428				Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Patterson GH, 2004, METHODS, V32, P445, DOI 10.1016/j.ymeth.2003.10.006; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Rupper AC, 2001, J CELL SCI, V114, P1283; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; STROM BL, 1995, CANCER, V76, P1747, DOI 10.1002/1097-0142(19951115)76:10<1747::AID-CNCR2820761011>3.0.CO;2-L; Uchiya K, 2004, INFECT IMMUN, V72, P6860, DOI 10.1128/IAI.72.12.6860-6869.2004; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vesterlund S, 2004, J MICROBIOL METH, V57, P23, DOI 10.1016/j.mimet.2003.11.014; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	48	246	258	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					725	U10		10.1038/nature06345	http://dx.doi.org/10.1038/nature06345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046412	Green Published			2022-12-28	WOS:000251209700055
J	Cam, HP; Noma, K; Ebina, H; Levin, HL; Grewal, SIS				Cam, Hugh P.; Noma, Ken-ichi; Ebina, Hirotaka; Levin, Henry L.; Grewal, Shiv I. S.			Host genome surveillance for retrotransposons by transposon-derived proteins	NATURE			English	Article							HUMAN CENTROMERE PROTEIN; FISSION YEAST; CENP-B; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; MOLECULAR-CLONING; DNA METHYLATION; HETEROCHROMATIN; SEQUENCE; ELEMENTS	Transposable elements and their remnants constitute a substantial fraction of eukaryotic genomes. Host genomes have evolved defence mechanisms, including chromatin modifications and RNA interference, to regulate transposable elements. Here we describe a genome surveillance mechanism for retrotransposons by transposase- derived centromeric protein CENP- B homologues of the fission yeast Schizosaccharomyces pombe. CENP- B homologues of S. pombe localize at and recruit histone deacetylases to silence Tf2 retrotransposons. CENP- Bs also repress solo long terminal repeats ( LTRs) and LTR- associated genes. Tf2 elements are clustered into 'Tf' bodies, the organization of which depends on CENP- Bs that display discrete nuclear structures. Furthermore, CENP- Bs prevent an 'extinct' Tf1 retrotransposon from re- entering the host genome by blocking its recombination with extant Tf2, and silence and immobilize a Tf1 integrant that becomes sequestered into Tf bodies. Our results reveal a probable ancient retrotransposon surveillance pathway important for host genome integrity, and highlight potential conflicts between DNA transposons and retrotransposons, major transposable elements believed to have greatly moulded the evolution of genomes.	[Cam, Hugh P.; Noma, Ken-ichi; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ebina, Hirotaka; Levin, Henry L.] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Levin, Henry/0000-0003-1728-118X; Grewal, Shiv/0000-0002-4552-9261	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001009] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523, ZIABC011208] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atwood A, 1998, J VIROL, V72, P1324, DOI 10.1128/JVI.72.2.1324-1333.1998; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gao X, 2005, TRENDS GENET, V21, P133, DOI 10.1016/j.tig.2005.01.006; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Halverson D, 1997, J CELL BIOL, V136, P487, DOI 10.1083/jcb.136.3.487; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Irelan JT, 2001, GENETICS, V157, P1191; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; JONES ME, 1994, GENETICS, V136, P1209; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; LEVIN HL, 1995, MOL CELL BIOL, V15, P3310; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Murakami Y, 1996, P NATL ACAD SCI USA, V93, P502, DOI 10.1073/pnas.93.1.502; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tawaramoto MS, 2003, J BIOL CHEM, V278, P51454, DOI 10.1074/jbc.M310388200; THON G, 1994, GENETICS, V138, P29; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	50	129	133	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					431	U2		10.1038/nature06499	http://dx.doi.org/10.1038/nature06499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18094683	Bronze			2022-12-28	WOS:000252554100037
J	Houweling, AR; Brecht, M				Houweling, Arthur R.; Brecht, Michael			Behavioural report of single neuron stimulation in somatosensory cortex	NATURE			English	Article							IN-VIVO; CORTICAL MICROSTIMULATION; NEOCORTICAL NEURONS; WHISKER DEFLECTION; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; RAT; REPRESENTATION; DISCRIMINATION; POPULATION	Understanding how neural activity in sensory cortices relates to perception is a central theme of neuroscience. Action potentials of sensory cortical neurons can be strongly correlated to properties of sensory stimuli(1) and reflect the subjective judgements of an individual about stimuli(2). Microstimulation experiments have established a direct link from sensory activity to behaviour(3,4), suggesting that small neuronal populations can influence sensory decisions(5). However, microstimulation does not allow identification and quantification of the stimulated cellular elements(6). The sensory impact of individual cortical neurons therefore remains unknown. Here we show that stimulation of single neurons in somatosensory cortex affects behavioural responses in a detection task. We trained rats to respond to microstimulation of barrel cortex at low current intensities. We then initiated short trains of action potentials in single neurons by juxtacellular stimulation. Animals responded significantly more often in single- cell stimulation trials than in catch trials without stimulation. Stimulation effects varied greatly between cells, and on average in 5% of trials a response was induced. Whereas stimulation of putative excitatory neurons led to weak biases towards responding, stimulation of putative inhibitory neurons led to more variable and stronger sensory effects. Reaction times for single- cell stimulation were long and variable. Our results demonstrate that single neuron activity can cause a change in the animal's detection behaviour, suggesting a much sparser cortical code for sensations than previously anticipated.	[Houweling, Arthur R.; Brecht, Michael] Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Houweling, Arthur R.; Brecht, Michael] Humboldt Univ, D-10115 Berlin, Germany; [Houweling, Arthur R.; Brecht, Michael] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Humboldt University of Berlin; Erasmus University Rotterdam; Erasmus MC	Houweling, AR (corresponding author), Bernstein Ctr Computat Neurosci, Philippstr 13,House 6, D-10115 Berlin, Germany.	arthur.houweling@bccn-berlin.de; michael.brecht@bccn-berlin.de		Brecht, Michael/0000-0002-5387-0953				Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; BARTLETT JR, 1980, ACTA NEUROBIOL EXP, V40, P713; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KRAUSS A, 2003, ANN M SOC NEUR; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Penfield W., 1950, CEREBRAL CORTEX MAN; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rieke F., 1997, SPIKES EXPLORING NEU; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; SWADLOW HA, 1992, J NEUROPHYSIOL, V68, P605, DOI 10.1152/jn.1992.68.2.605; Talwar SK, 1998, HEARING RES, V126, P135, DOI 10.1016/S0378-5955(98)00162-2; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; WARREN RA, 1992, SOMATOSENS MOT RES, V9, P297, DOI 10.3109/08990229209144779; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Zilles Karl, 1995, P649	31	291	293	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					65	U8		10.1038/nature06447	http://dx.doi.org/10.1038/nature06447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18094684				2022-12-28	WOS:000252079300034
J	Black, N				Black, Nick			London's last remaining Georgian workhouse infirmary under threat	BRITISH MEDICAL JOURNAL			English	Editorial Material									London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	nick.black@lshtm.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1312	1312		10.1136/bmj.39426.438877.DE	http://dx.doi.org/10.1136/bmj.39426.438877.DE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156244	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700026
J	Beyer, M; Nesterov, A; Block, I; Konig, K; Felgenhauer, T; Fernandez, S; Leibe, K; Torralba, G; Hausmann, M; Trunk, U; Lindenstruth, V; Bischoff, FR; Stadler, V; Breitling, F				Beyer, Mario; Nesterov, Alexander; Block, Ines; Koenig, Kai; Felgenhauer, Thomas; Fernandez, Simon; Leibe, Klaus; Torralba, Gloria; Hausmann, Michael; Trunk, Ulrich; Lindenstruth, Volker; Bischoff, F. Ralf; Stadler, Volker; Breitling, Frank			Combinatorial synthesis of peptide arrays onto a microchip	SCIENCE			English	Article							PARALLEL CHEMICAL SYNTHESIS; SUPPORT		Univ Heidelberg, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Lindenstruth, V (corresponding author), Univ Heidelberg, Kirchhoff Inst Phys, INF 227, D-69120 Heidelberg, Germany.	voli@kip.uni-heidelberg.de; r.bischoff@dkfz.de; v.stadler@dkfz.de; f.breitling@dkfz.de	Nesterov-Mueller, Alexander/H-1333-2013; /I-1543-2013; Block, Ines/Q-5507-2016	Block, Ines/0000-0003-1964-6031; Nesterov-Mueller, Alexander/0000-0001-8446-2728				Beyer M, 2006, BIOMATERIALS, V27, P3505, DOI 10.1016/j.biomaterials.2006.01.046; Egeland RD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni117; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Heller MJ, 2000, ELECTROPHORESIS, V21, P157, DOI 10.1002/(SICI)1522-2683(20000101)21:1<157::AID-ELPS157>3.0.CO;2-E; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723	6	100	108	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1888	1888		10.1126/science.1149751	http://dx.doi.org/10.1126/science.1149751			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096799				2022-12-28	WOS:000251786600048
J	Clutton-Brock, T				Clutton-Brock, Tim			Sexual selection in males and females	SCIENCE			English	Review							POTENTIAL REPRODUCTIVE RATES; MATE CHOICE; PARENTAL INVESTMENT; DOMINANT FEMALES; SIZE DIMORPHISM; SPOTTED HYENAS; COMPETITION; EVOLUTION; AGGRESSION; ANDROGENS	Research on sexual selection shows that the evolution of secondary sexual characters in males and the distribution of sex differences are more complex than was initially suggested but does not undermine our understanding of the evolutionary mechanisms involved. However, the operation of sexual selection in females has still received relatively little attention. Recent studies show that both intrasexual competition between females and male choice of mating partners are common, leading to strong sexual selection in females and, in extreme cases, to reversals in the usual pattern of sex differences in behavior and morphology.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Clutton-Brock, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk	Wang, Anna/F-6418-2014		Natural Environment Research Council [NE/C511348/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahnesjo I, 2001, BEHAV ECOL, V12, P397, DOI 10.1093/beheco/12.4.397; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Andersson Malte, 1994; Aubin-Horth N, 2007, MOL ECOL, V16, P1349, DOI 10.1111/j.1365-294X.2007.03249.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bebie N, 2006, MAMM BIOL, V71, P347, DOI 10.1016/j.mambio.2006.02.008; Bro-Jorgensen J, 2002, P NATL ACAD SCI USA, V99, P9290, DOI 10.1073/pnas.142125899; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; Clutton-Brock Tim H., 2004, P24, DOI 10.1017/CBO9780511542459.004; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CLUTTONBROCK TH, 1976, GROWING POINTS ETHOL, P195; DARWIN C, 1958, DESCENT MAN SELECTIO; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Domb LG, 2001, NATURE, V410, P204, DOI 10.1038/35065597; Drea CM, 2007, HORM BEHAV, V51, P555, DOI 10.1016/j.yhbeh.2007.02.006; Drea CM, 2002, P ROY SOC B-BIOL SCI, V269, P1981, DOI 10.1098/rspb.2002.2109; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; EVANS MR, 1992, BEHAV ECOL SOCIOBIOL, V29, P413; Fisher R.A., 1930, GENETICAL THEORY NAT; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Gowaty P. A, 1997, FEMINISM EVOLUTIONAR, P351; Gowaty PA, 2005, INTEGR COMP BIOL, V45, P931, DOI 10.1093/icb/45.5.931; Gowaty Patricia Adair, 2004, P37, DOI 10.1017/CBO9780511542459.005; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Houston AI, 2005, BIOL PHILOS, V20, P933, DOI 10.1007/s10539-005-9016-4; HUBBELL SP, 1987, AM NAT, V130, P91, DOI 10.1086/284700; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kappeler Peter M., 1993, Perspectives in Ethology, V10, P143; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Kvarnemo C, 2007, P ROY SOC B-BIOL SCI, V274, P521, DOI 10.1098/rspb.2006.3753; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; LeBas NR, 2003, P ROY SOC B-BIOL SCI, V270, P2159, DOI 10.1098/rspb.2003.2482; Mealey L., 2000, SEX DIFFERENCES DEV; O'Riain M. Justin, 2001, P143; Ostner J, 2003, NATURWISSENSCHAFTEN, V90, P141, DOI 10.1007/s00114-003-0404-9; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Pizzari T, 2006, SCIENCE, V312, P690; Place NJ, 2004, ADV EXP MED BIOL, V545, P243; Plusquellec P, 2001, APPL ANIM BEHAV SCI, V72, P1, DOI 10.1016/S0168-1591(00)00198-2; Queller DC, 1997, P ROY SOC B-BIOL SCI, V264, P1555, DOI 10.1098/rspb.1997.0216; Reeve H., 1991, BIOL NAKED MOLE RAT, P337; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Roughgarden J, 2006, SCIENCE, V311, P965, DOI 10.1126/science.1110105; Russell AF, 2004, EVOLUTION, V58, P1600; Simmons LW, 2006, P ROY SOC B-BIOL SCI, V273, P465, DOI 10.1098/rspb.2005.3309; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; Sutherland W.J., 1985, Oxford Surveys in Evolutionary Biology, V2, P90; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Tang-Martinez Z, 2005, INTEGR COMP BIOL, V45, P821, DOI 10.1093/icb/45.5.821; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; YALCINKAYA TM, 1993, SCIENCE, V260, P1929, DOI 10.1126/science.8391165; Zinner Dietmar P., 2004, P71, DOI 10.1017/CBO9780511542459.007	66	572	583	12	622	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1882	1885		10.1126/science.1133311	http://dx.doi.org/10.1126/science.1133311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096798	Green Published, Green Submitted			2022-12-28	WOS:000251786600047
J	Davidson, AG; Chan, V; O'Dell, R; Schieber, MH				Davidson, Adam G.; Chan, Vanessa; O'Dell, Ryan; Schieber, Marc H.			Rapid changes in throughput from single motor cortex neurons to muscle activity	SCIENCE			English	Article							SPIKE-TRIGGERED AVERAGES; PRIMATE CORTICOMOTONEURONAL CELLS; HAND MUSCLES; CORTICOSPINAL NEURONS; CONSCIOUS MONKEY; RECTIFIED EMG; FACILITATION; MOVEMENT; MOTONEURONS; PLASTICITY	Motor cortex output is capable of considerable reorganization, which involves modulation of excitability within the cortex. Does such reorganization also involve changes beyond the cortex, at the level of throughput from single motor cortex neurons to muscle activity? We examined such throughput during a paradigm that provided incentive for enhancing functional connectivity from motor cortex neurons to muscles. Short- latency throughput from a recorded neuron to muscle activity not present during some behavioral epochs often appeared during others. Such changes in throughput could not always be attributed to a higher neuron firing rate, to more ongoing muscle activity, or to neuronal synchronization, indicating that reorganization of motor cortex output may involve rapid changes in functional connectivity from single motor cortex neurons to alpha-motoneuron pools.	Univ Rochester, Sch Med & Dent, Dept Neurol & Neurobiol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Schieber, MH (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol & Neurobiol, 601 Elmwood Ave, Rochester, NY 14642 USA.	mhs@cvs.rochester.edu		O'Dell, Ryan/0000-0001-7673-6661	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027686] Funding Source: NIH RePORTER; NINDS NIH HHS [R01/R37-NS27686] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1998, J NEUROPHYSIOL, V80, P1391, DOI 10.1152/jn.1998.80.3.1391; BENNETT KMB, 1994, J PHYSIOL-LONDON, V477, P291, DOI 10.1113/jphysiol.1994.sp020191; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Davidson AG, 2007, J NEUROSCI, V27, P8053, DOI 10.1523/JNEUROSCI.0040-07.2007; Davidson AG, 2007, J NEUROSCI METH, V163, P283, DOI 10.1016/j.jneumeth.2007.03.010; FETZ EE, 1978, J PHYSIOL-PARIS, V74, P239; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fetz EE, 2002, BRAIN RES REV, V40, P53, DOI 10.1016/S0165-0173(02)00188-1; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Jackson A, 2006, J PHYSIOL-LONDON, V573, P107, DOI 10.1113/jphysiol.2005.100537; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; LAWRENCE DG, 1985, J COMP NEUROL, V232, P499, DOI 10.1002/cne.902320407; LEMON RN, 1986, J PHYSIOL-LONDON, V381, P497, DOI 10.1113/jphysiol.1986.sp016341; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; MEWES K, 1991, J NEUROPHYSIOL, V66, P1965, DOI 10.1152/jn.1991.66.6.1965; MUIR RB, 1973, J PHYSIOL-LONDON, V228, P749, DOI 10.1113/jphysiol.1973.sp010110; NIELSEN J, 1994, J PHYSIOL-LONDON, V477, P47, DOI 10.1113/jphysiol.1994.sp020170; Nudo RJ, 1996, J NEUROSCI, V16, P785; PALMER SS, 1985, J NEUROPHYSIOL, V54, P1194, DOI 10.1152/jn.1985.54.5.1194; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PORTER R, 1969, J NEUROPHYSIOL, V32, P443, DOI 10.1152/jn.1969.32.3.443; Schieber MH, 2005, J NEUROPHYSIOL, V94, P3325, DOI 10.1152/jn.00007.2005; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807	26	38	38	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1934	1937		10.1126/science.1149774	http://dx.doi.org/10.1126/science.1149774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096808				2022-12-28	WOS:000251786600062
J	Denofrio, LA; Russell, B; Lopatto, D; Lu, Y				Denofrio, Lauren A.; Russell, Brandy; Lopatto, David; Lu, Yi			Mentoring - Linking student interests to science curricula	SCIENCE			English	Editorial Material									Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Grinnell Coll, Dept Psychol, Grinnell, IA 50112 USA	University of Illinois System; University of Illinois Urbana-Champaign	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@uiuc.edu	liu, yi/GXE-9662-2022; Lu, Yi/GQQ-1069-2022; Lu, Yi/B-5461-2010	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709				Alberts B, 2005, CELL, V123, P739, DOI 10.1016/j.cell.2005.11.014; Beck MR, 2006, SCIENCE, V314, P1246, DOI 10.1126/science.1131917; Bransford JD., 2000, PEOPLE LEARN; Cuban L., 1999, SCHOLARS TRUMPED TEA; FISHMAN BJ, 1992, ETR&D-EDUC TECH RES, V40, P95, DOI 10.1007/BF02296846; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Handelsman Jo., 2005, ENTERING MENTORING; Linn MC, 2006, SCIENCE, V313, P1049, DOI 10.1126/science.1131408; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Lotan, 2014, DESIGNING GROUPWORK; National Research Council, 2003, BIO2010 TRANSF UND E; *NSF, 1998, SHAP FUT, V2; Pfund C, 2006, SCIENCE, V311, P473, DOI 10.1126/science.1123806; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131; Summers MF, 2006, SCIENCE, V311, P1870, DOI 10.1126/science.1125257; Wood WB, 2003, SCIENCE, V302, P1510, DOI 10.1126/science.1091803; Zurer PS, 2002, CHEM ENG NEWS, V80, P31, DOI 10.1021/cen-v080n034.p031	18	44	46	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1872	1873		10.1126/science.1150788	http://dx.doi.org/10.1126/science.1150788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096791	Green Submitted			2022-12-28	WOS:000251786600040
J	Liu, ET				Liu, Edison T.			Focus on research: Stromal effects in breasty cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Liu, ET (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.		Liu, Edison/C-4141-2008					Aprelikova O, 2001, J BIOL CHEM, V276, P25647, DOI 10.1074/jbc.C100265200; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Franklin WA, 1997, J CLIN INVEST, V100, P2639; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stark A, 2000, J CLIN ONCOL, V18, P267, DOI 10.1200/JCO.2000.18.2.267	6	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2537	2538		10.1056/NEJMp0707576	http://dx.doi.org/10.1056/NEJMp0707576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094373				2022-12-28	WOS:000251728900003
J	Asaria, P; Chisholm, D; Mathers, C; Ezzati, M; Beaglehole, R				Asaria, Perviz; Chisholm, Dan; Mathers, Colin; Ezzati, Majid; Beaglehole, Robert			Chronic diseases 3 - Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use	LANCET			English	Article							LOWER BLOOD-PRESSURE; DIETARY SALT; SODIUM-INTAKE; OBSERVATIONAL DATA; SMOKING; MORTALITY; INTERVENTIONS; RISK; EXCRETION; COUNTRIES	In 2005, WHO set a global goal to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year. To this end, we investigated how many deaths could potentially be averted over 10 years by implementation of selected population-based interventions, and calculated the financial costs of their implementation. We selected two interventions: to reduce salt intake in the population by 15% and to implement four key elements of the WHO Framework Convention on Tobacco Control (FCTC). We used methods from the WHO Comparative Risk Assessment project to estimate shifts in the distribution of risk factors associated with salt intake and tobacco use, and to model the effects on chronic disease mortality for 23 countries that account for 80% of chronic disease burden in the developing world. We showed that, over 10 years (2006-2015), 13.8 million deaths could be averted by implementation of these interventions, at a cost of less than US$0.40 per person per year in low-income and lower middle-income countries, and US$0.50-1.00 per person per year in upper middle-income countries (as of 2005). These two population-based intervention strategies could therefore substantially reduce mortality from chronic diseases, and make a major (and affordable) contribution towards achievement of the global goal to prevent and control chronic diseases.	WHO, Dept Hlth Syst Financing, CH-1211 Geneva 27, Switzerland; Kings Fund, London, England; Univ Auckland, Auckland 1, New Zealand; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	World Health Organization; University of Auckland; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Chisholm, D (corresponding author), WHO, Dept Hlth Syst Financing, CH-1211 Geneva 27, Switzerland.	chisholmd@who.int		Mathers, Colin/0000-0002-0617-6731				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; DAY NE, 1997, BMJ-BRIT MED J, V315, P484; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; Ezzati M, 2004, COMP QUANTIFICATION; Ferrante D, 2007, REV PANAM SALUD PUBL, V21, P37, DOI 10.1590/S1020-49892007000100005; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Forrester T, 2005, J HUM HYPERTENS, V19, P55, DOI 10.1038/sj.jhh.1001782; FROST CD, 1991, BRIT MED J, V302, P815, DOI 10.1136/bmj.302.6780.815; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; GUINDON GE, 2003, 11 HNP WORLD BANK; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; He J, 2002, ARCH INTERN MED, V162, P1619, DOI 10.1001/archinte.162.14.1619; Hooper L., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003656.PUB2; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Johns Benjamin, 2006, Cost Eff Resour Alloc, V4, P8, DOI 10.1186/1478-7547-4-8; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; LAWES CMM, 2002, ESTIMATING REDUCTION; Levy David T, 2004, J Public Health Manag Pract, V10, P338; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Nakamura M, 2003, CIRC J, V67, P530; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Ranson M Kent, 2002, Nicotine Tob Res, V4, P311, DOI 10.1080/14622200210141000; Rodgers A., 2004, COMP QUANTIFICATION; Selmer RM, 2000, J EPIDEMIOL COMMUN H, V54, P697, DOI 10.1136/jech.54.9.697; SHAFEY O, 2003, TOB CONTR COUNTR PRO; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; TANSEL A, 1993, APPL ECON, V25, P521, DOI 10.1080/00036849300000060; Tian HG, 1995, J HUM HYPERTENS, V9, P959; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, TABL COSTS PRIC US W; *WHO, GLOB INFOBASE EST; *WHO, 2003, UPD STAT WHO FRAM CO; *WHO MED CTR, INT MARK COMM; Willett W. C., 2006, Disease control priorities in developing countries, P833; World Bank, 2022, WORLD DEV IND 2022; World Health Organization, 2007, RED SALT INT POP REP; World Health Organization, 2005, WHO FRAM CONV TOB CO; World Health Organization, 2001, MACR HLTH INV HLTH E; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	65	413	431	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2044	2053		10.1016/S0140-6736(07)61698-5	http://dx.doi.org/10.1016/S0140-6736(07)61698-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18063027				2022-12-28	WOS:000251698600031
J	Chu, TF; Rupnick, MA; Kerkela, R; Dallabrida, SM; Zurakowski, D; Nguyen, L; Woulfe, K; Pravda, E; Cassiola, F; Desai, J; George, S; Morgan, JA; Harris, DM; Ismail, NS; Chen, JH; Schoen, FJ; Van den Abbeele, AD; Demetri, GD; Force, T; Chen, MH				Chu, Tammy F.; Rupnick, Maria A.; Kerkela, Risto; Dallabrida, Susan M.; Zurakowski, David; Nguyen, Lisa; Woulfe, Kathleen; Pravda, Elke; Cassiola, Flavia; Desai, Jayesh; George, Suzanne; Morgan, Jeffrey A.; Harris, David M.; Ismail, Nesreen S.; Chen, Jey-Hsin; Schoen, Frederick J.; Van den Abbeele, Annick D.; Demetri, George D.; Force, Thomas; Chen, Ming Hui			Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib	LANCET			English	Article							RENAL-CELL CARCINOMA; METASTATIC BREAST-CANCER; GASTROINTESTINAL STROMAL TUMORS; ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; FACTOR RECEPTORS; THERAPY; SU11248; HYPOTHYROIDISM	Background Sunitinib, a multitargeted tyrosine-kinase inhibitor, which is approved by both US and European Commission regulatory agencies for clinical use, extends survival of patients with metastatic renal-cell carcinoma and gastrointestinal stromal tumours, but concerns have arisen about its cardiac safety We therefore assessed the cardiovascular risk associated with sunitinib in patients with metastatic gastrointestinal stromal. tumours. Methods We retrospectively reviewed all cardiovascular events in 75 patients with imatinib-resistant, metastatic, gastrointestinal stromal. tumours who had been enrolled in a phase I/II trial investigating the efficacy of sunitinib. The composite cardiovascular endpoint was cardiac death, myocardial infarction, and congestive heart failure. We also examined sunitinib's effects on left ventricular ejection fraction (LVEF) and blood pressure. We investigated potential mechanisms of sunitinib-associated cardiac effects by studies in isolated rat cardiomyocytes and in mice. Findings Eight of 75 (11%) patients given repeating cycles of sunitinib in the phase I/II trial had a cardiovascular event, with congestive heart failure recorded in six of 75 (8%). Ten of 36 (28%) patients treated at the approved sunitinib dose had absolute LVEF reductions in ejection fraction (EF) of at least 10%, and seven of 36 (19%) had LVEF reductions of 15 EF% or more. Sunitinib induced increases in mean systolic and diastolic blood pressure, and 35 of 75 (47%) individuals developed hypertension (>150/100 mm Hg). Congestive heart failure and left ventricular dysfunction generally responded to sunitinib being withheld and institution of medical management. Sunitinib caused mitochondrial injury and cardiomyocyte apoptosis in mice and in cultured rat cardiomyocytes. Interpretation Left ventricular dysfunction might be due, in part, to direct cardiomyocyte toxicity, exacerbated by hypertension. Patients treated with sunitinib should be closely monitored for hypertension and LVEF reduction, especially those with a history of coronary artery disease or cardiac risk factors.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Vasc Biol Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Womens Hlth & Gender Biol Div, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA; Thomas Jefferson Univ, Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Cardiol, Philadelphia, PA 19107 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Jefferson University; Jefferson University	Chen, MH (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	minghui.chen@cardio.chboston.org	Desai, Jayesh/AAV-1237-2021; Van den Abbeele, Annick/AAK-9792-2020	Desai, Jayesh/0000-0003-4246-9344; Woulfe, Kathleen/0000-0001-9885-7026; Force, Thomas/0000-0002-0450-8659	NHLBI NIH HHS [R01 HL061688-11, R01 HL061688-10, R01 HL067371, R01 HL061688-09, HL61688, HL67371, R01 HL061688] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067371, R01HL061688] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACC/ AHA, 2005, ACC AHA 2005 GUID UP; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Baselga J, 1999, SEMIN ONCOL, V26, P78; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Fiedler W, 2005, BLOOD, V105, P986, DOI 10.1182/blood-2004-05-1846; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim DW, 2006, J CLIN ENDOCR METAB, V91, P4070, DOI 10.1210/jc.2005-2845; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Mann DL, 2006, NAT MED, V12, P881, DOI 10.1038/nm0806-881; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Pietras RJ, 1998, ONCOGENE, V17, P2235, DOI 10.1038/sj.onc.1202132; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Sica DA, 2006, J CLIN ONCOL, V24, P1329, DOI 10.1200/JCO.2005.04.5740; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Urbanova D, 2006, NEOPLASMA, V53, P183; *US NAT LIB MED, SUN PAG; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503	30	780	817	3	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2011	2019		10.1016/S0140-6736(07)61865-0	http://dx.doi.org/10.1016/S0140-6736(07)61865-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083403	Green Accepted			2022-12-28	WOS:000251698600028
J	Fisk, Z				Fisk, Zachary			Physics - A whiff of chemistry in heavy electron physics	SCIENCE			English	Editorial Material							SUPERCONDUCTIVITY		Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	University of California System; University of California Irvine	Fisk, Z (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	zfisk@uci.edu						Curro NJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.180514; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Nakatsuji S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.016401; Petrovic C, 2001, EUROPHYS LETT, V53, P354, DOI 10.1209/epl/i2001-00161-8; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; Shim JH, 2007, SCIENCE, V318, P1615, DOI 10.1126/science.1149064; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892	7	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1559	1560		10.1126/science.1151945	http://dx.doi.org/10.1126/science.1151945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063775				2022-12-28	WOS:000251421700021
J	Shibata, K; Nakamura, T; Matsumoto, T; Otsuji, K; Okamoto, TJ; Nishizuka, N; Kawate, T; Watanabe, H; Nagata, S; UeNo, S; Kitai, R; Nozawa, S; Tsuneta, S; Suematsu, Y; Ichimoto, K; Shimizu, T; Katsukawa, Y; Tarbell, TD; Berger, TE; Lites, BW; Shine, RA; Title, AM				Shibata, Kazunari; Nakamura, Tahei; Matsumoto, Takuma; Otsuji, Kenichi; Okamoto, Takenori J.; Nishizuka, Naoto; Kawate, Tomoko; Watanabe, Hiroko; Nagata, Shin'ichi; UeNo, Satoru; Kitai, Reizaburo; Nozawa, Satoshi; Tsuneta, Saku; Suematsu, Yoshinori; Ichimoto, Kiyoshi; Shimizu, Toshifumi; Katsukawa, Yukio; Tarbell, Theodore D.; Berger, Thomas E.; Lites, Bruce W.; Shine, Richard A.; Title, Alan M.			Chromospheric anemone jets as evidence of ubiquitous reconnection	SCIENCE			English	Article							X-RAY JETS; H-ALPHA SURGES; MAGNETIC RECONNECTION; SOLAR ATMOSPHERE; ALFVEN WAVES; NUMERICAL HYDRODYNAMICS; MODEL; SPICULES; SIMULATION; TELESCOPE	The heating of the solar chromosphere and corona is a long- standing puzzle in solar physics. Hinode observations show the ubiquitous presence of chromospheric anemone jets outside sunspots in active regions. They are typically 3 to 7 arc seconds = 2000 to 5000 kilometers long and 0.2 to 0.4 arc second = 150 to 300 kilometers wide, and their velocity is 10 to 20 kilometers per second. These small jets have an inverted Y- shape, similar to the shape of x- ray anemone jets in the corona. These features imply that magnetic reconnection similar to that in the corona is occurring at a much smaller spatial scale throughout the chromosphere and suggest that the heating of the solar chromosphere and corona may be related to small- scale ubiquitous reconnection.	Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan; Natl Astron Observ, Tokyo 1818588, Japan; Ibaraki Univ, Dept Sci, Mito, Ibaraki 3108512, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	Kyoto University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Ibaraki University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Lockheed Martin; National Center Atmospheric Research (NCAR) - USA	Shibata, K (corresponding author), Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan.	shibata@kwasan.kyoto-u.ac.jp	Berger, Thomas E./AAD-1010-2020; Nishizuka, Naoto/AAN-3633-2021	Berger, Thomas E./0000-0002-4989-475X; Nishizuka, Naoto/0000-0002-1050-7863; Matsumoto, Takuma/0000-0002-1043-9944; Shimizu, Toshifumi/0000-0003-4764-6856	Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish; STFC [PP/D002907/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aschwanden M., 2004, PHYS SOLAR CORONA; AXFORD WI, 1992, COSPAR COLL, V3, P1; Canfield RC, 1996, ASTROPHYS J, V464, P1016, DOI 10.1086/177389; Chae J, 1999, ASTROPHYS J, V513, pL75, DOI 10.1086/311910; Cirtain JW, 2007, SCIENCE, V318, P1580, DOI 10.1126/science.1147050; HOLLWEG JV, 1982, SOL PHYS, V75, P35, DOI 10.1007/BF00153458; Katsukawa Y, 2007, SCIENCE, V318, P1594, DOI 10.1126/science.1146046; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kudoh T, 1999, ASTROPHYS J, V514, P493, DOI 10.1086/306930; KUROKAWA H, 1993, IAU C, V46, P507; Litvinenko YE, 1999, ASTROPHYS J, V515, P435, DOI 10.1086/307001; Okamoto TJ, 2007, SCIENCE, V318, P1577, DOI 10.1126/science.1145447; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; PRIEST ER, 2000, MAGNETIC RECONNECTI; RUST DM, 1968, IAU S, V35, P77; Saito T, 2001, ASTROPHYS J, V554, P1151, DOI 10.1086/323146; SCHMIEDER B, 1995, SOL PHYS, V156, P245, DOI 10.1007/BF00670226; SHIBATA K, 1982, SOL PHYS, V77, P121, DOI 10.1007/BF00156100; SHIBATA K, 1992, PUBL ASTRON SOC JPN, V44, pL173; SHIBATA K, 1994, ASTROPHYS J, V431, pL51, DOI 10.1086/187470; Shibata K, 1997, ESA SP PUBL, V404, P103; Shimojo M, 1998, SOL PHYS, V178, P379, DOI 10.1023/A:1005091905214; Shimojo M, 1996, PUBL ASTRON SOC JPN, V48, P123, DOI 10.1093/pasj/48.1.123; SUEMATSU Y, 1982, SOL PHYS, V75, P99, DOI 10.1007/BF00153464; Suzuki TK, 2005, ASTROPHYS J, V632, pL49, DOI 10.1086/497536; Takeuchi A, 2001, ASTROPHYS J, V546, pL73, DOI 10.1086/318055; Yokoyama T, 1996, PUBL ASTRON SOC JPN, V48, P353, DOI 10.1093/pasj/48.2.353; YOKOYAMA T, 1995, NATURE, V375, P42, DOI 10.1038/375042a0; Yokoyama T, 1998, ESA SPEC PUBL, V421, P215	29	313	321	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1591	1594		10.1126/science.1146708	http://dx.doi.org/10.1126/science.1146708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063790	Green Submitted			2022-12-28	WOS:000251421700036
J	Wolff, T; Miller, T				Wolff, Tracy; Miller, Therese			Evidence for the reaffirmation of the U. S. preventive services task force recommendation on screening for high blood pressure	ANNALS OF INTERNAL MEDICINE			English	Article								Background: High blood pressure is common, and screening is a well-established evidence-based standard of current medical practice. Purpose: To perform a literature search for new, substantial evidence on screening for high blood pressure that would inform the reaffirmation of the U. S. Preventive Services Task Force recommendation on screening for high blood pressure. Data Sources: The PubMed and Cochrane databases were searched. The searches were limited to English-language articles on studies of adult humans (age > 18 years) that were published between 1 October 2001 and 31 March 2006 in core clinical journals. Study Selection: For the literature on benefits, meta-analyses; systematic reviews; and randomized, controlled trials were included. For harms, meta-analyses; systematic reviews; randomized, controlled trials; cohort studies; case-control studies; and case series of large, multisite databases were included. Two reviewers independently reviewed titles, abstracts, and full articles for inclusion. Data Extraction: No new evidence was found on benefits or harms of screening. Two reviewers extracted data from studies on the harms of early treatment, including adverse effects of drug therapy and adverse quality-of-life outcomes. Data Synthesis: No new evidence was found for the benefits of screening for high blood pressure. New evidence on the harms of treatment of early hypertension shows that pharmacologic therapy is associated with common side effects; serious adverse events are uncommon. Limitations: The nonsystematic search may have missed some smaller studies on the benefits and harms of screening and treatment for high blood pressure. Conclusion: No new evidence was found on the benefits of screening. Pharmacotherapy for early hypertension is associated with common side effects.	Agcy Healthcare Res & Qual, US Prevent Serv Task Force Program, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Wolff, T (corresponding author), Agcy Healthcare Res & Qual, US Prevent Serv Task Force Program, 540 Gaither Rd, Rockville, MD 20850 USA.							Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ebbs D, 2001, CARDIOLOGY, V96, P3, DOI 10.1159/000049095; Fogari R, 2001, AM J HYPERTENS, V14, P27, DOI 10.1016/S0895-7061(00)01214-0; Hollenberg NK, 2003, ARCH INTERN MED, V163, P1543, DOI 10.1001/archinte.163.13.1543; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Klein R, 1997, Trans Am Ophthalmol Soc, V95, P329; KLEIN R, 1997, T AM OPHTHAL SOC, V95, P348; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Padwal R, 2001, BMJ-BRIT MED J, V322, P977, DOI 10.1136/bmj.322.7292.977; White WB, 2004, AM HEART J, V148, P628, DOI 10.1016/j.ahj.2004.07.008	10	30	32	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					787	U47		10.7326/0003-4819-147-11-200712040-00010	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056663				2022-12-28	WOS:000251539100006
J	Dey, A; Francis, EJ; Adams, MWW; Babini, E; Takahashi, Y; Fukuyama, K; Hodgson, KO; Hedman, B; Solomon, EI				Dey, Abhishek; Jenney, Francis E., Jr.; Adams, Michael W. W.; Babini, Elena; Takahashi, Yasuhiro; Fukuyama, Keiichi; Hodgson, Keith O.; Hedman, Britt; Solomon, Edward I.			Solvent tuning of electrochemical potentials in the active sites of HiPIP versus ferredoxin	SCIENCE			English	Article							IRON-SULFUR PROTEINS; RAY-ABSORPTION SPECTROSCOPY; K-EDGE XAS; REDOX POTENTIALS; FE4S4 CLUSTERS; ELECTRONIC-STRUCTURE; AZOTOBACTER-VINELANDII; CHEMICAL-PROCESSES; SYNTHETIC ANALOGS; DFT CALCULATIONS	A persistent puzzle in the field of biological electron transfer is the conserved iron-sulfur cluster motif in both high potential iron-sulfur protein (HiPIP) and ferredoxin (Fd) active sites. Despite this structural similarity, HiPIPs react oxidatively at physiological potentials, whereas Fds are reduced. Sulfur K-edge x-ray absorption spectroscopy uncovers the substantial influence of hydration on this variation in reactivity. Fe-S covalency is much lower in natively hydrated Fd active sites than in HiPIPs but increases upon water removal; similarly, HiPIP covalency decreases when unfolding exposes an otherwise hydrophobically shielded active site to water. Studies on model compounds and accompanying density functional theory calculations support a correlation of Fe-S covalency with ease of oxidation and therefore suggest that hydration accounts for most of the difference between Fd and HiPIP reduction potentials.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Bologna, I-47023 Cesena, Italy; Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	Stanford University; University System of Georgia; University of Georgia; University of Bologna; Osaka University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Hodgson, KO (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hodgson@ssrl.slac.stanford.edu; hedman@ssrl.slac.stanford.edu; edward.solomon@stanford.edu	Babini, Elena/H-1744-2018; Takahashi, Yasuhiro/F-1119-2011; Dey, Abhishek/D-2825-2013; Dey, Abhishek/AAS-3103-2020	Babini, Elena/0000-0001-9906-4909; Takahashi, Yasuhiro/0000-0002-0588-6045; Dey, Abhishek/0000-0002-9166-3349; Dey, Abhishek/0000-0002-9166-3349; Adams, Michael/0000-0002-9796-5014; Jenney, Francis/0000-0002-1667-6924; Solomon, Edward/0000-0003-0291-3199	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060329] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-001209, RR-01209] Funding Source: Medline; NIGMS NIH HHS [GM 60329] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG FA, 1982, FEBS LETT, V150, P214, DOI 10.1016/0014-5793(82)81337-9; AVERILL BA, 1973, J AM CHEM SOC, V95, P3523, DOI 10.1021/ja00792a013; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; BLONK HL, 1991, INORG CHEM, V30, P3231, DOI 10.1021/ic00016a022; Boon EM, 2003, P NATL ACAD SCI USA, V100, P12543, DOI 10.1073/pnas.2035257100; CARTER CW, 1977, J BIOL CHEM, V252, P7802; CARTER CW, 1972, P NATL ACAD SCI USA, V69, P3526, DOI 10.1073/pnas.69.12.3526; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Dey A, 2005, J AM CHEM SOC, V127, P12046, DOI 10.1021/ja0519031; Dey A, 2006, J AM CHEM SOC, V128, P533, DOI 10.1021/ja0549695; Florian J, 1997, J PHYS CHEM B, V101, P5583, DOI 10.1021/jp9705075; Fukuta K., 2004, LAB MOUSE, P543; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P5514, DOI 10.1074/jbc.273.10.5514; Glaser T, 2000, ACCOUNTS CHEM RES, V33, P859, DOI 10.1021/ar990125c; Glaser T, 2001, J AM CHEM SOC, V123, P4859, DOI 10.1021/ja0155940; GLOUX J, 1995, J AM CHEM SOC, V117, P7513, DOI 10.1021/ja00133a024; GLOUX J, 1994, J AM CHEM SOC, V116, P1953, DOI 10.1021/ja00084a040; HEERING HA, 1995, EUR J BIOCHEM, V232, P811, DOI 10.1111/j.1432-1033.1995.811zz.x; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; JOHNSON RE, 1983, J AM CHEM SOC, V105, P7280, DOI 10.1021/ja00363a013; LANGEN R, 1992, J BIOL CHEM, V267, P25625; Lee SC, 2004, CHEM REV, V104, P1135, DOI 10.1021/cr0206216; LePape L, 1997, J AM CHEM SOC, V119, P9757, DOI 10.1021/ja963349o; LUZHKOV V, 1992, J COMPUT CHEM, V13, P199, DOI 10.1002/jcc.540130212; Morelli X, 2000, BIOCHEMISTRY-US, V39, P2530, DOI 10.1021/bi992306s; Neese F, 1999, INORG CHEM, V38, P4854, DOI 10.1021/ic990461p; ORMEJOHNSON NR, 1983, BIOCHIM BIOPHYS ACTA, V748, P68, DOI 10.1016/0167-4838(83)90028-6; OSULLIVAN T, 1985, J AM CHEM SOC, V107, P4096, DOI 10.1021/ja00299a066; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; SHERIDAN RP, 1981, J BIOL CHEM, V256, P5052; Solomon EI, 2005, COORDIN CHEM REV, V249, P97, DOI 10.1016/j.ccr.2004.03.020; SPIRO TG, 1982, METAL IONS BIOL, V4; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; Zhou CY, 2000, INORG CHIM ACTA, V300, P892, DOI 10.1016/S0020-1693(99)00593-9	41	145	146	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1464	1468		10.1126/science.1147753	http://dx.doi.org/10.1126/science.1147753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048692				2022-12-28	WOS:000251246100050
J	Barabash, S; Fedorov, A; Sauvaud, JJ; Lundin, R; Russell, CT; Futaana, Y; Zhang, TL; Andersson, H; Brinkfeldt, K; Grigoriev, A; Holmstrom, M; Yamauchi, M; Asamura, K; Baumjohann, W; Lammer, H; Coates, AJ; Kataria, DO; Linder, DR; Curtis, CC; Hsieh, KC; Sandel, BR; Grande, M; Gunell, H; Koskinen, HEJ; Kallio, E; Riihela, P; Sales, T; Schmidt, W; Kozyra, J; Krupp, N; Franz, M; Woch, J; Luhmann, J; McKenna-Lawlor, S; Mazelle, C; Thocaven, JJ; Orsini, S; Cerulli-Irelli, R; Mura, M; Milillo, M; Maggi, M; Roelof, E; Brandt, P; Szego, K; Winningham, JD; Frahm, RA; Scherrer, J; Sharber, JR; Wurz, P; Bochsler, P				Barabash, S.; Fedorov, A.; Sauvaud, J. J.; Lundin, R.; Russell, C. T.; Futaana, Y.; Zhang, T. L.; Andersson, H.; Brinkfeldt, K.; Grigoriev, A.; Holmstrom, M.; Yamauchi, M.; Asamura, K.; Baumjohann, W.; Lammer, H.; Coates, A. J.; Kataria, D. O.; Linder, D. R.; Curtis, C. C.; Hsieh, K. C.; Sandel, B. R.; Grande, M.; Gunell, H.; Koskinen, H. E. J.; Kallio, E.; Riihela, P.; Sales, T.; Schmidt, W.; Kozyra, J.; Krupp, N.; Franz, M.; Woch, J.; Luhmann, J.; McKenna-Lawlor, S.; Mazelle, C.; Thocaven, J. -J.; Orsini, S.; Cerulli-Irelli, R.; Mura, M.; Milillo, M.; Maggi, M.; Roelof, E.; Brandt, P.; Szego, K.; Winningham, J. D.; Frahm, R. A.; Scherrer, J.; Sharber, J. R.; Wurz, P.; Bochsler, P.			The loss of ions from Venus through the plasma wake	NATURE			English	Article							PIONEER VENUS; UPPER-ATMOSPHERE; EXPRESS; OXYGEN; MARS; ANALYZER; PICKUP; ATOMS	Venus, unlike Earth, is an extremely dry planet although both began with similar masses, distances from the Sun, and presumably water inventories. The high deuterium-to-hydrogen ratio in the venusian atmosphere relative to Earth's also indicates that the atmosphere has undergone significantly different evolution over the age of the Solar System(1). Present-day thermal escape is low for all atmospheric species. However, hydrogen can escape by means of collisions with hot atoms from ionospheric photochemistry(2), and although the bulk of O and O-2 are gravitationally bound, heavy ions have been observed to escape(3) through interaction with the solar wind. Nevertheless, their relative rates of escape, spatial distribution, and composition could not be determined from these previous measurements. Here we report Venus Express measurements showing that the dominant escaping ions are O+, He+ and H+. The escaping ions leave Venus through the plasma sheet (a central portion of the plasma wake) and in a boundary layer of the induced magnetosphere. The escape rate ratios are Q(H+)/Q(O+) = 1.9; Q(He+)/Q(O+) = 0.07. The first of these implies that the escape of H+ and O+, together with the estimated escape of neutral hydrogen and oxygen, currently takes place near the stoichometric ratio corresponding to water.	Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ Arizona, Tucson, AZ 85721 USA; Aberystwyth Univ, Aberystwyth SY23 3BZ, Ceredigion, Wales; W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; Univ Helsinki, Dept Phys Sci, FIN-00014 Helsinki, Finland; Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Natl Univ Ireland, Maynooth, Kildare, Ireland; Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest 114, Hungary; SW Res Inst, San Antonio, TX 78228 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	University of California System; University of California Los Angeles; Austrian Academy of Sciences; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of London; University College London; University of Arizona; Aberystwyth University; West Virginia University; University of Helsinki; Finnish Meteorological Institute; University of Michigan System; University of Michigan; Max Planck Society; University of California System; University of California Berkeley; Maynooth University; Istituto Nazionale Astrofisica (INAF); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Southwest Research Institute; University of Bern	Barabash, S (corresponding author), Swedish Inst Space Phys, S-98128 Kiruna, Sweden.	stas@irf.se	Futaana, Yoshifumi/P-5899-2014; Roelof, Edmond/G-6654-2019; Koskinen, Hannu E. J./B-4971-2017; Russell, Christopher T/E-7745-2012; kallio, esa/M-9541-2019; Brandt, Pontus C/N-1218-2016; Baumjohann, Wolfgang/A-1012-2010; Grande, Manuel/C-2242-2013; Gunell, Herbert/D-5611-2013; Kataria, Dhiren/AAH-4474-2021; Wurz, Peter/R-2273-2017; Kallio, Esa/F-9410-2014; Coates, Andrew/C-2396-2008	Futaana, Yoshifumi/0000-0002-7056-3517; Roelof, Edmond/0000-0002-2270-0652; Koskinen, Hannu E. J./0000-0003-3839-6461; Russell, Christopher T/0000-0003-1639-8298; kallio, esa/0000-0002-9791-804X; Brandt, Pontus C/0000-0002-4644-0306; Baumjohann, Wolfgang/0000-0001-6271-0110; Grande, Manuel/0000-0002-2233-2618; Gunell, Herbert/0000-0001-5379-1158; Kataria, Dhiren/0000-0002-1034-3854; Wurz, Peter/0000-0002-2603-1169; Kallio, Esa/0000-0002-9791-804X; Coates, Andrew/0000-0002-6185-3125; Mura, Alessandro/0000-0002-4552-4292; asamura, kazushi/0000-0002-6076-3814; Milillo, Anna/0000-0002-0266-2556	UK Space Agency [PP/D000831/1] Funding Source: researchfish	UK Space Agency		Barabash S, 2007, PLANET SPACE SCI, V55, P1772, DOI 10.1016/j.pss.2007.01.014; Barabash S, 2007, SCIENCE, V315, P501, DOI 10.1126/science.1134358; BRACE LH, 1982, PLANET SPACE SCI, V30, P29, DOI 10.1016/0032-0633(82)90069-1; Donahue T. M., 1997, VENUS 2 GEOLOGY GEOP, P385; Fox JL, 2004, ADV SPACE RES-SERIES, V33, P132, DOI 10.1016/j.asr.2003.08.014; HARTLE RE, 1995, ADV SPACE RES, V15, P117, DOI 10.1016/0273-1177(94)00073-A; INTRILIGATOR DS, 1989, GEOPHYS RES LETT, V16, P167, DOI 10.1029/GL016i002p00167; INTRILIGATOR DS, 1980, IEEE T GEOSCI REMOTE, V18, P39, DOI 10.1109/TGRS.1980.350258; KASPRZAK WT, 1993, GEOPHYS RES LETT, V20, P2747, DOI 10.1029/93GL02241; Krasnopolsky VA, 2005, ICARUS, V176, P395, DOI 10.1016/j.icarus.2005.02.005; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Lammer H, 2006, PLANET SPACE SCI, V54, P1445, DOI 10.1016/j.pss.2006.04.022; Luhmann JG, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002820; Luhmann JG, 2006, PLANET SPACE SCI, V54, P1457, DOI 10.1016/j.pss.2005.10.009; MCCOMAS DJ, 1986, J GEOPHYS RES, V91, P7939, DOI 10.1029/JA091iA07p07939; MCELROY MB, 1982, GEOPHYS RES LETT, V9, P649, DOI 10.1029/GL009i006p00649; MIHALOV JD, 1982, J GEOPHYS RES-SPACE, V87, P9045, DOI 10.1029/JA087iA11p09045; NAGY AF, 1981, GEOPHYS RES LETT, V8, P629, DOI 10.1029/GL008i006p00629; von Zahn U., 1983, Venus, P299; Zhang TL, 2006, PLANET SPACE SCI, V54, P1336, DOI 10.1016/j.pss.2006.04.018; ZHANG TL, 1991, J GEOPHYS RES-SPACE, V96, P11145, DOI 10.1029/91JA00088; ZHANG TL, 1990, J GEOPHYS RES-SPACE, V95, P14961, DOI 10.1029/JA095iA09p14961	22	139	140	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					650	653		10.1038/nature06434	http://dx.doi.org/10.1038/nature06434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046398	Green Published			2022-12-28	WOS:000251209700038
J	Park, IH; Zhao, R; West, JA; Yabuuchi, A; Huo, HG; Ince, TA; Lerou, PH; Lensch, MW; Daley, GQ				Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Ince, Tan A.; Lerou, Paul H.; Lensch, M. William; Daley, George Q.			Reprogramming of human somatic cells to pluripotency with defined factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; FIBROBLASTS; GENERATION; DIFFERENTIATION; INDUCTION; SELECTION; SURVIVAL; REGIONS; NANOG; LINES	Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo- derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors ( Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem ( iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune- deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient- specific cells might be established in culture.	[Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lerou, Paul H.; Lensch, M. William; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Ince, Tan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lerou, Paul H.] Brigham & Womens Hosp, Div Newborn Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	West, Jason/I-4445-2014	West, Jason/0000-0002-7252-8651; Ince, Tan/0000-0003-0315-6425				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yu J, 2007, SCIENCE, V318, P1917; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	24	2179	2504	8	749	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					141	U1		10.1038/nature06534	http://dx.doi.org/10.1038/nature06534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18157115				2022-12-28	WOS:000252214400032
J	Burnett, MM; Huang, MS; Seliem, RM				Burnett, Melissa M.; Huang, Mary S.; Seliem, Rania M.			A 5-month-old girl with skin lesions - Acute myeloid leukemia with a t(11q23) translocation, with involvement of the skin (leukemia cutis)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENERALIZED ERUPTIVE HISTIOCYTOMA; CONGENITAL LEUKEMIA; MUTATIONS; CHILDREN; NEONATE; INFANT		Massachusetts Gen Hosp, Dept Pediat Dermatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Cambridge Hosp, Cambridge Hlth Alliance, Dept Pediat Dermatol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Burnett, MM (corresponding author), Massachusetts Gen Hosp, Dept Pediat Dermatol, Boston, MA 02114 USA.							Bresters D, 2002, BRIT J HAEMATOL, V117, P513, DOI 10.1046/j.1365-2141.2002.03459.x; BRUNNING RD, 2001, PATHOLOGY GENETICS T, V3, P81; CAPUTO R, 1987, J AM ACAD DERMATOL, V17, P449, DOI 10.1016/S0190-9622(87)70228-X; Chessells JM, 2002, LEUKEMIA, V16, P776, DOI 10.1038/sj.leu.2402468; Dusenbery KE, 2003, J PEDIAT HEMATOL ONC, V25, P760, DOI 10.1097/00043426-200310000-00004; Friedlander SF, 1996, CLIN PEDIATR, V35, P531, DOI 10.1177/000992289603501008; Goodman WT, 2003, DERMATOLOGY, P1429; Grundy RG, 2000, J PEDIAT HEMATOL ONC, V22, P252, DOI 10.1097/00043426-200005000-00011; Kang HJ, 2005, LEUKEMIA RES, V29, P617, DOI 10.1016/j.leukres.2004.11.006; Kaspers GJL, 2005, LEUKEMIA, V19, P2025, DOI 10.1038/sj.leu.2403958; Kawasaki H, 2001, BLOOD, V98, P3589, DOI 10.1182/blood.V98.13.3589; Landers MC, 2005, PEDIATR DERMATOL, V22, P26, DOI 10.1111/j.1525-1470.2005.22106.x; Lerner LH, 1996, J AM ACAD DERMATOL, V35, P330, DOI 10.1016/S0190-9622(96)90662-3; PALLER AS, 2006, HURWITZ CLIN PEDIAT, P245; PALLER AS, 2006, HURWITZ CLIN PEDIAT, P205; Pui CH, 2000, LEUKEMIA, V14, P684, DOI 10.1038/sj.leu.2401725; RATNAM KV, 1994, DERMATOL CLIN, V12, P419, DOI 10.1016/S0733-8635(18)30190-6; REPISO T, 1995, BRIT J DERMATOL, V132, P978; Rubnitz JE, 2002, J CLIN ONCOL, V20, P2302, DOI 10.1200/JCO.2002.08.400; Solky BA, 2004, PEDIATR DERMATOL, V21, P551, DOI 10.1111/j.0736-8046.2004.21505.x; Tharp M. D., 2003, DERMATOLOGY, P1899; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Torrelo A, 2004, PEDIATR DERMATOL, V21, P458, DOI 10.1111/j.0736-8046.2004.21408.x; VALENT P, 2001, WHO CLASSIFICATION T, V3, P293; Wee SH, 2000, PEDIATR DERMATOL, V17, P453, DOI 10.1046/j.1525-1470.2000.01842.x; WEINSTEIN HJ, 1978, CLIN HAEMATOL, V7, P147; Wolfe LC, 2003, NEW ENGL J MED, V348, P2557, DOI 10.1056/NEJMcpc030012; Woods WG, 2006, PEDIATR BLOOD CANCER, V46, P565, DOI 10.1002/pbc.20646; Yen A, 1996, J AM ACAD DERMATOL, V34, P375, DOI 10.1016/S0190-9622(07)80012-0; Zhang IH, 2006, J AM ACAD DERMATOL, V54, pS22, DOI 10.1016/j.jaad.2005.04.038	30	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2616	2623		10.1056/NEJMcpc0706920	http://dx.doi.org/10.1056/NEJMcpc0706920			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094382				2022-12-28	WOS:000251728900013
J	Hawkes, N				Hawkes, Nigel			Being an NHS manager is a fool's errand	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1239	1239		10.1136/bmj.39423.645729.94	http://dx.doi.org/10.1136/bmj.39423.645729.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079546	Green Published			2022-12-28	WOS:000251832200031
J	Krkosek, M; Ford, JS; Morton, A; Lele, S; Myers, RA; Lewis, MA				Krkosek, Martin; Ford, Jennifer S.; Morton, Alexandra; Lele, Subhash; Myers, Ransom A.; Lewis, Mark A.			Declining wild salmon populations in relation to parasites from farm salmon	SCIENCE			English	Article							PACIFIC SALMON; ATLANTIC SALMON; SEA LICE; LEPEOPHTHEIRUS-SALMONIS; ONCORHYNCHUS-GORBUSCHA; DENSITY-DEPENDENCE; MARINE-ENVIRONMENT; PINK SALMON; TIME-SERIES; FISH	Rather than benefiting wild fish, industrial aquaculture may contribute to declines in ocean fisheries and ecosystems. Farm salmon are commonly infected with salmon lice ( Lepeophtheirus salmonis), which are native ectoparasitic copepods. We show that recurrent louse infestations of wild juvenile pink salmon ( Oncorhynchus gorbuscha), all associated with salmon farms, have depressed wild pink salmon populations and placed them on a trajectory toward rapid local extinction. The louse- induced mortality of pink salmon is commonly over 80% and exceeds previous fishing mortality. If outbreaks continue, then local extinction is certain, and a 99% collapse in pink salmon population abundance is expected in four salmon generations. These results suggest that salmon farms can cause parasite outbreaks that erode the capacity of a coastal ecosystem to support wild salmon populations.	Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada; Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; Dalhousie Univ, Dept Biol, Halifax, NS, Canada; Salmon Coast Field Stn, Simoom Sound, BC, Canada	University of Alberta; University of Alberta; Dalhousie University	Krkosek, M (corresponding author), Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada.	mkrkosek@ualberta.ca	Lewis, Mark/A-2659-2014; Krkosek, Martin/A-4003-2012; Lewis, Mark A/C-5015-2008	Lewis, Mark A/0000-0002-7155-7426				Beamish RJ, 2006, ICES J MAR SCI, V63, P1326, DOI 10.1016/j.icesjms.2006.04.011; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Goldburg R, 2005, FRONT ECOL ENVIRON, V3, P21, DOI 10.2307/3868441; Groot C., 1991, PACIFIC SALMON LIFE; Heard W.R., 1991, P119; Hilborn R, 2006, P NATL ACAD SCI USA, V103, P15277, DOI 10.1073/pnas.0607419103; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McVicar AH, 1997, ICES J MAR SCI, V54, P1093, DOI 10.1016/S1054-3139(97)80014-8; McVicar AH, 2004, AQUAC RES, V35, P751, DOI 10.1111/j.1365-2109.2004.01097.x; Morton A, 2005, N AM J FISH MANAGE, V25, P811, DOI 10.1577/M04-149.1; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Morton AB, 2003, CAN FIELD NAT, V117, P634, DOI 10.22621/cfn.v117i4.834; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; PEET CR, 2007, THESIS U VICTORIA; Pike AW, 2000, ADV PARASIT, V44, P233; Pinheiro JC, 2004, MIXED EFFECTS MODELS; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Volpe JP, 2001, CAN J FISH AQUAT SCI, V58, P197, DOI 10.1139/cjfas-58-1-197	30	284	288	5	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1772	1775		10.1126/science.1148744	http://dx.doi.org/10.1126/science.1148744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079401				2022-12-28	WOS:000251616800040
J	Gottwein, E; Mukherjee, N; Sachse, C; Frenzel, C; Majoros, WH; Chi, JTA; Braich, R; Manoharan, M; Soutschek, J; Ohler, U; Cullen, BR				Gottwein, Eva; Mukherjee, Neelanjan; Sachse, Christoph; Frenzel, Corina; Majoros, William H.; Chi, Jen-Tsan A.; Braich, Ravi; Manoharan, Muthiah; Soutschek, Jurgen; Ohler, Uwe; Cullen, Bryan R.			A viral microRNA functions as an orthologue of cellular miR-155	NATURE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; EXPRESSION; LYMPHOMA; CELLS; THOUSANDS; TARGETS; GENOME; RNAS	All metazoan eukaryotes express microRNAs ( miRNAs), roughly 22- nucleotide regulatory RNAs that can repress the expression of messenger RNAs bearing complementary sequences(1). Several DNA viruses also express miRNAs in infected cells, suggesting a role in viral replication and pathogenesis(2). Although specific viral miRNAs have been shown to autoregulate viral mRNAs(3,4) or downregulate cellular mRNAs(5,6), the function of most viral miRNAs remains unknown. Here we report that the miR- K12- 11 miRNA encoded by Kaposi's- sarcoma- associated herpes virus ( KSHV) shows significant homology to cellular miR- 155, including the entire miRNA 'seed' region(7). Using a range of assays, we show that expression of physiological levels of miR- K12- 11 or miR- 155 results in the downregulation of an extensive set of common mRNA targets, including genes with known roles in cell growth regulation. Our findings indicate that viral miR- K12- 11 functions as an orthologue of cellular miR- 155 and probably evolved to exploit a preexisting gene regulatory pathway in B cells. Moreover, the known aetiological role of miR- 155 in B- cell transformation(8-10) suggests that miR- K12- 11 may contribute to the induction of KSHV-positive B- cell tumours in infected patients.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Cenix BioSci GmbH, D-01307 Dresden, Germany; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	culle002@mc.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Mukherjee, Neelanjan/0000-0003-0017-1400	NIAID NIH HHS [R01 AI067968-01A1, R01 AI067968, R01 AI067968-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gottwein E, 2007, METHOD ENZYMOL, V427, P229, DOI 10.1016/S0076-6879(07)27013-2; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimaldi E, 2005, CLIN LAB HAEMATOL, V27, P91, DOI 10.1111/j.1365-2257.2005.00676.x; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	32	457	493	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1096	U17		10.1038/nature05992	http://dx.doi.org/10.1038/nature05992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075594	Green Accepted			2022-12-28	WOS:000251579900090
J	Kuriyan, J; Eisenberg, D				Kuriyan, John; Eisenberg, David			The origin of protein interactions and allostery in colocalization	NATURE			English	Review							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENE FUSION; REGULATORY SITES; DNA RECOGNITION; DOMAIN; EVOLUTION; BINDING	Two fundamental principles can account for how regulated networks of interacting proteins originated in cells. These are the law of mass action, which holds that the binding of one molecule to another increases with concentration, and the fact that the colocalization of molecules vastly increases their local concentrations. It follows that colocalization can amplify the effect on one protein of random mutations in another protein and can therefore, through natural selection, lead to interactions between proteins and to a startling variety of complex allosteric controls. It also follows that allostery is common and that homologous proteins can have different allosteric mechanisms. Thus, the regulated protein networks of organisms seem to be the inevitable consequence of natural selection operating under physical laws.	Univ Calif Berkeley, Howard Hughes Med Inst, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Calif Inst Quantitat Biosci, Dept Chem, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Energy Inst Genom & Proteom, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Energy Inst Genom & Proteom, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu; david@mbi.ucla.edu						Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; Beernink PT, 1999, P NATL ACAD SCI USA, V96, P5388, DOI 10.1073/pnas.96.10.5388; Behe Michael, 2007, EDGE EVOLUTION; BEHE MJ, 2003, DARWINS BLACK BOX BI; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Buchbinder JL, 2001, ANNU REV BIOPH BIOM, V30, P191, DOI 10.1146/annurev.biophys.30.1.191; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306; Deeds EJ, 2007, P NATL ACAD SCI USA, V104, P14952, DOI 10.1073/pnas.0702766104; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Doucleff M, 2005, J MOL BIOL, V353, P242, DOI 10.1016/j.jmb.2005.08.003; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; HWANG PK, 1986, NATURE, V324, P80, DOI 10.1038/324080a0; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lin K, 1996, SCIENCE, V273, P1539, DOI 10.1126/science.273.5281.1539; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Neet K, 1996, GENES CELLS, V1, P147, DOI 10.1046/j.1365-2443.1996.d01-234.x; NOGUCHI CT, 1985, ANNU REV BIOPHYS BIO, V14, P239, DOI 10.1146/annurev.biophys.14.1.239; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PALM D, 1985, NATURE, V313, P500, DOI 10.1038/313500a0; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003; RATH VL, 1994, NAT STRUCT BIOL, V1, P681, DOI 10.1038/nsb1094-681; Robinson CR, 1996, BIOCHEMISTRY-US, V35, P109, DOI 10.1021/bi9521194; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; Royer WE, 2005, J BIOL CHEM, V280, P27477, DOI 10.1074/jbc.R500006200; ROYER WE, 1989, J BIOL CHEM, V264, P21052; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Xu D, 1998, PROTEIN SCI, V7, P533; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	73	286	292	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					983	990		10.1038/nature06524	http://dx.doi.org/10.1038/nature06524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075577				2022-12-28	WOS:000251579900068
J	Relman, AS				Relman, Arnold S.			Medical professionalism in a commercialized health care market	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Relman, AS (corresponding author), Harvard Univ, Sch Med, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	arelman@rics.bwh.harvard.edu						*AM MED ASS, 1966, OP REP JUD COUNC; ARROW KJ, 1963, AM ECON REV, V53, P941; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Cohen JJ, 2007, JAMA-J AM MED ASSOC, V298, P670, DOI 10.1001/jama.298.6.670; DeAngelis CD, 2005, JAMA-J AM MED ASSOC, V294, P1107, DOI 10.1001/jama.294.9.1107; Freidson E., 2001, PROFESSIONALISM 3 LO; Herzlinger ReginaE., 2004, CONSUMER DRIVEN HLTH; Relman Arnold S., 2007, 2 OPINION RESCUING A; RELMAN AS, 1980, NEW ENGL J MED, V303, P963, DOI 10.1056/NEJM198010233031703; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; 2007, CAMB Q HEALTHC ETHIC, V16, P368	11	87	88	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2668	2670		10.1001/jama.298.22.2668	http://dx.doi.org/10.1001/jama.298.22.2668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073363				2022-12-28	WOS:000251546100019
J	Willi, C; Bodenmann, P; Ghali, WA; Faris, PD; Cornuz, J				Willi, Carole; Bodenmann, Patrick; Ghali, William A.; Faris, Peter D.; Cornuz, Jacques			Active smoking and the risk of type 2 diabetes - A systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MIDDLE-AGED JAPANESE; IMPAIRED FASTING GLUCOSE; BODY-FAT DISTRIBUTION; CIGARETTE-SMOKING; FOLLOW-UP; INSULIN-RESISTANCE; GENERAL-POPULATION; PROSPECTIVE COHORT; SEX-DIFFERENCES; RELATIVE RISK	Context Observational studies have suggested an association between active smoking and the incidence of type 2 diabetes. Objective To conduct a systematic review with meta-analysis of studies assessing the association between active smoking and incidence of type 2 diabetes. Data Sources A search of MEDLINE ( 1966 to May 2007) and EMBASE ( 1980 to May 2007) databases was supplemented by manual searches of bibliographies of key retrieved articles, reviews of abstracts from scientific meetings, and contact with experts. Study Selection Studies were included if they reported risk of impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes in relationship to smoking status at baseline; had a cohort design; and excluded persons with diabetes at baseline. Data Extraction and Data Synthesis Two authors independently extracted the data, including the presence or absence of active smoking at baseline, the risk of diabetes, methods used to detect diabetes, and key criteria of study quality. Relative risks ( RRs) were pooled using a random- effects model. Associations were tested in subgroups representing different patient characteristics and study quality criteria. Results The search yielded 25 prospective cohort studies ( N= 1.2 million participants) that reported 45 844 incident cases of diabetes during a study follow- up period ranging from 5 to 30 years. Of the 25 studies, 24 reported adjusted RRs greater than 1 ( range for all studies, 0.82- 3.74). The pooled adjusted RR was 1.44 ( 95% confidence interval [ Cl], 1.31- 1.58). Results were consistent and statistically significant in all subgroups. The risk of diabetes was greater for heavy smokers ( >= 20 cigarettes/ day; RR, 1.61; 95% Cl, 1.43- 1.80) than for lighter smokers ( RR, 1.29; 95% CI, 1.13-1.48) and lower for former smokers ( RR, 1.23; 95% Cl, 1.14- 1.33) compared with active smokers, consistent with a dose- response phenomenon. Conclusion Active smoking is associated with an increased risk of type 2 diabetes. Future research should attempt to establish whether this association is causal and to clarify its mechanisms.	Univ Lausanne, Dept Ambulatory Care & Community Med, CH-1011 Lausanne, Switzerland; Univ Lausanne, Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Lausanne; University of Lausanne; University of Calgary; University of Calgary	Willi, C (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, 44 Bugnon Ave, CH-1011 Lausanne, Switzerland.	carole.willi@hospvd.ch	Clair, Carole/AAF-6675-2021; Clair, Carole/D-9786-2014; Faris, Peter/AAJ-3436-2020	Clair, Carole/0000-0001-5281-0943; Clair, Carole/0000-0001-5281-0943; Faris, Peter/0000-0001-5208-817X; Bodenmann, Patrick/0000-0002-1058-1035				ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; [Anonymous], 2002, RED RISKS PROM HLTH; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Augustson EM, 2008, AM J PUBLIC HEALTH, V98, P549, DOI 10.2105/AJPH.2005.084137; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Botas P, 2003, DIABETIC MED, V20, P904, DOI 10.1046/j.1464-5491.2003.01006.x; Carlsson S, 2004, DIABETOLOGIA, V47, P1953, DOI 10.1007/s00125-004-1554-9; CASSANO PA, 1992, AM J EPIDEMIOL, V136, P1474, DOI 10.1093/oxfordjournals.aje.a116468; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; CHIOLERO A, IN PRESS AM J CLIN N; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; CHO NH, 2005, AM DIAB ASS JUN 10 1; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; Eliasson M, 2004, J INTERN MED, V256, P101, DOI 10.1111/j.1365-2796.2004.01344.x; ELIASSON M, 1995, ATHEROSCLEROSIS, V113, P41, DOI 10.1016/0021-9150(94)05425-I; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Frati AC, 1996, DIABETES CARE, V19, P112, DOI 10.2337/diacare.19.2.112; Gavin JR, 1997, DIABETES CARE, V20, P1183; GODSLAND IF, 1992, LANCET, V339, P1619, DOI 10.1016/0140-6736(92)91890-K; GORDON T, 1975, AM HEART J, V90, P322, DOI 10.1016/0002-8703(75)90320-8; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Haire-Joshu Debra, 2004, Diabetes Care, V27 Suppl 1, pS74; Healton CG, 2006, BRIT MED J, V333, P25, DOI 10.1136/bmj.38840.608704.80; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; JANZON L, 1983, DIABETOLOGIA, V25, P86; Kawakami N, 1997, AM J EPIDEMIOL, V145, P103; King H, 1998, DIABETES CARE, V21, pB9; LUNDGREN H, 1989, INT J OBESITY, V13, P413; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Ockene JK, 2000, HEALTH PSYCHOL, V19, P17, DOI 10.1037/0278-6133.19.Suppl1.17; OHLSON LO, 1985, DIABETES, V34, P1055, DOI 10.2337/diabetes.34.10.1055; Patja K, 2005, J INTERN MED, V258, P356, DOI 10.1111/j.1365-2796.2005.01545.x; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; SANDBERG H, 1973, J PHARMACOL EXP THER, V184, P787; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Seidell JC, 1997, HORM METAB RES, V29, P155, DOI 10.1055/s-2007-979011; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Simon JA, 1997, PREV MED, V26, P639, DOI 10.1006/pmed.1997.0230; Strandberg TE, 2000, NUTR METAB CARDIOVAS, V10, P239; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugimori H, 1998, J Med Syst, V22, P27, DOI 10.1023/A:1022650305109; Talamini G, 1999, DIGEST DIS SCI, V44, P1303, DOI 10.1023/A:1026670911955; Tanko LB, 2004, MENOPAUSE, V11, P104, DOI 10.1097/01.GME.0000079740.18541.DB; Tenenbaum A, 2005, INT J CARDIOL, V104, P275, DOI 10.1016/j.ijcard.2004.10.034; Uchimoto S, 1999, DIABETIC MED, V16, P951, DOI 10.1046/j.1464-5491.1999.00173.x; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wagner EH, 2002, BMJ-BRIT MED J, V325, P913, DOI 10.1136/bmj.325.7370.913; Waki K, 2005, DIABETIC MED, V22, P818; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Wareham NJ, 1996, METABOLISM, V45, P1551, DOI 10.1016/S0026-0495(96)90187-0; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727; Wild SH, 2006, BMJ-BRIT MED J, V333, P1009, DOI 10.1136/bmj.39024.568738.43; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Windham GC, 2005, ENVIRON HEALTH PERSP, V113, P1285, DOI 10.1289/ehp.7899; YEH HC, 2004, AM DIAB ASS JUN 4 8; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; 2005, MMWR MORB MOTAL WKLY, V54, P625; 1989, JAMA, V262, P1185	86	855	888	2	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2654	2664		10.1001/jama.298.22.2654	http://dx.doi.org/10.1001/jama.298.22.2654			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073361				2022-12-28	WOS:000251546100017
J	Klein, TA; Neumann, J; Reuter, M; Hennig, J; von Cramon, DY; Ullsperger, M				Klein, Tilmann A.; Neumann, Jane; Reuter, Martin; Hennig, Juergen; von Cramon, D. Yves; Ullsperger, Markus			Genetically determined differences in learning from errors	SCIENCE			English	Article							DOPAMINE-RECEPTOR GENE; REWARD DEFICIENCY SYNDROME; MEDIAL FRONTAL-CORTEX; HEALTHY-VOLUNTEERS; A1 ALLELE; MEMORY; POLYMORPHISMS; PARKINSONISM; PREDICTION; DISORDERS	The role of dopamine in monitoring negative action outcomes and feedback-based learning was tested in a neuroimaging study in humans grouped according to the dopamine D2 receptor gene polymorphism DRD2-TAQ-IA. In a probabilistic learning task, A1-allele carriers with reduced dopamine D2 receptor densities learned to avoid actions with negative consequences less efficiently. Their posterior medial frontal cortex (pMFC), involved in feedback monitoring, responded less to negative feedback than others' did. Dynamically changing interactions between pMFC and hippocampus found to underlie feedback-based learning were reduced in A1-allele carriers. This demonstrates that learning from errors requires dopaminergic signaling. Dopamine D2 receptor reduction seems to decrease sensitivity to negative action consequences, which may explain an increased risk of developing addictive behaviors in A1-allele carriers.	Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; Univ Bonn, D-5300 Bonn, Germany; Univ Giessen, Giessen, Germany; Max Planck Inst Neurol Res, Cologne, Germany	Max Planck Society; University of Bonn; Justus Liebig University Giessen; Max Planck Society	Klein, TA (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	tklein@cbs.mpg.de; ullsperger@nf.mpg.de	Ullsperger, Markus/E-2797-2010; Ullsperger, Markus/I-4760-2019	Ullsperger, Markus/0000-0003-3970-1982; Ullsperger, Markus/0000-0003-3970-1982	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH74457] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bowirrat A, 2005, AM J MED GENET B, V132B, P29, DOI 10.1002/ajmg.b.30080; Comings DE, 2000, PROG BRAIN RES, V126, P325; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Heekeren HR, 2007, NEUROREPORT, V18, P951, DOI 10.1097/WNR.0b013e3281532bd7; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Neumann J, 2003, NEUROIMAGE, V20, P1346, DOI 10.1016/S1053-8119(03)00443-9; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162	28	316	320	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1642	1645		10.1126/science.1145044	http://dx.doi.org/10.1126/science.1145044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063800				2022-12-28	WOS:000251421700051
J	Baker, TA				Baker, Tania A.			Arthur Kornberg (1918-2007) - Obituary	NATURE			English	Biographical-Item									MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					809	809		10.1038/450809a	http://dx.doi.org/10.1038/450809a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063999	Bronze			2022-12-28	WOS:000251394900039
J	Brand, S				Brand, Stewart			Whole Earth comes into focus	NATURE			English	Editorial Material																		Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; *NASA, NASA DEEP SPAC CLIM; VALERO F, DSCOVR MISSION SUMMA; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	5	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					797	797		10.1038/450797a	http://dx.doi.org/10.1038/450797a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063991	Bronze			2022-12-28	WOS:000251394900031
J	Budnitz, DS; Shehab, N; Kegler, SR; Richards, CL				Budnitz, Daniel S.; Shehab, Nadine; Kegler, Scott R.; Richards, Chesley L.			Medication use leading to emergency department visits for adverse drug events in older adults	ANNALS OF INTERNAL MEDICINE			English	Article							BEERS CRITERIA; ELDERLY OUTPATIENTS; BLEEDING COMPLICATIONS; NATIONAL SURVEILLANCE; ORAL ANTICOAGULATION; EXPLICIT CRITERIA; INAPPROPRIATE; POPULATION; OUTCOMES; WARFARIN	Background: The Beers criteria identify inappropriate use of medications in older adults. The number of and risk for adverse events from these medications are unknown. Objective: To estimate the number of and risk for emergency department visits for adverse events involving Beers criteria medications compared with other medications. Design: Nationally representative, public health surveillance of adverse drug events and a cross-sectional survey of outpatient medical visits. Setting: National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance System, 2004 - 2005; National Ambulatory Medical Care Survey, 2004; and National Hospital Ambulatory Medical Care Survey, 2004. Participants: Persons 65 years of age or older seeking emergency department and outpatient care. Measurements: Estimated number of and risks for emergency department visits for adverse drug events involving Beers criteria medications and other medications. Results: Among U. S. patients 65 years of age or older, an estimated 177 504 emergency department visits (95% Cl, 100 155 to 254 854 visits) for adverse drug events occurred both years. An estimated 3.6% (Cl, 2.8% to 4.5%) of these visits were for adverse events medications considered to be always potentially inappropriate, according to the Beers criteria, and 33.3% (Cl, 27.8% to 38.7%) of visits were for adverse events from 3 other medications ( warfarin [17.3%], insulin [13.0%], and digoxin [3.2%]). Accounting for outpatient prescription frequency, the risk for emergency department visits for adverse events due to these 3 medications was 35 times (Cl, 9.6 to 61) greater than that for medications considered to be always potentially inappropriate. Limitation: Adverse events were identified only in emergency departments. Conclusion: Compared with other medications, Beers criteria medications caused low numbers of and few risks for emergency department visits for adverse events. Performance measures and interventions targeting warfarin, insulin, and digoxin use could prevent more emergency department visits for adverse events.	CDCP, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; CDCP, Coordinating Ctr Environm Hlth & Injury Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Budnitz, DS (corresponding author), CDCP, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.			Budnitz, Daniel/0000-0002-0136-2623; Shehab, Nadine/0000-0001-8700-8539				AVOM J, 2001, JAMA-J AM MED ASSOC, V286, P2866; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, PHARMACOEPIDEM DR S, V16, P160, DOI 10.1002/pds.1242; Budnitz DS, 2005, ANN EMERG MED, V45, P197, DOI 10.1016/j.annemergmed.2004.09.020; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS43; Chang CM, 2005, PHARMACOTHERAPY, V25, P831, DOI 10.1592/phco.2005.25.6.831; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Copland M, 2001, ARCH INTERN MED, V161, P2125, DOI 10.1001/archinte.161.17.2125; Crownover Brian K, 2005, J Manag Care Pharm, V11, P416; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; De Wilde S, 2007, PHARMACOEPIDEM DR S, V16, P658, DOI 10.1002/pds.1306; Eaton L, 2007, BRIT MED J, V334, P714, DOI 10.1136/bmj.39170.698356.DB; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Field TS, 2005, MED CARE, V43, P1171, DOI 10.1097/01.mlr.0000185690.10336.70; Fillenbaum Gerda G, 2004, Am J Geriatr Pharmacother, V2, P92, DOI 10.1016/S1543-5946(04)90014-1; Food and Drug Administration (FDA), 2007, FUT DRUG SAF PROM PR; Fu AZ, 2007, MED CARE, V45, P472, DOI 10.1097/01.mlr.0000254571.05722.34; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; GANDHI TK, 2007, AHRQ PUBLICATION; Goldstein DJ, 2004, J AM GERIATR SOC, V52, P1580, DOI 10.1111/j.1532-5415.2004.52430_2.x; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Gupta S, 1996, CLIN THER, V18, P183, DOI 10.1016/S0149-2918(96)80189-5; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511, DOI 10.1093/gerona/61.5.511; Hanlon JT, 2002, MED CARE, V40, P166, DOI 10.1097/00005650-200202000-00011; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; *HEDIS, 2006, FIN NDC LISTS DRUGS; Hing Esther, 2006, Adv Data, P1; Huang BJ, 2002, PHARMACOEPIDEM DR S, V11, P127, DOI 10.1002/pds.688; Jackson SL, 2004, J INTERN MED, V256, P137, DOI 10.1111/j.1365-2796.2004.01352.x; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; KISH L, 1995, SURVEY SAMPLING, P206; Lapane KL, 2007, J AM GERIATR SOC, V55, P666, DOI 10.1111/j.1532-5415.2007.01153.x; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; Martins SDO, 2006, PHARM WORLD SCI, V28, P296, DOI 10.1007/s11096-006-9046-2; McCaig Linda F, 2006, Adv Data, P1; McDonnell PJ, 2006, AM J MANAG CARE, V12, P256; Middleton Kimberly R, 2006, Adv Data, P1; *NAT CTR HLTH STAT, 2006, PUBL US DAT FIL DOC; *NAT HEALTHC QUAL, 2006, AHRQ PUBL; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Perri M, 2005, ANN PHARMACOTHER, V39, P405, DOI 10.1345/aph.1E230; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Poon IO, 2007, J CLIN PHARM THER, V32, P21, DOI 10.1111/j.1365-2710.2007.00792.x; Pugh MJV, 2006, J MANAGE CARE PHARM, V12, P537, DOI 10.18553/jmcp.2006.12.7.537; Raebel MA, 2006, AM J MANAG CARE, V12, P268; Rask KJ, 2005, AM J MANAG CARE, V11, P145; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Schroeder T, 2001, NATL ELECT INJURY SU; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; STAFANACCI RD, 2006, ANN LONG TERM CARE, V14, P15; Steinman MA, 2007, MED CARE, V45, P95, DOI 10.1097/01.mlr.0000241111.11991.62; STUCK AE, 1994, ARCH INTERN MED, V154, P2195; Swagerty Daniel, 2005, J Am Med Dir Assoc, V6, P80, DOI 10.1016/j.jamda.2004.12.019; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vervloet D, 1998, BRIT MED J, V316, P1511, DOI 10.1136/bmj.316.7143.1511; Viswanathan H, 2005, CLIN THER, V27, P88, DOI 10.1016/j.clinthera.2005.01.009; Wagner AK, 2007, ANN INTERN MED, V146, P96, DOI 10.7326/0003-4819-146-2-200701160-00004; White TJ, 1999, PHARMACOECONOMICS, V15, P445, DOI 10.2165/00019053-199915050-00003; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823; Zhan CL, 2005, J AM GERIATR SOC, V53, P262, DOI 10.1111/j.1532-5415.2005.53112.x; 2005, MMWR MORB MORTAL WKL, V54, P380	69	425	437	2	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					755	U26		10.7326/0003-4819-147-11-200712040-00006	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056659				2022-12-28	WOS:000251539100002
J	Kiechl, S; Furtner, M; Knoflach, M; Werner, P; Willeit, J				Kiechl, Stefan; Furtner, Martin; Knoflach, Michael; Werner, Philipp; Willeit, Johann			Kaleidoscopic vision and a jerking leg on the ski slope	LANCET			English	Editorial Material							LIGHT		Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Kiechl, S (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at	Furtner, Martin/AAI-8231-2020	Knoflach, Michael/0000-0001-5576-6562				BAQUIS GD, 1985, STROKE, V16, P444, DOI 10.1161/01.STR.16.3.444; FISHER CM, 1962, CAN MED ASSOC J, V86, P1091; FURLAN AJ, 1979, ARCH NEUROL-CHICAGO, V36, P675, DOI 10.1001/archneur.1979.00500470045007; Kaiboriboon K, 2001, AM J OPHTHALMOL, V131, P674, DOI 10.1016/S0002-9394(00)00874-6; Klijn CJM, 2000, NEUROLOGY, V55, P1806	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1878	1878		10.1016/S0140-6736(07)61783-8	http://dx.doi.org/10.1016/S0140-6736(07)61783-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061063				2022-12-28	WOS:000251588700036
J	Koshnick, NC; Bluhm, H; Huber, ME; Moler, KA				Koshnick, Nicholas C.; Bluhm, Hendrik; Huber, Martin E.; Moler, Kathryn A.			Fluctuation superconductivity in mesoscopic aluminum rings	SCIENCE			English	Article							TRANSITION; ULTRATHIN; CYLINDERS; REGIME	Fluctuations are important near phase transitions, where they can be difficult to describe quantitatively. Superconductivity in mesoscopic rings is particularly intriguing because the critical temperature is an oscillatory function of magnetic field. There is an exact theory for thermal fluctuations in one-dimensional superconducting rings, which are therefore expected to be an excellent model system. We measured the susceptibility of many rings, one ring at a time, by using a scanning superconducting quantum interference device that can isolate magnetic signals that are seven orders of magnitude smaller than applied flux. We find that the fluctuation theory describes the results and that a single parameter characterizes the ways in which the fluctuations are especially important at magnetic fields where the critical temperature is suppressed.	Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Colorado, Dept Phys, Denver, CO 80204 USA	Stanford University; University of Colorado System; University of Colorado Denver	Moler, KA (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	kmoler@stanford.edu	Moler, Kathryn A/F-2541-2011; Huber, Martin/B-3354-2011; Bluhm, Hendrik/D-3422-2014	Huber, Martin/0000-0002-7638-902X; Moler, Kathryn/0000-0002-0233-8123; Bluhm, Hendrik/0000-0002-5224-7254				BERGER J, 1995, PHYS REV LETT, V75, P320, DOI 10.1103/PhysRevLett.75.320; Daumens M, 1998, PHYS LETT A, V248, P445, DOI 10.1016/S0375-9601(98)00741-5; Hayashi M, 2001, PHYSICA C, V352, P191, DOI 10.1016/S0921-4534(00)01722-6; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; LANGER JS, 1967, PHYS REV, V164, P498, DOI 10.1103/PhysRev.164.498; Lau CN, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.217003; LITTLE WA, 1962, PHYS REV LETT, V9, P9, DOI 10.1103/PhysRevLett.9.9; Liu Y, 2001, SCIENCE, V294, P2332, DOI 10.1126/science.1066144; Rosario MM, 2003, PHYSICA B, V329, P1415, DOI 10.1016/S0921-4526(02)02344-X; SCALAPINO DJ, 1972, PHYS REV B-SOLID ST, V6, P3409, DOI 10.1103/PhysRevB.6.3409; VONOPPEN F, 1992, PHYS REV B, V46, P3203, DOI 10.1103/PhysRevB.46.3203; Zhang XX, 1997, PHYS REV B, V55, P3128, DOI 10.1103/PhysRevB.55.3128	13	77	78	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1440	1443		10.1126/science.1148758	http://dx.doi.org/10.1126/science.1148758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048686	Green Submitted			2022-12-28	WOS:000251246100042
J	Gudel, M; Briggs, KR; Montmerle, T; Audard, M; Rebull, L; Skinner, SL				Guedel, Manuel; Briggs, Kevin R.; Montmerle, Thierry; Audard, Marc; Rebull, Luisa; Skinner, Stephen L.			Million-degree plasma pervading the extended Orion nebula	SCIENCE			English	Article							PHOTON IMAGING CAMERA; HII-REGIONS; XMM-NEWTON; FLOWS; DYNAMICS; BUBBLES; CLUSTER; GAS	Most stars form as members of large associations within dense, very cold ( 10 to 100 kelvin) molecular clouds. The nearby giant molecular cloud in Orion hosts several thousand stars of ages less than a few million years, many of which are located in or around the famous Orion Nebula, a prominent gas structure illuminated and ionized by a small group of massive stars ( the Trapezium). We present x- ray observations obtained with the X- ray Multi- Mirror satellite XMM- Newton, revealing that a hot plasma with a temperature of 1.7 to 2.1 million kelvin pervades the southwest extension of the nebula. The plasma flows into the adjacent interstellar medium. This x- ray outflow phenomenon must be widespread throughout our Galaxy.	[Guedel, Manuel; Briggs, Kevin R.] Paul Scherrer Inst, CH-5303 Wurenlingen, Switzerland; [Guedel, Manuel; Briggs, Kevin R.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Guedel, Manuel] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Guedel, Manuel] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Guedel, Manuel; Montmerle, Thierry] Univ Grenoble 1, CNRS, Lab Astrophys Grenoble, F-38041 Grenoble, France; [Briggs, Kevin R.] ETH, ETH Zentrum, Inst Astron, CH-8092 Zurich, Switzerland; [Audard, Marc] ISDC, CH-1290 Versoix, Switzerland; [Audard, Marc] Univ Geneva, Observ Geneva, CH-1290 Sauverny, Switzerland; [Rebull, Luisa] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Skinner, Stephen L.] Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80309 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Geneva; California Institute of Technology; University of Colorado System; University of Colorado Boulder	Gudel, M (corresponding author), Paul Scherrer Inst, CH-5303 Wurenlingen, Switzerland.	guedel@astro.phys.ethz.ch	Guedel, Manuel/C-8486-2015	Guedel, Manuel/0000-0001-9818-0588; Audard, Marc/0000-0003-4721-034X; Rebull, Luisa/0000-0001-6381-515X				Bally J, 2000, ASTRON J, V119, P2919, DOI 10.1086/301385; BLAAUW A, 1991, NATO ADV SCI I C-MAT, V342, P125; BURROWS DN, 1993, ASTROPHYS J, V406, P97, DOI 10.1086/172423; CASTOR J, 1975, ASTROPHYS J, V200, pL107, DOI 10.1086/181908; Diehl R, 2002, NEW ASTRON REV, V46, P547, DOI 10.1016/S1387-6473(02)00199-9; Feigelson ED, 2005, ASTROPHYS J SUPPL S, V160, P379, DOI 10.1086/432512; GAGNE M, 1995, ASTROPHYS J, V445, P280, DOI 10.1086/175694; Henney WJ, 2007, ASTRON J, V133, P2192, DOI 10.1086/513074; Henney WJ, 2005, ASTROPHYS J, V627, P813, DOI 10.1086/430593; Hillenbrand LA, 1998, ASTROPHYS J, V492, P540, DOI 10.1086/305076; Jaasen F, 2001, ASTRON ASTROPHYS, V365, pL1, DOI 10.1051/0004-6361:20000036; KU WHM, 1977, ASTROPHYS J, V234, pL59; LEITHERER C, 1988, ASTROPHYS J, V326, P356, DOI 10.1086/166097; MCCAUGHREAN MJ, 1994, ASTRON J, V108, P1382, DOI 10.1086/117160; O'Dell CR, 2003, ASTRON J, V125, P277, DOI 10.1086/345512; O'Dell CR, 2001, ANNU REV ASTRON ASTR, V39, P99, DOI 10.1146/annurev.astro.39.1.99; Palla F, 1999, ASTROPHYS J, V525, P772, DOI 10.1086/307928; Stahler S. W., 2005, FORMATION STARS; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Subrahmanyan R, 2001, ASTRON J, V121, P399, DOI 10.1086/318017; TENORIOTAGLE G, 1979, ASTRON ASTROPHYS, V71, P59; Townsley LK, 2006, ASTRON J, V131, P2140, DOI 10.1086/500532; Townsley LK, 2003, ASTROPHYS J, V593, P874, DOI 10.1086/376692; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087	24	96	97	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					309	312		10.1126/science.1149926	http://dx.doi.org/10.1126/science.1149926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18048651	Green Submitted			2022-12-28	WOS:000252436200031
J	Haag, JR; Pikaard, CS				Haag, Jeremy R.; Pikaard, Craig S.			RNA polymerase I: A multifunctional molecular machine	CELL			English	Editorial Material							STRUCTURAL BASIS; TRANSCRIPTION; SUBUNIT		[Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology2.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; KUHN CD, 2007, CELL; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; SOPTA M, 1985, J BIOL CHEM, V260, P353; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	11	13	14	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1224	1225		10.1016/j.cell.2007.12.005	http://dx.doi.org/10.1016/j.cell.2007.12.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160031	Bronze			2022-12-28	WOS:000252217200010
J	Granville-Chapman, J; Dunne, RL				Granville-Chapman, J.; Dunne, R. L.			Excuse me!	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Granville-Chapman, J.; Dunne, R. L.] Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England	Salisbury District Hospital	Granville-Chapman, J (corresponding author), Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England.	jgchapman@doctors.org.uk						Romney MG, 2001, J HOSP INFECT, V47, P251, DOI 10.1053/jhin.2000.0912	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1293	1293		10.1136/bmj.39422.578970.DE	http://dx.doi.org/10.1136/bmj.39422.578970.DE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156233	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700014
J	Linos, E; Linos, E; Colditz, G				Linos, Eleni; Linos, Elizabeth; Colditz, Graham			Did you pack you bags yourself?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Linos, Eleni; Linos, Elizabeth] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Linos, Elizabeth] MIT, Cambridge, MA 02139 USA; [Colditz, Graham] Washington Univ, Sch Med, St Louis, MO 63130 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Linos, E (corresponding author), Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.	elinos@hsph.harvard.edu	Linos, Eleni/C-4392-2014; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Linos, Eleni/0000-0002-5856-6301; , Eleni/0000-0003-2538-0700	NATIONAL CANCER INSTITUTE [R25CA098566] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA098566] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1290	1292		10.1136/bmj.39419.662998.BE	http://dx.doi.org/10.1136/bmj.39419.662998.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156232	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700012
J	Buchan, JR; Parker, R				Buchan, J. Ross; Parker, Roy			Molecular biology - The two faces of miRNA	SCIENCE			English	Editorial Material							HUMAN-CELLS; TRANSLATION; ACTIVATION; MICRORNAS; RNAS		Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Buchan, JR (corresponding author), Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu						Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	8	93	106	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1877	1878		10.1126/science.1152623	http://dx.doi.org/10.1126/science.1152623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096794				2022-12-28	WOS:000251786600043
J	Harvey, CD; Svoboda, K				Harvey, Christopher D.; Svoboda, Karel			Locally dynamic synaptic learning rules in pyramidal neuron dendrites	NATURE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; PROTEIN-SYNTHESIS; HIPPOCAMPAL-NEURONS; CELL-TYPE; IN-VIVO; SPINES; MEMORY; SYNAPSES; LTP	Long- term potentiation ( LTP) of synaptic transmission underlies aspects of learning and memory. LTP is input- specific at the level of individual synapses, but neural network models predict interactions between plasticity at nearby synapses. Here we show in mouse hippocampal pyramidal cells that LTP at individual synapses reduces the threshold for potentiation at neighbouring synapses. After input- specific LTP induction by two- photon glutamate uncaging or by synaptic stimulation, subthreshold stimuli, which by themselves were too weak to trigger LTP, caused robust LTP and spine enlargement at neighbouring spines. Furthermore, LTP induction broadened the presynaptic - postsynaptic spike interval for spike- timing- dependent LTP within a dendritic neighbourhood. The reduction in the threshold for LTP induction lasted similar to 10 min and spread over similar to 10 mm of dendrite. These local interactions between neighbouring synapses support clustered plasticity models of memory storage and could allow for the binding of behaviourally linked information on the same dendritic branch.	HHMI, Ashburn, VA 20147 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mehta MR, 2004, TRENDS NEUROSCI, V27, P69, DOI 10.1016/j.tins.2003.12.004; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; POLOGRUTO TA, 2004, THESIS HARVARD U; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; YASUDA R, 2004, SCI STKE 2004; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	53	391	400	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1195	U3		10.1038/nature06416	http://dx.doi.org/10.1038/nature06416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097401	Green Accepted			2022-12-28	WOS:000251786200042
J	Monthoux, P; Pines, D; Lonzarich, GG				Monthoux, P.; Pines, D.; Lonzarich, G. G.			Superconductivity without phonons	NATURE			English	Review							PRESSURE-INDUCED SUPERCONDUCTIVITY; WAVE SUPERCONDUCTIVITY; SPIN FLUCTUATIONS; P-WAVE; TEMPERATURE; STATE; FERROMAGNETISM; COEXISTENCE; PHASE; EXCITATIONS	The idea of superconductivity without the mediating role of lattice vibrations (phonons) has a long history. It was realized soon after the publication of the Bardeen-Cooper-Schrieffer ( BCS) theory of superconductivity 50 years ago that a full treatment of both the charge and spin degrees of freedom of the electron predicts the existence of attractive components of the effective interaction between electrons even in the absence of lattice vibrations - a particular example is the effective interaction that depends on the relative spins of the electrons. Such attraction without phonons can lead to electronic pairing and to unconventional forms of superconductivity that can be much more sensitive than traditional ( BCS) superconductivity to the precise details of the crystal structure and to the electronic and magnetic properties of a material.	Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; Los Alamos Natl Lab G756, Los Alamos, NM 87544 USA; Univ Calif Davis, Inst Complex Adapt Matter, Davis, CA 95616 USA; Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	University of Cambridge; University of Edinburgh; University of Edinburgh; University of California System; University of California Davis; University of California System; University of California Davis	Lonzarich, GG (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	GGL1@phy.cam.ac.uk			Engineering and Physical Sciences Research Council [EP/C511778/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Akazawa T, 2004, J PHYS SOC JPN, V73, P3129, DOI 10.1143/JPSJ.73.3129; ALDRICH CH, 1978, J LOW TEMP PHYS, V32, P689, DOI 10.1007/BF00056653; Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Aoki D, 2001, NATURE, V413, P613, DOI 10.1038/35098048; Arita R, 2000, J PHYS SOC JPN, V69, P1181, DOI 10.1143/JPSJ.69.1181; BARDEEN J, 1955, PHYS REV, V99, P1140, DOI 10.1103/PhysRev.99.1140; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1950, PHYS REV, V80, P567, DOI 10.1103/PhysRev.80.567; Barzykin V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.247002; Baskaran G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.197007; Bauer ED, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147005; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; BERK NF, 1966, PHYS REV LETT, V17, P433, DOI 10.1103/PhysRevLett.17.433; BOHM D, 1953, PHYS REV, V92, P609, DOI 10.1103/PhysRev.92.609; Braithwaite D, 2000, J PHYS-CONDENS MAT, V12, P1339, DOI 10.1088/0953-8984/12/7/317; BRINKMAN WF, 1974, PHYS REV A, V10, P2386, DOI 10.1103/PhysRevA.10.2386; Coleman P, 2001, NATURE, V410, P320, DOI 10.1038/35066674; COOPER LN, 1956, PHYS REV, V104, P1189, DOI 10.1103/PhysRev.104.1189; Curro N, 2005, MRS BULL, V30, P442, DOI 10.1557/mrs2005.121; EMERY VJ, 1986, SYNTHETIC MET, V13, P21, DOI 10.1016/0379-6779(86)90054-8; FAY D, 1980, PHYS REV B, V22, P3173, DOI 10.1103/PhysRevB.22.3173; FISK Z, 1988, SCIENCE, V239, P33, DOI 10.1126/science.239.4835.33; FISK Z, 1992, J ALLOY COMPD, V183, P303, DOI 10.1016/0925-8388(92)90754-W; Flouquet J, 2002, PHYS WORLD, V15, P41, DOI 10.1088/2058-7058/15/1/38; FROHLICH H, 1952, PROC R SOC LON SER-A, V215, P291, DOI 10.1098/rspa.1952.0212; FROHLICH H, 1950, PHYS REV, V79, P845, DOI 10.1103/PhysRev.79.845; Fukazawa H, 2003, J PHYS SOC JPN, V72, P2449, DOI 10.1143/JPSJ.72.2449; Gegenwart P, 1999, PHYS REV LETT, V82, P1293, DOI 10.1103/PhysRevLett.82.1293; Grosche FM, 2000, J PHYS-CONDENS MAT, V12, pL533, DOI 10.1088/0953-8984/12/32/101; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; HEISENBERG W, 1947, Z NATURFORSCH A, V2, P185; Hoddeson L, 2001, J STAT PHYS, V103, P625, DOI 10.1023/A:1010301602037; Holmes AT, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.024508; Honerkamp C, 2003, J LOW TEMP PHYS, V131, P159, DOI 10.1023/A:1022952414187; Huxley A, 2003, J PHYS-CONDENS MAT, V15, pS1945, DOI 10.1088/0953-8984/15/28/306; JEROME D, 1994, ORGANIC CONDUCTORS; Kitaoka Y, 2005, J PHYS-CONDENS MAT, V17, pS975, DOI 10.1088/0953-8984/17/11/030; Knebel G, 2002, HIGH PRESSURE RES, V22, P167, DOI 10.1080/08957950211370; Landau L. D., 1976, STAT PHYS 1; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; LEE PA, 2004, PHYS HIGH TEMPERATUR; Lonzarich G. G., 1997, ELECTRON; MACKE W, 1950, Z NATURFORSCH A, V5, P192; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MAXWELL E, 1950, PHYS REV, V78, P477, DOI 10.1103/PhysRev.78.477; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; MIYAKE K, 1986, PHYS REV B, V34, P6554, DOI 10.1103/PhysRevB.34.6554; Monthoux P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144403; Monthoux P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054504; Monthoux P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064517; Monthoux P, 1999, PHYS REV B, V59, P14598, DOI 10.1103/PhysRevB.59.14598; Monthoux P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064408; Monthoux P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224504; Monthoux P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054529; MONTHOUX P, 1991, PHYS REV LETT, V67, P3448, DOI 10.1103/PhysRevLett.67.3448; MORIYA T, 1990, J PHYS SOC JPN, V59, P2905, DOI 10.1143/JPSJ.59.2905; Moriya T., 1985, SPIN FLUCTUATIONS IT; NAKAJIMA S, 1973, PROG THEOR PHYS, V50, P1101, DOI 10.1143/PTP.50.1101; ONNES HK, 1911, COMMUN PHYS LAB U C, V124, P1; Onuki Y, 2004, J PHYS SOC JPN, V73, P769, DOI 10.1143/JPSJ.73.769; OSHEROFF DD, 1972, PHYS REV LETT, V28, P885, DOI 10.1103/PhysRevLett.28.885; OTT HR, 1983, PHYS REV LETT, V50, P1595, DOI 10.1103/PhysRevLett.50.1595; Parks R. D., 1969, SUPERCONDUCTIVITY, V2; PARKS RD, 1969, SUPERCONDUCTIVITY, V1; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; PINES D, 1990, PHYSICA B, V163, P78, DOI 10.1016/0921-4526(90)90133-F; REYNOLDS CA, 1950, PHYS REV, V78, P487, DOI 10.1103/PhysRev.78.487; Sarrao JL, 2002, NATURE, V420, P297, DOI 10.1038/nature01212; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; Shimizu K, 2001, NATURE, V412, P316, DOI 10.1038/35085536; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; TAILLEFER L, 1988, PHYS REV LETT, V60, P1570, DOI 10.1103/PhysRevLett.60.1570; Takimoto T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104504; Thalmeier P, 2005, FRONTIERS IN SUPERCONDUCTING MATERIALS, P109, DOI 10.1007/3-540-27294-1_3; Thompson JD, 2003, PHYSICA B, V329, P446, DOI 10.1016/S0921-4526(02)01987-7; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593; WOLLMAN DA, 1993, PHYS REV LETT, V71, P2134, DOI 10.1103/PhysRevLett.71.2134; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648	83	394	400	8	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1177	1183		10.1038/nature06480	http://dx.doi.org/10.1038/nature06480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097398				2022-12-28	WOS:000251786200039
J	Poeta, ML; Manola, J; Goldwasser, MA; Forastiere, A; Benoit, N; Califano, JA; Ridge, JA; Goodwin, J; Kenady, D; Saunders, J; Westra, W; Sidransky, D; Koch, WM				Poeta, M. Luana; Manola, Judith; Goldwasser, Meredith A.; Forastiere, Arlene; Benoit, Nicole; Califano, Joseph A.; Ridge, John A.; Goodwin, Jarrard; Kenady, Daniel; Saunders, John; Westra, William; Sidransky, David; Koch, Wayne M.			TP53 mutations and survival in squamous-cell carcinoma of the head and neck	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS; P53 GENE; BREAST-CANCER; SMOKING; ASSOCIATION; PROGNOSIS; ALCOHOL; TOBACCO; MODEL	Background: The abrogation of function of the tumor-suppressor protein p53 as a result of mutation of its gene, TP53, is one of the most common genetic alterations in cancer cells. We evaluated TP53 mutations and survival in patients with squamous-cell carcinoma of the head and neck. Methods: A total of 560 patients with squamous-cell carcinoma of the head and neck who were treated surgically with curative intent were enrolled in our prospective multicenter, 7-year study. TP53 mutations were analyzed in DNA from the tumor specimens with the use of the Affymetrix p53 chip and the Surveyor DNA endonuclease and denaturing high-performance liquid chromatography. Mutations were classified into two groups, disruptive and nondisruptive, according to the degree of disturbance of protein structure predicted from the crystal structure of the p53-DNA complexes. TP53 mutational status was compared with clinical outcome. Results: TP53 mutations were found in tumors from 224 of 420 patients (53.3%). As compared with wild-type TP53, the presence of any TP53 mutation was associated with decreased overall survival (hazard ratio for death, 1.4; 95% confidence interval [CI], 1.1 to 1.8; P=0.009), with an even stronger association with disruptive mutations (hazard ratio, 1.7; 95% CI, 1.3 to 2.4; P<0.001) and no significant association with nondisruptive mutations (hazard ratio, 1.2; 95% CI, 0.9 to 1.7; P=0.16). In multivariate analyses a disruptive TP53 alteration, as compared with the absence of a TP53 mutation, had an independent, significant association with decreased survival (hazard ratio, 1.7; 95% CI, 1.2 to 2.4; P=0.003). Conclusions: Disruptive TP53 mutations in tumor DNA are associated with reduced survival after surgical treatment of squamous-cell carcinoma of the head and neck.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Baltimore, MD 21287 USA; Greater Baltimore Med Ctr, Baltimore, MD USA; Univ Campus Biomed Rome, Ctr Integrated Res, Lab Mol Med & Biotechnol, Rome, Italy; Dana Farber Canc Inst, Boston, MA 02115 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33152 USA; Univ Kentucky, Lexington, KY USA	Johns Hopkins University; Greater Baltimore Medical Center; University Campus Bio-Medico - Rome Italy; Harvard University; Dana-Farber Cancer Institute; Fox Chase Cancer Center; University of Miami; University of Kentucky	Koch, WM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol, 601 N Caroline St,JHOC 6221, Baltimore, MD 21287 USA.	wkoch@jhmi.edu		POETA, Maria Luana/0000-0002-6364-727X	NATIONAL CANCER INSTITUTE [U10CA023318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013152] Funding Source: NIH RePORTER; NCI NIH HHS [U10 CA023318] Funding Source: Medline; NIDCR NIH HHS [R01 DE013152-09, R01 DE013152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BOFFETTA P, 1992, INT J CANCER, V52, P530, DOI 10.1002/ijc.2910520405; BORRESEN AL, 1995, GENE CHROMOSOME CANC, V14, P71, DOI 10.1002/gcc.2870140113; Bradford CR, 1999, HEMATOL ONCOL CLIN N, V13, P777, DOI 10.1016/S0889-8588(05)70092-7; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Erber R, 1998, ONCOGENE, V16, P1671, DOI 10.1038/sj.onc.1201690; FRIEND S, 1994, SCIENCE, V265, P334, DOI 10.1126/science.8023155; Gasco M, 2003, ORAL ONCOL, V39, P222, DOI 10.1016/S1368-8375(02)00163-X; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gonzalez MV, 1995, CLIN CANCER RES, V1, P1043; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Guimaraes DP, 2002, BIOCHIMIE, V84, P83, DOI 10.1016/S0300-9084(01)01356-6; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lewin F, 1998, CANCER-AM CANCER SOC, V82, P1367, DOI 10.1002/(SICI)1097-0142(19980401)82:7&lt;1367::AID-CNCR21&gt;3.0.CO;2-3; MEHTA CR, 1984, BIOMETRICS, V40, P819, DOI 10.2307/2530927; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Olshan AF, 1997, CANCER EPIDEM BIOMAR, V6, P499; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Salesiotis AN, 2000, CURR OPIN ONCOL, V12, P229, DOI 10.1097/00001622-200005000-00008; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Taylor D, 1999, HUM PATHOL, V30, P1221, DOI 10.1016/S0046-8177(99)90041-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wikman FP, 2000, CLIN CHEM, V46, P1555	36	526	546	4	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2552	2561		10.1056/NEJMoa073770	http://dx.doi.org/10.1056/NEJMoa073770			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094376	Green Accepted			2022-12-28	WOS:000251728900006
J	Wolff, T; Guirguis-Blake, J; Miller, T; Gillespie, M; Harris, R				Wolff, Tracy; Guirguis-Blake, Janelle; Miller, Therese; Gillespie, Michael; Harris, Russell			Screening for carotid artery stenosis: An update of the evidence for the US preventive services task force	ANNALS OF INTERNAL MEDICINE			English	Article							ISCHEMIC-STROKE SUBTYPES; RISK-FACTORS; CARDIOVASCULAR HEALTH; NEUROLOGIC COMPLICATIONS; CEREBRAL-ANGIOGRAPHY; DUPLEX ULTRASOUND; HEART-DISEASE; ENDARTERECTOMY; OUTCOMES; POPULATION	Background: Cerebrovascular disease is the third leading cause of death in the United States. The proportion of all strokes attributable to previously asymptomatic carotid artery stenosis (CAS) is low. In 1996, the U.S. Preventive Services Task Force concluded that evidence was insufficient to recommend for or against screening of asymptomatic persons for CAS by using physical examination or carotid ultrasonography. Purpose: To examine the evidence of benefits and harms of screening asymptomatic patients with duplex ultrasonography and treatment with carotid endarterectomy for CAS. Data Sources: MEDLINE and Cochrane Library (search dates January 1994 to April 2007), recent systematic reviews, reference lists of retrieved articles, and suggestions from experts. Study Selection: English-language randomized, controlled trials (RCTs) of screening for CAS; RCTs of carotid endarterectomy versus medical treatment; systematic reviews of screening tests; and observational studies of harms from carotid endarterectomy were selected to answer the following questions: Is there direct evidence that screening with ultrasonography for asymptomatic CAS reduces strokes? What is the accuracy of ultrasonography to detect CAS? Does intervention with carotid endarterectomy reduce morbidity or mortality? Does screening or carotid endarterectomy result in harm? Data Extraction: All studies were reviewed, abstracted, and rated for quality by using predefined Task Force criteria. Data Synthesis: No RCTs of screening for CAS have been done. According to systematic reviews, the sensitivity of ultrasonography is approximately 94% and the specificity is approximately 92%. Treatment of CAS in selected patients by selected surgeons could lead to an approximately 5-percentage point absolute reduction in strokes over 5 years. Thirty-day stroke and death rates from carotid endarterectomy vary from 2.7% to 4.7% in RCTs; higher rates have been reported in observational studies (up to 6.7%). Limitations: Evidence is inadequate to stratify people into categories of risk for clinically important CAS. The RCTs of carotid endarterectomy versus medical treatment were conducted in selected populations with selected surgeons. Conclusion: The actual stroke reduction from screening asymptomatic patients and treatment with carotid endarterectomy is unknown; the benefit is limited by a low overall prevalence of treatable disease in the general asymptomatic population and harms from treatment.	Ctr Primary Care Prevent & Clin Partnerships, Agcy Healthcare Res & Quality, Rockville, MD USA; Univ Washington, Tacoma, WA USA; Univ N Carolina, Chapel Hill, NC USA	University of Washington; University of Washington Tacoma; University of North Carolina; University of North Carolina Chapel Hill								[Anonymous], 1992, Mayo Clin Proc, V67, P513; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Bond R, 2003, STROKE, V34, P2290, DOI 10.1161/01.STR.0000087785.01407.CC; Bratzler D W, 1996, J Okla State Med Assoc, V89, P423; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; CLAGETT GP, 1984, SURGERY, V96, P823; COLGAN MP, 1988, J VASC SURG, V8, P674, DOI 10.1067/mva.1988.avs0080674; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Ergin A, 2004, AM J MED, V117, P219, DOI 10.1016/j.amjmed.2004.03.017; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; Finsterer J, 2004, LANCET, V364, P1124, DOI 10.1016/S0140-6736(04)17092-X; GRZYSKA U, 1990, NEURORADIOLOGY, V32, P296, DOI 10.1007/BF00593048; Halliday A, 2004, LANCET, V363, P1491; Halm EA, 2007, NEUROLOGY, V68, P187, DOI 10.1212/01.wnl.0000251197.98197.e9; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Health, 2005, MED BENEFITS, V22, P12; HEISERMAN JE, 1994, AM J NEURORADIOL, V15, P1401; Hertzer NR, 2001, J VASC SURG, V33, P234; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; HOBSON RW, 1986, STROKE, V17, P534; Horner RD, 2002, MED CARE, V40, P35; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kietselaer BLJH, 2004, LANCET, V364, P1124, DOI 10.1016/S0140-6736(04)17093-1; Koelemay MJW, 2004, STROKE, V35, P2306, DOI 10.1161/01.STR.0000141426.63959.cc; Kresowik TF, 2004, J VASC SURG, V39, P372, DOI 10.1016/j.jvs.2003.09.023; Kresowik TF, 2001, J VASC SURG, V33, P227, DOI 10.1067/mva.2001.111881; Kresowik TF, 2000, J VASC SURG, V31, P918, DOI 10.1067/mva.2000.106418; Kumar S, 2004, LANCET, V364, P1125, DOI 10.1016/S0140-6736(04)17094-3; Longstreth WT, 1998, STROKE, V29, P2371, DOI 10.1161/01.STR.29.11.2371; Mannami T, 2000, ARCH INTERN MED, V160, P2297, DOI 10.1001/archinte.160.15.2297; Masuhr F, 2004, LANCET, V364, P1123, DOI 10.1016/S0140-6736(04)17091-8; Mathiesen EB, 2001, CEREBROVASC DIS, V12, P44, DOI 10.1159/000047680; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Press MJ, 2006, ARCH INTERN MED, V166, P914, DOI 10.1001/archinte.166.8.914; PUJIA A, 1992, STROKE, V23, P818, DOI 10.1161/01.STR.23.6.818; Rockman CB, 2005, J VASC SURG, V42, P870, DOI 10.1016/j.jvs.2005.07.043; Rockman CB, 2004, J VASC SURG, V39, P44, DOI 10.1016/j.jvs.2003.07.008; Rodriguez BL, 2002, STROKE, V33, P230, DOI 10.1161/hs0102.101081; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rothwell PM, 2004, LANCET, V364, P1122, DOI 10.1016/S0140-6736(04)17090-6; Samsa G, 2002, STROKE, V33, P2944, DOI 10.1161/01.STR.0000038095.20079.F6; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; TELL GS, 1994, CIRCULATION, V90, P2905, DOI 10.1161/01.CIR.90.6.2905; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; WOLFF T, 2007, AHRQ PUBLICATION, P50; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	55	79	85	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					860	870		10.7326/0003-4819-147-12-200712180-00006	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087057				2022-12-28	WOS:000251787600006
J	Yu, F; Yao, H; Zhu, PC; Zhang, XQ; Pan, QH; Gong, C; Huang, YJ; Hu, XQ; Su, FX; Lieberman, J; Song, E				Yu, Fengyan; Yao, Herui; Zhu, Pengcheng; Zhang, Xiaoqin; Pan, Qiuhui; Gong, Chang; Huang, Yijun; Hu, Xiaoqu; Su, Fengxi; Lieberman, Judy; Song, Erwei			Iet-7 regulates self renewal and tumorigenicity of breast cancer cells	CELL			English	Article							MAMMARY STEM/PROGENITOR CELLS; IN-VITRO PROPAGATION; STEM-CELLS; LET-7; EXPRESSION; METASTASIS; SUPPRESSOR; MICRORNAS; REPRESSES; PATHWAYS	Cancers may arise from rare self-renewing tumor- initiating cells (T-IC). However, how T-IC self renewal, multipotent differentiation, and tumorigenicity are maintained remains obscure. Because miRNAs can regulate cell-fate decisions, we compared miRNA expression in self-renewing and differentiated cells from breast cancer lines and in breast T-IC (BT-IC) and non-BT-IC from 1 degrees breast cancers. Iet-7 miRNAs were markedly reduced in BT-IC and increased with differentiation. Infecting BT-IC with Iet-7-lentivirus reduced proliferation, mammosphere formation, and the proportion of undifferentiated cells in vitro and tumor formation and metastasis in NOD/SCID mice, while antagonizing Iet-7 by antisense oligonucleotides enhanced in vitro self renewal of non-T-IC. Increased Iet-7 paralleled reduced H-RAS and HMGA2, known Iet-7 targets. Silencing H-RAS in a BT-IC-enriched cell line reduced self renewal but had no effect on differentiation, while silencing HMGA2 enhanced differentiation but did not affect self renewal. Therefore Iet-7 regulates multiple BT-IC stem cell-like properties by silencing more than one target.	[Yu, Fengyan; Zhu, Pengcheng; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Yu, Fengyan; Yao, Herui; Zhang, Xiaoqin; Pan, Qiuhui; Gong, Chang; Hu, Xiaoqu; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Breast Surg, Guangzhou 510120, Peoples R China; [Huang, Yijun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510089, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Sun Yat Sen University; Sun Yat Sen University	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu; songew@mail.sysu.edu.cn	Lieberman, Judy/A-2717-2015					Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; BAIER D, 2007, CANCER RES, V67, P4010; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rogalla P, 1996, AM J PATHOL, V149, P775; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537	34	1508	1706	3	218	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1109	1123		10.1016/j.cell.2007.10.054	http://dx.doi.org/10.1016/j.cell.2007.10.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083101	Bronze			2022-12-28	WOS:000252217100019
J	Hart, DO; Raha, T; Lawson, ND; Green, MR				Hart, Daniel O.; Raha, Tamal; Lawson, Nathan D.; Green, Michael R.			Initiation of zebrafish haematopoiesis by the TATA-box-binding protein-related factor Trf3	NATURE			English	Article							EMBRYONIC-DEVELOPMENT; VERTEBRATE; TBP; EXPRESSION; XENOPUS; GENES; CELLS	TATA- box- binding protein ( TBP)- related factor 3, TRF3 ( also called TBP2), is a vertebrate- specific member of the TBP family that has a conserved carboxy- terminal region and DNA- binding domain virtually identical to that of TBP ( ref. 1). TRF3 is highly expressed during embryonic development, and studies in zebrafish and Xenopus have shown that it is required for normal embryogenesis(2,3). Here we show that zebrafish embryos depleted of Trf3 exhibit multiple developmental defects and, in particular, fail to undergo haematopoiesis. Expression profiling for Trf3-dependent genes identified mespa, which encodes a transcription factor whose murine orthologue is required for mesoderm specification(4), and chromatin immunoprecipitation verified that Trf3 binds to the mespa promoter. Depletion of Mespa resulted in developmental and haematopoietic defects markedly similar to those induced by Trf3 depletion. Injection of mespa messenger RNA ( mRNA) restored normal development to a Trf3- depleted embryo, indicating mespa is the single Trf3 target gene required for zebrafish embryogenesis. Zebrafish embryos depleted of Trf3 or Mespa also failed to express cdx4, a caudal- related gene required for haematopoiesis. Mespa binds to the cdx4 promoter, and epistasis analysis revealed an ordered trf3 - mespa - cdx4 pathway. Thus, in zebrafish, commitment of mesoderm to the haematopoietic lineage occurs through a transcription factor pathway initiated by a TBP- related factor.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu; michael.green@umassmed.edu		Lawson, Nathan/0000-0001-7788-9619	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P40 RR012546] Funding Source: Medline; NIGMS NIH HHS [R01 GM033977-23, R01 GM033977] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEVERLEY SM, 2001, CURRENT PROTOCOLS MO; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Langeland James A., 1997, P383; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Persengiev SP, 2003, P NATL ACAD SCI USA, V100, P14887, DOI 10.1073/pnas.2036440100; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Thisse B, 2001, ZFIN DIRECT DATA SUB; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	17	65	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1082	U12		10.1038/nature06349	http://dx.doi.org/10.1038/nature06349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18046332	Green Accepted			2022-12-28	WOS:000251579900087
J	Mai, NTH; Chau, TTH; Thwaites, G; Chuong, LV; Sinh, DX; Nghia, HDT; Tuan, PQ; Phong, ND; Phu, NH; Diep, TS; Chau, NVV; Duong, NM; Campbell, J; Schultsz, C; Parry, C; Torok, ME; White, N; Chinh, NT; Hien, TT; Stepniewska, K; Farrar, JJ				Mai, Nguyen Thi Hoang; Chau, Tran Thi Hong; Thwaites, Guy; Chuong, Ly Van; Sinh, Dinh Xuan; Nghia, Ho Dang Trung; Tuan, Phung Quoc; Phong, Nguyen Duy; Phu, Nguyen Hoan; Diep, To Song; Chau, Nguyen van Vinh; Duong, Nguyen Minh; Campbell, James; Schultsz, Constance; Parry, Chris; Torok, M. Estee; White, Nicholas; Chinh, Nguyen Tran; Hien, Tran Tinh; Stepniewska, Kasia; Farrar, Jeremy J.			Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: It is uncertain whether all adults with bacterial meningitis benefit from treatment with adjunctive dexamethasone. Methods: We conducted a randomized, double-blind, placebo-controlled trial of dexamethasone in 435 patients over the age of 14 years who had suspected bacterial meningitis. The goal was to determine whether dexamethasone reduced the risk of death at 1 month and the risk of death or disability at 6 months. Results: A total of 217 patients were assigned to the dexamethasone group, and 218 to the placebo group. Bacterial meningitis was confirmed in 300 patients (69.0%), probable meningitis was diagnosed in 123 patients (28.3%), and an alternative diagnosis was made in 12 patients (2.8%). An intention-to-treat analysis of all the patients showed that dexamethasone was not associated with a significant reduction in the risk of death at 1 month (relative risk, 0.79; 95% confidence interval [CI], 0.45 to 1.39) or the risk of death or disability at 6 months (odds ratio, 0.74; 95% CI, 0.47 to 1.17). In patients with confirmed bacterial meningitis, however, there was a significant reduction in the risk of death at 1 month (relative risk, 0.43; 95% CI, 0.20 to 0.94) and in the risk of death or disability at 6 months (odds ratio, 0.56; 95% CI, 0.32 to 0.98). These effects were not found in patients with probable bacterial meningitis. Results of multivariate analysis indicated that dexamethasone treatment for patients with probable bacterial meningitis was significantly associated with an increased risk of death at 1 month, an observation that may be explained by cases of tuberculous meningitis in the treatment group. Conclusions: Dexamethasone does not improve the outcome in all adolescents and adults with suspected bacterial meningitis; a beneficial effect appears to be confined to patients with microbiologically proven disease, including those who have received prior treatment with antibiotics. (Current Controlled Trials number, ISRCTN42986828.).	Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; Univ Med & Pharm, Ho Chi Minh City, Vietnam; Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Liverpool, Dept Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Oxford; Hochiminh City University of Medicine & Pharmacy; Imperial College London; University of Oxford; University of Liverpool	Farrar, JJ (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Thi, Nguyen/AAM-7074-2020; Thwaites, Guy E/R-4993-2019; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; Farrar, Jeremy J./HGA-7610-2022	Thwaites, Guy E/0000-0002-2858-2087; White, Nick/0000-0002-1897-1978; Farrar, Jeremy/0000-0002-2700-623X; Stepniewska, Kasia/0000-0002-1713-6209; Torok, Mili Estee/0000-0001-9098-8590	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Freeman HR, 2004, ANN TROP MED PARASIT, V98, P65, DOI 10.1179/000349804225003046; Huang Yu-Tsung, 2005, Journal of Microbiology Immunology and Infection, V38, P306; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; SCHELD WM, 1980, J CLIN INVEST, V66, P243, DOI 10.1172/JCI109850; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; van de Beek D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub2; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2005, NEW ENGL J MED, V352, P950; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2004, ANN INTERN MED, V141, P327, DOI 10.7326/0003-4819-141-4-200408170-00028	14	135	143	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2431	2440		10.1056/NEJMoa070852	http://dx.doi.org/10.1056/NEJMoa070852			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077808	Bronze			2022-12-28	WOS:000251564400004
J	Sparks, RSJ; Brown, RJ; Field, M; Gilbertson, M				Sparks, R. S. J.; Brown, R. J.; Field, M.; Gilbertson, M.			Kimberlite ascent and eruption	NATURE			English	Letter							PROPAGATION; DYKES; MODEL		Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; De Beers MRM Grp, Wells BA5 3DG, Somerset, England; Univ Bristol, Dept Mech Engn, Bristol BS8 1TR, Avon, England	University of Bristol; University of Bristol	Sparks, RSJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	steve.sparks@bristol.ac.uk	Gilbertson, Mark/AAK-2084-2021; Brown, Richard/B-5715-2008	Gilbertson, Mark/0000-0003-2579-5738; 				BARNETT W, IN PRESS J VOLCANOL; Brooker RA, 2001, CHEM GEOL, V174, P225, DOI 10.1016/S0009-2541(00)00353-3; Brown RJ, 2007, GEOLOGY, V35, P815, DOI 10.1130/G23670A.1; Fedortchouk Y, 2004, J PETROL, V45, P1725, DOI 10.1093/petrology/egh031; GERNON T, IN PRESS J VOLCANOL; GURNEY JJ, 1989, GEOL SOC AUSTR SPEC, V14, P935; LISTER JR, 1991, J GEOPHYS RES-SOLID, V96, P10049, DOI 10.1029/91JB00600; McLeod P, 1999, J VOLCANOL GEOTH RES, V92, P231, DOI 10.1016/S0377-0273(99)00053-0; Menand T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000589; Menand T, 2001, NATURE, V411, P678, DOI 10.1038/35079552; Mitchell R. H., 1986, KIMBERLITES MINERALO; Sparks RSJ, 2006, J VOLCANOL GEOTH RES, V155, P18, DOI 10.1016/j.jvolgeores.2006.02.010; Stripp GR, 2006, J METAMORPH GEOL, V24, P515, DOI 10.1111/j.1525-1314.2006.00652.x; WalterS AL, 2006, J VOLCANOL GEOTH RES, V155, P119, DOI 10.1016/j.jvolgeores.2006.02.005; Wilson L, 2007, NATURE, V447, P53, DOI 10.1038/nature05692	15	14	14	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					E21	E21		10.1038/nature06435	http://dx.doi.org/10.1038/nature06435			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075522	Bronze			2022-12-28	WOS:000251579900071
J	Whitcome, KK; Shapiro, LJ; Lieberman, DE				Whitcome, Katherine K.; Shapiro, Liza J.; Lieberman, Daniel E.			Fetal load and the evolution of lumbar lordosis in bipedal hominins	NATURE			English	Article							BACK-PAIN; PREGNANCY; SHAPE; SIZE; HOMO; MORPHOMETRICS; MORPHOLOGY; POSTURE; GROWTH; JOINTS	As predicted by Darwin(1), bipedal posture and locomotion are key distinguishing features of the earliest known hominins(2,3). Hominin axial skeletons show many derived adaptations for bipedalism, including an elongated lumbar region, both in the number of vertebrae and their lengths, as well as a marked posterior concavity of wedged lumbar vertebrae, known as a lordosis(4-6). The lordosis stabilizes the upper body over the lower limbs in bipeds by positioning the trunk's centre of mass ( COM) above the hips. However, bipedalism poses a unique challenge to pregnant females because the changing body shape and the extra mass associated with pregnancy shift the trunk's COM anterior to the hips. Here we show that human females have evolved a derived curvature and reinforcement of the lumbar vertebrae to compensate for this bipedal obstetric load. Similarly dimorphic morphologies in fossil vertebrae of Australopithecus suggest that this adaptation to fetal load preceded the evolution of Homo.	Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	Harvard University; University of Texas System; University of Texas Austin	Whitcome, KK (corresponding author), Harvard Univ, Dept Anthropol, 11 Divin Ave, Cambridge, MA 02138 USA.	whitcome@fas.harvard.edu						ADAMS MA, 1980, J BONE JOINT SURG BR, V62, P358, DOI 10.1302/0301-620X.62B3.6447702; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; ARENSBURG B, 1991, SQUELETTE MOUSTERIEN, V2, P113; Bogduk N., 1997, CLIN ANATOMY LUMBAR, V3; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; CORRUCCINI RS, 1987, AM J PHYS ANTHROPOL, V73, P289, DOI 10.1002/ajpa.1330730303; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Darwin Charles, 1871, DESCENT MAN; DeSilva J, 2006, J HUM EVOL, V51, P207, DOI 10.1016/j.jhevol.2006.05.006; DIGIOVANNI BF, 1989, SPINE, V14, P712, DOI 10.1097/00007632-198907000-00011; DUMAS GA, 1995, CLIN BIOMECH, V10, P98, DOI 10.1016/0268-0033(95)92046-O; DUNLOP RB, 1984, J BONE JOINT SURG BR, V66, P706, DOI 10.1302/0301-620X.66B5.6501365; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; *I MED NAT AC, 1990, NUTR PREGN 1; JACCARD J, 1996, LISREL APPROACHES IN; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Latimer Bruce, 1993, P266; LEE DR, 1991, AM J PRIMATOL, V24, P289, DOI 10.1002/ajp.1350240315; LORENZ M, 1983, SPINE, V8, P122, DOI 10.1097/00007632-198303000-00002; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; OSTGAARD HC, 1993, SPINE, V18, P61; PAL GP, 1987, J ANAT, V152, P93; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; ROSENBERG KR, 1996, EVOLUTIONARY ANTHR, V4, P161; Ruff C, 1998, PRIMATE LOCOMOTION, P449; Sanders WJ, 1998, J HUM EVOL, V34, P249, DOI 10.1006/jhev.1997.0193; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Schultz AH, 1949, AM J PHYS ANTHROP-NE, V7, P401, DOI 10.1002/ajpa.1330070307; Shapiro Liza, 1993, P121; Sokal R.R., 2012, BIOMETRY; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Trinkaus, 2014, SHANIDAR NEANDERTALS; Ubelaker DH, 2002, J FORENSIC SCI, V47, P19; Washburn S, 1952, AM J PHYS ANTHROPOL, V10, P251; Washburn SL, 1948, AM J PHYS ANTHROP-NE, V6, P199, DOI 10.1002/ajpa.1330060210; White A.A., 1990, CLIN BIOMECH; Zatsiorsky VM, 1998, J BIOMECH, V31, P161, DOI 10.1016/S0021-9290(97)00116-4; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	42	176	182	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1075	U11		10.1038/nature06342	http://dx.doi.org/10.1038/nature06342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075592	Green Published			2022-12-28	WOS:000251579900085
J	Tuteja, A; Choi, W; Ma, ML; Mabry, JM; Mazzella, SA; Rutledge, GC; McKinley, GH; Cohen, RE				Tuteja, Anish; Choi, Wonjae; Ma, Minglin; Mabry, Joseph M.; Mazzella, Sarah A.; Rutledge, Gregory C.; McKinley, Gareth H.; Cohen, Robert E.			Designing superoleophobic surfaces	SCIENCE			English	Article							OIL-REPELLENT SURFACES; ROUGH SURFACES; WATER; FILMS	Understanding the complementary roles of surface energy and roughness on natural nonwetting surfaces has led to the development of a number of biomimetic superhydrophobic surfaces, which exhibit apparent contact angles with water greater than 150 degrees and low contact angle hysteresis. However, superoleophobic surfaces-those that display contact angles greater than 150 degrees with organic liquids having appreciably lower surface tensions than that of water-are extremely rare. Calculations suggest that creating such a surface would require a surface energy lower than that of any known material. We show how a third factor, re-entrant surface curvature, in conjunction with chemical composition and roughened texture, can be used to design surfaces that display extreme resistance to wetting from a number of liquids with low surface tension, including alkanes such as decane and octane.	MIT, Dept Mech Engn, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; USAF, Res Lab, Edwards AFB, CA 93524 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Air Force	McKinley, GH (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	gareth@mit.edu; recohen@mit.edu	McKinley, Gareth H/G-4872-2011	McKinley, Gareth H/0000-0001-8323-2779; Mabry, Joseph/0000-0002-3818-252X				Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Barbieri L, 2007, LANGMUIR, V23, P1723, DOI 10.1021/la0617964; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f; Cao LL, 2007, LANGMUIR, V23, P4310, DOI 10.1021/la063572r; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s; Cheng YT, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895487; Coulson SR, 2000, CHEM MATER, V12, P2031, DOI 10.1021/cm000193p; Feng L., 2004, ANGEW CHEM INT EDIT, V116, P2046, DOI DOI 10.1002/ANGE.200353381; Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3; Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223; He B, 2003, LANGMUIR, V19, P4999, DOI 10.1021/la0268348; Herminghaus S, 2000, EUROPHYS LETT, V52, P165, DOI 10.1209/epl/i2000-00418-8; Krupenkin TN, 2007, LANGMUIR, V23, P9128, DOI 10.1021/la7008557; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Ma ML, 2007, ADV MATER, V19, P255, DOI 10.1002/adma.200601449; Ma ML, 2005, MACROMOLECULES, V38, P9742, DOI 10.1021/ma0511189; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142; Nosonovsky M, 2007, LANGMUIR, V23, P3157, DOI 10.1021/la062301d; PAN DHK, 1985, J APPL PHYS, V58, P2861, DOI 10.1063/1.335858; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Patankar NA, 2003, LANGMUIR, V19, P1249, DOI 10.1021/la026612+; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532; Shibuichi S, 1998, J COLLOID INTERF SCI, V208, P287, DOI 10.1006/jcis.1998.5813; Suk DE, 2002, MACROMOLECULES, V35, P3017, DOI 10.1021/ma011205a; Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zhu MF, 2006, J MATER SCI, V41, P3793, DOI 10.1007/s10853-005-5910-z; Zisman W.A., 1964, ADV CHEM SER, V43, P1, DOI [10.1021/ba-1964-0043.ch001, DOI 10.1021/BA-1964-0043.CH001]	35	2303	2425	101	2084	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1618	1622		10.1126/science.1148326	http://dx.doi.org/10.1126/science.1148326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063796				2022-12-28	WOS:000251421700044
J	Baudendistel, TE; Haase, AK; Fitzgerald, F				Baudendistel, Thomas E.; Haase, Amy K.; Fitzgerald, Faith			The leading diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PEUTZ-JEGHERS-SYNDROME; PHYSICAL-EXAMINATION; INTUSSUSCEPTION; MANAGEMENT; CANCER; ADULTS; RISK		Calif Pacific Med Ctr, Dept Med, San Francisco, CA 94115 USA; Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA	California Pacific Medical Center; University of California System; University of California Davis	Baudendistel, TE (corresponding author), Calif Pacific Med Ctr, Dept Med, 2351 Clay St,Suite 380, San Francisco, CA 94115 USA.	baudent@sutterhealth.org						Erkan N, 2005, INT J COLORECTAL DIS, V20, P452, DOI 10.1007/s00384-004-0713-2; Giardiello FM, 2006, CLIN GASTROENTEROL H, V4, P408, DOI 10.1016/j.cgh.2005.11.005; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JEGHERS H, 1949, NEW ENGL J MED, V241, P1031, DOI 10.1056/NEJM194912292412601; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; Lim W, 2003, BRIT J CANCER, V89, P308, DOI 10.1038/sj.bjc.6601030; MCGEE S, 2001, EVIDENCE BASED PHYSL, P33; NAGORNEY DM, 1981, ANN SURG, V193, P230, DOI 10.1097/00000658-198102000-00019; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Peutz JL, 1921, NEDERL MAANDSCHR GEN, V10, P134; UTSUNOMIYA J, 1975, JOHNS HOPKINS MED J, V136, P71; WEILBAECHER D, 1971, AM J SURG, V121, P531, DOI 10.1016/0002-9610(71)90133-4; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082	15	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2389	2393		10.1056/NEJMcps062653	http://dx.doi.org/10.1056/NEJMcps062653			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057342				2022-12-28	WOS:000251389200011
J	Boyce, W				Boyce, Walter			Earth monitoring: Vigilance is not enough	NATURE			English	Editorial Material									Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, NIH Ctr Rapid Influenza Surveillance & Res, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Boyce, W (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.							Gaidet N, 2007, J WILDLIFE DIS, V43, pS22	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					791	792		10.1038/450791a	http://dx.doi.org/10.1038/450791a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063984				2022-12-28	WOS:000251394900024
J	Bleecker, ER; Postma, DS; Lawrance, RM; Meyers, DA; Ambrose, HJ; Goldman, M				Bleecker, Eugene R.; Postma, Dirkje S.; Lawrance, Rachael M.; Meyers, Deborah A.; Ambrose, Helen J.; Goldman, Mitch			Effect of ADRB2 polymorphisms on response to longacting beta(2)-agonist therapy: a pharmacogenetic analysis of two randomised studies	LANCET			English	Article							ACTING BETA-AGONISTS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ASTHMA EXACERBATIONS; SALMETEROL; METAANALYSIS; MAINTENANCE; ASSOCIATION; HAPLOTYPE; ALBUTEROL	Background New evidence has suggested that people with asthma who are homozygous for arginine at aminoacid 16 of the beta(2)-adrenergic receptor (ADRB2) might not benefit from longacting beta(2)-agonist therapy. We, therefore, investigated whether ADRB2 polymorphisms affect response to longacting beta(2)-agonists in combination with inhaled corticosteroids. Methods Asthmatics were stratified by ADRB2 genotype in two studies to assess the effects of inhaled corticosteroids plus longacting beta(2)-agonists on asthma exacerbations. In study 1 (double-blind), 2250 asthmatics were randomly assigned to budesonide plus formoterol maintenance and reliever therapy, fixed-dose budesonide plus formoterol, or fixed-dose fluticasone plus salmeterol for 6 months. Study 2 (open-label) consisted of 405 asthmatics and compared an adjustable regimen of budesonide plus formoterol with fixed-dose budesonide plus formoterol and fixed-dose fluticasone plus salmeterol for 7 months. The relation between ADRB2 polymorphism, severe asthma exacerbations, and other asthma outcomes was analysed. Primary endpoints for studies 1 and 2 were severe asthma exacerbation and asthma control as assessed by measures of exacerbations, respectively. Findings In study 1, Gly16Arg genotype had no effect on the percentage of participants with severe exacerbations across all treatment groups (99 [12%] of 833 Gly/Gly, 110 [11%] of 1028 Gly/Arg, and 32 [9%] of 361 Arg/Arg participants). Secondary endpoints, including forced expiratory volume in 1 s, peak expiratory flow, use of as-needed medication, and number of nights with awakenings were similar between genotype groups. No relation was recorded between ADRB2 haplotype and primary and secondary endpoints. In study 2, the frequency of asthma exacerbations (15 [9%] of 168 Gly/Gly, 13 [8%] of 169 Gly/Arg, and 6 [9%] of 67 Arg/Arg participants) and other study endpoints were closely similar for all ADRB2 genotypes. Interpretation Since we showed no pharmacogenetic effect of ADRB2 variation on therapeutic response in asthma, patients, irrespective of their genotype, can continue to receive inhaled corticosteroids plus longacting beta(2)-agonists.	[Bleecker, Eugene R.; Meyers, Deborah A.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Ambrose, Helen J.] AstraZeneca, Macclesfield, Cheshire, England; [Lawrance, Rachael M.; Goldman, Mitch] AstraZeneca, Wilmington, DE USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Groningen; AstraZeneca; AstraZeneca	Bleecker, ER (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Med Ctr Blvd, Winston Salem, NC 27157 USA.	ebleeck@wfubmc.edu						[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Bleecker ER, 2006, J ALLERGY CLIN IMMUN, V118, P809, DOI 10.1016/j.jaci.2006.06.036; British Thoracic Society Scottish Intercollegiate Guidelines Network, BRIT GUID MAN ASTHM; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; BUSSE WW, 2007, COMPARISON ASTHMA EX; Calhoun WJ, 2003, J ALLERGY CLIN IMMUN, V112, P1088, DOI 10.1016/j.jaci.2003.09.044; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; CROW JF, 1988, GENETICS, V119, P473; Donohue James F, 2004, Chest, V126, p125S, DOI 10.1378/chest.126.2_suppl_1.125S; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Global Initiative for Asthma, 2006, GLOB STRAT ASTHM MAN; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; *NIH, 1997, NIH PUBL, V97; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sin DD, 2004, JAMA-J AM MED ASSOC, V292, P367, DOI 10.1001/jama.292.3.367; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Taylor DR, 2005, AM J RESP CRIT CARE, V172, P700, DOI 10.1164/rccm.200501-092OC; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	32	178	186	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2118	2125		10.1016/S0140-6736(07)61906-0	http://dx.doi.org/10.1016/S0140-6736(07)61906-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156033				2022-12-28	WOS:000252058600032
J	Escudier, B; Pluzanska, A; Koralewski, P; Ravaud, A; Bracarda, S; Szczylik, C; Chevreau, C; Filipek, M; Melichar, B; Bajetta, E; Gorbunova, V; Bay, JO; Bodrogi, I; Jagiello-Gruszfeld, A; Moore, N				Escudier, Bernard; Pluzanska, Anna; Koralewski, Piotr; Ravaud, Alain; Bracarda, Sergio; Szczylik, Cezary; Chevreau, Christine; Filipek, Marek; Melichar, Bohuslav; Bajetta, Emilio; Gorbunova, Vera; Bay, Jacques-Olivier; Bodrogi, Istvan; Jagiello-Gruszfeld, Agnieszka; Moore, Nicola		AVOREN Trial Investigators	Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; CANCER; ALPHA; THERAPY; SURVIVAL; TEMSIROLIMUS; COMBINATION; PACLITAXEL; GUIDELINES	Background Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of the combination treatment of the humanised anti-VEGF monoclonal antibody bevacizumab with interferon alfa was warranted. Methods In a multicentre, randomised, double-blind, phase III trial, 649 patients with previously untreated metastatic renal cell carcinoma were randomised to receive interferon alfa-2a (9 MIU subcutaneously three times weekly) and bevacizumab (10 mg/kg every 2 weeks; n=327) or placebo and interferon alfa-2a (n=322). The primary endpoint was overall survival. Secondary endpoints included progression-free survival and safety. An interim analysis of overall survival was prespecified after 250 deaths. On the basis of new second-fine therapies that became available while the trial was in progress, which could have confounded analyses of overall survival data, we agreed with regulatory agencies that the pre-planned final analysis of progression-free survival would be acceptable for regulatory submission. The protocol was amended to allow the study to be unblinded at this point. The final analysis of progression-free survival is reported here. Efficacy analyses were done by intention to treat. Ibis trial is registered with centerwatch.com, number BO017705E. Findings 325 patients in the bevacizumab plus interferon alfa group and 316 in the placebo plus interferon alfa group received at least one dose of study treatment. At the time of unblinding, 230 progression events had occurred in the bevacizumab plus interferon alfa group and 275 in the control group; there were 114 deaths in the bevacizumab plus interferon alfa group and 137 in the control group. Median duration of progression-free survival was significantly longer in the bevacizumab plus interferon alfa group than it was in the control group (10 . 2 months vs 5.4 months; HR 0.63, 95% Cl 0.52-0.75; p=0.0001). Increases in progression-free survival were seen with bevacizumab plus interferon alfa irrespective of risk group or whether reduced-dose interferon alfa was received. Deaths due to adverse events were reported in eight (2%) patients who received one or more doses of bevacizumab and seven (2%) of those who did not receive the drug. Only three deaths in the bevacizumab arm were considered by investigators to be possibly related to bevacizumab. The most commonly reported grade 3 or worse adverse events were fatigue (40 [12%] patients in the bevacizumab group vs 25 [8%] in the control group) and asthenia (34 [10%] vs 20 [7%]). Interpretation The combination of bevacizumab with interferon alfa as first-line treatment in patients with metastatic renal cell carcinoma results in a significant improvement in progression-free survival, compared with interferon alfa alone.	[Escudier, Bernard] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France; [Pluzanska, Anna] Klin Chemioterapii AM, Lodz, Poland; [Koralewski, Piotr] Szpital Rydygiera, Krakow, Poland; [Ravaud, Alain] CHU Bordeaux, Hop St Andre, Bordeaux, France; [Bracarda, Sergio] Azienda Osped, Perugia, Italy; [Szczylik, Cezary] Wojskowy Inst Med, Warsaw, Poland; [Chevreau, Christine] Inst Claudius Regaud, Toulouse, France; [Filipek, Marek] Szpital Wojewodzki Sw Luk, Tarnow, Poland; [Melichar, Bohuslav] Charles Univ Prague, Sch Med, Teaching Hosp, Hradec Kralove, Czech Republic; [Bajetta, Emilio] Osped Inst, Milan, Italy; [Gorbunova, Vera] Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; [Bay, Jacques-Olivier] Ctr Jean Perrin, Clermont Ferrand, France; [Bay, Jacques-Olivier] CHU Clermont Ferrand, Clermont Ferrand, France; [Bodrogi, Istvan] Natl Inst Oncol, Budapest, Hungary; [Jagiello-Gruszfeld, Agnieszka] OZ MSWiA, Olsztyn, Poland; [Moore, Nicola] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	UNICANCER; Gustave Roussy; CHU Bordeaux; University of Perugia; Azienda Ospedaliera di Perugia; Military Medical Institute; UNICANCER; Institut Claudius Regaud; Charles University Prague; University Hospital Hradec Kralove; Russian Academy of Medical Sciences; UNICANCER; Centre Jean Perrin; CHU Clermont Ferrand; National Institute of Oncology Hungary; Roche Holding	Escudier, B (corresponding author), Inst Gustave Roussy, Dept Med, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	escudier@igr.fr	Chevreau, Christine/A-5565-2015; Jagiello-Gruszfeld, Agnieszka i/S-6924-2018	Jagiello-Gruszfeld, Agnieszka i/0000-0002-2698-5499; Bracarda, Sergio/0000-0002-0703-2959; Ravaud, Alain/0000-0001-9455-6744				[Anonymous], 2003, COMM TERM CRIT ADV E; Azad NS, 2006, J CLIN ONCOL, V24, p121S; Brieger J, 1999, J MOL MED-JMM, V77, P505, DOI 10.1007/s001099900022; Bukowski RM, 2006, J CLIN ONCOL, V24, p222S; COPPIN C, 2005, COCHRANE DB SYST REV, V3; De Vita VT, 2001, CANC PRINCIPLES PRAC; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; DRABKIN HA, 2007, J CLIN ONCOL S, V25, pS245; Dutcher JP, 2007, J CLIN ONCOL, V25; Eggermont AM, 2007, J CLIN ONCOL, V25; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; FELDMAN DR, 2007, J CLIN ONCOL S, V25, pS259; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; GEORGE DJ, 2007, J CLIN ONCOL S, V25, pS243; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hainsworth JD, 2005, J CLIN ONCOL, V23, P7889, DOI 10.1200/JCO.2005.01.8234; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Karumanchi SA, 2002, CURR OPIN NEPHROL HY, V11, P37, DOI 10.1097/00041552-200201000-00006; Merchan JR, 2007, J CLIN ONCOL, V25; Miller KD, 2005, BREAST CANCER RES TR, V94, pS6; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Negrier S, 2005, J CLIN ONCOL, V23, p380S; Parton M, 2006, J CLIN ONCOL, V24, P5584, DOI 10.1200/JCO.2006.08.1638; Ramsey S, 2006, NAT CLIN PRACT UROL, V3, P478, DOI 10.1038/ncpuro0581; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Rouviere O, 2006, NAT CLIN PRACT ONCOL, V3, P200, DOI 10.1038/ncponc0479; Sablin MP, 2007, J CLIN ONCOL, V25; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schoenfeld AR, 2000, ONCOGENE, V19, P5851, DOI 10.1038/sj.onc.1203985; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thompson DS, 2006, J CLIN ONCOL, V24, p240S; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Yang JC, 2004, CLIN CANCER RES, V10, p6367S, DOI 10.1158/1078-0432.CCR-050006; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	43	1862	1922	0	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2103	2111		10.1016/S0140-6736(07)61904-7	http://dx.doi.org/10.1016/S0140-6736(07)61904-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156031				2022-12-28	WOS:000252058600030
J	Strand, V				Strand, Vibeke			Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; CORONARY HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; UPPER GASTROINTESTINAL TOXICITY; THERAPEUTIC ARTHRITIS RESEARCH; ADENOMA CHEMOPREVENTION TRIAL; VIDEO CAPSULE ENDOSCOPY; BLOOD-PRESSURE; RHEUMATOID-ARTHRITIS	Cyclo-oxygenase-2 selective inhibitors and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) are associated with increased risk of acute cardiovascular events. Only aspirin offers primary and secondary cardiovascular prophylaxis, but trials have not answered directly whether low-dose aspirin is cardioprotective with COX-2 inhibitors. A large inception cohort study showed that concomitant use of aspirin reduced risk of cardiovascular events when given with rofecoxib, celecoxib, sulindac, meloxicam, and indometacin but not when given with ibuprofen. In large trials assessing gastrointestinal safety, there were fewer gastrointestinal events in patients using both COX-2 inhibitors and aspirin than in those using non-selective NSAIDs and aspirin; significantly fewer uncomplicated upper gastrointestinal events took place in the MEDAL trial. Analysis of VIGOR and two capsule endoscopy studies showed significantly less distal gastrointestinal blood loss with COX-2 inhibitors than with non-selective NSAIDs. Endoscopy trials showed that low-dose aspirin does not diminish the gastrointestinal benefits of COX-2 inibitors over nonselective NSAIDs. In an elderly epidemiological cohort receiving aspirin, both celecoxib and rofecoxib reduced risk of admission for gastrointestinal events. Comparison of the cardiovascular and gastrointestinal risks is difficult: likelihood and severity of cardiovascular events differ between individuals, agents, and exposure. Mortality associated with gastrointestinal events is less frequent than with cardiovascular events, but asymptomatic ulcers can result in severe complications. Data support the conclusion that COX-2 inhibitors are preferable to non-selective NSAIDs in patients with chronic pain and cardiovascular risk needing low-dose aspirin, but relative risks and benefits should be assessed individually for each patient.	[Strand, Vibeke] Stanford Univ, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA	Stanford University	Strand, V (corresponding author), 306 Ramona Rd, Portola Valley, CA 94028 USA.	Vstrand@stanford.edu						Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; *ANT TRIAL COLL, 2002, BRIT MED J, V324, P717; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Bak S, 2003, STROKE, V34, P379, DOI 10.1161/01.STR.0000053029.45352.A0; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bogaty P, 2004, CIRCULATION, V110, P934, DOI 10.1161/01.CIR.0000139338.12464.5F; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2006, NEW ENGL J MED, V355, P221; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; Cheng HF, 2004, HYPERTENSION, V43, P525, DOI 10.1161/01.HYP.0000116221.27079.ea; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Corman SL, 2005, ANN PHARMACOTHER, V39, P1073, DOI 10.1345/aph.1E514; Crofford LJ, 2006, J RHEUMATOL, V33, P1403; Curtis JP, 2003, BRIT MED J, V327, P1322, DOI 10.1136/bmj.327.7427.1322; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; Fagard RH, 2006, CLIN EXP PHARMACOL P, V33, P853, DOI 10.1111/j.1440-1681.2006.04453.x; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Feenstra J, 2002, ARCH INTERN MED, V162, P265, DOI 10.1001/archinte.162.3.265; Fischer LM, 2005, PHARMACOTHERAPY, V25, P503, DOI 10.1592/phco.25.4.503.61021; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FitzGerald GA, 2003, LANCET, V361, P542, DOI 10.1016/S0140-6736(03)12560-3; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Furberg CD, 2005, CIRCULATION, V111, P249, DOI 10.1161/01.CIR.0000155081.76164.17; GENT M, 2001, CHEST, V119, P39; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Goldstein JL, 2007, CLIN GASTROENTEROL H, V5, P1167, DOI 10.1016/j.cgh.2007.06.009; Goldstein JL, 2006, ALIMENT PHARM THER, V23, P1489, DOI 10.1111/j.1365-2036.2006.02912.x; Goldstein JL, 2004, ARTHRITIS RHEUM, V50, P4099; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Goldstein JL, 2002, GASTROENTEROLOGY, V122, pA469; GOLDSTEIN JL, 2006, DIGESTIVE DIS WEEK; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; GURWITZ JH, 1994, JAMA-J AM MED ASSOC, V272, P781, DOI 10.1001/jama.272.10.781; Helin-Salmivaara A, 2006, EUR HEART J, V27, P1657, DOI 10.1093/eurheartj/ehl053; Hernandez-Diaz S, 2006, BASIC CLIN PHARMACOL, V98, P266, DOI 10.1111/j.1742-7843.2006.pto_302.x; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hudson M, 2005, J RHEUMATOL, V32, P1589; Huerta C, 2006, HEART, V92, P1610, DOI 10.1136/hrt.2005.082388; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Johnson AG, 1997, DRUG SAFETY, V17, P277, DOI 10.2165/00002018-199717050-00001; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kimmel SE, 2004, J AM COLL CARDIOL, V43, P985, DOI 10.1016/j.jacc.2003.08.064; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Kurth T, 2003, CIRCULATION, V108, P1191, DOI 10.1161/01.CIR.0000087593.07533.9B; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Laine L, 2003, GASTROENTEROLOGY, V124, P288, DOI 10.1053/gast.2003.50054; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2007, GASTROENTEROLOGY, V132, P490, DOI 10.1053/j.gastro.2006.11.012; LELETI R, 2005, TETRAHEDRON LETT, V46, P927; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; MacDonald TM, 1997, BMJ-BRIT MED J, V315, P1333, DOI 10.1136/bmj.315.7119.1333; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Martin BK, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010033; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; McGettigan P, 2006, BRIT J CLIN PHARMACO, V62, P358, DOI 10.1111/j.1365-2125.2006.02660.x; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Moore RA, 2005, ARTHRITIS RES THER, V7, pR644, DOI 10.1186/ar1704; Morgan Trefor, 2003, J Clin Hypertens (Greenwich), V5, P53, DOI 10.1111/j.1524-6175.2003.00514.x; Nissen SE, 2006, NEW ENGL J MED, V355, P203; Norgard B, 2004, ALIMENT PHARM THER, V19, P817, DOI 10.1111/j.1365-2036.2004.01913.x; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Pamuk ON, 2006, CLIN RHEUMATOL, V25, P123, DOI 10.1007/s10067-005-1167-9; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Rahme E, 2005, GASTROENTEROLOGY, V128, pA139; Rahme E, 2002, ARCH INTERN MED, V162, P1111, DOI 10.1001/archinte.162.10.1111; RAHME E, 2006, RHEUMATOLOGY, V46, P256; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Rodriguez LAG, 2003, EPIDEMIOLOGY, V14, P240; Rodriguez LAG, 2001, CLIN EXP RHEUMATOL, V19, pS41; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Schlienger RG, 2002, BRIT J CLIN PHARMACO, V54, P327, DOI 10.1046/j.1365-2125.2002.01637.x; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Serrano P, 2002, ALIMENT PHARM THER, V16, P1945, DOI 10.1046/j.1365-2036.2002.01355.x; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Singh G, 2006, ANN RHEUM DIS, V65, P61; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Singh G, 2005, ANN RHEUM DIS, V64, P85; Smeets RJEM, 2006, SPINE, V31, P90, DOI 10.1097/01.brs.0000192641.22003.83; Soininen H, 2007, DEMENT GERIATR COGN, V23, P8, DOI 10.1159/000096588; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P1378, DOI 10.1002/art.21887; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sowers JR, 2005, ARCH INTERN MED, V165, P161, DOI 10.1001/archinte.165.2.161; Strand V, 2002, ARTHRIT RHEUM-ARTHR, V47, P349, DOI 10.1002/art.10560; Strom BL, 1996, JAMA-J AM MED ASSOC, V275, P376, DOI 10.1001/jama.275.5.376; Sturkenboom MC, 2005, PHARMACOEPIDEM DR S, V14, pS57; Title LM, 2003, J AM COLL CARDIOL, V42, P1747, DOI 10.1016/j.jacc.2003.05.006; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; *US FDA, 2005, ARTHR DRUG SAF RISK; *US FDA, NEW INF HEALTHC PROF; *US FDA, 2001, ARTHR ADV COMM OP PA; *US FDA, 2005, ADV COMM BRIEF DOC C; *US FDA, 2005, CEL VALD CARD SAF FD; Walter MF, 2004, ATHEROSCLEROSIS, V177, P235, DOI 10.1016/j.atherosclerosis.2004.10.001; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; White WB, 2007, AM J CARDIOL, V99, P91, DOI 10.1016/j.amjcard.2006.07.069; White William B, 2004, Am J Ther, V11, P244, DOI 10.1097/01.mjt.0000127360.23508.04; Widlansky ME, 2003, HYPERTENSION, V42, P310, DOI 10.1161/01.HYP.0000084603.93510.28; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015; 2004, N ENGL J MED, V351, P2874	122	102	114	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2138	2151		10.1016/S0140-6736(07)61909-6	http://dx.doi.org/10.1016/S0140-6736(07)61909-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156036				2022-12-28	WOS:000252058600035
J	Woolhandler, S; Himmelstein, D				Woolhandler, Steffie; Himmelstein, David			Competition in a publicly funded healthcare system	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIVATE FOR-PROFIT; UNITED-STATES; HOSPITALS; METAANALYSIS; OUTCOMES; SERVICE; INSURANCE; MORTALITY; COSTS; HMO		Harvard Univ, Sch Med, Cambridge Hosp, Dept Med, Cambridge, MA 02138 USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital	Himmelstein, D (corresponding author), 1493 Cambridge St, Cambridge, MA 02139 USA.	david_himmelstein@hms.harvard.edu						Anders George, 2006, WALL ST J, pA1; [Anonymous], 2006, HOSP BAS EM CAR BREA; BERWICK DM, 2003, QUAL SAF HEALTH CARE, V12, P2; Braverman Harry, 1974, LABOR MONOPOLY CAPIT, P85; Coney S, 1996, LANCET, V347, P1825, DOI 10.1016/S0140-6736(96)91638-4; Dash E., 2006, NY TIMES 3      0409, P1; Davis K, 2007, MIRROR MIRROR WALL I; Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; Duckett SJ, 2000, MED J AUSTRALIA, V172, P439, DOI 10.5694/j.1326-5377.2000.tb124043.x; DVIS K, 2003, FEDERAL EMPLOYEE HLT; EICHENWALD K, 2003, NY TIMES        0812; EICHENWALD K, 1997, NY TIMES        0730, pD1; EICHENWALD K, 2003, NY TIMES        0807; FREEDBERG S, 1988, NY TIMES        0809, P1; Guyatt Gordon, 2007, OPEN MED, V1; Himmelstein DU, 2005, HLTH AFF MILLWOOD S, pW5, DOI DOI 10.1377/HLTHAFF.W5.6315689369; Hyde R, 2006, LANCET, V367, P1717, DOI 10.1016/S0140-6736(06)68751-5; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; *NHS CONS ASS NHS, 1995, J PUBLIC HLTH POLICY, V16, P452; Oliver A, 2007, MILBANK Q, V85, P5, DOI 10.1111/j.1468-0009.2007.00475.x; ORSZAG PR, 2007, COMMUNICATION   0628; *PHYS PAYM REV COM, 1996, ANN REP C; REEVES J, 2007, HOUSTON CHRONIC 0630; Retchin SM, 1997, JAMA-J AM MED ASSOC, V278, P119; SHAUGHNESSY PW, 1994, HEALTH CARE FINANC R, V16, P187; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; Willcox S, 2001, HEALTH AFFAIR, V20, P152, DOI 10.1377/hlthaff.20.3.152; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Woolhandler S, 1997, NEW ENGL J MED, V336, P769, DOI 10.1056/NEJM199703133361106; 2001, MEDICARE HMO DATA RE	32	29	29	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1126	1129		10.1136/bmj.39400.549502.94	http://dx.doi.org/10.1136/bmj.39400.549502.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240OE	18048539	Green Published			2022-12-28	WOS:000251596100031
J	Hu, WW; Feng, ZH; Teresky, AK; Levine, AJ				Hu, Wenwei; Feng, Zhaohui; Teresky, Angelika K.; Levine, Arnold J.			p53 regulates maternal reproduction through LIF	NATURE			English	Article							LEUKEMIA INHIBITORY FACTOR; IMPLANTATION FAILURE; POLYMORPHISM; BLASTOCYST; EXPRESSION; APOPTOSIS; PATHWAY; HUMANS; UTERUS; CELLS	Extensive studies have shown that p53 is important in tumour prevention(1). However, little is known about its normal physiological function. Here we show that p53 is important in reproduction, in a gender-specific manner. Significant decreases in embryonic implantation, pregnancy rate and litter size were observed in matings with p53(-/-) female mice but not with p53(-/-) male mice. The gene encoding leukaemia inhibitory factor (LIF), a cytokine critical for implantation(2), was identified as a p53-regulated gene that functions as the downstream mediator of this effect. p53 can regulate both basal and inducible transcription of LIF. Loss of p53 decreased both the level and function of LIF in uteri. Lower LIF levels were observed in the uteri of p53(-/-) mice than in those of p53(+/+) mice, particularly at day 4 of pregnancy, when transiently induced high levels of LIF were crucial for embryonic implantation. This observation probably accounts for the impaired implantation of embryos in p53(-/-) female mice. Administration of LIF to pregnant p53(-/-) mice restored maternal reproduction by improving implantation. These results demonstrate a function for p53 in maternal reproduction through the regulation of LIF. Evidence is accumulating that p53 may have a similar function in humans.	Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Institute for Advanced Study - USA	Levine, AJ (corresponding author), Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	alevine@ias.edu						ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Nagy A., 2003, MANIPULATING MOUSE E; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602	19	328	344	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					721	U8		10.1038/nature05993	http://dx.doi.org/10.1038/nature05993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046411				2022-12-28	WOS:000251209700054
J	Piccioni, G; Drossart, P; Sanchez-Lavega, A; Hueso, R; Taylor, FW; Wilson, CF; Grassi, D; Zasova, L; Moriconi, M; Adriani, A; Lebonnois, S; Coradini, A; Bezard, B; Angrilli, F; Arnold, G; Baines, KH; Bellucci, G; Benkhoff, J; Bibring, JP; Blanco, A; Blecka, MI; Carlson, RW; Di Lellis, A; Encrenaz, T; Erard, S; Fonti, S; Formisano, V; Fouchet, T; Garcia, R; Haus, R; Helbert, J; Ignatiev, NI; Irwin, PGJ; Langevin, Y; Lopez-Valverde, MA; Luz, D; Marinangeli, L; Orofino, V; Rodin, AV; Roos-Serote, MC; Saggin, B; Stam, DM; Titov, D; Visconti, G; Zambelli, M				Piccioni, G.; Drossart, P.; Sanchez-Lavega, A.; Hueso, R.; Taylor, F. W.; Wilson, C. F.; Grassi, D.; Zasova, L.; Moriconi, M.; Adriani, A.; Lebonnois, S.; Coradini, A.; Bezard, B.; Angrilli, F.; Arnold, G.; Baines, K. H.; Bellucci, G.; Benkhoff, J.; Bibring, J. P.; Blanco, A.; Blecka, M. I.; Carlson, R. W.; Di Lellis, A.; Encrenaz, T.; Erard, S.; Fonti, S.; Formisano, V.; Fouchet, T.; Garcia, R.; Haus, R.; Helbert, J.; Ignatiev, N. I.; Irwin, P. G. J.; Langevin, Y.; Lopez-Valverde, M. A.; Luz, D.; Marinangeli, L.; Orofino, V.; Rodin, A. V.; Roos-Serote, M. C.; Saggin, B.; Stam, D. M.; Titov, D.; Visconti, G.; Zambelli, M.		VIRTIS-Venis Express Tech Te	South-polar features on Venus similar to those near the North Pole	NATURE			English	Article							CLOUD STRUCTURE; PIONEER ORBITER; NIGHT-SIDE; ATMOSPHERE; SPECTRA	Venus has no seasons, slow rotation and a very massive atmosphere, which is mainly carbon dioxide with clouds primarily of sulphuric acid droplets. Infrared observations by previous missions to Venus revealed a bright 'dipole' feature surrounded by a cold 'collar' at its north pole(1-4). The polar dipole is a 'double-eye' feature at the centre of a vast vortex that rotates around the pole, and is possibly associated with rapid downwelling. The polar cold collar is a wide, shallow river of cold air that circulates around the polar vortex. One outstanding question has been whether the global circulation was symmetric, such that a dipole feature existed at the south pole. Here we report observations of Venus' south-polar region, where we have seen clouds with morphology much like those around the north pole, but rotating somewhat faster than the northern dipole. The vortex may extend down to the lower cloud layers that lie at about 50 km height and perhaps deeper. The spectroscopic properties of the clouds around the south pole are compatible with a sulphuric acid composition.	INAF IASF, Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; CNR, ISAC, I-00133 Rome, Italy; INAF IFSI, I-00133 Rome, Italy; Univ Paris Diderot, UPMC, Observ Paris, LESIA, F-92195 Meudon, France; Univ Basque Country, Escuela Super Ingn, Dept Fis Aplicada 1, Bilbao 48013, Spain; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Russian Acad Sci, Inst Space Res, Moscow 117997, Russia; Meteorol Dynam Lab, F-75252 Paris 05, France; Univ Padua, CISAS, I-35131 Padua, Italy; German Aerosp Ctr, DLR, Inst Planetary Explorat, Planetary Phys Sect, D-12489 Berlin, Germany; Jet Propuls Lab, Pasadena, CA 91011 USA; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Lecce, Dipartimento Fis, I-73100 Lecce, Italy; Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; AMDLSPACE srl, I-00149 Rome, Italy; Inst Phys Globe Paris, Dept Etud Spatiales, F-94107 St Maur des Fosses, France; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Univ G DAnnunzio, Dipartimento Sci, Int Res Sch Planetary Sci, I-65127 Pescara, Italy; Univ Nova Lisboa, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Politecn Milan, I-23900 Lecce, Italy; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Aquila, Dipartimento Fis, I-67010 Laquila, Italy	Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Basque Country; University of Oxford; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; UDICE-French Research Universities; Sorbonne Universite; University of Padua; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Salento; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); G d'Annunzio University of Chieti-Pescara; Universidade de Lisboa; Universidade Nova de Lisboa; Polytechnic University of Milan; University of Amsterdam; Max Planck Society; University of L'Aquila	Piccioni, G (corresponding author), INAF IASF, Ist Astrofis Spaziale & Fis Cosm, Via Fosso Cavaliere 100, I-00133 Rome, Italy.	Giuseppe.piccioni@iasf-roma.inaf.it	Rodin, Alexander V./L-1904-2013; Rodin, Alexander/M-8693-2019; Cardesin-Moinelo, Alejandro/AAF-2783-2021; Piccioni, Giuseppe/T-9272-2017; Helbert, Jorn/P-1570-2019; Sanchez-Lavega, Agustin/Z-3639-2019; saggin, bortolino/G-2831-2018; Fouchet, Thierry/C-6374-2017; Grassi, Davide/B-7916-2018; Luz, David/J-4588-2013; Hueso, Ricardo/Z-3277-2019; Bellucci, Giancarlo/ABA-9201-2020; Garcia, Raphael F./B-2612-2012; Drossart, Pierre/H-8670-2013; Wilson, Colin/AAI-3307-2020; Tosi, Federico/F-2321-2018; moriconi, maria luisa/B-7201-2009; Filacchione, Gianrico/S-2320-2017	Rodin, Alexander V./0000-0002-3601-7790; Rodin, Alexander/0000-0002-3601-7790; Cardesin-Moinelo, Alejandro/0000-0001-8932-9694; Piccioni, Giuseppe/0000-0002-7893-6808; Helbert, Jorn/0000-0001-5346-9505; saggin, bortolino/0000-0002-4033-3585; Fouchet, Thierry/0000-0001-9040-8285; Grassi, Davide/0000-0003-1653-3066; Luz, David/0000-0002-9473-8035; Hueso, Ricardo/0000-0003-0169-123X; Bellucci, Giancarlo/0000-0003-0867-8679; Garcia, Raphael F./0000-0003-1460-6663; Wilson, Colin/0000-0001-5355-1533; Tosi, Federico/0000-0003-4002-2434; moriconi, maria luisa/0000-0003-2609-2620; Filacchione, Gianrico/0000-0001-9567-0055; Adriani, Alberto/0000-0003-4998-8008; Knoll, Ralph/0000-0001-8871-112X; Capaccioni, Fabrizio/0000-0003-1631-4314; Lopez-Valverde, M. A./0000-0002-7989-4267; Taylor, Fred/0000-0002-0675-9769; Erard, Stephane/0000-0002-9099-8366; Bezard, Bruno/0000-0002-5433-5661; Blecka, Maria/0000-0002-6473-1211; Sanchez-Lavega, Agustin/0000-0001-7355-1522; Ignatiev, Nikolay/0000-0002-6358-7094; Sanchez-Lavega, Agustin/0000-0001-7234-7634; BETTANINI FECIA DI COSSATO, Carlo/0000-0001-5457-9108; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; MARINANGELI, Lucia/0000-0001-5417-6122; De Nino, Maurizio/0000-0002-1171-7272; LEBONNOIS, SEBASTIEN/0000-0002-2390-8164				ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; CARLSON RW, 1993, PLANET SPACE SCI, V41, P477, DOI 10.1016/S0032-0633(97)82111-3; CRISP D, 1989, SCIENCE, V246, P506, DOI 10.1126/science.246.4929.506; Drossart P, 2007, PLANET SPACE SCI, V55, P1653, DOI 10.1016/j.pss.2007.01.003; ELSON LS, 1982, J ATMOS SCI, V39, P2356, DOI 10.1175/1520-0469(1982)039<2356:WIITPR>2.0.CO;2; ESPOSITO LW, 1997, VENUS 2, P415; GRINSPOON DH, 1993, PLANET SPACE SCI, V41, P515, DOI 10.1016/S0032-0633(97)82115-0; KAMP LW, 1988, NATURE, V336, P360, DOI 10.1038/336360a0; MURRAY BC, 1974, SCIENCE, V183, P1307, DOI 10.1126/science.183.4131.1307; PICCIONI G, IN PRESS VIRTIS VISI; POLLACK JB, 1993, ICARUS, V103, P1, DOI 10.1006/icar.1993.1055; SCHOFIELD JT, 1983, NATURE, V305, P116, DOI 10.1038/305116a0; SUOMI VE, 1978, SCIENCE, V201, P1009, DOI 10.1126/science.201.4360.1009; TAYLOR FW, 1979, NATURE, V279, P613, DOI 10.1038/279613a0; TAYLOR FW, 1979, SCIENCE, V205, P65, DOI 10.1126/science.205.4401.65; TAYLOR FW, 1990, VEROFFENTLICHUNGEN F, V18, P93; TAYLOR FW, 1990, MIDDLE ATMOSPHERE VE, V18, P93; Zasova LV, 2007, PLANET SPACE SCI, V55, P1712, DOI 10.1016/j.pss.2007.01.011	19	96	96	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					637	640		10.1038/nature06209	http://dx.doi.org/10.1038/nature06209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046395	Green Submitted			2022-12-28	WOS:000251209700035
J	Livingston, EH				Livingston, Edward H.			Obesity, mortality, and bariatric surgery death rates - Commentary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS-SURGERY; LONG-TERM MORTALITY; HOSPITAL VOLUME; 7 COUNTRIES; OUTCOMES; ATHEROSCLEROSIS; PENNSYLVANIA; TRENDS; IMPACT; US		Univ Texas, SW Med Ctr, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Livingston, EH (corresponding author), Univ Texas, SW Med Ctr, Div Gastrointestinal & Endocrine Surg, 5323 Harry Hines Blvd,Room E7-126, Dallas, TX 75390 USA.	edward.livingston@utsouthwestern.edu						Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Carbonell AM, 2005, AM SURGEON, V71, P308; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; *DEP VET AFF, SCREEN MAN OV OB; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum DR, 2007, JAMA-J AM MED ASSOC, V298, P1442, DOI 10.1001/jama.298.12.1442; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84; KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1; Liu JH, 2003, AM SURGEON, V69, P823; Livingston Edward H, 2006, Surg Obes Relat Dis, V2, P362, DOI 10.1016/j.soard.2006.02.009; Livingston EH, 2006, ARCH SURG-CHICAGO, V141, P1115, DOI 10.1001/archsurg.141.11.1115; Livingston EH, 2005, SURGERY, V137, P16, DOI 10.1016/j.surg.2004.05.049; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; MENOTTI A, 1995, INT J EPIDEMIOL, V24, P515, DOI 10.1093/ije/24.3.515; MONTENEGRO MR, 1968, LAB INVEST, V18, P594; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Omalu BI, 2007, ARCH SURG-CHICAGO, V142, P923, DOI 10.1001/archsurg.142.10.923; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Trus TL, 2005, SURG ENDOSC, V19, P616, DOI 10.1007/s00464-004-8827-8; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	25	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2406	2408		10.1001/jama.298.20.2406	http://dx.doi.org/10.1001/jama.298.20.2406			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18046786				2022-12-28	WOS:000251163400021
J	Bhopal, R				Bhopal, Raj			The beautiful skull and Blumenbach's errors	BRITISH MEDICAL JOURNAL			English	Editorial Material							RACE		Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	Bhopal, R (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	Raj.bhopal@ed.ac.uk						Bhopal R. S., 2007, Ethnicity, race and health in multicultural societies: foundations for better epidemiology, public health, and health care; Blumenbach J. F., 1865, ANTHR TREATISES JF B; Kitson PJ, 2000, ELH-ENGL LIT HIST, V67, P515, DOI 10.1353/elh.2000.0017; LINNAEUS C, 1806, GEN SYSTEM NATURE 3; Rahemtulla T, 2005, BMJ-BRIT MED J, V330, P1036, DOI 10.1136/bmj.330.7499.1036; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311	6	28	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1308	1309		10.1136/bmj.39413.463958.80	http://dx.doi.org/10.1136/bmj.39413.463958.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156242	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252182700024
J	Buckwalter, JG				Buckwalter, J. Galen			The good patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2534	2535		10.1056/NEJMp078226	http://dx.doi.org/10.1056/NEJMp078226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094372				2022-12-28	WOS:000251728900002
J	Sahakian, B; Morein-Zamir, S				Sahakian, Barbara; Morein-Zamir, Sharon			Professor's little helper	NATURE			English	Editorial Material							SCHIZOPHRENIA; COGNITION		Univ Cambridge, Dept Psychiat, Cambridge CB2 2QQ, England; MRC, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge	Sahakian, B (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge CB2 2QQ, England.		Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research Council [G0001354] Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; COMASHERRERA A, 2003, 1728 PSSRU; DAVIDSON M, 1995, SCHIZOPHR RES, V17, P123, DOI 10.1016/0920-9964(95)00037-M; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Lorist MM, 2003, BRAIN COGNITION, V53, P82, DOI 10.1016/S0278-2626(03)00206-9; MOREINZAMIR S, 2007, SCHIZOPHR B; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1015, DOI 10.1097/chi.0b013e3180686d7e; Turner DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1363, DOI 10.1038/sj.npp.1300457; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906	10	223	228	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1157	1159		10.1038/4501157a	http://dx.doi.org/10.1038/4501157a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HA	18097378				2022-12-28	WOS:000251786200018
J	Diederichs, S; Haber, DA				Diederichs, Sven; Haber, Daniel A.			Dual role for argonautes in MicroRNA processing and Posttranscriptional regulation of MicroRNA expression	CELL			English	Article							RNA-INTERFERENCE; PASSENGER-STRAND; NUCLEAR EXPORT; COMPLEX; DICER; SIRNA; INITIATION; CLEAVAGE; GENES; IDENTIFICATION	MicroRNAs are small endogenous noncoding RNAs involved in posttranscriptional gene regulation. During microRNA biogenesis, Drosha and Dicer process the primary transcript (pri-miRNA) through a precursor hairpin (pre-miRNA) to the mature miRNA. The miRNA is incorporated into the RNA-Induced Silencing Complex (RISC) with Argonaute proteins, the effector molecules in RNA interference (RNAi). Here, we show that all Argonautes elevate mature miRNA expression posttranscriptionally, independent of RNase activity. Also, we identify a role for the RISC slicer Argonaute2 (Ago2) in cleaving the pre-miRNA to an additional processing intermediate, termed Ago2 cleaved precursor miRNA or ac-pre-miRNA. This endogenous, on-pathway intermediate results from cleavage of the pre-miRNA hairpin 12 nucleotides from its 3'-end. By analogy to siRNA processing, Ago2 cleavage may facilitate removal of the nicked passenger strand from RISC after maturation. The multiple roles of Argonautes in the RNAi effector phase and miRNA biogenesis and maturation suggest coordinate regulation of microRNA expression and function.	[Diederichs, Sven; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Diederichs, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	sdiederichs@bics.bwh.harvard.edu; haber@helix.mgh.harvard.edu	Diederichs, Sven/J-6237-2012	Diederichs, Sven/0000-0001-7901-4752	PHS HHS [R01 95281] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; OCARROLL D, 2007, GENES DEV; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	51	473	497	5	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1097	1108		10.1016/j.cell.2007.10.032	http://dx.doi.org/10.1016/j.cell.2007.10.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083100	Bronze			2022-12-28	WOS:000252217100018
J	Macquaker, JHS; Bohacs, KM				Macquaker, Joe H. S.; Bohacs, Kevin M.			Geology - On the accumulation of mud	SCIENCE			English	Editorial Material							DEPOSITION; FACIES		Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; ExxonMobil Upstream Res Co, Houston, TX 77027 USA	University of Manchester; Exxon Mobil Corporation	Macquaker, JHS (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	Joe.Macquaker@Manchester.ac.uk; Kevin.M.Bohacs@exxonmobil.com						BOHACS KM, 1998, MUDSTONES SHALES, V1, P32; CLUFF RM, 1980, J SEDIMENT PETROL, V50, P767; Krone R., 1962, FLUME STUDIES TRANSP; MacQuaker JHS, 2007, J SEDIMENT RES, V77, P324, DOI 10.2110/jsr.2007.029; MCCAVE IN, 1971, J SEDIMENT PETROL, V41, P89; Nittrouer CA, 1999, MAR GEOL, V154, P3, DOI 10.1016/S0025-3227(98)00128-5; OBRIEN NR, 1996, SPECIAL PUBLICATION, V116, P23; Schieber J, 1999, J SEDIMENT RES, V69, P909, DOI 10.2110/jsr.69.909; Schieber J, 2007, SCIENCE, V318, P1760, DOI 10.1126/science.1147001	9	70	80	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1734	1735		10.1126/science.1151980	http://dx.doi.org/10.1126/science.1151980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079390				2022-12-28	WOS:000251616800027
J	Zhu, ZM; Gauthier, DJ; Boyd, RW				Zhu, Zhaoming; Gauthier, Daniel J.; Boyd, Robert W.			Stored light in an optical fiber via stimulated Brillouin scattering	SCIENCE			English	Article							STORAGE; PHOTONS; STATES	Electrons in correlated insulators are prevented from conducting by Coulomb repulsion between them. When an insulator- to- metal transition is induced in a correlated insulator by doping or heating, the resulting conducting state can be radically different from that characterized by free electrons in conventional metals. We report on the electronic properties of a prototypical correlated insulator vanadium dioxide in which the metallic state can be induced by increasing temperature. Scanning near- field infrared microscopy allows us to directly image nanoscale metallic puddles that appear at the onset of the insulator- to- metal transition. In combination with far- field infrared spectroscopy, the data reveal the Mott transition with divergent quasi- particle mass in the metallic puddles. The experimental approach used sets the stage for investigations of charge dynamics on the nanoscale in other inhomogeneous correlated electron systems.	Duke Univ, Dept Phys, Durham, NC 27708 USA; Univ Rochester, Inst Opt, Rochester, NY 14627 USA	Duke University; University of Rochester	Gauthier, DJ (corresponding author), Duke Univ, Dept Phys, Box 90305, Durham, NC 27708 USA.	gauthier@phy.duke.edu	Gauthier, Daniel J/G-1336-2011	Gauthier, Daniel J/0000-0002-4473-217X				Abedin KS, 2005, OPT EXPRESS, V13, P10266, DOI 10.1364/OPEX.13.010266; Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Boyd R. W., 2003, NONLINEAR OPTICS; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Dodin IY, 2002, OPT COMMUN, V214, P83, DOI 10.1016/S0030-4018(02)02144-2; Dodin IY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.165001; Fleischhauer M, 2000, OPT COMMUN, V179, P395, DOI 10.1016/S0030-4018(99)00679-3; LIN H, 1995, OPT LETT, V20, P1658, DOI 10.1364/OL.20.001658; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; RAMASWAMI R, 2002, OPTICAL NETWORK PRAC, pCH12; Tucker RS, 2005, J LIGHTWAVE TECHNOL, V23, P4046, DOI 10.1109/JLT.2005.853125; Turukhin AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.023602; Xu QF, 2007, NAT PHYS, V3, P406, DOI 10.1038/nphys600; Yanik MF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233903	18	279	298	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1748	1750		10.1126/science.1149066	http://dx.doi.org/10.1126/science.1149066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079395				2022-12-28	WOS:000251616800032
J	Robinson, CV; Sali, A; Baumeister, W				Robinson, Carol V.; Sali, Andrej; Baumeister, Wolfgang			The molecular sociology of the cell	NATURE			English	Review							NUCLEAR-PORE COMPLEX; PROTEIN-PROTEIN INTERACTIONS; X-RAY-SCATTERING; MASS-SPECTROMETRY; ANGSTROM RESOLUTION; RIBOSOMAL-SUBUNIT; 20S PROTEASOME; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; CRYOELECTRON MICROSCOPY	Proteomic studies have yielded detailed lists of the proteins present in a cell. Comparatively little is known, however, about how these proteins interact and are spatially arranged within the 'functional modules' of the cell: that is, the 'molecular sociology' of the cell. This gap is now being bridged by using emerging experimental techniques, such as mass spectrometry of complexes and single- particle cryo- electron microscopy, to complement traditional biochemical and biophysical methods. With the development of integrative computational methods to exploit the data obtained, such hybrid approaches will uncover the molecular architectures, and perhaps even atomic models, of many protein complexes. With these structures in hand, researchers will be poised to use cryo- electron tomography to view protein complexes in action within cells, providing unprecedented insights into protein- interaction networks.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	University of Cambridge; University of California System; University of California San Francisco; Max Planck Society	Robinson, CV (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk; sali@salilab.org; baumeist@biochem.mpg.de		robinson, carol/0000-0001-7829-5505				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013; ALBER F, 2004, PRACTICAL BIOINFORMA, P1950; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Anand GS, 2003, P NATL ACAD SCI USA, V100, P13264, DOI 10.1073/pnas.2232255100; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Baumeister W, 2005, FEBS LETT, V579, P933, DOI 10.1016/j.febslet.2004.10.102; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Blundell T.L., 1976, PROTEIN CRYSTALLOGRA; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Davis FP, 2006, NUCLEIC ACIDS RES, V34, P2943, DOI 10.1093/nar/gkl353; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guan JQ, 2003, BIOCHEMISTRY-US, V42, P11992, DOI 10.1021/bi034914k; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kwon YD, 2004, J MOL BIOL, V335, P233, DOI 10.1016/j.jmb.2003.08.029; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MacBeath G, 2000, SCIENCE, V289, P1760; MALHOTRA A, 1994, J MOL BIOL, V240, P308, DOI 10.1006/jmbi.1994.1448; McCoy MA, 2002, J AM CHEM SOC, V124, P2104, DOI 10.1021/ja017242z; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nagar B, 2005, STRUCTURE, V13, P169, DOI 10.1016/j.str.2005.01.001; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Nickell S, 2007, FEBS LETT, V581, P2751, DOI 10.1016/j.febslet.2007.05.028; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Poliakov A, 2007, J STRUCT BIOL, V157, P371, DOI 10.1016/j.jsb.2006.09.003; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ruotolo BT, 2007, ANGEW CHEM INT EDIT, V46, P8001, DOI 10.1002/anie.200702161; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Todd AE, 2005, J MOL BIOL, V348, P1235, DOI 10.1016/j.jmb.2005.03.037; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5; van Dijk ADJ, 2007, J PROTEOME RES, V6, P1530, DOI 10.1021/pr060651f; Vasilescu J, 2006, CURR OPIN BIOTECH, V17, P394, DOI 10.1016/j.copbio.2006.06.008; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; VON HELDEN G, 1995, SCIENCE, V267, P1483, DOI 10.1126/science.267.5203.1483; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Wuthrich K, 2001, NAT STRUCT BIOL, V8, P923, DOI 10.1038/nsb1101-923; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	100	394	404	6	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					973	982		10.1038/nature06523	http://dx.doi.org/10.1038/nature06523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075576				2022-12-28	WOS:000251579900067
J	Tatsioni, A; Bonitsis, NG; Ioannidis, JPA				Tatsioni, Athina; Bonitsis, Nikolaos G.; Ioannidis, John P. A.			Persistence of contradicted claims in the literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONJUGATED EQUINE ESTROGENS; VITAMIN-E SUPPLEMENTATION; BETA-CAROTENE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; CORONARY-DISEASE; HORMONE-THERAPY; E CONSUMPTION; ANTIOXIDANT; RISK	Context Some research findings based on observational epidemiology are contradicted by randomized trials, but may nevertheless still be supported in some scientific circles. Objectives To evaluate the change over time in the content of citations for 2 highly cited epidemiological studies that proposed major cardiovascular benefits associated with vitamin E in 1993; and to understand how these benefits continued being defended in the literature, despite strong contradicting evidence from large randomized clinical trials (RCTs). To examine the generalizability of these findings, we also examined the extent of persistence of supporting citations for the highly cited and contradicted protective effects of beta-carotene on cancer and of estrogen on Alzheimer disease. Data Sources For vitamin E, we sampled articles published in 1997, 2001, and 2005 ( before, early, and late after publication of refuting evidence) that referenced the highly cited epidemiological studies and separately sampled articles published in 2005 and referencing the major contradicting RCT ( HOPE trial). We also sampled articles published in 2006 that referenced highly cited articles proposing benefits associated with beta-carotene for cancer ( published in 1981 and contradicted long ago by RCTs in 1994-1996) and estrogen for Alzheimer disease ( published in 1996 and contradicted recently by RCTs in 2004). Data Extraction The stance of the citing articles was rated as favorable, equivocal, and unfavorable to the intervention. We also recorded the range of counterarguments raised to defend effectiveness against contradicting evidence. Results For the 2 vitamin E epidemiological studies, even in 2005, 50% of citing articles remained favorable. A favorable stance was independently less likely in more recent articles, specifically in articles that also cited the HOPE trial ( odds ratio for 2001, 0.05 [95% confidence interval, 0.01-0.19; P <. 001] and the odds ratio for 2005, 0.06 [95% confidence interval, 0.02-0.24; P <. 001], as compared with 1997), and in general/internal medicine vs specialty journals. Among articles citing the HOPE trial in 2005, 41.4% were unfavorable. In 2006, 62.5% of articles referencing the highly cited article that had proposed beta-carotene and 61.7% of those referencing the highly cited article on estrogen effectiveness were still favorable; 100% and 96%, respectively, of the citations appeared in specialty journals; and citations were significantly less favorable (P=. 001 and P=. 009, respectively) when the major contradicting trials were also mentioned. Counterarguments defending vitamin E or estrogen included diverse selection and information biases and genuine differences across studies in participants, interventions, cointerventions, and outcomes. Favorable citations to beta-carotene, long after evidence contradicted its effectiveness, did not consider the contradicting evidence. Conclusion Claims from highly cited observational studies persist and continue to be supported in the medical literature despite strong contradictory evidence from randomized trials.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Univ Ioannina, Sch Med, Dept Dermatol, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; Tufts Univ, Sch Med, Dept Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Univ Campus, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Tatsioni, Athina/AAQ-5413-2020; Ioannidis, John P. A./G-9836-2011					Alissa EM, 2005, ASIA PAC J CLIN NUTR, V14, P137; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Barron AM, 2006, ANTIOXID REDOX SIGN, V8, P2047, DOI 10.1089/ars.2006.8.2047; Bazerman MH, 2002, HARVARD BUS REV, V80, P96; Bimonte-Nelson HA, 2006, EUR J NEUROSCI, V24, P229, DOI 10.1111/j.1460-9568.2006.04867.x; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Buchanan AV, 2006, INT J EPIDEMIOL, V35, P562, DOI 10.1093/ije/dyl001; Cherubini A, 2005, CURR PHARM DESIGN, V11, P2017, DOI 10.2174/1381612054065783; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Djulbegovic B, 1999, AM J MED, V106, P198, DOI 10.1016/S0002-9343(98)00391-X; Dumas J, 2006, NEUROPSYCHOPHARMACOL, V31, P2065, DOI 10.1038/sj.npp.1301042; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Eichholzer M, 2001, INT J VITAM NUTR RES, V71, P5, DOI 10.1024/0300-9831.71.1.5; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; GRAY JAM, 1997, EVIDENCE BASED HEALT; Henderson VW, 2006, NEUROSCIENCE, V138, P1031, DOI 10.1016/j.neuroscience.2005.06.017; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hyman M, 2005, ALTERN THER HEALTH M, V11, P14; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Kavvoura FK, 2007, PLOS MED, V4, P456, DOI 10.1371/journal.pmed.0040079; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; KOEHLER JJ, 1993, ORGAN BEHAV HUM DEC, V56, P28, DOI 10.1006/obhd.1993.1044; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; KYZAS PA, 2007, EUR J CANC      1102; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Linfante A, 2004, CIRCULATION, V110, P664; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Marks AE, 2001, CAMB ARCHAEOL J, V11, P17, DOI 10.1017/S0959774301000026; McAsey ME, 2006, EXP NEUROL, V197, P197, DOI 10.1016/j.expneurol.2005.09.008; Meydani M, 2001, J NUTR, V131, p366S, DOI 10.1093/jn/131.2.366S; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Morrison JH, 2006, J NEUROSCI, V26, P10332, DOI 10.1523/JNEUROSCI.3369-06.2006; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Petitti DB, 2005, AM J EPIDEMIOL, V162, P415, DOI 10.1093/aje/kwi224; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Resch KI, 2000, J ROY SOC MED, V93, P164, DOI 10.1177/014107680009300402; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rosenfeld RM, 2004, ORL-J OTO-RHIN-LARYN, V66, P186, DOI 10.1159/000079876; Santocono M, 2006, J PHOTOCH PHOTOBIO B, V85, P205, DOI 10.1016/j.jphotobiol.2006.07.009; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Singh M, 2006, EXP BIOL MED, V231, P514; Spinler SA, 2001, ANN PHARMACOTHER, V35, P589; Stampfer M, 1997, CONTROL CLIN TRIALS, V18, P494, DOI 10.1016/S0197-2456(97)00050-0; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINBERG D, 1990, JAMA-J AM MED ASSOC, V264, P3047, DOI 10.1001/jama.264.23.3047; STEINBERG D, 1991, CIRCULATION, V84, P1420, DOI 10.1161/01.CIR.84.3.1420; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; *THOMS SCI I SCI I, ISI WEB KNOWL; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Vogel RA, 2005, J AM COLL CARDIOL, V46, P184, DOI 10.1016/j.jacc.2005.05.031; Xu HX, 2006, ANN NY ACAD SCI, V1089, P324, DOI 10.1196/annals.1386.036; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	60	164	169	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2517	2526		10.1001/jama.298.21.2517	http://dx.doi.org/10.1001/jama.298.21.2517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056905	Bronze			2022-12-28	WOS:000251361900017
J	Adshead, F; Stachenko, S				Adshead, Fiona; Stachenko, Sylvie			International cooperation to combat chronic diseases	LANCET			English	Editorial Material							HEALTH		[Adshead, Fiona] Dept Hlth, London SW1A 2NS, England; [Stachenko, Sylvie] Publ Hlth Agcy Canada, WHO, Collaborating Ctr Chron Dis Policy, Ottawa, ON, Canada	Public Health Agency of Canada; World Health Organization	Adshead, F (corresponding author), Dept Hlth, London SW1A 2NS, England.	fiona.adshead@dh.gsi.gov.uk						Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; *HLTH CAN, 2007, HLTH CAN TOB CONTR P; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; *PAHO WHO CHRON DI, 2007, CHRON DIS PREV CONTR; *PUBL HLTH AG CAN, 2006, POL RES IN TYP 2 EV; *PUBL HLTH AG CAN, POL OBS NONC DIS; Rao M, 2007, LANCET, V370, P1111, DOI 10.1016/S0140-6736(07)61260-4; Suhrcke M, 2007, LANCET, V370, P1467, DOI 10.1016/S0140-6736(07)61616-X; *UK DEP HLTH, 2007, PARTN BETT HLTH; *UK DEP HLTH, 2007, HLTH IS GLOB; *WHO, 2007, WORLD BANK WHO RAIS	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2078	2080		10.1016/S0140-6736(07)61878-9	http://dx.doi.org/10.1016/S0140-6736(07)61878-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156016				2022-12-28	WOS:000252058600008
J	Matsubara, H; Yoshimoto, S; Saito, H; Yue, JL; Tanaka, Y; Noda, S				Matsubara, Hideki; Yoshimoto, Susumu; Saito, Hirohisa; Yue, Jianglin; Tanaka, Yoshinori; Noda, Susumu			GaN photonic-crystal surface-emitting laser at blue-violet wavelengths	SCIENCE			English	Article							DISTRIBUTED-FEEDBACK; DESIGN; MODE	Shorter- wavelength surface- emitting laser sources are important for a variety of fields, including photonics, information processing, and biology. We report on the creation of a current- driven blueviolet photonic- crystal surface- emitting laser. We have developed a fabrication method, named "air holes retained overgrowth," in order to construct a two- dimensional gallium nitride ( GaN)/air photonic- crystal structure. The resulting periodic structure has a photonic- crystal band- edge effect sufficient for the successful operation of a current- injection surface- emitting laser. This represents an important step in the development of laser sources that could be focused to a size much less than the wavelength and be integrated two- dimensionally at such short wavelengths.	[Matsubara, Hideki; Yoshimoto, Susumu; Saito, Hirohisa; Yue, Jianglin; Tanaka, Yoshinori; Noda, Susumu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Matsubara, Hideki; Yue, Jianglin; Tanaka, Yoshinori; Noda, Susumu] Japan Sci & Technol Agcy, Kyoto 6158510, Japan; [Noda, Susumu] Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto 6158510, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	snoda@kuee.kyoto-u.ac.jp						Choi YS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147713; Colombelli R, 2003, SCIENCE, V302, P1374, DOI 10.1126/science.1090561; David A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189159; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Imada M, 1999, APPL PHYS LETT, V75, P316, DOI 10.1063/1.124361; Imada M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195306; Meier M, 1999, APPL PHYS LETT, V74, P7, DOI 10.1063/1.123116; Miyai E, 2006, NATURE, V441, P946, DOI 10.1038/441946a; Noda S, 2001, SCIENCE, V293, P1123, DOI 10.1126/science.1061738; Sakai K, 2005, IEEE J SEL AREA COMM, V23, P1335, DOI 10.1109/JSAC.2005.851205; Sakai K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2220057; USUI A, 1997, JPN J APPL PHYS, V36, P899; Vurgaftman I, 2003, IEEE J QUANTUM ELECT, V39, P689, DOI 10.1109/JQE.2003.811943	13	260	271	9	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					445	447		10.1126/science.1150413	http://dx.doi.org/10.1126/science.1150413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18096768				2022-12-28	WOS:000252576600032
J	Ketting, RF				Ketting, Rene F.			A dead end for microRNAs	CELL			English	Editorial Material									Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Ketting, RF (corresponding author), Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	ketting@niob.knaw.nl		Ketting, Rene/0000-0001-6161-5621				Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; KEDDE M, 2007, CELL; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	10	30	31	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1226	1227		10.1016/j.cell.2007.12.004	http://dx.doi.org/10.1016/j.cell.2007.12.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160032	Bronze			2022-12-28	WOS:000252217200011
J	Hellden, A; Odar-Cederlof, I; Larsson, K; Fehrman-Ekholm, I; Linden, T				Hellden, Anders; Odar-Cederlof, Ingegerd; Larsson, Kajsa; Fehrman-Ekholm, Ingela; Linden, Thomas			Death delusion	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hellden, Anders; Odar-Cederlof, Ingegerd; Larsson, Kajsa] Karolinska Univ Hosp, Stockholm, Sweden; [Fehrman-Ekholm, Ingela] Queen Sophias Hosp, Stockholm, Sweden; [Linden, Thomas] Gothenburg Univ, S-41124 Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Hellden, A (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	anders.hellden@ki.se	Helldén, Anders/ABA-8079-2021; linden, thomas/GRS-0014-2022; Hellden, Anders/AAN-7404-2020	Helldén, Anders/0000-0001-9061-9808; Hellden, Anders/0000-0001-9061-9808; Linden, Thomas KA/0000-0002-2444-8892				BERRIOS GE, 1995, ACTA PSYCHIAT SCAND, V91, P185, DOI 10.1111/j.1600-0447.1995.tb09764.x; Cotard J., 1882, ARCH NEUROL-PARIS, V4, P152; Hellden A, 2003, NEPHROL DIAL TRANSPL, V18, P1135, DOI 10.1093/ndt/gfg119; Scepkowski Lisa A, 2003, Behav Cogn Neurosci Rev, V2, P261, DOI 10.1177/1534582303260119	4	10	11	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1305	1305		10.1136/bmj.39408.393137.BE	http://dx.doi.org/10.1136/bmj.39408.393137.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156240	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252182700022
J	Cibelli, J				Cibelli, Jose			Development - Is therapeutic cloning dead?	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION		Michigan State Univ, Dept Anim Sci, Cellular Reprogramming Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Physiol, Cellular Reprogramming Lab, E Lansing, MI 48824 USA; Program Cell Therapy & Regenerat Med Andalusia, Seville, Spain	Michigan State University; Michigan State University	Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci, Cellular Reprogramming Lab, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Lanza RP, 1999, NAT MED, V5, P975, DOI 10.1038/12404; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; ROBERT EDWARDS AND PATRICK STEPTOE, 1980, MATTER LIFE; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	16	17	19	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1879	1880		10.1126/science.1153229	http://dx.doi.org/10.1126/science.1153229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096796				2022-12-28	WOS:000251786600045
J	Greene, M				Greene, Mott			The demise of the lone author	NATURE			English	Editorial Material									Univ Puget Sound, Tacoma, WA 98416 USA		Greene, M (corresponding author), Univ Puget Sound, Tacoma, WA 98416 USA.			Greene, Mott/0000-0002-4864-1806				[Anonymous], 1999, NATURE, V399, P393	1	96	97	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1165	1165		10.1038/4501165a	http://dx.doi.org/10.1038/4501165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HA	18097387				2022-12-28	WOS:000251786200027
J	Patocs, A; Zhang, L; Xu, YM; Weber, F; Caldes, T; Mutter, GL; Platzer, P; Eng, C				Patocs, Attila; Zhang, Li; Xu, Yaomin; Weber, Frank; Caldes, Trinidad; Mutter, George L.; Platzer, Petra; Eng, Charis			Breast-cancer stromal cells with TP53 mutations and nodal metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATIC MUTATIONS; P53; BRCA1; CARCINOMAS; GENE; HETEROZYGOSITY; TRANSFORMATION; PROGRESSION; EPITHELIUM; PROGNOSIS	Background: The importance of cross-talk between a cancer and its microenvironment has been increasingly recognized. We hypothesized that mutational inactivation of the tumor-suppressor gene TP53 and genomic alterations in stromal cells of a tumor's microenvironment contribute to the clinical outcome. Methods: We performed TP53 mutation analysis and genomewide analysis of loss of heterozygosity and allelic imbalance on DNA from isolated neoplastic epithelial and stromal cells from 43 patients with hereditary breast cancer and 175 patients with sporadic breast cancer. Compartment-specific patterns and TP53 mutations were analyzed. Associations between compartment-specific TP53 status, loss of heterozygosity or allelic imbalance, and clinical and pathological characteristics were computed. Results: TP53 mutations were associated with an increased loss of heterozygosity and allelic imbalance in both hereditary and sporadic breast cancers, but samples from patients with hereditary disease had more frequent mutations than did those from patients with sporadic tumors (74.4% vs. 42.3%, P=0.001). Only 1 microsatellite locus (2p25.1) in stromal cells from hereditary breast cancers was associated with mutated TP53, whereas there were 66 such loci in cells from sporadic breast cancers. Somatic TP53 mutations in stroma, but not epithelium, of sporadic breast cancers were associated with regional nodal metastases (P=0.003). A specific set of five loci linked to an increased loss of heterozygosity and allelic imbalance in the stroma of sporadic tumors was associated with nodal metastases in the absence of TP53 mutations. No associations were found between any of the clinical or pathological features of hereditary breast cancer with somatic TP53 mutations. Conclusions: Stroma-specific loss of heterozygosity or allelic imbalance are associated with somatic TP53 mutations and regional lymph-node metastases in sporadic breast cancer but not in hereditary breast cancer.	Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; San Carlos Univ Hosp, Mol Oncol Lab, Madrid, Spain; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Hospital Clinico San Carlos; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Eng, C (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Haviv, Izhak/E-3782-2015; Mutter, George L/C-5819-2009; Weber, Frank/A-1883-2012	Haviv, Izhak/0000-0002-0837-5005; Weber, Frank/0000-0002-0995-667X; Patocs, Attila/0000-0001-7506-674X; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [1P01CA97189-01A2, 1P50/U54CA113001-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Agresti A, 2003, CATEGORICAL DATA ANA; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Barclay WW, 2005, ENDOCRINOLOGY, V146, P13, DOI 10.1210/en.2004-1123; BISSELL MJ, 1987, J CELL SCI, P327; Chen SL, 2003, MOL CARCINOGEN, V36, P204, DOI 10.1002/mc.10110; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Eissa S, 1997, ANTICANCER RES, V17, P3091; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gasco M, 2003, HUM MUTAT, V21, P301, DOI 10.1002/humu.10173; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hayward SW, 2001, CANCER RES, V61, P8135; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Hothorn LA, 2006, J BIOPHARM STAT, V16, P711, DOI 10.1080/10543400600860576; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P681, DOI 10.1038/ng1202-681b; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Maffini MV, 2005, AM J PATHOL, V167, P1405, DOI 10.1016/S0002-9440(10)61227-8; Marsh DJ, 1997, CANCER RES, V57, P500; Martin AM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e34; Matrisian LM, 2001, CANCER RES, V61, P3844; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; *NCCN, 2007, GEN FAM HIGH RISK AS; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Overgaard J, 2000, ACTA ONCOL, V39, P327, DOI 10.1080/028418600750013096; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Rines RD, 1998, CARCINOGENESIS, V19, P979, DOI 10.1093/carcin/19.6.979; Shekhar MPV, 2001, CANCER RES, V61, P1320; Smith PD, 1999, ONCOGENE, V18, P2451, DOI 10.1038/sj.onc.1202565; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang Xiaojuan, 2002, Breast Cancer, V9, P216, DOI 10.1007/BF02967592; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062	38	238	253	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2543	2551		10.1056/NEJMoa071825	http://dx.doi.org/10.1056/NEJMoa071825			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094375				2022-12-28	WOS:000251728900005
J	Rancz, EA; Ishikawa, T; Duguid, I; Chadderton, P; Mahon, S; Hausser, M				Rancz, Ede A.; Ishikawa, Taro; Duguid, Ian; Chadderton, Paul; Mahon, Severine; Haeusser, Michael			High-fidelity transmission of sensory information by single cerebellar mossy fibre boutons	NATURE			English	Article							GRANULE CELL LAYER; IN-VIVO; PURKINJE-CELLS; RAT; RESPONSES; SYNAPSE; CORTEX; BRAIN; INTEGRATION; MORPHOLOGY	Understanding the transmission of sensory information at individual synaptic connections requires knowledge of the properties of presynaptic terminals and their patterns of firing evoked by sensory stimuli. Such information has been difficult to obtain because of the small size and inaccessibility of nerve terminals in the central nervous system. Here we show, by making direct patch- clamp recordings in vivo from cerebellar mossy fibre boutons - the primary source of synaptic input to the cerebellar cortex(1,2) - that sensory stimulation can produce bursts of spikes in single boutons at very high instantaneous firing frequencies ( more than 700 Hz). We show that the mossy fibre - granule cell synapse exhibits high- fidelity transmission at these frequencies, indicating that the rapid burst of excitatory postsynaptic currents underlying the sensory- evoked response of granule cells(3) can be driven by such a presynaptic spike burst. We also demonstrate that a single mossy fibre can trigger action potential bursts in granule cells in vitro when driven with in vivo firing patterns. These findings suggest that the relay from mossy fibre to granule cell can act in a 'detonator' fashion, such that a single presynaptic afferent may be sufficient to transmit the sensory message. This endows the cerebellar mossy fibre system with remarkable sensitivity and high fidelity in the transmission of sensory information.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Mahon, Severine/E-7195-2017; mahon, severine/AAG-9225-2021; Ishikawa, Taro/AAX-9928-2020; Rancz, Ede Attila/AAS-6867-2020; Hausser, Michael/AAW-6827-2020	mahon, severine/0000-0001-8339-9034; Ishikawa, Taro/0000-0003-2335-439X; Hausser, Michael/0000-0002-2673-8957; Rancz, Ede Attila/0000-0002-7951-1385; Chadderton, Paul/0000-0002-6276-1011; Duguid, Ian/0000-0001-6966-2641	Wellcome Trust [068699] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; CAJAL SR, 2004, TEXTURA SISTEMA NERV; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; LEUSEN I, 1972, PHYSIOL REV, V52, P1, DOI 10.1152/physrev.1972.52.1.1; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Morissette J, 1996, EXP BRAIN RES, V109, P240; Palay S. L., 1974, CEREBELLAR CORTEX CY; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Simpson JI, 2005, PROG BRAIN RES, V148, P329, DOI 10.1016/S0079-6123(04)48026-1; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74	33	209	210	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1245	U12		10.1038/nature05995	http://dx.doi.org/10.1038/nature05995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097412	Green Accepted			2022-12-28	WOS:000251786200053
J	Boynton, P				Boynton, Petra			Medicine and the media - A remedy for lonely hearts?	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Dept Primary Care & Populat Sci, London WC1E 6BT, England	University of London; University College London	Boynton, P (corresponding author), UCL, Dept Primary Care & Populat Sci, London WC1E 6BT, England.	p.boynton@pcps.ucl.ac.uk		Boynton, Petra/0000-0001-6699-2266					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1240	1240		10.1136/bmj.39420.414803.34	http://dx.doi.org/10.1136/bmj.39420.414803.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079547	Green Published			2022-12-28	WOS:000251832200032
J	Dodd, AN; Gardner, MJ; Hotta, CT; Hubbard, KE; Dalchau, N; Love, J; Assie, JM; Robertson, FC; Jakobsen, MK; Goncalves, J; Sanders, D; Webb, AAR				Dodd, Antony N.; Gardner, Michael J.; Hotta, Carlos T.; Hubbard, Katharine E.; Dalchau, Neil; Love, John; Assie, Jean-Maurice; Robertson, Fiona C.; Jakobsen, Mia Kyed; Goncalves, Jorge; Sanders, Dale; Webb, Alex A. R.			The Arabidopsis circadian clock incorporates a cADPR-based feedback loop	SCIENCE			English	Article							CYCLIC ADP-RIBOSE; FREE CALCIUM; OSCILLATIONS; RHYTHMS; CA2+; TRANSCRIPTION; EXPRESSION; CYCLASE; PLANTS	Transcriptional feedback loops are a feature of circadian clocks in both animals and plants. We show that the plant circadian clock also incorporates the cytosolic signaling molecule cyclic adenosine diphosphate ribose (cADPR). cADPR modulates the circadian oscillator's transcriptional feedback loops and drives circadian oscillations of Ca2+ release. The effects of antagonists of cADPR signaling, manipulation of cADPR synthesis, and mathematical simulation of the interaction of cADPR with the circadian clock indicate that cADPR forms a feedback loop within the plant circadian clock.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Cambridge; University of Cambridge; University of York - UK	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	alex.webb@plantsci.cam.ac.uk	Goncalves, Jorge M/GRN-8101-2022; Goncalves, Jorge/GYD-3756-2022; Rosa, Bruce/F-6393-2010; Hotta, Carlos Takeshi/G-9760-2012; Hubbard, Katharine/ABF-1833-2021; Dalchau, Neil/E-1323-2011	Goncalves, Jorge M/0000-0002-5228-6165; Hotta, Carlos Takeshi/0000-0003-3349-6121; Hubbard, Katharine/0000-0002-4862-0466; Dalchau, Neil/0000-0002-4872-6914; Webb, Alex/0000-0003-0261-4375	BBSRC [BB/E002692/1] Funding Source: UKRI; EPSRC [EP/E02761X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E02761X/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E002692/1, P19207] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Very AA, 2000, P NATL ACAD SCI USA, V97, P9801, DOI 10.1073/pnas.160250397; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	22	160	164	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1789	1792		10.1126/science.1146757	http://dx.doi.org/10.1126/science.1146757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18084825				2022-12-28	WOS:000251616800046
J	Komatsu, M; Waguri, S; Koike, M; Sou, Y; Ueno, T; Hara, T; Mizushima, N; Iwata, J; Ezaki, J; Murata, S; Hamazaki, J; Nishito, Y; Iemura, S; Natsume, T; Yanagawa, T; Uwayama, J; Warabi, E; Yoshida, H; Ishii, T; Kobayashi, A; Yamamoto, M; Yue, Z; Uchiyama, Y; Kominami, E; Tanaka, K				Komatsu, Masaaki; Waguri, Satoshi; Koike, Masato; Sou, Yu-shin; Ueno, Takashi; Hara, Taichi; Mizushima, Noboru; Iwata, Jun-ichi; Ezaki, Junji; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro; Kobayashi, Akira; Yamamoto, Masayuki; Yue, Zhenyu; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji			Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice	CELL			English	Article							BINDING PROTEIN P62; SYSTEM; AGGREGATION; DISSECTION; HUNTINGTIN; DISEASE	Inactivation of constitutive autophagy results in formation of cytoplasmic protein inclusions and leads to liver injury and neurodegeneration, but the details of abnormalities related to impaired autophagy are largely unknown. Here we used mouse genetic analyses to define the roles of autophagy in the aforementioned events. Were-port that the ubiquitin-and LC3-binding protein "p62'' regulates the formation of protein aggregates and is removed by autophagy. Thus, genetic ablation of p62 suppressed the appearance of ubiquitin-positive protein aggregates in hepatocytes and neurons, indicating that p62 plays an important role in inclusion body formation. Moreover, loss of p62 markedly attenuated liver injury caused by autophagy deficiency, whereas it had little effect on neuronal degeneration. Our findings highlight the unexpected role of homeostatic level of p62, which is regulated by autophagy, in controlling intracellular inclusion body formation, and indicate that the pathologic process associated with autophagic deficiency is cell-type specific.	[Komatsu, Masaaki; Sou, Yu-shin; Iwata, Jun-ichi; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Waguri, Satoshi; Sou, Yu-shin; Ueno, Takashi; Iwata, Jun-ichi; Ezaki, Junji; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Koike, Masato; Uchiyama, Yasuo] Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; [Hara, Taichi; Mizushima, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Hara, Taichi; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo 1138519, Japan; [Mizushima, Noboru] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr JBIRC, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO JST, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Tokyo Metropolitan Institute of Medical Science; Juntendo University; Japan Science & Technology Agency (JST); Fukushima Medical University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Natsume, Tohru/M-7627-2018; Kominami, Eiki/D-3802-2009; Koike, Masato/F-9584-2010; Kobayashi, Akira/AAN-8003-2020; Murata, Shigeo/A-1426-2010; Yanagawa, Toru/GYU-6448-2022; Mizushima, Noboru/C-3635-2009; hamazaki, jun/AAG-4823-2019; Komatsu, Masaaki/B-8321-2011; Yamamoto, Masayuki/A-4873-2010	Natsume, Tohru/0000-0002-1510-2582; Koike, Masato/0000-0002-3174-5684; Murata, Shigeo/0000-0002-3177-3503; Yanagawa, Toru/0000-0003-0868-2563; Mizushima, Noboru/0000-0002-6258-6444; hamazaki, jun/0000-0002-7145-3424; Komatsu, Masaaki/0000-0001-7672-7722; Yamamoto, Masayuki/0000-0002-9073-9436; Kobayashi, Akira/0000-0001-9727-1218; Sou, Yu-shin/0000-0002-7219-9106				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fortun J, 2003, J NEUROSCI, V23, P10672; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishii T, 1996, BIOCHEM BIOPH RES CO, V226, P456, DOI 10.1006/bbrc.1996.1377; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079	36	1660	1715	2	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1149	1163		10.1016/j.cell.2007.10.035	http://dx.doi.org/10.1016/j.cell.2007.10.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083104	Bronze			2022-12-28	WOS:000252217100022
J	Miller, CT; Beleza, S; Pollen, AA; Schluter, D; Kittles, RA; Shriver, MD; Kingsley, DM				Miller, Craig T.; Beleza, Sandra; Pollen, Alex A.; Schluter, Dolph; Kittles, Rick A.; Shriver, Mark D.; Kingsley, David M.			cis-regulatory changes in kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans	CELL			English	Article							MORPHOLOGICAL EVOLUTION; MELANOCYTE DEVELOPMENT; GENETIC ARCHITECTURE; SKIN PIGMENTATION; PELVIC REDUCTION; MICE; MUTATIONS; PATTERNS; COLOR; POPULATIONS	Dramatic pigmentation changes have evolved within most vertebrate groups, including fish and humans. Here we use genetic crosses in sticklebacks to investigate the parallel origin of pigmentation changes in natural populations. High-resolution mapping and expression experiments show that light gills and light ventrums map to a divergent regulatory allele of the Kit ligand (Kitlg) gene. The divergent allele reduces expression in gill and skin tissue and is shared by multiple derived freshwater populations with reduced pigmentation. In humans, Europeans and East Asians also share derived alleles at the KITLG locus. Strong signatures of selection map to regulatory regions surrounding the gene, and admixture mapping shows that the KITLG genomic region has a significant effect on human skin color. These experiments suggest that regulatory changes in Kitlg contribute to natural variation in vertebrate pigmentation, and that similar genetic mechanisms may underlie rapid evolutionary change in fish and humans.	[Miller, Craig T.; Pollen, Alex A.; Kingsley, David M.] Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; [Miller, Craig T.; Pollen, Alex A.; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Beleza, Sandra] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4250400 Oporto, Portugal; [Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Kittles, Rick A.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Universidade do Porto; University of British Columbia; University of British Columbia; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kingsley, DM (corresponding author), Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu	Miller, Craig/GWQ-5012-2022	Schluter, Dolph/0000-0003-1683-7836; Beleza, Sandra/0000-0002-7004-3431; Shriver, Mark/0000-0003-0006-0479	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [P50 HG002568, P50 HG002568-06, R01 HG002154-06] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568, R01HG002154] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bedell MA, 1996, GENETICS, V142, P935; BELL MA, 1994, EVOLUTION THREESPINE; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Boughman JW, 2005, EVOLUTION, V59, P361; *BROAD I, 2006, DRAFT STICKL GEN; Charlier C, 1996, MAMM GENOME, V7, P138, DOI 10.1007/s003359900034; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cott H. B., 1940, ADAPTIVE COLOURATION; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Fay JC, 2000, GENETICS, V155, P1405; Girvan JR, 1998, P ROY SOC B-BIOL SCI, V265, P913, DOI 10.1098/rspb.1998.0378; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Johnsen S, 2002, P ROY SOC B-BIOL SCI, V269, P243, DOI 10.1098/rspb.2001.1855; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kingsley David M., 2007, P41; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; MCPHAIL JD, 1969, J FISH RES BOARD CAN, V26, P3183, DOI 10.1139/f69-301; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; MOODIE GEE, 1972, HEREDITY, V28, P155, DOI 10.1038/hdy.1972.21; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; MOTRO B, 1991, DEVELOPMENT, V113, P1207; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rajaraman S, 2002, GENETICS, V162, P341; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com	58	268	270	4	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1179	1189		10.1016/j.cell.2007.10.055	http://dx.doi.org/10.1016/j.cell.2007.10.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083106	Green Accepted, Bronze			2022-12-28	WOS:000252217100024
J	Miura, H; Satoh, M; Nasuno, T; Noda, AT; Oouchi, K				Miura, Hiroaki; Satoh, Masaki; Nasuno, Tomoe; Noda, Akira T.; Oouchi, Kazuyoshi			A Madden-Julian Oscillation event realistically simulated by a global cloud-resolving model	SCIENCE			English	Article							PAPUA-NEW-GUINEA; TOGA-COARE-IOP; INTRASEASONAL VARIABILITY; EQUATORIAL WAVES; TROPICAL CLOUDS; DAY-PERIOD; CONVECTION; PARAMETERIZATION; DISTURBANCES; SENSITIVITY	A Madden-Julian Oscillation ( MJO) is a massive weather event consisting of deep convection coupled with atmospheric circulation, moving slowly eastward over the Indian and Pacific Oceans. Despite its enormous influence on many weather and climate systems worldwide, it has proven very difficult to simulate an MJO because of assumptions about cumulus clouds in global meteorological models. Using a model that allows direct coupling of the atmospheric circulation and clouds, we successfully simulated the slow eastward migration of an MJO event. Topography, the zonal sea surface temperature gradient, and interplay between eastward- and westward-propagating signals controlled the timing of the eastward transition of the convective center. Our results demonstrate the potential making of month- long MJO predictions when global cloud-resolving models with realistic initial conditions are used.	Japan Agcy Marine Earth Sci & Technol, Frontier Res Ctr Global Change, Kanazawa Ku, Kanagawa 2360001, Japan; Univ Tokyo, Ctr Climate Syst Res, Chiba 2778568, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo	Miura, H (corresponding author), Japan Agcy Marine Earth Sci & Technol, Frontier Res Ctr Global Change, Kanazawa Ku, 3173-25 Showamachi, Kanagawa 2360001, Japan.	miurah@jamstec.go.jp	Satoh, Masaki/G-3325-2015	Satoh, Masaki/0000-0003-3580-8897				ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; Grabowski WW, 1998, J ATMOS SCI, V55, P3264, DOI 10.1175/1520-0469(1998)055<3264:CRMOCS>2.0.CO;2; Grabowski WW, 2003, J ATMOS SCI, V60, P847, DOI 10.1175/1520-0469(2003)060<0847:MLCSSS>2.0.CO;2; HENDON HH, 1994, J GEOPHYS RES-ATMOS, V99, P8073, DOI 10.1029/94JD00045; Kerr RA, 2006, SCIENCE, V313, P1040, DOI 10.1126/science.313.5790.1040; Khairoutdinov M, 2005, J ATMOS SCI, V62, P2136, DOI 10.1175/JAS3453.1; Lin JL, 2006, J CLIMATE, V19, P2665, DOI 10.1175/JCLI3735.1; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Maloney ED, 2001, J CLIMATE, V14, P2015, DOI 10.1175/1520-0442(2001)014<2015:TSOIVI>2.0.CO;2; Masunaga H, 2006, J ATMOS SCI, V63, P2777, DOI 10.1175/JAS3783.1; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25, DOI [DOI 10.2151/JMSJ1965.44.1_25, 10.2151/jmsj1965.44.1_25]; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Miura H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023672; Miura H, 2007, MON WEATHER REV, V135, P4038, DOI 10.1175/2007MWR2101.1; Miura H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027448; NAKAZAWA T, 1988, J METEOROL SOC JPN, V66, P823, DOI 10.2151/jmsj1965.66.6_823; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; SATOH S, 1995, J METEOROL SOC JPN, V73, P443, DOI 10.2151/jmsj1965.73.2B_443; Slingo JM, 1996, CLIM DYNAM, V12, P325, DOI 10.1007/BF00231106; TAKAHASHI N, 1995, J METEOROL SOC JPN, V73, P427, DOI 10.2151/jmsj1965.73.2B_427; TAKAYABU YN, 1993, J METEOROL SOC JPN, V71, P221, DOI 10.2151/jmsj1965.71.2_221; TAKAYABU YN, 1994, J METEOROL SOC JPN, V72, P433; Tomita H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022459; Waliser DE, 2003, B AM METEOROL SOC, V84, P33, DOI 10.1175/BAMS-84-1-33; Wheeler M, 1999, J ATMOS SCI, V56, P374, DOI 10.1175/1520-0469(1999)056<0374:CCEWAO>2.0.CO;2; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158	27	286	292	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1763	1765		10.1126/science.1148443	http://dx.doi.org/10.1126/science.1148443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079399				2022-12-28	WOS:000251616800037
J	Hessa, T; Meindl-Beinker, NM; Bernsel, A; Kim, H; Sato, Y; Lerch-Bader, M; Nilsson, I; White, SH; von Heijne, G				Hessa, Tara; Meindl-Beinker, Nadja M.; Bernsel, Andreas; Kim, Hyun; Sato, Yoko; Lerch-Bader, Mirjam; Nilsson, IngMarie; White, Stephen H.; von Heijne, Gunnar			Molecular code for transmembrane-helix recognition by the Sec61 translocon	NATURE			English	Article							CHANNEL VOLTAGE SENSOR; MEMBRANE-PROTEIN; HYDROPHOBIC MISMATCH; CHARGED RESIDUES; ER MEMBRANE; INTEGRATION; DERIVATION; SEQUENCES; INSERTION; COMPLEX	Transmembrane alpha-helices in integral membrane proteins are recognized co-translationally and inserted into the membrane of the endoplasmic reticulum by the Sec61 translocon. A full quantitative description of this phenomenon, linking amino acid sequence to membrane insertion efficiency, is still lacking. Here, using in vitro translation of a model protein in the presence of dog pancreas rough microsomes to analyse a large number of systematically designed hydrophobic segments, we present a quantitative analysis of the position- dependent contribution of all 20 amino acids to membrane insertion efficiency, as well as of the effects of transmembrane segment length and flanking amino acids. The emerging picture of translocon- mediated transmembrane helix assembly is simple, with the critical sequence characteristics mirroring the physical properties of the lipid bilayer.	Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; Stockholm Univ, AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA	Stockholm University; Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	White, Stephen H/B-1053-2009; von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019; Nilsson, IngMarie/H-2887-2012; White, Stephen/N-1507-2019	White, Stephen H/0000-0001-8540-7907; von Heijne, Gunnar/0000-0002-4490-8569; 				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Meindl-Beinker NM, 2006, EMBO REP, V7, P1111, DOI 10.1038/sj.embor.7400818; Monne M, 2001, FEBS LETT, V496, P96, DOI 10.1016/S0014-5793(01)02415-2; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Sadlish H, 2004, J MEMBRANE BIOL, V202, P115, DOI 10.1007/s00232-004-0715-6; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; SIMLEY WC, 1996, BIOCHEMISTRY-US, V35, P5109; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	30	520	526	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1026	U2		10.1038/nature06387	http://dx.doi.org/10.1038/nature06387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075582				2022-12-28	WOS:000251579900075
J	Liu, V; Cutler, CS; Young, AZ				Liu, Vincent; Cutler, Corey S.; Young, Alison Z.			A woman with generalized, ulcerated skin lesions - Aggressive epidermotropic CD8+cytotoxic cutaneous T-cell lymphoma, with pseudoepitheliomatous epidermal hyperplasia, possibly paraneoplastic	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSPLANTATION; CARCINOMA		Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Dermatol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA USA; Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	University of Iowa; University of Iowa; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Liu, V (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Dermatol, Iowa City, IA 52242 USA.							AGNARSSON BA, 1990, J AM ACAD DERMATOL, V22, P569, DOI 10.1016/0190-9622(90)70074-R; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Berti E, 1999, AM J PATHOL, V155, P483, DOI 10.1016/S0002-9440(10)65144-9; Courville P, 1999, BRIT J DERMATOL, V140, P421; Daldon PEC, 2003, J CUTAN PATHOL, V30, P443, DOI 10.1034/j.1600-0560.2003.00082.x; Herbert KE, 2004, BONE MARROW TRANSPL, V34, P521, DOI 10.1038/sj.bmt.1704641; Isaacson PG, 2005, J PATHOL, V205, P255, DOI 10.1002/path.1703; JABER PW, 1993, J AM ACAD DERMATOL, V29, P299, DOI 10.1016/0190-9622(93)70180-2; LeBoit PE, 2006, WHO CLASSIFICATION T; Lu D, 2003, J CUTAN PATHOL, V30, P222; MCKEE PH, 1981, HISTOPATHOLOGY, V5, P425, DOI 10.1111/j.1365-2559.1981.tb01803.x; Molina A, 2005, J CLIN ONCOL, V23, P6163, DOI 10.1200/JCO.2005.02.774; Oyama Y, 2003, HEMATOL ONCOL CLIN N, V17, P1475, DOI 10.1016/S0889-8588(03)00114-X; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502	14	15	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2496	2505		10.1056/NEJMcpc0706687	http://dx.doi.org/10.1056/NEJMcpc0706687			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077814				2022-12-28	WOS:000251564400013
J	Pal, C; Macia, MD; Oliver, A; Schachar, I; Buckling, A				Pal, Csaba; Macia, Maria D.; Oliver, Antonio; Schachar, Ira; Buckling, Angus			Coevolution with viruses drives the evolution of bacterial mutation rates	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ASEXUAL POPULATIONS; ADAPTIVE EVOLUTION; LOCAL ADAPTATION; HIGH-FREQUENCY; GENES; INFECTION; PARASITES; MUTANTS	Bacteria with greatly elevated mutation rates ( mutators) are frequently found in natural(1-3) and laboratory(4,5) populations, and are often associated with clinical infections(6,7). Although mutators may increase adaptability to novel environmental conditions, they are also prone to the accumulation of deleterious mutations. The long-term maintenance of high bacterial mutation rates is therefore likely to be driven by rapidly changing selection pressures(8-14), in addition to the possible slow transition rate by point mutation from mutators to non- mutators(15). One of the most likely causes of rapidly changing selection pressures is antagonistic coevolution with parasites(16,17). Here we show whether coevolution with viral parasites could drive the evolution of bacterial mutation rates in laboratory populations of the bacterium Pseudomonas fluorescens(18). After fewer than 200 bacterial generations, 25% of the populations coevolving with phages had evolved 10- to 100- fold increases in mutation rates owing to mutations in mismatch-repair genes; no populations evolving in the absence of phages showed any significant change in mutation rate. Furthermore, mutator populations had a higher probability of driving their phage populations extinct, strongly suggesting that mutators have an advantage against phages in the coevolutionary arms race. Given their ubiquity, bacteriophages may play an important role in the evolution of bacterial mutation rates.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; IUNICS, Hosp Son Dureta, Microbiol Serv, Palma de Mallorca 07014, Spain; IUNICS, Hosp Son Dureta, Unidad Invest, Palma de Mallorca 07014, Spain	University of Oxford; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears	Buckling, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	cpal@ramet.elte.hu; angus.buckling@zoo.ox.ac.uk	Oliver, Antonio/E-4048-2012; Oliver, Antonio/V-5541-2019; Sandstedt, Sara A/A-3001-2010	Oliver, Antonio/0000-0001-9327-1894; Oliver, Antonio/0000-0001-9327-1894; Buckling, Angus/0000-0003-1170-4604; Macia, Maria Dolores/0000-0001-5038-1356	NERC [NE/D014115/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014115/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agrawal A, 2002, EVOL ECOL RES, V4, P79; Andre JB, 2006, GENETICS, V172, P611, DOI 10.1534/genetics.105.046680; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Denamur E, 2002, J BACTERIOL, V184, P605, DOI 10.1128/JB.184.2.605-609.2002; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; ISHII K, 1989, GENETICS, V121, P163; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; Luria SE, 1943, GENETICS, V28, P491; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Morgan AD, 2006, J EVOLUTION BIOL, V19, P1956, DOI 10.1111/j.1420-9101.2006.01148.x; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Palmer ME, 2006, GENETICS, V173, P461, DOI 10.1534/genetics.105.049445; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tanaka MM, 2003, GENETICS, V164, P843; Tenaillon O, 1999, GENETICS, V152, P485; Trong HNG, 2005, ANTIMICROB AGENTS CH, V49, P2098, DOI 10.1128/AAC.49.5.2098-2101.2005; West SA, 1999, J EVOLUTION BIOL, V12, P1003	30	216	219	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1079	1081		10.1038/nature06350	http://dx.doi.org/10.1038/nature06350			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18059461				2022-12-28	WOS:000251579900086
J	Grafton, RQ; Kompas, T; Hilborn, RW				Grafton, R. Q.; Kompas, T.; Hilborn, R. W.			Economics of overexploitation revisited	SCIENCE			English	Article									Australian Natl Univ, Crawford Sch, Canberra, ACT 0200, Australia; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Australian National University; University of Washington; University of Washington Seattle	Grafton, RQ (corresponding author), Australian Natl Univ, Crawford Sch, Ellery Crescent, Canberra, ACT 0200, Australia.	quentin.grafton@anu.edu.au	Grafton, Quentin/AAS-2316-2021; Grafton, Quentin/A-5277-2008; Hilborn, Ray W/D-6332-2013; Kompas, Tom/M-8851-2019; Kompas, T/F-5930-2010	Grafton, Quentin/0000-0002-0048-9083; Grafton, Quentin/0000-0002-0048-9083; Kompas, Tom/0000-0002-0665-0966; Kompas, T/0000-0002-0665-0966				CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; CLARK CW, 1975, J ENVIRON ECON MANAG, V2, P92, DOI 10.1016/0095-0696(75)90002-9; FAO, 2007, STAT WORLD FISH AQ 2; GRAFTON RQ, 1995, J ENVIRON ECON MANAG, V28, P48, DOI 10.1006/jeem.1995.1004; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Hannesson R, 2007, MAR RESOUR ECON, V22, P69, DOI 10.1086/mre.22.1.42629536; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Judd Kenneth, 1999, NUMERICAL METHODS EC; [No title captured]	9	160	164	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1601	1601		10.1126/science.1146017	http://dx.doi.org/10.1126/science.1146017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063793				2022-12-28	WOS:000251421700039
J	Tauber, E; Kollaritsch, H; Korinek, M; Rendi-Wagner, P; Jilma, B; Firbas, C; Schranz, S; Jong, E; Klingler, A; Dewasthaly, S; Klade, CS				Tauber, E.; Kollaritsch, H.; Korinek, M.; Rendi-Wagner, P.; Jilma, B.; Firbas, C.; Schranz, S.; Jong, E.; Klingler, A.; Dewasthaly, S.; Klade, C. S.			Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial	LANCET			English	Article							LIVE FLAVIVIRUS VACCINES; B-ENCEPHALITIS; COMPLICATIONS; SA14-14-2; EFFICACY; POINTS	Background Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in southeast Asia. Although no treatment is currently available, vaccination effectively prevents the disease. In a non-inferiority study, we aimed to compare the safety and immunogenicity of a novel, second-generation, inactivated candidate vaccine for JEV with a licensed, mouse-brain-derived vaccine. Methods We included 867 adults in a multicentre, multinational, observer-blinded, randomised controlled phase III trial. Study sites were located in the USA, Germany, and Austria. Volunteers received either the JEV test vaccine intramuscularly on a two-dose schedule (on days 0 and 28; n=430) or the licensed vaccine subcutaneously according to its recommended three-dose schedule (on days 0, 7, and 28; n=437). The primary endpoint was immunogenicity, with respect to neutralising JEV-specific antibodies assessed by a plaque-reduction neutralisation test, which was assessable in 725 patients in the per-protocol population. This trial is registered as a clinical trial, EudraCT number 2004-002474-36. Findings The safety profile of the test vaccine was good, and its local tolerability profile was more favourable than that of the licensed vaccine. Frequency of adverse events was similar between treatment groups, and vaccine-related adverse events were generally mild. The seroconversion rate of the test vaccine was 98% compared with 95% for the licensed vaccine on day 56 (95% CI for the difference -1.33 to 3.43). Geometric mean titre for recipients of the test vaccine was 244 (range 5-19783), compared with 102 (5-1864) for the licensed vaccine (ratio 2.3 [95% CI 1.967-2.75]). Interpretation The test JEV vaccine has a promising immunogenicity and safety profile.	Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria; Med Univ Vienna, Ctr Physiol & Pathophysiol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; Univ Washington, Dept Med, Seattle, WA USA; Med Univ Innsbruck, Dept Gen & Transplant Surg, Theoret Surg Unit, Innsbruck, Austria; Intercell AG, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Washington; University of Washington Seattle; Medical University of Innsbruck; Intercell	Jilma, B (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria.	Bernd.Jilma@meduniwien.ac.at		Kollaritsch, Herwig/0000-0001-6393-516X; Jilma, Bernd/0000-0001-5652-7977; Tauber, Erich/0000-0001-8042-2403				Ahmad K, 2002, LANCET, V360, P395, DOI 10.1016/S0140-6736(02)09628-9; ANDERSEN MM, 1991, LANCET, V337, P1044, DOI 10.1016/0140-6736(91)92707-9; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0; *CDC, IN JAP ENC VIR VACC; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; HAMMON WMD, 1973, AM J TROP MED HYG, V22, P524, DOI 10.4269/ajtmh.1973.22.524; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Hombach J, 2004, LANCET, V364, P498, DOI 10.1016/S0140-6736(04)16800-1; Liu ZL, 1997, J INFECT DIS, V176, P1366, DOI 10.1086/517323; Lyons A, 2007, VACCINE, V25, P3445, DOI 10.1016/j.vaccine.2006.12.046; Marfin AA, 2005, INFECT DIS CLIN N AM, V19, P151, DOI 10.1016/j.idc.2004.11.004; Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Monnet FP, 2003, EUR PSYCHIAT, V18, P269, DOI 10.1016/j.eurpsy.2003.09.001; Ohrr H, 2005, LANCET, V366, P1375, DOI 10.1016/S0140-6736(05)67567-8; Ostlund MR, 2004, SCAND J INFECT DIS, V36, P512, DOI 10.1080/00365540410020640; OYA A, 1988, Acta Paediatrica Japonica, V30, P175; Parida M, 2006, EMERG INFECT DIS, V12, P1427, DOI 10.3201/eid1209.060200; Plesner AM, 1996, LANCET, V348, P202, DOI 10.1016/S0140-6736(05)66156-9; Robinson H C, 1991, Can Dis Wkly Rep, V17, P173; RUFF TA, 1991, LANCET, V338, P881, DOI 10.1016/0140-6736(91)91531-X; Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3; Shlim DR, 2002, CLIN INFECT DIS, V35, P183, DOI 10.1086/341247; Solomon T, 2004, INFECT CENTRAL NERVO; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Tsai YB, 2000, EARTHQ ENG ENG SEISM, V2, P1; World Health Organization, 2005, WKLY EPIDEMIOL REC, V80, P241; World Health Organization (WHO), 2007, WKLY EPIDEMIOL REC, V82, P17	32	131	139	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1847	1853		10.1016/S0140-6736(07)61780-2	http://dx.doi.org/10.1016/S0140-6736(07)61780-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061060				2022-12-28	WOS:000251588700031
J	Eswaramoorthy, SK; Howe, JM; Muralidharan, G				Eswaramoorthy, Santhana K.; Howe, James M.; Muralidharan, Govindarajan			In situ determination of the nanoscale chemistry and behavior of solid-liquid systems	SCIENCE			English	Article							ELECTRON-MICROSCOPY; ALLOY PARTICLES; INTERFACE; GROWTH; TEMPERATURE; KINETICS	Many fundamental questions in crystal-growth behavior remain unanswered because of the difficulties encountered in simultaneously observing phases and determining elemental concentrations and redistributions while crystals nucleate and grow at the nanoscale. We show that these obstacles can be overcome by performing energy-dispersive x-ray spectroscopy on partially molten Al-Si-Cu-Mg alloy particles during in situ heating in a transmission electron microscope. Using this technique, we were able to (i) determine that the aluminum and silicon concentrations change in a complementary and symmetric manner about the solid-liquid interface as a function of temperature; (ii) directly measure the solid- and liquid-phase compositions at equilibrium and in highly undercooled conditions for quantitative comparison with thermodynamic calculations of the liquidus and solidus phase boundaries; and (iii) provide direct evidence for homogeneous nucleation of the aluminum-rich solid.	Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22904 USA; Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	University of Virginia; United States Department of Energy (DOE); Oak Ridge National Laboratory	Howe, JM (corresponding author), Univ Virginia, Dept Mat Sci & Engn, 140 Chem Dr, Charlottesville, VA 22904 USA.	jh9s@virginia.edu	Eswara, Santhana/E-9143-2010; Muralidharan, Govindarajan/J-6155-2015	Eswara, Santhana/0000-0003-4151-2304; 				Arai S, 1999, J ELECTRON MICROSC, V48, P317, DOI 10.1093/oxfordjournals.jmicro.a023683; BYRAPPA K, 2003, CRYSTAL GROWTH TECHN; Chang J, 2005, PHIL MAG LETT, V85, P247, DOI 10.1080/09500830500229550; Das SK, 2001, MAT SCI ENG A-STRUCT, V304, P159, DOI 10.1016/S0921-5093(00)01483-0; Daulton TL, 2002, J MICROBIOL METH, V50, P39, DOI 10.1016/S0167-7012(02)00013-1; Donnelly SE, 2002, SCIENCE, V296, P507, DOI 10.1126/science.1068521; Dreybrodt W, 1999, BOREAS, V28, P347, DOI 10.1111/j.1502-3885.1999.tb00224.x; Eswaramoorthy SK, 2007, MICROSC MICROANAL, V13, P291, DOI 10.1017/S1431927607070699; Flemings MC., 1974, SOLIDIFICATION PROCE; Jackson KA, 2002, INTERFACE SCI, V10, P159, DOI 10.1023/A:1015824230008; Jackson KA, 1958, LIQUID METALS SOLIDI; Johnson E, 2002, SCIENCE, V296, P477, DOI 10.1126/science.1070400; King WE, 2005, J APPL PHYS, V97, DOI 10.1063/1.1927699; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Liu RP, 2004, METALL MATER TRANS A, V35A, P607, DOI 10.1007/s11661-004-0372-5; Lupis C., 1983, CHEM THERMODYN, P169; Mondolfo L., 1976, ALUMINIUM ALLOYS, P368, DOI [10.1016/b978-0-408-70932-3.50079-6, DOI 10.1016/B978-0-408-70932-3.50079-6]; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; Pennycook SJ, 2006, MRS BULL, V31, P36, DOI 10.1557/mrs2006.4; RAPPAZ M, 2004, SOLIDIFICATION PROCE; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; RHINES FN, 1956, PHASE DIAGRAMS METAL, P5; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Storaska GA, 2004, PHILOS MAG, V84, P2619, DOI 10.1080/14786430410001671395; Storaska GA, 2004, MAT SCI ENG A-STRUCT, V368, P183, DOI 10.1016/j.msea.2003.10.315; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; Tiller W. A., 1991, SCI CRYSTALLIZATION; TURNBULL D, 1950, J APPL PHYS, V21, P804, DOI 10.1063/1.1699763; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yokota T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265504	30	49	51	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1437	1440		10.1126/science.1146511	http://dx.doi.org/10.1126/science.1146511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048685				2022-12-28	WOS:000251246100041
J	Nowacki, M; Vijayan, V; Zhou, Y; Schotanus, K; Doak, TG; Landweber, LF				Nowacki, Mariusz; Vijayan, Vikram; Zhou, Yi; Schotanus, Klaas; Doak, Thomas G.; Landweber, Laura F.			RNA-mediated epigenetic programming of a genome-rearrangement pathway	NATURE			English	Article							INTERNAL ELIMINATED SEGMENTS; NON-MENDELIAN INHERITANCE; DNA-POLYMERASE-ALPHA; DOUBLE-STRAND BREAKS; PARAMECIUM-TETRAURELIA; BINDING-PROTEIN; GENE; EVOLUTION; RECOMBINATION; INFORMATION	Genome- wide DNA rearrangements occur in many eukaryotes but are most exaggerated in ciliates, making them ideal model systems for epigenetic phenomena. During development of the somatic macronucleus, Oxytricha trifallax destroys 95% of its germ line, severely fragmenting its chromosomes, and then unscrambles hundreds of thousands of remaining fragments by permutation or inversion. Here we demonstrate that DNA or RNA templates can orchestrate these genome rearrangements in Oxytricha, supporting an epigenetic model for sequence- dependent comparison between germline and somatic genomes. A complete RNA cache of the maternal somatic genome may be available at a specific stage during development to provide a template for correct and precise DNA rearrangement. We show the existence of maternal RNA templates that could guide DNA assembly, and that disruption of specific RNA molecules disables rearrangement of the corresponding gene. Injection of artificial templates reprogrammes the DNA rearrangement pathway, suggesting that RNA molecules guide genome rearrangement.	[Nowacki, Mariusz; Zhou, Yi; Schotanus, Klaas; Doak, Thomas G.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Vijayan, Vikram] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Vijayan, Vikram/0000-0003-3948-7568; Doak, Thomas/0000-0001-5487-553X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059708-07, R01 GM059708, R01 GM059708-08, R01 GM059708-06, R01 GM059708-05A1, R01 GM059708-06S1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chang WJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-6; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; DERR LK, 1993, NATURE, V361, P170, DOI 10.1038/361170a0; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Herbert A, 1999, NAT GENET, V21, P265, DOI 10.1038/6780; Hoffman DC, 1997, NUCLEIC ACIDS RES, V25, P1883, DOI 10.1093/nar/25.10.1883; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; King ML, 2005, BIOL CELL, V97, P19; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Landweber LF, 2000, P NATL ACAD SCI USA, V97, P3298, DOI 10.1073/pnas.040574697; LAUGHLIN TJ, 1983, J PROTOZOOL, V30, P63, DOI 10.1111/j.1550-7408.1983.tb01035.x; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Lolle SJ, 2006, NATURE, V443, pE8, DOI 10.1038/nature05252; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Mayer KM, 1999, GENETICS, V151, P597; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MOLLENBECK M, UNPUB PLOS BIOL; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; NevoCaspi Y, 1997, CURR GENET, V32, P32, DOI 10.1007/s002940050245; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paschka AG, 2003, EUR J PROTISTOL, V39, P449, DOI 10.1078/0932-4739-00019; Peng P, 2006, NATURE, V443, pE8, DOI 10.1038/nature05251; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Prescott JD, 1998, CHROMOSOMA, V107, P293, DOI 10.1007/s004120050311; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737	37	204	213	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					153	U4		10.1038/nature06452	http://dx.doi.org/10.1038/nature06452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18046331	Green Accepted			2022-12-28	WOS:000252214400034
J	Ramagopalan, SV; Knight, M; Ebers, GC; Knight, JC				Ramagopalan, Sreeram V.; Knight, Marian; Ebers, George C.; Knight, Julian C.			Origins of magic: review of genetic and epigenetic effects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMON VARIANT; HARRY-POTTER; CHILDHOOD; ADULT	Objective To assess the evidence for a genetic basis to magic. Design Literature review. Setting Harry Potter novels of J K Rowling. Participants Muggles, witches, wizards, and squibs. Interventions Limited. Main outcome measures Family and twin studies, magical ability, and specific magical skills. Results Magic shows strong evidence of heritability, with familial aggregation and concordance in twins. Evidence suggests magical ability to be a quantitative trait. Specific magical skills, notably being able to speak to snakes, predict the future, and change hair colour, all seem heritable. Conclusions A multilocus model with a dominant gene for magic might exist, controlled epistatically by one or more loci, possibly recessive in nature. Magical enhancers regulating gene expression may be involved, combined with mutations at specific genes implicated in speech and hair colour such as FOXP2 and MCR1.	[Ramagopalan, Sreeram V.; Ebers, George C.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Dept Clin Neurol, Oxford OX1 2JD, England; [Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Knight, JC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	julian@well.ox.ac.uk	Knight, Julian/C-7242-2009; Knight, Julian Charles/W-2399-2019; Knight, Marian/B-6225-2009	Knight, Julian/0000-0002-0377-5536; Knight, Julian Charles/0000-0002-0377-5536; Knight, Marian/0000-0002-1984-4575; Ebers, George/0000-0003-4771-4177	Wellcome Trust [074318] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Craig JM, 2005, NATURE, V436, P776, DOI 10.1038/436776a; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Dodd AN, 2005, NATURE, V437, P318, DOI 10.1038/437318d; Falconer D. S., 1989, Introduction to quantitative genetics.; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Rowling J., 2005, H POTTER HALF BLOOD; Rowling J.K., 2003, H POTTER ORDER PHOEN; Rowling J.K., 1997, HARRY POTTER PHILOS; Rowling J.K., 1998, HARRY POTTER CHAMBER; Rowling J.K, 2007, HARRY POTTER DEATHLY; ROWLING JK, 2000, H POTTER GOBLET FIRE; ROWLING JK, 1999, H POTTER PRISONER A; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121	22	2	3	2	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1299	1301		10.1136/bmj.39414.582639.BE	http://dx.doi.org/10.1136/bmj.39414.582639.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156238	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252182700019
J	Tumer, EC; Brainard, MS				Tumer, Evren C.; Brainard, Michael S.			Performance variability enables adaptive plasticity of 'crystallized' adult birdsong	NATURE			English	Article							AUDITORY-FEEDBACK; ZEBRA FINCH; SENSORIMOTOR CONTROL; SONG; MODEL; MAINTENANCE; FOREBRAIN; CONTEXT; LESIONS; PERTURBATION	Significant trial- by- trial variation persists even in the most practiced skills. One prevalent view is that such variation is simply 'noise' that the nervous system is unable to control or that remains below threshold for behavioural relevance(1-3). An alternative hypothesis is that such variation enables trial- and- error learning, in which the motor system generates variation and differentially retains behaviours that give rise to better outcomes. Here we test the latter possibility for adult bengalese finch song. Adult bird-song is a complex, learned motor skill that is produced in a highly stereotyped fashion from one rendition to the next(4,5). Nevertheless, there is subtle trial- by- trial variation even in stable, 'crystallized' adult song(6-8). We used a computerized system to monitor small natural variations in the pitch of targeted song elements and deliver real- time auditory disruption to a subset of those variations. Birds rapidly shifted the pitch of their vocalizations in an adaptive fashion to avoid disruption. These vocal changes were precisely restricted to the targeted features of song. Hence, birds were able to learn effectively by associating small variations in their vocal behaviour with differential outcomes. Such a process could help to maintain stable, learned song despite changes to the vocal control system arising from ageing or injury. More generally, our results suggest that residual variability in well learned skills is not entirely noise but rather reflects meaningful motor exploration that can support continuous learning and optimization of performance.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tumer, EC (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Dept Physiol, San Francisco, CA 94143 USA.	evren@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907	NIDCD NIH HHS [R01 DC006636] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Amir O, 2003, J ACOUST SOC AM, V113, P1102, DOI 10.1121/1.1536632; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Dent ML, 2000, J ACOUST SOC AM, V107, P2657, DOI 10.1121/1.428651; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya Kenji, 2000, P469; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HELD R, 1966, J EXP PSYCHOL, V72, P887, DOI 10.1037/h0023868; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Okanoya K, 1997, J NEUROBIOL, V33, P343; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Sundberg J, 1996, VOCAL FOLD, P291; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zevin JD, 2004, J NEUROSCI, V24, P5849, DOI 10.1523/JNEUROSCI.1891-04.2004	32	278	283	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1240	U11		10.1038/nature06390	http://dx.doi.org/10.1038/nature06390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097411				2022-12-28	WOS:000251786200052
J	Lauer, MS; Pothier, CE; Magid, DJ; Smith, SS; Kaftan, MW				Lauer, Michael S.; Pothier, Claire E.; Magid, David J.; Smith, S. Scott; Kaftan, Michael W.			An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-RATE RECOVERY; ALL-CAUSE MORTALITY; PROGNOSTIC VALUE; SCORE; SYMPTOMS; DEATH	Background: The exercise treadmill test is recommended for risk stratification among patients with intermediate to high pretest probability of coronary artery disease. Posttest risk stratification is based on the Duke treadmill score, which includes only functional capacity and measures of ischemia. Objective: To develop and externally validate a post-treadmill test, multivariable mortality prediction rule for adults with suspected coronary artery disease and normal electrocardiograms. Design: Prospective cohort study conducted from September 1990 to May 2004. Setting: Exercise treadmill laboratories in a major medical center (derivation set) and a separate HMO (validation set). Patients: 33 268 patients in the derivation set and 5821 in the validation set. All patients had normal electrocardiograms and were referred for evaluation of suspected coronary artery disease. Measurements: The derivation set patients were followed for a median of 6.2 years. A nomogram-illustrated model was derived on the basis of variables easily obtained in the stress laboratory, including age; sex; history of smoking, hypertension, diabetes, or typical angina; and exercise findings of functional capacity, ST-segment changes, symptoms, heart rate recovery, and frequent ventricular ectopy in recovery. Results: The derivation data set included 1619 deaths. Although both the Duke treadmill score and our nomogram-illustrated model were significantly associated with death (P < 0.001), the nomogram was better at discrimination (concordance index for right-censored data, 0.83 vs. 0.73) and calibration. We reclassified many patients with intermediate- to high-risk Duke treadmill scores as low risk on the basis of the nomogram. The model also predicted 3-year mortality rates well in the validation set: Based on an optimal cut-point for a negative predictive value of 0.97, derivation and validation rates were, respectively, 1.7% and 2.5% below the cut-point and 25% and 29% above the cut-point. Limitations: Blood test-based measures or left ventricular ejection fraction were not included. The nomogram can be applied only to patients with a normal electrocardiogram. Clinical utility remains to be tested. Conclusion: A simple nomogram based on easily obtained pretest and exercise test variables predicted all-cause mortality in adults with suspected coronary artery disease and normal electrocardiograms.	[Lauer, Michael S.; Pothier, Claire E.; Magid, David J.; Smith, S. Scott; Kaftan, Michael W.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Lauer, Michael S.; Pothier, Claire E.; Magid, David J.; Smith, S. Scott; Kaftan, Michael W.] Cleveland Clin Fdn, Cleveland, OH USA; [Lauer, Michael S.; Pothier, Claire E.; Magid, David J.; Smith, S. Scott; Kaftan, Michael W.] NHLBI, Bethesda, MD USA; [Lauer, Michael S.; Pothier, Claire E.; Magid, David J.; Smith, S. Scott; Kaftan, Michael W.] Kaiser Permanente, Denver, CO USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaiser Permanente	Lauer, MS (corresponding author), NHLBI, Div Prevent & Populat Sci, 6701 Rockledge Dr, Bethesda, MD 20892 USA.	lauerm@nhlbi.nih.gov	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Kattan, Michael/0000-0002-3840-4161	NHLBI NIH HHS [HL66004, HL072771] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004, R01HL072771] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Chen MS, 2004, CIRCULATION, V110, P2851, DOI 10.1161/01.CIR.0000147539.39775.F4; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; COX DR, 1972, J R STAT SOC B, V34, P187; Fearon WF, 2002, CLIN CARDIOL, V25, P117, DOI 10.1002/clc.4960250307; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Gibbons RJ, 2002, LANCET, V359, P1536, DOI 10.1016/S0140-6736(02)08525-2; Goraya TY, 2000, ANN INTERN MED, V132, P862, DOI 10.7326/0003-4819-132-11-200006060-00003; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ho KT, 2002, MAYO CLIN PROC, V77, P515, DOI 10.4065/77.6.515; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Jones RC, 2004, AM J MED, V117, P380, DOI 10.1016/j.amjmed.2004.06.004; Khan MA, 1998, HEART, V79, P262, DOI 10.1136/hrt.79.3.262; Kligfield P, 2006, CIRCULATION, V114, P2070, DOI 10.1161/CIRCULATIONAHA.105.561944; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; Lauer M, 2005, CIRCULATION, V112, P771, DOI 10.1161/CIRCULATIONAHA.105.166543; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 2003, JAMA-J AM MED ASSOC, V289, P2575, DOI 10.1001/jama.289.19.2575; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Morise AP, 2003, J AM COLL CARDIOL, V42, P842, DOI 10.1016/S0735-1097(03)00837-4; MORRIS CK, 1993, AM HEART J, V125, P1717, DOI 10.1016/0002-8703(93)90764-Z; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Prakash M, 2001, CHEST, V120, P1003, DOI 10.1378/chest.120.3.1003; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911	30	57	61	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					821	828		10.7326/0003-4819-147-12-200712180-00001	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087052				2022-12-28	WOS:000251787600001
J	Korponay-Szabo, IR; Szabados, K; Pusztai, J; Uhrin, K; Ludmany, E; Nemes, E; Kaukinen, K; Kapitany, A; Koskinen, L; Sipka, S; Imre, A; Maki, M				Korponay-Szabo, Ilma R.; Szabados, Katalin; Pusztai, Janosne; Uhrin, Katalin; Ludmany, Eva; Nemes, Eva; Kaukinen, Katri; Kapitany, Aniko; Koskinen, Lotta; Sipka, Sandor; Imre, Aniko; Maki, Markku			Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORTH-AMERICAN POPULATIONS; TRANSGLUTAMINASE; PREVALENCE; CHILDREN; RISK; GLUTEN	Objective To evaluate the feasibility and diagnostic accuracy of screening for coeliac disease by rapid detection of IgA antibodies to tissue transglutaminase performed in primary care. Design District nurses screened 6 year old children using rapid antibody testing of finger prick blood. They also collected capillary blood samples for laboratory determination of IgA and IgG antibodies to endomysium and IgA antibodies to tissue transglutaminase. Children with positive rapid test results were directly sent for biopsy of the small intestine. Setting Primary care in Jasz-Nagykun-Szolnok county, Hungary. Participants 2690 children (77% of 6 year olds living in the county) and 120 nurses. Main outcome measures Positivity for antibodies to endomysium or transglutaminase in the laboratory and coeliac disease confirmed at biopsy. Results 37 children (1.4%, 95% confidence interval 0.9% to 1.8%) had biopsy confirmed coeliac disease. Only five of these children had been diagnosed clinically before screening. Rapid testing had a 78.1% sensitivity (70.0% to 89.3%) and 100% specificity (88.4% to 100%) for a final diagnosis of coeliac disease by biopsy. Sensitivity was 65.1% (50.2% to 77.6%) and specificity was 100% (99.8% to 100%) compared with combined results of IgA and IgG laboratory tests. Trained laboratory workers detected 30 of the 31 newly diagnosed IgA competent patients with the rapid test kit used blindly. Median time to biopsy after a positive rapid test result was significantly shorter (20 days, range 4-148) than after a positive laboratory result (142 days, 70-256; P<0.001). Children with coeliac disease detected at screening were smaller and had worse health status than their peers but they improved on a gluten-free diet. ConclusionsA simple rapid antibody test enabled primary care nurses to detect patients with coeliac disease in the community who were not picked up in clinical care. Extra training is needed to improve sensitivity.	Tampere Univ Hosp & Med Sch, Paediat Res Ctr, Tampere 33014, Finland; Univ Debrecen, Dept Paediat, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; Heim Pal Childrens Hosp, Coeliac Dis Ctr, H-1089 Budapest, Hungary; Hetenyi Geza Cty Hosp, Dept Infectol, H-5000 Szolnok, Hungary; Cty Inst Publ Hlth & Hlth Officer Serv, H-5000 Szolnok, Hungary; Hetenyi Geza Cty Hosp, Dept Pathol, H-5000 Szolnok, Hungary; Tampere Univ Hosp & Med Sch, Dept Gastroenterol & Alimentary Tract Surg, Tampere 33014, Finland; Univ Debrecen, Reg Immunol Lab, Dept Internal Med 3, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; Univ Helsinki, Dept Med Genet, Biomed Helsinki, FIN-00014 Helsinki, Finland	Tampere University; Tampere University Hospital; University of Debrecen; Tampere University; Tampere University Hospital; University of Debrecen; University of Helsinki	Maki, M (corresponding author), Tampere Univ Hosp & Med Sch, Paediat Res Ctr, Tampere 33014, Finland.	markku.maki@uta.fi	Korponay-Szabó, Ilma/AFK-1690-2022; Korponay-Szabó, Ilma/AAF-9048-2022; Korponay-Szabó, Ilma/A-7287-2008					Berti I, 2006, DIGEST LIVER DIS, V38, P461, DOI 10.1016/j.dld.2005.12.007; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; CORRAO G, 1994, GUT, V35, P771, DOI 10.1136/gut.35.6.771; DARVAY S, 1997, REFERENCE VALUES INV; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2003, GUT, V52, P168, DOI 10.1136/gut.52.2.168; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; Korponay-Szabo IB, 1998, Z GASTROENTEROL, V36, P553; Korponay-Szabo IR, 2005, ALIMENT PHARM THER, V22, P729, DOI 10.1111/j.1365-2036.2005.02663.x; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Korponay-Szabo IR, 1999, J PEDIATR GASTR NUTR, V28, P26, DOI 10.1097/00005176-199901000-00008; Kumar PJ, 2003, GUT, V52, P170, DOI 10.1136/gut.52.2.170; Lahdeaho ML, 2005, J PEDIATR GASTR NUTR, V41, P44; Landgraf JM., 1999, CHQ USERS MANUAL; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; Nemec G, 2006, AM J GASTROENTEROL, V101, P1597, DOI 10.1111/j.1572-0241.2006.00597.x; Orban I, 2001, CLIN EXP RHEUMATOL, V19, pS81; Raivio T, 2006, ALIMENT PHARM THER, V24, P147, DOI 10.1111/j.1365-2036.2006.02957.x; Ravikumara M, 2007, J PEDIATR GASTR NUTR, V45, P497, DOI 10.1097/MPG.0b013e31812e5710; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; Simell S, 2005, SCAND J GASTROENTERO, V40, P1182, DOI 10.1080/00365520510024034; Sood A, 2006, J GASTROEN HEPATOL, V21, P1622, DOI 10.1111/j.1440-1746.2006.04281.x; Tesei N, 2003, ALIMENT PHARM THERAP, V17, P1415, DOI 10.1046/j.1365-2036.2003.01595.x; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verkasalo MA, 2005, SCAND J GASTROENTERO, V40, P1407, DOI 10.1080/00365520510023792; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Zipser RD, 2003, DIGEST DIS SCI, V48, P761, DOI 10.1023/A:1022897028030	35	109	113	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2007	335	7632					1244	1247		10.1136/bmj.39405.472975.80	http://dx.doi.org/10.1136/bmj.39405.472975.80			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18063612	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000251832200034
J	Rodriguez, JA; Ma, S; Liu, P; Hrbek, J; Evans, J; Perez, M				Rodriguez, J. A.; Ma, S.; Liu, P.; Hrbek, J.; Evans, J.; Perez, M.			Activity of CeOx and TiOx nanoparticles grown on Au(111) in the water-gas shift reaction	SCIENCE			English	Article							CARBON-MONOXIDE; CO OXIDATION; CERIUM OXIDE; GOLD; CATALYSTS; SURFACES; OXYGEN; STM; XPS; AU	The high performance of Au-CeO2 and Au-TiO2 catalysts in the water- gas shift ( WGS) reaction ( H2O + CO --> H-2 + CO2) relies heavily on the direct participation of the oxide in the catalytic process. Although clean Au( 111) is not catalytically active for the WGS, gold surfaces that are 20 to 30% covered by ceria or titania nanoparticles have activities comparable to those of good WGS catalysts such as Cu( 111) or Cu( 100). In TiO2-x/Au( 111) and CeO2-x/Au( 111), water dissociates on O vacancies of the oxide nanoparticles, CO adsorbs on Au sites located nearby, and subsequent reaction steps take place at the metal- oxide interface. In these inverse catalysts, the moderate chemical activity of bulk gold is coupled to that of a more reactive oxide.	Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; Cent Univ Venezuela, Fac Ciencias, Caracas 1020A, Venezuela	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Central Venezuela	Rodriguez, JA (corresponding author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	rodrigez@bnl.gov	Hrbek, Jan/I-1020-2013					Albaret T, 1999, FARADAY DISCUSS, V114, P285, DOI 10.1039/a903066b; AU CT, 1988, SURF SCI, V197, P391, DOI 10.1016/0039-6028(88)90635-8; Bondzie VA, 1999, CATAL LETT, V63, P143, DOI 10.1023/A:1019012903936; Bunluesin T, 1998, APPL CATAL B-ENVIRON, V15, P107, DOI 10.1016/S0926-3373(97)00040-4; Burch R, 2006, PHYS CHEM CHEM PHYS, V8, P5483, DOI 10.1039/b607837k; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Hernandez NC, 2006, J AM CHEM SOC, V128, P15600, DOI 10.1021/ja0670153; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; DELLEY B, 1992, J CHEM PHYS, V113, P7752; Dulub O, 2007, SCIENCE, V317, P1052, DOI 10.1126/science.1144787; Esch F, 2005, SCIENCE, V309, P752, DOI 10.1126/science.1111568; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Fu Q, 2005, APPL CATAL B-ENVIRON, V56, P57, DOI 10.1016/j.apcatb.2004.07.015; Liu P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2722747; Ma S, 2007, J PHYS CHEM C, V111, P3685, DOI 10.1021/jp064366v; Min BK, 2007, CHEM REV, V107, P2709, DOI 10.1021/cr050954d; NAKAMURA J, 1990, J CHEM SOC FARADAY T, V86, P2725, DOI 10.1039/ft9908602725; OVESEN CV, 1992, J CATAL, V134, P445, DOI 10.1016/0021-9517(92)90334-E; Ricote S, 2006, APPL CATAL A-GEN, V303, P35, DOI 10.1016/j.apcata.2006.01.025; Rodriguez JA, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1946748; Rodriguez JA, 2007, ANGEW CHEM INT EDIT, V46, P1329, DOI 10.1002/anie.200603931; Song D, 2005, NANO LETT, V5, P1327, DOI 10.1021/nl0505703; Spivey JJ, 2005, CATAL TODAY, V100, P171, DOI 10.1016/j.cattod.2004.12.011; Suh DJ, 2005, J POWER SOURCES, V142, P70, DOI 10.1016/j.jpowsour.2004.09.012; Wang X, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2136876; Zhao XE, 2007, SURF SCI, V601, P2445, DOI 10.1016/j.susc.2007.04.106; Zhou J, 2006, SURF SCI, V600, P1540, DOI 10.1016/j.susc.2006.02.009	27	814	820	35	1281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1757	1760		10.1126/science.1150038	http://dx.doi.org/10.1126/science.1150038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079397				2022-12-28	WOS:000251616800035
J	Rothlin, CV; Ghosh, S; Zuniga, EI; Oldstone, MBA; Lemke, G				Rothlin, Carla V.; Ghosh, Sourav; Zuniga, Elina I.; Oldstone, Michael B. A.; Lemke, Greg			TAM receptors are pleiotropic inhibitors of the innate immune response	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYRO-3 FAMILY RECEPTORS; TYROSINE KINASE; NEGATIVE REGULATION; CYTOKINE SIGNALING-1; APOPTOTIC CELLS; PROTEIN-S; SUPPRESSOR; MER; INFLAMMATION	The activation of Toll-like receptors (TLRs) in dendritic cells (DCs) triggers a rapid inflammatory response to pathogens. However, this response must be tightly regulated because unrestrained TLR signaling generates a chronic inflammatory milieu that often leads to autoimmunity. We have found that the TAM receptor tyrosine kinases-Tyro3, Axl, and Mer- broadly inhibit both TLR and TLR-induced cytokine-receptor cascades. Remarkably, TAM inhibition of inflammation is transduced through an essential stimulator of inflammation - the type I interferon receptor (IFNAR) - and its associated transcription factor STAT1. TLR induction of IFNAR-STAT1 signaling upregulates the TAM system, which in turn usurps the IFNAR-STAT1 cassette to induce the cytokine and TLR suppressors SOCS1 and SOCS3. These results illuminate a self-regulating cycle of inflammation, in which the obligatory, cytokine-dependent activation of TAM signaling hijacks a proinflammatory pathway to provide an intrinsic feedback inhibitor of both TLR- and cytokine-driven immune responses.	[Rothlin, Carla V.; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Ghosh, Sourav] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Zuniga, Elina I.; Oldstone, Michael B. A.] Scripps Res Inst, Mol & Integrat Neurosci Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Scripps Research Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	lemke@salk.edu		Rothlin, Carla V/0000-0002-5693-5572; Ghosh, Sourav/0000-0001-5990-8708	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927, R01AI009484, R37AI009484] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09484, AI05540, AI45927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Brouwer JLR, 2004, BLOOD, V104, P143, DOI 10.1182/blood-2003-11-4085; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Meesters EW, 2007, BLOOD COAGUL FIBRIN, V18, P21, DOI 10.1097/01.mbc.0000256022.01900.c2; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ruiz-Irastorza G, 2001, LANCET, V357, P1027, DOI 10.1016/S0140-6736(00)04239-2; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Smiley ST, 1997, P NATL ACAD SCI USA, V94, P11484, DOI 10.1073/pnas.94.21.11484; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Wormald S, 2007, CURR OPIN HEMATOL, V14, P9, DOI 10.1097/00062752-200701000-00004; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	43	705	742	4	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1124	1136		10.1016/j.cell.2007.10.034	http://dx.doi.org/10.1016/j.cell.2007.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083102	Bronze			2022-12-28	WOS:000252217100020
J	Hirayama, J; Sahar, S; Grimaldi, B; Tamaru, T; Takamatsu, K; Nakahata, Y; Sassone-Corsi, P				Hirayama, Jun; Sahar, Saurabh; Grimaldi, Benedetto; Tamaru, Teruya; Takamatsu, Ken; Nakahata, Yasukazu; Sassone-Corsi, Paolo			CLOCK-mediated acetylation of BMAL1 controls circadian function	NATURE			English	Article							MAMMALIAN CRY1; FEEDBACK LOOP; C-TERMINUS; IN-VIVO; MECHANISM; HISTONES; PROTEIN; GENETICS; RHYTHMS; TIME	Regulation of circadian physiology relies on the interplay of interconnected transcriptional - translational feedback loops(1,2). The CLOCK - BMAL1 complex activates clock- controlled genes, including cryptochromes ( Crys), the products of which act as repressors by interacting directly with CLOCK - BMAL1(3,4). We have demonstrated that CLOCK possesses intrinsic histone acetyltransferase activity and that this enzymatic function contributes to chromatin- remodelling events implicated in circadian control of gene expression(5). Here we show that CLOCK also acetylates a non- histone substrate: its own partner, BMAL1, is specifically acetylated on a unique, highly conserved Lys 537 residue. BMAL1 undergoes rhythmic acetylation in mouse liver, with a timing that parallels the downregulation of circadian transcription of clock- controlled genes. BMAL1 acetylation facilitates recruitment of CRY1 to CLOCK - BMAL1, thereby promoting transcriptional repression. Importantly, ectopic expression of a K537R- mutated BMAL1 is not able to rescue circadian rhythmicity in a cellular model of peripheral clock. These findings reveal that the enzymatic interplay between two clock core components(6,7) is crucial for the circadian machinery.	Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; Toho Univ, Fac Med, Dept Physiol, Tokyo 1438540, Japan	University of California System; University of California Irvine; Toho University	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011	Nakahata, Yasukazu/0000-0003-3814-5822; Hirayama, Jun/0000-0002-8485-3320; Grimaldi, Benedetto/0000-0002-2589-9302				Belden WJ, 2006, TRENDS BIOCHEM SCI, V31, P610, DOI 10.1016/j.tibs.2006.09.009; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	30	370	390	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1086	U13		10.1038/nature06394	http://dx.doi.org/10.1038/nature06394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075593				2022-12-28	WOS:000251579900088
J	Olesen, C; Picard, M; Winther, AML; Gyrup, C; Morth, JP; Oxvig, C; Moller, JV; Nissen, P				Olesen, Claus; Picard, Martin; Winther, Anne-Marie Lund; Gyrup, Claus; Morth, J. Preben; Oxvig, Claus; Moller, Jesper Vuust; Nissen, Poul			The structural basis of calcium transport by the calcium pump	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; PHOSPHOENZYME INTERMEDIATE; RECONSTITUTED PROTEOLIPOSOMES; CRYSTAL-STRUCTURES; A-DOMAIN; BINDING; PROTEIN; ATPASE; NA+,K+-ATPASE; HYDROLYSIS	The sarcoplasmic reticulum Ca2+-ATPase, a P-type ATPase, has a critical role in muscle function and metabolism. Here we present functional studies and three new crystal structures of the rabbit skeletal muscle Ca2+-ATPase, representing the phosphoenzyme intermediates associated with Ca2+ binding, Ca2+ translocation and dephosphorylation, that are based on complexes with a functional ATP analogue, beryllium fluoride and aluminium fluoride, respectively. The structures complete the cycle of nucleotide binding and cation transport of Ca2+-ATPase. Phosphorylation of the enzyme triggers the onset of a conformational change that leads to the opening of a luminal exit pathway defined by the transmembrane segments M1 through M6, which represent the canonical membrane domain of P-type pumps. Ca2+ release is promoted by translocation of the M4 helix, exposing Glu 309, Glu 771 and Asn 796 to the lumen. The mechanism explains how P-type ATPases are able to form the steep electrochemical gradients required for key functions in eukaryotic cells.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Ole Worms Alle,Blg 1185, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Picard, Martin/A-3236-2016	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Picard, Martin/0000-0002-6518-8900; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989; Oxvig, Claus/0000-0002-4715-9719; Nissen, Poul/0000-0003-0948-6628				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; Apell HJ, 2004, REV PHYSIOL BIOCH P, V150, P1, DOI 10.1007/s10254-003-0018-9; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 2002, METHOD ENZYMOL, V354, P177; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEMEIS L, 1981, SARCOPLASMIC RETICUL; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FEHER JJ, 1983, BIOCHIM BIOPHYS ACTA, V727, P389, DOI 10.1016/0005-2736(83)90424-8; Fiske CH, 1925, J BIOL CHEM, V66, P375; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; HASSELBACH W, 1980, BASIC RES CARDIOL, V75, P2, DOI 10.1007/BF02001387; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAUGER P, 1991, ELECTROGENIC PUMPS, pCH8; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LEVY D, 1990, J BIOL CHEM, V265, P19524; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MELTZER S, 1984, J BIOL CHEM, V259, P4244; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; TAYLOR JS, 1981, J BIOL CHEM, V256, P9793; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	63	354	362	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1036	U5		10.1038/nature06418	http://dx.doi.org/10.1038/nature06418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075584				2022-12-28	WOS:000251579900077
J	Wells, JA; McClendon, CL				Wells, James A.; McClendon, Christopher L.			Reaching for high-hanging fruit in drug discovery at protein-protein interfaces	NATURE			English	Review							SMALL-MOLECULE ANTAGONISTS; HUMAN-PAPILLOMAVIRUS TYPE-11; BINDING-SITE; HOT-SPOT; CRYSTAL-STRUCTURE; MAXIMAL AFFINITY; LEAD DISCOVERY; P53 PATHWAY; IN-VIVO; INHIBITORS	Targeting the interfaces between proteins has huge therapeutic potential, but discovering small- molecule drugs that disrupt protein - protein interactions is an enormous challenge. Several recent success stories, however, indicate that protein - protein interfaces might be more tractable than has been thought. These studies discovered small molecules that bind with drug- like potencies to 'hotspots' on the contact surfaces involved in protein - protein interactions. Remarkably, these small molecules bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner. Some of these small molecules are now making their way through clinical trials, so this high-hanging fruit might not be far out of reach.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94156 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94156 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94156 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St 503A, San Francisco, CA 94156 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Braisted AC, 2003, J AM CHEM SOC, V125, P3714, DOI 10.1021/ja034247i; Brown SP, 2006, CHEMMEDCHEM, V1, P70, DOI 10.1002/cmdc.200500013; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emerson SD, 2003, PROTEIN SCI, V12, P811, DOI 10.1110/ps.0232803; Erlanson DA, 2006, CURR OPIN BIOTECH, V17, P643, DOI 10.1016/j.copbio.2006.10.007; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; FLETTERICK RJ, 1975, P NATL ACAD SCI USA, V72, P38, DOI 10.1073/pnas.72.1.38; Fry DC, 2006, BIOPOLYMERS, V84, P535, DOI 10.1002/bip.20608; Fry DC, 2004, J BIOMOL NMR, V30, P163, DOI 10.1023/B:JNMR.0000048856.84603.9b; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goudreau N, 2007, BIOORGAN MED CHEM, V15, P2690, DOI 10.1016/j.bmc.2007.01.036; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Hajduk PJ, 2006, MOL INTERV, V6, P266, DOI 10.1124/mi.6.5.8; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jennings LD, 2004, BIOORGAN MED CHEM, V12, P5115, DOI 10.1016/j.bmc.2004.07.031; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Ke HM, 2004, FRONT BIOSCI-LANDMRK, V9, P2285, DOI 10.2741/1396; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Koblish HK, 2006, MOL CANCER THER, V5, P160, DOI 10.1158/1535-7163.MCT-05-0199; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lee LP, 2001, PROTEIN SCI, V10, P362, DOI 10.1110/ps.40001; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Marsters J C Jr, 1994, Bioorg Med Chem, V2, P949, DOI 10.1016/S0968-0896(00)82044-1; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Parks DJ, 2005, BIOORG MED CHEM LETT, V15, P765, DOI 10.1016/j.bmcl.2004.11.009; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; PICKSLEY SM, 1994, ONCOGENE, V9, P2523; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Raimundo BC, 2004, J MED CHEM, V47, P3111, DOI 10.1021/jm049967u; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; ROBIN WS, 1998, BIOTECHNOL BIOENG, V61, P61; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sadowsky JD, 2007, CHEMBIOCHEM, V8, P903, DOI 10.1002/cbic.200600546; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Smith RD, 2006, J MOL GRAPH MODEL, V24, P414, DOI 10.1016/j.jmgm.2005.08.002; Strong Michael, 2007, Prog Drug Res, V64, P193; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Tilley JW, 1997, J AM CHEM SOC, V119, P7589, DOI 10.1021/ja970702x; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Tsao DHH, 2006, BIOORGAN MED CHEM, V14, P7953, DOI 10.1016/j.bmc.2006.07.050; Uvebrant K, 2007, J BIOMOL SCREEN, V12, P464, DOI 10.1177/1087057107300464; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; White PW, 2003, J BIOL CHEM, V278, P26765, DOI 10.1074/jbc.M303608200; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Xiao H, 2007, MOL IMMUNOL, V44, P784, DOI 10.1016/j.molimm.2006.04.018; YANKEELOV JA, 1965, J BIOL CHEM, V240, P1593; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Yoakim C, 2003, BIOORG MED CHEM LETT, V13, P2539, DOI 10.1016/S0960-894X(03)00510-9; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	99	1513	1554	5	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1001	1009		10.1038/nature06526	http://dx.doi.org/10.1038/nature06526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075579				2022-12-28	WOS:000251579900070
J	Behrens, MM; Ali, SS; Dao, DN; Lucero, J; Shekhtman, G; Quick, KL; Dugan, LL				Behrens, M. Margarita; Ali, Sameh S.; Dao, Diep N.; Lucero, Jacinta; Shekhtman, Grigoriy; Quick, Kevin L.; Dugan, Laura L.			Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase	SCIENCE			English	Article							DECARBOXYLASE-67 MESSENGER-RNA; NMDA RECEPTOR HYPOFUNCTION; PREFRONTAL CORTEX; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOPHRENIA; NEURONS; PHENCYCLIDINE; IMMUNOREACTIVITY; PARVALBUMIN	Abuse of the dissociative anesthetic ketamine can lead to a syndrome indistinguishable from schizophrenia. In animals, repetitive exposure to this N-methyl-D-aspartate-receptor antagonist induces the dysfunction of a subset of cortical fast-spiking inhibitory interneurons, with loss of expression of parvalbumin and the gamma-aminobutyric acid-producing enzyme GAD67. We show here that exposure of mice to ketamine induced a persistent increase in brain superoxide due to activation in neurons of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Decreasing superoxide production prevented the effects of ketamine on inhibitory interneurons in the prefrontal cortex. These results suggest that NADPH oxidase may represent a novel target for the treatment of ketamine-induced psychosis.	Univ Calif San Diego, Dept Med, Div Geriatr Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Behrens, MM (corresponding author), Univ Calif San Diego, Dept Med, Div Geriatr Med, La Jolla, CA 92093 USA.	mbehrens@ucsd.edu; ladugan@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Nanozymes, Nanozymes/D-8197-2019	Ali, Sameh Saad/0000-0002-0339-6106				AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Cochran SM, 2002, SYNAPSE, V46, P206, DOI 10.1002/syn.10126; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hart B A, 1992, Biotechnol Ther, V3, P119; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Kato-Negishi M, 2004, DEV BRAIN RES, V152, P99, DOI 10.1016/j.devbrainres.2004.05.013; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; Morrow BA, 2007, PSYCHOPHARMACOLOGY, V192, P283, DOI 10.1007/s00213-007-0708-0; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Woo TUW, 2004, ARCH GEN PSYCHIAT, V61, P649, DOI 10.1001/archpsyc.61.7.649; Xia S, 2002, NEUROBIOL DIS, V9, P282, DOI 10.1006/nbdi.2002.0478; Zuo DY, 2007, PHARMACOL BIOCHEM BE, V86, P1, DOI 10.1016/j.pbb.2006.05.010	29	432	458	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1645	1647		10.1126/science.1148045	http://dx.doi.org/10.1126/science.1148045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063801				2022-12-28	WOS:000251421700052
J	Brandenberger, R				Brandenberger, Robert			Astronomy - A texture in the sky?	SCIENCE			English	Editorial Material							COSMIC STRUCTURE FORMATION; MICROWAVE-ANISOTROPY; GLOBAL TEXTURE; STRINGS		McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	McGill University	Brandenberger, R (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	rhb@physics.mcgill.ca						Albrecht A, 1997, PHYS REV LETT, V79, P4736, DOI 10.1103/PhysRevLett.79.4736; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Cruz M, 2007, SCIENCE, V318, P1612, DOI 10.1126/science.1148694; Durrer R, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.123005; GUTH AH, 2004, MEASURING MODELING U, P31; KAISER N, 1984, NATURE, V310, P391, DOI 10.1038/310391a0; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Linde A.D., 1990, PARTICLE PHYS INFLAT; MUKHANOV VF, 1981, JETP LETT+, V33, P532; MUKHANOV VF, 1992, PHYS REP, V215, P203, DOI 10.1016/0370-1573(92)90044-Z; Netterfield CB, 2002, ASTROPHYS J, V571, P604, DOI 10.1086/340118; Pen UL, 1997, PHYS REV LETT, V79, P1611, DOI 10.1103/PhysRevLett.79.1611; TUROK N, 1989, PHYS REV LETT, V63, P2625, DOI 10.1103/PhysRevLett.63.2625; TUROK N, 1990, PHYS REV LETT, V64, P2736, DOI 10.1103/PhysRevLett.64.2736; Vilenkin A., 1994, COSMIC STRINGS OTHER	15	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1560	1561		10.1126/science.1151994	http://dx.doi.org/10.1126/science.1151994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063776				2022-12-28	WOS:000251421700022
J	Day, J; Beamish, J				Day, James; Beamish, John			Low-temperature shear modulus changes in solid He-4 and connection to supersolidity	NATURE			English	Article							HCP HE-4; SOUND-VELOCITY; BCC HE-3; DISLOCATIONS; IMPURITIES; CRYSTALS; HELIUM	Superfluidity - liquid flow without friction - is familiar in helium. The first evidence for 'supersolidity', its analogue in quantum solids, came from torsional oscillator measurements(1,2) involving He-4. At temperatures below 200 mK, the torsional oscillator frequencies increased, suggesting that some of the solid decoupled from the oscillator. This behaviour has been replicated by several groups(3-7), but solid He-4 does not respond to pressure differences(8), and persistent currents and other signatures of superflow have not been seen. Both experiments and theory(9-14) indicate that defects are involved; these should also affect the solid's mechanical behaviour. Here we report a measurement of the shear modulus of solid He-4 at low frequencies and strains. We observe large increases below 200 mK, with the same dependence on measurement amplitude, He-3 impurity concentration and annealing as the decoupling seen in the torsional oscillator experiments. We explain this unusual elastic behaviour in terms of a dislocation network that is pinned by He-3 at the lowest temperatures but becomes mobile above 100 mK. The frequency changes in the torsional oscillator experiments appear to be related to the motion of these dislocations, perhaps by disrupting a possible supersolid state.	Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada	University of Alberta	Beamish, J (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada.	beamish@phys.ualberta.ca		Day, James/0000-0003-4324-3486				Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; BEAMISH JR, 1983, PHYS REV B, V28, P1419, DOI 10.1103/PhysRevB.28.1419; BEAMISH JR, 1982, PHYS REV B, V26, P6104, DOI 10.1103/PhysRevB.26.6104; Boninsegni M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.035301; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Ceperley DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155303; CLARK AC, 2007, NONCLASSICAL ROTATIO; Day J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105304; de Gennes PG, 2006, CR PHYS, V7, P561, DOI 10.1016/j.crhy.2006.06.008; Dorsey AT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055301; GRANATO A, 1956, J APPL PHYS, V27, P583, DOI 10.1063/1.1722436; HUSE DA, 2007, DISSIPATION PEAK IND; IWASA I, 1980, J PHYS SOC JPN, V49, P1722, DOI 10.1143/JPSJ.49.1722; IWASA I, 1979, J PHYS SOC JPN, V46, P1119, DOI 10.1143/JPSJ.46.1119; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kim E., 2007, B AM PHYS SOC, V52, P610; Kondo M, 2007, J LOW TEMP PHYS, V148, P695, DOI 10.1007/s10909-007-9471-1; Lin X, 2007, NATURE, V449, P1025, DOI 10.1038/nature06228; Nussinov Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014530; PAALANEN MA, 1981, PHYS REV LETT, V46, P664, DOI 10.1103/PhysRevLett.46.664; Penzev A, 2007, J LOW TEMP PHYS, V148, P677, DOI 10.1007/s10909-007-9452-4; Pollet L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.135301; Prokof'ev N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.155302; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; TONER J, 2007, QUENCHED DISORDER EN; Tsymbalenko, 1978, SOV PHYS JETP, V47, P787	30	264	267	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					853	856		10.1038/nature06383	http://dx.doi.org/10.1038/nature06383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064007	Green Submitted			2022-12-28	WOS:000251394900050
J	Falutz, J; Allas, S; Blot, K; Potvin, D; Kotler, D; Somero, M; Berger, D; Brown, S; Richmond, G; Fessel, J; Turner, R; Grinspoon, S				Falutz, Julian; Allas, Soraya; Blot, Koenraad; Potvin, Diane; Kotler, Donald; Somero, Michael; Berger, Daniel; Brown, Stephen; Richmond, Gary; Fessel, Jeffrey; Turner, Ralph; Grinspoon, Steven			Metabolic effects of a growth hormone-releasing factor in patients with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	14th Conference on Retroviruses and Opportunistic Infections	FEB 25-28, 2007	Los Angeles, CA				HUMAN-IMMUNODEFICIENCY-VIRUS; CARDIOVASCULAR RISK-FACTORS; VISCERAL ADIPOSE-TISSUE; INFECTED PATIENTS; BODY-COMPOSITION; FAT DISTRIBUTION; WEIGHT-LOSS; METFORMIN; LIPODYSTROPHY; ROSIGLITAZONE	Background: Visceral adipose tissue accumulates during antiretroviral therapy in many patients who are infected with the human immunodeficiency virus (HIV); this process is associated with an increased cardiovascular risk. We assessed the use of a growth hormone-releasing factor analogue, tesamorelin, to decrease visceral adiposity. Methods: We randomly assigned 412 patients with HIV (86% of whom were men) who had an accumulation of abdominal fat to receive a daily subcutaneous injection of either 2 mg of tesamorelin or placebo for 26 weeks. The primary end point was the percent change from baseline in visceral adipose tissue as shown on computed tomography. Secondary end points included triglyceride levels, the ratio of total cholesterol to high-density lipoprotein (HDL) cholesterol, the level of insulin-like growth factor I (IGF-I), and self-assessed body image. Glycemic measures included glucose and insulin levels. Results: The measure of visceral adipose tissue decreased by 15.2% in the tesamorelin group and increased by 5.0% in the placebo group; the levels of triglycerides decreased by 50 mg per deciliter and increased by 9 mg per deciliter, respectively, and the ratio of total cholesterol to HDL cholesterol decreased by 0.31 and increased by 0.21, respectively (P<0.001 for all comparisons). Levels of total cholesterol and HDL cholesterol also improved significantly in the tesamorelin group. Levels of IGF-I increased by 81.0% in the tesamorelin group and decreased by 5.0% in the placebo group (P<0.001). Adverse events did not differ significantly between the two study groups, but more patients in the tesamorelin group withdrew from the study because of an adverse event. No significant differences were observed in glycemic measures. Conclusions: Daily tesamorelin for 26 weeks decreased visceral fat and improved lipid profiles, effects that might be useful in HIV-infected patients who have treatment-associated central fat accumulation.	Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; Theratechnol, Montreal, PQ, Canada; Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, New York, NY USA; Northstar Hlth Care, Chicago, IL USA; AIDS Res Alliance, W Hollywood, CA USA; Kaiser Fdn Res Inst, San Francisco, CA USA; Phase V Technol, Wellesley Hills, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; McGill University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Harvard University; Harvard Medical School	Grinspoon, S (corresponding author), Massachusetts Gen Hosp, Program Nutr Metab, LON 207, Boston, MA 02114 USA.	sgrinspoon@partners.org		Blot, Koenraad/0000-0001-9120-4102				Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; Blanch J, 2004, CLIN INFECT DIS, V38, P1469; Dolan SE, 2006, ARCH INTERN MED, V166, P1225, DOI 10.1001/archinte.166.11.1225; Driscoll SD, 2004, AIDS, V18, P465, DOI 10.1097/00002030-200402200-00013; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Engelson ES, 2006, METABOLISM, V55, P1327, DOI 10.1016/j.metabol.2006.05.018; Engelson ES, 1999, AM J CLIN NUTR, V69, P1162; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Falutz J, 2005, AIDS, V19, P1279, DOI 10.1097/01.aids.0000180099.35146.30; Fitch KV, 2006, AIDS, V20, P1843, DOI 10.1097/01.aids.0000244203.95758.db; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grunfeld C, 2007, JAIDS-J ACQ IMM DEF, V45, P286; Hadigan C, 2004, ANN INTERN MED, V140, P786, DOI 10.7326/0003-4819-140-10-200405180-00008; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Kobayashi J, 2002, INT J OBESITY, V26, P398, DOI 10.1038/sj.ijo.0801921; Kotler DP, 2004, JAIDS-J ACQ IMM DEF, V35, P239, DOI 10.1097/00126334-200403010-00004; Koutkia P, 2004, JAMA-J AM MED ASSOC, V292, P210, DOI 10.1001/jama.292.2.210; MAACHI M, 2006, 8 INT WORKSH ADV DRU; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Mazzone T, 2007, DIABETES, V56, P849, DOI 10.2337/db06-0935; Morricone L, 2002, NUTR METAB CARDIOVAS, V12, P275; Mulligan K, 2007, AIDS, V21, P47, DOI 10.1097/QAD.0b013e328011220e; Nakamura T, 1997, INT J OBESITY, V21, P580, DOI 10.1038/sj.ijo.0800445; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; Schambelan M, 1996, ANN INTERN MED, V125, P873, DOI 10.7326/0003-4819-125-11-199612010-00002; THOMPSON M, 2003, 2 INT AIDS SOC C HIV; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; van Wijk JP, 2005, ANN INTERN MED, V143, P695, DOI 10.7326/0003-4819-143-9-200511010-00025; van Wijk JPH, 2005, ANN INTERN MED, V143, P337, DOI 10.7326/0003-4819-143-5-200509060-00009; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153	37	141	147	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2359	2370		10.1056/NEJMoa072375	http://dx.doi.org/10.1056/NEJMoa072375			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	237QA	18057338				2022-12-28	WOS:000251389200006
J	Ramsakal, A; Mangat, L				Ramsakal, Asha; Mangat, Lovpreet			Lingua villosa nigra	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Ramsakal, A (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.								0	10	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2388	2388		10.1056/NEJMicm065655	http://dx.doi.org/10.1056/NEJMicm065655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057341				2022-12-28	WOS:000251389200009
J	Sui, XM; LaMonte, MJ; Laditka, JN; Hardin, JW; Chase, N; Hooker, SP; Blair, SN				Sui, Xuemei; LaMonte, Michael J.; Laditka, James N.; Hardin, James W.; Chase, Nancy; Hooker, Steven P.; Blair, Steven N.			Cardiorespiratory fitness and adiposity as mortality predictors in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; TO-HIP RATIO; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; PUBLIC-HEALTH; GRIP STRENGTH; OBESITY; WOMEN	Context Although levels of physical activity and aerobic capacity decline with age and the prevalence of obesity tends to increase with age, the independent and joint associations among fitness, adiposity, and mortality in older adults have not been adequately examined. Objective To determine the association among cardiorespiratory fitness ("fitness"), adiposity, and mortality in older adults. Design, Setting, and Patients Cohort of 2603 adults aged 60 years or older ( mean age, 64.4 [SD, 4.8] years; 19.8% women) enrolled in the Aerobics Center Longitudinal Study who completed a baseline health examination during 1979-2001. Fitness was assessed by a maximal exercise test, and adiposity was assessed by body mass index (BMI), waist circumference, and percent body fat. Low fitness was defined as the lowest fifth of the sex-specific distribution of maximal treadmill exercise test duration. The distributions of BMI, waist circumference, and percent body fat were grouped for analysis according to clinical guidelines. Main Outcome Measure All-cause mortality through December 31, 2003. Results There were 450 deaths during a mean follow-up of 12 years and 31 236 person-years of exposure. Death rates per 1000 person-years, adjusted for age, sex, and examination year were 13.9, 13.3, 18.3, and 31.8 across BMI groups of 18.524.9, 25.0-29.9, 30.0-34.9, and >= 35.0, respectively (P=.01 for trend); 13.3 and 18.2 for normal and high waist circumference (>= 88 cm in women; >= 102 cm in men) (P=. 004); 13.7 and 14.6 for normal and high percent body fat (>= 30% in women; >= 25% in men) ( P=. 51); and 32.6, 16.6, 12.8, 12.3, and 8.1 across incremental fifths of fitness ( P <. 001 for trend). The association between waist circumference and mortality persisted after further adjustment for smoking, baseline health status, and BMI ( P=. 02) but not after additional adjustment for fitness ( P=. 86). Fitness predicted mortality risk after further adjustment for smoking, baseline health, and either BMI, waist circumference, or percent body fat ( P <. 001 for trend). Conclusions In this study population, fitness was a significant mortality predictor in older adults, independent of overall or abdominal adiposity. Clinicians should consider the importance of preserving functional capacity by recommending regular physical activity for older individuals, normal-weight and overweight alike.	Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; Univ S Carolina, Ctr Hlth Serv & Policy Res, Columbia, SC 29208 USA; Univ S Carolina, Prevent Res Ctr, Columbia, SC 29208 USA; Univ Buffalo, Dept Social & Prevent Med, Buffalo, NY USA; Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Texas System; University of North Texas Denton	Sui, XM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA.	msui@gwm.sc.edu	Hardin, James/P-4772-2019; Hardin, James W/Q-7617-2016; LaMonte, Mike/AAC-9953-2021	Hardin, James/0000-0003-0506-5500; Hardin, James W/0000-0003-0506-5500; Hooker, Steven/0000-0001-9969-6244	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006945, R37AG006945] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL062508-04, R01 HL062508-01, R01 HL062508, R01 HL062508-02, R01 HL062508-03, HL62508] Funding Source: Medline; NIA NIH HHS [R37 AG006945, R01 AG006945-15, R01 AG006945-13, R01 AG006945, AG06945, R01 AG006945-14] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; ANDERSON LH, 2005, PREV CHRONIC DIS, V2; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BARLOW CE, 1995, INT J OBESITY, V19, pS41; Blair SN, 2000, AM J HEALTH PROMOT, V15, P1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Bray G A, 1993, Obes Res, V1, P203; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Elia M, 2001, OBES RES, V9, p244S, DOI 10.1038/oby.2001.126; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; HASKELL WL, 1992, MED SCI SPORT EXER, V24, pS201, DOI 10.1249/00005768-199206001-00004; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lindqvist P, 2006, EUR J EPIDEMIOL, V21, P789, DOI 10.1007/s10654-006-9074-1; Lurie N, 2000, ACAD MED, V75, P12, DOI 10.1097/00001888-200001000-00006; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; SCHOENBORN CA, 2004, VITAL HLTH STAT, V10, P1; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	46	410	423	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2507	2516		10.1001/jama.298.21.2507	http://dx.doi.org/10.1001/jama.298.21.2507			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237GJ	18056904	Green Accepted, Bronze			2022-12-28	WOS:000251361900016
J	Jeoung, JH; Dobbek, H				Jeoung, Jae-Hun; Dobbek, Holger			Carbon dioxide activation at the Ni,Fe-cluster of anaerobic carbon monoxide dehydrogenase	SCIENCE			English	Article							CO DEHYDROGENASE; CLOSTRIDIUM-THERMOACETICUM; RHODOSPIRILLUM-RUBRUM; ACTIVE-SITE; CARBOXYDOTHERMUS-HYDROGENOFORMANS; CLUSTER; METALLOCLUSTERS; COORDINATION; CATALYSIS; SYNTHASE	Anaerobic CO dehydrogenases catalyze the reversible oxidation of CO to CO2 at a complex Ni-, Fe-, and S-containing metal center called cluster C. We report crystal structures of CO dehydrogenase II from Carboxydothermus hydrogenoformans in three different states. In a reduced state, exogenous CO2 supplied in solution is bound and reductively activated by cluster C. In the intermediate structure, CO2 acts as a bridging ligand between Ni and the asymmetrically coordinated Fe, where it completes the square-planar coordination of the Ni ion. It replaces a water/hydroxo ligand bound to the Fe ion in the other two states. The structures define the mechanism of CO oxidation and CO2 reduction at the Ni-Fe site of cluster C.	Univ Bayreuth, Lab Prot Kristallog, D-95440 Bayreuth, Germany; Univ Bayreuth, Forsch Zent Biomakromol, D-95440 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Dobbek, H (corresponding author), Univ Bayreuth, Lab Prot Kristallog, POB 101251, D-95440 Bayreuth, Germany.	holger.dobbek@uni-bayreuth.de						Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Dobbek H, 2004, J AM CHEM SOC, V126, P5382, DOI 10.1021/ja037776v; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; ENSIGN SA, 1995, BIOCHEMISTRY-US, V34, P5372, DOI 10.1021/bi00016a008; Feng J, 2004, J AM CHEM SOC, V126, P9094, DOI 10.1021/ja048811g; Feng J, 2004, BIOCHEMISTRY-US, V43, P1552, DOI 10.1021/bi0357199; Fraser DM, 1999, BIOCHEMISTRY-US, V38, P15706, DOI 10.1021/bi990398f; GRAHAME DA, 1995, BIOCHEMISTRY-US, V34, P4617, DOI 10.1021/bi00014a015; Ha SW, 2007, J BIOL CHEM, V282, P10639, DOI 10.1074/jbc.M610641200; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Leitner W, 1996, COORDIN CHEM REV, V153, P257, DOI 10.1016/0010-8545(95)01226-5; LINDAHL PA, 1990, J BIOL CHEM, V265, P3880; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Lindahl PA, 2002, BIOCHEMISTRY-US, V41, P2097, DOI 10.1021/bi015932+; MACGREGOR SA, 1994, INORG CHEM, V33, P3616, DOI 10.1021/ic00094a030; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; Rees DC, 2002, ANNU REV BIOCHEM, V71, P221, DOI 10.1146/annurev.biochem.71.110601.135406; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Svetlitchnyi V, 2001, J BACTERIOL, V183, P5134, DOI 10.1128/JB.183.17.5134-5144.2001	22	375	379	9	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1461	1464		10.1126/science.1148481	http://dx.doi.org/10.1126/science.1148481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048691				2022-12-28	WOS:000251246100049
J	Kedde, M; Strasser, MJ; Boldajipour, B; Vrielink, JAFO; Le Sage, C; Nagel, R; Voorhoeve, PM; Van Duijse, J; Orom, UA; Lund, AH; Perrakis, A; Raz, E; Agami, R; Slanchev, K				Kedde, Martijn; Strasser, Markus J.; Boldajipour, Bijan; Vrielink, Joachim A. F. Oude; Le Sage, Carlos; Nagel, Remco; Voorhoeve, P. Mathijs; Van Duijse, Josyanne; Orom, Ulf Andersson; Lund, Anders H.; Perrakis, Anastassis; Raz, Erez; Agami, Reuven; Slanchev, Krasimir			RNA-binding protein Dnd1 inhibits microRNA access to target mRNA	CELL			English	Article							GERM-CELL TUMORS; EMBRYONIC-DEVELOPMENT; CHROMATOID BODY; DEAD-END; ZEBRAFISH; GENE; EXPRESSION; MIRNAS; IDENTIFICATION; REPRESSION	MicroRNAs (miRNAs) are inhibitors of gene expression capable of controlling processes in normal development and cancer. In mammals, miRNAs use a seed sequence of 6 -8 nucleotides (nt) to associate with 30 untranslated regions (3'UTRs) of mRNAs and inhibit their expression. Intriguingly, occasionally not only the miRNA-targeting site but also sequences in its vicinity are highly conserved throughout evolution. We therefore hypothesized that conserved regions in mRNAs may serve as docking platforms for modulators of miRNA activity. Here we demonstrate that the expression of dead end 1 (Dnd1), an evolutionary conserved RNA-binding protein (RBP), counteracts the function of several miRNAs in human cells and in primordial germ cells of zebrafish by binding mRNAs and prohibiting miRNAs from associating with their target sites. These effects of Dnd1 are mediated through uridine-rich regions present in the miRNA-targeted mRNAs. Thus, our data unravel a novel role of Dnd1 in protecting certain mRNAs from miRNA-mediated repression.	[Strasser, Markus J.; Boldajipour, Bijan; Raz, Erez; Slanchev, Krasimir] Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany; [Kedde, Martijn; Vrielink, Joachim A. F. Oude; Le Sage, Carlos; Nagel, Remco; Voorhoeve, P. Mathijs; Van Duijse, Josyanne; Agami, Reuven] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; [Strasser, Markus J.; Boldajipour, Bijan; Raz, Erez; Slanchev, Krasimir] Univ Munster, Ctr Mol Biol Inflammat, ZMBE, Inst Cell Biol, D-48149 Munster, Germany; [Perrakis, Anastassis] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Max Planck Society; Netherlands Cancer Institute; University of Munster; Netherlands Cancer Institute	Raz, E (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37070 Gottingen, Germany.	erezraz@uni-muenster.de; r.agami@nki.nl	Orom, Ulf A/G-1327-2010; Perrakis, Anastassis/E-8704-2013; Kedde, Martijn/F-9716-2016; Ørom, Ulf A/F-6727-2010; agami, reuven/GOG-8289-2022; Lund, Anders H./F-4786-2014	Perrakis, Anastassis/0000-0002-1151-6227; Lund, Anders H./0000-0002-7407-3398; Agami, Reuven/0000-0002-2848-2473; Boldajipour, Bijan/0000-0003-2065-555X; Orom, Ulf/0000-0002-0643-0592				Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2006, J BIOL CHEM, V281, P40503, DOI 10.1074/jbc.M607676200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Koprunner M, 2001, GENE DEV, V15, P2877; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; VOORHOEVE PM, 2006, BIOCHIM BIOPHYS ACTA, V1775, P274; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Westerfield M, 1995, ZEBRAFISH BOOK; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	43	547	581	3	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1273	1286		10.1016/j.cell.2007.11.034	http://dx.doi.org/10.1016/j.cell.2007.11.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18155131	Bronze, Green Submitted			2022-12-28	WOS:000252217200017
J	Mehra, MR; Uber, PA; Ventura, HO				Mehra, Mandeep R.; Uber, Patricia A.; Ventura, Hector O.			Death messengers	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAKING BAD-NEWS		[Mehra, Mandeep R.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Uber, Patricia A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Ochsner Clin Fdn, New Orleans, LA 70121 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Ochsner Health System	Mehra, MR (corresponding author), Univ Maryland, Dept Med, 22 S Greene St, Baltimore, MD 21201 USA.	mmehra@medicine.umaryland.edu	Mehra, Mandeep R/G-3484-2013; Mehra, Mandeep R/O-7273-2019	Mehra, Mandeep R/0000-0001-8683-7044; Mehra, Mandeep R/0000-0001-8683-7044				Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Mueller PS, 2002, POSTGRAD MED, V112, P15, DOI 10.3810/pgm.2002.09.1318; Ptacek JT, 1996, JAMA-J AM MED ASSOC, V276, P496; Vandekieft GK, 2001, AM FAM PHYSICIAN, V64, P1975	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1296	1297		10.1136/bmj.39409.501435.AE	http://dx.doi.org/10.1136/bmj.39409.501435.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156236	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252182700017
J	Cohen, RA; Parikh, SM				Cohen, Robert A.; Parikh, Samir M.			Images in clinical medicine: Calcinosis associated with renal failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Cohen, RA (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	rcohen@bidmc.harvard.edu							0	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2615	2615		10.1056/NEJMicm067693	http://dx.doi.org/10.1056/NEJMicm067693			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094381				2022-12-28	WOS:000251728900011
J	Foulkes, WD				Foulkes, William D.			Focus on research: p53 - Master and commander	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada	McGill University; McGill University	Foulkes, WD (corresponding author), McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada.		Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651				GREENBLATT MS, 1994, CANCER RES, V54, P4855; HARRIS L, IN PRESS J CLIN ONCO; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; VOUSDEN KH, 1983, NAT REV MOL CELL BIO, V8, P275	5	23	27	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2539	2541		10.1056/NEJMp0707422	http://dx.doi.org/10.1056/NEJMp0707422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094374				2022-12-28	WOS:000251728900004
J	Cravatt, BF; Simon, GM; Yates, JR				Cravatt, Benjamin F.; Simon, Gabriel M.; Yates, John R., III			The biological impact of mass-spectrometry-based proteomics	NATURE			English	Review							SITE-SPECIFIC PHOSPHORYLATION; DNA-DAMAGE RESPONSE; QUANTITATIVE-ANALYSIS; PROTEIN IDENTIFICATION; PLASMODIUM-FALCIPARUM; SIGNALING NETWORKS; COMPLEX PROTEOMES; CYSTIC-FIBROSIS; HUMAN GENOME; HUMAN-CELLS	In the past decade, there have been remarkable advances in proteomic technologies. Mass spectrometry has emerged as the preferred method for in- depth characterization of the protein components of biological systems. Using mass spectrometry, key insights into the composition, regulation and function of molecular complexes and pathways have been gained. From these studies, it is clear that mass- spectrometry- based proteomics is now a powerful 'hypothesis- generating engine' that, when combined with complementary molecular, cellular and pharmacological techniques, provides a framework for translating large data sets into an understanding of complex biological processes.	Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu; jyates@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA087660] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA087660-07, R01 CA087660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Causler B, 2004, MASS SPECTROM REV, V23, P350, DOI 10.1002/mas.10080; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Conrads TP, 2000, ANAL CHEM, V72, P3349, DOI 10.1021/ac0002386; Coulombe B, 2004, MOL CELL PROTEOMICS, V3, P851, DOI 10.1074/mcp.R400009-MCP200; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2004, CURR OPIN CHEM BIOL, V8, P54, DOI 10.1016/j.cbpa.2003.11.004; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jin M, 2005, ANAL CHEM, V77, P7845, DOI 10.1021/ac051519m; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Krebs MP, 2004, TRENDS BIOCHEM SCI, V29, P648, DOI 10.1016/j.tibs.2004.10.009; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kumar N, 2004, INT J PARASITOL, V34, P1451, DOI 10.1016/j.ijpara.2004.10.013; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Michnick SW, 2004, DRUG DISCOV TODAY, V9, P262, DOI 10.1016/S1359-6446(03)03022-8; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perrimon N, 2007, GENETICS, V175, P7, DOI 10.1534/genetics.106.069963; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Ranish JA, 2004, NAT GENET, V36, P707, DOI 10.1038/ng1385; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang XD, 2001, GENE DEV, V15, P2922; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang Y, 2000, GENE DEV, V14, P927; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Yates JR, 2004, ANNU REV BIOPH BIOM, V33, P297, DOI 10.1146/annurev.biophys.33.111502.082538; Zabrouskov V, 2005, J AM SOC MASS SPECTR, V16, P2027, DOI 10.1016/j.jasms.2005.08.004; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	75	535	561	6	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					991	1000		10.1038/nature06525	http://dx.doi.org/10.1038/nature06525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075578				2022-12-28	WOS:000251579900069
J	Cirtain, JW; Golub, L; Lundquist, L; van Ballegooijen, A; Savcheva, A; Shimojo, M; DeLuca, E; Tsuneta, S; Sakao, T; Reeves, K; Weber, M; Kano, R; Narukage, N; Shibasaki, K				Cirtain, J. W.; Golub, L.; Lundquist, L.; van Ballegooijen, A.; Savcheva, A.; Shimojo, M.; DeLuca, E.; Tsuneta, S.; Sakao, T.; Reeves, K.; Weber, M.; Kano, R.; Narukage, N.; Shibasaki, K.			Evidence for Alfven waves in solar x-ray jets	SCIENCE			English	Article							MAGNETOHYDRODYNAMIC TURBULENCE; WIND; TELESCOPE; DYNAMICS	Coronal magnetic fields are dynamic, and field lines may misalign, reassemble, and release energy by means of magnetic reconnection. Giant releases may generate solar flares and coronal mass ejections and, on a smaller scale, produce x-ray jets. Hinode observations of polar coronal holes reveal that x-ray jets have two distinct velocities: one near the Alfven speed (similar to 800 kilometers per second) and another near the sound speed ( 200 kilometers per second). Many more jets were seen than have been reported previously; we detected an average of 10 events per hour up to these speeds, whereas previous observations documented only a handful per day with lower average speeds of 200 kilometers per second. The x-ray jets are about 2 x 10(3) to 2 x 10(4) kilometers wide and 1 x 10(5) kilometers long and last from 100 to 2500 seconds. The large number of events, coupled with the high velocities of the apparent outflows, indicates that the jets may contribute to the high-speed solar wind.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Nobeyama Solar Radio Observ, Nagano 3841305, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Cirtain, JW (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	Jonathan.W.Cirtain@nasa.gov	Shibasaki, Kiyoto/AAG-5951-2020; DeLuca, Edward E/L-7534-2013; Shimojo, Masumi/J-2605-2016; Reeves, Katharine/P-9163-2014	Shibasaki, Kiyoto/0000-0003-4707-5897; DeLuca, Edward E/0000-0001-7416-2895; Shimojo, Masumi/0000-0002-2350-3749; Narukage, Noriyuki/0000-0002-6330-3944; Reeves, Katharine/0000-0002-6903-6832; Golub, Leon/0000-0001-9638-3082	STFC [PP/D002907/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Chapman S., 1957, SMITHSONIAN CONTRIB, V2, P1, DOI DOI 10.5479/SI.00810231.2-1.1; Cranmer SR, 2005, ASTROPHYS J SUPPL S, V156, P265, DOI 10.1086/426507; Cranmer SR, 1999, ASTROPHYS J, V518, P937, DOI 10.1086/307330; Cranmer SR, 2007, ASTROPHYS J SUPPL S, V171, P520, DOI 10.1086/518001; DERE KP, 1983, ASTROPHYS J, V267, pL65, DOI 10.1086/184004; Dobrzycka D, 2002, ASTROPHYS J, V565, P621, DOI 10.1086/324431; Matthaeus WH, 1999, ASTROPHYS J, V523, pL93, DOI 10.1086/312259; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; SCHMIEDER B, 1989, ASTRON ASTROPHYS, V213, P402; SHIBATA K, 1992, PUBL ASTRON SOC JPN, V44, pL173; Shimojo M, 1996, PUBL ASTRON SOC JPN, V48, P123, DOI 10.1093/pasj/48.1.123; VELLI M, 1993, ASTRON ASTROPHYS, V308, P228; WANG YM, 1993, ASTROPHYS J, V410, pL123, DOI 10.1086/186895; Wood BE, 1999, ASTROPHYS J, V523, P444, DOI 10.1086/307721	14	359	362	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1580	1582		10.1126/science.1147050	http://dx.doi.org/10.1126/science.1147050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063786				2022-12-28	WOS:000251421700032
J	O'Brien, JL				O'Brien, Jeremy L.			Optical quantum computing	SCIENCE			English	Review							COMPUTATION		Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Bristol BS8 1UB, Avon, England; Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England	University of Bristol; University of Bristol	O'Brien, JL (corresponding author), Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Merchant Venturers Bldg,Woodland Rd, Bristol BS8 1UB, Avon, England.	Jeremy.OBrien@bristol.ac.uk	O'Brien, Jeremy L/A-6290-2008	O'Brien, Jeremy/0000-0002-3576-8285				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060302; Benjamin SC, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/194; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Browne DE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010501; Browne DE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.067901; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Dawson CM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.052306; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Devitt SJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052312; DiVincenzo DP, 1998, SUPERLATTICE MICROST, V23, P419, DOI 10.1006/spmi.1997.0520; Franson JD, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062302; Gasparoni S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020504; Gilchrist A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052328; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Grangier P., 2004, NEW J PHYS, V6; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Jelezko F, 2004, J PHYS-CONDENS MAT, V16, pR1089, DOI 10.1088/0953-8984/16/30/R03; Kiesel N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210502; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Koashi M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.030301; Lim YL, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012304; Lu CY, 2007, NAT PHYS, V3, P91, DOI 10.1038/nphys507; Maunz P, 2007, NAT PHYS, V3, P538, DOI 10.1038/nphys644; MIGDAL A, 2004, J MOD OPTIC, P51; Nielsen MA, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.042323; Nielsen MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040503; Nielsen Michael A., 2002, QUANTUM COMPUTATION; O'Brien JL, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060303; O'Brien JL, 2003, NATURE, V426, P264, DOI 10.1038/nature02054; Pittman TB, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052332; Pittman TB, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.032316; Pittman TB, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062311; Prevedel R, 2007, NATURE, V445, P65, DOI 10.1038/nature05346; Ralph TC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.100501; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062324; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012314; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Yoran N, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.037903; [No title captured]	50	644	658	12	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1567	1570		10.1126/science.1142892	http://dx.doi.org/10.1126/science.1142892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063781	Green Submitted			2022-12-28	WOS:000251421700027
J	Okamoto, TJ; Tsuneta, S; Berger, TE; Ichimoto, K; Katsukawa, Y; Lites, BW; Nagata, S; Shibata, K; Shimizu, T; Shine, RA; Suematsu, Y; Tarbell, TD; Title, AM				Okamoto, T. J.; Tsuneta, S.; Berger, T. E.; Ichimoto, K.; Katsukawa, Y.; Lites, B. W.; Nagata, S.; Shibata, K.; Shimizu, T.; Shine, R. A.; Suematsu, Y.; Tarbell, T. D.; Title, A. M.			Coronal transverse magnetohydrodynamic waves in a solar prominence	SCIENCE			English	Article							H-ALPHA; FILAMENTS; DYNAMICS; THREADS; LIMB; MASS; MOTIONS; REGION	Solar prominences are cool 10(4) kelvin plasma clouds supported in the surrounding 106 kelvin coronal plasma by as-yet-undetermined mechanisms. Observations from Hinode show fine-scale threadlike structures oscillating in the plane of the sky with periods of several minutes. We suggest that these represent Alfven waves propagating on coronal magnetic field lines and that these may play a role in heating the corona.	Natl Astron Observ, Tokyo 1818588, Japan; Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan; Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University; Kyoto University; Lockheed Martin; National Center Atmospheric Research (NCAR) - USA; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Okamoto, TJ (corresponding author), Natl Astron Observ, Tokyo 1818588, Japan.	joten.okamoto@nao.ac.jp		Okamoto, Joten/0000-0003-3765-1774; Shimizu, Toshifumi/0000-0003-4764-6856	Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish; STFC [PP/D002907/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Chae J, 2000, SOL PHYS, V195, P333, DOI 10.1023/A:1005242832293; HIRAYAMA T, 1985, SOL PHYS, V100, P415, DOI 10.1007/BF00158439; Karpen JT, 2006, ASTROPHYS J, V637, P531, DOI 10.1086/498237; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; KUPERUS M, 1974, ASTRON ASTROPHYS, V31, P189; LEROY JL, 1984, ASTRON ASTROPHYS, V131, P33; Lin Y, 2005, SOL PHYS, V226, P239, DOI 10.1007/s11207-005-6876-3; MALHERBE JM, 1983, ASTRON ASTROPHYS, V119, P197; Martin SF, 1998, SOL PHYS, V182, P107, DOI 10.1023/A:1005026814076; Nakariakov V. M., 2005, LRSP, V2, P41, DOI DOI 10.12942/LRSP-2005-3; Patsourakos S, 2002, SOL PHYS, V208, P253, DOI 10.1023/A:1020510120772; SCHMIEDER B, 1991, ASTRON ASTROPHYS, V252, P353; Schrijver CJ, 1999, SOL PHYS, V187, P261, DOI 10.1023/A:1005194519642; Schrijver CJ, 2002, SOL PHYS, V206, P69, DOI 10.1023/A:1014957715396; SIMON G, 1986, ASTRON ASTROPHYS, V166, P319; SUEMATSU Y, 1990, PUBL ASTRON SOC JPN, V42, P187; VIAL JC, 1979, SOL PHYS, V61, P39, DOI 10.1007/BF00155445; WITHBROE GL, 1977, ANNU REV ASTRON ASTR, V15, P363, DOI 10.1146/annurev.aa.15.090177.002051; Zirker JB, 1998, NATURE, V396, P440, DOI 10.1038/24798	19	282	287	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1577	1580		10.1126/science.1145447	http://dx.doi.org/10.1126/science.1145447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063785	Green Submitted			2022-12-28	WOS:000251421700031
J	Contant, CME; Hop, WCJ; van 't Sant, HP; Oostvogel, HJM; Smeets, HJ; Stassen, LPS; Neijenhuis, PA; Idenburg, FJ; Dijkhuis, CM; Heres, P; van Tets, WF; Gerritsen, JJGM; Weidema, WF				Contant, Caroline M. E.; Hop, Wim C. J.; van 't Sant, Hans Pieter; Oostvogel, Henk J. M.; Smeets, Harm J.; Stassen, Laurents P. S.; Neijenhuis, Peter A.; Idenburg, Floris J.; Dijkhuis, Cees M.; Heres, Piet; van Tets, Willem F.; Gerritsen, Jos J. G. M.; Weidema, Wibo F.			Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial	LANCET			English	Article							POLYETHYLENE-GLYCOL SOLUTION; OPEN COLON SURGERY; CLINICAL-TRIAL; SODIUM-PHOSPHATE; PREOPERATIVE PREPARATION; NO PREPARATION; LAVAGE; TRANSLOCATION; CONTAMINATION; RESECTION	Background Mechanical bowel preparation is a common practice before elective colorectal surgery. We aimed to compare the rate of anastomotic leakage after elective colorectal. resections and primary anastomoses between patients who did or did not have mechanical bowel preparation. Methods We did a multicentre randomised non-inferiority study at 13 hospitals. We randomly assigned 1431 patients who were going to have elective colorectal. surgery to either receive mechanical bowel preparation or not. Patients who did not have mechanical bowel preparation had a normal meal on the day before the operation. Those who did were given a fluid diet, and mechanical bowel preparation with either polyethylene glycol or sodium phosphate. The primary endpoint was anastomotic leakage, and the study was designed to test the hypothesis that patients who are given mechanical bowel preparation before colorectal surgery do not have a lower risk of anastomotic leakage than those who are not. The median follow-up was 24 days (IQR 17-34). We analysed patients who were treated as per protocol. This study is registered with ClinicalTrials.gov; number NCT00288496. Findings 77 patients were excluded: 46 who did not have a bowel resection; 21 because of missing outcome data; and 10 who withdrew, cancelled, or were excluded for other reasons. The rate of anastomotic leakage did not differ between both groups: 32/670 (4.8%) patients who had mechanical bowel preparation and 37/684 (5.4%) in those who did not (difference 0.6%, 95% CI -1.7% to 2.9%, p=0.69). Patients who had mechanical bowel preparation had fewer abscesses after anastomotic leakage than those who did not (2/670 [0.3%] vs 17/684 [2.5%], p=0.001). Other septic complications, fascia dehiscence, and mortality did not differ between groups. Interpretation We advise that mechanical bowel preparation before elective colorectal. surgery can safely be abandoned.	[Contant, Caroline M. E.; van 't Sant, Hans Pieter; Weidema, Wibo F.] Ikazia Hosp, Dept Surg, NL-3083 AN Rotterdam, Netherlands; [Hop, Wim C. J.] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Oostvogel, Henk J. M.] Elisabeth Hosp, Dept Surg, Tilburg, Netherlands; [Smeets, Harm J.] Bronovo Hosp, Dept Surg, The Hague, Netherlands; [Stassen, Laurents P. S.] Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands; [Neijenhuis, Peter A.] Rijnland Hosp, Dept Surg, Leiderdorp, Netherlands; [Idenburg, Floris J.] Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands; [Dijkhuis, Cees M.] Oosterschelde Hosp, Dept Surg, Goes, Netherlands; [Heres, Piet] Waterland Hosp, Dept Surg, Purmerend, Netherlands; [van Tets, Willem F.] Lucas Andreas Hosp, Dept Surg, Amsterdam, Netherlands; [Gerritsen, Jos J. G. M.] Med Spectrum Twente, Dept Surg, Enschede, Netherlands	Ikazia Hospital; Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Haaglanden Medical Center; Bronovo Hospital; Reinier de Graaf Hospital; Rijnland Hospital; Haaglanden Medical Center; Sint Lucas Andreas Hospital; Medical Spectrum Twente	Contant, CME (corresponding author), Ikazia Hosp, Dept Surg, Montessoriweg 1, NL-3083 AN Rotterdam, Netherlands.	brusselcontant@chello.nl						BARKER K, 1971, BRIT J SURG, V58, P270, DOI 10.1002/bjs.1800580409; Beloosesky Y, 2003, ARCH INTERN MED, V163, P803, DOI 10.1001/archinte.163.7.803; Brownson P, 1992, BRIT J SURG, V79, P461; Bucher P, 2005, BRIT J SURG, V92, P409, DOI 10.1002/bjs.4900; BURKE P, 1994, BRIT J SURG, V81, P907, DOI 10.1002/bjs.1800810639; CHUNG RS, 1979, AM J SURG, V137, P75, DOI 10.1016/0002-9610(79)90014-X; DUNPHY JE, 1971, CANCER, V28, P181, DOI 10.1002/1097-0142(197107)28:1<181::AID-CNCR2820280136>3.0.CO;2-9; Ell C, 2003, ENDOSCOPY, V35, P300, DOI 10.1055/s-2003-38150; Fa-Si-Oen P, 2005, DIS COLON RECTUM, V48, P1509, DOI 10.1007/s10350-005-0068-y; Fa-Si-Oen PR, 2005, CLIN MICROBIOL INFEC, V11, P158, DOI 10.1111/j.1469-0691.2004.01012.x; Frizelle FA, 2005, DIS COLON RECTUM, V48, P393, DOI 10.1007/s10350-004-0778-6; Golub R, 1997, J AM COLL SURGEONS, V184, P364; Guenaga KF, 2005, COCHRANE DB SYST REV, V1; Hamilton D, 1996, BRIT J CLIN PRACT, V50, P73; Hookey LC, 2004, AM J GASTROENTEROL, V99, P2217, DOI 10.1111/j.1572-0241.2004.40482.x; IRVING AD, 1987, BRIT J SURG, V74, P580, DOI 10.1002/bjs.1800740711; Jung B, 2007, BRIT J SURG, V94, P689, DOI 10.1002/bjs.5816; Kale TI, 1998, DIS COLON RECTUM, V41, P636, DOI 10.1007/BF02235274; Mahajna A, 2005, DIS COLON RECTUM, V48, P1626, DOI 10.1007/s10350-005-0073-1; Miettinen RPJ, 2000, DIS COLON RECTUM, V43, P669; NICHOLS RL, 1971, SURG GYNECOL OBSTETR, V132, P323; Oliveira L, 1997, DIS COLON RECTUM, V40, P585, DOI 10.1007/BF02055384; Platell C, 2006, BRIT J SURG, V93, P427, DOI 10.1002/bjs.5274; Platell C, 1998, DIS COLON RECTUM, V41, P875, DOI 10.1007/BF02235369; POOLE GV, 1991, SOUTHERN MED J, V84, P1412, DOI 10.1097/00007611-199111000-00036; Ram E, 2005, ARCH SURG-CHICAGO, V140, P285, DOI 10.1001/archsurg.140.3.285; SANTOS JCM, 1994, BRIT J SURG, V81, P1673, DOI 10.1002/bjs.1800811139; Slim K, 2004, BRIT J SURG, V91, P1125, DOI 10.1002/bjs.4651; Zmora O, 2003, ANN SURG, V237, P363, DOI 10.1097/00000658-200303000-00010	29	201	219	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2112	2117		10.1016/S0140-6736(07)61905-9	http://dx.doi.org/10.1016/S0140-6736(07)61905-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156032				2022-12-28	WOS:000252058600031
J	Saif-ur-Rehman; Rasoul, MZ; Wodak, A; Claeson, M; Friedman, J; Sayed, GD				Saif-ur-Rehman; Rasoul, Mohammad Zafar; Wodak, Alex; Claeson, Mariam; Friedman, Jed; Sayed, Ghulam Dastagir			Responding to HIV in Afghanistan	LANCET			English	Editorial Material									[Claeson, Mariam] World Bank, AIDS S Asia Reg, Washington, DC 20433 USA; [Saif-ur-Rehman] Minist Publ Hlth, Natl AIDS Control Programme, Kabul, Afghanistan; [Rasoul, Mohammad Zafar] Minist Counter Narcot, Kabul, Afghanistan; [Wodak, Alex] St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia; [Friedman, Jed] World Bank, Dev Econ Res Grp, Washington, DC 20433 USA; [Sayed, Ghulam Dastagir] World Bank, Kabul, Afghanistan	The World Bank; St Vincents Hospital Sydney; The World Bank; The World Bank	Claeson, M (corresponding author), World Bank, AIDS S Asia Reg, 1818 H St NW, Washington, DC 20433 USA.	mclaeson@worldbank.org	Friedman, Jed/AAA-1326-2020					*2004 AFGH NAT HLT, 2006, HLTH SEEK BEH HLTH; ATANASIJEVIC M, 2007, MDM HARM REDUCTION N; BEALL J, URBAN LIVELIHOODS AF; BERTOZZI S, 2006, HIV AIDS PREVENTION, P331; *CENTR INT AG, WORLD FACT BOOK AFGH; International Monetary Fund, 2006, WORLD EC OUTL DAT; KASSI M, INJECTING DRUG USERS; MILLS A, CHALLENGE PAPER COMM; MOSES S, 2006, AIDS S ASIA UND RESP; Razzaghi E, 2006, LANCET, V368, P434, DOI 10.1016/S0140-6736(06)69132-0; Saidel T. J., 2003, International Journal of Drug Policy, V14, P63, DOI 10.1016/S0955-3959(02)00209-8; SAIDEL TJ, 2006, HARM REDUCTION J, V3, P26; TODD CS, 2006, PREVALENCE HIV VIRAL; TODD CS, 2007, EMERGING INFECT DIS; *UN OFF DRUGS CRIM, AFGH DRUG IND STRUCT; *UN OFF DRUGS CRIM, 2005, GOV AFGH MIN COUNT; *UN OFF DRUGS CRIM, 2007, OP SURV; UNICEF, AFGH STAT; United Nations Office on Drugs and Crime, 2006, AFGH OP SURV; Waldman Ronald, 2006, BRIEFING PAPER SERIE; Zaba B, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200406002-00001	21	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2167	2169		10.1016/S0140-6736(07)61911-4	http://dx.doi.org/10.1016/S0140-6736(07)61911-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156038				2022-12-28	WOS:000252058600039
J	Hilton, DR				Hilton, David R.			Geochemistry - The leaking mantle	SCIENCE			English	Editorial Material							SAN-ANDREAS FAULT; HELIUM; SYSTEM		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Hilton, DR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	drhilton@ucsd.edu	Hilton, David/B-7611-2008					Flesch LM, 2000, SCIENCE, V287, P834, DOI 10.1126/science.287.5454.834; Kennedy BM, 2007, SCIENCE, V318, P1433, DOI 10.1126/science.1146511; Kennedy BM, 2006, GEOTHERMICS, V35, P26, DOI 10.1016/j.geothermics.2005.09.004; Kennedy BM, 1997, SCIENCE, V278, P1278, DOI 10.1126/science.278.5341.1278; LUPTON JE, 1975, EARTH PLANET SC LETT, V26, P133, DOI 10.1016/0012-821X(75)90080-1; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Pepin RO, 2002, REV MINERAL GEOCHEM, V47, P191, DOI 10.2138/rmg.2002.47.7; Umeda K, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB005031	9	26	34	4	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1389	1390		10.1126/science.1151983	http://dx.doi.org/10.1126/science.1151983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048671				2022-12-28	WOS:000251246100025
J	Patzold, M; Hausler, B; Bird, MK; Tellmann, S; Mattei, R; Asmar, SW; Dehant, V; Eidel, W; Imamura, T; Simpson, RA; Tyler, GL				Paetzold, M.; Haeusler, B.; Bird, M. K.; Tellmann, S.; Mattei, R.; Asmar, S. W.; Dehant, V.; Eidel, W.; Imamura, T.; Simpson, R. A.; Tyler, G. L.			The structure of Venus' middle atmosphere and ionosphere	NATURE			English	Article							RADIO OCCULTATION; SOLAR-CYCLE	The atmosphere and ionosphere of Venus have been studied in the past by spacecraft with remote sensing(1-4) or in situ techniques(3,4). These early missions, however, have left us with questions about, for example, the atmospheric structure in the transition region from the upper troposphere to the lower mesosphere (50-90 km) and the remarkably variable structure of the ionosphere. Observations become increasingly difficult within and below the global cloud deck (<50 km altitude), where strong absorption greatly limits the available investigative spectrum to a few infrared windows and the radio range. Here we report radio-sounding results from the first Venus Express Radio Science(5) (VeRa) occultation season. We determine the fine structure in temperatures at upper cloud-deck altitudes, detect a distinct day-night temperature difference in the southern middle atmosphere, and track day-to-day changes in Venus' ionosphere.	Univ Cologne, Rhein Inst Umweltforsch, Abt Planetenforsch, D-50931 Cologne, Germany; Univ Bundeswehr Munchen, Inst Raumfahrttech, D-85577 Neubiberg, Germany; Argelander Inst Astron, D-53121 Bonn, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Observ Royal Belgique, B-1180 Brussels, Belgium; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan; Stanford Univ, Space Telecommun & Radiosci Lab, Stanford, CA 94305 USA	University of Cologne; Bundeswehr University Munich; University of Bonn; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Stanford University	Patzold, M (corresponding author), Univ Cologne, Rhein Inst Umweltforsch, Abt Planetenforsch, Aachener Str 201-209, D-50931 Cologne, Germany.	paetzold@geo.uni-koeln.de						[Anonymous], 1967, SCIENCE, V158, P1678, DOI 10.1126/science.158.3809.1678; BOUGHER SW, 1997, VENUS II GEOLOGY GEO; FJELDBO G, 1971, ASTRON J, V76, P123, DOI 10.1086/111096; Fox JL, 2001, J GEOPHYS RES-SPACE, V106, P21305, DOI 10.1029/2001JA000069; Fox JL, 1997, SPACE SCI S, P161; Hausler B, 2006, PLANET SPACE SCI, V54, P1315, DOI 10.1016/j.pss.2006.04.032; HOWARD HT, 1974, SCIENCE, V183, P1297, DOI 10.1126/science.183.4131.1297; Hunten D. M., 1983, VENUS; JENKINS JM, 1994, ICARUS, V110, P79, DOI 10.1006/icar.1994.1108; KLIORE AJ, 1991, J GEOPHYS RES-SPACE, V96, P21281, DOI 10.1029/91JA01829; KLIORE AJ, 1991, J GEOPHYS RES-SPACE, V96, P11065, DOI 10.1029/91JA00672; Kliore AJ, 1980, J GEOPHYS RES-SPACE, V85, P7957, DOI 10.1029/JA085iA13p07957; Taylor FW, 1980, J GEOPHYS RES-SPACE, V85, P7963, DOI 10.1029/JA085iA13p07963; von Zahn U., 1983, Venus, P299	14	78	80	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					657	660		10.1038/nature06239	http://dx.doi.org/10.1038/nature06239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046400				2022-12-28	WOS:000251209700040
J	Russell, CT; Zhang, TL; Delva, M; Magnes, W; Strangeway, RJ; Wei, HY				Russell, C. T.; Zhang, T. L.; Delva, M.; Magnes, W.; Strangeway, R. J.; Wei, H. Y.			Lightning on Venus inferred from whistler-mode waves in the ionosphere	NATURE			English	Article								The occurrence of lightning in a planetary atmosphere enables chemical processes to take place that would not occur under standard temperatures and pressures(1-3). Although much evidence has been reported for lightning on Venus(4-8), some searches have been negative(9-11) and the existence of lightning has remained controversial. A definitive detection would be the confirmation of electromagnetic, whistler-mode waves propagating from the atmosphere to the ionosphere. Here we report observations of Venus' ionosphere that reveal strong, circularly polarized, electromagnetic waves with frequencies near 100 Hz. The waves appear as bursts of radiation lasting 0.25 to 0.5 s, and have the expected properties of whistler-mode signals generated by lightning discharges in Venus' clouds.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria	University of California System; University of California Los Angeles; Austrian Academy of Sciences	Russell, CT (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	ctrussell@igpp.ucla.edu	Russell, Christopher T/E-7745-2012	Russell, Christopher T/0000-0003-1639-8298				BARNUN A, 1980, ICARUS, V42, P338, DOI 10.1016/0019-1035(80)90099-8; BORUCKI WJ, 1991, J GEOPHYS RES-SPACE, V96, P11033, DOI 10.1029/91JA01097; Desch SJ, 2002, REP PROG PHYS, V65, P955, DOI 10.1088/0034-4885/65/6/202; Gurnett DA, 2001, NATURE, V409, P313, DOI 10.1038/35053009; GURNETT DA, 1991, SCIENCE, V253, P1522, DOI 10.1126/science.253.5027.1522; HANSELL SA, 1995, ICARUS, V117, P345, DOI 10.1006/icar.1995.1160; Krasnopolsky VA, 2006, ICARUS, V182, P80, DOI 10.1016/j.icarus.2005.12.003; KRASNOPOLSKY VA, 1983, PLANET SPACE SCI, V31, P1363, DOI 10.1016/0032-0633(83)90072-7; Ksanfomaliti L.V., 1983, COSMIC RES+, V21, P279; RUSSELL CT, 1990, ADV SPACE RES-SERIES, V10, P125, DOI 10.1016/0273-1177(90)90173-W; RUSSELL CT, 1990, ADV SPACE RES-SERIES, V10, P37, DOI 10.1016/0273-1177(90)90163-T; RUSSELL CT, 1993, ANNU REV EARTH PL SC, V21, P43, DOI 10.1146/annurev.ea.21.050193.000355; RUSSELL CT, 1989, GEOPHYS RES LETT, V16, P579, DOI 10.1029/GL016i006p00579; SAGDEEV RZ, 1986, SCIENCE, V231, P1411, DOI 10.1126/science.231.4744.1411; Zhang TL, 2006, PLANET SPACE SCI, V54, P1336, DOI 10.1016/j.pss.2006.04.018	15	74	77	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					661	662		10.1038/nature05930	http://dx.doi.org/10.1038/nature05930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046401				2022-12-28	WOS:000251209700041
J	von Elm, E; Altman, DG; Egger, M; Pocock, SJ; Gotzsche, PC; Vandenbroucke, JP				von Elm, Erik; Altman, Douglas G.; Egger, Matthias; Pocock, Stuart J.; Gotzsche, Peter C.; Vandenbroucke, Jan P.		STROBE Initiative	The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-RESEARCH; QUALITY; CONSORT; EXTENSION; INTERVENTIONS; HARMS; BIAS; NEED	Much biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalisability. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) initiative developed recommendations on what should be included in an accurate and complete report of an observational study. We defined the scope of the recommendations to cover three main study designs: cohort, case-control, and cross-sectional studies. We convened a 2-day workshop in September, 2004, with methodologists, researchers, and journal editors to draft a checklist of items. This list was subsequently revised during several meetings of the coordinating group and in e-mail discussions with the larger group of STROBE contributors, taking into account empirical evidence and methodological considerations. The workshop and the subsequent iterative process of consultation and revision resulted in a checklist of 22 items (the STROBE statement) that relate to the title, abstract, introduction, methods, results, and discussion sections of articles. 18 items are common to all three study designs and four are specific for cohort, case-control, or cross-sectional studies. A detailed explanation and elaboration document is published separately and is freely available on the websites of PLoS Medicine, Annals of Internal Medicine, and Epidemiology. We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies.	Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Oxford, Ctr Stat Med, Oxford, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ London, London Sch Hyg & Trop Med, London, England; Nord Cochrane Ctr, Copenhagen, Denmark; Univ Leiden Hosp, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands	University of Bern; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC)	von Elm, E (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	strobe@ispm.unibe.ch	Vandenbroucke, Jan/AAM-3928-2020; Ioannidis, John P. A./G-9836-2011	Vandenbroucke, Jan/0000-0001-5668-6716; Egger, Matthias/0000-0001-7462-5132; von Elm, Erik/0000-0002-7412-0406				[Anonymous], 1981, Am J Epidemiol, V114, P609; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Black N, 1996, BRIT MED J, V312, P1215; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2004, BMJ-BRIT MED J, V328, P39, DOI 10.1136/bmj.328.7430.39; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lee W, 2007, BRIT J PSYCHIAT, V190, P204, DOI 10.1192/bjp.bp.106.027250; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2004, CAN MED ASSOC J, V171, P349, DOI 10.1503/cmaj.1040031; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Ormerod AD, 2001, BRIT J DERMATOL, V145, P378, DOI 10.1046/j.1365-2133.2001.04404.x; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; Rennie D, 2001, JAMA-J AM MED ASSOC, V285, P2006, DOI 10.1001/jama.285.15.2006; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Schriger DL, 2005, ANN EMERG MED, V45, P437, DOI 10.1016/j.annemergmed.2004.09.022; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; VANDENBROUCKE JP, IN PRESS ANN INTERN; VANDENBROUCKE JP, IN PRESS EPIDEMIOLOG	29	8138	8166	3	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1453	1457		10.1016/S0140-6736(07)61602-X	http://dx.doi.org/10.1016/S0140-6736(07)61602-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	18064739	Green Published, Green Accepted			2022-12-28	WOS:000250386000022
J	Kopka, A				Kopka, Andreas			Ghost in the machine?	BRITISH MEDICAL JOURNAL			English	Editorial Material									So Gen Hosp, Greater Glasgow Univ Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Kopka, A (corresponding author), So Gen Hosp, Greater Glasgow Univ Hosp, Glasgow G51 4TF, Lanark, Scotland.	a.kopka@doctors.org.uk						DAVIS PD, 1998, BASIC PHYS MEASUREME; Pilotto S, 2001, LASER MED SCI, V16, P2, DOI 10.1007/PL00011332	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1298	1298		10.1136/bmj.39408.651053.AD	http://dx.doi.org/10.1136/bmj.39408.651053.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156237	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000252182700018
J	Groth, A; Corpet, A; Cook, AJL; Roche, D; Bartek, J; Lukas, J; Almouzni, G				Groth, Anja; Corpet, Armelle; Cook, Adam J. L.; Roche, Daniele; Bartek, Jiri; Lukas, Jiri; Almouzni, Genevieve			Regulation of replication fork progression through histone supply and demand	SCIENCE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; DNA-REPLICATION; STRUCTURAL BASIS; HUMAN ASF1; CHROMATIN; H3; ATR; COMPLEXES; HELICASE	DNA replication in eukaryotes requires nucleosome disruption ahead of the replication fork and reassembly behind. An unresolved issue concerns how histone dynamics are coordinated with fork progression to maintain chromosomal stability. Here, we characterize a complex in which the human histone chaperone Asf1 and MCM2-7, the putative replicative helicase, are connected through a histone H3-H4 bridge. Depletion of Asf1 by RNA interference impedes DNA unwinding at replication sites, and similar defects arise from overproduction of new histone H3-H4 that compromises Asf1 function. These data link Asf1 chaperone function, histone supply, and replicative unwinding of DNA in chromatin. We propose that Asf1, as a histone acceptor and donor, handles parental and new histones at the replication fork via an Asf1-( H3- H4)- MCM2- 7 intermediate and thus provides a means to fine- tune replication fork progression and histone supply and demand.	Inst Curie, Lab Nucl Dynam & Genome Plastic, CNRS, UMR218, F-75248 Paris 05, France; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Danish Cancer Society; Danish Cancer Society	Almouzni, G (corresponding author), Inst Curie, Lab Nucl Dynam & Genome Plastic, CNRS, UMR218, 26 Rue Ulm, F-75248 Paris 05, France.	Genevieve.Almouzni@curie.fr	Bartek, Jiri/G-5870-2014; Groth, Anja/AAH-5386-2019; Almouzni, Genevieve/ABG-1029-2021; Corpet, Armelle/GLT-6199-2022	Groth, Anja/0000-0003-0577-1771; Almouzni, Genevieve/0000-0001-5570-0723; Cook, Adam/0000-0002-5735-522X; Lukas, Jiri/0000-0001-9087-506X; Corpet, Armelle/0000-0002-2126-5783				Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fujita M, 1997, J BIOL CHEM, V272, P10928; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	25	325	330	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1928	1931		10.1126/science.1148992	http://dx.doi.org/10.1126/science.1148992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096807	Green Published			2022-12-28	WOS:000251786600060
J	Chambers, I; Silva, J; Colby, D; Nichols, J; Nijmeijer, B; Robertson, M; Vrana, J; Jones, K; Grotewold, L; Smith, A				Chambers, Ian; Silva, Jose; Colby, Douglas; Nichols, Jennifer; Nijmeijer, Bianca; Robertson, Morag; Vrana, Jan; Jones, Ken; Grotewold, Lars; Smith, Austin			Nanog safeguards pluripotency and mediates germline development	NATURE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE EPIBLAST; ES CELLS; EXPRESSION; GENES; NETWORK; PROTEIN; CLONING	Nanog is a divergent homeodomain protein found in mammalian pluripotent cells and developing germ cells(1,2). Deletion of Nanog causes early embryonic lethality(2), whereas constitutive expression enables autonomous self- renewal of embryonic stem cells(1). Nanog is accordingly considered a core element of the pluripotent transcriptional network(3-7). However, here we report that Nanog fluctuates in mouse embryonic stem cells. Transient downregulation of Nanog appears to predispose cells towards differentiation but does not mark commitment. By genetic deletion we show that, although they are prone to differentiate, embryonic stem cells can self- renew indefinitely in the permanent absence of Nanog. Expanded Nanog null cells colonize embryonic germ layers and exhibit multilineage differentiation both in fetal and adult chimaeras. Although they are also recruited to the germ line, primordial germ cells lacking Nanog fail to mature on reaching the genital ridge. This defect is rescued by repair of the mutant allele. Thus Nanog is dispensible for expression of somatic pluripotency but is specifically required for formation of germ cells. Nanog therefore acts primarily in construction of inner cell mass and germ cell states rather than in the housekeeping machinery of pluripotency. We surmise that Nanog stabilizes embryonic stem cells in culture by resisting or reversing alternative gene expression states.	Univ Edinburgh, MRC Ctr Dev Stem Cell Biol, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England	University of Edinburgh; University of Cambridge; University of Cambridge; University of Cambridge	Chambers, I (corresponding author), Univ Edinburgh, MRC Ctr Dev Stem Cell Biol, Inst Stem Cell Res, Sch Biol Sci, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	ichambers@ed.ac.uk	Vrana, Jan/F-7306-2014; Chambers, Ian/H-5416-2011; Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019	Vrana, Jan/0000-0001-6171-8516; Chambers, Ian/0000-0003-2605-1597; Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682; Nijmeijer-Winter, Bianca/0000-0002-9429-8439; Nichols, Jennifer/0000-0002-8650-1388	Medical Research Council [G0300723B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [G15381/2] Funding Source: Medline; Medical Research Council [G9806702, G0300058] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0300058, G9806702] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHAMBERS I, 2004, REND FIS ACC LINCEI, P83; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Vallier L, 2001, P NATL ACAD SCI USA, V98, P2467, DOI 10.1073/pnas.041617198; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	33	1107	1157	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1230	U8		10.1038/nature06403	http://dx.doi.org/10.1038/nature06403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097409				2022-12-28	WOS:000251786200050
J	Nagrath, S; Sequist, LV; Maheswaran, S; Bell, DW; Irimia, D; Ulkus, L; Smith, MR; Kwak, EL; Digumarthy, S; Muzikansky, A; Ryan, P; Balis, UJ; Tompkins, RG; Haber, DA; Toner, M				Nagrath, Sunitha; Sequist, Lecia V.; Maheswaran, Shyamala; Bell, Daphne W.; Irimia, Daniel; Ulkus, Lindsey; Smith, Matthew R.; Kwak, Eunice L.; Digumarthy, Subba; Muzikansky, Alona; Ryan, Paula; Balis, Ulysses J.; Tompkins, Ronald G.; Haber, Daniel A.; Toner, Mehmet			Isolation of rare circulating tumour cells in cancer patients by microchip technology	NATURE			English	Article							METASTATIC BREAST-CANCER; ON-A-CHIP; PERIPHERAL-BLOOD; CARCINOMA-CELLS; EXPRESSION; FLOW; MICROFLUIDICS; ENUMERATION; SEPARATION	Viable tumour- derived epithelial cells ( circulating tumour cells or CTCs) have been identified in peripheral blood from cancer patients and are probably the origin of intractable metastatic disease(1-4). Although extremely rare, CTCs represent a potential alternative to invasive biopsies as a source of tumour tissue for the detection, characterization and monitoring of non-haematologic cancers(5-8). The ability to identify, isolate, propagate and molecularly characterize CTC subpopulations could further the discovery of cancer stem cell biomarkers and expand the understanding of the biology of metastasis. Current strategies for isolating CTCs are limited to complex analytic approaches that generate very low yield and purity(9). Here we describe the development of a unique microfluidic platform ( the 'CTC-chip') capable of efficient and selective separation of viable CTCs from peripheral whole blood samples, mediated by the interaction of target CTCs with antibody ( EpCAM)- coated microposts under precisely controlled laminar flow conditions, and without requisite pre- labelling or processing of samples. The CTC- chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 ( 99%) samples, with a range of 5-1,281 CTCs per ml and approximately 50% purity. In addition, CTCs were isolated in 7/7 patients with early- stage prostate cancer. Given the high sensitivity and specificity of the CTC- chip, we tested its potential utility in monitoring response to anti- cancer therapy. In a small cohort of patients with metastatic cancer undergoing systemic treatment, temporal changes in CTC numbers correlated reasonably well with the clinical course of disease as measured by standard radiographic methods. Thus, the CTC- chip provides a new and effective tool for accurate identification and measurement of CTCs in patients with cancer. It has broad implications in advancing both cancer biology research and clinical cancer management, including the detection, diagnosis and monitoring of cancer(10).	Harvard Univ, Sch Med, Surg Serv, Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, BioMEMS Resource Ctr, Massachusetts Gen Hosp, Boston, MA 02114 USA; Shriners Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Toner, M (corresponding author), Harvard Univ, Sch Med, Surg Serv, Massachusetts Gen Hosp, Boston, MA 02114 USA.	mtoner@hms.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Balis, Ulysses/0000-0002-4168-1477	NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bell DW, 2006, CLIN CANCER RES, V12, P3875, DOI 10.1158/1078-0432.CCR-06-0670; Braun S, 2004, NEW ENGL J MED, V351, P824, DOI 10.1056/NEJMe048163; Chang WC, 2005, LAB CHIP, V5, P64, DOI 10.1039/b400455h; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; DRUMMOND JE, 1984, INT J MULTIPHAS FLOW, V10, P515, DOI 10.1016/0301-9322(84)90079-X; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Kahn HJ, 2004, BREAST CANCER RES TR, V86, P237, DOI 10.1023/B:BREA.0000036897.92513.72; Kraeft SK, 2004, CLIN CANCER RES, V10, P3020, DOI 10.1158/1078-0432.CCR-03-0361; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rao CG, 2005, INT J ONCOL, V27, P49; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Smerage JB, 2006, BRIT J CANCER, V94, P8, DOI 10.1038/sj.bjc.6602871; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Terstappen LWMM, 1998, VOX SANG, V74, P269, DOI 10.1111/j.1423-0410.1998.tb05431.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Zieglschmid V, 2005, CRIT REV CL LAB SCI, V42, P155, DOI 10.1080/10408360590913696	32	2752	3021	78	2152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1235	U10		10.1038/nature06385	http://dx.doi.org/10.1038/nature06385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097410	Green Accepted			2022-12-28	WOS:000251786200051
J	Yasunaga, H				Yasunaga, Hideo			Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan	LANCET			English	Article								In 1977, the US Food and Drug Administration revoked all licences for fibrinogen concentrate because of the risk for hepatitis infection and suspected lack of effectiveness. However, in Japan, fibrinogen concentrate was used routinely for treatment of obstetric bleeding until 1988. Even in 1997, academic texts by Japanese authorities in obstetrics still recommended that obstetricians use the product. An estimated 10 000 cases of hepatitis C infection are attributable to use of fibrinogen in Japan and are a result of authoritarianism that hindered effective policy changes. Scientists have a duty to refine repeatedly the quality of their evidence, and policymakers need to adjust existing policies continually to accord with the latest scientific evidence.	Tokyo Univ Hosp, Dept Planning Informat & Management, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Yasunaga, H (corresponding author), Tokyo Univ Hosp, Dept Planning Informat & Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	yasunagah-jyo@h.u-tokyo.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X				AMEMIYA A, 1988, OBSTET GYNECOL THER, V57, P1; *CENTR PHARM AFF C, 1987, KETS YOZ SAIH CHOS H; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CRONBERG S, 1963, LANCET, V1, P967; FEINSTEIN DI, 1982, BLOOD, V60, P284; HASEGAWA I, 2003, KANZO S2, V44, pA430; IGARASHI M, 1996, SANFUJINKA SAISHIN S, P709; INOUE N, 1989, J JPN SOC INTERN MED, V78, P726; KAJII T, 1963, LANCET, V1, P501; Kanai Masatoshi, 2004, Nihon Rinsho, V62 Suppl 7, P272; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; MAINWARING RL, 1966, J AMER MED ASSOC, V195, P437, DOI 10.1001/jama.195.6.437; MAKI M, 1980, BUNBENJI SHUKKETSU N, P209; *MIN HLTH LAB WELF, 2002, FIB SEIZ SHIY NO; *MIN HLTH LAB WELF, 2002, FIB SEIZ NIYOR C GAT; NAKAYAMA M, 1990, KONNICHI NO CHIRYO S, V32, P672; PRINCE AM, 1974, LANCET, V2, P241; PRITCHARD JA, 1967, AM J OBSTET GYNECOL, V97, P681, DOI 10.1016/0002-9378(67)90454-1; RETTEW PL, 1957, OBSTET GYNECOL, V10, P169; SAKAMOTO S, 1991, PURINSHIPURU SANKA F, P622; SEINO Y, 1991, MED J MISAWA MUNI HO, V1, P2; SUZUKI S, 1996, SHUSANKI SHUKKETSU N, P242; TAMAYA T, 1997, SANFUJINKA NO YOUTEN, P270; *WORLD FED HEM, 2003, WORLD FED HEM 3 GLOB; YASUMIZU T, 1992, HAI RISUKU NINSHIN K; YOKOI Y, 1984, JPN J TRANSFUS MED, V30, P370; Yoshizawa H, 2005, INTERVIROLOGY, V49, P7, DOI 10.1159/000087257; ZAINO EC, 1960, OBSTET GYNECOL, V15, P404; 2001, KANEN TAISAKU NI KAN; 1978, FED REG, V43, P1131	30	23	23	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2063	2067		10.1016/S0140-6736(07)61867-4	http://dx.doi.org/10.1016/S0140-6736(07)61867-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083405				2022-12-28	WOS:000251698600033
J	Lee, JS; Shukla, A; Schneider, J; Swanson, SK; Washburn, MP; Florens, L; Bhaumik, SR; Shilatifard, A				Lee, Jung-Shin; Shukla, Abhijit; Schneider, Jessica; Swanson, Selene K.; Washburn, Michael P.; Florens, Laurence; Bhaumik, Sukesh R.; Shilatifard, Ali			Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS	CELL			English	Article							SPECTRAL ABUNDANCE FACTORS; RNA-POLYMERASE-II; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; TRANSCRIPTIONAL REGULATION; COVALENT MODIFICATIONS; MAMMALIAN CHROMATIN; SHOTGUN PROTEOMICS; TRITHORAX FAMILY	COMPASS, the yeast homolog of the mammalian MLL complex, is a histone H3 lysine 4 (H3K4) methylase consisting of Set1 (KMT2) and seven other polypeptides, including Cps35, the only essential subunit. Histone H2B monoubiquitination by Rad6/Bre1 is required for both H3K4 methylation by COMPASS, and H3K79 methylation by Dot1. However, the molecular mechanism for such histone crosstalk is poorly understood. Here, we demonstrate that histone H2B monoubiquitination controls the binding of Cps35 with COMPASS complex. Cps 35 is required for COMPASS' catalytic activity in vivo, and the addition of exogenous purified Cps35 to COMPASS purified from a Delta rad6 background results in the generation of a methylation competent COMPASS. Cps35 associates with the chromatin of COMPASS-regulated genes in a H2BK123 monoubiquitination-dependent but Set1-independent manner. Cps35 is also required for proper H3K79 trimethylation. These findings offer insight into the molecular role of Cps35 in translating the H2B monoubiquitination signal into H3 methylation.	[Lee, Jung-Shin; Schneider, Jessica; Swanson, Selene K.; Washburn, Michael P.; Florens, Laurence; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shukla, Abhijit; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Stowers Institute for Medical Research; Southern Illinois University System; Southern Illinois University	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers-institute.org		Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; BERGER SL, 2007, IN PRESS NATURE; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; BREEN TR, 1991, MECH DEVELOP, V35, P113, DOI 10.1016/0925-4773(91)90062-B; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; PARVI R, 2006, CELL, V125, P703; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; STEWARD MM, 2006, NATURE SMB, V13, P853; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wood A, 2005, BIOCHEM CELL BIOL, V83, P460, DOI 10.1139/O05-116; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	59	300	311	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1084	1096		10.1016/j.cell.2007.09.046	http://dx.doi.org/10.1016/j.cell.2007.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083099	Bronze			2022-12-28	WOS:000252217100017
J	Tsujimoto, Y; Tassel, C; Hayashi, N; Watanabe, T; Kageyama, H; Yoshimura, K; Takano, M; Ceretti, M; Ritter, C; Paulus, W				Tsujimoto, Y.; Tassel, C.; Hayashi, N.; Watanabe, T.; Kageyama, H.; Yoshimura, K.; Takano, M.; Ceretti, M.; Ritter, C.; Paulus, W.			Infinite-layer iron oxide with a square-planar coordination	NATURE			English	Article							MAGNETIC-PROPERTIES; HIGH-PRESSURE; PEROVSKITE; SUPERCONDUCTIVITY; TRANSITION; SEPARATION; HYDRIDE; SRFEO3; PHASES; LANIO2	Conventional high- temperature reactions limit the control of coordination polyhedra in transition- metal oxides to those obtainable within the bounds of known coordination geometries for a given transition metal(1). For example, iron atoms are almost exclusively coordinated by three- dimensional polyhedra such as tetrahedra and octahedra. However, recent works have shown that binary metal hydrides act as reducing agents at low temperatures, allowing access to unprecedented structures(2-4). Here we show the reaction of a perovskite SrFeO3 with CaH2 to yield SrFeO2, a new compound bearing a square- planar oxygen coordination around Fe2(+). SrFeO2 is isostructural with 'infinite layer' cupric oxides(5-8), and exhibits a magnetic order far above room temperature in spite of the two-dimensional structure, indicating strong in-layer magnetic interactions due to strong Fe d to O p hybridization. Surprisingly, SrFeO2 remains free from the structural instability that might well be expected at low temperatures owing to twofold orbital degeneracy in the Fe2+ ground state with D-4h point symmetry. The reduction and the oxidation between SrFeO2 and SrFeO3 proceed via the brownmillerite- type intermediate SrFeO2.5, and start at the relatively low temperature of similar to 400 K, making the material appealing for a variety of applications, including oxygen ion conduction, oxygen gas absorption and catalysis.	Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; Univ Rennes 1, Sci Chim Rennes UMR CNRS 6226, F-35042 Rennes, France; Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; Res Inst Prod Dev, Sakyo Ku, Kyoto 6060805, Japan; Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	Kyoto University; Universite de Rennes; Kyoto University; Kyoto University; Institut Laue-Langevin (ILL)	Kageyama, H (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	kage@kuchem.kyoto-u.ac.jp	Tsujimoto, Yoshihiro/H-6034-2012; Ceretti, Monica/F-6189-2019; Ceretti, Monica/E-4497-2015; Tassel, Cedric/L-5051-2014; Kageyama, Hiroshi/A-4602-2010	Tsujimoto, Yoshihiro/0000-0003-2140-3362; Ceretti, Monica/0000-0001-9704-8251; Tassel, Cedric/0000-0002-8867-4813; 				Adler P, 2000, J SOLID STATE CHEM, V155, P381, DOI 10.1006/jssc.2000.8928; AZUMA M, 1992, NATURE, V356, P775, DOI 10.1038/356775a0; Badwal SPS, 2001, ADV MATER, V13, P993, DOI 10.1002/1521-4095(200107)13:12/13<993::AID-ADMA993>3.0.CO;2-#; Battle PD, 1998, CHEM COMMUN, P987, DOI 10.1039/a801220b; Berry JF, 2006, SCIENCE, V312, P1937, DOI 10.1126/science.1128506; Blundred GD, 2004, ANGEW CHEM INT EDIT, V43, P3562, DOI 10.1002/anie.200453819; Bouwkamp MW, 2006, J AM CHEM SOC, V128, P13340, DOI 10.1021/ja064711u; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; CRESPIN M, 1983, J CHEM SOC FARAD T 2, V79, P1181, DOI 10.1039/f29837901181; GREENWOOD NN, 1971, MOSSBAUER SPECTROSCO, pCH3; GRENIER JC, 1992, J SOLID STATE CHEM, V96, P20, DOI 10.1016/S0022-4596(05)80293-2; Hayashi N, 2001, J MATER CHEM, V11, P2235, DOI 10.1039/b103259n; Hayward MA, 2006, CHEM MATER, V18, P321, DOI 10.1021/cm051659c; Hayward MA, 2005, CHEM MATER, V17, P670, DOI 10.1021/cm048220p; Hayward MA, 2002, SCIENCE, V295, P1882, DOI 10.1126/science.1068321; Hayward MA, 1999, J AM CHEM SOC, V121, P8843, DOI 10.1021/ja991573i; Hayward MA, 2000, CHEM MATER, V12, P2182, DOI 10.1021/cm9906811; Hazen R. M., 1974, American Mineralogist, V59, P1166; Hodges JP, 2000, J SOLID STATE CHEM, V151, P190, DOI 10.1006/jssc.1999.8640; Hyde B. G., 1989, INORGANIC CRYSTAL ST; Izumi F, 2000, MATER SCI FORUM, V321-3, P198, DOI 10.4028/www.scientific.net/MSF.321-324.198; LEINENWEBER K, 1995, PHYS CHEM MINER, V22, P251, DOI 10.1007/BF00202258; Mostovoy M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137205; Poltavets VV, 2006, J AM CHEM SOC, V128, P9050, DOI 10.1021/ja063031o; RODRIGUEZCARVAJ.J, 1993, J PHYS B ATOM MOL PH, V192, P55; Sammells AF, 2000, CATAL TODAY, V56, P325, DOI 10.1016/S0920-5861(99)00290-4; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; SIEGRIST T, 1988, NATURE, V334, P231, DOI 10.1038/334231a0; SMITH MG, 1991, NATURE, V351, P549, DOI 10.1038/351549a0; TAKANO M, 1991, PHYS REV LETT, V67, P3267, DOI 10.1103/PhysRevLett.67.3267; TAKANO M, 1989, PHYSICA C, V159, P375, DOI 10.1016/S0921-4534(89)80007-3; TAKEDA Y, 1986, J SOLID STATE CHEM, V63, P237, DOI 10.1016/0022-4596(86)90174-X; Wang YD, 2001, MATER LETT, V49, P361, DOI 10.1016/S0167-577X(00)00400-6; Wells AF., 1962, STRUCTURAL INORGANIC, V3	34	350	356	16	448	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1062	U8		10.1038/nature06382	http://dx.doi.org/10.1038/nature06382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075589	Green Submitted			2022-12-28	WOS:000251579900082
J	Downs, SH; Schindler, C; Liu, LJS; Keidel, D; Bayer-Oglesby, L; Brutsche, MH; Gerbase, MW; Keller, R; Kunzli, N; Leuenberger, P; Probst-Hensch, NM; Tschopp, JM; Zellweger, JP; Rochat, T; Schwartz, J; Ackermann-Liebrich, U				Downs, Sara H.; Schindler, Christian; Liu, L. -J. Sally; Keidel, Dirk; Bayer-Oglesby, Lucy; Brutsche, Martin H.; Gerbase, Margaret W.; Keller, Roland; Kuenzli, Nino; Leuenberger, Philippe; Probst-Hensch, Nicole M.; Tschopp, Jean-Marie; Zellweger, Jean-Pierre; Rochat, Thierry; Schwartz, Joel; Ackermann-Liebrich, Ursula		SAPALDIA Team	Reduced exposure to PM10 and attenuated age-related decline in lung function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PARTICULATE AIR-POLLUTION; LONG-TERM EXPOSURE; FOLLOW-UP; UNITED-STATES; SWISS COHORT; MORTALITY; POLLUTANTS; PARTICLES; FINE	Background Air pollution has been associated with impaired health, including reduced lung function in adults. Moving to cleaner areas has been shown to attenuate adverse effects of air pollution on lung function in children but not in adults. Methods We conducted a prospective study of 9651 adults ( 18 to 60 years of age) randomly selected from population registries in 1990 and assessed in 1991, with 8047 participants reassessed in 2002. There was complete information on lung volumes and flows ( e. g., forced vital capacity [ FVC], forced expiratory volume in 1 second [ FEV1], FEV1 as a percentage of FVC, and forced expiratory flow between 25 and 75% of the FVC [FEF25-75]), smoking habits, and spatially resolved concentrations of particulate matter that was less than 10 mu m in aerodynamic diameter (PM10) from a validated dispersion model assigned to residential addresses for 4742 participants at both the 1991 and the 2002 assessments and in the intervening years. Results Overall exposure to individual home outdoor PM10 declined over the 11-year follow-up period (median, -5.3 mu g per cubic meter; interquartile range, -7.5 to -4.2). In mixed-model regression analyses, with adjustment for confounders, PM10 concentrations at baseline, and clustering within areas, there were significant negative associations between the decrease in PM10 and the rate of decline in FEV1 (P = 0.045), FEV1 as a percentage of FVC (P = 0.02), and FEF25-75 (P = 0.001). The net effect of a decline of 10 mu g of PM10 per cubic meter over an 11-year period was to reduce the annual rate of decline in FEV1 by 9% and of FEF25-75 by 16%. Cumulative exposure in the interval between the two examinations showed similar associations. Conclusions Decreasing exposure to airborne particulates appears to attenuate the decline in lung function related to exposure to PM10. The effects are greater in tests reflecting small-airway function.	Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Univ Basel Hosp, Div Pneumol, CH-4031 Basel, Switzerland; Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; Hosp Aarau, Hirslanden Klin, Aarau, Switzerland; Univ Lausanne Hosp, Serv Pulmonol, Lausanne, Switzerland; CHU Vaudois, Lausanne, Switzerland; Univ Zurich, Inst Social & Prevent Med, Dept Mol Epidemiol & Canc Registry, CH-8006 Zurich, Switzerland; Inst Clin Pathol, Dept Mol Epidemiol & Canc Registry, Zurich, Switzerland; Ctr Valaisan Pneumol, Montana, Switzerland; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Inst Municipal Invest Med, Inst Catalana Recerca & Estud Avancats, E-08003 Barcelona, Spain; Inst Municipal Invest Med, Ctr Res Environm Epidemiol, E-08003 Barcelona, Spain; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	University of Basel; University of Basel; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Washington; University of Washington Seattle; ICREA; Harvard University; Harvard T.H. Chan School of Public Health	Ackermann-Liebrich, U (corresponding author), Univ Basel, Inst Social & Prevent Med, Steinengraben 49, CH-4051 Basel, Switzerland.	ackermann-liebrich@unibas.ch	Schindler, Christian/D-3472-2015; Downs, Sara H/D-8478-2011; Kuenzli, Nino/F-7195-2014	Downs, Sara H/0000-0003-1044-3182; Kuenzli, Nino/0000-0001-8360-080X; Keidel, Dirk/0000-0003-4706-5728; Brutsche, Martin/0000-0002-1612-3609; Gemperli, Armin/0000-0002-2363-0625; Bayer-Oglesby, Lucy/0000-0001-8750-2158	ICREA Funding Source: Custom	ICREA(ICREA)		Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Avol Edward, 2005, NEW ENGL J MED, V352, P1276; Avol EL, 2001, AM J RESP CRIT CARE, V164, P2067, DOI 10.1164/ajrccm.164.11.2102005; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 1996, AM J RESP CRIT CARE, V154, pS250, DOI 10.1164/ajrccm/154.6_Pt_2.S250; Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Evelson P, 2000, BBA-GEN SUBJECTS, V1523, P209, DOI 10.1016/S0304-4165(00)00124-0; Finkelstein MM, 2003, CAN MED ASSOC J, V169, P397; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Hole DJ, 1996, BRIT MED J, V313, P711; Jerrett M, 2005, SOC SCI MED, V60, P2845, DOI 10.1016/j.socscimed.2004.11.006; Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; KUNZLI N, 1995, EUR RESPIR J, V8, P371, DOI 10.1183/09031936.95.08030371; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Larson T, 2004, J AIR WASTE MANAGE, V54, P1175, DOI 10.1080/10473289.2004.10470976; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; Liu LJS, 2003, ENVIRON HEALTH PERSP, V111, P909, DOI 10.1289/ehp.6011; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; MATHYS P, 2001, ICP INFORMATION NEWS, V27, P190; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; Nel A, 2005, SCIENCE, V309, P1326; Oglesby L, 2000, J AIR WASTE MANAGE, V50, P1251, DOI 10.1080/10473289.2000.10464156; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P1063, DOI 10.2307/3434960; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas-Bracho L, 2000, J EXPO ANAL ENV EPID, V10, P294, DOI 10.1038/sj.jea.7500092; Sarnat JA, 2001, ENVIRON HEALTH PERSP, V109, P1053, DOI 10.2307/3454961; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sekine K, 2004, OCCUP ENVIRON MED, V61, P350, DOI 10.1136/oem.2002.005934; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; *SWISS AG ENV FOR, 2003, MOD PM PM AMB CONC S; TASHKIN DP, 1994, AM J RESP CRIT CARE, V149, P1209, DOI 10.1164/ajrccm.149.5.8173761; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197	46	257	265	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2338	2347		10.1056/NEJMoa073625	http://dx.doi.org/10.1056/NEJMoa073625			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057336				2022-12-28	WOS:000251389200004
J	Nisbet, E				Nisbet, Euan			Earth monitoring: Cinderella science	NATURE			English	Editorial Material									Univ London, Royal Holloway & Bedford New Coll, Atmospher Grp, Dept Geol, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Nisbet, E (corresponding author), Univ London, Royal Holloway & Bedford New Coll, Atmospher Grp, Dept Geol, Egham TW20 0EX, Surrey, England.							KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; Keeling CD, 1998, ANNU REV ENERG ENV, V23, P25, DOI 10.1146/annurev.energy.23.1.25	2	41	47	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					789	790		10.1038/450789a	http://dx.doi.org/10.1038/450789a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063983	Bronze			2022-12-28	WOS:000251394900023
J	Spence, D; Melville, C				Spence, Des; Melville, Catriona			Vaginal discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHLAMYDIA-TRACHOMATIS; NEISSERIA-GONORRHOEAE; PARTNER NOTIFICATION; INFECTIONS; SWABS; MANAGEMENT; TRENDS		Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland; Sandyford Initiat, Glasgow G3 7NB, Lanark, Scotland		Spence, D (corresponding author), Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland.	destwo@yahoo.co.uk	Melville, Catriona/AAW-1387-2021	Melville, Catriona/0000-0001-5891-0259				Bignell C., 2005, NATL GUIDELINE DIAGN; Blake D R, 2003, J Pediatr Adolesc Gynecol, V16, P25, DOI 10.1016/S1083-3188(02)00207-3; Brown AE, 2004, SEX TRANSM INFECT, V80, P159, DOI 10.1136/sti.2004.009571; Burckhardt F, 2006, SEX TRANSM INFECT, V82, P24, DOI 10.1136/sti.2004.011882; Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; DANIELS D, 2002, FORSTER NATL GUIDELI; *FFPRHC BASHH GUID, 2006, J FAM PLAN REPROD H, V32, P33; Garrow SC, 2002, SEX TRANSM INFECT, V78, P278, DOI 10.1136/sti.78.4.278; Gaydos CA, 2002, J CLIN MICROBIOL, V40, P758, DOI 10.1128/JCM.40.3.758-761.2002; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; HAY P, 2006, NATL GUIDELINE MANAG; HOMER PJ, 2006, NATL GUIDELINE MANAG; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N, 2006, BRIT MED J, V332, P14, DOI 10.1136/bmj.38678.405370.7C; Melville C, 2005, J FAM PLAN REPROD H, V31, P26, DOI 10.1783/0000000052973112; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; ODowd T, 1996, BRIT J GEN PRACT, V46, P415; Padilla LA, 2005, INT J GYNECOL OBSTET, V88, P84, DOI 10.1016/j.ijgo.2004.09.015; Shaw C, 2003, SEX TRANSM INFECT, V79, P246, DOI 10.1136/sti.79.3.246; SHERRARD J, 2007, NATL GUIDELINE MANAG; SPENCE C, 2006, CLIN EVID, V15, P2403; Thinkhamrop J, 1999, INT J GYNECOL OBSTET, V66, P143, DOI 10.1016/S0020-7292(99)00057-0; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; *WHO, 2005, SEX TRANSM OTH REPR, V5; *WHO, 2005, SEX TRANSM OTH REPR, V7; *WHO, 2005, SEX TRANSM OTH REPR, V1; *WHO, 2005, SEX TRANSM OTH REPR, V8; *WHO, 2005, SEX TRANSM OTH REPR, V6; *WHO, 2005, SEX TRANSM OTH REPR, V9; *WHO, 2005, SEX TRANSM OTH REPR, V2; *WHO, 2005, SEX TRANSM OTH REPR, V3; *WHO, 2005, SEX TRANSM OTH REPR, V4; Wilson J, 2004, SEX TRANSM INFECT, V80, P8, DOI 10.1136/sti.2002.002733; WILSON J, 2003, SEXUAL HLTH OBSTET G, P33; Wilson JD, 2005, INT J STD AIDS, V16, P736, DOI 10.1258/095646205774763081	37	20	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2007	335	7630					1147	1151		10.1136/bmj.39378.633287.80	http://dx.doi.org/10.1136/bmj.39378.633287.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048541	Green Published			2022-12-28	WOS:000251596100037
J	Stott, D				Stott, Daniel			Learning the second way	BRITISH MEDICAL JOURNAL			English	Article									Univ London, St Georges Med Sch, London WC1E 7HU, England	St Georges University London; University of London	Stott, D (corresponding author), Univ London, St Georges Med Sch, London WC1E 7HU, England.	danielstott@hotmail.com							0	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1122	1123		10.1136/bmj.39400.460139.941	http://dx.doi.org/10.1136/bmj.39400.460139.941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048536	Green Published			2022-12-28	WOS:000251596100028
J	Raes, F; Swart, R				Raes, Frank; Swart, Rob			Climate change - Climate assessment: What's next?	SCIENCE			English	Editorial Material									Commiss European Communities, Directorate Gen Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; MNP, Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands	European Commission Joint Research Centre; EC JRC ISPRA Site; Netherlands National Institute for Public Health & the Environment	Raes, F (corresponding author), Commiss European Communities, Directorate Gen Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy.	frank.raes@jrc.it		Swart, Rob/0000-0002-1563-1150				Bernstein, 2007, **DROPPED REF**; Raes F., 2006, ANSWERS URBINO QUEST; Sliggers J., 2004, CLEARING AIR 25 YEAR; Stern Nicholas, 2007, EC CLIMATE CHANGE	4	10	10	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1386	1386		10.1126/science.1147873	http://dx.doi.org/10.1126/science.1147873			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048669				2022-12-28	WOS:000251246100023
J	Douglas, RJ				Douglas, Robert J.			Champagne: the safer choice for celebrations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ESOPHAGEAL OBSTRUCTION		Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5081, Australia	Royal Adelaide Hospital	Douglas, RJ (corresponding author), Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5081, Australia.	rabs01@hotmail.com		Douglas, Robert/0000-0003-2207-728X				MONTAGNE P, 2001, LAROUSSE GASTRONOMIQ, P242; PRAKASH K, 1989, NEW ENGL J MED, V321, P121; ROTTMAN SJ, 1988, ANN EMERG MED, V17, P869, DOI 10.1016/S0196-0644(88)80590-0	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1281	1281		10.1136/bmj.39419.449942.AD	http://dx.doi.org/10.1136/bmj.39419.449942.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156226	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700006
J	Palmer, SC; McGregor, DO; Macaskill, P; Craig, JC; Elder, GJ; Strippoli, GFM				Palmer, Suetonia C.; McGregor, David O.; Macaskill, Petra; Craig, Jonathan C.; Elder, Grahame J.; Strippoli, Giovanni F. M.			Meta-analysis: Vitamin D compounds in chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Review							INTRAVENOUS CALCITRIOL TREATMENT; CHRONIC-HEMODIALYSIS PATIENTS; BONE-MINERAL DENSITY; MILD SECONDARY HYPERPARATHYROIDISM; PARICALCITOL ZEMPLAR(R) CAPSULE; PARATHYROID-HORMONE SECRETION; MODERATE RENAL-FAILURE; LOW-DOSE CALCITRIOL; CONTROLLED-TRIAL; DOUBLE-BLIND	Background: Vitamin D compounds are widely used to prevent and treat secondary hyperparathyroidism. Purpose: To determine whether vitamin D therapy improves biochemical markers of mineral metabolism and cardiovascular and mortality outcomes in chronic kidney disease. Data Sources: MEDLINE (January 1966 to July 2007), EMBASE (January 1980 to July 2007), and Cochrane databases were searched without language restriction. Study Selection: Randomized, controlled trials of vitamin D compounds in chronic kidney disease were identified. Data Extraction: Two authors independently extracted data. Data Synthesis: Seventy-six trials were identified for inclusion; 3667 participants were enrolled. Vitamin D compounds did not reduce the risk for death, bone pain, vascular calcification, or parathyroidectomy. Compared with placebo, established vitamin D sterols were associated with an increased risk for hypercalcemia (relative risk, 2.37 [95% Cl, 1.16 to 4.85]) and hyperphosphatemia (relative risk, 1.77 [Cl, 1.15 to 2.74]) but did not show a consistent reduction in parathyroid hormone (PTH) levels. Compared with placebo, more recently developed vitamin D analogues were associated with hypercalcernia (relative risk, 5.15 [Cl, 1.06 to 24.97]) but not hyperphosphatemia, and levels of PTH were reduced (weighted mean difference, -10.77 pmol/L [Cl, -20.51 to -1.03 pmol/L]). For suppression of PTH, intravenous administration was superior to oral vitamin D, but higher intravenous doses were used. Limitations: Few studies reported patient-level outcomes, including mortality (8 of 76 trials), and only 5 trials directly compared the effects of treatment with newer vitamin D compounds versus established ones. Heterogeneity in some comparisons remained unexplained by metaregression analyses. Conclusion: Vitamin D compounds do not consistently reduce PTH levels, and beneficial effects on patient-level outcomes are unproven. The value of vitamin D treatment for people with chronic kidney disease remains uncertain.	Christchurch Sch Med, Dept Med & Hlth Sci, Christchurch 8001, New Zealand; Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand; Univ Sydney, Ctr Transplant & Renal Res, Sch Publ Hlth, Westmead Millenium Inst, Sydney, NSW, Australia; Natl Hlth & Med Res Council, Ctr Clin Res Excellence Renal Med, Westmead, NSW, Australia	University of Otago; University of Otago; University of Sydney; Westmead Institute for Medical Research	Palmer, SC (corresponding author), Christchurch Sch Med, Dept Med & Hlth Sci, PO Box 4345, Christchurch 8001, New Zealand.	strippoli@negrisud.it	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Macaskill, Petra/0000-0001-5879-6193; Strippoli, Giovanni/0000-0002-6936-0616				Agarwal R, 2005, KIDNEY INT, V68, P2823, DOI 10.1111/j.1523-1755.2005.00755.x; Akiba T, 1998, AM J KIDNEY DIS, V32, P238, DOI 10.1053/ajkd.1998.v32.pm9708607; Akizawa T, 2004, THER APHER DIAL, V8, P480, DOI 10.1111/j.1774-9987.2004.00191.x; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; [Anonymous], US RENAL DATA SYSTEM; Ardissino G, 2000, PEDIATR NEPHROL, V14, P664, DOI 10.1007/s004670000365; Bacchini G, 1997, NEPHRON, V77, P267, DOI 10.1159/000190286; BAKER LRI, 1989, KIDNEY INT, V35, P661, DOI 10.1038/ki.1989.36; BAKER LRI, 1986, CLIN NEPHROL, V26, P185; Berl T, 1980, Contrib Nephrol, V18, P72; BIRKENHAGERFRENKEL DH, 1995, J BONE MINER RES, V10, P197; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Borazan A, 2003, J INT MED RES, V31, P489, DOI 10.1177/147323000303100604; BRENNAN P, 1994, BRIT MED J, V309, P727, DOI 10.1136/bmj.309.6956.727; BUCCIANTI G, 1981, DIALYSIS TRANSPLANT, V10, P523; CARAVACA F, 1995, NEPHROL DIAL TRANSPL, V10, P665; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2003, NEFROLOGIA, V23, P117; CHAN JCM, 1994, J PEDIATR-US, V124, P520, DOI 10.1016/S0022-3476(05)83128-2; CHRISTIANSEN C, 1978, LANCET, V2, P700; Coburn JW, 2004, AM J KIDNEY DIS, V43, P877, DOI 10.1053/j.ajkd.2004.01.012; COEN G, 1982, KIDNEY INT, V22, P96; Coen G, 2002, NEPHRON, V91, P103, DOI 10.1159/000057611; COEN G, 1994, ITAL J MINER ELECT M, V8, P117; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coyne D, 2006, AM J KIDNEY DIS, V47, P263, DOI 10.1053/j.ajkd.2005.10.007; Delmez JA, 2000, CLIN NEPHROL, V54, P301; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEUBER HJ, 2003, NEPHROL DIAL TRANSPL, V18, P142; Di Leo C, 2003, CLIN NEPHROL, V59, P59; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; DJUKANOVIC L, 1994, RENAL FAILURE, V16, P715, DOI 10.3109/08860229409044901; Dobrez DG, 2004, NEPHROL DIAL TRANSPL, V19, P1174, DOI 10.1093/ndt/gfh123; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Elder Grahame, 2006, Nephrology (Carlton), V11 Suppl 1, pS230, DOI 10.1111/j.1440-1797.2006.00508.x; ElReshaid K, 1997, AM J NEPHROL, V17, P505, DOI 10.1159/000169179; FISCHER ER, 1993, CLIN NEPHROL, V40, P216; FOURNIER A, 1993, NIEREN HOCHDRUCK, V22, P39; Frazao JM, 2000, AM J KIDNEY DIS, V36, P550, DOI 10.1053/ajkd.2000.16193; Gadallah M F, 2000, Adv Perit Dial, V16, P303; Gallieni M, 2000, CLIN NEPHROL, V53, P188; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Goldsmith DJA, 1997, NEPHRON, V77, P37, DOI 10.1159/000190244; Gonzalez EA, 2003, J AM SOC NEPHROL, V14, p199A; Greenbaum LA, 2005, PEDIATR NEPHROL, V20, P622, DOI 10.1007/s00467-004-1792-6; Greenbaum LA, 2007, AM J KIDNEY DIS, V49, P814, DOI 10.1053/j.ajkd.2007.03.008; Haddad A, 2004, DIALYSIS TRANSPLANT, V33, P492; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; HAMDY NAT, 1995, BRIT MED J, V310, P358, DOI 10.1136/bmj.310.6976.358; Hayashi M, 2004, NEPHROL DIAL TRANSPL, V19, P2067, DOI 10.1093/ndt/gfh329; HERRMANN P, 1994, NEPHRON, V67, P48, DOI 10.1159/000187887; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Indridason OS, 2000, KIDNEY INT, V57, P282, DOI 10.1046/j.1523-1755.2000.00819.x; Jegger D, 2006, AM J PHYSIOL-HEART C, V291, pH1942, DOI 10.1152/ajpheart.00091.2006; JONES CL, 1994, CLIN NEPHROL, V42, P44; JUTTMANN JR, 1979, NETH J MED, V22, P172; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Khajehdehi P, 2003, J RENAL NUTR, V13, P78, DOI 10.1053/jren.2003.50026; Kihara T, 2004, NEPHRON CLIN PRACT, V98, pC93, DOI 10.1159/000080680; Klaus G., 1995, Pediatric Nephrology, V9, pC75; Koshikawa S, 2002, NEPHRON, V90, P413, DOI 10.1159/000054729; LAZARO RP, 1980, ARCH NEUROL-CHICAGO, V37, P555, DOI 10.1001/archneur.1980.00500580051007; Lee GH, 2007, J RENAL NUTR, V17, P38, DOI 10.1053/j.jrn.2006.07.006; LEE WT, 1994, J AM SOC NEPHROL, V5, P1344; LEVIN A, 1995, J AM SOC NEPHROL, V6, P937; Levine BS, 1996, J AM SOC NEPHROL, V7, P488; LIOU HH, 1995, J AM SOC NEPHROL, V6, P966; LIOU HH, 1994, MINER ELECTROL METAB, V20, P97; Llach F, 1998, AM J KIDNEY DIS, V32, pS48, DOI 10.1053/ajkd.1998.v32.pm9808143; Lopez I, 2006, J AM SOC NEPHROL, V17, P795, DOI 10.1681/ASN.2005040342; Martin KJ, 1998, J AM SOC NEPHROL, V9, P1427; Martin KJ, 2001, AM J KIDNEY DIS, V38, pS57, DOI 10.1053/ajkd.2001.28112; MARTINEZ J, 1996, NEPHROL DIAL TRANSPL, V11, P1206; MAXWELL DR, 1978, CLIN PHARMACOL THER, V23, P515; MEMMOS DE, 1981, BRIT MED J, V282, P1919, DOI 10.1136/bmj.282.6280.1919; Mitsopoulos E, 2006, AM J KIDNEY DIS, V48, P114, DOI 10.1053/j.ajkd.2006.04.060; Mochizuki T, 2007, CLIN NEPHROL, V67, P12; Moe SM, 1998, NEPHROL DIAL TRANSPL, V13, P1234, DOI 10.1093/ndt/13.5.1234; Moe SM, 2001, AM J KIDNEY DIS, V38, P792, DOI 10.1053/ajkd.2001.27697; MORINIERE P, 1985, NEPHRON, V39, P309, DOI 10.1159/000183396; NORDAL KP, 1988, J CLIN ENDOCR METAB, V67, P929, DOI 10.1210/jcem-67-5-929; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Panichi V, 1998, CLIN NEPHROL, V49, P245; PECOVNIKBALON B, 1995, AM J NEPHROL, V15, P401; Perales MCS, 1999, NEFROLOGIA, V19, P237; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; PIRAINO B, 1988, CLIN NEPHROL, V30, P57; POPOVTZER MM, 1992, BONE, V13, P369, DOI 10.1016/8756-3282(92)90453-4; PRZEDLACKI J, 1995, NEPHRON, V69, P433, DOI 10.1159/000188515; Qiu P, 2003, J AM SOC NEPHROL, V14, p484A; QUARLES LD, 1994, KIDNEY INT, V45, P1710, DOI 10.1038/ki.1994.223; Ritz E, 1995, NEPHROL DIAL TRANSPL, V10, P2228, DOI 10.1093/ndt/10.12.2228; Rix M, 2004, NEPHROL DIAL TRANSPL, V19, P870, DOI 10.1093/ndt/gfg595; RUEDIN P, 1994, KIDNEY INT, V45, P245, DOI 10.1038/ki.1994.30; Salusky IB, 1998, KIDNEY INT, V54, P907, DOI 10.1046/j.1523-1755.1998.00045.x; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Slatopolsky E, 2003, KIDNEY INT, V63, P2020, DOI 10.1046/j.1523-1755.2003.00029.x; Sprague SM, 2003, KIDNEY INT, V63, P1483, DOI 10.1046/j.1523-1755.2003.00878.x; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Tarrass F, 2006, CLIN NEPHROL, V65, P415; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tentori F, 2006, KIDNEY INT, V70, P1858, DOI 10.1038/sj.ki.5001868; TOUGAARD L, 1976, LANCET, V1, P1044; Tsuruoka S, 2003, BRIT J CLIN PHARMACO, V55, P531, DOI 10.1046/j.1365-2125.2003.01809.x; Turk S, 2002, NEPHRON, V90, P188, DOI 10.1159/000049041; VANDERMERWE WM, 1990, NEPHROL DIAL TRANSPL, V5, P874, DOI 10.1093/ndt/5.10.874; VARGHESE Z, 1992, NEPHRON, V60, P286, DOI 10.1159/000186767; WATSON AR, 1989, CHILD NEPHROL UROL, V9, P220; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wu-Wong JR, 2006, J PHARMACOL EXP THER, V318, P90, DOI 10.1124/jpet.106.101261; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Zisman AL, 2005, AM J NEPHROL, V25, P591, DOI 10.1159/000089707; EVALUATION COLECALCI; COMPARISON CHOLECALC; STUDY ZEMPLAR INJECT	118	187	196	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					840	853		10.7326/0003-4819-147-12-200712180-00004	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087055				2022-12-28	WOS:000251787600004
J	Burling, D; East, JE; Taylor, SA				Burling, David; East, James E.; Taylor, Stuart A.			Rational imaging - Investigating rectal bleeding	BRITISH MEDICAL JOURNAL			English	Article							CT COLONOGRAPHY; BARIUM ENEMA; ASYMPTOMATIC ADULTS; COLORECTAL POLYPS; COLONOSCOPY; METAANALYSIS; CANCER		St Marks Hosp, Intestinal Imaging Ctr, Harrow HA1 3UJ, Middx, England; St Marks Hosp, Wolfson Unit Endoscopy, Harrow HA1 3UJ, Middx, England; Univ Coll Hosp, Dept Specialist Radiol, London NW1 2BU, England	Imperial College London; Imperial College London; University of London; University College London	Burling, D (corresponding author), St Marks Hosp, Intestinal Imaging Ctr, Harrow HA1 3UJ, Middx, England.	burlingdavid@yahoo.co.uk		Taylor, Stuart/0000-0002-6765-8806				Burling D, 2006, RADIOLOGY, V239, P464, DOI 10.1148/radiol.2392051101; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Hamilton W, 2004, FAM PRACT, V21, P99, DOI 10.1093/fampra/cmh121; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; *NAT I HLTH CLIN E, 2006, COMP TOM COL VIRT CO; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; SAUNDERS BP, 1995, CLIN RADIOL, V50, P318, DOI 10.1016/S0009-9260(05)83424-5; Sosna J, 2003, AM J ROENTGENOL, V181, P1593, DOI 10.2214/ajr.181.6.1811593; Tawn DJ, 2005, CLIN RADIOL, V60, P558, DOI 10.1016/j.crad.2004.09.014; Taylor SA, 2003, AM J ROENTGENOL, V181, P913, DOI 10.2214/ajr.181.4.1810913; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Xiong T, 2005, BRIT J RADIOL, V78, P22, DOI 10.1259/bjr/67998962	13	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1260	1262		10.1136/bmj.39379.598090.AD	http://dx.doi.org/10.1136/bmj.39379.598090.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079550	Green Published			2022-12-28	WOS:000251832200038
J	Corden, JL				Corden, Jeffry L.			Transcription - Seven ups the code	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; PHOSPHORYLATION		Johns Hopkins Med Sch, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Corden, JL (corresponding author), Johns Hopkins Med Sch, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jcorden@jhmi.edu						Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006	11	36	37	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1735	1736		10.1126/science.1152624	http://dx.doi.org/10.1126/science.1152624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079391				2022-12-28	WOS:000251616800028
J	Henzler-Wildman, K; Kern, D				Henzler-Wildman, Katherine; Kern, Dorothee			Dynamic personalities of proteins	NATURE			English	Review							CHARACTERIZING CHEMICAL-EXCHANGE; CIS-TRANS ISOMERASE; MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; ORDER PARAMETERS; CONFORMATIONAL DYNAMICS; RELAXATION METHODS; BACKBONE DYNAMICS; FOLDING FUNNELS; ENZYME DYNAMICS	Because proteins are central to cellular function, researchers have sought to uncover the secrets of how these complex macromolecules execute such a fascinating variety of functions. Although static structures are known for many proteins, the functions of proteins are governed ultimately by their dynamic character ( or 'personality'). The dream is to 'watch' proteins in action in real time at atomic resolution. This requires addition of a fourth dimension, time, to structural biology so that the positions in space and time of all atoms in a protein can be described in detail.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Kern, D (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	dkern@brandeis.edu		Henzler-Wildman, Katherine/0000-0002-5295-2121	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070251] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM070251] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Best RB, 2005, J MOL BIOL, V349, P185, DOI 10.1016/j.jmb.2005.03.001; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; BROOKS CL, 1989, J MOL BIOL, V208, P159, DOI 10.1016/0022-2836(89)90093-4; CHANDLER D, 1986, J STAT PHYS, V42, P49, DOI 10.1007/BF01010840; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Dellago C, 2007, TOP CURR CHEM, V268, P291, DOI 10.1007/128_085; Deniz AA, 2008, J R SOC INTERFACE, V5, P15, DOI 10.1098/rsif.2007.1021; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Franks WT, 2005, J AM CHEM SOC, V127, P12291, DOI 10.1021/ja044497e; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GERTNER BJ, 1989, J CHEM PHYS, V90, P3537, DOI 10.1063/1.455864; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Johnson CK, 2006, BIOCHEMISTRY-US, V45, P14233, DOI 10.1021/bi061058e; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Lee AL, 2002, BIOCHEMISTRY-US, V41, P13814, DOI 10.1021/bi026380d; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lorieau JL, 2006, J AM CHEM SOC, V128, P11505, DOI 10.1021/ja062443u; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Palmer AG, 2005, METHOD ENZYMOL, V394, P430, DOI 10.1016/S0076-6879(05)94018-4; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; SCHLIWA M, 2003, MOL MOTORS; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tugarinov V, 2005, BIOCHEMISTRY-US, V44, P15970, DOI 10.1021/bi0519809; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Wintrode PL, 1997, J MOL BIOL, V266, P1050, DOI 10.1006/jmbi.1996.0785; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034	98	1637	1654	13	565	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					964	972		10.1038/nature06522	http://dx.doi.org/10.1038/nature06522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075575				2022-12-28	WOS:000251579900066
J	Nielsen, SB; Stephenson, R; Thomsen, E				Nielsen, Soren B.; Stephenson, Randell; Thomsen, Erik			Dynamics of Mid-Palaeocene North Atlantic rifting linked with European intra-plate deformations	NATURE			English	Article							RIFTED MARGIN; SEA; GREENLAND; ALPINE; FORELAND; BASIN	The process of continental break- up provides a large- scale experiment that can be used to test causal relations between plate tectonics and the dynamics of the Earth's deep mantle(1,2). Detailed diagnostic information on the timing and dynamics of such events, which are not resolved by plate kinematic reconstructions, can be obtained from the response of the interior of adjacent continental plates to stress changes generated by plate boundary processes. Here we demonstrate a causal relationship between North Atlantic continental rifting at similar to 62 Myr ago and an abrupt change of the intra- plate deformation style in the adjacent European continent. The rifting involved a left- lateral displacement between the North American- Greenland plate and Eurasia, which initiated the observed pause in the relative convergence of Europe and Africa(3). The associated stress change in the European continent was significant and explains the sudden termination of a similar to 20- Myr- long contractional intra- plate deformation within Europe(4), during the late Cretaceous period to the earliest Palaeocene epoch, which was replaced by low- amplitude intra- plate stress- relaxation features(5). The pre- rupture tectonic stress was large enough to have been responsible for precipitating continental break- up, so there is no need to invoke a thermal mantle plume as a driving mechanism. The model explains the simultaneous timing of several diverse geological events, and shows how the intra- continental stratigraphic record can reveal the timing and dynamics of stress changes, which cannot be resolved by reconstructions based only on plate kinematics.	Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus C, Denmark; Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands	Aarhus University; Vrije Universiteit Amsterdam	Nielsen, SB (corresponding author), Aarhus Univ, Dept Earth Sci, Hoegh Guldbergsgade 2, DK-8000 Aarhus C, Denmark.	sbn@geo.au.dk	Stephenson, Randell A/A-3741-2012; Nielsen, Søren/A-5288-2012; Thomsen, Erik/A-4842-2012	Stephenson, Randell A/0000-0003-4868-8601; 				Anderson DL, 2001, SCIENCE, V293, P2016, DOI 10.1126/science.1065448; Christiansen RL, 2002, GEOL SOC AM BULL, V114, P1245, DOI 10.1130/0016-7606(2002)114<1245:UMOOTY>2.0.CO;2; CLOETINGH S, 1985, EARTH PLANET SC LETT, V75, P157, DOI 10.1016/0012-821X(85)90098-6; Dean K., 1999, PETROLEUM GEOLOGY NW, V5, P533, DOI [DOI 10.1144/0050533, 10.1144/0050533]; Dezes P, 2004, TECTONOPHYSICS, V389, P1, DOI 10.1016/j.tecto.2004.06.011; ENGLAND RW, 1988, SPEC PUBL GEOLOGICAL, V39; FALEIDE JI, 1991, TECTONOPHYSICS, V189, P73, DOI 10.1016/0040-1951(91)90488-E; Franke D, 2001, MAR PETROL GEOL, V18, P1083, DOI 10.1016/S0264-8172(01)00041-1; Harrison JC, 1999, B CAN PETROL GEOL, V47, P223; Imber J, 2005, AAPG BULL, V89, P1043, DOI 10.1306/02240504043; Karson JA, 1998, GEOLOGY, V26, P39, DOI 10.1130/0091-7613(1998)026<0039:TFAPIT>2.3.CO;2; Kent AJR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000743; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; Luterbacher H. P., 2004, GEOLOGIC TIME SCALE, P384, DOI DOI 10.1017/CBO9780511536045.021; Martini E, 1971, 2 P PLANKT C TECN RO, V2, P739; Mogensen TE, 2000, GEOL SOC SPEC PUBL, V167, P379, DOI 10.1144/GSL.SP.2000.167.01.14; Nagy J, 2005, PALAEOGEOGR PALAEOCL, V222, P161, DOI 10.1016/j.palaeo.2005.03.014; Nielsen SB, 2005, NATURE, V435, P195, DOI 10.1038/nature03599; O'Connor JM, 2000, NATURE, V408, P954, DOI 10.1038/35050066; PERCHNIELSEN K, 1979, CRETACEOUS TERTIARY, V1, P115; RITCHIE JD, 1999, PETROLEUM GEOLOGY NW, P573, DOI DOI 10.1144/0050573; ROEST WR, 1989, GEOLOGY, V17, P1000, DOI 10.1130/0091-7613(1989)017<1000:SFSITL>2.3.CO;2; Rosenbaum G, 2002, TECTONOPHYSICS, V359, P117, DOI 10.1016/S0040-1951(02)00442-0; Saalmann K, 2002, GEOL MAG, V139, P47, DOI 10.1017/S0016756801006069; Schettino A., 2001, EOS T AM GEOPHYS UN, V82, P530, DOI [10.1029/01EO00316, DOI 10.1029/01EO00316, DOI 10.1029/01E000316]; Tegner C, 1998, EARTH PLANET SC LETT, V156, P75, DOI 10.1016/S0012-821X(97)00206-9; Vandycke S, 2002, TECTONOPHYSICS, V357, P119, DOI 10.1016/S0040-1951(02)00365-7; Wybraniec S., 1998, EOS T AM GEOPHYS UN, V79, P437; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C, V2nd, P1; Ziegler PA, 1995, TECTONOPHYSICS, V252, P7, DOI 10.1016/0040-1951(95)00102-6	30	81	81	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1071	1074		10.1038/nature06379	http://dx.doi.org/10.1038/nature06379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075591				2022-12-28	WOS:000251579900084
J	Abegunde, DO; Mathers, CD; Adam, T; Ortegon, M; Strong, K				Abegunde, Dele O.; Mathers, Colin D.; Adam, Taghreed; Ortegon, Monica; Strong, Kathleen			Chronic diseases 1 - The burden and costs of chronic diseases in low-income and middle-income countries	LANCET			English	Article							CORONARY-HEART-DISEASE; ECONOMIC BURDEN; PATTERNS; CARE	This paper estimates the disease burden and loss of economic output associated with chronic diseases-mainly cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes-in 23 selected countries which account for around 80% of the total burden of chronic disease mortality in developing countries. In these 23 selected low-income and middle-income countries, chronic diseases were responsible for 50% of the total disease burden in 2005. For 15 of the selected countries where death registration data are available, the estimated age-standardised death rates for chronic diseases in 2005 were 54% higher for men and 86% higher for women than those for men and women in high-income countries. If nothing is done to reduce the risk of chronic diseases, an estimated US$84 billion of economic production will be lost from heart disease, stroke, and diabetes alone in these 23 countries between 2006 and 2015. Achievement of a global goal for chronic disease prevention and control-an additional 2% yearly reduction in chronic disease death rates over the next 10 years-would avert 24 million deaths in these countries, and would save an estimated $8 billion, which is almost 10% of the projected loss in national income over the next 10 years.	WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Mathers, CD (corresponding author), WHO, Dept Measurement & Hlth Informat, CH-1211 Geneva, Switzerland.	mathersc@who.int		Mathers, Colin/0000-0002-0617-6731; Strong, Kathleen/0000-0002-8092-1955				*AM HEART ASS, 2001, HEART DIS STROK STRO; [Anonymous], 2005, PREV CHRON DIS VIT I; Arndt C., 2001, S AFRICAN J EC, V68, P1; BAIER SL, 2002, CORRELATION TFP ALPH; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; Chakraborty S, 2004, J ECON THEORY, V116, P119, DOI 10.1016/j.jet.2003.07.005; Cohen JW, 2003, HEALTH AFFAIR, V22, P129, DOI 10.1377/hlthaff.22.2.129; CUDDINGTON JT, 1994, J DEV ECON, V43, P363, DOI 10.1016/0304-3878(94)90013-2; Currie CJ, 1997, HEART, V78, P544, DOI 10.1136/hrt.78.6.544; CUTLER DM, 2006, 12124 NAT BUR EC RES; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Easterly W, 2001, WORLD BANK ECON REV, V15, P177, DOI 10.1093/wber/15.2.177; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Goldman DP, 2006, HEALTH AFFAIR, V25, pW389, DOI 10.1377/hlthaff.25.w389; GREEN M, 2002, EC HLTH CARE; Guimaraes AC, 1998, CVD PREVENTION, V1, P306; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lopez-Casasnovas G, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P357; LORENTZEN PI, 2005, 65 NAT BUR EC RES; Lyratzopoulos G, 2006, HEART, V92, P1361, DOI 10.1136/hrt.2005.085563; MANTONE J, 2005, MOD HEALTHCARE, V35, P8; MANTONE J, 2005, MOD HEALTHCARE, V35, P14; Martinez Tania L. Rocha, 2003, Arq. Bras. Cardiol., V80, P635, DOI 10.1590/S0066-782X2003000600006; Mathers CD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-66; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; *MIN PLAN ORC GEST, 2004, AN DISP DOM AL EST N; *MIN SAUD MIN HLTH, 2007, VIGG FACT RISC PROT; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; NORDHAUS W, 2003, HLTH NATIONS CONTRIB; ODEYI A, 2007, PUBLIC POLICY CHALLE; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; Sala-I-Martin X, 2004, AM ECON REV, V94, P813, DOI 10.1257/0002828042002570; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Suhrcke M., 2006, CHRONIC DIS EC PERSP; SUHRCKE M, 2006, IS CARDIOVASCULAR DI; Swan T., 1956, ECON REC, V32, P334, DOI [10.1111/j.1475-4932.1956.tb00434.x, DOI 10.1111/J.1475-4932.1956.TB00434.X]; Szwarcwald Célia Landmann, 2005, Cad. Saúde Pública, V21, pS4, DOI 10.1590/S0102-311X2005000700001; Tu Ha T, 2004, Issue Brief Cent Stud Health Syst Change, P1; Viscusi WK, 1998, DUKE LAW J, V47, P1095, DOI 10.2307/1373032; *WHO, 2003, BRAZ MOD WORLD HLTH; World Health Organization, 2004, WORLD HLTH REP 2004	49	887	930	2	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1929	1938		10.1016/S0140-6736(07)61696-1	http://dx.doi.org/10.1016/S0140-6736(07)61696-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18063029				2022-12-28	WOS:000251517600031
J	Gaziano, TA; Galea, G; Reddy, KS				Gaziano, Thomas A.; Galea, Gauden; Reddy, K. Srinath			Chronic diseases 2 - Scaling up interventions for chronic disease prevention: the evidence	LANCET			English	Article							CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; COST-EFFECTIVENESS ANALYSIS; STANFORD 5-CITY PROJECT; LIFE-STYLE INTERVENTION; BODY-MASS INDEX; DIABETES PREVENTION; PHYSICAL-ACTIVITY; HEALTH-EDUCATION; BLOOD-PRESSURE	Interventions to prevent morbidity and mortality from chronic diseases need to be cost effective and financially feasible in countries of low or middle income before recommendations for their scale-up can be made. We review the cost-effectiveness estimates on policy interventions (both population-based and personal) that are likely to lead to substantial reductions in chronic diseases-in particular, cardiovascular disease, diabetes, cancer, and chronic respiratory disease. We reviewed data from regions of low, middle, and high income, where available, as well as the evidence for making policy interventions where available effectiveness or cost-effectiveness data are lacking. The results confirm that the cost-effectiveness evidence for tobacco control measures, salt reduction, and the use of multidrug regimens for patients with high-risk cardiovascular disease strongly supports the feasibility of the scale-up of these interventions. Further assessment to determine the best national policies to achieve reductions in consumption of saturated and trans fat-chemically hydrogenated plant oils-could eventually lead to substantial reductions in cardiovascular disease. Finally, we review evidence for policy implementation in areas of strong causality or highly probable benefit-eg, changes in personal interventions for diabetes reduction, restructuring of health systems, and wider policy decisions.	Harvard Univ, Sch Med, Boston, MA USA; WHO, CH-1211 Geneva, Switzerland; Publ Hlth Fdn India, New Delhi, India	Harvard University; Harvard Medical School; World Health Organization; Public Health Foundation of India	Gaziano, TA (corresponding author), Brigham & Womens Hosp, Harvard Program Hlth Decis Sci, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	tgaziano@partners.org		Galea, Gauden/0000-0002-2257-6014				Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Campbell K, 2002, COCHRANE DB SYST REV, V2; Conunission on Social Determinants of Health, CONC FRAM ACT SOC DE; Craig BM, 2002, AM J MED, V113, P491, DOI 10.1016/S0002-9343(02)01266-4; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; FARQUHAR JW, 1977, LANCET, V1, P1192; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Fortmann SP, 2000, AM J EPIDEMIOL, V152, P316, DOI 10.1093/aje/152.4.316; FORTMANN SP, 1981, AM J CLIN NUTR, V34, P2030, DOI 10.1093/ajcn/34.10.2030; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hagberg LA, 2006, SCAND J PUBLIC HEALT, V34, P641, DOI 10.1080/14034940600627853; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; Hodge AM, 1996, INT J OBESITY, V20, P137; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NISSINEN A, 1986, MED CARE, V24, P767, DOI 10.1097/00005650-198608000-00012; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; PUSKA P, 1989, ANN MED, V21, P169, DOI 10.3109/07853898909149928; PUSKA P, 1995, N KARELIA PROJECT 20; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; ROSSOUW JE, 1993, INT J EPIDEMIOL, V22, P428, DOI 10.1093/ije/22.3.428; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; Schmitz MKH, 2000, MED CLIN N AM, V84, P491, DOI 10.1016/S0025-7125(05)70233-9; Schooler C, 1997, ANN EPIDEMIOL, V7, pS54, DOI 10.1016/S1047-2797(97)80008-7; Sevick MA, 2000, AM J PREV MED, V19, P1, DOI 10.1016/S0749-3797(00)00154-9; Tosteson ANA, 1997, CIRCULATION, V95, P24, DOI 10.1161/01.CIR.95.1.24; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Food and Drug Administration Center for Food and Safety and Applied Nutrition, 2003, FED REG         0711, V68, P41433; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Willett W. C., 2006, Disease control priorities in developing countries, P833; WILLETT WC, 1994, AM J PUBLIC HEALTH, V84, P722, DOI 10.2105/AJPH.84.5.722; World Health Organization, 2004, WORLD HLTH ASS RES 5; World Health Organization, 2001, MACR HLTH INV HLTH E; Yu ZJ, 1999, PREV MED, V29, P165, DOI 10.1006/pmed.1999.0530; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	48	155	163	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1939	1946		10.1016/S0140-6736(07)61697-3	http://dx.doi.org/10.1016/S0140-6736(07)61697-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18063028				2022-12-28	WOS:000251517600032
J	Adams, PC; Barton, JC				Adams, Paul C.; Barton, James C.			Haemochromatosis	LANCET			English	Review							HEREDITARY HEMOCHROMATOSIS; IRON-OVERLOAD; C282Y HOMOZYGOTES; HFE C282Y; NATURAL-HISTORY; SERUM FERRITIN; TRANSFERRIN SATURATION; PHENOTYPIC-EXPRESSION; CLINICAL EXPRESSION; HEPATIC-FIBROSIS	Since the discovery of the haemochromatosis gene (HFE, chromosome 6p21.3) associated with haemochromatosis in 1996, many studies about diverse aspects of this common genetic disorder have been done. Some patients present with cirrhosis and show high mortality, whereas many asymptomatic homozygotes for the C282Y mutation in the haemochromatosis gene identified in population screening studies, who have been followed up for many years, do not develop iron overload. Studies described the usefulness of transferrin saturation and serum ferritin tests, and the acceptability of genetic testing for haemochromatosis. Phlebotomy therapy improves hepatic fibrosis. Here, we summarise some new findings in haemochromatosis, a disorder first described in 1865.	Univ Western Ontario Hosp, Dept Med, London, ON N6A 5A5, Canada; So Iron Disorders Ctr, Birmingham, AL USA	Western University (University of Western Ontario)	Adams, PC (corresponding author), Univ Western Ontario Hosp, Dept Med, 339 Windermere Rd, London, ON N6A 5A5, Canada.	padams@uwo.ca		Adams, Paul/0000-0002-9921-2956; Barton, James/0000-0003-2876-8276				Acton RT, 2007, CLIN GENET, V71, P518, DOI 10.1111/J.1399-0004.2007.00804.X; Acton RT, 2006, DIABETES CARE, V29, P2084, DOI 10.2337/dc05-1592; Adams PC, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2007.02.027; Adams PC, 1996, HEPATOLOGY, V23, P724, DOI 10.1002/hep.510230411; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Adams PC, 2005, CLIN CHEM, V51, P1048, DOI 10.1373/clinchem.2005.048371; Adams PC, 1999, AM J GASTROENTEROL, V94, P1593; Adams PC, 2006, NAT CLIN PRACT GASTR, V3, P178, DOI 10.1038/ncpgasthep0465; Adams PC, 2005, LANCET, V366, P269, DOI 10.1016/S0140-6736(05)66384-2; Adams PC, 1999, HEPATOLOGY, V29, P1324, DOI 10.1002/hep.510290425; ADAMS PC, 1990, CLIN INVEST MED, V13, P256; ADAMS PC, 1993, J CLIN GASTROENTEROL, V16, P207, DOI 10.1097/00004836-199304000-00008; ADAMS PC, 1993, CAN J GASTROENTEROL, V7, P37, DOI 10.1155/1993/537378; Allen KJ, 2006, HEPATOLOGY, V44, p211A; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Anderson RT, 2005, GENET MED, V7, P557, DOI 10.1097/01.GIM.0000177531.53338.65; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Asberg A, 2002, SCAND J GASTROENTERO, V37, P719, DOI 10.1080/00365520212510; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Barton James C, 2007, Curr Gastroenterol Rep, V9, P74, DOI 10.1007/s11894-008-0024-9; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Beaton MD, 2006, CAN J GASTROENTEROL, V20, P257, DOI 10.1155/2006/428048; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Beutler E, 2004, MAYO CLIN PROC, V79, P305, DOI 10.4065/79.3.305; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Carter K, 2003, BRIT J HAEMATOL, V122, P326, DOI 10.1046/j.1365-2141.2003.04436.x; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; Delatycki M, 2002, LANCET, V359, P1433, DOI 10.1016/S0140-6736(02)08369-1; Delatycki MB, 2005, LANCET, V366, P314, DOI 10.1016/S0140-6736(05)63012-7; Deugnier Y, 2002, BRIT J HAEMATOL, V118, P1170, DOI 10.1046/j.1365-2141.2002.03718.x; Distante S, 2004, HUM GENET, V115, P269, DOI 10.1007/s00439-004-1152-4; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Fargion S, 2001, BLOOD, V97, P3707, DOI 10.1182/blood.V97.12.3707; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fletcher LM, 2002, GASTROENTEROLOGY, V122, P281, DOI 10.1053/gast.2002.30992; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Gagne G, 2007, CLIN GENET, V71, P46, DOI 10.1111/j.1399-0004.2006.00727.x; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005; GARRY P, 2005, AM J CLIN NUTR, V62, P611; Gleeson F, 2004, EUR J GASTROEN HEPAT, V16, P859, DOI 10.1097/00042737-200409000-00008; GOODNOUGH LT, 1991, J LAB CLIN MED, V118, P289; Hall MA, 2005, GENET MED, V7, P311, DOI 10.1097/01.GIM.0000162874.58370.C0; Hall MA, 2007, J FAM PRACTICE, V56, P829; Hicken BL, 2003, AM J GASTROENTEROL, V98, P2072, DOI 10.1016/S0002-9270(02)06014-8; Hramiak IM, 1997, CLIN INVEST MED, V20, P110; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Kowdley KV, 2005, GASTROENTEROLOGY, V129, P494, DOI 10.1053/j.gastro.2005.05.004; Krayenbuehl PA, 2006, CLIN CHEM, V52, P1552, DOI 10.1373/clinchem.2005.065417; Le Gac G, 2004, HUM MOL GENET, V13, P1913, DOI 10.1093/hmg/ddh206; Lee PL, 2004, BRIT J HAEMATOL, V127, P224, DOI 10.1111/j.1365-2141.2004.05165.x; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; McCune CA, 2006, GUT, V55, P554, DOI 10.1136/gut.2005.070342; McLaren GD, 2006, BLOOD, V108, p444A, DOI 10.1182/blood.V108.11.1545.1545; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Patch C, 2005, GENET MED, V7, P550, DOI 10.1097/01.GIM.0000182466.87113.ce; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2006, ANNU REV NUTR, V26, P251, DOI 10.1146/annurev.nutr.26.061505.111226; Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294; Power TE, 2001, GENET TEST, V5, P107, DOI 10.1089/109065701753145556; Rasmussen ML, 2001, ATHEROSCLEROSIS, V154, P739, DOI 10.1016/S0021-9150(00)00623-7; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Van Vlierberghe H, 2001, J HEPATOL, V35, P707, DOI 10.1016/S0168-8278(01)00203-3; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Wojcik JP, 2002, CAN J GASTROENTEROL, V16, P297, DOI 10.1155/2002/161569; Yamashita C, 2003, CLIN GASTROENTEROL H, V1, P388, DOI 10.1053/S1542-3565(03)00187-3	76	125	131	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1855	1860		10.1016/S0140-6736(07)61782-6	http://dx.doi.org/10.1016/S0140-6736(07)61782-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061062				2022-12-28	WOS:000251588700033
J	Shelton, JD				Shelton, James D.			Ten myths and one truth about generalised HIV epidemics	LANCET			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						Cassell MM, 2007, LANCET INFECT DIS, V7, P491, DOI 10.1016/S1473-3099(07)70114-7; *CDCP KEN, 2004, KEN DEM HLTH SURV 20; Gray RH, 2007, LANCET, V370, P200, DOI 10.1016/S0140-6736(07)61058-7; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; *MIN HLTH SOC WELF, 2005, LES DEM HLTH SURV 20; Shelton JD, 2006, LANCET, V368, P1947, DOI 10.1016/S0140-6736(06)69787-0; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; *UNAIDS WHO, 2007, AIDS EP UPD; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI	12	51	51	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1809	1811		10.1016/S0140-6736(07)61755-3	http://dx.doi.org/10.1016/S0140-6736(07)61755-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061042	Green Submitted			2022-12-28	WOS:000251588700008
J	Chakrapani, V; Angus, JC; Anderson, AB; Wolter, SD; Stoner, BR; Sumanasekera, GU				Chakrapani, Vidhya; Angus, John C.; Anderson, Alfred B.; Wolter, Scott D.; Stoner, Brian R.; Sumanasekera, Gamini U.			Charge transfer equilibria between diamond and an aqueous oxygen electrochemical redox couple	SCIENCE			English	Article							SURFACE CONDUCTIVE LAYER; CARBON NANOTUBES; HYDROGEN; ADSORPTION; MECHANISM; TRANSPORT; FILMS	Undoped, high-quality diamond is, under almost all circumstances, one of the best insulators known. However, diamond covered with chemically bound hydrogen shows a pronounced conductivity when exposed to air. This conductivity arises from positive-charge carriers ( holes) and is confined to a narrow near-surface region. Although several explanations have been proposed, none has received wide acceptance, and the mechanism remains controversial. Here, we report the interactions of hydrogen-terminated, macroscopic diamonds and diamond powders with aqueous solutions of controlled pH and oxygen concentration. We show that electrons transfer between the diamond and an electrochemical reduction/oxidation couple involving oxygen. This charge transfer is responsible for the surface conductivity and also influences contact angles and zeta potentials. The effect is not confined to diamond and may play a previously unrecognized role in other disparate systems.	Case Western Reserve Univ, Cleveland, OH 44106 USA; Duke Univ, Durham, NC 27708 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA; Univ Louisville, Louisville, KY 40291 USA	Case Western Reserve University; Duke University; Research Triangle Institute; University of Louisville	Angus, JC (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	john.angus@case.edu	Stoner, Brian R/D-9747-2011	Stoner, Brian/0000-0002-3975-3195				Adamson A. W., 1982, PHYS CHEM SURFACES, V4th; BARD AJ, 1991, PURE APPL CHEM, V63, P569, DOI 10.1351/pac199163040569; Bermudez VM, 1996, J APPL PHYS, V80, P1190, DOI 10.1063/1.362924; Bradley K, 2000, PHYS REV LETT, V85, P4361, DOI 10.1103/PhysRevLett.85.4361; Chakrapani V, 2005, ELECTROCHEM SOLID ST, V8, pE4, DOI 10.1149/1.1828351; CHAKRAPANI V, 2007, THESIS CASE W RESERV; Chakrapani V, 2007, MATER RES SOC SYMP P, V956, P89; COLLINS AT, 1979, PROPERTIES DIAMOND, P99; Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801; Dean J. A., 1999, LANGES HDB CHEM; Denisenko A, 2001, DIAM RELAT MATER, V10, P667, DOI 10.1016/S0925-9635(00)00531-8; EVANS T, 1992, PROPERTIES NATURAL S, P239; Foord JS, 2002, DIAM RELAT MATER, V11, P856, DOI 10.1016/S0925-9635(01)00689-6; Gi RS, 1997, JPN J APPL PHYS 1, V36, P2057, DOI 10.1143/JJAP.36.2057; Gi RS, 1999, JPN J APPL PHYS 1, V38, P3492; Gurevich Y. Y., 1982, ELEKTROKHIMIYA, V18, P1477; Hayashi K, 1997, J APPL PHYS, V81, P744, DOI 10.1063/1.364299; Hayashi K, 1996, APPL PHYS LETT, V68, P376, DOI 10.1063/1.116690; Hiemenz P. C., 1997, PRINCIPLES COLLOID S, V3rd; Kawarada H, 2001, PHYS STATUS SOLIDI A, V185, P79, DOI 10.1002/1521-396X(200105)185:1<79::AID-PSSA79>3.0.CO;2-8; Kazaoui S, 2001, APPL PHYS LETT, V78, P3433, DOI 10.1063/1.1372208; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; LANDSTRASS MI, 1989, APPL PHYS LETT, V55, P975, DOI 10.1063/1.101694; Larsson K, 2005, J PHYS CHEM B, V109, P10304, DOI 10.1021/jp050419h; LIDE DR, 2003, C R C HDB CHEM PHYS; Looi HJ, 1998, DIAM RELAT MATER, V7, P550, DOI 10.1016/S0925-9635(97)00252-5; Lovall D, 2000, PHYS REV B, V61, P5683, DOI 10.1103/PhysRevB.61.5683; Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472; Maier F, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.165411; MAKI T, 1992, JPN J APPL PHYS 2, V31, pL1446, DOI 10.1143/JJAP.31.L1446; MATSUKA N, 1984, DESALINATION, V51, P163, DOI 10.1016/0011-9164(84)85003-1; NEUMANN AW, 1979, TECHNIQUES MEASURING, V2; Petrini D, 2007, J PHYS CHEM C, V111, P13804, DOI 10.1021/jp070565i; Piantanida G, 2001, J APPL PHYS, V89, P8259, DOI 10.1063/1.1368395; Picozzi S, 2004, J VAC SCI TECHNOL A, V22, P1466, DOI 10.1116/1.1705587; PLESKOV YV, 1987, J ELECTROANAL CHEM, V228, P19; Qi D, 2007, J AM CHEM SOC, V129, P8084, DOI 10.1021/ja072133r; Rao TN, 1999, J ELECTROCHEM SOC, V146, P680, DOI 10.1149/1.1391662; Rezek B, 2003, APPL PHYS LETT, V82, P2266, DOI 10.1063/1.1564293; Ristein J, 2004, J ELECTROCHEM SOC, V151, pE315, DOI 10.1149/1.1785797; Ristein J, 2002, DIAM RELAT MATER, V11, P359, DOI 10.1016/S0925-9635(02)00022-5; Ristein J, 2006, SCIENCE, V313, P1057, DOI 10.1126/science.1127589; Sumanasekera GU, 2000, PHYS REV LETT, V85, P1096, DOI 10.1103/PhysRevLett.85.1096; Tracy KM, 2003, J APPL PHYS, V94, P3939, DOI 10.1063/1.1598630; Trigwell S, 2003, IEEE T IND APPL, V39, P79, DOI 10.1109/TIA.2002.807228; Wiles JA, 2004, J PHYS CHEM B, V108, P20296, DOI 10.1021/jp0457904; WOODS GS, 1994, EMIS DATAREVIEWS SER, V9, P83; Zahab A, 2000, PHYS REV B, V62, P10000, DOI 10.1103/PhysRevB.62.10000; Zhao YG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144406	49	485	490	6	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1424	1430		10.1126/science.1148841	http://dx.doi.org/10.1126/science.1148841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048683				2022-12-28	WOS:000251246100038
J	Semigran, MJ; Stevenson, LW; Passeri, JJ; Stone, JR; Madsen, JC				Semigran, Marc J.; Stevenson, Lynne Warner; Passeri, Jonathan J.; Stone, James R.; Madsen, Joren C.			A 47-year-old man with left ventricular dysfunction after heart transplantation - Moderate-to-severe atherosclerosis of the donor heart with thrombosis of the left anterior descending coronary artery and extensive anterior and septal myocardial infarction. Mild acute cellular rejection. Pericardial amyloid deposition.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC TRANSPLANTATION; DISEASE; DEATH		Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University	Semigran, MJ (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.							Arbustini E, 1996, AM J CARDIOL, V78, P795, DOI 10.1016/S0002-9149(96)00424-9; Chu KE, 2005, CARDIOVASC PATHOL, V14, P219, DOI 10.1016/j.carpath.2005.03.009; *DEP HLTH HUM SERV, 2005, 2005 ANN REP US ORG; Drobinski Gerard, 2002, J Interv Cardiol, V15, P403, DOI 10.1111/j.1540-8183.2002.tb01075.x; GALLO P, 1994, CARDIOVASC PATHOL, V3, P173, DOI 10.1016/1054-8807(94)90027-2; Gillmore JD, 2006, BLOOD, V107, P1227, DOI 10.1182/blood-2005-08-3253; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; LIPSKI A, 1993, J HEART LUNG TRANSPL, V12, P1065; Michaels PJ, 2003, J HEART LUNG TRANSPL, V22, P58, DOI 10.1016/S1053-2498(02)00472-2; Pelosi F, 1997, AM J CARDIOL, V79, P532, DOI 10.1016/S0002-9149(97)00806-0; Pittaluga J, 1997, CHEST, V111, P511, DOI 10.1378/chest.111.2.511; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; SUDHAKER S, 2005, J HEART LUNG TRANSPL, V24, pS122; Taylor DO, 2006, J HEART LUNG TRANSPL, V25, P869, DOI 10.1016/j.healun.2006.05.002; Zangari M, 2003, SEMIN THROMB HEMOST, V29, P275; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	16	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2286	2297		10.1056/NEJMcpc079031	http://dx.doi.org/10.1056/NEJMcpc079031			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046033				2022-12-28	WOS:000251176400012
J	Samarasekera, U				Samarasekera, Udani			Pressure grows against homoeopathy in the UK	LANCET			English	Editorial Material								Health service funding is being stopped for some of the UK's homoeopathic hospitals, following an active campaign by doctors and scientists. Does this signal the beginning of the end of homoeopathy on the UK's National Health Service?											0	16	16	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2007	370	9600					1677	1678		10.1016/S0140-6736(07)61708-5	http://dx.doi.org/10.1016/S0140-6736(07)61708-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18062065				2022-12-28	WOS:000251091200009
J	John, EM; Miron, A; Gong, G; Phipps, AI; Felberg, A; Li, FP; West, DW; Whittemore, AS				John, Esther M.; Miron, Alexander; Gong, Gail; Phipps, Amanda I.; Felberg, Anna; Li, Frederick P.; West, Dee W.; Whittemore, Alice S.			Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER PATIENTS; POPULATION-BASED SERIES; SENSITIVE GEL-ELECTROPHORESIS; AFRICAN-AMERICAN FAMILIES; SAN-LUIS VALLEY; BREAST/OVARIAN CANCER; OVARIAN-CANCER; GENETIC EPIDEMIOLOGY; HIGH PROPORTION; GERMLINE MUTATIONS	Context Information on the prevalence of pathogenic BRCA1 mutation carriers in racial/ ethnic minority populations is limited. Objective To estimate BRCA1 carrier prevalence in Hispanic, African American, and Asian American female breast cancer patients compared with non- Hispanic white patients with and without Ashkenazi Jewish ancestry. Design, Setting, and Participants We estimated race/ ethnicity- specific prevalence of BRCA1 in a population- based, multiethnic series of female breast cancer patients younger than 65 years at diagnosis who were enrolled at the Northern California site of the Breast Cancer Family Registry during the period 1996- 2005. Race/ ethnicity and religious ancestry were based on self- report. Weighted estimates of prevalence and 95% confidence intervals ( CIs) were based on Horvitz- Thompson estimating equations. Main Outcome Measure Estimates of BRCA1 prevalence. Results Estimates of BRCA1 prevalence were 3.5% ( 95% CI, 2.1%- 5.8%) in Hispanic patients ( n = 393), 1.3% ( 95% CI, 0.6%- 2.6%) in African American patients ( n = 341), and 0.5% ( 95% CI, 0.1%- 2.0%) in Asian American patients ( n = 444), compared with 8.3% ( 95% CI, 3.1%- 20.1%) in Ashkenazi Jewish patients ( n= 41) and 2.2% ( 95% CI, 0.7%- 6.9%) in other non- Hispanic white patients ( n= 508). Prevalence was particularly high in young ( < 35 years) African American patients ( 5/30 patients [ 16.7%]; 95% CI, 7.1%- 34.3%). 185delAG was the most common mutation in Hispanics, found in 5 of 21 carriers ( 24%). Conclusions Among African American, Asian American, and Hispanic patients in the Northern California Breast Cancer Family Registry, the prevalence of BRCA1 mutation carriers was highest in Hispanics and lowest in Asian Americans. The higher carrier prevalence in Hispanics may reflect the presence of unrecognized Jewish ancestry in this population.	No Calif Canc Ctr, Fremont, CA 94538 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Stanford University; Harvard University; Dana-Farber Cancer Institute	John, EM (corresponding author), No Calif Canc Ctr, 2201 Walnut Ave,Ste 300, Fremont, CA 94538 USA.	ejohn@nccc.org			NCI NIH HHS [CA78564, U01 CA69417, U01 CA069417-10, U01 CA069417, CA-95-003, CA94069] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095003, R01CA078564, R01CA094069, U01CA069417] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; *BREAST CANC INF C, BRCA1 MUT DAT; Brown MA, 2002, HUM MUTAT, V19, P435, DOI 10.1002/humu.10055; Chen WY, 2002, J CLIN ONCOL, V20, P4485, DOI 10.1200/JCO.2002.08.147; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Emi M, 1998, JPN J CANCER RES, V89, P12, DOI 10.1111/j.1349-7006.1998.tb00472.x; Fackenthal JD, 2005, J MED GENET, V42, P276, DOI 10.1136/jmg.2004.020446; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gad S, 2002, ONCOGENE, V21, P6841, DOI 10.1038/sj.onc.1205685; Gallardo M, 2006, BREAST CANCER RES TR, V95, P81, DOI 10.1007/s10549-005-9047-1; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gao Q, 2000, HUM GENET, V107, P186, DOI 10.1007/s004390000290; Gao Q, 2000, HUM GENET, V107, P192, DOI 10.1007/s004390000342; Gao Q, 1997, AM J HUM GENET, V60, P1233; Haffty BG, 2006, J MED GENET, V43, P133, DOI 10.1136/jmg.2005.034744; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Hogervorst FBL, 2003, CANCER RES, V63, P1449; Infante M, 2006, J HUM GENET, V51, P611, DOI 10.1007/s10038-006-0404-7; Jara L, 2006, CANCER GENET CYTOGEN, V166, P36, DOI 10.1016/j.cancergencyto.2005.08.019; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Llort Gemma, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9014.abs; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Makriyianni I, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029785; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Martin-Philips O, 2003, TULSA STUD WOMEN LIT, V22, P417, DOI 10.2307/20059163; Matsuda MLD, 2002, INT J CANCER, V98, P596, DOI 10.1002/ijc.10194; McKean-Cowdin R, 2005, HUM GENET, V116, P497, DOI 10.1007/s00439-004-1240-5; Mew NA, 2002, CLIN GENET, V62, P151, DOI 10.1034/j.1399-0004.2002.620208.x; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Pal T, 2004, CANCER EPIDEM BIOMAR, V13, P1794; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Polite BN, 2005, PERSPECT BIOL MED, V48, pS166; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Ruiz-Flores P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9084; Shen Dejun, 2000, Journal of the National Medical Association, V92, P29; Sng JH, 2000, BRIT J CANCER, V82, P538; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; Suter NM, 2004, CANCER EPIDEM BIOMAR, V13, P181, DOI 10.1158/1055-9965.EPI-03-0196; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; van Orsouw NJ, 1999, J MED GENET, V36, P747, DOI 10.1136/jmg.36.10.747; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Whittemore AS, 2004, CANCER EPIDEM BIOMAR, V13, P2078; Whittemore AS, 1997, STAT MED, V16, P153, DOI 10.1002/(SICI)1097-0258(19970130)16:2<153::AID-SIM477>3.0.CO;2-7; Wolfram Research Inc, 2005, MATH VERS 5 2	60	236	237	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2869	2876		10.1001/jama.298.24.2869	http://dx.doi.org/10.1001/jama.298.24.2869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159056	Bronze			2022-12-28	WOS:000251816000019
J	Kesselheim, AS; Studdert, DM				Kesselheim, Aaron S.; Studdert, David M.			Role of professional organizations in regulating physician expert witness testimony	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LITIGATION		Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoeconom, Boston, MA 02120 USA; Univ Melbourne, Fac Law, Melbourne, Vic, Australia; Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Melbourne; University of Melbourne	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoeconom, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Studdert, David/AAF-3116-2021; Kesselheim, Aaron/R-6793-2017	Studdert, David/0000-0003-0585-5537; Kesselheim, Aaron/0000-0002-8867-2666				Ashar BH, 2005, SOUTH MED J, V98, P444, DOI 10.1097/01.SMJ.0000145282.48033.18; Eitel DR, 1997, J LEGAL MED, V18, P345, DOI 10.1080/01947649709511039; Gatowski SI, 2001, LAW HUMAN BEHAV, V25, P433, DOI 10.1023/A:1012899030937; Gomez JCB, 2005, J LEGAL MED, V26, P385, DOI 10.1080/01947640500218356; HERRMANN M, 2005, NATL LAW J      0228; Kesselheim AS, 2006, OBSTET GYNECOL, V108, P273, DOI 10.1097/01.AOG.0000225969.08432.75; NORBUT M, 2005, AM MED NEWS     1121, P11; Rosenbaum JT, 1997, SCIENCE, V276, P1524, DOI 10.1126/science.276.5318.1524; Walker JM, 2005, MIAMI DAILY BUS 0808, P1	9	19	19	3	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2907	2909		10.1001/jama.298.24.2907	http://dx.doi.org/10.1001/jama.298.24.2907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243RW	18159060				2022-12-28	WOS:000251816000024
J	Redelmeier, DA; Greenwald, JA				Redelmeier, Donald A.; Greenwald, J. Ari			Competing risks of mortality with marathons: retrospective analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY CARDIAC-ARREST; CARDIOVASCULAR-DISEASE; SUDDEN-DEATH; EXERCISE; RECOMMENDATIONS; REHABILITATION; PREVENTION; INJURIES; RUNNERS	Objective To determine from a societal perspective the risk of sudden cardiac death associated with running in an organised marathon compared with the risk of dying from a motor vehicle crash that might otherwise have taken place if the roads had not been closed. Design Population based retrospective analysis with linked ecological comparisons of sudden death. Setting Marathons with at least 1000 participants that had two decades of history and took place on public roads in the United States, 1975-2004. Main outcome measures Sudden death attributed to cardiac causes or to motorvehicle trauma. Results The marathons provided results for 3 292 268 runners on 750 separate days encompassing about 14 million hours of exercise. There were 26 sudden cardiac deaths observed, equivalent to a rate of 0.8 per 100000 participants (95% confidence interval 0.5 to 1.1). Because of road closure, an estimated 46 motorvehicle fatalities were prevented, equivalent to a relative risk reduction of 35% (95% confidence interval 17% to 49%). The net reduction in sudden death during marathons amounted to a ratio of about 1.8 crash deaths saved for each case of sudden cardiac death observed (95% confidence interval: 0.7 to 3.8). The net reduction in total deaths could not be explained by re-routing traffic to other regions or days and was consistent across different parts of the country, decades of the century, seasons of the year, days of the week, degree of competition, and course difficulty. Conclusion Organised marathons are not associated with an increase in sudden deaths from a societal perspective, contrary to anecdotal impressions fostered by news media.	[Redelmeier, Donald A.; Greenwald, J. Ari] Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Serv Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada.	Redelmeierdar@ices.on.ca						[Anonymous], 2004, WORLD REP ROAD TRAFF; ARMNOLD D, 2002, BOSTON GLOBE    0419, pB3; ARNOLD D, 2002, BOSTON GLOBE    0419, pB3; BRODY JE, 2006, NY TIMES        0620; Caselli MA, 1997, J AM PODIAT MED ASSN, V87, P34, DOI 10.7547/87507315-87-1-34; CERIO R, 1985, ARCH EMERG MED, V2, P89; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Evans L., 2004, TRAFFIC SAFETY; Girasek DC, 2006, INJURY PREV, V12, P71, DOI 10.1136/ip.2005.008839; Greenidge J, 1996, BOSTON GLOBE    0416, P51; Hecht HS, 2001, CIRCULATION, V104, pE58; Jaworski Carrie A, 2005, Curr Sports Med Rep, V4, P137; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; MANIER J, 1998, CHICAGO TRIBUNE 1122, P1; Maron BJ, 2000, NEW ENGL J MED, V343, P1409, DOI 10.1056/NEJM200011093431911; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; Maron BJ, 2001, CIRCULATION, V103, P327; Mitten MJ, 2002, JOHNS L REV, V76, P5; NOAKES TD, 1987, MED SCI SPORT EXER, V19, P187; Ratliff NB, 2002, LANCET, V360, P542, DOI 10.1016/S0140-6736(02)09744-1; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Redelmeier DA, 2003, NEW ENGL J MED, V348, P368, DOI 10.1056/NEJM200301233480423; REDELMEIER DA, 2004, CHANCE, V17, P19; REYNODLS G, 2006, NY TIMES        1207; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Sanchez LD, 2006, AM J EMERG MED, V24, P608, DOI 10.1016/j.ajem.2006.01.023; SAPERSTEIN S, 1986, WASHINGTON POST 1104, pB1; Sedivy R, 1997, MODERN PATHOL, V10, P247; SHAFIR E, 2004, PREFERECE BELIEF SIM; Simons Stephen M, 2004, Curr Sports Med Rep, V3, P112; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; U.S. Bureau of the Census, 2004, STAT ABSTR US 2004 2; *US BUR CENS, STAT ABSTR US 2004 2; *US DEP TRANSP, 2003, TRAFF SAF FACTS; WEBER B, 1994, NY TIMES        1108, pB13; WEINREB A, 2004, CANADA FREE PRE 1020; WILSON T, 2000, CHICAGO TRIBUNE 1024, P5; Woolley P.J., 2006, WASH POST, pA19; WRIGHT W, 2002, HONOLULU ADVERT 1209, pA1	43	61	64	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1275	1277		10.1136/bmj.39384.551539.25	http://dx.doi.org/10.1136/bmj.39384.551539.25			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156224	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000252182700004
J	Boughman, JW				Boughman, Janette W.			Sticklebacks and humans walk hand in fin to lighter skin	CELL			English	Editorial Material							ADAPTIVE EVOLUTION; ADAPTATION	In this issue, Miller et al. (2007) show that evolution makes repeated use of the same genes to produce light pigmentation in animals as divergent as stickleback fish and humans. This study indicates that analyzing parallel evolution at the genetic level could help to answer a number of outstanding questions in evolutionary genetics.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Boughman, JW (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jboughman@wisc.edu		Boughman, Janette/0000-0002-5731-7389				BARRETT RDH, 2007, TRENDS ECOL EVO 1112; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; MILLER CT, 2007, CELL; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	9	1	1	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1041	1043		10.1016/j.cell.2007.11.029	http://dx.doi.org/10.1016/j.cell.2007.11.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083094	Bronze			2022-12-28	WOS:000252217100012
J	Blow, N				Blow, Nathan			Delivering the future	NATURE			English	Article							IN-VIVO; GENE											Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	5	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1117	1122		10.1038/4501117a	http://dx.doi.org/10.1038/4501117a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075597	Bronze			2022-12-28	WOS:000251579900094
J	Evans, JP				Evans, James P.			Health care in the age of genetic medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu			NHGRI NIH HHS [P20HG03387] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003387] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Cunningham PJ, 2000, HEALTH AFFAIR, V19, P158, DOI 10.1377/hlthaff.19.3.158; Himmelstein D. U., 2005, ILLNESS INJURY CONTR; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; MCWILLIAM A, 2006, HLTH CARE SAVINGS PE; URBINA I, 2006, NY TIMES        0111	5	20	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2670	2672		10.1001/jama.298.22.2670	http://dx.doi.org/10.1001/jama.298.22.2670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073364				2022-12-28	WOS:000251546100020
J	Pandharipande, PP; Pun, BT; Herr, DL; Maze, M; Girard, TD; Miller, RR; Shintani, AK; Thompson, JL; Jackson, JC; Deppen, SA; Stiles, RA; Dittus, RS; Bernard, GR; Ely, EW				Pandharipande, Pratik P.; Pun, Brenda T.; Herr, Daniel L.; Maze, Mervyn; Girard, Timothy D.; Miller, Russell R.; Shintani, Ayumi K.; Thompson, Jennifer L.; Jackson, James C.; Deppen, Stephen A.; Stiles, Renee A.; Dittus, Robert S.; Bernard, Gordon R.; Ely, E. Wesley			Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients - The MENDS randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; CONFUSION ASSESSMENT METHOD; DELIRIUM; RELIABILITY; AGITATION; DURATION; VALIDITY; ICU; INTERRUPTION	Context Lorazepam is currently recommended for sustained sedation of mechanically ventilated intensive care unit ( ICU) patients, but this and other benzodiazepine drugs may contribute to acute brain dysfunction, ie, delirium and coma, associated with prolonged hospital stays, costs, and increased mortality. Dexmedetomidine induces sedation via different central nervous system receptors than the benzodiazepine drugs and may lower the risk of acute brain dysfunction. Objective To determine whether dexmedetomidine reduces the duration of delirium and coma in mechanically ventilated ICU patients while providing adequate sedation as compared with lorazepam. Design, Setting, Patients, and Intervention Double- blind, randomized controlled trial of 106 adult mechanically ventilated medical and surgical ICU patients at 2 tertiary care centers between August 2004 and April 2006. Patients were sedated with dexmedetomidine or lorazepam for as many as 120 hours. Study drugs were titrated to achieve the desired level of sedation, measured using the Richmond Agitation-Sedation Scale ( RASS). Patients were monitored twice daily for delirium using the Confusion Assessment Method for the ICU ( CAM- ICU). Main Outcome Measures Days alive without delirium or coma and percentage of days spent within 1 RASS point of the sedation goal. Results Sedation with dexmedetomidine resulted in more days alive without delirium or coma ( median days, 7.0 vs 3.0; P=. 01) and a lower prevalence of coma ( 63% vs 92%; P <. 001) than sedation with lorazepam. Patients sedated with dexmedetomidine spent more time within 1 RASS point of their sedation goal compared with patients sedated with lorazepam ( median percentage of days, 80% vs 67%; P=. 04). The 28- day mortality in the dexmedetomidine group was 17% vs 27% in the lorazepam group ( P=. 18) and cost of care was similar between groups. More patients in the dexmedetomidine group ( 42% vs 31%; P=. 61) were able to complete post- ICU neuropsychological testing, with similar scores in the tests evaluating global cognitive, motor speed, and attention functions. The 12- month time to death was 363 days in the dexmedetomidine group vs 188 days in the lorazepam group ( P=. 48). Conclusion In mechanically ventilated ICU patients managed with individualized targeted sedation, use of a dexmedetomidine infusion resulted in more days alive without delirium or coma and more time at the targeted level of sedation than with a lorazepam infusion.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Accreditat & Stand, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; VA Tennessee Valley Geriatr Res Educ & Clin Ctr, Nashville, TN USA; Washington Hosp Ctr, Dept Surg & Surg Crit Care, Washington, DC 20010 USA; Univ London Imperial Coll Sci Technol & Med, Dept Anaesthet Pain Med & Intens Care, London, England	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; MedStar Washington Hospital Center; Imperial College London	Pandharipande, PP (corresponding author), 526 MAB,1211 21st Ave S, Nashville, TN 37212 USA.	pratik.pandharipande@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019; Girard, Timothy/I-3008-2019; Herr, Daniel/X-4215-2019	Ely, E. Wesley/0000-0003-3957-2172; Girard, Timothy/0000-0002-9833-4871; Pandharipande, Pratik/0000-0002-1389-8580; Herr, Daniel/0000-0001-8533-9000	NIA NIH HHS [AG0727201] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bourne RS, 2004, ANAESTHESIA, V59, P374, DOI 10.1111/j.1365-2044.2004.03664.x; Brattebo G, 2002, BMJ-BRIT MED J, V324, P1386, DOI 10.1136/bmj.324.7350.1386; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Chambers J. M., 1983, GRAPHICAL METHODS DA; Devlin JW, 2006, CRIT CARE MED, V34, P556, DOI 10.1097/01.CCM.0000199058.88904.D6; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ibacache ME, 2004, ANESTH ANALG, V98, P60, DOI 10.1213/01.ANE.0000094947.20838.8E; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; LEVANEN J, 1995, ANESTHESIOLOGY, V82, P1117, DOI 10.1097/00000542-199505000-00005; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; Maldonado J, 2003, AM SOC AN ANN M SAN, V99, pA465; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Maze M, 2001, CRIT CARE CLIN, V17, P881, DOI 10.1016/S0749-0704(05)70185-8; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Mihic SJ, 1997, ALCOHOL HEALTH RES W, V21, P127; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; PANDHARIPANDE P, IN PRESS J TRAUMA; Pandharipande P, 2006, CRIT CARE CLIN, V22, P313, DOI 10.1016/j.ccc.2006.02.010; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Slomka J, 2000, Am J Crit Care, V9, P412; Spreen O, 1998, COMPENDIUM NEUROPSYC; TANIOS MA, 2005, P AM THORAC SOC, V2, pA793; van der Mast RC, 1998, J GERIATR PSYCH NEUR, V11, P138, DOI 10.1177/089198879801100304; VanderMast RC, 1996, J PSYCHOSOM RES, V41, P109, DOI 10.1016/0022-3999(96)00006-2; Weinert C R, 2001, Am J Crit Care, V10, P156; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D; WIJDICKS EFM, 2002, NEUROLOGIC COMPLICAT; Young C, 2000, CRIT CARE MED, V28, P854, DOI 10.1097/00003246-200003000-00041; SOCIAL SECURITY DEAT	44	896	954	2	51	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2644	2653		10.1001/jama.298.22.2644	http://dx.doi.org/10.1001/jama.298.22.2644			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073360	Bronze			2022-12-28	WOS:000251546100016
J	Dubrovinskaia, N; Dubrovinsky, L; Solozhenko, VL				Dubrovinskaia, Natalia; Dubrovinsky, Leonid; Solozhenko, Vladimir L.			Comment on "synthesis of ultra-incompressible superhard rhenium diboride at ambient pressure"	SCIENCE			English	Editorial Material									Univ Heidelberg, Inst Mineral, D-69120 Heidelberg, Germany; Univ Bayreuth, Lehrstuhl Kristallog, Inst Phys, D-95440 Bayreuth, Germany; Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; Univ Paris 13, CNRS, Lab Proprietes Mecan & Thermodynam Mat, F-93430 Villetaneuse, France	Ruprecht Karls University Heidelberg; University of Bayreuth; University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); Universite Paris 13	Dubrovinskaia, N (corresponding author), Univ Heidelberg, Inst Mineral, D-69120 Heidelberg, Germany.	natalia.dubrovinskaia@min.uni-heidelberg.de	Solozhenko, Vladimir L./E-1975-2011; Dubrovinskaia, Natalia/A-8013-2015	Solozhenko, Vladimir L./0000-0002-0881-9761; Dubrovinskaia, Natalia/0000-0002-8256-5675; Dubrovinsky, Leonid/0000-0002-3717-7585				Bansal N.P., 2005, HDB CERAMIC COMPOSIT; Berman R., 1965, PHYS PROPERTIES DIAM; Brazhkin V, 2004, NAT MATER, V3, P576, DOI 10.1038/nmat1196; Chung HY, 2007, SCIENCE, V316, P436, DOI 10.1126/science.1139322; Dubrovinskaia N, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711277; GOGOTSI YG, 1999, NATO ASI SERIES, V3; LAPLACA S, 1962, ACTA CRYSTALLOGR, V15, P97, DOI 10.1107/S0365110X62000298	7	83	85	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1550	1550		10.1126/science.1147650	http://dx.doi.org/10.1126/science.1147650			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063772				2022-12-28	WOS:000251421700016
J	Behuniak, SM				Behuniak, Susan M.			Words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												behuniak@lemoyne.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2458	2458		10.1001/jama.298.21.2458	http://dx.doi.org/10.1001/jama.298.21.2458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056896				2022-12-28	WOS:000251361900001
J	Schnipper, LE				Schnipper, Lowell E.			Update in oncology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LUNG-CANCER; INTRAPERITONEAL CISPLATIN		Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Schnipper, LE (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, 330 Brookline Ave, Boston, MA 02215 USA.	lschnipp@bidmc.harvard.edu						Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; *AM CANC SOC BREAS, 2007, CA-CANCER J CLIN, V57, P75; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Unger M, 2006, NEW ENGL J MED, V355, P1822, DOI 10.1056/NEJMe068207; WELCH HG, 2007, NY TIMES        0313	9	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					775	782		10.7326/0003-4819-147-11-200712040-00008	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056661				2022-12-28	WOS:000251539100004
J	Snyder, L; Neubauer, RL				Snyder, Lois; Neubauer, Richard L.		Amer Coll of Phys E P & H R C	Pay-for-performance principles that promote patient-centered care: An ethics manifesto	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN; QUALITY; IMPROVE	Pay-for-performance programs are growing, but little evidence exists on their effectiveness or on their potential unintended consequences and effects on the patient-physician relationship. Pay-for-performance has the potential to help improve the quality of care, if it can be aligned with the goals of medical professionalism. Initiatives that provide incentives for a few specific elements of a single disease or condition, however, may neglect the complexity of care for the whole patient, especially the elderly patient with multiple chronic conditions. Such programs could also result in the deselection of patients, " playing to the measures" rather than focusing on the patient as a whole, and misalignment of perceptions between physicians and patients. The primary focus of the quality movement in health care should not be on " pay for" or "performance" based on limited measures, but rather on the patient. The American College of Physicians hopes to move the pay-for-performance debate forward with a patient-centered focus one that puts the needs and interests of the patient first-as these programs evolve.	Amer Coll Phys Ctr Ethics & Profess, Philadelphia, PA USA; Alaska Native Med Ctr, Anchorage, AK USA	Alaska Native Medical Center	Snyder, L (corresponding author), Amer Coll Phys Ctr Ethics & Profess, 190 N Indepedence Mall W, Philadelphia, PA USA.	lsnyder@acponline.org						*AM COLL PHYS, US PERF MEAS IMPR PH; *AM COLL PHYS, LINK PHYS PAYM QUAL; *AM MED ASS, PRINC PAY PERF PROGR; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braddock CH, 2005, J GEN INTERN MED, V20, P1057, DOI 10.1111/j.1525-1497.2005.00217.x; FITZGERALD F, 2006, IM NEWS, V39, P14; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Povar GJ, 2004, ANN INTERN MED, V141, P131, DOI 10.7326/0003-4819-141-2-200407200-00012; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Snyder L, 2005, ANN INTERN MED, V142, P560, DOI 10.7326/0003-4819-142-7-200504050-00014; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Wolff JL, 2005, ANN INTERN MED, V143, P439, DOI 10.7326/0003-4819-143-6-200509200-00008; Woo B, 2006, NEW ENGL J MED, V355, P864, DOI 10.1056/NEJMp068154	13	81	82	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					792	233		10.7326/0003-4819-147-11-200712040-00011	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056664				2022-12-28	WOS:000251539100007
J	Makovicky, E				Makovicky, Emil			Comment on "decagonal and quasi-crystalline tilings in medieval Islamic architecture"	SCIENCE			English	Editorial Material									Univ Copenhagen, Dept Geog & Geol, DK-1350 Copenhagen, Denmark	University of Copenhagen	Makovicky, E (corresponding author), Univ Copenhagen, Dept Geog & Geol, Oestervoldgade 10, DK-1350 Copenhagen, Denmark.	emilm@geol.ku.dk						BONNER J, 2003, ISAMA BRIDGES C P, P1; Lu PJ, 2007, SCIENCE, V315, P1106, DOI 10.1126/science.1135491; Lu PJ, 2007, SCIENCE, V316, P981, DOI 10.1126/science.316.5827.981; Makovicky E., 1992, FIVEFOLD SYMMETRY, P67; SCHNEIDER G, 1980, GEOMETRISCHE BAUOMAM	5	17	17	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855								10.1126/science.1146262	http://dx.doi.org/10.1126/science.1146262			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	235PF	18048668				2022-12-28	WOS:000251246100019
J	Gates, S; Fisher, JD; Cooke, MW; Carter, YH; Lamb, SE				Gates, S.; Fisher, J. D.; Cooke, M. W.; Carter, Y. H.; Lamb, S. E.			Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis	BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-TRIALS	Objective To evaluate the effectiveness of multifactorial assessment and intervention programmes to prevent falls and injuries among older adults recruited to trials in primary care, community, or emergency care settings. Design Systematic review of randomised and quasi-randomised controlled trials, and meta-analysis Data sources Six databases (Medline, Embase, CENTRAL, CINAHL, PsycINFO, Social Science Citation Index) to 22 March 2007, reference lists of included studies, and previous reviews. Review methods Eligible studies were randomised or quasi-randomised trials that evaluated interventions to prevent falls that were based in emergency departments, primary care, or the community, that assessed multiple risk factors for falling and provided or arranged for treatments to address these risk factors. Data extraction Outcomes were number of falters, fall related injuries, fall rate, death, admission to hospital, contacts with health services, move to institutional care, physical activity, and quality of life. Methodological quality assessment included allocation concealment, blinding, tosses and exclusions, intention to treat analysis, and reliability of outcome measurement. Results 19 studies, of variable methodological quality, were included. The combined risk ratio for the number of falters during follow-up among 18 trials was 0.91 (95% confidence interval 0.82 to 1.02) and for fall. related injuries (eight trials) was 0.90 (0.68 to 1.20). No differences were found in admissions to hospital, emergency department attendance, death, or move to institutional care. Subgroup analyses found no evidence of different effects between interventions in different locations, populations selected for high risk of falls or unselected, and multidisciplinary teams including a doctor, but interventions that actively provide treatments may be more effective than those that provide only knowledge and referral. Conclusions Evidence that multifactorial fall prevention programmes in primary care community or emergency care settings are effective in reducing the number of falters or fall related injuries is limited. Data were insufficient to assess fall and injury rates.	[Gates, S.; Fisher, J. D.; Cooke, M. W.; Carter, Y. H.; Lamb, S. E.] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Lamb, S. E.] Univ Oxford, Kadoorie Crit Care Res Ctr, Oxford OX1 2JD, England	University of Warwick; University of Oxford	Gates, S (corresponding author), Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	s.gates@warwick.ac.uk		Lamb, Sarah/0000-0003-4349-7195				Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Deeks J, 2006, COCHRANE HDB SYSTEMA; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Department of Health, 2001, NAT SERV FRAM OLD PE; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gillespie LD, 2003, COCHRANE DATABASE SY; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill-Westmoreland EE, 2002, NURS RES, V51, P1, DOI 10.1097/00006199-200201000-00002; HOPEWELL S, 2004, 12 COCHR C BRIDG GAP; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; LAMB S, 2007, IN PRESS SCOPING EXE; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Mackenzie L, 2006, CLIN REHABIL, V20, P331, DOI 10.1191/0269215506cr947oa; National Institute for Health and Clinical Excellence, 2004, FALLS ASS PREV FALLS	16	289	300	1	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					130	133		10.1136/bmj.39412.525243.BE	http://dx.doi.org/10.1136/bmj.39412.525243.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18089892	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252819400030
J	Gurley, KA; Rink, JC; Alvarado, AS				Gurley, Kyle A.; Rink, Jochen C.; Alvarado, Alejandro Sanchez			beta-catenin defines head versus tail identity during planarian regeneration and Homeostasis	SCIENCE			English	Article							WNT SIGNALING PATHWAY; CELL-FATE; C-ELEGANS; EMBRYOS; POLARITY; TRANSCRIPTION; ASYMMETRIES; ROLES	After amputation, freshwater planarians properly regenerate a head or tail from the resulting anterior or posterior wound. The mechanisms that differentiate anterior from posterior and direct the replacement of the appropriate missing body parts are unknown. We found that in the planarian Schmidtea mediterranea, RNA interference ( RNAi) of beta-catenin or dishevelled causes the inappropriate regeneration of a head instead of a tail at posterior amputations. Conversely, RNAi of the beta-catenin antagonist adenomatous polyposis coli results in the regeneration of a tail at anterior wounds. In addition, the silencing of beta-catenin is sufficient to transform the tail of uncut adult animals into a head. We suggest that beta-catenin functions as a molecular switch to specify and maintain anteroposterior identity during regeneration and homeostasis in planarians.	[Gurley, Kyle A.; Rink, Jochen C.; Alvarado, Alejandro Sanchez] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Neurobiol & Anat, 401 MREB,20N 1900E, Salt Lake City, UT 84132 USA.	sanchez@neuro.utah.edu			NATIONAL CANCER INSTITUTE [T32CA093247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082016, R01GM057260] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA093247, T32 CA093247] Funding Source: Medline; NIGMS NIH HHS [F32GM082016, R01 GM057260-08, F32 GM082016, R01 GM057260, R0-1 GM57260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; BREMBECK FH, 2004, SCI STKE, pPE48; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Morgan TH, 1904, AM NAT, V38, P502; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014	25	338	347	0	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					323	327		10.1126/science.1150029	http://dx.doi.org/10.1126/science.1150029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18063757	Green Accepted			2022-12-28	WOS:000252436200036
J	Shaikh, N; Morone, NE; Lopez, J; Chianese, J; Sangvai, S; D'Amico, F; Hoberman, A; Wald, ER				Shaikh, Nader; Morone, Natalia E.; Lopez, John; Chianese, Jennifer; Sangvai, Shilpa; D'Amico, Frank; Hoberman, Alejandro; Wald, Ellen R.			Does this child have a urinary tract infection?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEBRILE YOUNG-CHILDREN; EMERGENCY-DEPARTMENT; INFANTS; PREVALENCE; FEVER; BACTERIAL	Context Urinary tract infection ( UTI) is a frequently occurring pediatric illness that, if left untreated, can lead to permanent renal injury. Accordingly, accurate diagnosis of UTI is important. Objective To review the diagnostic accuracy of symptoms and signs for the diagnosis of UTI in infants and children. Data Sources A search of MEDLINE and EMBASE databases was conducted for articles published between 1966 and October 2007, as well as a manual review of bibliographies of all articles meeting inclusion criteria, 1 previously published systematic review, 3 clinical skills textbooks, and 2 experts in the field, yielding 6988 potentially relevant articles. Study Selection Studies were included if they contained data on signs or symptoms of UTI in children through age 18 years. Of 337 articles examined, 12 met all inclusion criteria. Data Extraction Two evaluators independently reviewed, rated, and abstracted data from each article. Data Synthesis In infants with fever, history of a previous UTI ( likelihood ratio [ LR] range, 2.3- 2.9), temperature higher than 40 C ( LR range, 3.2- 3.3), and suprapubic tenderness ( LR, 4.4; 95% confidence interval [ CI], 1.6- 12.4) were the findings most useful for identifying those with a UTI. Among male infants, lack of circumcision increased the likelihood of a UTI ( summary LR, 2.8; 95% CI, 1.9- 4.3); and the presence of circumcision was the only finding with an LR of less than 0.5 ( summary LR, 0.33; 95% CI, 0.18- 0.63). Combinations of findings were more useful than individual findings in identifying infants with a UTI ( for temperature > 39 degrees C for >48 hours without another potential source for fever on examination, the LR for all findings present was 4.0; 95% CI, 1.2- 13.0; and for temperature <39 degrees C with another source for fever, the LR was 0.37; 95% CI, 0.16- 0.85). In verbal children, abdominal pain ( LR, 6.3; 95% CI, 2.5- 16.0), back pain ( LR, 3.6; 95% CI, 2.1- 6.1), dysuria, frequency, or both ( LR range, 2.2- 2.8), and new- onset urinary incontinence ( LR, 4.6; 95% CI, 2.8- 7.6) increased the likelihood of a UTI. Conclusions Although individual signs and symptoms were helpful in the diagnosis of a UTI, they were not sufficiently accurate to definitively diagnose UTIs. Combination of findings can identify infants with a low likelihood of a UTI.	Childrens Hosp Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15213 USA; Childrens Hosp Pittsburgh, Dept Internal Med, Sch Med, Pittsburgh, PA 15213 USA; Ohio State Univ, Sch Med, Dept Pediat, Columbus, OH 43210 USA; Duquesne Univ, Dept Math, Pittsburgh, PA 15219 USA; Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Duquesne University; University of Wisconsin System; University of Wisconsin Madison	Shaikh, N (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, Sch Med, 3705 5th Ave, Pittsburgh, PA 15213 USA.	nader.shaikh@chp.edu	, Natalia/AAS-8745-2021; Sangvai, Shilpa/E-4014-2011	, Natalia/0000-0002-8405-5396; 	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023267] Funding Source: NIH RePORTER; NCRR NIH HHS [K12 RR023267] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Chen L, 2006, PEDIATR EMERG CARE, V22, P485, DOI 10.1097/01.pec.0000226872.31501.d0; CRAIN EF, 1990, PEDIATRICS, V86, P363; DICKINSON JA, 1979, BMJ-BRIT MED J, V1, P1330, DOI 10.1136/bmj.1.6174.1330; Downs SH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e54; Freedman AL, 2005, J UROLOGY, V173, P949, DOI 10.1097/01.ju.0000152092.03931.9a; Gorelick MH, 2000, ARCH PEDIAT ADOL MED, V154, P386, DOI 10.1001/archpedi.154.4.386; HEALE WF, 1973, MED J AUSTRALIA, V1, P1138, DOI 10.5694/j.1326-5377.1973.tb110983.x; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; HOBERMAN A, 1994, J PEDIATR-US, V124, P513, DOI 10.1016/S0022-3476(05)83127-0; HOBERMAN A, 1993, PEDIATRICS, V91, P1196; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; Hulbert J, 1973, J R Coll Gen Pract, V23, P556; KROBER MS, 1985, AM J DIS CHILD, V139, P889, DOI 10.1001/archpedi.1985.02140110043025; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Musa-Aisien AS, 2003, ANN TROP PAEDIATR, V23, P39, DOI 10.1179/000349803125002850; Newman TB, 2002, ARCH PEDIAT ADOL MED, V156, P44, DOI 10.1001/archpedi.156.1.44; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PYLKKANEN J, 1979, ACTA PAEDIATR SCAND, V68, P341, DOI 10.1111/j.1651-2227.1979.tb05017.x; ROBERTS KB, 1983, J PEDIATR-US, V103, P864, DOI 10.1016/S0022-3476(83)80702-1; Shaikh N, 2003, PEDIATRICS, V112, P1134, DOI 10.1542/peds.112.5.1134; SHAIKH N, IN PRESS PEDIAT INFE; Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16; Stoll ML, 2004, ARCH PEDIAT ADOL MED, V158, P671, DOI 10.1001/archpedi.158.7.671; Struthers S, 2003, ARCH DIS CHILD, V88, P250, DOI 10.1136/adc.88.3.250; White AA, 2005, CURR ALLERGY ASTHM R, V5, P1, DOI 10.1007/s11882-005-0046-4; Zorc JJ, 2005, PEDIATRICS, V116, P644, DOI 10.1542/peds.2004-1825	26	132	136	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2895	2904		10.1001/jama.298.24.2895	http://dx.doi.org/10.1001/jama.298.24.2895			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159059				2022-12-28	WOS:000251816000022
J	Price, DE; Redfern, RM				Price, David E.; Redfern, Robert M.			"Did you see it? Where did it go?"	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Price, David E.] Morriston Hosp, Dept Endocrinol, Swansea SA6 6NL, W Glam, Wales; [Redfern, Robert M.] Morriston Hosp, Dept Neurosurg, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital; Morriston Hospital	Price, DE (corresponding author), Morriston Hosp, Dept Endocrinol, Swansea SA6 6NL, W Glam, Wales.	robert.redfern@swansea-tr.wales.nhs.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1284	1284		10.1136/bmj.39406.712743.AD	http://dx.doi.org/10.1136/bmj.39406.712743.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156228	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252182700008
J	Ekberg, H; Tedesco-Silva, H; Demirbas, A; Vitko, S; Nashan, B; Gurkan, A; Margreiter, R; Hugo, C; Grinyo, JM; Frei, U; Vanrenterghem, Y; Daloze, P; Halloran, PF				Ekberg, Henrik; Tedesco-Silva, Helio; Demirbas, Alper; Vitko, Stefan; Nashan, Bjorn; Guerkan, Alp; Margreiter, Raimund; Hugo, Christian; Grinyo, Josep M.; Frei, Ulrich; Vanrenterghem, Yves; Daloze, Pierre; Halloran, Philip F.		ELITE Symphony Study	Reduced exposure to calcineurin inhibitors in renal transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE MICROEMULSION; ALLOGRAFT RECIPIENTS; MULTICENTER TRIAL; TACROLIMUS; SIROLIMUS; IMMUNOSUPPRESSION; EFFICACY; NEPHROTOXICITY	Background: Immunosuppressive regimens with the fewest possible toxic effects are desirable for transplant recipients. This study evaluated the efficacy and relative toxic effects of four immunosuppressive regimens. Methods: We randomly assigned 1645 renal-transplant recipients to receive standard-dose cyclosporine, mycophenolate mofetil, and corticosteroids, or daclizumab induction, mycophenolate mofetil, and corticosteroids in combination with low-dose cyclosporine, low-dose tacrolimus, or low-dose sirolimus. The primary end point was the estimated glomerular filtration rate (GFR), as calculated by the Cockcroft-Gault formula, 12 months after transplantation. Secondary end points included acute rejection and allograft survival. Results: The mean calculated GFR was higher in patients receiving low-dose tacrolimus (65.4 ml per minute) than in the other three groups (range, 56.7 to 59.4 ml per minute). The rate of biopsy-proven acute rejection was lower in patients receiving low-dose tacrolimus (12.3%) than in those receiving standard-dose cyclosporine (25.8%), low-dose cyclosporine (24.0%), or low-dose sirolimus (37.2%). Allograft survival differed significantly among the four groups (P=0.02) and was highest in the low-dose tacrolimus group (94.2%), followed by the low-dose cyclosporine group (93.1%), the standard-dose cyclosporine group (89.3%), and the low-dose sirolimus group (89.3%). Serious adverse events were more common in the low-dose sirolimus group than in the other groups (53.2% vs. a range of 43.4 to 44.3%), although a similar proportion of patients in each group had at least one adverse event during treatment (86.3 to 90.5%). Conclusions: A regimen of daclizumab, mycophenolate mofetil, and corticosteroids in combination with low-dose tacrolimus may be advantageous for renal function, allograft survival, and acute rejection rates, as compared with regimens containing daclizumab induction plus either low-dose cyclosporine or low-dose sirolimus or with standard-dose cyclosporine without induction. (ClinicalTrials.gov number, NCT00231764.).	Lund Univ, Malmo, Sweden; Univ Fed Sao Paulo, Sao Paulo, Brazil; Akdeniz Univ, Antalya, Turkey; Inst Klin & Expt Med, Prague, Czech Republic; Hannover Med Sch, D-30623 Hannover, Germany; SB Tepecik Hosp, Izmir, Turkey; Univ Klin, Innsbruck, Austria; Univ Hosp, Erlangen, Germany; Ciutat Univ Bellvitge, Barcelona, Spain; Free Univ Berlin, Klinikum Rudolf Virchow, Charite, D-1000 Berlin, Germany; Katholieke Univ Leuven, Louvain, Belgium; CHU Montreal, Notre Dame Hosp, Montreal, PQ, Canada; Univ Alberta, Edmonton, AB, Canada	Lund University; Universidade Federal de Sao Paulo (UNIFESP); Akdeniz University; Institute for Clinical & Experimental Medicine (IKEM); Hannover Medical School; Izmir Tepecik Training & Research Hospital; University of Erlangen Nuremberg; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; Universite de Montreal; University of Alberta	Ekberg, H (corresponding author), Univ Hosp, Dept Nephrol & Transplantat, S-20503 Malmo, Sweden.	henrik.ekberg@med.lu.se	Nashan, Björn/H-9087-2019; ieong, bee/C-5840-2012; Halloran, Philip/J-1390-2012	Nashan, Björn/0000-0001-7587-9935; Halloran, Philip/0000-0003-1371-1947				Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CURTIS JJ, 1994, AM J KIDNEY DIS, V23, P471, DOI 10.1016/S0272-6386(12)81015-8; Curtis JJ, 2002, CURR HYPERTENS REP, V4, P377, DOI 10.1007/s11906-002-0067-5; Dean PG, 2004, TRANSPLANTATION, V77, P1555, DOI 10.1097/01.TP.0000123082.31092.53; Ekberg H, 2007, AM J TRANSPLANT, V7, P560, DOI 10.1111/j.1600-6143.2006.01645.x; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Kobashigawa JA, 1997, TRANSPLANTATION, V63, P331, DOI 10.1097/00007890-199702150-00001; Kreis H, 2000, TRANSPLANTATION, V69, P1252, DOI 10.1097/00007890-200004150-00009; Langer RM, 2002, TRANSPLANTATION, V74, P804, DOI 10.1097/00007890-200209270-00012; LUKE RG, 1991, AM J HYPERTENS, V4, P468, DOI 10.1093/ajh/4.5.468; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Rostaing L, 2005, TRANSPLANTATION, V79, P807, DOI 10.1097/01.TP.0000154915.20524.0A; Sperschneider H, 2001, TRANSPLANT P, V33, P1279, DOI 10.1016/S0041-1345(00)02477-5; Vincenti F, 2001, TRANSPLANTATION, V71, P1282, DOI 10.1097/00007890-200105150-00017; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE; *WYETH PHARM, 2006, ASS RAP SIR CONT IMM	21	1309	1363	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2562	2575		10.1056/NEJMoa067411	http://dx.doi.org/10.1056/NEJMoa067411			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094377	Green Published			2022-12-28	WOS:000251728900007
J	Sawaya, GF; Guirguis-Blake, A; LeFevre, M; Harris, R; Petitti, D				Sawaya, George F.; Guirguis-Blake, Anelle; LeFevre, Michael; Harris, Russell; Petitti, Diana		USPSTF	Update on the methods of the US preventive services task force: Estimating certainty and magnitude of net benefit	ANNALS OF INTERNAL MEDICINE			English	Article							ABDOMINAL AORTIC-ANEURYSM	The major goal of the U.S. Preventive Services Task Force (USPSTF) is to provide a reliable and accurate source of evidence-based recommendations on a wide range of preventive services. In this article, the USPSTF updates and reviews the process by which it evaluates evidence, determines the certainty and magnitude of net benefit, and gives a final letter grade to recommendations. Because direct evidence about prevention is often unavailable, the Task Force usually considers indirect evidence. To guide its selection of indirect evidence, a "chain of evidence" is constructed within an analytic framework. The Task Force examines evidence of various research designs that addresses the key questions within the framework. New terms have been added to describe the USPSTF's judgment about the evidence for each key question: "convincing," "adequate," or "inadequate." For increased clarity, the USPSTF has changed its description of overall evidence of net benefit for the preventive service from "good," "fair," or "poor" quality to "high," "moderate," or "low" certainty. This rating considers the extent to which an uninterrupted chain of evidence exists across the analytic framework. Individual studies will continue to be judged as being of "good," "fair," or "poor" quality. Using outcomes tables, the USPSTF estimates the magnitude of benefits and the magnitude of harms, and synthesizes them into an estimate of the magnitude of net benefit. Although some judgment is required at all steps, the USPSTF strives to make the process as explicit and transparent as possible. The USPSTF anticipates that its methods for making evidence-based recommendations will continue to evolve.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Tacoma, WA USA; Univ Missouri, Columbia, MO USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Univ So Calif, Los Angeles, CA USA	University of California System; University of California San Francisco; University of Washington; University of Washington Tacoma; University of Missouri System; University of Missouri Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Southern California								Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; USPSTF, 2007, ANN INTERN MED, V147, P854, DOI 10.7326/0003-4819-147-12-200712180-00005; Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006	5	141	141	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					871	875		10.7326/0003-4819-147-12-200712180-00007	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087058				2022-12-28	WOS:000251787600007
J	Matthews, AJ; Singhruck, P; Heywood, KJ				Matthews, Adrian J.; Singhruck, Patama; Heywood, Karen J.			Deep ocean impact of a Madden-Julian Oscillation observed by Argo floats	SCIENCE			English	Article							INTRASEASONAL KELVIN WAVES; SEA-SURFACE TEMPERATURE; EASTERN PACIFIC	Using the new Argo array of profiling floats that gives unprecedented space- time coverage of the upper 2000 meters of the global ocean, we present definitive evidence of a deep tropical ocean component of the Madden- Julian Oscillation ( MJO). The surface wind stress anomalies associated with the MJO force eastward- propagating oceanic equatorial Kelvin waves that extend downward to 1500 meters. The amplitude of the deep ocean anomalies is up to six times the amplitude of the observed annual cycle. This deep ocean sink of energy input from the wind is potentially important for understanding phenomena such as El Nino- Southern Oscillation and for interpreting deep ocean measurements made from ships.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Matthews, AJ (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	a.j.matthews@uea.ac.uk	Heywood, Karen J/L-1757-2016; Matthews, Adrian J/A-6444-2011	Heywood, Karen J/0000-0001-9859-0026; Matthews, Adrian J/0000-0003-0492-1168				Alverson K, 2006, SCIENCE, V314, P1657, DOI 10.1126/science.1135358; Cravatte S, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001511; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Gould J., 2011, EOS T AGU, V85, P185, DOI [10.1029/2004EO190002, DOI 10.1029/2004EO190002]; Hendon HH, 1996, J ATMOS SCI, V53, P1751, DOI 10.1175/1520-0469(1996)053<1751:PSCFBI>2.0.CO;2; Hendon HH, 1998, J ATMOS SCI, V55, P88, DOI 10.1175/1520-0469(1998)055<0088:OKWATM>2.0.CO;2; HEYWOOD KJ, 1994, OCEANOL ACTA, V17, P255; Hosoda S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026070; JOHNSON ES, 1993, J PHYS OCEANOGR, V23, P608, DOI 10.1175/1520-0485(1993)023<0608:SOIKWI>2.0.CO;2; KESSLER WS, 1993, J PHYS OCEANOGR, V23, P1192, DOI 10.1175/1520-0485(1993)023<1192:TAWDRW>2.0.CO;2; KESSLER WS, 1995, J GEOPHYS RES-OCEANS, V100, P10613, DOI 10.1029/95JC00382; Kutsuwada K, 2002, J PHYS OCEANOGR, V32, P1133, DOI 10.1175/1520-0485(2002)032<1133:IVITUE>2.0.CO;2; Lau WKM, 2005, S-P B ENVIRON SCI, P1, DOI 10.1007/b138817; Lavender KL, 2000, NATURE, V407, P66, DOI 10.1038/35024048; MADDEN RA, 1994, MON WEATHER REV, V122, P814, DOI 10.1175/1520-0493(1994)122<0814:OOTDTO>2.0.CO;2; Matthews AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021666; Matthews AJ, 2004, Q J ROY METEOR SOC, V130, P1991, DOI 10.1256/qj.02.123; McPhaden MJ, 2002, J CLIMATE, V15, P2632, DOI 10.1175/1520-0442(2002)015<2632:MLTBOI>2.0.CO;2; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Roundy PE, 2006, J CLIMATE, V19, P5253, DOI 10.1175/JCLI3893.1; Seo KH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022511; Shinoda T, 1998, J CLIMATE, V11, P1685, DOI 10.1175/1520-0442(1998)011<1685:IVOSFA>2.0.CO;2; Tsuchiya M, 1996, J MAR RES, V54, P541, DOI 10.1357/0022240963213583; WAIISER DE, 2005, GEOPHYS RES LETT, V32; Woolnough SJ, 2000, J CLIMATE, V13, P2086, DOI 10.1175/1520-0442(2000)013<2086:TRBCAS>2.0.CO;2; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Zhang CD, 2002, J CLIMATE, V15, P2429, DOI 10.1175/1520-0442(2002)015<2429:SAOEAT>2.0.CO;2; Zhang CD, 2001, J CLIMATE, V14, P1309, DOI 10.1175/1520-0442(2001)014<1309:IPISST>2.0.CO;2	28	42	44	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1765	1769		10.1126/science.1147312	http://dx.doi.org/10.1126/science.1147312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079400				2022-12-28	WOS:000251616800038
J	Stevens, B; Allen, NJ; Vazquez, LE; Howell, GR; Christopherson, KS; Nouri, N; Micheva, KD; Mehalow, AK; Huberman, AD; Stafford, B; Sher, A; Litke, AM; Lambris, JD; Smith, SJ; John, SWM; Barres, BA				Stevens, Beth; Allen, Nicola J.; Vazquez, Luis E.; Howell, Gareth R.; Christopherson, Karen S.; Nouri, Navid; Micheva, Kristina D.; Mehalow, Adrienne K.; Huberman, Andrew D.; Stafford, Benjamin; Sher, Alexander; Litke, Alan M.; Lambris, John D.; Smith, Stephen J.; John, Simon W. M.; Barres, Ben A.			The classical complement cascade mediates CNS synapse elimination	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; VISUAL-CORTEX; DBA/2J MICE; EXPRESSION; PLASTICITY; GLAUCOMA; CELLS; C1Q; ACTIVATION	During development, the formation of mature neural circuits requires the selective elimination of inappropriate synaptic connections. Here we show that C1q, the initiating protein in the classical complement cascade, is expressed by postnatal neurons in response to immature astrocytes and is localized to synapses throughout the postnatal CNS and retina. Mice deficient in complement protein C1q or the downstream complement protein C3 exhibit large sustained defects in CNS synapse elimination, as shown by the failure of anatomical refinement of retinogeniculate connections and the retention of excess retinal innervation by lateral geniculate neurons. Neuronal C1q is normally downregulated in the adult CNS; however, in a mouse model of glaucoma, C1q becomes upregulated and synaptically relocalized in the adult retina early in the disease. These findings support a model in which unwanted synapses are tagged by complement for elimination and suggest that complement-mediated synapse elimination may become aberrantly reactivated in neurodegenerative disease.	[Stevens, Beth; Allen, Nicola J.; Vazquez, Luis E.; Christopherson, Karen S.; Nouri, Navid; Huberman, Andrew D.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Micheva, Kristina D.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Howell, Gareth R.; Mehalow, Adrienne K.; John, Simon W. M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Howell, Gareth R.; Mehalow, Adrienne K.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Stafford, Benjamin; Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Jackson Laboratory; University of California System; University of California Santa Cruz; University of Pennsylvania	Stevens, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	beths@stanfordmedalumni.org	Micheva, Kristina/ABH-6913-2020; Quill, Barry/O-2614-2014; Lambris, John/Q-5633-2018	Micheva, Kristina/0000-0003-1138-3732; Quill, Barry/0000-0002-0578-5703; Lambris, John/0000-0002-9370-5776; Smith, Stephen/0000-0002-2290-8701; Sher, Alexander/0000-0001-6655-6456; Mehalow, Adrienne/0000-0002-1744-827X	NIDA NIH HHS [R01 DA015043, DA15043] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cowell RM, 2003, J NEUROSCI, V23, P9459; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Fiske BK, 2000, NEUROSCIENCE, V96, P807, DOI 10.1016/S0306-4522(99)00601-6; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Gasque P, 1998, J IMMUNOL, V160, P3543; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; JENNINGS C, 1994, NATURE, V372, P498, DOI 10.1038/372498a0; John SWM, 1999, J GLAUCOMA, V8, P400; JOHNSON SA, 1994, DEV BRAIN RES, V80, P163, DOI 10.1016/0165-3806(94)90101-5; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Maslinska D, 1998, FOLIA NEUROPATHOL, V36, P145; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mitchell DA, 2007, MOL IMMUNOL, V44, P2997, DOI 10.1016/j.molimm.2006.12.027; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Nilsson LG, 1996, BEHAV GENET, V26, P555, DOI 10.1007/BF02361228; PRASAD SS, 1994, BRAIN RES, V639, P73, DOI 10.1016/0006-8993(94)91766-3; Ritch R, 1996, GLAUCOMAS CLIN SCI; Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schiefer J, 1999, J NEUROCYTOL, V28, P439, DOI 10.1023/A:1007048903862; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007	47	1868	1911	6	139	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1164	1178		10.1016/j.cell.2007.10.036	http://dx.doi.org/10.1016/j.cell.2007.10.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083105	Bronze			2022-12-28	WOS:000252217100023
J	Morth, JP; Pedersen, BP; Toustrup-Jensen, MS; Sorensen, TLM; Petersen, J; Andersen, JP; Vilsen, B; Nissen, P				Morth, J. Preben; Pedersen, Bjorn P.; Toustrup-Jensen, Mads S.; Sorensen, Thomas L. -M.; Petersen, Janne; Andersen, Jens Peter; Vilsen, Bente; Nissen, Poul			Crystal structure of the sodium-potassium pump	NATURE			English	Article							TRANSMEMBRANE SEGMENT M1; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CATION-BINDING; ALPHA-SUBUNIT; K+-ATPASE; DENSITY-MODIFICATION; GAMMA-SUBUNIT; FXYD PROTEINS; ION-TRANSPORT	The Na+, K+-ATPase generates electrochemical gradients for sodium and potassium that are vital to animal cells, exchanging three sodium ions for two potassium ions across the plasma membrane during each cycle of ATP hydrolysis. Here we present the X- ray crystal structure at 3.5 angstrom resolution of the pig renal Na+, K 1- ATPase with two rubidium ions bound ( as potassium congeners) in an occluded state in the transmembrane part of the alpha-subunit. Several of the residues forming the cavity for rubidium/potassium occlusion in the Na+, K+-ATPase are homologous to those binding calcium in the Ca2+- ATPase of sarco( endo) plasmic reticulum. The beta- and gamma-subunits specific to the Na+, K+- ATPase are associated with transmembrane helices alpha M7/alpha M10 and alpha M9, respectively. The alpha-subunit corresponds to a fragment of the V- type ATPase c subunit. The carboxy terminus of the alpha-subunit is contained within a pocket between transmembrane helices and seems to be a novel regulatory element controlling sodium affinity, possibly influenced by the membrane potential.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk; pn@mb.au.dk	Sørensen, Thomas Lykke-Møller/AAA-7052-2020; Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Pedersen, Bjørn/H-4128-2017; Pedersen, Bjørn/AAT-2409-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Pedersen, Bjørn/0000-0001-7860-7230; Pedersen, Bjørn/0000-0001-7860-7230; Vilsen, Bente/0000-0002-4727-9382; Andersen, Jens Peter/0000-0003-0654-4300; Nissen, Poul/0000-0003-0948-6628; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861				ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hebert H, 2001, J MOL BIOL, V314, P479, DOI 10.1006/jmbi.2001.5137; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; POST RL, 1972, J BIOL CHEM, V247, P6530; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1987, J BIOL CHEM, V262, P10511; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	52	654	684	9	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1043	U6		10.1038/nature06419	http://dx.doi.org/10.1038/nature06419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075585				2022-12-28	WOS:000251579900078
J	Kmietowicz, Z				Kmietowicz, Zosia			Better safe than sorry?	BRITISH MEDICAL JOURNAL			English	Article												zkmietowicz@bmj.com						ALLAN PL, MED HEADLINES; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; *CLIN ADV COMM DIA, 2007, REP SAF EFF CT SCREE; McMahon PM, 2007, BRIT MED J, V334, P271, DOI 10.1136/bmj.39090.662963.80; *ROYAL COLL RAD, 1998, MAK BEST US CLIN RAD; *US FDA, WHOL BOD SCANN US CO; 2000, IONISING RAD MED EXP	7	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1182	1184		10.1136/bmj.39415.528623.AD	http://dx.doi.org/10.1136/bmj.39415.528623.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063642	Green Published			2022-12-28	WOS:000251707800028
J	Goldacre, B				Goldacre, Ben			Behold the Christmas miracle of antioxidants	BRITISH MEDICAL JOURNAL			English	Editorial Material												ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1124	1124		10.1136/bmj.39413.403750.59	http://dx.doi.org/10.1136/bmj.39413.403750.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048537	Green Published			2022-12-28	WOS:000251596100029
J	Motzer, RJ; Basch, E				Motzer, Robert J.; Basch, Ethan			Targeted drugs for metastatic renal cell carcinoma	LANCET			English	Editorial Material							RANDOMIZED PHASE-II; INTERFERON-ALPHA; 1ST-LINE TREATMENT; BEVACIZUMAB; TRIAL; TEMSIROLIMUS; SUNITINIB		[Motzer, Robert J.; Basch, Ethan] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Genitourinary Oncol Serv, New York, NY 10021 USA; [Motzer, Robert J.] Cornell Univ, Weil Med Coll, New York, NY USA; [Basch, Ethan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Serv Res Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Genitourinary Oncol Serv, New York, NY 10021 USA.	motzerr@mskcc.org		Motzer, Robert/0000-0001-6925-2327				Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bukowski RM, 2007, J CLIN ONCOL, V25, P4536, DOI 10.1200/JCO.2007.11.5154; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; *JOINT FORM COMM, 2007, BRIT NAT FORM; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2007, J UROLOGY, V178, P1883, DOI 10.1016/j.juro.2007.07.030; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Parasuraman S, 2007, J CLIN ONCOL, V25; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Szczylik C, 2007, J CLIN ONCOL, V25; Thiesse P, 1997, J CLIN ONCOL, V15, P3507, DOI 10.1200/JCO.1997.15.12.3507; *US DEP HHS, 2006, MED PRESCR DRUG PLAN; *US DEP HHS, 2007, ASP PRIC FIL PAYM A; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	16	57	58	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2071	2073		10.1016/S0140-6736(07)61874-1	http://dx.doi.org/10.1016/S0140-6736(07)61874-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156012				2022-12-28	WOS:000252058600004
J	Miwa, K; Takano, J; Omori, H; Seki, M; Shinozaki, K; Fujiwara, T				Miwa, Kyoko; Takano, Junpei; Omori, Hiroyuki; Seki, Motoaki; Shinozaki, Kazuo; Fujiwara, Toru			Plants tolerant of high boron levels	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRANSPORTER		Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Tokyo 1030027, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/G-4202-2013; Takano, Junpei/A-5255-2012; FUJIWARA, Toru/A-4119-2011; Seki, Motoaki/I-2854-2012; MIWA, Kyoko/D-4220-2009	Shinozaki, Kazuo/0000-0002-6317-9867; Seki, Motoaki/0000-0001-8288-0467; Miwa, Kyoko/0000-0001-7328-3628; Takano, Junpei/0000-0002-7474-3101				CARTWRIGHT B, 1984, AUST J SOIL RES, V22, P261, DOI 10.1071/SR9840261; Hayes JE, 2004, PLANT PHYSIOL, V136, P3376, DOI 10.1104/pp.103.037028; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102	6	202	216	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1417	1417		10.1126/science.1146634	http://dx.doi.org/10.1126/science.1146634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048682				2022-12-28	WOS:000251246100036
J	Scheiermann, C; Meda, P; Aurrand-Lions, M; Madani, R; Yiangou, Y; Coffey, P; Salt, TE; Ducrest-Gay, D; Caille, D; Howell, O; Reynolds, R; Lobrinus, A; Adams, RH; Yu, ASL; Anand, P; Imhof, BA; Nourshargh, S				Scheiermann, Christoph; Meda, Paolo; Aurrand-Lions, Michel; Madani, Rime; Yiangou, Yiangos; Coffey, Peter; Salt, Thomas E.; Ducrest-Gay, Dominique; Caille, Dorothee; Howell, Owain; Reynolds, Richard; Lobrinus, Alexander; Adams, Ralf H.; Yu, Alan S. L.; Anand, Praveen; Imhof, Beat A.; Nourshargh, Sussan			Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves	SCIENCE			English	Article							AUTOTYPIC ADHERENS JUNCTIONS; JAM FAMILY; E-CADHERIN; AXONS; MICE; DIFFERENTIATION; PROTEINS; CELLS	JAM-C is an adhesion molecule that is expressed on cells within the vascular compartment and epithelial cells and, to date, has been largely studied in the context of inflammatory events. Using immunolabeling procedures in conjunction with confocal and electron microscopy, we show here that JAM-C is also expressed in peripheral nerves and that this expression is localized to Schwann cells at junctions between adjoining myelin end loops. Sciatic nerves from JAM-C-deficient [having the JAM-C gene knocked out (KO)] mice exhibited loss of integrity of the myelin sheath and defective nerve conduction as indicated by morphological and electrophysiological studies, respectively. In addition, behavioral tests showed motor abnormalities in the KO animals. JAM-C was also expressed in human sural nerves with an expression profile similar to that seen in mice. These results demonstrate that JAM-C is a component of the autotypic junctional attachments of Schwann cells and plays an important role in maintaining the integrity and function of myelinated peripheral nerves.	Imperial Coll London, Natl Heart & Lung Inst, London, England; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; Univ Geneva, Fac Med, Ctr Med Univ, Geneva, Switzerland; Inst J Paoli I Calmettes, INSERM, UMR 599, F-13009 Marseille, France; Imperial Coll London, Div Neurosci & Mental Hlth, Peripheral Neuropathy Unit, London, England; UCL, Inst Ophthalmol, London, England; Imperial Coll London, Dept Cellular & Mol Neurosci, Div Neurosci & Mental Hlth, London, England; Canc Res UK, London Res Inst, London, England; Univ So Calif, Keck Sch Med, Dept Med, Div Nephrol, Los Angeles, CA USA	Imperial College London; University of London; Queen Mary University London; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Imperial College London; University of London; University College London; Imperial College London; Cancer Research UK; University of Southern California	Nourshargh, S (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	s.nourshargh@qmul.ac.uk	Yu, Alan/AID-7467-2022; Adams, Ralf H/AAE-9274-2019; Scheiermann, Christoph/B-8261-2014; Aurrand-Lions, Michel/O-9953-2016	Scheiermann, Christoph/0000-0002-9212-0995; Aurrand-Lions, Michel/0000-0002-8361-3034; Yiangou, Yiangos/0000-0003-3518-5474; Nourshargh, Sussan/0000-0001-5677-1806; Yu, Alan/0000-0002-1776-2533; Coffey, Peter/0000-0002-5427-2939; Howell, Owain/0000-0003-2157-9157	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; British Heart Foundation [PG/03/123/16102] Funding Source: Medline; NIDDK NIH HHS [R01 DK062283] Funding Source: Medline; Wellcome Trust [064920] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scherer SS, 2002, J PERIPHER NERV SYST, V7, P1, DOI 10.1046/j.1529-8027.2002.02001.x; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	17	48	49	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1472	1475		10.1126/science.1149276	http://dx.doi.org/10.1126/science.1149276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048693	Green Accepted			2022-12-28	WOS:000251246100052
J	Stewart, CL; Roux, KJ; Burke, B				Stewart, Colin L.; Roux, Kyle J.; Burke, Brian			Blurring the boundary: The nuclear envelope extends its reach	SCIENCE			English	Review							DISTINCT FUNCTIONAL DOMAINS; RETINOBLASTOMA GENE-PRODUCT; A-TYPE LAMINS; MEMBRANE PROTEIN; INOSITOL 1,4,5-TRISPHOSPHATE; TRANSCRIPTIONAL REPRESSOR; MUSCULAR-DYSTROPHY; BINDING-PROTEIN; EMERIN-BINDING; LMNA MUTATIONS	The past decade has seen a complete rethinking of the traditional view of the nuclear envelope as simply a passive enclosure for the chromosomes. The convergence of several lines of clinical and basic research has revealed additional roles in both signaling and mitotic progression. It is becoming apparent that the nuclear envelope defines not only nuclear organization but also that of the cytoskeleton and, in this way, integrates both nuclear and cytoplasmic architecture.	Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Inst Med Biol, Singapore 138668, Singapore	State University System of Florida; University of Florida; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Burke, B (corresponding author), Univ Florida, Dept Anat & Cell Biol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	bburke@ufl.edu	Roux, Kyle/AAH-2019-2021	Roux, Kyle/0000-0001-7530-5528				AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bengtsson L, 2007, FEBS J, V274, P1374, DOI 10.1111/j.1742-4658.2007.05696.x; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; CALLAN HG, 1950, PROC R SOC SER B-BIO, V137, P367, DOI 10.1098/rspb.1950.0047; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Cohen S, 2006, J GEN VIROL, V87, P3209, DOI 10.1099/vir.0.82232-0; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fairley EAL, 1999, J CELL SCI, V112, P2571; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; GALL JG, 1967, J CELL BIOL, V32, P391, DOI 10.1083/jcb.32.2.391; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lattanzi G, 2003, BIOCHEM BIOPH RES CO, V303, P764, DOI 10.1016/S0006-291X(03)00415-7; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lee KK, 2001, J CELL SCI, V114, P4567; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; OZAKI T, 1994, ONCOGENE, V9, P2649; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Prunuske AJ, 2006, CURR OPIN CELL BIOL, V18, P108, DOI 10.1016/j.ceb.2005.12.004; Raharjo WH, 2001, J CELL SCI, V114, P4447; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Sakaki M, 2001, J BIOCHEM-TOKYO, V129, P321, DOI 10.1093/oxfordjournals.jbchem.a002860; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Santella L, 1997, CELL CALCIUM, V22, P11, DOI 10.1016/S0143-4160(97)90085-3; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Talim B, 2003, NEUROMUSCULAR DISORD, V13, P660; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	108	196	202	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1408	1412		10.1126/science.1142034	http://dx.doi.org/10.1126/science.1142034			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048680				2022-12-28	WOS:000251246100034
J	Keeley, P				Keeley, Paul			Pimp my slang	BRITISH MEDICAL JOURNAL			English	Editorial Material									Glasgow Royal Infirm, Dept Palliat Med, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Keeley, P (corresponding author), Glasgow Royal Infirm, Dept Palliat Med, Glasgow G4 0SF, Lanark, Scotland.	paul.keeley@northglasgow.scot.nhs.uk		Keeley, Paul/0000-0002-3169-8187					0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1295	1295		10.1136/bmj.39414.699005.94	http://dx.doi.org/10.1136/bmj.39414.699005.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156235	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252182700016
J	Nelson, CA; Zeanah, CH; Fox, NA; Marshall, PJ; Smyke, AT; Guthrie, D				Nelson, Charles A., III; Zeanah, Charles H.; Fox, Nathan A.; Marshall, Peter J.; Smyke, Anna T.; Guthrie, Donald			Cognitive recovery in socially deprived young children: The Bucharest early intervention project	SCIENCE			English	Article							INTERNATIONAL RESEARCH COLLABORATION; ETHICAL CONSIDERATIONS; BRAIN; DEPRIVATION	In a randomized controlled trial, we compared abandoned children reared in institutions to abandoned children placed in institutions but then moved to foster care. Young children living in institutions were randomly assigned to continued institutional care or to placement in foster care, and their cognitive development was tracked through 54 months of age. The cognitive outcome of children who remained in the institution was markedly below that of never- institutionalized children and children taken out of the institution and placed into foster care. The improved cognitive outcomes we observed at 42 and 54 months were most marked for the youngest children placed in foster care. These results point to the negative sequelae of early institutionalization, suggest a possible sensitive period in cognitive development, and underscore the advantages of family placements for young abandoned children.	Harvard Univ, Sch Med, Boston, MA 02215 USA; Childrens Hosp, Boston, MA 02215 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA; Univ Maryland, College Pk, MD 20742 USA; Temple Univ, Philadelphia, PA 19122 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Tulane University; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Los Angeles	Nelson, CA (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.	charles.nelson@childrens.harvard.edu	Zeanah, Charles H/AAO-3756-2020	Zeanah, Charles/0000-0002-7004-6819				Bayley N, 1993, BAYLEY SCALES INFANT; BRUER JT, 2001, CRITICAL THINKING CR, P209; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; CURTIS JW, 2003, RESILIENCE VULNERABI, P463; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Gunnar MR, 2001, DEV COGN NEUROSCI, P617; *HARC ASS, 2000, WECHSL PRESCH PRIM S; HARLOW HF, 1971, P NATL ACAD SCI USA, V68, P1534, DOI 10.1073/pnas.68.7.1534; Johnson DE, 2000, MINN SYM CHILD PSYCH, V31, P113; JOHNSON DE, 1992, JAMA-J AM MED ASSOC, V268, P3446, DOI 10.1001/jama.268.24.3446; Lindsey JC, 1999, CLIN NEUROPHARMACOL, V22, P44, DOI 10.1097/00002826-199901000-00009; Little R, 1996, BIOMETRICS, V52, P1324, DOI 10.2307/2532847; MORISON SJ, 1995, MERRILL PALMER QUART, V41, P411; Rutter M, 1998, J CHILD PSYCHOL PSYC, V39, P465, DOI 10.1017/S0021963098002236; Rutter ML, 2001, BRIT J PSYCHIAT, V179, P97, DOI 10.1192/bjp.179.2.97; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Smyke AT, 2007, J CHILD PSYCHOL PSYC, V48, P210, DOI 10.1111/j.1469-7610.2006.01694.x; TANNER JM, 1973, TXB PEDIAT; Wassenaar DR, 2006, INF MENTAL HLTH J, V27, P577, DOI 10.1002/imhj.20108; Weijer C, 2004, NAT MED, V10, P570, DOI 10.1038/nm0604-570; Zeanah CH, 2003, DEV PSYCHOPATHOL, V15, P885, DOI 10.1017/S0954579403000452; Zeanah CH, 2000, J DEV BEHAV PEDIATR, V21, P230; ZEANAH CH, 2006, HDB EARLY CHILDHOOD, P424; Zeanah CH, 2006, INF MENTAL HLTH J, V27, P581, DOI 10.1002/imhj.20117; Zeanah CH, 2006, INF MENTAL HLTH J, V27, P559, DOI 10.1002/imhj.20107	25	577	586	3	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1937	1940		10.1126/science.1143921	http://dx.doi.org/10.1126/science.1143921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096809				2022-12-28	WOS:000251786600063
J	Bretag, AH				Bretag, Allan H.			Stem cell treatment of dystrophic dogs	NATURE			English	Letter							MUSCLE		Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia	University of South Australia	Bretag, AH (corresponding author), Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia.	a.bretag@unisa.edu.au						De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; GUYTON AC, 1986, TXB MED PHYSL, P230; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282	5	11	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					E23	E23		10.1038/nature06437	http://dx.doi.org/10.1038/nature06437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097347	Bronze			2022-12-28	WOS:000251786200037
J	Heath, I				Heath, Iona			The road to hell ...	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com						McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1185	1185		10.1136/bmj.39414.473600.59	http://dx.doi.org/10.1136/bmj.39414.473600.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063643	Green Published			2022-12-28	WOS:000251707800029
J	Hurtley, SM; Pennisi, E				Hurtley, Stella M.; Pennisi, Elizabeth			Introduction - Journey to the center of the cell	SCIENCE			English	Editorial Material																			0	0	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1399	1399		10.1126/science.318.5855.1399	http://dx.doi.org/10.1126/science.318.5855.1399			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048677				2022-12-28	WOS:000251246100031
J	Petersen, CP; Reddien, PW				Petersen, Christian P.; Reddien, Peter W.			Smed-beta-catenin-1 is required for anteroposterior blastema polarity in planarian regeneration	SCIENCE			English	Article							BETA-CATENIN; SPEMANNS ORGANIZER; WNT; EVOLUTION; PATHWAY; EMBRYOS; XENOPUS	Planarian flatworms can regenerate heads at anterior- facing wounds and tails at posterior- facing wounds throughout the body. How this regeneration polarity is specified has been a classic problem for more than a century. We identified a planarian gene, Smed-beta catenin-1, that controls regeneration polarity. Posterior- facing blastemas regenerate a head instead of a tail in Smed-beta catenin- 1( RNAi) animals. Smed-beta catenin- 1 is required after wounding and at any posterior- facing wound for polarity. Additionally, intact Smed-beta catenin- 1( RNAi) animals display anteriorization during tissue turnover. Five Wnt genes and a secreted Frizzled- related Wnt antagonist- like gene are expressed in domains along the anteroposterior axis that reset to new positions during regeneration, which suggests that Wnts control polarity through Smed-beta catenin-1. Our data suggest that beta-catenin specifies the posterior character of the anteroposterior axis throughout the Bilateria and specifies regeneration polarity in planarians.	[Petersen, Christian P.; Reddien, Peter W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu	Petersen, Christian P./GZG-4541-2022	Petersen, Christian P./0000-0001-7552-6865; /0000-0002-5569-333X				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BRONDSTED HV, 1969, PLANARIAN REGENERATI, P276; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Miyawaki K, 2004, MECH DEVELOP, V121, P119, DOI 10.1016/j.mod.2004.01.002; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; RANDOLPH H, 1897, ARCH ENTW MECH ORG, V5, P352; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	25	267	275	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					327	330		10.1126/science.1149943	http://dx.doi.org/10.1126/science.1149943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18063755				2022-12-28	WOS:000252436200037
J	Jones, DM; Head, IM; Gray, ND; Adams, JJ; Rowan, AK; Aitken, CM; Bennett, B; Huang, H; Brown, A; Bowler, BFJ; Oldenburg, T; Erdmann, M; Larter, SR				Jones, D. M.; Head, I. M.; Gray, N. D.; Adams, J. J.; Rowan, A. K.; Aitken, C. M.; Bennett, B.; Huang, H.; Brown, A.; Bowler, B. F. J.; Oldenburg, T.; Erdmann, M.; Larter, S. R.			Crude-oil biodegradation via methanogenesis in subsurface petroleum reservoirs	NATURE			English	Article							DEEP SUBSURFACE; AROMATIC-HYDROCARBONS; FIELD; DEGRADATION; MICROORGANISMS; ACCUMULATIONS; OXIDATION; BACTERIA; ORIGIN; WATERS	Biodegradation of crude oil in subsurface petroleum reservoirs has adversely affected the majority of the world's oil, making recovery and refining of that oil more costly(1). The prevalent occurrence of biodegradation in shallow subsurface petroleum reservoirs(2,3) has been attributed to aerobic bacterial hydrocarbon degradation stimulated by surface recharge of oxygen- bearing meteoric waters(2). This hypothesis is empirically supported by the likelihood of encountering biodegraded oils at higher levels of degradation in reservoirs near the surface(4,5). More recent findings, however, suggest that anaerobic degradation processes dominate subsurface sedimentary environments(6), despite slow reaction kinetics and uncertainty as to the actual degradation pathways occurring in oil reservoirs. Here we use laboratory experiments in microcosms monitoring the hydrocarbon composition of degraded oils and generated gases, together with the carbon isotopic compositions of gas and oil samples taken at wellheads and a Rayleigh isotope fractionation box model, to elucidate the probable mechanisms of hydrocarbon degradation in reservoirs. We find that crude- oil hydrocarbon degradation under methanogenic conditions in the laboratory mimics the characteristic sequential removal of compound classes seen in reservoir- degraded petroleum. The initial preferential removal of n-alkanes generates close to stoichiometric amounts of methane, principally by hydrogenotrophic methanogenesis. Our data imply a common methanogenic biodegradation mechanism in subsurface degraded oil reservoirs, resulting in consistent patterns of hydrocarbon alteration, and the common association of dry gas with severely degraded oils observed worldwide. Energy recovery from oilfields in the form of methane, based on accelerating natural methanogenic biodegradation, may offer a route to economic production of difficult- to- recover energy from oilfields.	[Jones, D. M.; Head, I. M.; Gray, N. D.; Rowan, A. K.; Aitken, C. M.; Brown, A.; Bowler, B. F. J.; Larter, S. R.] Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, J. J.; Bennett, B.; Huang, H.; Oldenburg, T.; Larter, S. R.] Univ Calgary, Dept Geol & Geophys, Petr Reservoir Grp, Calgary, AB T2A 1N4, Canada; [Erdmann, M.] Norsk Hydro Oil & Energy, R&D Ctr, N-5020 Bergen, Norway	Newcastle University - UK; University of Calgary	Larter, SR (corresponding author), Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	slarter@ucalgary.ca	Sherry, Angela/AAD-9302-2019; Abu Laban, Nidal/E-5809-2011; Sherry, Angela/A-3293-2012	Sherry, Angela/0000-0003-2642-5376; Sherry, Angela/0000-0003-2642-5376; Larter, Stephen/0000-0001-7195-1477; gray, neil/0000-0002-2395-4320; Head, Ian/0000-0002-5373-162X	Natural Environment Research Council [NE/E01657X/1] Funding Source: researchfish; NERC [NE/E01657X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams J, 2006, J GEOCHEM EXPLOR, V89, P1, DOI 10.1016/j.gexplo.2005.11.004; Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; Anderson RT, 2000, NATURE, V404, P722, DOI 10.1038/35008145; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; Bennett B, 1996, ANAL CHEM, V68, P3697, DOI 10.1021/ac960299x; Bennett B, 2000, ANAL CHEM, V72, P1039, DOI 10.1021/ac9910482; Boreham CJ, 2001, APPEA J, V41, P523, DOI [DOI 10.1071/AJ00026, 10.1071/AJ00026]; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FEDORAK PM, 1981, CAN J MICROBIOL, V27, P432, DOI 10.1139/m81-066; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; HORSTAD I, 1992, ORG GEOCHEM, V19, P107, DOI 10.1016/0146-6380(92)90030-2; HORSTAD I, 1992, ORG GEOCHEM, V19, P1; Karlsson W., 1986, HABITAT HYDROCARBONS, P181; KREJCIGRAF K, 1932, AAPG BULL, V16, P1038; Larter S, 2006, AAPG BULL, V90, P921, DOI 10.1306/01270605130; Larter S, 2005, ORG GEOCHEM, V36, P299, DOI 10.1016/j.orggeochem.2004.07.015; Larter S, 2003, ORG GEOCHEM, V34, P601, DOI 10.1016/S0146-6380(02)00240-1; Larter SR, 2005, PETROLEUM GEOLOGY NW, P633; LOVLEY DR, 1989, NATURE, V339, P297, DOI 10.1038/339297a0; MAGOT M, 1994, RECHERCHE, V228, P936; Masterson WD, 2001, ORG GEOCHEM, V32, P411, DOI 10.1016/S0146-6380(00)00187-X; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pallasser RJ, 2000, ORG GEOCHEM, V31, P1363, DOI 10.1016/S0146-6380(00)00101-7; Palmer S.E., 1993, ORG GEOCHEM, P511, DOI 10.1007/978-1-4615-2890-6_23; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETERS KE, 1993, BIOMARKER GUIDE INTE, P252; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; REUTER P, 1994, NATURE, V372, P455; Roadifer R. E., 1987, EXPLORATION HEAVY CR, P3; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Volkman J.K., 1984, ORG GEOCHEM, V6, P619, DOI DOI 10.1016/0146-6380(84)90084-6; Wenger LM, 2002, SPE RESERV EVAL ENG, V5, P375, DOI 10.2118/80168-PA; WILLIAMS JA, 1986, ORG GEOCHEM, V10, P451, DOI 10.1016/0146-6380(86)90045-8; Winters J.C., 1969, AM CHEM SOC DIV PET, pE22; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	38	485	519	6	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					176	U6		10.1038/nature06484	http://dx.doi.org/10.1038/nature06484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18075503				2022-12-28	WOS:000252214400039
J	Berendt, L; Hakansson, C; Bach, KF; Dalhoff, K; Andreasen, PB; Petersen, LG; Andersen, E; Poulsen, HE				Berendt, Louise; Hakansson, Cecilia; Bach, Karin Friis; Dalhoff, Kim; Andreasen, Per Buch; Petersen, Lene Grejs; Andersen, Elin; Poulsen, Henrik Enghusen			Effect of European clinical trials directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency, 1993-2006	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine the impact of the European Union's Clinical Trials Directive on the number of academic drug trials carried out in Denmark. Design Retrospective review of applications ford rug trials to the Danish Medicines Agency, 1993-2006. Review methods Applications for drug trials for alternate years were classified as academic or commercial trials. A random subset of academic trials was reviewed for number of participants in and intended monitoring of the trials. Results Academic and commercial drug trials showed an identical steady decline from 1993 to 2006 and no noticeable change after 2004 when good clinical practice became mandatory for academic trials. Conclusion The Clinical Trials Directive introduced in May 2004 to ensure good clinical practice for academic drug trials was not associated with a decline in research activity in Denmark; presumably because good clinical practice units had already been in place in Danish universities since 1999. With such an infrastructure academic researchers can do drug trials under the same regulations as drug companies.	[Berendt, Louise; Hakansson, Cecilia; Dalhoff, Kim; Poulsen, Henrik Enghusen] Rigshosp, Dept Clin Pharmacol Q7642, DK-2100 Copenhagen, Denmark; [Berendt, Louise; Hakansson, Cecilia; Petersen, Lene Grejs; Andersen, Elin] Danish Med Agcy, DK-2300 Copenhagen, Denmark; [Bach, Karin Friis; Andreasen, Per Buch] Copenhagen Univ Hosp, Gentofte Hosp, GCP Unit, Hellerup, Denmark; [Dalhoff, Kim; Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Poulsen, HE (corresponding author), Rigshosp, Dept Clin Pharmacol Q7642, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	hepo@rh.dk		Poulsen, Henrik Enghusen/0000-0003-4242-9924				Hemminki A, 2006, BMJ-BRIT MED J, V332, P501, DOI 10.1136/bmj.332.7540.501; Mayor S, 2004, BRIT MED J, V328, P1036, DOI 10.1136/bmj.328.7447.1036; Morice AH, 2003, LANCET, V361, P1568, DOI 10.1016/S0140-6736(03)13211-4; SINGER E, 2007, BASIC CLIN PHARM S1, V101, P11	4	18	19	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					33	35		10.1136/bmj.39401.470648.BE	http://dx.doi.org/10.1136/bmj.39401.470648.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18063611	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252327500033
J	Srivastava, R				Srivastava, Ranjana			In search of redemption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												docranjana@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2837	2839		10.1001/jama.298.24.2837	http://dx.doi.org/10.1001/jama.298.24.2837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159047				2022-12-28	WOS:000251816000001
J	Frohlich, MW; Chase, MW				Frohlich, Michael W.; Chase, Mark W.			After a dozen years of progress the origin of angiosperms is still a great mystery	NATURE			English	Review							MADS-BOX GENES; SEED PLANT PHYLOGENY; AGAMOUS SUBFAMILY; EVOLUTION; PATTERNS; GENOME; DIVERSIFICATION; ARCHAEFRUCTUS; HYDATELLACEAE; DUPLICATION	Here we discuss recent advances surrounding the origin of angiosperms. Putatively primitive characters are now much better understood because of a vastly improved understanding of angiosperm phylogenetics, and recent discoveries of fossil flowers have provided an increasingly detailed picture of early diversity in the angiosperms. The 'anthophyte theory', the dominant concept of the 1980s and 1990s, has been eclipsed; Gnetales, previously thought to be closest to the angiosperms, are related instead to other extant gymnosperms, probably most closely to conifers. Finally, new theories of flower origins have been proposed based on gene function, duplication and loss, as well as on morphology. Further studies of genetic mechanisms that control reproductive development in seed plants provide a most promising avenue for further research, including tests of these recent theories. Identification of fossils with morphologies that convincingly place them close to angiosperms could still revolutionize understanding of angiosperm origins.	Royal Bot Gardens Kew, Richmond TW9 3DS, Surrey, England	Royal Botanic Gardens, Kew	Frohlich, MW (corresponding author), Royal Bot Gardens Kew, Richmond TW9 3DS, Surrey, England.	m.frohlich@kew.org	Chase, Mark W/A-6642-2011					Albert V. A., 1998, MOL SYSTEMATICS PLAN, P349; Anderson J.M., 2003, HEYDAY GYMNOSPERMS S; Auras S, 2006, NATURWISSENSCHAFTEN, V93, P616, DOI 10.1007/s00114-006-0150-x; Bateman RM, 2006, J EXP BOT, V57, P3471, DOI 10.1093/jxb/erl128; Baum DA, 2006, ANNU PLANT REV, V20, P3; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Burleigh JG, 2007, INT J PLANT SCI, V168, P111, DOI 10.1086/509586; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; David-Schwartz R, 2007, INT J PLANT SCI, V168, P49, DOI 10.1086/509660; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; Doyle J. A., 1996, INT J PLANT SCI S, V157, P3; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Doyle JA, 1996, INT J PLANT SCI, V157, pS3, DOI 10.1086/297401; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; Friedman WE, 2003, EVOLUTION, V57, P216, DOI 10.1111/j.0014-3820.2003.tb00257.x; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Friis EM, 2003, TRENDS PLANT SCI, V8, P369, DOI 10.1016/S1360-1385(03)00161-4; Frohlich M.W., 2002, DEV GENETICS PLANT E, P85; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 2003, NAT REV GENET, V4, P559, DOI 10.1038/nrg1114; FROHLICH MW, 2006, DEV GENETICS FLOWER, P63; Hilton J, 2006, J TORREY BOT SOC, V133, P119, DOI 10.3159/1095-5674(2006)133[119:PATBOS]2.0.CO;2; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Jaramillo MA, 2007, INT J PLANT SCI, V168, P61, DOI 10.1086/509078; Ji Q, 2004, ACTA GEOL SIN-ENGL, V78, P883; Kim S, 2005, INT J PLANT SCI, V166, P185, DOI 10.1086/427479; Klavins SD, 2002, AM J BOT, V89, P664, DOI 10.3732/ajb.89.4.664; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Krassilov VA, 1997, ANGIOSPERM ORIGINS M; Litt A, 2007, INT J PLANT SCI, V168, P73, DOI 10.1086/509662; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEYEN SV, 1988, BOT J LINN SOC, V97, P171, DOI 10.1111/j.1095-8339.1988.tb02459.x; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Nalefski EA, 2006, BIOCHEMISTRY-US, V45, P13794, DOI 10.1021/bi0602011; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; RETALLACK G, 1981, PALEOBIOLOGY, V7, P54, DOI 10.1017/S009483730000378X; Rudall PJ, 2007, AM J BOT, V94, P1073, DOI 10.3732/ajb.94.7.1073; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Saarela JM, 2007, NATURE, V446, P312, DOI 10.1038/nature05612; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Soltis DE, 2007, TRENDS PLANT SCI, V12, P358, DOI 10.1016/j.tplants.2007.06.012; SOLTIS PS, 2005, ANGIOSPERM PHYLOGENY; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Taylor DW, 2006, PALEOBIOLOGY, V32, P179, DOI 10.1666/0094-8373(2006)32[179:BEFTPO]2.0.CO;2; Theissen G, 2004, CRIT REV PLANT SCI, V23, P129, DOI 10.1080/07352680490433240; Theissen G, 2002, DEV GENETICS PLANT E, P173, DOI DOI 10.1201/9781420024982.CH9; Vazquez-Lobo A, 2007, EVOL DEV, V9, P446, DOI 10.1111/j.1525-142X.2007.00182.x; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x	54	88	93	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1184	1189		10.1038/nature06393	http://dx.doi.org/10.1038/nature06393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097399				2022-12-28	WOS:000251786200040
J	Otto, SB; Rall, BC; Brose, U				Otto, Sonja B.; Rall, Bjoern C.; Brose, Ulrich			Allometric degree distributions facilitate food-web stability	NATURE			English	Article							PREY BODY-SIZE	In natural ecosystems, species are linked by feeding interactions that determine energy fluxes and create complex food webs. The stability of these food webs(1,2) enables many species to coexist and to form diverse ecosystems. Recent theory finds predator - prey body- mass ratios to be critically important for food- web stability(3-5). However, the mechanisms responsible for this stability are unclear. Here we use a bioenergetic consumer - resource model(6) to explore how and why only particular predator - prey body- mass ratios promote stability in tri- trophic ( three- species) food chains. We find that this 'persistence domain' of ratios is constrained by bottom- up energy availability when predators are much smaller than their prey and by enrichment- driven dynamics when predators are much larger. We also find that 97% of the tri- trophic food chains across five natural food webs(7) exhibit body- mass ratios within the predicted persistence domain. Further analyses of randomly rewired food webs show that body mass and allometric degree distributions in natural food webs mediate this consistency. The allometric degree distributions hold that the diversity of species' predators and prey decreases and increases, respectively, with increasing species' body masses. Our results demonstrate how simple relationships between species' body masses and feeding interactions may promote the stability of complex food webs.	Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany; Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA 94703 USA	Technical University of Darmstadt	Otto, SB (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	sonotto@bio.tu-darmstadt.de	Brose, Ulrich/I-3488-2014; Rall, Björn C./G-1508-2013; Brose, Ulrich/AAT-7547-2020	Rall, Björn C./0000-0002-3191-8389; Brose, Ulrich/0000-0001-9156-583X				Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Brose U., 2005, ECOLOGY, V86, P2545, DOI [DOI 10.1890/05-0379, 10.1890/05-0379]; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Fussmann GF, 2002, ECOL LETT, V5, P394, DOI 10.1046/j.1461-0248.2002.00329.x; GARD TC, 1980, MATH BIOSCI, V49, P61, DOI 10.1016/0025-5564(80)90110-8; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jonsson T, 1998, J THEOR BIOL, V193, P407, DOI 10.1006/jtbi.1998.0708; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Koelle K, 2005, ECOL LETT, V8, P167, DOI 10.1111/j.1461-0248.2004.00703.x; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; MURATORI S, 1992, SIAM J APPL MATH, V52, P1688, DOI 10.1137/0152097; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	30	217	219	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1226	U7		10.1038/nature06359	http://dx.doi.org/10.1038/nature06359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097408				2022-12-28	WOS:000251786200049
J	DeVita, MA; Caplan, AL				DeVita, Michael A.; Caplan, Arthur L.			Caring for organs or for patients? Ethical concerns about the uniform anatomical gift act (2006)	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDERS; LIFE; PREFERENCES; PROGRAM; CARE; END	In 2006, the National Conference of Commissioners on Uniform State Laws rewrote the Uniform Anatomical Gift Act. To overcome the problem of family members prohibiting organ donation from their deceased loved ones even when a donor card existed, the commissioners modified the act to prevent end-of-life care from precluding organ donation, An unintended consequence of the new wording creates the potential for end-of-life care that prioritizes care of the potential donor organs over care and comfort of the dying person. The commissioners have now revised the act, but the original version has already been legislated in many states, with others poised to follow. To protect dying patients' wishes about their end-of-life care, states that have legislated or are considering the original act must replace it with the revised version. A long-term and important ethical precept must stand: Care of dying patients takes precedence over organs. Another laudable goal must be promoted as well: Organ donation is an important part of end-of-life care.	Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	DeVita, MA (corresponding author), Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Rm C-111,200 Lothrop St, Pittsburgh, PA 15213 USA.							Arnold RM, 1996, CRIT CARE CLIN, V12, P29, DOI 10.1016/S0749-0704(05)70213-X; CAPLAN A, 2007, LAW MUST RIGHT DYING, pA16; *COMM INCR RAT ORG, 2006, ORG DON OPP ACT, P109; Hickman SE, 2004, J AM GERIATR SOC, V52, P1424, DOI 10.1111/j.1532-5415.2004.52402.x; Lee MA, 2000, J AM GERIATR SOC, V48, P1219, DOI 10.1111/j.1532-5415.2000.tb02594.x; Siminoff LA, 2006, J GEN INTERN MED, V21, P995, DOI 10.1007/BF02743151; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017	8	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					876	879		10.7326/0003-4819-147-12-200712180-00008	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243HO	18087059				2022-12-28	WOS:000251787600008
J	Davenport, A; Gura, V; Ronco, C; Beizai, M; Ezon, C; Rambod, E				Davenport, Andrew; Gura, Victor; Ronco, Claudio; Beizai, Masoud; Ezon, Carlos; Rambod, Edmond			A wearable haemodialysis device for patients with end-stage renal failure: a pilot study	LANCET			English	Article							REPLACEMENT THERAPY; DIALYSIS; DISEASE; WALES	Background More frequent haemodialysis can improve both survival and quality of life of patients with chronic kidney disease. However, there is little capacity in the UK to allow patients to have more frequent haemodialysis treatments in hospital and satellite haemodialysis units. New means of delivering haemodialysis are therefore required. Our aim was to assess the safety and efficiency of a wearable haemodialysis device. Methods Eight patients with end-stage kidney failure (five men, three women, mean age 51.7 [SD 13.8] years) who were established on regular haemodialysis were fitted with a wearable haemodialysis device for 4-8 h. Patients were given unfractionated heparin for anticoagulation, as they would be for standard haemodialysis. Findings There were no important cardiovascular changes and no adverse changes in serum electrolytes or acid-base balance. There was no evidence of clinically significant haemolysis in any patient. Mean blood flow was 58 . 6 (SD 11 . 7) mL/min, with a dialysate flow of 47.1 (7.8) mL/min. The mean plasma urea. clearance rate was 22.7 (5.2) mL/min and the mean plasma creatinine clearance rate was 20.7 (4-8) mL/min. Clotting of the vascular access occurred in two patients when the dose of heparin was decreased and the partial thromboplastin time returned towards the normal reference range in both of these patients. The fistula needle became dislodged in one patient, but safety mechanisms prevented blood loss, the needle was replaced, and treatment continued. Interpretation This wearable haemodialysis device shows promising safety and efficacy results, although further studies will be necessary to confirm these results.	Royal Free & Univ Coll Hosp Med Sch, Ctr Nephrol, Div Med, London, England; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA USA; Osped San Bortolo, Div Nefrol, Vicenza, Italy; Xcorporeal Inc, Los Angeles, CA USA; BioQuantetics Inc, Los Angeles, CA USA	University of London; University College London; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Davenport, A (corresponding author), Royal Free & Univ Coll Med Sch, UCL Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk	Gura, Victor/HGA-8677-2022	Ronco, Claudio/0000-0002-6697-4065				Blagg Christopher R, 2006, Hemodial Int, V10, P371, DOI 10.1111/j.1542-4758.2006.00132.x; Daugirdas JT, 2005, SEMIN NEPHROL, V25, P76, DOI 10.1016/j.semnephrol.2004.09.013; Davenport Andrew, 2006, Hemodial Int, V10, P162; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Gura V, 2006, ASAIO J, V52, P59, DOI 10.1097/01.mat.0000195283.58995.83; Gura V, 2005, CONTRIB NEPHROL, V149, P325, DOI 10.1159/000085694; GURA V, IN PRESS KIDNEY INT; Kutner N G, 1998, Geriatr Nephrol Urol, V8, P77, DOI 10.1023/A:1008384814079; Lindsay RM, 2004, CURR OPIN NEPHROL HY, V13, P631, DOI 10.1097/00041552-200411000-00008; Lindsay RM, 2003, AM J KIDNEY DIS, V42, pS5, DOI 10.1016/S0272-6386(03)00531-6; MACTIER R, 2007, MODULE 3A HAEMODIALY; Nissenson Allen R, 2005, Hemodial Int, V9, P210, DOI 10.1111/j.1492-7535.2005.01135.x; Pierratos A, 2006, Minerva Urol Nefrol, V58, P99; Raj DSC, 1999, AM J KIDNEY DIS, V34, P597, DOI 10.1016/S0272-6386(99)70382-3; Roderick P, 2005, HEALTH TECHNOL ASSES, V9, P1; Stephens R L, 1976, Proc Eur Dial Transplant Assoc, V12, P511; Twardowski ZJ, 2007, BLOOD PURIFICAT, V25, P90, DOI 10.1159/000096403; White P, 2006, QJM-INT J MED, V99, P445, DOI 10.1093/qjmed/hcl054	19	130	139	3	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2005	2010		10.1016/S0140-6736(07)61864-9	http://dx.doi.org/10.1016/S0140-6736(07)61864-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083402				2022-12-28	WOS:000251698600027
J	Gray, R; Barnwell, J; McConkey, C; Hills, RK; Williams, NS; Kerr, DJ				Gray, Richard; Barnwell, Jennifer; McConkey, Christopher; Hills, Robert K.; Williams, Norman S.; Kerr, David J.		QUASAR Collaborative Grp	Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study	LANCET			English	Article							III COLON-CANCER; FOLINIC ACID; STAGE-III; POOLED ANALYSIS; RECTAL-CANCER; PHASE-III; DUKES B; THERAPY; FLUOROURACIL; LEUCOVORIN	Background The aim of the QUASAR trial was to determine the size and duration of any survival benefit from adjuvant Chemotherapy for patients with colorectal cancer at low risk of recurrence, for whom the indication for such treatment is unclear. Methods After apparently curative resections of colon or rectal cancer, 3239 patients (2963 [91%] with stage II [node negative] disease, 2291 [71%] with colon cancer, median age 63 [IQR 56-68] years) enrolled between May, 1994, and December, 2003, from 150 centres in 19 countries were randomly assigned to receive chemotherapy with fluorouracil and folinic acid (n=1622) or to observation (with chemotherapy considered on recurrence; n=1617). Chemotherapy was delivered as six 5-day courses every 4 weeks or as 30 once-weekly courses of intravenous fluorouracil (370 mg/m(2)) with high-dose (175 mg) L-folinic acid or low-dose (25 mg) L-folinic acid. Until 1997, levamisole (12 courses of 450 mg over 3 days repeated every 2 weeks) or placebo was added. After 1997, patients who were assigned to receive chemotherapy were given fluorouracil and low-dose folinic acid only. The primary outcome was all-cause mortality. Analyses were done by intention to treat. This trial is registered with the International Clinical Trial Registry, number ISRCTN82375386. Findings At the time of analysis, 61 (3.8%) patients in the chemotherapy group and 50 (3.1%) in the observation group had missing follow-up. After a median follow-up of 5.5 (range 0-10.6) years, there were 311 deaths in the chemotherapy group and 370 in the observation group; the relative risk of death from any cause with chemotherapy versus observation alone was 0.82 (95% CI 0.70-0.95; p=0.008). There were 293 recurrences in the chemotherapy group and 359 in the observation group; the relative risk of recurrence with chemotherapy versus observation alone was 0.78 (0.67-0.91; p=0.001). Treatment efficacy did not differ significantly by tumour site, stage, sex, age, or chemotherapy schedule. Eight (0.5%) patients in the chemotherapy group and four (0.25%) in the observation group died from non-colorectal cancer causes within 30 weeks of randomisation; only one of these deaths was deemed to be possibly chemotherapy related. Interpretation Chemotherapy with fluorouracil and folinic acid could improve survival of patients with stage II colorectal cancer, although the absolute improvements are small: assuming 5-year mortality without chemotherapy is 20%, the relative risk of death seen here translates into an absolute improvement in survival of 3.6% (95% Cl 1.0-6.0).	Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; Univ Birmingham, CRUK Trials Unit, Birmingham, W Midlands, England; Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; Cardiff Univ, Welsh Sch Med, Cardiff, Wales; Royal London Hosp, London E1 1BB, England; Univ Oxford, Dept Clin Pharmacol, Oxford, England	University of Birmingham; University of Birmingham; University of Warwick; Cardiff University; Barts Health NHS Trust; Royal London Hospital; University of Oxford	Gray, R (corresponding author), Univ Birmingham Sch Med, Inst Canc Studies, CRUK Clin Trial Unit, QUASAR Study Off, Birmingham B15 2TT, W Midlands, England.	QUASAR@trials.bham.ac.uk		Hills, Robert/0000-0003-0166-0062; Steele, Robert JC/0000-0003-4248-6785				*7 KINGS FUND FOR, 1990, BRIT J SURG, V77, P1063; AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; COLLINS R, 1996, OXFORD TXB MED, V1, P21; Davidson-Homewood J, 2003, PSYCHO-ONCOL, V12, P675, DOI 10.1002/pon.684; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; FERLAY J, 2004, 5 IARC; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; FRANCINI G, 1994, GASTROENTEROLOGY, V106, P899, DOI 10.1016/0016-5085(94)90748-X; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Glimelius B, 2005, ACTA ONCOL, V44, P904, DOI 10.1080/02841860500355900a; Goldberg RM, 2006, J CLIN ONCOL, V24, P4085, DOI 10.1200/JCO.2006.06.9039; Gray RG, 2000, LANCET, V355, P1588; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Jansen SJT, 2004, J CLIN ONCOL, V22, P3181, DOI 10.1200/JCO.2004.06.109; KERR DJ, 1989, BRIT J CANCER, V60, P807, DOI 10.1038/bjc.1989.370; Kerr DJ, 2000, ANN ONCOL, V11, P947, DOI 10.1023/A:1008303229469; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; LABIANCA R, 1995, LANCET, V345, P939; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Melville A, 1998, QUAL HEALTH CARE, V7, P103, DOI 10.1136/qshc.7.2.103; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; OConnell MJ, 1997, J CLIN ONCOL, V15, P246, DOI 10.1200/JCO.1997.15.1.246; Piedbois P, 2004, J CLIN ONCOL, V22, P3766, DOI 10.1200/JCO.2004.03.104; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; Smith RE, 2004, JNCI-J NATL CANCER I, V96, P1128, DOI 10.1093/jnci/djh220; SMITH RE, 2003, P AN M AM SOC CLIN, V22, P294; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Wolmark N, 1999, J CLIN ONCOL, V17, P3553, DOI 10.1200/JCO.1999.17.11.3553; WOLMARK N, 2005, P AN M AM SOC CLIN, V23, pS16; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZITTOUN J, 1991, BRIT J CANCER, V63, P885, DOI 10.1038/bjc.1991.194	39	976	1000	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2020	2029		10.1016/s0140-6736(07)61866-2	http://dx.doi.org/10.1016/s0140-6736(07)61866-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083404				2022-12-28	WOS:000251698600029
J	Westley, H				Westley, Hannah			Thin living	BRITISH MEDICAL JOURNAL			English	Editorial Material												hannah.westley@wanadoo.fr							0	20	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1236	1237		10.1136/bmj.39409.451678.AD	http://dx.doi.org/10.1136/bmj.39409.451678.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079544	Green Published			2022-12-28	WOS:000251832200029
J	Charnoz, S; Brahic, A; Thomas, PC; Porco, CC				Charnoz, Sebastien; Brahic, Andre; Thomas, Peter C.; Porco, Carolyn C.			The equatorial ridges of Pan and Atlas: Terminal accretionary ornaments?	SCIENCE			English	Article							SATURNS RINGS; SMALL SATELLITES; IMAGING SCIENCE	In the outer regions of Saturn's main rings, strong tidal forces balance gravitational accretion processes. Thus, unusual phenomena may be expected there. The Cassini spacecraft has recently revealed the strange "flying saucer" shape of two small satellites, Pan and Atlas, located in this region, showing prominent equatorial ridges. The accretion of ring particles onto the equatorial surfaces of already-formed bodies embedded in the rings may explain the formation of the ridges. This ridge formation process is in good agreement with detailed Cassini images showing differences between rough polar and smooth equatorial terrains. We propose that Pan and Atlas ridges are kilometers-thick "ring-particle piles" formed after the satellites themselves and after the flattening of the rings but before the complete depletion of ring material from their surroundings.	Univ Paris 07, CNRS, CEA, Lab AIM, F-91191 Gif Sur Yvette, France; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Cornell University	Charnoz, S (corresponding author), Univ Paris 07, CNRS, CEA, Lab AIM, F-91191 Gif Sur Yvette, France.	charnoz@cea.fr						BRAHIC A, 1981, NATURE, V289, P447, DOI 10.1038/289447a0; CAMPBELL JK, 1989, ASTRON J, V97, P1485, DOI 10.1086/115088; Charnoz S, 2001, ASTRON ASTROPHYS, V373, P683, DOI 10.1051/0004-6361:20010517; COWELL JA, 2006, GEORL, V33, DOI UNSP L07201; Karjalainen R, 2004, ICARUS, V172, P328, DOI 10.1016/j.icarus.2004.05.022; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; Poincare H., 1905, LECONS MECANIQUE CEL; Porco CC, 2007, SCIENCE, V318, P1602, DOI 10.1126/science.1143977; Porco C.C., 2005, B AM ASTRONOMICAL SO, V37, P768; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; ROCHE E, 1849, MEM ACAD SCI MONTPEL, V1, P243; SHOWALTER MR, 1991, NATURE, V351, P709, DOI 10.1038/351709a0; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; Spitale JN, 2006, ASTRON J, V132, P692, DOI 10.1086/505206; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581; ZEBKER HA, 1985, ICARUS, V64, P531, DOI 10.1016/0019-1035(85)90074-0; [No title captured]	17	42	42	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1622	1624		10.1126/science.1148631	http://dx.doi.org/10.1126/science.1148631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063797				2022-12-28	WOS:000251421700045
J	Koskinen, TT; Aylward, AD; Miller, S				Koskinen, Tommi T.; Aylward, Alan D.; Miller, Steve			A stability limit for the atmospheres of giant extrasolar planets	NATURE			English	Article							H-3(+); EVAPORATION; EVOLUTION; HYDROGEN; ESCAPE	Recent observations of the planet HD209458b indicate that it is surrounded by an expanded atmosphere of atomic hydrogen that is escaping hydrodynamically(1-3). Theoretically, it has been shown that such escape is possible at least inside an orbit of 0.1 AU ( refs 4 and 5), and also that H-3(+) ions play a crucial role in cooling the upper atmosphere(5,6). Jupiter's atmosphere is stable(7), so somewhere between 5 and 0.1 AU there must be a crossover between stability and instability. Here we show that there is a sharp breakdown in atmospheric stability between 0.14 and 0.16 AU for a Jupiter- like planet orbiting a solar- type star. These results are in contrast to earlier modelling(4,8) that implied much higher thermospheric temperatures and more significant evaporation farther from the star. ( We use a three- dimensional, time- dependent coupled thermosphere - ionosphere model(6) and properly include cooling by H-3(+) ions, allowing us to model globally the redistribution of heat and changes in molecular composition.) Between 0.2 and 0.16 AU cooling by H-3(+) ions balances heating by the star, but inside 0.16 AU molecular hydrogen dissociates thermally, suppressing the formation of H-3(+) and effectively shutting down that mode of cooling.			Koskinen, TT (corresponding author), UCL, Dept Phys & Astron, Atmospher Phys Lab, London WC1E 6BT, England.	tommi@apl.ucl.ac.uk		Miller, Steven/0000-0002-7159-6871				Ballester GE, 2007, NATURE, V445, P511, DOI 10.1038/nature05525; Baraffe I, 2004, ASTRON ASTROPHYS, V419, pL13, DOI 10.1051/0004-6361:20040129; des Etangs AL, 2007, ASTRON ASTROPHYS, V461, P1185, DOI 10.1051/0004-6361:20065014; HUNTEN DM, 1973, J ATMOS SCI, V30, P1481, DOI 10.1175/1520-0469(1973)030<1481:TEOLGF>2.0.CO;2; Koskinen TT, 2007, ASTROPHYS J, V661, P515, DOI 10.1086/513594; Lammer H, 2003, ASTROPHYS J, V598, pL121, DOI 10.1086/380815; Miller S, 2006, PHILOS T R SOC A, V364, P3121, DOI 10.1098/rsta.2006.1877; Neale L, 1996, ASTROPHYS J, V464, P516, DOI 10.1086/177341; Ribas I, 2005, ASTROPHYS J, V622, P680, DOI 10.1086/427977; Rice WKM, 2005, ASTROPHYS J, V630, P1107, DOI 10.1086/432244; Shkolnik E, 2006, ASTRON J, V132, P1267, DOI 10.1086/506476; Strobel DF, 2002, GEOPH MONOG SERIES, V130, P7, DOI 10.1029/130GM02; Tian F, 2005, ASTROPHYS J, V621, P1049, DOI 10.1086/427204; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Yelle RV, 2004, ICARUS, V170, P167, DOI 10.1016/j.icarus.2004.02.008	16	73	75	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					845	848		10.1038/nature06378	http://dx.doi.org/10.1038/nature06378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064005				2022-12-28	WOS:000251394900048
J	Bechtluft, P; van Leeuwen, RGH; Tyreman, M; Tomkiewicz, D; Nouwen, N; Tepper, HL; Driessen, AJM; Tans, SJ				Bechtluft, Philipp; van Leeuwen, Ruud G. H.; Tyreman, Matthew; Tomkiewicz, Danuta; Nouwen, Nico; Tepper, Harald L.; Driessen, Arnold J. M.; Tans, Sander J.			Direct observation of chaperone-induced changes in a protein folding pathway	SCIENCE			English	Article							MALTOSE-BINDING PROTEIN; ATOMIC-FORCE MICROSCOPY; TERTIARY STRUCTURE; SUBSTRATE PROTEIN; SECB; EXPORT; MOLECULE; TRANSLOCATION; MEMBRANE; PEPTIDE	How chaperone interactions affect protein folding pathways is a central problem in biology. With the use of optical tweezers and all-atom molecular dynamics simulations, we studied the effect of chaperone SecB on the folding and unfolding pathways of maltose binding protein (MBP) at the single-molecule level. In the absence of SecB, we find that the MBP polypeptide first collapses into a molten globulelike compacted state and then folds into a stable core structure onto which several a helices are finally wrapped. Interactions with SecB completely prevent stable tertiary contacts in the core structure but have no detectable effect on the folding of the external a helices. It appears that SecB only binds to the extended or molten globulelike structure and retains MBP in this latter state. Thus during MBP translocation, no energy is required to disrupt stable tertiary interactions.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands	AMOLF; University of Groningen; University of Groningen	Tans, SJ (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	tans@amolf.nl	Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019; van Leeuwen, R.G.H./L-4481-2015; Tans, Sander/AAS-2901-2020	Driessen, Arnold J.M./0000-0001-9258-9104				Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; CHUN SY, 1993, J BIOL CHEM, V268, P20855; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Crane JM, 2006, J MOL BIOL, V363, P63, DOI 10.1016/j.jmb.2006.07.021; de Cock H, 1998, MOL MICROBIOL, V27, P469, DOI 10.1046/j.1365-2958.1998.00695.x; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Duan XQ, 2001, J MOL BIOL, V306, P1115, DOI 10.1006/jmbi.2001.4456; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; LECKER SH, 1990, EMBO J, V9, P2309, DOI 10.1002/j.1460-2075.1990.tb07402.x; LIU G, 1988, J BIOL CHEM, V263, P14790; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Stan G, 2007, P NATL ACAD SCI USA, V104, P8803, DOI 10.1073/pnas.0700607104; TOPPING TB, 1994, PROTEIN SCI, V3, P730; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040	30	107	108	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1458	1461		10.1126/science.1144972	http://dx.doi.org/10.1126/science.1144972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048690				2022-12-28	WOS:000251246100048
J	Libert, S; Pletcher, SD				Libert, Sergiy; Pletcher, Scott D.			Modulation of longevity by environmental sensing	CELL			English	Review							RESTRICTION-INDUCED LONGEVITY; EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; C-ELEGANS; NEURONS; DIET		[Libert, Sergiy; Pletcher, Scott D.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Libert, Sergiy; Pletcher, Scott D.] Baylor Coll Med, Interdepartmental Program Cellular & Mol Biol, Houston, TX 77030 USA; [Pletcher, Scott D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Pletcher, SD (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Pl, Houston, TX 77030 USA.	pletcher@bcm.tmc.edu	Libert, Sergiy/D-8136-2016	Libert, Sergiy/0000-0003-2497-5390				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Gerisch B, 2004, DEVELOPMENT, V131, P1765, DOI 10.1242/dev.01068; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Lans H, 2007, DEV BIOL, V303, P474, DOI 10.1016/j.ydbio.2006.11.028; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Murakami H, 2007, AGING CELL, V6, P483, DOI 10.1111/j.1474-9726.2007.00303.x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030	20	40	41	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1231	1234		10.1016/j.cell.2007.12.002	http://dx.doi.org/10.1016/j.cell.2007.12.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160034	Bronze			2022-12-28	WOS:000252217200013
J	Bos, MJ; van Rijn, MJE; Witteman, JCM; Hofman, A; Koudstaal, PJ; Breteler, MMB				Bos, Michiel J.; van Rijn, Marie Josee E.; Witteman, Jacqueline C. M.; Hofman, Albert; Koudstaal, Peter J.; Breteler, Monique M. B.			Incidence and prognosis of transient neurological attacks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHORT-TERM PROGNOSIS; ISCHEMIC ATTACK; FOLLOW-UP; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; GLOBAL AMNESIA; MINOR STROKE; RISK-FACTORS; ROTTERDAM; DIAGNOSIS	Context Transient neurological attacks ( TNAs) are attacks with temporary ( < 24 hours) neurological symptoms. These symptoms can be focal, nonfocal, or a mixture of both. The prognostic significance of TNAs with focal symptoms ( better known as transient ischemic attacks [ TIAs]) is well understood. Conversely, hardly anything is known about the prognostic significance of TNAs with nonfocal or mixed symptoms. Objective To study the incidence and prognosis of focal TNAs ( or TIAs), nonfocal TNAs, and mixed TNAs. Design, Setting, and Participants The study population comprised 6062 community-dwelling Rotterdam Study participants who were aged 55 years or older and free from stroke, myocardial infarction, and dementia at baseline ( 1990-1993). They were followed up for events until January 1, 2005. We analyzed the associations between incident TNAs and subsequent adverse events with age- and sex- adjusted Cox regression models. Main Outcome Measures Stroke, ischemic heart disease, or dementia. Results During 60 535 person- years, 548 participants developed TNA ( 282 focal, 228 nonfocal, and 38 mixed). The incidence rate per 1000 person- years was 4.7 ( 95% confidence interval [ CI], 4.1- 5.2) for focal TNA, 3.8 ( 95% CI, 3.3- 4.3) for nonfocal TNA, and 0.6 ( 95% CI, 0.4- 0.9) for mixed TNA. Participants with focal TNA were at higher risk of subsequent stroke than participants without TNA ( n= 46 vs 540; hazard ratio [ HR], 2.14; 95% confidence interval [ CI]; 1.57- 2.91) but had an equal risk of ischemic heart disease and dementia. Nonfocal TNA patients were at higher risk of stroke ( 27 vs 540; HR, 1.56; 95% CI, 1.08- 2.28) and dementia ( 30 vs 552; HR, 1.59; 95% CI, 1.11- 2.26) than participants without TNA. Mixed TNA patients were at higher risk of stroke ( 6 vs 540; HR, 2.48; 95% CI, 1.11- 5.56), ischemic heart disease ( 8 vs 779; HR, 2.26; 95% CI, 1.07- 4.78), vascular death ( 8 vs 594; HR, 2.54; 95% CI, 1.31-4.91), and dementia ( 7 vs 552; HR, 3.46; 95% CI, 1.72- 6.98) than participants without TNA. Conclusion Patients who experience nonfocal TNAs, and especially those with mixed TNAs, have a higher risk of major vascular diseases and dementia than persons without TNA.	Erasmus Sch Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Erasmus Sch Ctr, Dept Neurol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam	Breteler, MMB (corresponding author), Erasmus Sch Ctr, Dept Epidemiol & Biostat, Dr Molewaterpl 50,POB 2040, NL-3000 CA Rotterdam, Netherlands.		Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305				[Anonymous], 1975, Stroke, V6, P564; Bos MJ, 2006, CIRCULATION, V114, P1591, DOI 10.1161/CIRCULATIONAHA.106.619833; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Bots ML, 1997, STROKE, V28, P768, DOI 10.1161/01.STR.28.4.768; BOTS ML, 1997, STROKE, V28, P763; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Daffertshofer M, 2004, STROKE, V35, P2453, DOI 10.1161/01.STR.0000144050.90132.8e; EVANS JG, 1990, AGE AGEING, V19, P43, DOI 10.1093/ageing/19.1.43; GANDOLFO C, 1992, EUR NEUROL, V32, P52, DOI 10.1159/000116787; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2005, STROKE, V36, P724, DOI 10.1161/str.36.4.724; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; KOUDSTAAL PJ, 1992, LANCET, V340, P630, DOI 10.1016/0140-6736(92)92170-K; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pantoni L, 2005, EUR J NEUROL, V12, P350, DOI 10.1111/j.1468-1331.2004.00982.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Strickberger SA, 2006, CIRCULATION, V113, P316, DOI 10.1161/CIRCULATIONAHA.105.170274; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4	28	114	117	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2877	2885		10.1001/jama.298.24.2877	http://dx.doi.org/10.1001/jama.298.24.2877			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159057	Bronze			2022-12-28	WOS:000251816000020
J	Cook, C; Tarbet, H; Ball, D				Cook, Christopher; Tarbet, Helen; Ball, David			Classically intoxicated	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London		c.c.h.cook@durham.ac.uk	Cook, Christopher C.H./D-2428-2009	Cook, Christopher C.H./0000-0001-7700-7639				BABOR TF, 2003, ALCOHOL NO ORDINARY, P189; Davidson James, 1997, COURTESANS FISHCAKES; HUNTER RL, 1983, EUBULUS FRAGMENTS, P189; HUNTER RL, 1983, EUBULUS FRAGMENTS, P186; Kassel R., 1986, POETAE COMICI GRAECI, V5; *PRIM MIN STRAT UN, 2004, ALC HARM RED STRAT E; ROLLESTON JD, 1927, BRIT J INEBRIETY, V24, P101	7	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1302	1304		10.1136/bmj.39420.333565.BE	http://dx.doi.org/10.1136/bmj.39420.333565.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156239	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700020
J	Vreeman, RC; Carroll, AE				Vreeman, Rachel C.; Carroll, Aaron E.			Medical myths	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carroll, Aaron E.] Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc		rvreeman@iupui.edu							0	25	25	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1288	1289		10.1136/bmj.39420.420370.25	http://dx.doi.org/10.1136/bmj.39420.420370.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156231	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000252182700011
J	Hanna, J; Wernig, M; Markoulaki, S; Sun, CW; Meissner, A; Cassady, JP; Beard, C; Brambrink, T; Wu, LC; Townes, TM; Jaenisch, R				Hanna, Jacob; Wernig, Marius; Markoulaki, Styliani; Sun, Chiao-Wang; Meissner, Alexander; Cassady, John P.; Beard, Caroline; Brambrink, Tobias; Wu, Li-Chen; Townes, Tim M.; Jaenisch, Rudolf			Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin	SCIENCE			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; DISEASE	It has recently been demonstrated that mouse and human fibroblasts can be reprogrammed into an embryonic stem cell- like state by introducing combinations of four transcription factors. However, the therapeutic potential of such induced pluripotent stem ( iPS) cells remained undefined. By using a humanized sickle cell anemia mouse model, we show that mice can be rescued after transplantation with hematopoietic progenitors obtained in vitro from autologous iPS cells. This was achieved after correction of the human sickle hemoglobin allele by gene- specific targeting. Our results provide proof of principle for using transcription factor- induced reprogramming combined with gene and cell therapy for disease treatment in mice. The problems associated with using retroviruses and oncogenes for reprogramming need to be resolved before iPS cells can be considered for human therapy.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Townes, TM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA.	ttownes@uab.edu; Jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012; wang, baocheng/B-7805-2008	Hanna, Jacob/0000-0003-2042-9974; wang, baocheng/0000-0002-8236-8014	NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057619] Funding Source: NIH RePORTER; NCI NIH HHS [5-RO1-CA087869, 5-R37-CA084198] Funding Source: Medline; NHLBI NIH HHS [2-R01-HL057619] Funding Source: Medline; PHS HHS [5-RO1-HDO45022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	1089	1320	3	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1920	1923		10.1126/science.1152092	http://dx.doi.org/10.1126/science.1152092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18063756				2022-12-28	WOS:000251786600058
J	Fishman, JA				Fishman, Jay A.			Medical progress: Infection in solid-organ transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPATITIS-C VIRUS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; RESISTANT CYTOMEGALOVIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; VISCERAL LEISHMANIASIS; RISK-FACTORS; LIVER-TRANSPLANTATION; FUNGAL-INFECTIONS; VIRAL-INFECTION; RENAL-TRANSPLANTATION		Massachusetts Gen Hosp, Transplant Infect Dis & Compromised Host Program, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fishman, JA (corresponding author), Massachusetts Gen Hosp, Transplant Infect Dis & Compromised Host Program, 55 Fruit St,GRJ 504, Boston, MA 02114 USA.	jfishman@partners.org	Hug, Balthasar L./G-1568-2010					Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Angelis M, 2003, LIVER TRANSPLANT, V9, P451, DOI 10.1053/jlts.2003.50094; Avery RK, 2004, CURR OPIN INFECT DIS, V17, P353, DOI 10.1097/01.qco.0000136936.13662.74; Basset D, 2005, MICROBES INFECT, V7, P1370, DOI 10.1016/j.micinf.2005.06.002; Bert R, 2005, LIVER TRANSPLANT, V11, P1093, DOI 10.1002/lt.20491; Boivin G, 2006, TRANSPL INFECT DIS, V8, P58; Boivin G, 2005, TRANSPL INFECT DIS, V7, P166, DOI 10.1111/j.1399-3062.2005.00112.x; Boletis JN, 1999, CLIN INFECT DIS, V28, P1308, DOI 10.1086/514784; Campdera FG, 1998, AM J NEPHROL, V18, P171, DOI 10.1159/000013329; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P210; CHAZOUILLERES O, 1995, J GASTROEN HEPATOL, V10, P471, DOI 10.1111/j.1440-1746.1995.tb01603.x; CHEESEMAN SH, 1980, ANN INTERN MED, V93, P39, DOI 10.7326/0003-4819-93-1-39; Curry MP, 2004, TRANSPLANTATION, V78, P955, DOI 10.1097/01.TP.0000140927.63952.58; D'Albuquerque LAC, 2007, AM J TRANSPLANT, V7, P680, DOI 10.1111/j.1600-6143.2007.01663.x; Delmonico FL, 2000, CLIN INFECT DIS, V31, P781, DOI 10.1086/314000; Dharnidharka VR, 2001, TRANSPLANTATION, V71, P1065, DOI 10.1097/00007890-200104270-00010; Drachenberg CB, 2003, AM J TRANSPLANT, V3, P1383, DOI 10.1046/j.1600-6135.2003.00237.x; Dummer JS, 2004, J HEART LUNG TRANSPL, V23, P1376, DOI 10.1016/j.healun.2003.09.028; Everhart, 1999, HEPATOLOGY, V30, P1110; Everhart JE, 1999, HEPATOLOGY, V29, P1220, DOI 10.1002/hep.510290412; Falagas ME, 1996, CLIN INFECT DIS, V23, P468, DOI 10.1093/clinids/23.3.468; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Fishman J A, 2003, Transpl Infect Dis, V5, P109, DOI 10.1034/j.1399-3062.2003.00028.x; Fishman JA, 1996, TRANSPLANTATION, V62, P147, DOI 10.1097/00007890-199607270-00001; Fishman JA, 2003, J INFECT DIS, V188, P1405, DOI 10.1086/379256; Fishman JA, 1998, ANTIMICROB AGENTS CH, V42, P995, DOI 10.1128/AAC.42.5.995; Fishman JA, 2002, NEW ENGL J MED, V347, P527, DOI 10.1056/NEJMe020076; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Frapier JM, 2001, J HEART LUNG TRANSPL, V20, P912, DOI 10.1016/S1053-2498(01)00263-7; Freeman RB, 1999, TRANSPLANTATION, V68, P1107, DOI 10.1097/00007890-199910270-00008; Fung J, 2004, LIVER TRANSPLANT, V10, pS39, DOI 10.1002/lt.20261; Gane E, 1998, LANCET, V351, P454; Gane E, 1997, LANCET, V350, P1729, DOI 10.1016/S0140-6736(97)05535-9; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Green M, 2002, AM J TRANSPLANT, V2, P894, DOI 10.1034/j.1600-6143.2002.21003.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Harbarth S, 1996, INTENS CARE MED, V22, P1133, DOI 10.1007/BF01699244; Harris NL, 1997, SEMIN DIAGN PATHOL, V14, P8; Herrero IA, 2002, NEW ENGL J MED, V346, P867, DOI 10.1056/NEJM200203143461121; Hirsch HH, 2006, ADV EXP MED BIOL, V577, P160; Hirsch HH, 2006, NAT CLIN PRACT NEPHR, V2, P240, DOI 10.1038/ncpneph0179; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Humar A, 2000, TRANSPLANTATION, V69, P2357, DOI 10.1097/00007890-200006150-00024; Humar A, 2005, J INFECT DIS, V192, P1154, DOI 10.1086/444398; Humar A, 2005, AM J TRANSPLANT, V5, P1065, DOI 10.1111/j.1600-6143.2005.00797.x; Husain S, 2003, CLIN INFECT DIS, V37, P221, DOI 10.1086/375822; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kalil AC, 2005, ANN INTERN MED, V143, P870, DOI 10.7326/0003-4819-143-12-200512200-00005; Kalil RSN, 2003, AM J TRANSPLANT, V3, P79, DOI 10.1034/j.1600-6143.2003.30114.x; Karchmer A W, 1995, Trans Am Clin Climatol Assoc, V106, P38; Keven K, 2004, Transpl Infect Dis, V6, P10, DOI 10.1111/j.1399-3062.2004.00040.x; KIRKLIN JK, 1994, J HEART LUNG TRANSPL, V13, P394; Kotton CN, 2005, J AM SOC NEPHROL, V16, P1758, DOI 10.1681/ASN.2004121113; Kruger RM, 1999, TRANSPLANTATION, V68, P1272, DOI 10.1097/00007890-199911150-00010; Kumar D, 2007, AM J TRANSPLANT, V7, P633, DOI 10.1111/j.1600-6143.2007.01668.x; Lake JR, 2006, J HEPATOL, V44, P627, DOI 10.1016/j.jhep.2006.02.002; Lake JR, 2003, LIVER TRANSPLANT, V9, pS63, DOI 10.1053/jlts.2003.50264; LoPresti F, 1997, J CLIN MICROBIOL, V35, P1706, DOI 10.1128/JCM.35.7.1706-1709.1997; Luan FL, 2006, TRANSPL P, V38, P3673, DOI 10.1016/j.transproceed.2006.10.105; Migueles Stephen A, 2004, Curr HIV/AIDS Rep, V1, P12, DOI 10.1007/s11904-004-0002-2; Morelon E, 2000, NEW ENGL J MED, V343, P225, DOI 10.1056/NEJM200007203430317; Moreno S, 2005, LIVER TRANSPLANT, V11, P76, DOI 10.1002/lt.20318; Muder RR, 2000, AM J MED, V108, P346, DOI 10.1016/S0002-9343(00)00320-X; Munoz SJ, 2002, LIVER TRANSPLANT, V8, pS82, DOI 10.1053/jlts.2002.35783; Munoz-Price LS, 2004, CLIN INFECT DIS, V39, P1293, DOI 10.1086/425002; Mylonakis E, 2006, CLIN INFECT DIS, V42, P1350; Mylonakis E, 2002, CLIN INFECT DIS, V34, P1337, DOI 10.1086/340101; NALESNIK MA, 1988, AM J PATHOL, V133, P173; Newell KA, 1996, TRANSPLANTATION, V62, P370, DOI 10.1097/00007890-199608150-00012; Palau LA, 1997, AM J TROP MED HYG, V57, P413, DOI 10.4269/ajtmh.1997.57.413; Pappas PG, 2006, AM J TRANSPLANT, V6, P386, DOI 10.1111/j.1600-6143.2005.01176.x; PASTORE M, 1995, ARCH DIS CHILD, V72, P403, DOI 10.1136/adc.72.5.403; Patel R, 1996, TRANSPLANTATION, V62, P926, DOI 10.1097/00007890-199610150-00010; Patel R, 2001, ANTIMICROB AGENTS CH, V45, P621, DOI 10.1128/AAC.45.2.621-623.2001; Paya CV, 1999, TRANSPLANTATION, V68, P1517, DOI 10.1097/00007890-199911270-00015; PORTOLES J, 1994, TRANSPLANTATION, V57, P1677; Preiksaitis, 2005, AM J TRANSPLANT, V5, P635; Preiksaitis JK, 2005, AM J TRANSPLANT, V5, P218, DOI 10.1111/j.1600-6143.2004.00692.x; Preiksaitis JK, 2001, CLIN INFECT DIS, V33, pS38, DOI 10.1086/320903; PREIKSAITIS JK, 2004, AM J TRANSPLANT S10, V4, P51; Razonable Raymund R, 2003, Herpes, V10, P60; Rodriguez M, 2004, CLIN MICROBIOL REV, V17, P770, DOI 10.1128/CMR.17.4.770-782.2004; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; Rowe DT, 1997, J CLIN MICROBIOL, V35, P1612, DOI 10.1128/JCM.35.6.1612-1615.1997; Rubin R H, 2000, Transpl Infect Dis, V2, P112, DOI 10.1111/j.1399-3062.2000.020303.x; RUBIN RH, 1977, TRANSPLANTATION, V24, P458, DOI 10.1097/00007890-197712000-00010; RUBIN RH, 1991, NEW ENGL J MED, V324, P1057, DOI 10.1056/NEJM199104113241509; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; RUBIN RH, 1981, AM J MED, V70, P405, DOI 10.1016/0002-9343(81)90780-4; Sarwal MM, 2006, IMMUNOL REV, V210, P138, DOI 10.1111/j.0105-2896.2006.00359.x; SCHOOLEY RT, 1983, NEW ENGL J MED, V308, P307, DOI 10.1056/NEJM198302103080603; SCOGGIN CH, 1977, ANN INTERN MED, V87, P456, DOI 10.7326/0003-4819-87-4-456; Seehofer D, 2005, TRANSPLANTATION, V80, pS120, DOI 10.1097/01.tp.0000186919.00303.ec; Sester M, 2003, TRANSPLANTATION, V76, P1229, DOI 10.1097/01.TP.0000083894.61333.56; Singh N, 2003, INFECT DIS CLIN N AM, V17, P113, DOI 10.1016/S0891-5520(02)00067-3; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018; STRIPPOLI GF, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005133.PUB2; Trautwein C, 2004, J HEPATOL, V41, P362, DOI 10.1016/j.jhep.2004.06.013; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; Vats A, 2006, ADV EXP MED BIOL, V577, P213; Wagner JA, 1995, TRANSPLANTATION, V60, P1473, DOI 10.1097/00007890-199560120-00018; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; West M, 1999, CLIN TRANSPLANT, V13, P318, DOI 10.1034/j.1399-0012.1999.130407.x; Westall GP, 2003, TRANSPLANTATION, V75, P2064, DOI 10.1097/01.TP.0000069234.04901.A3; Wilck M, 2005, CURR OPIN ORGAN TRAN, V10, P301, DOI 10.1097/01.mot.0000183245.66967.b3; Williams MA, 2002, J IMMUNOL, V169, P5387, DOI 10.4049/jimmunol.169.10.5387; WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R; Zamora MR, 2004, AM J TRANSPLANT, V4, P1219, DOI 10.1111/j.1600-6143.2004.00505.x; Zeevi A, 2005, TRANSPL IMMUNOL, V15, P17, DOI 10.1016/j.trim.2005.03.019	110	1206	1251	2	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2601	2614		10.1056/NEJMra064928	http://dx.doi.org/10.1056/NEJMra064928			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094380				2022-12-28	WOS:000251728900010
J	Lewis-Jones, S; Mugglestone, MA				Lewis-Jones, Sue; Mugglestone, Moira A.		Guideline Dev Grp	Guidelines - Management of atopic eczema in children aged up to 12 years: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article							DERMATITIS		Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Dundee	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk						Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Beattie PE, 2003, CLIN EXP DERMATOL, V28, P549, DOI 10.1046/j.1365-2230.2003.01357.x; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; Kerr OA, 2007, BRIT J DERMATOL, V157, P1; Kerr OA, 2005, BRIT J DERMATOL, V153, P1; *NAT I HLTH CLIN E, 2007, AT ECZ CHILDR MAN AT; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Zuberbier T, 2006, J ALLERGY CLIN IMMUN, V118, P226, DOI 10.1016/j.jaci.2006.02.031	8	45	47	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1263	1264		10.1136/bmj.39405.503773.AD	http://dx.doi.org/10.1136/bmj.39405.503773.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079551	Green Published			2022-12-28	WOS:000251832200039
J	Madon, T; Hofman, KJ; Kupfer, L; Glass, RI				Madon, Temina; Hofman, Karen J.; Kupfer, Linda; Glass, Roger I.			Public health - Implementation science	SCIENCE			English	Editorial Material							MALARIA; CIRCUMCISION; COVERAGE		NIH, Div Adv Sci & Policy Anal, John E Fogarty Int Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hofman, KJ (corresponding author), NIH, Div Adv Sci & Policy Anal, John E Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	hofmank@mail.nih.gov		Madon, Temina/0000-0003-2427-3655; Kupfer, Linda/0000-0002-6886-6818; HOFMAN, KAREN/0000-0001-9512-7220				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Buekens P, 2004, JAMA-J AM MED ASSOC, V291, P2639, DOI 10.1001/jama.291.21.2639; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Feachem RGA, 2004, TROP MED INT HEALTH, V9, P1139, DOI 10.1111/j.1365-3156.2004.01343.x; Fixsen DD, 2005, FMHI PUBL, V231; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GLOB FOR HLTH RES, 2007, REALHEALTHNEWS; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; LENGELER C, 2001, COCHRANE REV; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Quinn TC, 2007, CURR OPIN INFECT DIS, V20, P33, DOI 10.1097/QCO.0b013e328012c5bc; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Savedoff W. D., 2006, WILL WE EVER LEARN I; SKOUFIAS E, 2005, 139 INT FOOD POL RES	19	224	230	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1728	1729		10.1126/science.1150009	http://dx.doi.org/10.1126/science.1150009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	240VR	18079386				2022-12-28	WOS:000251616800022
J	Munch, J; Rucker, E; Standker, L; Adermann, K; Goffinet, C; Schindler, M; Wildum, S; Chinnadurai, R; Rajan, D; Specht, A; Gimenez-Gallego, G; Sanchez, PC; Fowler, DM; Koulov, A; Kelly, JW; Mothes, W; Grivel, JC; Margolis, L; Keppler, OT; Forssmann, WG; Kirchhoff, F				Muench, Jan; Ruecker, Elke; Staendker, Ludger; Adermann, Knut; Goffinet, Christine; Schindler, Michael; Wildum, Steffen; Chinnadurai, Raghavan; Rajan, Devi; Specht, Anke; Gimenez-Gallego, Guillermo; Cuevas Sanchez, Pedro; Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.; Mothes, Walther; Grivel, Jean-Charles; Margolis, Leonid; Keppler, Oliver T.; Forssmann, Wolf-Georg; Kirchhoff, Frank			Semen-derived amyloid fibrils drastically enhance HIV infection	CELL			English	Article							SEXUAL TRANSMISSION; ACID-PHOSPHATASE; VIRAL LOAD; VIRUS; PROTEIN; MEN; QUANTIFICATION; FUSION; CELLS; MODEL	Sexual intercourse is the major route of HIV transmission. To identify endogenous factors that affect the efficiency of sexual viral transmission, we screened a complex peptide/protein library derived from human semen. We show that naturally occurring fragments of the abundant semen marker prostatic acidic phosphatase (PAP) form amyloid fibrils. These fibrils, termed Semen-derived Enhancer of Virus Infection (SEVI), capture HIV virions and promote their attachment to target cells, thereby enhancing the infectious virus titer by several orders of magnitude. Physiological concentrations of SEVI amplified HIV infection of T cells, macrophages, ex vivo human tonsillar tissues, and transgenic rats in vivo, as well as trans-HIV infection of T cells by dendritic or epithelial cells. Amyloidogenic PAP fragments are abundant in seminal fluid and boost semen-mediated enhancement of HIV infection. Thus, they may play an important role in sexual transmission of HIV and could represent new targets for its prevention.	[Staendker, Ludger; Adermann, Knut; Forssmann, Wolf-Georg] IPF PharmaCeut GmbH, D-30625 Hannover, Germany; [Muench, Jan; Ruecker, Elke; Schindler, Michael; Wildum, Steffen; Chinnadurai, Raghavan; Rajan, Devi; Specht, Anke; Kirchhoff, Frank] Univ Clin Ulm, Inst Virol, D-89081 Ulm, Germany; [Staendker, Ludger; Adermann, Knut; Forssmann, Wolf-Georg] Hannover Med Sch, Ctr Pharmacol, D-30625 Hannover, Germany; [Adermann, Knut] VIRO Pharmaceut GmbH & Co KG, D-30625 Hannover, Germany; [Goffinet, Christine; Keppler, Oliver T.] Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany; [Gimenez-Gallego, Guillermo] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Cuevas Sanchez, Pedro] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mothes, Walther] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Grivel, Jean-Charles; Margolis, Leonid] NICHHD, Bethesda, MD 20892 USA	Ulm University; Hannover Medical School; Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario Ramon y Cajal; Scripps Research Institute; Scripps Research Institute; Yale University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Forssmann, WG (corresponding author), IPF PharmaCeut GmbH, D-30625 Hannover, Germany.	wg.forssman@pharis.de; frank.kirchhoff@uniklinik-ulm.de	Goffinet, Christine/L-4878-2019; Kirchhoff, Frank/O-8367-2018; Schindler, Michael/C-1647-2015	Goffinet, Christine/0000-0002-3959-004X; Kirchhoff, Frank/0000-0002-7052-2360; Schindler, Michael/0000-0001-8989-5813; Jan, Munch/0000-0001-7316-7141; Koulov, Atanas/0000-0003-0262-7002; Wildum, Steffen/0000-0001-9779-5740; Grivel, Jean-Charles/0000-0003-0365-3181	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067057] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Collins KA, 2001, AM J FOREN MED PATH, V22, P228, DOI 10.1097/00000433-200109000-00004; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dittmar MT, 1999, AIDS RES HUM RETROV, V15, P707, DOI 10.1089/088922299310791; Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; GRAVES HCB, 1985, NEW ENGL J MED, V312, P338, DOI 10.1056/NEJM198502073120603; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Keppler OT, 2002, J EXP MED, V195, P719, DOI 10.1084/jem.20011549; Kiessling Ann A, 2005, Methods Mol Biol, V304, P71; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maroun L, 2003, SCAND J UROL NEPHROL, V37, P519, DOI 10.1080/00365590310001764; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; RONNBERG L, 1981, INT J ANDROL, V4, P372, DOI 10.1111/j.1365-2605.1981.tb00721.x; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Rucker E, 2004, J VIROL, V78, P10197, DOI 10.1128/JVI.78.18.10197-10201.2004; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tachet A, 1999, AIDS, V13, P823, DOI 10.1097/00002030-199905070-00012; TERMUSSI PA, 2003, EMBO J, V22, P355; TeviBenissan C, 1997, CLIN DIAGN LAB IMMUN, V4, P367; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	44	419	441	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1059	1071		10.1016/j.cell.2007.10.014	http://dx.doi.org/10.1016/j.cell.2007.10.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083097	Bronze			2022-12-28	WOS:000252217100015
J	Davi, G; Patrono, C				Davi, Giovanni; Patrono, Carlo			Mechanisms of disease: Platelet activation and atherothrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INCREASED THROMBOXANE BIOSYNTHESIS; ACUTE MYOCARDIAL-INFARCTION; VON-WILLEBRAND-FACTOR; IN-VIVO FORMATION; CD40 LIGAND; DIABETES-MELLITUS; CYCLOOXYGENASE-2 INHIBITION; ENDOGENOUS BIOSYNTHESIS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS		Univ Cattolica Sacro Cuore, Dept Pharmacol, Sch Med, I-00168 Rome, Italy; G Annunzio Univ Fdn, Ctr Excellence Aging, Chieti, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; G d'Annunzio University of Chieti-Pescara	Patrono, C (corresponding author), Univ Cattolica Sacro Cuore, Dept Pharmacol, Sch Med, Largo F Vito 1, I-00168 Rome, Italy.	carlo.patrono@rm.unicatt.it		Patrono, Carlo/0000-0002-6447-2424				Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; [Anonymous], 1988, LANCET, V2, P349; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Calara F, 2001, J PATHOL, V195, P257, DOI 10.1002/path.915; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Chackalamannil S, 2006, J MED CHEM, V49, P5389, DOI 10.1021/jm0603670; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cullen L, 1998, J PHARMACOL EXP THER, V287, P578; DAVI G, 1992, CIRCULATION, V85, P1792, DOI 10.1161/01.CIR.85.5.1792; Davi G, 1997, CIRCULATION, V96, P69; Davi G, 2002, JAMA-J AM MED ASSOC, V288, P2008, DOI 10.1001/jama.288.16.2008; Davi G, 2001, CIRCULATION, V104, P1124, DOI 10.1161/hc3501.095287; DAVI G, 1990, NEW ENGL J MED, V322, P1769, DOI 10.1056/NEJM199006213222503; Davi G, 1999, CIRCULATION, V99, P224; Davi G, 1997, ARTERIOSCL THROM VAS, V17, P3230, DOI 10.1161/01.ATV.17.11.3230; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; DIMINNO G, 1993, J CLIN INVEST, V92, P1400, DOI 10.1172/JCI116715; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Egan, 2005, CIRCULATION, V111, P2412, DOI 10.1161/CIRCULATIONAHA.105.5755; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fateh-Moghadam S, 2005, ARTERIOSCL THROM VAS, V25, P1299, DOI 10.1161/01.ATV.0000165699.41301.c5; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; FITZGERALD GA, 1983, CIRCULATION, V67, P1174, DOI 10.1161/01.CIR.67.6.1174; Folts JD, 1999, J AM COLL CARDIOL, V33, P295, DOI 10.1016/S0735-1097(98)00601-9; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harding SA, 2004, CIRCULATION, V109, P1926, DOI 10.1161/01.CIR.0000127128.52679.E4; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; KOUDSTAAL PJ, 1993, STROKE, V24, P219, DOI 10.1161/01.STR.24.2.219; Koyama H, 2003, CIRCULATION, V108, P524, DOI 10.1161/01.CIR.0000081765.88440.51; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Kulkarni S, 2000, J CLIN INVEST, V105, P783, DOI 10.1172/JCI7569; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Loscalzo J, 2003, BIOCHEM SOC T, V31, P1059; Macaulay IC, 2005, J CLIN INVEST, V115, P3370, DOI 10.1172/JCI26885; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; Marcus AJ, 2005, SEMIN THROMB HEMOST, V31, P234, DOI 10.1055/s-2005-869528; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P5890; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Methia N, 2001, BLOOD, V98, P1424, DOI 10.1182/blood.V98.5.1424; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; Minuz P, 2002, CIRCULATION, V106, P2800, DOI 10.1161/01.CIR.0000039528.49161.E9; Moncada S, 2006, PHILOS T R SOC B, V361, P735, DOI 10.1098/rstb.2005.1775; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; NOWAK J, 1987, CIRCULATION, V76, P6, DOI 10.1161/01.CIR.76.1.6; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; PATRONO C, 1986, J CLIN INVEST, V77, P590, DOI 10.1172/JCI112341; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PATRONO C, 2004, CHEST, V3, pS2314; Pignatelli P, 2004, CIRCULATION, V110, P1326, DOI 10.1161/01.CIR.0000134963.77201.55; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Pratico D, 2000, BLOOD, V96, P3823, DOI 10.1182/blood.V96.12.3823.h8003823_3823_3826; ROBERTS LJ, 1981, J BIOL CHEM, V256, P8384; Rocca B, 2005, J THROMB HAEMOST, V3, P1597, DOI 10.1111/j.1538-7836.2005.01380.x; Rocca B, 2002, P NATL ACAD SCI USA, V99, P7634, DOI 10.1073/pnas.112202999; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Santilli F, 2006, J AM COLL CARDIOL, V47, P391, DOI 10.1016/j.jacc.2005.03.079; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; SHATTIL SJ, 1987, BLOOD, V70, P307; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; Tan KT, 2005, THROMB HAEMOSTASIS, V94, P488, DOI 10.1160/TH05-03-0201; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Vaidyula VR, 2006, DIABETES, V55, P202, DOI 10.2337/diabetes.55.1.202; vanKooten F, 1997, STROKE, V28, P1557, DOI 10.1161/01.STR.28.8.1557; VEJAR M, 1990, THROMB HAEMOSTASIS, V63, P163; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Watson SP, 2005, J THROMB HAEMOST, V3, P2098, DOI 10.1111/j.1538-7836.2005.01550.x; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Williams PC, 2005, BLOOD, V106, P2737, DOI 10.1182/blood-2005-02-0664; Yu GY, 2005, BLOOD, V105, P3545, DOI 10.1182/blood-2004-07-2617; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	114	1531	1628	3	169	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2482	2494		10.1056/NEJMra071014	http://dx.doi.org/10.1056/NEJMra071014			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077812				2022-12-28	WOS:000251564400009
J	Pedersen, BP; Buch-Pedersen, MJ; Morth, JP; Palmgren, MG; Nissen, P				Pedersen, Bjorn P.; Buch-Pedersen, Morten J.; Morth, J. Preben; Palmgren, Michael G.; Nissen, Poul			Crystal structure of the plasma membrane proton pump	NATURE			English	Article							H+-ATPASE; CALCIUM-PUMP; ANGSTROM RESOLUTION; ROTATION; BACTERIORHODOPSIN; SYNTHASE; BINDING; SECTOR; NMR	A prerequisite for life is the ability to maintain electrochemical imbalances across biomembranes. In all eukaryotes the plasma membrane potential and secondary transport systems are energized by the activity of P- type ATPase membrane proteins: H+-ATPase ( the proton pump) in plants and fungi(1-3), and Na+, K+-ATPase ( the sodium - potassium pump) in animals(4). The name P- type derives from the fact that these proteins exploit a phosphorylated reaction cycle intermediate of ATP hydrolysis(5). The plasma membrane proton pumps belong to the type III P- type ATPase subfamily, whereas Na+, K+-ATPase and Ca(2+-)ATPase are type II6. Electron microscopy has revealed the overall shape of proton pumps(7), however, an atomic structure has been lacking. Here we present the first structure of a P- type proton pump determined by X- ray crystallography. Ten transmembrane helices and three cytoplasmic domains define the functional unit of ATP- coupled proton transport across the plasma membrane, and the structure is locked in a functional state not previously observed in P- type ATPases. The transmembrane domain reveals a large cavity, which is likely to be filled with water, located near the middle of the membrane plane where it is lined by conserved hydrophilic and charged residues. Proton transport against a high membrane potential is readily explained by this structural arrangement.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Univ Copenhagen, Dept Plant Biol, Plant Physiol & Anat Lab, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	palmgren@life.ku.dk; pn@mb.au.dk	Morth, Jens Preben/G-4450-2013; Pedersen, Bjørn/H-4128-2017; Morth, Jens Preben/AAP-7834-2021; Palmgren, Michael/A-9808-2013; Nissen, Poul/D-5774-2014; Pedersen, Bjørn/AAT-2409-2021	Morth, Jens Preben/0000-0003-4077-0192; Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Palmgren, Michael/0000-0002-9982-6114; Pedersen, Bjørn/0000-0001-7860-7230; Nissen, Poul/0000-0003-0948-6628				Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; AMORY A, 1982, J BIOL CHEM, V257, P2509; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; BRISKIN DP, 1991, PLANT PHYSIOL, V95, P242, DOI 10.1104/pp.95.1.242; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dutra MB, 1998, J BIOL CHEM, V273, P17411, DOI 10.1074/jbc.273.28.17411; ERASO P, 1994, J BIOL CHEM, V269, P10393; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944	39	283	298	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1111	U19		10.1038/nature06417	http://dx.doi.org/10.1038/nature06417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075595				2022-12-28	WOS:000251579900093
J	de Kroon, H				de Kroon, Hans			Ecology - How do roots interact?	SCIENCE			English	Editorial Material							PLANT; COMPETITION		Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	de Kroon, H (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	H.deKroon@science.ru.nl	de Kroon, Hans/B-3359-2009	de Kroon, Hans/0000-0001-6151-3561				Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; De Kroon H, 2003, ECOL STU AN, V168, P215; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Gersani M, 1998, EVOL ECOL, V12, P223, DOI 10.1023/A:1006587813950; Hess L, 2007, J ECOL, V95, P241, DOI 10.1111/j.1365-2745.2006.01204.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; Maina GG, 2002, PLANT ECOL, V160, P235, DOI 10.1023/A:1015822003011; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Turnbull LA, 2007, J ECOL, V95, P79, DOI 10.1111/j.1365-2745.2006.01184.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529	16	99	104	13	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1562	1563		10.1126/science.1150726	http://dx.doi.org/10.1126/science.1150726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063777				2022-12-28	WOS:000251421700024
J	De Pontieu, B; McIntosh, SW; Carlsson, M; Hansteen, VH; Tarbell, TD; Schrijver, CJ; Title, AM; Shine, RA; Tsuneta, S; Katsukawa, Y; Ichimoto, K; Suematsu, Y; Shimizu, T; Nagata, S				De Pontieu, B.; McIntosh, S. W.; Carlsson, M.; Hansteen, V. H.; Tarbell, T. D.; Schrijver, C. J.; Title, A. M.; Shine, R. A.; Tsuneta, S.; Katsukawa, Y.; Ichimoto, K.; Suematsu, Y.; Shimizu, T.; Nagata, S.			Chromospheric Alfvenic waves strong enough to power the solar wind	SCIENCE			English	Article							PARAMETRIC DECAY; ACCELERATION; ATMOSPHERE; SPICULES; DRIVEN; MODELS	Alfven waves have been invoked as a possible mechanism for the heating of the Sun's outer atmosphere, or corona, to millions of degrees and for the acceleration of the solar wind to hundreds of kilometers per second. However, Alfven waves of sufficient strength have not been unambiguously observed in the solar atmosphere. We used images of high temporal and spatial resolution obtained with the Solar Optical Telescope onboard the Japanese Hinode satellite to reveal that the chromosphere, the region sandwiched between the solar surface and the corona, is permeated by Alfven waves with strong amplitudes on the order of 10 to 25 kilometers per second and periods of 100 to 500 seconds. Estimates of the energy flux carried by these waves and comparisons with advanced radiative magnetohydrodynamic simulations indicate that such Alfven waves are energetic enough to accelerate the solar wind and possibly to heat the quiet corona.	Lockheed Martin Solar & Astrophys Lab, Org ADBS, 3251 Hanover St,Bldg 252, Palo Alto, CA 94304 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; Natl Astron Observ, Tokyo 1818588, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan	Lockheed Martin; National Center Atmospheric Research (NCAR) - USA; University of Oslo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Kyoto University; Kyoto University	De Pontieu, B (corresponding author), Lockheed Martin Solar & Astrophys Lab, Org ADBS, 3251 Hanover St,Bldg 252, Palo Alto, CA 94304 USA.	bdp@lmsal.com		Schrijver, Carolus/0000-0002-6010-8182; Shimizu, Toshifumi/0000-0003-4764-6856	STFC [PP/D002907/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Axford WI, 1999, SPACE SCI REV, V87, P25, DOI 10.1023/A:1005197529250; Beckers J. M., 1968, SOL PHYS, V3, P367, DOI DOI 10.1007/BF00171614; BELCHER JW, 1975, ASTROPHYS J, V200, P369, DOI 10.1086/153798; Cranmer SR, 1999, ASTROPHYS J, V518, P937, DOI 10.1086/307330; Cranmer SR, 2007, ASTROPHYS J SUPPL S, V171, P520, DOI 10.1086/518001; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; Del Zanna L, 2001, ASTRON ASTROPHYS, V367, P705, DOI 10.1051/0004-6361:20000455; Hansteen VH, 2005, ESA SP PUBL, V592, P483; HANSTEEN VH, 1995, J GEOPHYS RES-SPACE, V100, P21577, DOI 10.1029/95JA02300; Hansteen VH, 2007, ASTR SOC P, V368, P107; HOLLWEG JV, 1981, SOL PHYS, V70, P25, DOI 10.1007/BF00154391; HOLLWEG JV, 1982, SOL PHYS, V75, P35, DOI 10.1007/BF00153458; HOLLWEG JV, 1978, SOL PHYS, V56, P305, DOI 10.1007/BF00152474; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kudoh T, 1999, ASTROPHYS J, V514, P493, DOI 10.1086/306930; Matthaeus WH, 1999, ASTROPHYS J, V523, pL93, DOI 10.1086/312259; Pruneti F, 1997, ESA SP PUBL, V404, P623; Raouafi NE, 2007, ASTROPHYS J, V658, P643, DOI 10.1086/510286; Raouafi NE, 2003, ASTRON ASTROPHYS, V412, P271, DOI 10.1051/0004-6361:20031407; Suzuki TK, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011502; Tomczyk S, 2007, SCIENCE, V317, P1192, DOI 10.1126/science.1143304; Trujillo Bueno J, 2005, ASTROPHYS J, V619, pL191, DOI 10.1086/428124; TSUNETA S, SOL PHYS; Tu CY, 2001, J GEOPHYS RES-SPACE, V106, P8233, DOI 10.1029/2000JA000024; VEDINI A, 2007, ASTROPHYS J, V662, P669; VELLI M, 1993, ASTRON ASTROPHYS, V270, P304	26	646	648	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1574	1577		10.1126/science.1151747	http://dx.doi.org/10.1126/science.1151747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063784				2022-12-28	WOS:000251421700030
J	Douketis, JD; Gu, CS; Schulman, S; Ghirarduzzi, A; Pengo, V; Prandoni, P				Douketis, James D.; Gu, Chu Shu; Schulman, Sam; Ghirarduzzi, Angelo; Pengo, Vittorio; Prandoni, Paolo			The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; DURATION; WARFARIN; EPISODE; AUTOPSY	Background: The long-term risk for fatal pulmonary embolism ( PE) after treatment of venous thromboembolism (VTE) may be an important factor in the decision to discontinue this treatment. Objective: To provide reliable and precise estimates of the annual risk for fatal PE and the case-fatality rate of disease recurrence and to assess these outcomes according to the initial presentation of VTE (deep venous thrombosis [DVT], PE, or both) and its etiology (secondary or idiopathic) in patients who have discontinued anticoagulant therapy. Design: Prospective cohort study. Setting: Academic medical centers. Patients: Inception cohort of patients with a first episode of symptomatic VTE who discontinued anticoagulant therapy. Measurements: Incidence rates of any fatal PE (which included sudden death from possible fatal PE) and definite or probable PE per 100 person-years of follow-up and case-fatality rate of recurrent VTE. Results: Of 2052 patients studied, 1450 had DVT, 310 had PE, and 292 had DVT and PE. The mean duration of previous anticoagulant therapy was 6 months (range, 3 to 39 months), and the mean duration of follow-up after discontinuation of treatment was 54 months (range, 1 to 120 months). The annual risk for any fatal PE and definite or probable fatal PE after discontinuation of anticoagulation was 0.49 events (95% Cl, 0.36 to 0.64 events) per 100 person-years and 0.19 events (Cl, 0.12 to 0.30 events) per 100 person-years, respectively. The case-fatality rate of recurrent disease was 9.0% (Cl, 6.8% to 11.8%) for any fatal PE and 3.8% (Cl, 2.4% to 5.9%) for definite or probable fatal PE. Limitation: The findings are less pertinent to patients with active cancer, permanent immobility, or high-risk thrombophilia. Conclusion: The risk for fatal PE is 0.19 to 0.49 events per 100 person-years for patients who have finished a course of anticoagulant therapy for a first episode of symptomatic VTE. The casefatality rate for death from recurrent PE is 4% to 9%. This information helps to inform patient prognosis and may assist clinicians in deciding whether to discontinue anticoagulant therapy for VTE.	McMaster Univ, Hamilton, ON, Canada; Karolinska Univ Hosp, Stockholm, Sweden; Arcispedale Santa Maria Nouva, Reggio Emilia, Italy; Univ Padua, Padua, Italy	McMaster University; Karolinska Institutet; Karolinska University Hospital; IRCCS Arcispedale S. Maria Nuova; University of Padua	Douketis, JD (corresponding author), St Josephs Hosp, Rm F-544, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	jdouket@mcmaster.ca	Pengo, Vittorio/GSE-5972-2022; Pengo, Vittorio/AAV-9491-2020; Douketis, James/AAO-5659-2021; Schulman, Sam/I-7559-2019	Pengo, Vittorio/0000-0003-2064-6071; Pengo, Vittorio/0000-0003-2064-6071; Schulman, Sam/0000-0002-8512-9043				Aalten CM, 2006, NETH J MED, V64, P186; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Attems Johannes, 2004, Wien Med Wochenschr, V154, P159, DOI 10.1007/s10354-004-0057-0; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Douketis JD, 2006, ARCH INTERN MED, V166, P853, DOI 10.1001/archinte.166.8.853; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Douketis JD, 2000, ARCH INTERN MED, V160, P3431, DOI 10.1001/archinte.160.22.3431; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Janke RM, 2000, J CLIN EPIDEMIOL, V53, P103, DOI 10.1016/S0895-4356(99)00147-X; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Keeling D, 2006, BLOOD REV, V20, P173, DOI 10.1016/j.blre.2005.09.001; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Loughrey MB, 2000, ULSTER MED J, V69, P83; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piccioli A, 1996, AM HEART J, V132, P1010, DOI 10.1016/S0002-8703(96)90014-9; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	28	165	171	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					766	U36		10.7326/0003-4819-147-11-200712040-00007	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056660				2022-12-28	WOS:000251539100003
J	Amarenco, P; Steg, PG				Amarenco, Pierre; Steg, P. Gabriel			The paradox of cholesterol and stroke	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; PREVENTION; RISK; REDUCTION; STATINS		INSERM, U698, Paris, France; Univ Paris 07, Paris, France; Bichat Claude Bernard Univ Hosp, Dept Neurol, F-75018 Paris, France; Bichat Claude Bernard Univ Hosp, Stroke Ctr, F-75018 Paris, France; Bichat Claude Bernard Univ Hosp, Dept Cardiol, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Amarenco, P (corresponding author), INSERM, U698, Paris, France.	pierre.amarenco@bch.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019	STEG, Philippe Gabriel/0000-0001-6896-2941				Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2004, LANCET NEUROL, V3, P271, DOI 10.1016/S1474-4422(04)00734-3; Amarenco P, 2006, CIRCULATION, V114, P628; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Collins R, 2004, LANCET, V363, P757; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lin Mao-Shin, STROKE, V42, P2850, DOI [10.1161/STROKEAHA.111.613133, DOI 10.1161/STROKEAHA.120.032374, 10.1161/STROKEAHA.115.009643, DOI 10.1161/STROKEAHA.115.009643, 10.1161/STROKEAHA.108.537704, DOI 10.1161/STROKEAHA.107.493106]; Patel A, 2005, EUR HEART J, V26, P1910, DOI 10.1093/eurheartj/ehi407; Qizilbash N, 1995, LANCET, V346, P1647; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	16	23	25	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1803	1804		10.1016/S0140-6736(07)61751-6	http://dx.doi.org/10.1016/S0140-6736(07)61751-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061038				2022-12-28	WOS:000251588700004
J	Gallo, EM; Winslow, MM; Cante-Barrett, K; Radermacher, AN; Ho, L; McGinnis, L; Iritani, B; Neilson, JR; Crabtree, GR				Gallo, Elena M.; Winslow, Monte M.; Cante-Barrett, Kirsten; Radermacher, Amy N.; Ho, Lena; McGinnis, Lisa; Iritani, Brian; Neilson, Joel R.; Crabtree, Gerald R.			Calcineurin sets the bandwidth for discrimination of signals during thymocyte development	NATURE			English	Article							T-CELL DEVELOPMENT; POSITIVE SELECTION; NEGATIVE SELECTION; CD4+8+ THYMOCYTES; ALPHA-BETA; ACTIVATION; EXPRESSION; MATURATION; REQUIREMENT; TOLERANCE	At critical times in development, cells are able to convert graded signals into discrete developmental outcomes; however, the mechanisms involved are poorly understood. During thymocyte development, cell fate is determined by signals originating from the alpha beta T-cell receptor. Low-affinity/avidity interactions between the T-cell receptor and peptide-MHC complexes direct differentiation to the single-positive stage (positive selection), whereas high-affinity/avidity interactions induce death by apoptosis (negative selection)(1,2). Here we show that mice deficient in both calcineurin and nuclear factor of activated T cells (NFAT) c2/c3 lack a population of preselection thymocytes with enhanced ability to activate the mitogen-activated protein kinase (Raf-MEK-ERK) pathway, and fail to undergo positive selection. This defect can be partially rescued with constitutively active Raf, indicating that calcineurin controls MAPK signalling. Analysis of mice deficient in both Bim (which is required for negative selection) and calcineurin revealed that calcineurin-induced ERK (extracellular signal-regulated kinase) sensitization is required for differentiation in response to 'weak' positive selecting signals but not in response to 'strong' negative selecting signals (which normally induce apoptosis). These results indicate that early calcineurin/NFAT signalling produces a developmental period of ERK hypersensitivity, allowing very weak signals to induce positive selection. This mechanism might be generally useful in the discrimination of graded signals that induce different cell fates.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Neilson, Joel R./0000-0002-3408-608X; Iritani, Brian/0000-0003-1903-7850; Cante-Barrett, Kirsten/0000-0003-0418-8445; Ho, Lena/0000-0002-9358-621X	NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001445, T32AI007290, R01AI053568] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011060] Funding Source: NIH RePORTER; NCRR NIH HHS [K26 RR024462] Funding Source: Medline; NIAID NIH HHS [T32 AI007290, R01 AI053568] Funding Source: Medline; NIH HHS [K26 OD011060] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEVELT CN, 1993, J EXP MED, V178, P1867, DOI 10.1084/jem.178.6.1867; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PENIT C, 1986, J IMMUNOL, V137, P2115; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	28	45	45	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					731	U11		10.1038/nature06305	http://dx.doi.org/10.1038/nature06305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046413	Green Accepted			2022-12-28	WOS:000251209700056
J	Otero, R; Lukas, M; Kelly, REA; Xu, W; Laegsgaard, E; Stensgaard, I; Kantorovich, LN; Besenbacher, F				Otero, Roberto; Lukas, Maya; Kelly, Ross E. A.; Xu, Wei; Laegsgaard, Erik; Stensgaard, Ivan; Kantorovich, Lev N.; Besenbacher, Flemming			Elementary structural motifs in a random network of cytosine adsorbed on a gold(111) surface	SCIENCE			English	Article							ORGANIC-MOLECULES; METAL-SURFACES; SOLID-SURFACES; DNA BASES; MICROSCOPY; GUANINE	Nonsymmetrical organic molecules adsorbed on solid surfaces may assemble into random networks, thereby providing model systems for organic glasses that can be directly observed by scanning tunneling microscopy ( STM). We investigated the structure of a disordered cytosine network on a gold( 111) surface created by thermal quenching, to temperatures below 150 K, of the two- dimensional fluid present on the surface at room temperature. Comparison of STM images to density functional theory calculations allowed us to identify three elementary structural motifs ( zigzag filaments and five- and six- membered rings) that underlie the whole supramolecular random network. The identification of elementary structural motifs may provide a new framework for understanding medium- range order in amorphous and glassy systems.	[Otero, Roberto; Lukas, Maya; Xu, Wei; Laegsgaard, Erik; Stensgaard, Ivan; Besenbacher, Flemming] Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Otero, Roberto; Lukas, Maya; Xu, Wei; Laegsgaard, Erik; Stensgaard, Ivan; Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Kelly, Ross E. A.; Kantorovich, Lev N.] Kings Coll London, Sch Phys Sci & Engn, Dept Phys, London WC2R 2LS, England	Aarhus University; Aarhus University; University of London; King's College London	Besenbacher, F (corresponding author), Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.	fbe@inano.dk	Kelly, Ross/C-3283-2008; Martin, Roberto Otero/E-4516-2011; Besenbacher, Flemming/A-9623-2010; Kantorovich, Lev/Q-1203-2019; Xu, Wei/B-2570-2016	Martin, Roberto Otero/0000-0001-6936-4003; Kantorovich, Lev/0000-0001-9379-6834; Xu, Wei/0000-0003-0216-794X				Barth JV, 2007, ANNU REV PHYS CHEM, V58, P375, DOI 10.1146/annurev.physchem.56.092503.141259; Chen Q, 2003, NAT MATER, V2, P324, DOI 10.1038/nmat878; Furukawa M, 2001, J CHEM PHYS, V115, P3419, DOI 10.1063/1.1384551; Kelly REA, 2005, J PHYS CHEM B, V109, P22045, DOI 10.1021/jp055207z; MOSS SC, 1969, PHYS REV LETT, V23, P1167, DOI 10.1103/PhysRevLett.23.1167; Otero R, 2005, ANGEW CHEM INT EDIT, V44, P2270, DOI 10.1002/anie.200461586; Otero R, 2006, ANNU REV PHYS CHEM, V57, P497, DOI 10.1146/annurev.physchem.57.032905.104634; Perdigao LMA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.195423; Ramos MA, 1997, PHYS REV LETT, V78, P82, DOI 10.1103/PhysRevLett.78.82; Rosei F, 2003, PROG SURF SCI, V71, P95, DOI 10.1016/S0079-6816(03)00004-2; Schunack M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.156102; Schunack M, 2001, PHYS REV LETT, V86, P456, DOI 10.1103/PhysRevLett.86.456; TAO NJ, 1993, J PHYS CHEM-US, V97, P910, DOI 10.1021/j100106a017; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Zallen R., 2004, PHYS AMORPHOUS SOLID	16	147	148	4	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					312	315		10.1126/science.1150532	http://dx.doi.org/10.1126/science.1150532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18079368				2022-12-28	WOS:000252436200032
J	Ismail, S; Mulley, G				Ismail, Sadia; Mulley, Graham			Visiting times	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ismail, Sadia] Pinderfields Gen Hosp, Wakefield WF1 4DG, England; [Mulley, Graham] St James Univ Hosp, Leeds, W Yorkshire, England	Pinderfields Hospital; Saint James's University Hospital	Ismail, S (corresponding author), Pinderfields Gen Hosp, Wakefield WF1 4DG, England.	sadiaismail@doctors.org							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1316	1317		10.1136/bmj.39420.392373.BE	http://dx.doi.org/10.1136/bmj.39420.392373.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156246	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000252182700029
J	Jones, E; Palmer, I; Wessely, S				Jones, Edgar; Palmer, Ian; Wessely, Simon			Enduring beliefs about effects of gassing in war: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEMICAL WARFARE; GULF-WAR; NERVE; GAS	Objectives To discover the content of enduring beliefs held by first world war veterans about their experience of having been gassed. Design Collection and thematic analysis of written and reported statements from a sample of veterans about gassing. Subjects 103 veterans with a war pension. Results Twelve themes were identified, which were related to individual statements. The systemic nature of chemical weapons played a key part in ideas and beliefs about their capacity to cause enduring harm to health. Unlike shrapnel or a bullet that had a defined physical presence, gas had unseen effects within the body, while its capacity to cause damage was apparent from vesicant effects to skin and eyes. The terror inspired by chemical weapons also served to maintain memories of being gassed, while anti-gas measures were themselves disconcerting or a source of discomfort. Conclusions Chronic symptoms and work difficulties maintained beliefs about the potency of chemical weapons. In the period after the war, gas continued to inspire popular revulsion and was associated with a sense of unfairness.	[Jones, Edgar; Wessely, Simon] Inst Psychiat, London SE5 9RJ, England; [Jones, Edgar; Wessely, Simon] Weston Educ Ctr, Kings Ctr Mil Hlth Res, London SE5 9RJ, England; [Palmer, Ian] St Thomas Hosp, Med Assessment Programme, London SE1 7EH, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Jones, E (corresponding author), Inst Psychiat, London SE5 9RJ, England.	edgar.jones@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929; Jones, Edgar/0000-0002-4610-9584	Economic and Social Research Council [RES-000-23-1057] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Alexander DA, 2003, BRIT J PSYCHIAT, V183, P491, DOI 10.1192/bjp.183.6.491; Brewer NT, 2006, RISK ANAL, V26, P337, DOI 10.1111/j.1539-6924.2006.00750.x; Bullman T, 2000, ANN EPIDEMIOL, V10, P333, DOI 10.1016/S1047-2797(00)00060-0; Cook Tim, 2000, WAR SOC, V18, P47, DOI DOI 10.1179/072924700791201379; FULLERTON CS, 1990, MIL MED, V155, P54, DOI 10.1093/milmed/155.2.54; GILCHRIST HL, 1933, RESIDUAL EFFECTS WAR, V1; GILCHRIST HL, 1933, RESIDUAL EFRFECTS WA, V1; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Haber L.F., 1976, GAS WARFARE 1915 194, P10; HABER LF, 1955, POISONOUS CLOUD CHEM, pR3; JONES E, IN PRESS PSYCHOL MED; Lee H A, 2004, J R Army Med Corps, V150, P14; MEAKINS JC, 1918, CHANGES OBSERVED HEA; O'Brien L S, 1993, J R Army Med Corps, V139, P41; Ogawa Y, 2000, ACS SYM SER, V745, P333; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Prentiss A.M., 1937, CHEM WAR TREATISE CH, p[670, 680]; Riddle JR, 2003, MIL MED, V168, P606, DOI 10.1093/milmed/168.8.606; Roff S R, 2001, Med Confl Surviv, V17, P348, DOI 10.1080/13623690108409595; Stokes JW, 1997, MIL PSYCHOL, V9, P395, DOI 10.1207/s15327876mp0904_8; Stuart JA, 2003, J NERV MENT DIS, V191, P431, DOI 10.1097/01.NMD.0000081634.28356.6B; 1915, TIMES           0429, P9	22	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1313	1315		10.1136/bmj.39420.533461.25	http://dx.doi.org/10.1136/bmj.39420.533461.25			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156245	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000252182700027
J	Clayton, DD				Clayton, Donald D.			History of science - Hoyle's equation	SCIENCE			English	Editorial Material									Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	Clemson University	Clayton, DD (corresponding author), Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA.	cdonald@clemson.edu						BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CAMERON AGW, 1957, 41 CRL AT EN CAN LTD; Hoyle F., 1954, ASTROPHYS J SUPPL S, V1, P121, DOI 10.1086/190005; 2007, NUCL ASTROPHYSICS 19	4	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1876	1877		10.1126/science.1151167	http://dx.doi.org/10.1126/science.1151167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096793				2022-12-28	WOS:000251786600042
J	Berland, G				Berland, Gretchen			The view from the other side - Patients, doctors, and the power of a camera	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Berland, G (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.							Iezzoni LI, 2003, WALKING FAILS MOBILI; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Minkler M., 2003, COMMUNITY BASED PART; Pink S., 2021, DOING VISUAL ETHNOGR, V4th ed.	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2533	+		10.1056/NEJMp0706823	http://dx.doi.org/10.1056/NEJMp0706823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094371				2022-12-28	WOS:000251728900001
J	Dong, KC; Berger, JM				Dong, Ken C.; Berger, James M.			Structural basis for gate-DNA recognition and bending by type IIA topoisomerases	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI PRIMASE; CRYSTAL-STRUCTURE; 2-GATE MECHANISM; PROTEIN; GYRASE; TOPOLOGY; DOMAIN; TRANSPORT; COMPLEX	Type II topoisomerases disentangle DNA to facilitate chromosome segregation, and represent a major class of therapeutic targets. Although these enzymes have been studied extensively, a molecular understanding of DNA binding has been lacking. Here we present the structure of a complex between the DNA- binding and cleavage core of Saccharomyces cerevisiae Topo II ( also known as Top2) and a gate- DNA segment. The structure reveals that the enzyme enforces a 150 degrees DNA bend through a mechanism similar to that of remodelling proteins such as integration host factor. Large protein conformational changes accompany DNA deformation, creating a bipartite catalytic site that positions the DNA backbone near a reactive tyrosine and a coordinated magnesium ion. This configuration closely resembles the catalytic site of type IA topoisomerases, reinforcing an evolutionary link between these structurally and functionally distinct enzymes. Binding of DNA facilitates opening of an enzyme dimerization interface, providing visual evidence for a key step in DNA transport.	Univ Calif Berkeley, Div Biochem & Mol Biol, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Chem Biol Grad Program, Dept Chem, Coll Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Div Biochem & Mol Biol, Dept Mol & Cell Biol, Inst QB3, Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BERGER JM, 1995, THESIS HARVARD U; Buck GR, 2004, J MOL BIOL, V340, P933, DOI 10.1016/j.jmb.2004.05.034; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; GOTO T, 1984, J BIOL CHEM, V259, P422; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; HOOPER DC, 2003, QUINOLONE ANTIMICROB, pR14; HOWARD MT, 1991, J MOL BIOL, V217, P53, DOI 10.1016/0022-2836(91)90610-I; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P6402, DOI 10.1021/bi00394a015; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; ROCA J, 1993, J BIOL CHEM, V268, P14250; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; THOMSEN B, 1990, J MOL BIOL, V215, P237, DOI 10.1016/S0022-2836(05)80342-0; Trigueros S, 2004, J MOL BIOL, V335, P723, DOI 10.1016/j.jmb.2003.11.011; TSE YC, 1980, J BIOL CHEM, V255, P5560; Vologodskii AV, 2001, P NATL ACAD SCI USA, V98, P3045, DOI 10.1073/pnas.061029098; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2000, NUCLEIC ACIDS RES, V28, P4815, DOI 10.1093/nar/28.24.4815; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	50	218	226	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1201	U4		10.1038/nature06396	http://dx.doi.org/10.1038/nature06396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097402				2022-12-28	WOS:000251786200043
J							USPSTF	Screening for carotid artery stenosis: US preventive services task force recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article							MULTISTATE UTILIZATION; DUPLEX ULTRASOUND; ENDARTERECTOMY; OUTCOMES; APPROPRIATENESS	Description: Update of the 1996 U.S. Preventive Services Task Force statement about screening for asymptomatic carotid artery stenosis (CAS) in the general population. Methods: The U.S. Preventive Services Task Force examined the evidence on the natural history of CAS; systematic reviews of the accuracy of screening tests; observational studies of the harms of screening and treatment of asymptomatic CAS; and randomized, controlled trials of the benefits of treatment for CAS with carotid endarterectomy. Recommendation: Do not screen for asymptomatic CAS in the general adult population. (Grade D recommendation).	Agcy Healthcare Res & Quality, Rockville, MD USA		Agcy Healthcare Res & Quality, Rockville, MD USA.							Finsterer J, 2004, LANCET, V364, P1124, DOI 10.1016/S0140-6736(04)17092-X; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; GURESHI AI, 2007, J NEUROIMAGING, V17, P19; Halliday A, 2004, LANCET, V363, P1491; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; Hertzer NR, 2001, J VASC SURG, V33, P234; Horner RD, 2002, MED CARE, V40, P35; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kietselaer BLJH, 2004, LANCET, V364, P1124, DOI 10.1016/S0140-6736(04)17093-1; Kresowik TF, 2004, J VASC SURG, V39, P372, DOI 10.1016/j.jvs.2003.09.023; Kresowik TF, 2001, J VASC SURG, V33, P227, DOI 10.1067/mva.2001.111881; Kumar S, 2004, LANCET, V364, P1125, DOI 10.1016/S0140-6736(04)17094-3; Masuhr F, 2004, LANCET, V364, P1123, DOI 10.1016/S0140-6736(04)17091-8; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; ROCKVILLE MD, 1996, GUIDE CLIN PREVENTIV; Rothwell PM, 2004, LANCET, V364, P1122, DOI 10.1016/S0140-6736(04)17090-6; *SOC VASC SURG, 2007, SVS POS STAT VAS SCR; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WOLFF T, 2007, AHRQ PUBLICATION; Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006	21	59	61	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					854	859		10.7326/0003-4819-147-12-200712180-00005	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087056				2022-12-28	WOS:000251787600005
J	Huang, CH; Mandelker, D; Schmidt-Kittler, O; Samuels, Y; Velculescu, VE; Kinzler, KW; Vogelstein, B; Gabelli, SB; Amzel, LM				Huang, Chuan-Hsiang; Mandelker, Diana; Schmidt-Kittler, Oleg; Samuels, Yardena; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Gabelli, Sandra B.; Amzel, L. Mario			The structure of a human p110 alpha/p85 alpha complex elucidates the effects of oncogenic PI3K alpha mutations	SCIENCE			English	Article							CANCER-SPECIFIC MUTATIONS; PROTEIN-KINASE B; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR GENE; PHOSPHOINOSITIDE 3-KINASE; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; REGULATORY SUBUNIT	PIK3CA, one of the two most frequently mutated oncogenes in human tumors, codes for p110 alpha, the catalytic subunit of a phosphatidylinositol 3- kinase, isoform alpha ( PI3K alpha, p110 alpha/p85). Here, we report a 3.0 angstrom resolution structure of a complex between p110 alpha and a polypeptide containing the p110 alpha- binding domains of p85 alpha, a protein required for its enzymatic activity. The structure shows that many of the mutations occur at residues lying at the interfaces between p110 alpha and p85 alpha or between the kinase domain of p110 alpha and other domains within the catalytic subunit. Disruptions of these interactions are likely to affect the regulation of kinase activity by p85 or the catalytic activity of the enzyme, respectively. In addition to providing new insights about the structure of PI3K alpha, these results suggest specific mechanisms for the effect of oncogenic mutations in p110 alpha and p85 alpha.	Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; gabelli@jhmi.edu; mamzel@jhmi.edu	Gabelli, Sandra B/A-3705-2008; Velculescu, Victor/ABF-4846-2020	Gabelli, Sandra B/0000-0003-1205-5204; Velculescu, Victor/0000-0003-1195-438X; Huang, Chuan-Hsiang/0000-0001-9993-8004; Samuels, Yardena/0000-0002-3349-7266; Amzel, L. Mario/0000-0002-0129-9572	NCI NIH HHS [CA 43460] Funding Source: Medline; NIGMS NIH HHS [GM07309, GM066895, GM 07184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA043460, R01CA043460] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895, T32GM007184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Actor B, 2002, GENE CHROMOSOME CANC, V34, P416, DOI 10.1002/gcc.10087; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; END P, 1993, J BIOL CHEM, V268, P10066; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Philp AJ, 2001, CANCER RES, V61, P7426; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	58	419	444	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1744	1748		10.1126/science.1150799	http://dx.doi.org/10.1126/science.1150799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079394				2022-12-28	WOS:000251616800031
J	Phillips, AN; Leen, C; Wilson, A; Anderson, J; Dunn, D; Schwenk, A; Orkin, C; Hill, T; Fisher, M; Walsh, J; Pillay, D; Bansi, L; Gazzard, B; Easterbrook, P; Gilson, R; Johnson, M; Sabin, CA				Phillips, Andrew N.; Leen, Clifford; Wilson, Alan; Anderson, Jane; Dunn, David; Schwenk, Achim; Orkin, Chloe; Hill, Teresa; Fisher, Martin; Walsh, John; Pillay, Deenan; Bansi, Loveleen; Gazzard, Brian; Easterbrook, Philippa; Gilson, Richard; Johnson, Margaret; Sabin, Caroline A.		UK Collaborative HIV Cohort Study	Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study	LANCET			English	Article							ADHERENCE; RESISTANCE; EFFICACY; INDIVIDUALS; PREDICTORS; PROTEASE	Background The long-term durability of viral-load suppression provided by the three original antiretroviral drugs is not well characterised. We estimated the proportion of patients who had extensive triple-class failure during long-term follow-up and examined characteristics associated with an increased rate of failure. Methods 7916 patients who started antiretroviral therapy with three or more drugs were followed up from the time that therapy started until the last viral-load measure. Extensive triple-class virological failure was defined by failure of three subclasses of nucleoside reverse transcriptase inhibitors, a non-nucleoside reverse transcriptase inhibitor, and a ritonavir-boosted protease inhibitor. Findings 167 patients developed extensive triple-class failure during 27 441 person-years of follow-up. The Kaplan-Meier estimate for the cumulative risk of extensive triple-class failure was 9.2% by 10 years (95% CI 5.0-13.4). There was evidence that this rate has decreased over time (adjusted hazard ratio 0 . 86 [0.77-0.96] per year more recent; p=0 . 006). Of the 167 patients with extensive triple-class failure, 101 (60%) subsequently had at least one viral load less than 50 copies per mL. The risk of death by 5 years from the time of extensive triple-class failure was 10 . 6% (2 . 4-18.8, nine deaths). Interpretation We have shown that extensive virological failure of the three main classes of drugs occurs slowly in routine clinical practice. This finding has implications for the planning of treatment programmes in developing countries, where additional drugs outside these classes are unlikely to be available for some time.	UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Edinburgh, Western Gen Hosp, Edinburgh, Midlothian, Scotland; Homerton Hosp, London, England; MRC, Clin Trials Unit, London, England; N Middlesex Univ Hosp, London, England; Barts & London NHS Trust, London, England; Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; St Marys Hosp, London, England; Hlth Protect Agcy, Ctr Infect, RFUCMS, Dept Infect, London, England; Chelsea & Westminster NHS Trust, London, England; Kings Coll Hosp London, London, England; UCL Royal Free & Univ Coll Med Sch, Mortimer Market Ctr, London, England; UCL Royal Free NHS Trust, London, England	University of London; University College London; UCL Medical School; University of Edinburgh; Medical Research Council Clinical Trials Unit; Barts Health NHS Trust; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Imperial College London; Health Protection Agency; University of London; University College London; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; UCL Medical School; University of London; University College London	Phillips, AN (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Hampstead Campus,Rowland Hill St, London NW3 2PF, England.	a.phillips@pcps.ucl.ac.uk	Phillips, Andrew N/B-4427-2008; Easterbrook, Philippa J/A-3937-2009; Anderson, Jane/A-1632-2012; Sabin, Caroline/C-2464-2008; Gilson, Richard J C/C-5123-2009	Phillips, Andrew N/0000-0003-2384-4807; Anderson, Jane/0000-0001-5294-8707; Sabin, Caroline/0000-0001-5173-2760; Dunn, David/0000-0003-1836-4446; Easterbrook, Philippa/0000-0002-2603-5418; Leen, Clifford/0000-0001-8439-7719	MRC [G0600337, MC_U122886351, G0200585] Funding Source: UKRI; Medical Research Council [MC_U122886351, G0200585, G0600337] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; COOPER D, 2007, 14 C RETR OPP INF FE; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lohse N, 2005, AIDS, V19, P815, DOI 10.1097/01.aids.0000168976.51843.9f; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; NELSON M, 2007, 14 C RETR OPP INF FE; Sabin C, 2004, HIV MED, V5, P115; Sabin CA, 2005, BMJ-BRIT MED J, V330, P695, DOI 10.1136/bmj.38369.669850.8F	18	53	57	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1923	1928		10.1016/S0140-6736(07)61815-7	http://dx.doi.org/10.1016/S0140-6736(07)61815-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068516				2022-12-28	WOS:000251517600030
J	Stremlau, M				Stremlau, Matthew			GE prize-winning essay - Why old world monkeys are resistant to HIV-1	SCIENCE			English	Editorial Material							TRIM5-ALPHA RESTRICTION FACTOR; RETROVIRAL RESTRICTION; B30.2(SPRY) DOMAIN; INFECTION; PRIMATES; CAPSIDS; DEFENSE; AIDS		US Dept State, US Global AIDS Coordinators Off, Washington, DC 20522 USA		Stremlau, M (corresponding author), US Dept State, US Global AIDS Coordinators Off, Washington, DC 20522 USA.	stremlauMH@state.gov	Liu, FL/D-1795-2009					ALTER HJ, 1984, SCIENCE, V226, P549, DOI 10.1126/science.6093251; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bieniasz PD, 2003, TRENDS MICROBIOL, V11, P286, DOI 10.1016/S0966-842X(03)00123-9; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343	16	8	9	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1565	1566		10.1126/science.1152905	http://dx.doi.org/10.1126/science.1152905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063779				2022-12-28	WOS:000251421700026
J	Papsin, BC; Gordon, KA				Papsin, Blake C.; Gordon, Karen A.			Cochlear implants for children with severe-to-profound hearing loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENTAL DECISION-MAKING; SPEECH-PERCEPTION; GJB2 CONNEXIN-26; SURGICAL COMPLICATIONS; BACTERIAL-MENINGITIS; LANGUAGE-SKILLS; DEAF-CHILDREN; BRAIN-STEM; AGE; MUTATIONS	A 4- month- old baby girl whose parents and 6- year- old brother have severe- to- profound sensorineural hearing loss is referred for consideration for cochlear implantation. Each of the baby's parents had previously received a cochlear implant in adulthood, and her older brother had received a cochlear implant at 18 months of age. The family uses oral communication in the English language. The baby had been diagnosed with sensorineural hearing loss during newborn screening, and she was fitted with bilateral hearing aids without clinically significant benefit. Bilateral profound sensorineural hearing loss, with pure- tone thresholds of 100 dB or higher, is confirmed and a homozygous mutation in the connexin 26 gene ( GJB2) is identified. It is recommended that the child undergo auditory- verbal therapy followed by implantation of a unilateral cochlear implant at 12 months of age.	Hosp Sick Children, Dept Otolaryngol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gordon, KA (corresponding author), Hosp Sick Children, Dept Otolaryngol, 555 Univ Ave,Rm 6D08, Toronto, ON M5G 1X8, Canada.	karen.gordon@utoronto.ca						Alexiades G, 2001, LARYNGOSCOPE, V111, P1608, DOI 10.1097/00005537-200109000-00022; [Anonymous], 2005, OTOL NEUROTOL, V26, P1097; Arnoldner C, 2005, ACTA OTO-LARYNGOL, V125, P228, DOI 10.1080/00016480410022895; Balkany T, 1996, OTOLARYNG HEAD NECK, V114, P748, DOI 10.1016/S0194-5998(96)70097-9; Barbi M, 2003, PEDIATR INFECT DIS J, V22, P39, DOI 10.1097/00006454-200301000-00012; Beadle EAR, 2005, OTOL NEUROTOL, V26, P1152, DOI 10.1097/01.mao.0000180483.16619.8f; Bhatia K, 2004, OTOL NEUROTOL, V25, P730, DOI 10.1097/00129492-200409000-00015; Biernath KR, 2006, PEDIATRICS, V117, P284, DOI 10.1542/peds.2005-0824; Brown Carolyn J, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P383, DOI 10.1097/00020840-200310000-00013; Buchman CA, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/00005537-200410001-00001; Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices, 2003, MMWR Morb Mortal Wkly Rep, V52, P739; COLLETTI V, 2006, 8 EUR S PED COCHL IM, P49; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Cote M, 2007, LARYNGOSCOPE, V117, P1225, DOI 10.1097/MLG.0b013e31805c9a06; Cushing SL, 2006, LARYNGOSCOPE, V116, P1787, DOI 10.1097/01.mlg.0000231303.85828.20; Dai P, 2007, GENET MED, V9, P283, DOI 10.1097/GIM.0b013e31804d2371; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Dettman SJ, 2007, EAR HEARING, V28, p11S, DOI 10.1097/AUD.0b013e31803153f8; Dutt SN, 2005, J LARYNGOL OTOL, V119, P759, DOI 10.1258/002221505774481291; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Fayad JN, 2006, LARYNGOSCOPE, V116, P1310, DOI 10.1097/01.mlg.0000227176.09500.28; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers AE, 2003, EAR HEARING, V24, p46S, DOI 10.1097/01.AUD.0000051689.57380.1B; Geers AE, 1997, OTOLARYNG HEAD NECK, V117, P150, DOI 10.1016/S0194-5998(97)70167-0; Geers Ann E, 2006, Adv Otorhinolaryngol, V64, P50, DOI 10.1159/000094644; Gordon KA, 2007, HEARING RES, V233, P97, DOI 10.1016/j.heares.2007.08.001; Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2004, EAR HEARING, V25, P447, DOI 10.1097/01.aud.0000146178.84065.b3; Gordon KA, 2007, NEUROREPORT, V18, P613, DOI 10.1097/WNR.0b013e3280b10c15; Gysin C, 2000, J OTOLARYNGOL, V29, P285; Hammes DM, 2002, ANN OTO RHINOL LARYN, V111, P74, DOI 10.1177/00034894021110S516; James AL, 2004, LARYNGOSCOPE, V114, P2191, DOI 10.1097/01.mlg.0000149456.75758.4c; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A., 2006, REPROGRAMMING CEREBR, P193; Kudo T, 2001, OTOL NEUROTOL, V22, P858, DOI 10.1097/00129492-200111000-00025; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Li YL, 2004, INT J PEDIATR OTORHI, V68, P1027, DOI 10.1016/j.ijporl.2004.03.010; Li YL, 2003, ARCH PEDIAT ADOL MED, V157, P162, DOI 10.1001/archpedi.157.2.162; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Mok M, 2007, AUDIOL NEURO-OTOL, V12, P295, DOI 10.1159/000103210; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; *NAD, COCHL IMPL NAD POS S; *NAT I DEAFN OTH C, STAT HEAR DIS EAR IN; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Olusanya BO, 2007, LANCET, V369, P1860; Olusanya BO, 2007, LANCET, V369, P1314, DOI 10.1016/S0140-6736(07)60602-3; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Parisier SC, 2001, LARYNGOSCOPE, V111, P26, DOI 10.1097/00005537-200101000-00005; Peters BR, 2007, OTOL NEUROTOL, V28, P649, DOI 10.1097/01.mao.0000281807.89938.60; PONTON CW, 2006, REPROGRAMMING CEREBR, P213; Postelmans JTF, 2007, J LARYNGOL OTOL, V121, P318, DOI 10.1017/S022215106003471; Propst EJ, 2006, INT J PEDIATR OTORHI, V70, P435, DOI 10.1016/j.ijporl.2005.07.013; RAPIN I, 1978, J OTOLARYNGOL, V7, P473; Reefhuis J, 2003, NEW ENGL J MED, V349, P435, DOI 10.1056/NEJMoa031101; Richter B, 2002, INT J PEDIATR OTORHI, V64, P111, DOI 10.1016/S0165-5876(02)00037-X; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Shahin H, 2002, HUM GENET, V110, P284, DOI 10.1007/s00439-001-0674-2; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Steinberg A, 2000, INT J PEDIATR OTORHI, V55, P99, DOI 10.1016/S0165-5876(00)00373-6; Tait M, 2007, INT J PEDIATR OTORHI, V71, P1605, DOI 10.1016/j.ijporl.2007.07.003; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; Tomblin JB, 1999, J SPEECH LANG HEAR R, V42, P497, DOI 10.1044/jslhr.4202.497; Tyler RS, 2007, EAR HEARING, V28, p86S, DOI 10.1097/AUD.0b013e31803153e2; Uziel AS, 2007, OTOL NEUROTOL, V28, P615, DOI 10.1097/01.mao.0000281802.59444.02; Wackym PA, 2007, EAR HEARING, V28, p80S, DOI 10.1097/AUD.0b013e3180315117; Waltzman SB, 2002, OTOLARYNG HEAD NECK, V126, P505, DOI 10.1067/mhn.2002.124472; Wang YC, 2002, EUR J HUM GENET, V10, P495, DOI 10.1038/sj.ejhg.5200838; Wolfe J, 2007, OTOL NEUROTOL, V28, P589, DOI 10.1097/MAO.0b013e318067bd24	71	74	77	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2380	2387		10.1056/NEJMct0706268	http://dx.doi.org/10.1056/NEJMct0706268			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057340				2022-12-28	WOS:000251389200008
J	Sharfstein, JM; North, M; Serwint, JR				Sharfstein, Joshua M.; North, Marisa; Serwint, Janet R.			Over the counter but no longer under the radar - Pediatric cough and cold medications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University								*CONS HEALTHC PROD, BRIEF INF FOOD DR; *FOOD DRUG ADM, 2007, NONPR DRUG ADV COMM, P29; Srinivasan A., 2007, Morbidity and Mortality Weekly Report, V56, P1	3	92	96	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2321	2324		10.1056/NEJMp0707400	http://dx.doi.org/10.1056/NEJMp0707400			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057333				2022-12-28	WOS:000251389200001
J	Williamson, IG; Rumsby, K; Benge, S; Moore, M; Smith, PW; Cross, M; Little, P				Williamson, Ian G.; Rumsby, Kate; Benge, Sarah; Moore, Michael; Smith, Peter W.; Cross, Martine; Little, Paul			Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; RESPIRATORY-TRACT INFECTION; GENERAL-PRACTICE; ACUTE RHINOSINUSITIS; DOUBLE-BLIND; PRIMARY-CARE; PRESCRIBING STRATEGIES; PHYSICAL-EXAMINATION; CLINICAL-TRIAL; PENICILLIN V	Context Acute sinusitis is a common clinical problem that usually results in a prescription for antibiotics but the role of antibiotics is debated. Anti-inflammatory drugs such as topical steroids may be beneficial but are underresearched. Objective To determine the effectiveness of amoxicillin and topical budesonide in acute maxillary sinusitis. Design, Setting, and Patients A double-blind, randomized, placebo-controlled factorial trial of 240 adults ( aged >= 16 years) with acute nonrecurrent sinusitis ( had >= 2 diagnostic criteria: purulent rhinorrhea with unilateral predominance, local pain with unilateral predominance, purulent rhinorrhea bilateral, presence of pus in the nasal cavity) at 58 family practices ( 74 family physicians) between November 2001 and November 2005. Patients were randomized to 1 of 4 treatment groups: antibiotic and nasal steroid; placebo antibiotic and nasal steroid; antibiotic and placebo nasal steroid; placebo antibiotic and placebo nasal steroid. Intervention A dose of 500 mg of amoxicillin 3 times per day for 7 days and 200 mu g of budesonide in each nostril once per day for 10 days. Main Outcome Measures Proportion clinically cured at day 10 using patient symptom diaries and the duration and severity of symptoms. Results The proportions of patients with symptoms lasting 10 or more days were 29 of 100 (29%) for amoxicillin vs 36 of 107 (33.6%) for no amoxicillin (adjusted odds ratio, 0.99;95% confidence interval, 0.57-1.73). The proportions of patients with symptoms lasting 10 or more days were 32 of 102 (31.4%) for topical budesonide vs 33 of 105 (31.4%) for no budesonide ( adjusted odds ratio, 0.93; 95% confidence interval, 0.54-1.62). Secondary analysis suggested that nasal steroids were significantly more effective in patients with less severe symptoms at baseline. Conclusion Neither an antibiotic nor a topical steroid alone or in combination was effective as a treatment for acute sinusitis in the primary care setting. Trial Registration isrctn. org Identifier: ISRCTN60825437.	Univ Southampton, Dept Med, Southampton SO1 65ST, Hants, England; Southampton Stat Sci Res Inst, Southampton, Hants, England; NightingaleSurg, Romsey, Hants, England	University of Southampton	Williamson, IG (corresponding author), Univ Southampton, Dept Med, Aldermoor Close, Southampton SO1 65ST, Hants, England.	igw@soton.ac.uk	Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509; Little, Paul/0000-0003-3664-1873; Smith, Peter/0000-0003-4423-5410; Rumsby, Kate/0000-0002-8573-3718				Ah-See KW, 2007, BMJ-BRIT MED J, V334, P358, DOI 10.1136/bmj.39092.679722.BE; Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Barlan IB, 1997, ANN ALLERG ASTHMA IM, V78, P598, DOI 10.1016/S1081-1206(10)63223-1; Benninger MS, 2000, OTOLARYNG HEAD NECK, V122, P1, DOI 10.1016/S0194-5998(00)70135-5; BERG O, 1988, ACTA OTO-LARYNGOL, V105, P343, DOI 10.3109/00016488809097017; Bucher HC, 2003, ARCH INTERN MED, V163, P1793, DOI 10.1001/archinte.163.15.1793; DAY SJ, 1989, BMJ-BRIT MED J, V299, P663, DOI 10.1136/bmj.299.6700.663; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; De Sutter AI, 2002, J FAM PRACTICE, V51, P317; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; Dolor RJ, 2001, JAMA-J AM MED ASSOC, V286, P3097, DOI 10.1001/jama.286.24.3097; Engels EA, 2000, J CLIN EPIDEMIOL, V53, P852, DOI 10.1016/S0895-4356(00)00209-2; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; HANSEN JG, 1995, BRIT MED J, V311, P233, DOI 10.1136/bmj.311.6999.233; Hansen JG, 2000, SCAND J PRIM HEALTH, V18, P44; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; Hueston WJ, 1998, J FAM PRACTICE, V46, P487; KENNEDY DW, 1995, ANN OTO RHINOL LARYN, V104, P22; LAU J, 1999, 9 AG HEALTHC RES QUA; Lindbaek M, 1996, Fam Med, V28, P183; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Low DE, 1997, CAN MED ASSOC J, V156, pS1; Lund VJ, 1997, BRIT J HOSP MED, V57, P308; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V116, P1289, DOI 10.1016/j.jaci.2005.08.044; Merenstein D, 2005, J FAM PRACTICE, V54, P144; Nayak AS, 2002, ANN ALLERG ASTHMA IM, V89, P271, DOI 10.1016/S1081-1206(10)61954-0; Norrelund N, 1978, Ugeskr Laeger, V140, P2792; Office of Population Censuses and Surveys, 1994, MORB STAT GEN PRACT; Osguthorpe JD, 1999, MED CLIN N AM, V83, P27, DOI 10.1016/S0025-7125(05)70085-7; PETO R, 1978, BIOMEDICINE, V28, P24; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; VANDUIJN NP, 1992, BRIT MED J, V305, P684, DOI 10.1136/bmj.305.6855.684; Varonen H, 2003, SCAND J PRIM HEALTH, V21, P121, DOI 10.1080/02813430310001743; Williams Jr JW, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000243; WILLIAMS JW, 1993, JAMA-J AM MED ASSOC, V270, P1242, DOI 10.1001/jama.270.10.1242; WILLIAMS JW, 1992, ANN INTERN MED, V117, P705, DOI 10.7326/0003-4819-117-9-705; Williamson I, 2006, J FAM PRACTICE, V55, P789; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24; Zalmanovici A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub2	46	83	87	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2487	2496		10.1001/jama.298.21.2487	http://dx.doi.org/10.1001/jama.298.21.2487			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056902	Bronze			2022-12-28	WOS:000251361900014
J	Dandona, L; Dandona, R				Dandona, Lalit; Dandona, Rakhi			Drop of HIV estimate for India to less than half	LANCET			English	Editorial Material							SOUTH-INDIA; PREVALENCE; HIV/AIDS		George Inst Int Hlth India, Hyderabad 500033, Andhra Pradesh, India; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Dandona, L (corresponding author), George Inst Int Hlth India, Hyderabad 500033, Andhra Pradesh, India.	ldandona@george.org.in		Dandona, Rakhi/0000-0003-0926-788X				Alnwick D., 2007, BRINGING HIV PREVENT; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2004, NATL MED J INDIA, V17, P160; Dandona L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-308; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Gupte N, 2007, JAIDS-J ACQ IMM DEF, V45, P570, DOI 10.1097/QAI.0b013e3181161c8b; Halperin DT, 2004, LANCET, V364, P1035, DOI 10.1016/S0140-6736(04)17054-2; *JOINT UN PROGR HI, 2006, 2006 REP GLOB AIDS E; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; *NAT FAM HLTH SURV, HIV PREV; *UNAIDS, Q A IND REV AIDS EST; *UNAIDS WHO, 2007, AIDS EP UPD; 2007, NEWS POST INDIA 0706	13	28	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1811	1813		10.1016/S0140-6736(07)61756-5	http://dx.doi.org/10.1016/S0140-6736(07)61756-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061043				2022-12-28	WOS:000251588700009
J	Lohmander, LS; Roos, EM				Lohmander, L. Stefan; Roos, Ewa M.			Clinical update: treating osteoarthritis	LANCET			English	Editorial Material							EVIDENCE BASED RECOMMENDATIONS; EULAR-STANDING-COMMITTEE; TASK-FORCE; KNEE OSTEOARTHRITIS; MANAGEMENT; COMBINATION; RISK		[Lohmander, L. Stefan; Roos, Ewa M.] Lund Univ, Clin Sci Lund, Dept Orthopaed, SE-22185 Lund, Sweden; [Roos, Ewa M.] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	Lund University; University of Southern Denmark	Lohmander, LS (corresponding author), Lund Univ, Clin Sci Lund, Dept Orthopaed, SE-22185 Lund, Sweden.	stefan.lohmander@med.lu.se	Lohmander, Stefan/I-8326-2012; Lohmander, Stefan/AAL-8314-2021; Roos, Ewa M/A-5416-2012	Lohmander, Stefan/0000-0002-5424-9448; Roos, Ewa M/0000-0001-5425-2199				Brouwer RW, 2005, COCHRANE DB SYST REV, V1; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Fransen M, 2003, COCHRANE DB SYST REV, V3; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; MCGETTIGAN P, 2006, JAMA-J AM MED ASSOC, V296, P1653; Mikesky AE, 2006, ARTHRIT RHEUM-ARTHR, V55, P690, DOI 10.1002/art.22245; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Roddy E, 2006, BEST PRACT RES CL RH, V20, P81, DOI 10.1016/j.berh.2005.09.006; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Turner AP, 2007, ARTHRIT RHEUM-ARTHR, V57, P267, DOI 10.1002/art.22537; *UK NAT I HLTH CLI, 2007, OST DRAFT GUID CONS; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886	20	77	87	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2082	2084		10.1016/S0140-6736(07)61879-0	http://dx.doi.org/10.1016/S0140-6736(07)61879-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156017				2022-12-28	WOS:000252058600010
J	Nebel, CE				Nebel, Christoph E.			Surface-conducting diamond	SCIENCE			English	Editorial Material							HYDROGEN-TERMINATED DIAMOND; MECHANISM; FILMS; LAYER		[Nebel, Christoph E.] Natl Inst Adv Ind Sci & Technol, Diamond Res Ctr, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Nebel, CE (corresponding author), Natl Inst Adv Ind Sci & Technol, Diamond Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	christoph.nebel@aist.go.jp						Chakrapani V, 2007, SCIENCE, V318, P1424, DOI 10.1126/science.1148841; EHRENREICH H, 1991, SOLID STATE PHYS, V45, pR9; GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550; LANDSTRASS MI, 1989, APPL PHYS LETT, V55, P975, DOI 10.1063/1.101694; Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472; Nebel CE, 2004, DIAM RELAT MATER, V13, P2031, DOI 10.1016/j.diamond.2004.06.028; Nebel CE, 2001, APPL PHYS LETT, V79, P4541, DOI 10.1063/1.1429756; Nebel CE, 2007, J PHYS D APPL PHYS, V40, P6443, DOI 10.1088/0022-3727/40/20/S21; Rezek B, 2007, SENSOR ACTUAT B-CHEM, V122, P596, DOI 10.1016/j.snb.2006.07.004; Rezek B, 2003, APPL PHYS LETT, V82, P2266, DOI 10.1063/1.1564293; Ristein J, 2004, J ELECTROCHEM SOC, V151, pE315, DOI 10.1149/1.1785797; Stutzmann M, 2006, PHYS STATUS SOLIDI A, V203, P3424, DOI 10.1002/pssa.200622512; Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779	13	71	72	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1391	+		10.1126/science.1151314	http://dx.doi.org/10.1126/science.1151314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048673				2022-12-28	WOS:000251246100027
J	Dessaud, E; Yang, LL; Hill, K; Cox, B; Ulloa, F; Ribeiro, A; Mynett, A; Novitch, BG; Briscoe, J				Dessaud, Eric; Yang, Lin Lin; Hill, Katy; Cox, Barny; Ulloa, Fausto; Ribeiro, Ana; Mynett, Anita; Novitch, Bennett G.; Briscoe, James			Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism	NATURE			English	Article							PROGENITOR-CELL IDENTITY; VENTRAL NEURAL-TUBE; NEURONAL FATE; FLOOR PLATE; TRANSDUCTION; SPECIFICATION; INDUCTION; GENE; PATHWAY; PATTERN	Morphogens act in developing tissues to control the spatial arrangement of cellular differentiation(1,2). The activity of a morphogen has generally been viewed as a concentration-dependent response to a diffusible signal, but the duration of morphogen signalling can also affect cellular responses(3). One such example is the morphogen sonic hedgehog (SHH). In the vertebrate central nervous system and limbs, the pattern of cellular differentiation is controlled by both the amount and the time of SHH exposure(4-7). How these two parameters are interpreted at a cellular level has been unclear. Here we provide evidence that changing the concentration or duration of SHH has an equivalent effect on intracellular signalling. Chick neural cells convert different concentrations of SHH into time-limited periods of signal transduction, such that signal duration is proportional to SHH concentration. This depends on the gradual desensitization of cells to ongoing SHH exposure, mediated by the SHH-dependent upregulation of patched 1 (PTC1), a ligand-binding inhibitor of SHH signalling(8). Thus, in addition to its role in shaping the SHH gradient(8-10), PTC1 participates cell autonomously in gradient sensing. Together, the data reveal a novel strategy for morphogen interpretation, in which the temporal adaptation of cells to a morphogen integrates the concentration and duration of a signal to control differential gene expression.	Natl Inst Med Res, London NW7 1AA, England; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	MRC National Institute for Medical Research; University of Michigan System; University of Michigan	Briscoe, J (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	james.briscoe@nimr.mrc.ac.uk	Ulloa, Fausto/AAB-2787-2019	Novitch, Bennett/0000-0002-2696-3708; Dessaud, Eric/0000-0001-9723-6658; Briscoe, James/0000-0002-1020-5240; Ribeiro, Ana/0000-0003-0132-9740	Medical Research Council [MC_U117560541] Funding Source: Medline; NINDS NIH HHS [R01 NS072804] Funding Source: Medline; MRC [MC_U117560541] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072804] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Bourillot PY, 2002, DEVELOPMENT, V129, P2167; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yang Y, 1997, DEVELOPMENT, V124, P4393	33	397	399	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					717	U7		10.1038/nature06347	http://dx.doi.org/10.1038/nature06347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046410	Green Published			2022-12-28	WOS:000251209700053
J	Graves, L; Stratton, G; Ridgers, ND; Cable, NT				Graves, Lee; Stratton, Gareth; Ridgers, N. D.; Cable, N. T.			Energy expenditure in adolescents playing new generation computer games	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To compare the energy expenditure of adolescents when playing sedentary and new generation active computer games. Design Cross sectional comparison of four computer games. Setting Research laboratories. Participants Six boys and five girls aged 13-15 years. Procedure Participants were fitted with a monitoring device validated to predict energy expenditure. They played four computer games for 15 minutes each. One of the games was sedentary (XBOX 360) and the otherthree were active (Wii Sports). Main outcome measure Predicted energy expenditure, compared using repeated measures analysis of variance. Results Mean (standard deviation) predicted energy expenditure when playing Wii Sports bowling (190.6 (22.2) kj/kg/min), tennis (202.5 (31.5) kj/kg/min), and boxing (198:1 (33.9) kj/kg/min) was significantly greater than when playing sedentary games (125.5 (13.7) kj/kg/min) (P<0.001). Predicted energy expenditure was at least 65.1 (95% confidence interval 47.3 to 82.9) kj/kg/min greater when playing active rather than sedentary games. Conclusions Playing new generation active computer games uses significantly more energy than playing sedentary computer games but not as much energy as playing the sport itself. The energy used when playing active Wii Sports games was not of high enough intensity to contribute towards the recommended daily amount of exercise in children.	[Graves, Lee; Stratton, Gareth; Ridgers, N. D.; Cable, N. T.] Liverpool John Moores Univ, Sport & Exercise Sci Res Inst, Liverpool L3 2ET, Merseyside, England	Liverpool John Moores University	Stratton, G (corresponding author), Liverpool John Moores Univ, Sport & Exercise Sci Res Inst, Henry Cotton Campus, Liverpool L3 2ET, Merseyside, England.	g.stratton@ljmu.ac.uk	Ridgers, Nicola/AGN-1339-2022; stratton, Gareth/Z-5471-2019; Ridgers, Nicola/B-2092-2013	stratton, Gareth/0000-0001-5618-0803; Ridgers, Nicola/0000-0001-5713-3515; Graves, Lee/0000-0002-3323-313X; Cable, Nigel/0000-0003-3766-9835					0	176	178	2	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1282	1284		10.1136/bmj.39415.632951.80	http://dx.doi.org/10.1136/bmj.39415.632951.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156227	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700007
J	Stott, R				Stott, Robin			Climate change - 2057	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Medact, London N1 6HT, England		Stott, R (corresponding author), Medact, London N1 6HT, England.	stott@dircon.co.uk						Ferriman A, 2007, BRIT MED J, V334, P111, DOI 10.1136/bmj.39097.611806.DB; Sachs JD, 2005, SCI AM, V293, P56, DOI 10.1038/scientificamerican0905-56; Simmons M. R., 2005, TWILIGHT DESERT; [World Wildlife Fund Nature WWF], 2006, LIV PLAN REP 2006	4	0	0	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1318	1319		10.1136/bmj.39420.654583.25	http://dx.doi.org/10.1136/bmj.39420.654583.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156247	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252182700030
J	Berg, IA; Kockelkorn, D; Buckel, W; Fuchs, G				Berg, Ivan A.; Kockelkorn, Daniel; Buckel, Wolfgang; Fuchs, Georg			A 3-hydroxypropionate/4-hydroxybutyrate autotrophic carbon dioxide assimilation pathway in archaea	SCIENCE			English	Article							CO2 FIXATION PATHWAY; CHLOROFLEXUS-AURANTIACUS; GEN-NOV; CYCLE; CARBOXYLASE; COENZYME; METALLOSPHAERA; FERMENTATION; CATALYSIS	The assimilation of carbon dioxide (CO2) into organic material is quantitatively the most important biosynthetic process. We discovered that an autotrophic member of the archaeal order Sulfolobales, Metallosphaera sedula, fixed CO2 with acetyl- coenzyme A ( acetyl- CoA)/propionyl- CoA carboxylase as the key carboxylating enzyme. In this system, one acetyl-CoA and two bicarbonate molecules were reductively converted via 3- hydroxypropionate to succinyl- CoA. This intermediate was reduced to 4-hydroxybutyrate and converted into two acetyl- CoA molecules via 4-hydroxybutyryl-CoA dehydratase. The key genes of this pathway were found not only in Metallosphaera but also in Sulfolobus, Archaeoglobus, and Cenarchaeum species. Moreover, the Global Ocean Sampling database contains half as many 4-hydroxybutyryl-CoA dehydratase sequences as compared with those found for another key photosynthetic CO2-fixing enzyme, ribulose-1,5-bisphosphate carboxylase-oxygenase. This indicates the importance of this enzyme in global carbon cycling.	Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Marburg, Fachbereich Biol, D-35032 Marburg, Germany	University of Freiburg; Philipps University Marburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020	Berg, Ivan/0000-0002-1864-4969				Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Burton NP, 1999, ARCH MICROBIOL, V172, P349, DOI 10.1007/s002030050771; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; HOLO H, 1989, ARCH MICROBIOL, V151, P252, DOI 10.1007/BF00413138; Hu YJ, 2006, J BACTERIOL, V188, P4350, DOI 10.1128/JB.00138-06; Huber H., 2001, BERGEYS MANUAL SYSTE, V1, P198; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Ishii M, 1996, ARCH MICROBIOL, V166, P368, DOI 10.1007/BF01682981; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; KANDLER O, 1981, ZBL BAKT MIK HYG I C, V2, P111, DOI 10.1016/S0721-9571(81)80034-8; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Naser U, 2005, BIOORG CHEM, V33, P53, DOI 10.1016/j.bioorg.2004.09.001; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHERF U, 1994, ARCH MICROBIOL, V161, P239, DOI 10.1007/BF00248699; STETTER KO, 1988, SYST APPL MICROBIOL, V10, P172, DOI 10.1016/S0723-2020(88)80032-8; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	31	386	479	17	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1782	1786		10.1126/science.1149976	http://dx.doi.org/10.1126/science.1149976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079405				2022-12-28	WOS:000251616800044
J	Roan, NR; Greene, WC				Roan, Nadia R.; Greene, Warner C.			A seminal finding for understanding HIV transmission	CELL			English	Editorial Material							INFECTION; PLASMA	Although the worldwide incidence of HIV infection is high, the retrovirus displays a surprisingly low infectivity in vitro. As a potential explanation for this discrepancy, Munch et al. (2007) now identify and characterize a factor found in human semen that under certain conditions can enhance HIV infectivity by more than 100,000-fold.	[Roan, Nadia R.; Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Roan, NR (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	nroan@gladstone.ucsf.edu; wgreene@gladstone.ucsf.edu						DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Fung KYC, 2004, PROSTATE, V61, P171, DOI 10.1002/pros.20089; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; MUNCH J, 2007, CELL; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Pomerantz RJ, 2003, NATURE, V424, P136, DOI 10.1038/424136a; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Starita-Geribaldi M, 2001, MOL HUM REPROD, V7, P715, DOI 10.1093/molehr/7.8.715; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; *UNAIDS, 2007, JOINT UN PROGR HIV A; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200	11	20	23	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1044	1046		10.1016/j.cell.2007.11.030	http://dx.doi.org/10.1016/j.cell.2007.11.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083095	Bronze			2022-12-28	WOS:000252217100013
J	Luo, ZX				Luo, Zhe-Xi			Transformation and diversification in early mammal evolution	NATURE			English	Review							OSSIFIED MECKELS CARTILAGE; MIDDLE-EAR; DUAL ORIGIN; UPPER MOLAR; RADIATION; CONSTRAINTS; DIVERGENCE; MONOTREMES; PHYLOGENY; ANATOMY	Evolution of the earliest mammals shows successive episodes of diversification. Lineage- splitting in Mesozoic mammals is coupled with many independent evolutionary experiments and ecological specializations. Classic scenarios of mammalian morphological evolution tend to posit an orderly acquisition of key evolutionary innovations leading to adaptive diversification, but newly discovered fossils show that evolution of such key characters as the middle ear and the tribosphenic teeth is far more labile among Mesozoic mammals. Successive diversifications of Mesozoic mammal groups multiplied the opportunities for many dead- end lineages to iteratively evolve developmental homoplasies and convergent ecological specializations, parallel to those in modern mammal groups.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA		Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021					ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BEVER GS, 2005, SCIENCE, V309, pA1492, DOI DOI 10.1126/SCIENCE.1112248; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; CHOW M, 1982, Australian Mammalogy, V5, P127; Cifelli RL, 2001, J PALEONTOL, V75, P1214, DOI 10.1666/0022-3360(2001)075<1214:EMR>2.0.CO;2; Crompton A., 1971, EARLY MAMMALS, P65; Crompton A.W., 1972, P231; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; de Muizon Christian, 1998, Geodiversitas, V20, P19; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; FILLER AG, 1986, THESIS HARVARD U; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hunter John P., 2006, Journal of Mammalian Evolution, V13, P89, DOI 10.1007/s10914-006-9006-6; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Lillegraven JA, 1979, MESOZOIC MAMMALS 1 2; Lopatin AV, 2006, SCIENCE, V313, P1092, DOI 10.1126/science.1128530; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; MAIER W, 1993, MAMMAL PHYLOGENY, P165; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; Martin T, 2006, SCIENCE, V311, P1109, DOI 10.1126/science.1124294; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; Martin T, 2005, SCIENCE, V307, P861, DOI 10.1126/science.1107202; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; MUSSER AM, 2006, THESIS U NEW S WALES; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; PATTERSON BRUAN, 1956, FIELDIANA GEOL, V13, P1; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rich TH, 2002, J VERTEBR PALEONTOL, V22, P466, DOI 10.1671/0272-4634(2002)022[0466:ETMAAA]2.0.CO;2; Rich Thomas H., 2001, Records of the Queen Victoria Museum, V110, P1; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 2005, SCIENCE, V309, DOI 10.1126/science.1111294; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sanchez-Villagra MR, 2002, J MORPHOL, V251, P219, DOI 10.1002/jmor.1085; Sidor CA, 2001, EVOLUTION, V55, P1419; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sigogneau-Russell D, 2003, ACTA PALAEONTOL POL, V48, P357; Sigogneau-Russell D, 2001, CR ACAD SCI II A, V333, P141, DOI 10.1016/S1251-8050(01)01612-3; Sigogneau-Russell D, 1998, CR ACAD SCI II A, V327, P571, DOI 10.1016/S1251-8050(99)80040-8; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Wang YQ, 1998, J VERTEBR PALEONTOL, V18, P777, DOI 10.1080/02724634.1998.10011106; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Woodburne Michael O., 2003, Journal of Mammalian Evolution, V10, P195, DOI 10.1023/B:JOMM.0000015104.29857.f0; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	98	368	382	9	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1011	1019		10.1038/nature06277	http://dx.doi.org/10.1038/nature06277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075580				2022-12-28	WOS:000251579900073
J	Ershova, I; Rider, O; Gorelov, V				Ershova, Irina; Rider, Olga; Gorelov, Vladimir			Polyclinics in London	LANCET			English	Editorial Material									Calderdale Royal Hosp, Halifax HX3 0PW, W Yorkshire, England; Royal Bournemouth Hosp, Bournemouth, Dorset, England		Gorelov, V (corresponding author), Calderdale Royal Hosp, Halifax HX3 0PW, W Yorkshire, England.	vgorelov@doctors.org.uk						BATTY D, 2007, GUARDIAN UNLIMI 0711; DARZI A, FRAMEWORK ACTION FUT; *MIN HLTH RUSS FED, 1992, GRAD TRANS PRIM CAR; Rese A, 2005, BMJ-BRIT MED J, V331, P204, DOI 10.1136/bmj.331.7510.204	4	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1890	1891		10.1016/S0140-6736(07)61793-0	http://dx.doi.org/10.1016/S0140-6736(07)61793-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068500				2022-12-28	WOS:000251517600010
J	Baker, JL; Olsen, LW; Sorensen, TIA				Baker, Jennifer L.; Olsen, Lina W.; Sorensen, Thorkild I. A.			Childhood body-mass index and the risk of coronary heart disease in adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSE-SPECIFIC MORTALITY; OBESITY EPIDEMIC; FOLLOW-UP; OVERWEIGHT CHILDREN; METABOLIC SYNDROME; CAROTID-ARTERY; BIRTH COHORT; GROWTH; ASSOCIATION; ADOLESCENTS	Background: The worldwide epidemic of childhood obesity is progressing at an alarming rate. Risk factors for coronary heart disease (CHD) are already identifiable in overweight children. The severity of the long-term effects of excess childhood weight on CHD, however, remains unknown. Methods: We investigated the association between body-mass index (BMI) in childhood (7 through 13 years of age) and CHD in adulthood (25 years of age or older), with and without adjustment for birth weight. The subjects were a cohort of 276,835 Danish schoolchildren for whom measurements of height and weight were available. CHD events were ascertained by linkage to national registers. Cox regression analyses were performed. Results: In 5,063,622 person-years of follow-up, 10,235 men and 4318 women for whom childhood BMI data were available received a diagnosis of CHD or died of CHD as adults. The risk of any CHD event, a nonfatal event, and a fatal event among adults was positively associated with BMI at 7 to 13 years of age for boys and 10 to 13 years of age for girls. The associations were linear for each age, and the risk increased across the entire BMI distribution. Furthermore, the risk increased as the age of the child increased. Adjustment for birth weight strengthened the results. Conclusions: Higher BMI during childhood is associated with an increased risk of CHD in adulthood. The associations are stronger in boys than in girls and increase with the age of the child in both sexes. Our findings suggest that as children are becoming heavier worldwide, greater numbers of them are at risk of having CHD in adulthood.	Ctr Hlth & Soc, Inst Prevent Med, DK-1357 Copenhagen, Denmark		Baker, JL (corresponding author), Ctr Hlth & Soc, Inst Prevent Med, Oster Sogade 18,1st Fl, DK-1357 Copenhagen, Denmark.		Baker, Jennifer L./AAH-4693-2020; Baker, Jennifer/F-1917-2010	Baker, Jennifer L./0000-0002-9649-6615; Baker, Jennifer/0000-0002-9649-6615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070491] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK070491-02, F32 DK070491, F32DK070491] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Ahlgren M, 2004, NEW ENGL J MED, V351, P1619, DOI 10.1056/NEJMoa040576; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; Barker D. J. P., 1994, MOTHERS BABIES DIS L; BARKER DJP, 1989, LANCET, V2, P577; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; DIPIETRO L, 1994, INT J OBESITY, V18, P585; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Juel K, 1999, DAN MED BULL, V46, P354; KUCZMARSKI RJ, 2000, DHHS PUBLICATION; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; MOSSBERG HO, 1989, LANCET, V2, P491; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; Pedersen CB, 2006, DAN MED BULL, V53, P441; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rossner S, 2002, INT J OBESITY, V26, pS2, DOI 10.1038/sj.ijo.0802209; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Sinha R, 2002, NEW ENGL J MED, V346, P1756; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; *STANB DENM, 2006, DANM STAT; Strand BH, 2007, AM J EPIDEMIOL, V165, P85, DOI 10.1093/aje/kwj352; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	42	1078	1125	1	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2329	2337		10.1056/NEJMoa072515	http://dx.doi.org/10.1056/NEJMoa072515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057335	Green Accepted			2022-12-28	WOS:000251389200003
J	Terada, K; Anand, M; Sokol, AK; Bischoff, A; Sano, Y				Terada, Kentaro; Anand, Mahesh; Sokol, Anna K.; Bischoff, Addi; Sano, Yuji			Cryptomare magmatism 4.35 Gyr ago recorded in lunar meteorite Kalahari 009	NATURE			English	Article							MARE-BASALT METEORITE; VOLCANISM; EVOLUTION; PETROGENESIS; GEOCHEMISTRY; STRATIGRAPHY	The origin and evolution of the Moon remain controversial(1,2), with one of the most important questions for lunar evolution being the timing and duration of basaltic ( mare) magmatism(1,3-8). Here we report the result of ion microprobe U - Pb dating of phosphates in a lunar meteorite, Kalahari 009, which is classified as a very- low- Ti mare- basalt breccia. In situ analyses of five phosphate grains, associated with basaltic clasts, give an age of 4.35+/-0.15 billion years. These ancient phosphate ages are thought to represent the crystallization ages of parental basalt magma, making Kalahari 009 one of the oldest known mare basalts. We suggest that mare basalt volcanism on the Moon started as early as 4.35 Gyr ago, relatively soon after its formation and differentiation, and preceding the bulk of lunar volcanism which ensued after the late heavy bombardment around 3.8- 3.9 Gyr ( refs 7 and 8). Considering the extremely low abundances of incompatible elements such as thorium and the rare earth elements in Kalahari 009 ( ref. 9) and recent remote- sensing observations illustrating that the cryptomaria tend to be of very- low- Ti basalt type(10-12), we conclude that Kalahari 009 is our first sample of a very- low- Ti cryptomare from the Moon.	Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; Open Univ, CEPSAR, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Inst Planetol, D-48149 Munster, Germany; Univ Tokyo, Ocean Res Inst, Ctr Adv Marine Res, Nakano Ku, Tokyo 1648639, Japan	Hiroshima University; Open University - UK; Natural History Museum London; University of Tokyo	Terada, K (corresponding author), Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan.	terada@sci.hiroshima-u.ac.jp; M.Anand@open.ac.uk	Terada, Kentaro/AAN-5930-2021; Sano, Yuji/B-8971-2015; Anand, Mahesh/E-9259-2013	Sano, Yuji/0000-0002-3305-5644; Anand, Mahesh/0000-0003-4026-4476; Terada, Kentaro/0000-0003-0120-1229				Anand M, 2006, GEOCHIM COSMOCHIM AC, V70, P246, DOI 10.1016/j.gca.2005.08.018; Anand M, 2003, GEOCHIM COSMOCHIM AC, V67, P3499, DOI 10.1016/S0016-7037(03)00134-0; ANTONENKO I, 1999, LUNAR PLANET SCI C, V30; DASCH EJ, 1987, GEOCHIM COSMOCHIM AC, V51, P3241, DOI 10.1016/0016-7037(87)90132-3; DICKINSON T, 1985, P LUNAR PLANET SCI C, V15, pC365; Elkins-Tanton LT, 2004, EARTH PLANET SC LETT, V222, P17, DOI 10.1016/j.epsl.2004.02.017; FERNANDES VA, 2007, LUNAR PLANET SCI C, V38; Giguere TA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002069; Gillis JJ, 2004, GEOCHIM COSMOCHIM AC, V68, P3791, DOI 10.1016/j.gca.2004.03.024; Hawke B.R., 1981, P LUNAR PLANET SCI, V12, P665; Hawke BR, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002383; HAWKE BR, 2005, LUNAR PLANET SCI C, V36; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; Hiesinger H, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001985; LEICH DA, 1975, MOON PLANETS, V14, P407, DOI 10.1007/BF00569674; LUDWIG KR, 2001, SPECIAL PUBLICATIO A, V1; NYQUIST LE, 2001, CENTURY SPACE SCI, P1325; Papike JJ, 1997, GEOCHIM COSMOCHIM AC, V61, P2343, DOI 10.1016/S0016-7037(97)00086-0; Sano Y, 1999, CHEM GEOL, V153, P249, DOI 10.1016/S0009-2541(98)00163-6; Schultz P.H., 1979, P LUNAR PLANET SCI C, P2899; SCHULTZ PH, 1983, NATURE, V302, P233, DOI 10.1038/302233a0; Schulz T, 2007, METEORIT PLANET SCI, V42, pA137; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Snyder G. A., 2000, ORIGIN EARTH MOON, p361 395; Sokol AK, 2005, METEORIT PLANET SCI, V40, pA177, DOI 10.1111/j.1945-5100.2005.tb00423.x; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; TAYLOR LA, 1983, EARTH PLANET SC LETT, V66, P33, DOI 10.1016/0012-821X(83)90124-3; Terada K, 2007, EARTH PLANET SC LETT, V259, P77, DOI 10.1016/j.epsl.2007.04.029; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	31	80	83	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					849	U14		10.1038/nature06356	http://dx.doi.org/10.1038/nature06356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064006				2022-12-28	WOS:000251394900049
J	Farag, N; Ship, A				Farag, Nadine; Ship, Amy			Update: An 81-year-old woman with temporal arteritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Shmerling RH, 2006, JAMA-J AM MED ASSOC, V295, P2525, DOI 10.1001/jama.295.21.2525	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2536	2536		10.1001/jama.298.21.2536	http://dx.doi.org/10.1001/jama.298.21.2536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056906				2022-12-28	WOS:000251361900019
J	Diamond, A; Barnett, WS; Thomas, J; Munro, S				Diamond, Adele; Barnett, W. Steven; Thomas, Jessica; Munro, Sarah			The early years - Preschool program improves cognitive control	SCIENCE			English	Editorial Material							CHILDREN; INHIBITION; CHILDHOOD; ABILITY; MEMORY; RISK		Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; Rutgers State Univ, Natl Inst Early Educ Res, New Brunswick, NJ 08903 USA	University of British Columbia; BC Childrens Hospital; University of British Columbia; Rutgers State University New Brunswick	Diamond, A (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	adele.diamond@ubc.ca	Barnett, William/GWU-7996-2022	Diamond, Adele/0000-0002-1453-6434	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019685] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARNETT WS, 2006, ED EFFECTIVENESS TOO; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bodrova E., 2012, APPROACHES EARLY CHI, V6th ed., P241; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Diamond A, 2005, PSYCHOL SCI, V16, P291, DOI 10.1111/j.0956-7976.2005.01530.x; Diamond A., 2006, LIFESPAN COGNITION M, P70, DOI [10.1093/acprof:oso/9780195169539.003.0006, DOI 10.1093/ACPROF:OSO/9780195169539.003.0006]; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Gathercole SE, 2005, J CHILD PSYCHOL PSYC, V46, P598, DOI 10.1111/j.1469-7610.2004.00379.x; Gilliam W. S., 2005, PREKINDERGARTNERS LE; Kerns KA, 1999, DEV NEUROPSYCHOL, V16, P273, DOI 10.1207/S15326942DN1602_9; LEWIN T, 2005, NY TIMES        0517, pA12; LURIA AR, 1965, READINGS PSYCHOL COG, P350; McClelland MM, 2000, EARLY CHILD RES Q, V15, P307, DOI 10.1016/S0885-2006(00)00069-7; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; O'Shaughnessy TE, 2003, REM SPEC EDUC, V24, P27, DOI 10.1177/074193250302400103; Rimm-Kaufman SE, 2000, EARLY CHILD RES Q, V15, P147, DOI 10.1016/S0885-2006(00)00049-1; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; SAIFER S, 2007, 17 ANN C EUR EARL CH; Vygotsky L.S, 1978, MIND SOC DEV HIGHER, DOI DOI 10.2307/J.CTVJF9VZ4.11; VYGOTSKY LS, 1967, SOV PSYCHOL-USSR, V5, P6, DOI 10.2753/RPO1061-040505036	25	1159	1182	12	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1387	1388		10.1126/science.1151148	http://dx.doi.org/10.1126/science.1151148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	235PF	18048670	Green Accepted			2022-12-28	WOS:000251246100024
J	Joyce, GF				Joyce, Gerald F.			Leslie Orgel (1927-2007) - Obituary	NATURE			English	Biographical-Item									Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu							0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					627	627		10.1038/450627a	http://dx.doi.org/10.1038/450627a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046392				2022-12-28	WOS:000251209700032
J	Sidow, A; Lacroute, P				Sidow, Arend; Lacroute, Philippe			Fruit fly family fun	CELL			English	Editorial Material							DROSOPHILA; EVOLUTION; GENOMES		[Sidow, Arend; Lacroute, Philippe] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sidow, Arend; Lacroute, Philippe] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Pathol, SUMC L235, Stanford, CA 94305 USA.	arend@stanford.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340	8	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1222	1223		10.1016/j.cell.2007.12.003	http://dx.doi.org/10.1016/j.cell.2007.12.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160030	Bronze			2022-12-28	WOS:000252217200009
J	McSharry, PE				McSharry, Patrick E.			Altitude and athletic performance: statististical analysis using football results	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To assess the effect of altitude on match results and physiological performance of a large and diverse population of professional athletes. Design Statistical analysis of international football (soccer) scores and results. Data resources FIFA extensive database of 1460 football matches in 10 countries spanning over 100 years. Results Altitude had a significant (P<0.001) negative impact on physiological performance as revealed through the overall underperformance of low altitude teams when playing against high altitude teams in South America. High altitude teams score more and concede fewer goals with increasing altitude difference. Each additional 1000 m of altitude difference increases the goal difference by about half of a goal. The probability of the home team winning for two teams from the same altitude is 0.537, whereas this rises to 0.825 for a home team with an altitude difference of 3695 m (such as Bolivia v Brazil) and falls to 0.213 when the altitude difference is -3695 m (such as Brazil v Bolivia). Conclusions Altitude provides a significant advantage for high altitude teams when playing international football games at both low and high altitudes. Lowland teams are unable to acclimatise to high altitude, reducing physiological performance. As physiological performance does not protect against the effect of altitude, better predictors of individual susceptibility to altitude illness would facilitate team selection.	Univ Oxford, Dept Engn Sci, Syst Anal Modelling & Predict Grp, Oxford OX1 3PJ, England	University of Oxford	McSharry, PE (corresponding author), Univ Oxford, Dept Engn Sci, Syst Anal Modelling & Predict Grp, Parks Rd, Oxford OX1 3PJ, England.	patrick@mcsharry.net	Rodríguez, Ferran A. A/H-4892-2011; MCSHARRY, PATRICK/AGJ-2462-2022	Rodríguez, Ferran A. A/0000-0002-2280-8962; 					0	28	30	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1278	1281		10.1136/bmj.39393.451516.AD	http://dx.doi.org/10.1136/bmj.39393.451516.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156225	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252182700005
J	Shuster, S				Shuster, Sam			Sex, aggression, and humour: responses to unicycling	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Buss D. M., 2003, EVOLUTION DESIRE STR; Darwin C., 1871, P475; MILLER G, 2001, MATING MIND	3	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1320	1322		10.1136/bmj.39414.552060.BE	http://dx.doi.org/10.1136/bmj.39414.552060.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	248UO	18156248	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000252182700032
J	Zhang, Q; Stelzer, AC; Fisher, CK; Al-Hashimi, HM				Zhang, Qi; Stelzer, Andrew C.; Fisher, Charles K.; Al-Hashimi, Hashim M.			Visualizing spatially correlated dynamics that directs RNA conformational transitions	NATURE			English	Article							RESIDUAL DIPOLAR COUPLINGS; HIV-1 TAR RNA; LIQUID-CRYSTALLINE PHASE; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; BACKBONE DYNAMICS; PROTEIN-STRUCTURE; RELAXATION; RECOGNITION; REVEALS	RNAs fold into three- dimensional ( 3D) structures that subsequently undergo large, functionally important, conformational transitions in response to a variety of cellular signals(1-3). RNA structures are believed to encode spatially tuned flexibility that can direct transitions along specific conformational pathways(4,5). However, this hypothesis has proved difficult to examine directly because atomic movements in complex biomolecules cannot be visualized in 3D by using current experimental methods. Here we report the successful implementation of a strategy using NMR that has allowed us to visualize, with complete 3D rotational sensitivity, the dynamics between two RNA helices that are linked by a functionally important trinucleotide bulge over timescales extending up to milliseconds. The key to our approach is to anchor NMR frames of reference onto each helix and thereby directly measure their dynamics, one relative to the other, using 'relativistic' sets of residual dipolar couplings ( RDCs)(6,7). Using this approach, we uncovered super- large amplitude helix motions that trace out a surprisingly structured and spatially correlated 3D dynamic trajectory. The two helices twist around their individual axes by approximately 536 and 1106 in a highly correlated manner ( R = 0.97) while simultaneously ( R = 0.81 - 0.92) bending by about 94 degrees. Remarkably, the 3D dynamic trajectory is dotted at various positions by seven distinct ligand- bound conformations of the RNA. Thus even partly unstructured RNAs can undergo structured dynamics that directs ligand- induced transitions along specific predefined conformational pathways.	Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Zhang, Qi/E-1722-2011; Zhang, Qi/B-5869-2014; Zhang, Qi/F-3323-2010	Zhang, Qi/0000-0003-1754-4058; 				AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Al-Hashimi HM, 2005, CHEMBIOCHEM, V6, P1506, DOI 10.1002/cbic.200500002; Al-Hashimi HM, 2002, J MOL BIOL, V315, P95, DOI 10.1006/jmbi.2001.5235; Bailor MH, 2007, NAT PROTOC, V2, P1536, DOI 10.1038/nprot.2007.221; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; Clore GM, 2004, BIOCHEMISTRY-US, V43, P10678, DOI 10.1021/bi049357w; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Du ZH, 2002, CHEM BIOL, V9, P707, DOI 10.1016/S1074-5521(02)00151-5; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Furtig B, 2007, BIOPOLYMERS, V86, P360, DOI 10.1002/bip.20761; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Meissner A, 1999, J MAGN RESON, V139, P439, DOI 10.1006/jmre.1999.1788; Micura R, 2003, CHEMBIOCHEM, V4, P984, DOI 10.1002/cbic.200300664; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Saenger W., 1984, PRINCIPLES NUCL ACID; SAUPE A, 1968, ANGEW CHEM INT EDIT, V7, P97, DOI 10.1002/anie.196800971; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; ZHANG Q, UNPUB NATURE METHODS; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	36	204	206	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1263	U14		10.1038/nature06389	http://dx.doi.org/10.1038/nature06389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097416	Green Published			2022-12-28	WOS:000251786200057
J	Friel, S; Chopra, M; Satcher, D				Friel, Sharon; Chopra, Mickey; Satcher, David			Unequal weight: equity oriented policy responses to the global obesity epidemic	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Commiss Social Determinants Hlth, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; MRC, Hlth Syst Res Unit, Cape Town, South Africa; Morehouse Sch Med, Ctr Excellence Hlth Dispar, Atlanta, GA 30310 USA	University of London; University College London; Morehouse School of Medicine	Friel, S (corresponding author), UCL, Commiss Social Determinants Hlth, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	s.friel@ucl.ac.uk		Friel, Sharon/0000-0002-8345-5435	National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER; NIMHD NIH HHS [U54 MD008173] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))			0	98	100	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1241	1243		10.1136/bmj.39377.622882.47	http://dx.doi.org/10.1136/bmj.39377.622882.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079548	Green Published			2022-12-28	WOS:000251832200033
J	Watson, R				Watson, Rory			Steps to a leaner Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material												RoryWatson@compuserve.com							0	10	10	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1238	1238		10.1136/bmj.39423.452106.AD	http://dx.doi.org/10.1136/bmj.39423.452106.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079545	Green Published			2022-12-28	WOS:000251832200030
J	Thauer, RK				Thauer, Rudolf K.			Microbiology - A fifth pathway of carbon fixation	SCIENCE			English	Editorial Material							CYCLE		Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society	Thauer, RK (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	thauer@mpi-marburg.mpg.de						Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; BUCHANAN BB, 1990, PHOTOSYNTH RES, V24, P47, DOI 10.1007/BF00032643; CALVIN M, 1961, NATURE, V192, P799; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Herter S, 2002, J BIOL CHEM, V277, P20277, DOI 10.1074/jbc.M201030200; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; RAGSDALE SW, 1991, CRIT REV BIOCHEM MOL, V26, P261, DOI 10.3109/10409239109114070; Wachtershauser G, 2007, CHEM BIODIVERS, V4, P584, DOI 10.1002/cbdv.200790052	9	88	141	9	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1732	1733		10.1126/science.1152209	http://dx.doi.org/10.1126/science.1152209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079388				2022-12-28	WOS:000251616800025
J	Vecchi, GA; Soden, BJ				Vecchi, Gabriel A.; Soden, Brian J.			Effect of remote sea surface temperature change on tropical cyclone potential intensity	NATURE			English	Article							ATLANTIC HURRICANE ACTIVITY; FREQUENCY VARIABILITY; MODEL; SENSITIVITY; RAINFALL; INCREASE; MAXIMUM; IMPACT	The response of tropical cyclone activity to global warming is widely debated(1-10). It is often assumed that warmer sea surface temperatures provide a more favourable environment for the development and intensification of tropical cyclones, but cyclone genesis and intensity are also affected by the vertical thermodynamic properties of the atmosphere(1,10-13). Here we use climate models and observational reconstructions to explore the relationship between changes in sea surface temperature and tropical cyclone 'potential intensity' - a measure that provides an upper bound on cyclone intensity(10-14) and can also reflect the likelihood of cyclone development(15,16). We find that changes in local sea surface temperature are inadequate for characterizing even the sign of changes in potential intensity, but that long- term changes in potential intensity are closely related to the regional structure of warming; regions that warm more than the tropical average are characterized by increased potential intensity, and vice versa. We use this relationship to reconstruct changes in potential intensity over the twentieth century from observational reconstructions of sea surface temperature. We find that, even though tropical Atlantic sea surface temperatures are currently at a historical high, Atlantic potential intensity probably peaked in the 1930s and 1950s, and recent values are near the historical average. Our results indicate that - per unit local sea surface temperature change - the response of tropical cyclone activity to natural climate variations, which tend to involve localized changes in sea surface temperature, may be larger than the response to the more uniform patterns of greenhouse- gas- induced warming.	NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami	Vecchi, GA (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA.	Gabriel.A.Vecchi@noaa.gov	Vecchi, Gabriel/A-2413-2008; Soden, Brian/ABC-3659-2021	Vecchi, Gabriel/0000-0002-5085-224X; Soden, Brian/0000-0001-9693-8236				[Anonymous], 1984, QUATERNARY RES, V21, P123, DOI 10.1016/0033-5894(84)90098-X; [Anonymous], 26 C HURR TROP MET A; Bister M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000776; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Camargo SJ, 2007, J CLIMATE, V20, P4819, DOI 10.1175/JCLI4282.1; Elsner JB, 2006, B AM METEOROL SOC, V87, P763, DOI 10.1175/BAMS-87-6-763; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2000, MON WEATHER REV, V128, P1139, DOI 10.1175/1520-0493(2000)128<1139:ASAOTC>2.0.CO;2; EMANUEL KA, IN PRESS J CLIM; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Gordon H. B., 2002, 60 CSIRO ATM RES; GUALDI S, 2006, CLARIS NEWS, V4, P7; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Knutson TR, 2007, B AM METEOROL SOC, V88, P1549, DOI 10.1175/BAMS-88-10-1549; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Latif M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027969; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Shen WX, 2000, J CLIMATE, V13, P109, DOI 10.1175/1520-0442(2000)013<0109:ASSOTT>2.0.CO;2; Smith TM, 2003, J CLIMATE, V16, P1495, DOI 10.1175/1520-0442-16.10.1495; Sobel AH, 2002, J CLIMATE, V15, P2702, DOI 10.1175/1520-0442(2002)015<2702:TESITT>2.0.CO;2; Tang BH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021072; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vecchi GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028905; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Vimont DJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029683; Wang CZ, 2006, J CLIMATE, V19, P3011, DOI 10.1175/JCLI3770.1; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	32	310	313	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1066	U9		10.1038/nature06423	http://dx.doi.org/10.1038/nature06423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075590				2022-12-28	WOS:000251579900083
J	Lewis, BA				Lewis, Beth A.			Should the internet be used to promote healthy living?	LANCET			English	Editorial Material							WEIGHT-LOSS; INTERVENTIONS; ADULTS		HealthPartners Res Fdn, Minneapolis, MN 55440 USA	HealthPartners Institute for Education & Research	Lewis, BA (corresponding author), HealthPartners Res Fdn, Minneapolis, MN 55440 USA.	beth.a.lewis@healthpartners.com						Cook RF, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e17; *EUR COMM, 2006, WEEK EUR JUN 16; Jeffery RW, 2004, AM J MANAG CARE, V10, P378; MADDEN M, 2004, INTERNET PENETRATION; Marcus BH, 2007, ARCH INTERN MED, V167, P944, DOI 10.1001/archinte.167.9.944; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Wilcox S, 2006, AM J PUBLIC HEALTH, V96, P1201, DOI 10.2105/AJPH.2005.074690	8	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1891	1892		10.1016/S0140-6736(07)61794-2	http://dx.doi.org/10.1016/S0140-6736(07)61794-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18068501				2022-12-28	WOS:000251517600011
J	Chamero, P; Marton, TF; Logan, DW; Flanagan, K; Cruz, JR; Saghatelian, A; Cravatt, BF; Stowers, L				Chamero, Pablo; Marton, Tobias F.; Logan, Darren W.; Flanagan, Kelly; Cruz, Jason R.; Saghatelian, Alan; Cravatt, Benjamin F.; Stowers, Lisa			Identification of protein pheromones that promote aggressive behaviour	NATURE			English	Article							MAJOR URINARY PROTEINS; MUTANT MICE; VOMERONASAL NEURONS; HOUSE MOUSE; SIGNALS; SYSTEM; GENES; TRP2	Mice use pheromones, compounds emitted and detected by members of the same species, as cues to regulate social behaviours such as pup suckling, aggression and mating(1). Neurons that detect pheromones are thought to reside in at least two separate organs within the nasal cavity: the vomeronasal organ (VNO) and the main olfactory epithelium (MOE)(2). Each pheromone ligand is thought to activate a dedicated subset of these sensory neurons. However, the nature of the pheromone cues and the identity of the responding neurons that regulate specific social behaviours are largely unknown. Here we show, by direct activation of sensory neurons and analysis of behaviour, that at least two chemically distinct ligands are sufficient to promote male-male aggression and stimulate VNO neurons. We have purified and analysed one of these classes of ligand and found its specific aggression-promoting activity to be dependent on the presence of the protein component of the major urinary protein (MUP) complex, which is known to comprise specialized lipocalin proteins bound to small organic molecules(1,3,4). Using calcium imaging of dissociated vomeronasal neurons (VNs), we have determined that the MUP protein activates a sensory neuron subfamily characterized by the expression of the G-protein G alpha(o) subunit ( also known as Gnao) and Vmn2r putative pheromone receptors (V2Rs). Genomic analysis indicates species-specific co-expansions of MUPs and V2Rs, as would be expected among pheromone-signalling components. Finally, we show that the aggressive behaviour induced by the MUPs occurs exclusively through VNO neuronal circuits. Our results substantiate the idea of MUP proteins as pheromone ligands that mediate male-male aggression through the accessory olfactory neural pathway.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92030 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92030 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Scripps Research Institute; Scripps Research Institute; Harvard University	Stowers, L (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92030 USA.	stowers@scripps.edu	Logan, Darren/D-5629-2009; Stowers, Lisa/K-6137-2015	Logan, Darren/0000-0003-1545-5510; Chamero, Pablo/0000-0002-4305-1073; Stowers, Lisa/0000-0002-4403-1269				BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Flower DR, 1996, BIOCHEM J, V318, P1; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; MUGFORD RA, 1970, NATURE, V226, P967, DOI 10.1038/226967a0; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Xia J, 2006, EUR J NEUROSCI, V24, P3333, DOI 10.1111/j.1460-9568.2006.05244.x	24	389	399	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					899	U23		10.1038/nature05997	http://dx.doi.org/10.1038/nature05997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064011				2022-12-28	WOS:000251394900060
J	Thase, ME				Thase, Michael E.			Molecules that mediate mood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thase, ME (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							Berton O, 2007, NEURON, V55, P289, DOI 10.1016/j.neuron.2007.06.033; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905	3	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2400	2402		10.1056/NEJMcibr0706377	http://dx.doi.org/10.1056/NEJMcibr0706377			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057345				2022-12-28	WOS:000251389200014
J	Tuffs, A				Tuffs, Annette			Medicine and the media - Thalidomide - the drama continues	BRITISH MEDICAL JOURNAL			English	Editorial Material												ATuffs@web.de						Tuffs A, 2007, BRIT MED J, V334, P933, DOI 10.1136/bmj.39199.637986.59	1	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1125	1125		10.1136/bmj.39409.445058.59	http://dx.doi.org/10.1136/bmj.39409.445058.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048538	Green Published			2022-12-28	WOS:000251596100030
J	Lockwood, CA; Menter, CG; Moggi-Cecchi, J; Keyser, AW				Lockwood, Charles A.; Menter, Colin G.; Moggi-Cecchi, Jacopo; Keyser, Andre W.			Extended male growth in a fossil hominin species	SCIENCE			English	Article							SEXUAL-DIMORPHISM; PRIMATES; DISPERSAL; EVOLUTION; BEHAVIOR; DRIMOLEN; SPHINX; SIZE	In primates that are highly sexually dimorphic, males often reach maturity later than females, and young adult males do not show the size, morphology, and coloration of mature males. Here we describe extended male development in a hominin species, Paranthropus robustus. Ranking a large sample of facial remains on the basis of dental wear stages reveals a difference in size and robusticity between young adult and old adult males. Combined with estimates of sexual dimorphism, this pattern suggests that male reproductive strategy focused on monopolizing groups of females, in a manner similar to that of silverback gorillas.	UCL, Dept Anthropol, London WC1E 6BT, England; Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; Univ Johannesburg, Dept Anthropol & Dev Studies, Johannesburg, South Africa; Univ Florence, Dipartimento Biol Anim & Genet, Lab Antropol, I-50122 Florence, Italy; Univ Florence, Museo Storia Nat, I-50122 Florence, Italy	University of London; University College London; University of Witwatersrand; University of Johannesburg; University of Florence; University of Florence	Lockwood, CA (corresponding author), UCL, Dept Anthropol, Gower St, London WC1E 6BT, England.	c.lockwood@ucl.ac.uk		MOGGI CECCHI, IACOPO/0000-0001-5055-8369				ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; Brain C, 1993, TRANSVAAL MUSEUM MON, P23; Brain C.K., 1981, HUNTERS HUNTED INTRO; Carlson KJ, 2003, J HUM EVOL, V44, P431, DOI 10.1016/S0047-2484(03)00025-3; COWLISHAW G, 1994, BEHAVIOUR, V131, P293, DOI 10.1163/156853994X00488; Dean M.C., 1988, P43; DEAN MC, 1981, FOLIA PRIMATOL, V36, P111, DOI 10.1159/000156011; FOLEY RA, 1989, SCIENCE, V243, P901, DOI 10.1126/science.2493158; Hillson S., 2005, TEETH; Janson Charles H., 1993, P57; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; Keyser AW, 2000, S AFR J SCI, V96, P193; Keyser AW, 2000, S AFR J SCI, V96, P189; LEIGH SR, 1995, AM J PHYS ANTHROPOL, V97, P339, DOI 10.1002/ajpa.1330970402; Lockwood CA, 1999, AM J PHYS ANTHROPOL, V108, P97, DOI 10.1002/(SICI)1096-8644(199901)108:1<97::AID-AJPA6>3.0.CO;2-O; MCHENRY HM, 1994, J HUM EVOL, V27, P77, DOI 10.1006/jhev.1994.1036; Pickering TR, 2004, AM J PHYS ANTHROPOL, V125, P1, DOI 10.1002/ajpa.10278; Plavcan JM, 2002, J HUM EVOL, V42, P579, DOI 10.1006/jhev.2001.0542; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Pusey A.E., 1987, P250; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Setchell JM, 2004, FOLIA PRIMATOL, V75, P121, DOI 10.1159/000078302; Setchell JM, 2006, AM J PHYS ANTHROPOL, V131, P498, DOI 10.1002/ajpa.20478; Setchell Joanna M., 2004, P175, DOI 10.1017/CBO9780511542459.012; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Vrba E.S., 1985, P195; Watts David P., 1993, P148; Wolpoff M.H., 1975, P245	32	74	79	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1443	1446		10.1126/science.1149211	http://dx.doi.org/10.1126/science.1149211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048687	Green Published			2022-12-28	WOS:000251246100043
J	O'Brien, JL				O'Brien, Jeremy L.			Physics - Precision without entanglement	SCIENCE			English	Editorial Material							STANDARD QUANTUM LIMIT; STATE		Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Bristol BS8 1UB, Avon, England; Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England	University of Bristol; University of Bristol	O'Brien, JL (corresponding author), Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Bristol BS8 1UB, Avon, England.	Jeremy.OBrien@bristol.ac.uk	O'Brien, Jeremy L/A-6290-2008	O'Brien, Jeremy/0000-0002-3576-8285				Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; de Burgh M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042301; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; KITAEV AY, 1996, ELECT COLL COMPUT CO; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Resch KJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.223601; Rudolph T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.217905; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552	12	7	7	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1393	1394		10.1126/science.1152581	http://dx.doi.org/10.1126/science.1152581			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048675				2022-12-28	WOS:000251246100029
J	Svedhem, H; Titov, DV; Taylor, FW; Witasse, O				Svedhem, Hakan; Titov, Dmitry V.; Taylor, Fredric W.; Witasse, Olivier			Venus as a more Earth-like planet	NATURE			English	Article							EXPRESS	Venus is Earth's near twin in mass and radius, and our nearest planetary neighbour, yet conditions there are very different in many respects. Its atmosphere, mostly composed of carbon dioxide, has a surface temperature and pressure far higher than those of Earth. Only traces of water are found, although it is likely that there was much more present in the past, possibly forming Earth-like oceans. Here we discuss how the first year of observations by Venus Express brings into focus the evolutionary paths by which the climates of two similar planets diverged from common beginnings to such extremes. These include a CO2-driven greenhouse effect, erosion of the atmosphere by solar particles and radiation, surface-atmosphere interactions, and atmospheric circulation regimes defined by differing planetary rotation rates.	European Space Agcy, Estec, NL-2200 AG Noordwijk, Netherlands; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Space Res Inst, IKI, Moscow 117997, Russia; Univ Oxford, Dept Atmospher Ocean & Planetary Phys, Oxford OX1 3PU, England	European Space Agency; Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Oxford	Svedhem, H (corresponding author), European Space Agcy, Estec, PB 299, NL-2200 AG Noordwijk, Netherlands.	h.svedhem@esa.int	Witasse, Olivier/AGL-7805-2022	Witasse, Olivier/0000-0003-3461-5604; Taylor, Fred/0000-0002-0675-9769				Baines KH, 2006, PLANET SPACE SCI, V54, P1263, DOI 10.1016/j.pss.2006.04.034; Gierasch P. J., 1997, VENUS 2 GEOLOGY GEOP, P459; Peralta J, 2007, ICARUS, V190, P469, DOI 10.1016/j.icarus.2007.03.028; Svedhem H, 2007, PLANET SPACE SCI, V55, P1636, DOI 10.1016/j.pss.2007.01.013; Taylor FW, 2006, PLANET SPACE SCI, V54, P1249, DOI 10.1016/j.pss.2006.04.031; Titov DV, 2006, PLANET SPACE SCI, V54, P1279, DOI 10.1016/j.pss.2006.04.017	6	68	71	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					629	632		10.1038/nature06432	http://dx.doi.org/10.1038/nature06432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046393				2022-12-28	WOS:000251209700033
J	Huber, D; Petreanu, L; Ghitani, N; Ranade, S; Hromadka, T; Mainen, Z; Svoboda, K				Huber, Daniel; Petreanu, Leopoldo; Ghitani, Nima; Ranade, Sachin; Hromadka, Tomas; Mainen, Zach; Svoboda, Karel			Sparse optical microstimulation in barrel cortex drives learned behaviour in freely moving mice	NATURE			English	Article							LIGHT-INDUCED ACTIVATION; ELECTRICAL-STIMULATION; NEURONS; CHANNELRHODOPSIN-2; PHOTOSTIMULATION; REPRESENTATION	Electrical microstimulation can establish causal links between the activity of groups of neurons and perceptual and cognitive functions(1-6). However, the number and identities of neurons microstimulated, as well as the number of action potentials evoked, are difficult to ascertain(7,8). To address these issues we introduced the light- gated algal channel channelrhodopsin- 2 (ChR2)(9) specifically into a small fraction of layer 2/3 neurons of the mouse primary somatosensory cortex. ChR2 photostimulation in vivo reliably generated stimulus- locked action potentials(10-13) at frequencies up to 50 Hz. Here we show that naive mice readily learned to detect brief trains of action potentials ( five light pulses, 1 ms, 20 Hz). After training, mice could detect a photostimulus firing a single action potential in approximately 300 neurons. Even fewer neurons ( approximately 60) were required for longer stimuli ( five action potentials, 250 ms). Our results show that perceptual decisions and learning can be driven by extremely brief epochs of cortical activity in a sparse subset of supragranular cortical pyramidal neurons.	[Huber, Daniel; Petreanu, Leopoldo; Ghitani, Nima; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Huber, Daniel; Petreanu, Leopoldo; Ranade, Sachin; Hromadka, Tomas; Mainen, Zach; Svoboda, Karel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Mainen, Zachary/0000-0001-7913-9109; Ranade, Sachin/0000-0002-5150-5776; Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Leal-Campanario R, 2006, P NATL ACAD SCI USA, V103, P10052, DOI 10.1073/pnas.0603584103; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Libet B, 1973, HDB SENSORY PHYSL, P743, DOI [10.1007/978-3-642-65438-1_20, DOI 10.1007/978-3-642-65438-1_20]; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	30	368	376	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					61	U7		10.1038/nature06445	http://dx.doi.org/10.1038/nature06445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18094685	Green Accepted			2022-12-28	WOS:000252079300033
J	Hunt, T; Bergsten, J; Levkanicova, Z; Papadopoulou, A; John, OS; Wild, R; Hammond, PM; Ahrens, D; Balke, M; Caterino, MS; Gomez-Zurita, J; Ribera, I; Barraclough, TG; Bocakova, M; Bocak, L; Vogler, AP				Hunt, Toby; Bergsten, Johannes; Levkanicova, Zuzana; Papadopoulou, Anna; John, Oliver St.; Wild, Ruth; Hammond, Peter M.; Ahrens, Dirk; Balke, Michael; Caterino, Michael S.; Gomez-Zurita, Jesus; Ribera, Ignacio; Barraclough, Timothy G.; Bocakova, Milada; Bocak, Ladislav; Vogler, Alfried P.			A comprehensive phylogeny of beetles reveals the evolutionary origins of a superradiation	SCIENCE			English	Article							COLEOPTERA; DIVERSITY	Beetles represent almost one- fourth of all described species, and knowledge about their relationships and evolution adds to our understanding of biodiversity. We performed a comprehensive phylogenetic analysis of Coleoptera inferred from three genes and nearly 1900 species, representing more than 80% of the world's recognized beetle families. We defined basal relationships in the Polyphaga supergroup, which contains over 300,000 species, and established five families as the earliest branching lineages. By dating the phylogeny, we found that the success of beetles is explained neither by exceptional net diversification rates nor by a predominant role of herbivory and the Cretaceous rise of angiosperms. Instead, the pre- Cretaceous origin of more than 100 present- day lineages suggests that beetle species richness is due to high survival of lineages and sustained diversification in a variety of niches.	Nat Hist Museum, Dept Entomol, London SW7 5BD, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Palacky Univ, Dept Zool, Fac Sci, Olomouc 77146, Czech Republic; Zool Staatssammlung Munchen, D-81247 Munich, Germany; Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; IBMB CSIC, Barcelona 08034, Spain; CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Biol Evolut, E-28006 Madrid, Spain; Palacky Univ, Dept Biol, Pedagog Fac, Olomouc 77140, Czech Republic	Natural History Museum London; Imperial College London; Palacky University Olomouc; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Palacky University Olomouc	Vogler, AP (corresponding author), Nat Hist Museum, Dept Entomol, Cromwell Rd, London SW7 5BD, England.	a.vogler@imperial.ac.uk	BOCAKOVA, Milada/D-5989-2018; Gomez-Zurita, Jesus/C-4248-2008; Ribera, Ignacio/K-2909-2017; Bocak, Ladislav/J-5989-2019; Ahrens, Dirk/AAR-1310-2021; Papadopoulou, Anna/K-5492-2014	BOCAKOVA, Milada/0000-0002-2507-0887; Gomez-Zurita, Jesus/0000-0001-7337-6541; Ribera, Ignacio/0000-0002-2791-7615; Papadopoulou, Anna/0000-0002-4656-4894; Barraclough, Timothy/0000-0002-8084-2640; Hunt, Toby/0000-0001-8377-0841	NERC [NE/E010962/1] Funding Source: UKRI; Natural Environment Research Council [NE/E010962/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Beutel R.G., 2005, COLEOPTERA BEETLES, V1; Caterino MS, 2005, MOL PHYLOGENET EVOL, V34, P655, DOI 10.1016/j.ympev.2004.11.012; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; CROWSON RA, 1955, NATURAL CLASSIFICATI; Crowson RA, 1981, BIOL COLEOPTERA; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Erwin TL, 1985, TAXONOMY PHYLOGENY Z, P437; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Ge SQ, 2007, SYST ENTOMOL, V32, P635, DOI 10.1111/j.1365-3113.2007.00392.x; GOULD SJ, 1996, DINOSAURS HAYSTACK, P377; Grimaldi David, 2005, pi; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; Lawrence J.F., 1995, P779; LAWRENCE JF, 1982, ANNU REV ECOL SYST, V13, P261, DOI 10.1146/annurev.es.13.110182.001401; Lawrence John F., 2001, Special Publication of the Japan Coleopterological Society, V1, P351; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; PAKALUK J, 1995, BIOL PHYLOGENY CLASS; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Slipinski Stanislaw A., 1991, P79; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Viviani VR, 2002, CELL MOL LIFE SCI, V59, P1833, DOI 10.1007/PL00012509; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]	24	684	732	12	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1913	1916		10.1126/science.1146954	http://dx.doi.org/10.1126/science.1146954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096805				2022-12-28	WOS:000251786600056
J	Gaal, P; Kuehn, W; Reimann, K; Woerner, M; Elsaesser, T; Hey, R				Gaal, P.; Kuehn, W.; Reimann, K.; Woerner, M.; Elsaesser, T.; Hey, R.			Internal motions of a quasiparticle governing its ultrafast nonlinear response	NATURE			English	Article							ELECTRIC-FIELD; POLARONS; PLASMA; SPACE; TRANSIENTS; AMPLITUDES	A charged particle modifies the structure of the surrounding medium: examples include a proton in ice(1), an ion in a DNA molecule(2), an electron at an interface(3), or an electron in an organic(4) or inorganic crystal(5-7). In turn, the medium acts back on the particle. In a polar or ionic solid, a free electron distorts the crystal lattice, displacing the atoms from their equilibrium positions. The electron, when considered together with its surrounding lattice distortion, is a single quasiparticle(5,6), known as the Frohlich polaron(8,9). The basic properties of polarons and their drift motion in a weak electric field are well known(10-12). However, their non-linear high- field properties - relevant for transport on nanometre length and ultrashort timescales - are not understood. Here we show that a high electric field in the terahertz range drives the polaron in a GaAs crystal into a highly nonlinear regime where, in addition to the drift motion, the electron is impulsively moved away from the centre of the surrounding lattice distortion. In this way, coherent lattice vibrations ( phonons) and concomitant drift velocity oscillations are induced that persist for several hundred femtoseconds. They modulate the optical response at infrared frequencies between absorption and stimulated emission. Such quantum coherent processes directly affect high- frequency transport in nanostructures and may be exploited in novel terahertz-driven optical modulators and switches.	Mas Born Inst Nichtlineare Opt & Kurzzeitspekt, D-12489 Berlin, Germany; Paul Drude Inst Festkorperelekt, D-10117 Berlin, Germany	Paul Drude Institute for Solid State Electronics	Woerner, M (corresponding author), Mas Born Inst Nichtlineare Opt & Kurzzeitspekt, D-12489 Berlin, Germany.	woerner@mbi-berlin.de	Elsaesser, Thomas/P-7608-2014; Reimann, Klaus/B-8824-2009; Gaal, Peter/M-7005-2017	Elsaesser, Thomas/0000-0003-3056-6665; Reimann, Klaus/0000-0003-4290-0659; Gaal, Peter/0000-0002-5429-0045				BANYAI L, 1993, PHYS REV LETT, V70, P1674, DOI 10.1103/PhysRevLett.70.1674; Barnett RN, 2001, SCIENCE, V294, P567, DOI 10.1126/science.1062864; Bartel T, 2005, OPT LETT, V30, P2805, DOI 10.1364/OL.30.002805; Bingham R, 2007, NATURE, V445, P721, DOI 10.1038/445721a; Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; Braun M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.248301; Cowin JP, 1999, NATURE, V398, P405, DOI 10.1038/18848; Faugeras C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107403; FROHLICH H, 1954, ADV PHYS, V3, P325, DOI 10.1080/00018735400101213; Gaal P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.187402; Hase M, 2003, NATURE, V426, P51, DOI 10.1038/nature02044; Hendry E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.081101; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; JANSSEN N, 1995, PHYS REV B, V52, P9406, DOI 10.1103/PhysRevB.52.9406; JENSEN JH, 1988, PHYS REV B, V38, P13387, DOI 10.1103/PhysRevB.38.13387; LEE TD, 1953, PHYS REV, V90, P297, DOI 10.1103/PhysRev.90.297; Li B, 2006, SCIENCE, V311, P1436, DOI 10.1126/science.1122190; MAGNUS W, 1993, PHYS REV B, V47, P1276, DOI 10.1103/PhysRevB.47.1276; Meinert G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.245203; PEETERS FM, 1985, PHYS REV B, V31, P4890, DOI 10.1103/PhysRevB.31.4890; Reimann K, 2003, OPT LETT, V28, P471, DOI 10.1364/OL.28.000471; Ronnow HM, 2006, NATURE, V440, P1025, DOI 10.1038/nature04650; SIGG H, 1985, PHYS REV B, V31, P5253, DOI 10.1103/PhysRevB.31.5253; Stroucken T, 1996, PHYS REV B, V53, P2026, DOI 10.1103/PhysRevB.53.2026; Wu Q, 1997, APPL PHYS LETT, V71, P1285, DOI 10.1063/1.119873; WU Q, 1995, APPL PHYS LETT, V67, P3523, DOI 10.1063/1.114909	26	110	111	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1210	1213		10.1038/nature06399	http://dx.doi.org/10.1038/nature06399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097404				2022-12-28	WOS:000251786200045
J	Bergmann, A				Bergmann, Andreas			Autophagy and cell death: No longer at odds	CELL			English	Editorial Material								Autophagy has been associated with both cell survival and cell death, but the role of autophagy in cell death has been controversial. In this issue, Berry and Baehrecke (2007) report that autophagy is involved in physiological cell death during Drosophila development and is controlled by similar mechanisms as those that control its function in cell survival.	Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bergmann, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd,Unit 1000, Houston, TX 77030 USA.	abergman@mdanderson.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068016, R01GM081543, R01GM074977] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM081543-01, GM081543, GM069016, R01 GM068016-05, R01 GM068016, GM074977, R01 GM074977-01A1, R01 GM081543, R01 GM074977] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; BERRY DL, 2007, CELL; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	10	71	77	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1032	1034		10.1016/j.cell.2007.11.027	http://dx.doi.org/10.1016/j.cell.2007.11.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083090	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000252217100008
J	Mak, TW				Mak, Tak Wah			Gene targeting in embryonic stem cells scores a knockout in Stockholm	CELL			English	Article							PLURIPOTENTIAL CELLS; MOUSE EMBRYOS; LINE		Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Mak, Tak Wah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Mak, Tak Wah] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Mak, TW (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca						Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Callaway E, 2007, NATURE, V448, P516, DOI 10.1038/448516a; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; PALMITER RD, 1985, CELL, V41, P343, DOI 10.1016/S0092-8674(85)80004-0; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; YU J, 2007, SCIENCE         1120, DOI DOI 10.1126/SCIENCE.1151526	13	43	47	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1027	1031		10.1016/j.cell.2007.11.033	http://dx.doi.org/10.1016/j.cell.2007.11.033			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083089	Bronze			2022-12-28	WOS:000252217100007
J	Yeoh, S; O'Donnell, RA; Koussis, K; Dluzewski, AR; Ansell, KH; Osborne, SA; Hackett, F; Withers-Martinez, C; Mitchell, GH; Bannister, LH; Bryans, JS; Kettleborough, CA; Blackman, MJ				Yeoh, Sharon; O'Donnell, Rebecca A.; Koussis, Konstantinos; Dluzewski, Anton R.; Ansell, Keith H.; Osborne, Simon A.; Hackett, Fiona; Withers-Martinez, Chrislaine; Mitchell, Graham H.; Bannister, Lawrence H.; Bryans, Justin S.; Kettleborough, Catherine A.; Blackman, Michael J.			Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes	CELL			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; PARASITOPHOROUS VACUOLE ANTIGEN; DENSE GRANULES; EGRESS; SERA; CELL; PROTEOLYSIS; INHIBITION; DOMAIN; STAGE	The most virulent form of malaria is caused by waves of replication of blood stages of the protozoan pathogen Plasmodium falciparum. The parasite divides within an intraerythrocytic parasitophorous vacuole until rupture of the vacuole and host-cell membranes releases merozoites that invade fresh erythrocytes to repeat the cycle. Despite the importance of merozoite egress for disease progression, none of the molecular factors involved are known. We report that, just prior to egress, an essential serine protease called PfSUB1 is discharged from previously unrecognized parasite organelles (termed exonemes) into the parasitophorous vacuole space. There, PfSUB1 mediates the proteolytic maturation of at least two essential members of another enzyme family called SERA. Pharmacological blockade of PfSUB1 inhibits egress and ablates the invasive capacity of released merozoites. Our findings reveal the presence in the malarial parasitophorous vacuole of a regulated, PfSUB1-mediated proteolytic processing event required for release of viable parasites from the host erythrocyte.	[Yeoh, Sharon; O'Donnell, Rebecca A.; Koussis, Konstantinos; Dluzewski, Anton R.; Hackett, Fiona; Withers-Martinez, Chrislaine; Blackman, Michael J.] Natl Inst Med Res, Div Parasitol, London NE7 1AA, England; [Ansell, Keith H.; Osborne, Simon A.; Bryans, Justin S.; Kettleborough, Catherine A.] Med Res Council Technol, Drug Dicovery Grp, London NE7 1AA, England; [Mitchell, Graham H.; Bannister, Lawrence H.] Guys Kings & St Thomas Hosp Sch Biomed & Life Sci, London SE1 1UL, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, London NE7 1AA, England.	mblackm@nimr.mrc.ac.uk	Kousis, Konstantinos/K-7371-2019; Mitchell, Graham/AAA-5654-2020	Kousis, Konstantinos/0000-0002-6737-8724; Yeoh, Sharon/0000-0002-8530-1405; Mitchell, G.H./0000-0002-4922-8044	MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: Medline; Wellcome Trust [069515] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AIKAWA M, 1990, EXP PARASITOL, V71, P326, DOI 10.1016/0014-4894(90)90037-D; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; ANDERS RF, 1987, MOL STRATEGIES PARAS, P333; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Blackman MJ, 2002, BIOCHEMISTRY-US, V41, P12244, DOI 10.1021/bi0263661; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; DEBRABANT A, 1989, MOL BIOCHEM PARASIT, V33, P151, DOI 10.1016/0166-6851(89)90029-7; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Gelhaus C, 2005, BIOL CHEM, V386, P499, DOI 10.1515/BC.2005.059; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; KNAPP B, 1991, MOL BIOCHEM PARASIT, V44, P1, DOI 10.1016/0166-6851(91)90215-R; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; Ling IT, 2003, MOL BIOCHEM PARASIT, V127, P47, DOI 10.1016/S0166-6851(02)00302-X; MCCOUBRIE JE, 2007, IN PRESS INFECT 0924, DOI DOI 10.1128/IAI.00405.07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Pang XL, 1999, INFECT IMMUN, V67, P1821; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200	33	240	244	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1072	1083		10.1016/j.cell.2007.10.049	http://dx.doi.org/10.1016/j.cell.2007.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083098	Bronze, Green Accepted			2022-12-28	WOS:000252217100016
J	Katsukawa, Y; Berger, TE; Ichimoto, K; Lites, BW; Nagata, S; Shimizu, T; Shine, RA; Suematsu, Y; Tarbell, TD; Title, AM; Tsuneta, S				Katsukawa, Y.; Berger, T. E.; Ichimoto, K.; Lites, B. W.; Nagata, S.; Shimizu, T.; Shine, R. A.; Suematsu, Y.; Tarbell, T. D.; Title, A. M.; Tsuneta, S.			Small-scale jetlike features in penumbral chromospheres	SCIENCE			English	Article							HIGH-RESOLUTION OBSERVATIONS; FINE-STRUCTURE; MAGNETIC-FIELDS; EVOLUTION; SUNSPOTS	We observed fine-scale jetlike features, referred to as penumbral microjets, in chromospheres of sunspot penumbrae. The microjets were identified in image sequences of a sunspot taken through a Ca II H-line filter on the Solar Optical Telescope on board the Japanese solar physics satellite Hinode. The microjets' small width of 400 kilometers and short duration of less than 1 minute make them difficult to identify in existing observations. The microjets are possibly caused by magnetic reconnection in the complex magnetic configuration in penumbrae and have the potential to heat the corona above a sunspot.	Natl Astron Observ Japan, Tokyo 1818588, Japan; Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Lockheed Martin; National Center Atmospheric Research (NCAR) - USA; Kyoto University; Kyoto University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Katsukawa, Y (corresponding author), Natl Astron Observ Japan, 2-21-1 Osawa, Tokyo 1818588, Japan.	yukio.katsukawa@nao.ac.jp		Shimizu, Toshifumi/0000-0003-4764-6856	STFC [PP/D002907/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		ALISSANDRAKIS CE, 1988, ASTRON ASTROPHYS, V201, P339; Aschwanden MJ, 2000, ASTROPHYS J, V535, P1047, DOI 10.1086/308867; BECKERS JM, 1969, SOL PHYS, V7, P351, DOI 10.1007/BF00146140; De Pontieu B, 2007, ASTROPHYS J, V655, P624, DOI 10.1086/509070; FOUKAL P, 1971, SOL PHYS, V20, P298, DOI 10.1007/BF00159759; Ichimoto K, 2004, P SOC PHOTO-OPT INS, V5487, P1142, DOI 10.1117/12.550989; Katsukawa Y, 2003, PUBL ASTRON SOC JPN, V55, P1025, DOI 10.1093/pasj/55.5.1025; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Langhans K, 2005, ASTRON ASTROPHYS, V436, P1087, DOI 10.1051/0004-6361:20052678; LITES BW, 1993, ASTROPHYS J, V418, P928, DOI 10.1086/173450; MALTBY P, 1975, SOL PHYS, V43, P91, DOI 10.1007/BF00155146; MULLER R, 1973, SOL PHYS, V29, P55, DOI 10.1007/BF00153440; Pillet VM, 2000, ASTRON ASTROPHYS, V361, P734; RIMMELE TR, 1994, ASTRON ASTROPHYS, V290, P972; Rubio LRB, 2004, ASTRON ASTROPHYS, V427, P319, DOI 10.1051/0004-6361:20041277; Rutten RJ, 2006, ASTR SOC P, V354, P276; SHIBATA K, 1995, ADV SPACE RES-SERIES, V17, P9; SHINE RA, 1994, ASTROPHYS J, V430, P413, DOI 10.1086/174416; Sobotka M, 1999, ASTRON ASTROPHYS, V348, P621; SUEMATSU Y, 1995, ASTROPHYS J, V450, P411, DOI 10.1086/176151; THOMAS JH, 1984, ASTROPHYS J, V285, P368, DOI 10.1086/162514; TITLE AM, 1993, ASTROPHYS J, V403, P780, DOI 10.1086/172249; Tsiropoula G, 2000, ASTRON ASTROPHYS, V355, P375; Tziotziou K, 2005, ASTRON ASTROPHYS, V444, P265, DOI 10.1051/0004-6361:20053604; van der Voort LHMR, 2003, ASTRON ASTROPHYS, V403, P277, DOI 10.1051/0004-6361:20030237; WITTMANN A, 1969, SOL PHYS, V7, P366, DOI 10.1007/BF00146141	26	154	156	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1594	1597		10.1126/science.1146046	http://dx.doi.org/10.1126/science.1146046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063791				2022-12-28	WOS:000251421700037
J	Papeix, C; Habert, MO; Jarquin, S; Cohen, L				Papeix, Caroline; Habert, Marie-Odile; Jarquin, Sergio; Cohen, Laurent			A dent in the head	LANCET			English	Editorial Material									Hop La Pitie Salpetriere, Dept Neurol, Pole Malad Syst Nerveux, F-75651 Paris 13, France; Hop La Pitie Salpetriere, Dept Nucl Med, F-75651 Paris, France; Hop La Pitie Salpetriere, Dept Neuroradiol, F-75651 Paris 13, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Papeix, C (corresponding author), Hop La Pitie Salpetriere, Dept Neurol, Pole Malad Syst Nerveux, 47-83 Bd Hop, F-75651 Paris 13, France.	caroline.papeix@psl.ap-hop-paris.fr	Habert, Marie-Odile/AAO-3763-2020	cohen, laurent/0000-0002-5010-9085					0	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1854	1854		10.1016/S0140-6736(07)61781-4	http://dx.doi.org/10.1016/S0140-6736(07)61781-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061061				2022-12-28	WOS:000251588700032
J	Grey, K; Calver, CR				Grey, Kathleen; Calver, Clive R.			Ediacaran oxidation and biotic evolution	NATURE			English	Letter							ISOTOPE STRATIGRAPHY; OFFICER BASIN		Geol Survey Western Australia, Dept Ind & Resources, Perth, WA 6004, Australia; Mineral Resources Tasmania, Rosny Pk, Tas 7018, Australia	Geological Survey of Western Australia	Grey, K (corresponding author), Geol Survey Western Australia, Dept Ind & Resources, Perth, WA 6004, Australia.	ccalver@mrt.tas.gov.au						Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Calver CR, 1998, AUST J EARTH SCI, V45, P513, DOI 10.1080/08120099808728409; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GREY K, 2005, MEMOIRS ASS AUSTRALA, V31, P1; Williams SS, 2006, RECLAIMING AUTHORSHIP: LITERARY WOMEN IN AMERICA, 1850-1900, P17, DOI 10.1016/j.revpalbo.2005.07.014	5	6	7	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					E17	E17		10.1038/nature06360	http://dx.doi.org/10.1038/nature06360			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046342				2022-12-28	WOS:000251209700043
J	Sun, J; Pang, ZP; Qin, D; Fahim, AT; Adachi, R; Sudhof, TC				Sun, Jianyuan; Pang, Zhiping P.; Qin, Dengkui; Fahim, Abigail T.; Adachi, Roberto; Suedhof, Thomas C.			A dual-Ca2+-sensor model for neurotransmitter release in a central synapse	NATURE			English	Article							SHORT-TERM DEPRESSION; CALCIUM-CHANNEL TYPES; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; ASYNCHRONOUS RELEASE; DETERMINES FAST; CA2+ CHANNELS; CALYX; MODULATION; SENSOR	Ca2+-triggered synchronous neurotransmitter release is well described, but asynchronous release-in fact, its very existence-remains enigmatic. Here we report a quantitative description of asynchronous neurotransmitter release in calyx-of-Held synapses. We show that deletion of synaptotagmin 2 (Syt2) in mice selectively abolishes synchronous release, allowing us to study pure asynchronous release in isolation. Using photolysis experiments of caged Ca2+, we demonstrate that asynchronous release displays a Ca2+ cooperativity of similar to 2 with a Ca2+ affinity of similar to 44 mu M, in contrast to synchronous release, which exhibits a Ca2+ cooperativity of similar to 5 with a Ca2+ affinity of similar to 38 mu M. Our results reveal that release triggered in wild-type synapses at low Ca2+ concentrations is physiologically asynchronous, and that asynchronous release completely empties the readily releasable pool of vesicles during sustained elevations of Ca2+. We propose a dual-Ca2+-sensor model of release that quantitatively describes the contributions of synchronous and asynchronous release under conditions of different presynaptic Ca2+ dynamics.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu	Pang, Zhiping/AAF-5757-2020	Adachi, Roberto/0000-0002-0146-0768; Fahim, Abigail/0000-0001-9737-054X; Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atluri PP, 1998, J NEUROSCI, V18, P8214; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Chuhma N, 2002, J NEUROPHYSIOL, V87, P222, DOI 10.1152/jn.00235.2001; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Ravin R, 1997, J PHYSIOL-LONDON, V501, P251, DOI 10.1111/j.1469-7793.1997.tb00001.x; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2006, P NATL ACAD SCI USA, V103, P2880, DOI 10.1073/pnas.0511300103; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Wu LG, 1999, J NEUROSCI, V19, P726; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	43	260	265	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					676	U4		10.1038/nature06308	http://dx.doi.org/10.1038/nature06308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046404	Green Accepted			2022-12-28	WOS:000251209700046
J	Zhang, XW; Pickin, KA; Bose, R; Jura, N; Cole, PA; Kuriyan, J				Zhang, Xuewu; Pickin, Kerry A.; Bose, Ron; Jura, Natalia; Cole, Philip A.; Kuriyan, John			Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NEGATIVE REGULATOR; LUNG-CANCER; SIGNAL; COMPLEX; RALT; CONFORMATION; MUTATIONS; GEFITINIB; MECHANISM	Members of the epidermal growth factor receptor family (EGFR/ERBB1, ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are key targets for inhibition in cancer therapy(1). Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the carboxy-terminal lobe (C lobe) of one kinase domain induces an active conformation in the other(2). The cytoplasmic protein MIG6 (mitogen-induced gene 6; also known as ERRFI1) interacts with and inhibits the kinase domains of EGFR and ERBB2 (refs 3-5). Crystal structures of complexes between the EGFR kinase domain and a fragment of MIG6 show that a similar to 25-residue epitope (segment 1) from MIG6 binds to the distal surface of the Clobe of the kinase domain. Biochemical and cell-based analyses confirm that this interaction contributes to EGFR inhibition by blocking the formation of the activating dimer interface. A longer MIG6 peptide that is extended C terminal to segment 1 has increased potency as an inhibitor of the activated EGFR kinase domain, while retaining a critical dependence on segment 1. We show that signalling by EGFR molecules that contain constitutively active kinase domains still requires formation of the asymmetric dimer, underscoring the importance of dimer interface blockage in MIG6-mediated inhibition.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Calif Inst Quantitat Sci, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096504, R01 CA096504-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; ANASTASI S, 2007, ONCOGENE        0618; Ballaro C, 2005, EMBO REP, V6, P755, DOI 10.1038/sj.embor.7400458; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	22	268	274	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					741	U13		10.1038/nature05998	http://dx.doi.org/10.1038/nature05998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046415	Green Accepted, Green Submitted			2022-12-28	WOS:000251209700058
J	Carnes, D; Anwer, Y; Underwood, M; Harding, G; Parsons, S				Carnes, Dawn; Anwer, Yasir; Underwood, Martin; Harding, Geoff; Parsons, Suzanne		TOIB Study Team	Influences on older people's decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							REPLACEMENT SURGERY; PRIMARY-CARE; MEDICATION; ADULTS; OSTEOARTHRITIS; TRIAL; PERSPECTIVES; MEDICINES; ADHERENCE; PHYSICIAN	Objective To explore the factors that influence older people's decision making regarding use of topical or oral ibuprofen for their knee pain. Design Qualitative interview study nested within a randomised controlled trial and a patient preference study that compared advice to use oral or topical non-steroidal anti-inflammatory drugs (NSAIDs) for knee pain in older people. Setting 11 general practices. Participants 30 people aged 50 with knee pain. Results Participants' decision making was influenced by their perceptions of the associated risk of adverse effects, presence of other illness, nature of their pain, advice received, and practicality. Although participants' understanding of how the medications worked was sometimes poor, their decision making about the use of NSAIDs seemed logical and appropriate. Participants' model for treatment was to use topical NSAIDs for mild, local, and transient pain and oral NSAIDs for moderate to severe, generalised, and constant pain (in the absence of other more serious illness or risk of adverse effects). Participants showed marked tolerance and normalisation of adverse effects. Conclusion Participants had clear ideas about the appropriate use of oral and topical NSAIDs. Taking such views into account when prescribing may improve adherence, judgment of efficacy, and the doctor-patient relationship. Tolerance and normalisation of adverse effects in these patients indicate that closer monitoring of older people who use NSAIDs might be needed.	[Carnes, Dawn; Anwer, Yasir; Underwood, Martin; Parsons, Suzanne] Queen Mary Univ London, Barts & The London, Ctr Hlth Sci, London E1 2AT, England; [Harding, Geoff] Royal Cornwall Hosp, Peninsula Coll Med & Dent Primary Care, Truro TR1 3LJ, England	University of London; Queen Mary University London; Royal Cornwall Hospital	Underwood, M (corresponding author), Queen Mary Univ London, Barts & The London, Ctr Hlth Sci, London E1 2AT, England.	m.underwood@warwick.ac.uk	Parsons, Suzanne/E-7805-2010; Underwood, Martin/D-6364-2015	Underwood, Martin/0000-0002-0309-1708	MRC [MC_U122785831] Funding Source: UKRI; National Institute for Health Research [01/09/02] Funding Source: researchfish; Medical Research Council [MC_U122785831, MC_U122797165] Funding Source: Medline; Department of Health [01/09/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Awad MA, 2000, COMMUNITY DENT ORAL, V28, P119, DOI 10.1034/j.1600-0528.2000.028002119.x; Belcher VN, 2006, J GEN INTERN MED, V21, P298, DOI 10.1111/j.1525-1497.2006.00329.x; Benson J, 2006, FAM PRACT, V23, P80, DOI 10.1093/fampra/cmi081; Borders TF, 2004, HEALTH SERV RES, V39, P35, DOI 10.1111/j.1475-6773.2004.00214.x; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Clark JP, 2004, J BONE JOINT SURG AM, V86A, P1366, DOI 10.2106/00004623-200407000-00003; Cross PL, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-55; Elliott RA, 2007, J GEN INTERN MED, V22, P805, DOI 10.1007/s11606-007-0193-5; Fraenkel L, 2004, ARTHRIT RHEUM-ARTHR, V51, P210, DOI 10.1002/art.20247; Goodacre LJ, 2004, RHEUMATOLOGY, V43, P583, DOI 10.1093/rheumatology/keh116; Herve C, 2004, EXP AGING RES, V30, P253, DOI 10.1080/03610730490447886; KING G, 2001, POLIT ANAL, V9, P1; Mitchell HL, 2006, RHEUMATOLOGY, V45, P771, DOI 10.1093/rheumatology/kei214; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; Sale JEM, 2006, ARTHRIT RHEUM-ARTHR, V55, P272, DOI 10.1002/art.21853; Spinewine A, 2005, BMJ-BRIT MED J, V331, P935, DOI 10.1136/bmj.38551.410012.06; Stead M, 2005, J MED ETHICS, V31, P664, DOI 10.1136/jme.2004.011064; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Townsend A, 2003, BRIT MED J, V327, P837, DOI 10.1136/bmj.327.7419.837; Toye FM, 2006, SOC SCI MED, V63, P43, DOI 10.1016/j.socscimed.2005.11.054; UNDERWOOD M, 2007, BMJ; UNDERWOOD MR, IN PRESS HTLH TECHNO; UNDERWOOD MR, IN PRESS HLTH TECHNO; Victor CR, 2004, J EVAL CLIN PRACT, V10, P63, DOI 10.1111/j.1365-2753.2003.00395.x; Williams B, 2005, QJM-INT J MED, V98, P885, DOI 10.1093/qjmed/hci139	27	33	34	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 19	2008	336	7636					142	+		10.1136/bmj.39401.699063.BE	http://dx.doi.org/10.1136/bmj.39401.699063.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18056742	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252819400033
J	Vavylonis, D; Wu, JQ; Hao, S; O'Shaughnessy, B; Pollard, TD				Vavylonis, Dimitrios; Wu, Jian-Qiu; Hao, Steven; O'Shaughnessy, Ben; Pollard, Thomas D.			Assembly mechanism of the contractile ring for cytokinesis by fission yeast	SCIENCE			English	Article							F-ACTIN; SCHIZOSACCHAROMYCES-POMBE; MYOSIN-II; PROFILIN; DYNAMICS; FORMINS; CDC12P; SITE	Animals and fungi assemble a contractile ring of actin filaments and the motor protein myosin to separate into individual daughter cells during cytokinesis. We used fluorescence microscopy of live fission yeast cells to observe that membrane- bound nodes containing myosin were broadly distributed around the cell equator and assembled into a contractile ring through stochastic motions, after a meshwork of dynamic actin filaments appeared. Analysis of node motions and numerical simulations supported a mechanism whereby transient connections are established when myosins in one node capture and exert force on actin filaments growing from other nodes.	[Vavylonis, Dimitrios; Wu, Jian-Qiu; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Vavylonis, Dimitrios; O'Shaughnessy, Ben] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Hao, Steven; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Columbia University; Lehigh University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Wu, Jian-qiu/G-6835-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026132, R01GM026132, R01GM026338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-26132, R01 GM026132, GM-26338, R01 GM026338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai R, 2002, J CELL SCI, V115, P887; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Howard J., 2001, MECH MOTOR PROTEINS; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Motegi F, 2000, J CELL SCI, V113, P1813; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	20	271	272	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					97	100		10.1126/science.1151086	http://dx.doi.org/10.1126/science.1151086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18079366				2022-12-28	WOS:000252084000040
J	Branzei, D; Foiani, M				Branzei, Dana; Foiani, Marco			Template switching: From replication fork repair to genome rearrangements	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; GENE AMPLIFICATION; BREAKS		[Branzei, Dana; Foiani, Marco] FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Branzei, Dana; Foiani, Marco] Univ Milan, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan	Branzei, D (corresponding author), FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Foiani, Marco/M-8234-2014; Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022	Foiani, Marco/0000-0003-4795-834X; Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888				Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; LEE JA, 2007, CELL; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723	11	38	40	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1228	1230		10.1016/j.cell.2007.12.007	http://dx.doi.org/10.1016/j.cell.2007.12.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160033	Bronze			2022-12-28	WOS:000252217200012
J	Grant, GB; Fridkin, S; Chang, DC; Park, BJ				Grant, Gavin B.; Fridkin, Scott; Chang, Douglas C.; Park, Benjamin J.			Postrecall surveillance following a multistate Fusarium keratitis outbreak, 2004 through 2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SINGAPORE		CDCP, Epidem Intelligence Serv, Office Workforce & Career Dev, Atlanta, GA USA; CDCP, Coordinating Ctr Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Div Bacterial Foodborne & Mycot Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grant, GB (corresponding author), CDCP, Epidem Intelligence Serv, Office Workforce & Career Dev, Atlanta, GA USA.	gbgrant@cdc.gov		Grant, Gavin/0000-0002-3271-5735				Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Donnio A, 2007, AM J OPHTHALMOL, V143, P356, DOI 10.1016/j.ajo.2006.09.021; Khor WB, 2006, JAMA-J AM MED ASSOC, V295, P2867, DOI 10.1001/jama.295.24.2867; Saw SM, 2007, ARCH OPHTHALMOL-CHIC, V125, P611, DOI 10.1001/archopht.125.5.611; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114	5	17	17	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2867	2868		10.1001/jama.298.24.2867	http://dx.doi.org/10.1001/jama.298.24.2867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159055	Bronze			2022-12-28	WOS:000251816000018
J	von Hobe, M				von Hobe, Marc			Atmospheric science - Revisiting ozone depletion	SCIENCE			English	Editorial Material							ANTARCTIC OZONE; CHLORINE; CL2O2		Forschungszentrum Julich, Inst Chem & Dynam Geosphere ICG Stratosphere 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	von Hobe, M (corresponding author), Forschungszentrum Julich, Inst Chem & Dynam Geosphere ICG Stratosphere 1, Postfach 1913, D-52425 Julich, Germany.	m.von.hobe@fz-juelich.de	von Hobe, Marc/N-3265-2019; von Hobe, Marc/A-7969-2013	von Hobe, Marc/0000-0001-6034-6562; 				ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; BURKHOLDER JB, 1990, J PHYS CHEM-US, V94, P687, DOI 10.1021/j100365a033; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Frieler K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025466; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Newman PA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025232; Pope FD, 2007, J PHYS CHEM A, V111, P4322, DOI 10.1021/jp067660w; Sander S. P., 2006, 062 JET PROP LAB; Schiermeier Q, 2007, NATURE, V449, P382, DOI 10.1038/449382a; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; von Hobe M, 2007, ATMOS CHEM PHYS, V7, P3055, DOI 10.5194/acp-7-3055-2007; WMO, 2007, 50 WMO	13	22	22	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1878	1879		10.1126/science.1151597	http://dx.doi.org/10.1126/science.1151597			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096795				2022-12-28	WOS:000251786600044
J	Eknoyan, G				Eknoyan, Garabed			Artificial kidneys: progress and promise	LANCET			English	Editorial Material							NOCTURNAL HEMODIALYSIS; FUTURE		Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Eknoyan, G (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	geknoyan@bcm.edu						Cameron JS, 2002, HIST TREATMENT RENAL; Chertow GM, 2001, J AM SOC NEPHROL, V12, P2850, DOI 10.1681/ASN.V12122850; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Davenport A, 2007, LANCET, V370, P2005, DOI 10.1016/S0140-6736(07)61864-9; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Humes HD, 2006, KIDNEY INT, V69, P1115, DOI 10.1038/sj.ki.5000204; Kooman JP, 2007, BLOOD PURIFICAT, V25, P377, DOI 10.1159/000107774; Nissenson AR, 2005, BLOOD PURIFICAT, V23, P269, DOI 10.1159/000085882; Rastogi A, 2007, ADV CHRONIC KIDNEY D, V14, P249, DOI 10.1053/j.ackd.2007.05.001; Stephens R L, 1976, Proc Eur Dial Transplant Assoc, V12, P511; Suri RS, 2007, KIDNEY INT, V71, P349, DOI 10.1038/sj.ki.5002032; Walsh M, 2005, KIDNEY INT, V67, P1500, DOI 10.1111/j.1523-1755.2005.00228.x	12	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1977	1978		10.1016/S0140-6736(07)61839-X	http://dx.doi.org/10.1016/S0140-6736(07)61839-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083384				2022-12-28	WOS:000251698600004
J	Wallis, S				Wallis, Stephen			It started with a kiss (perhaps)	LANCET			English	Editorial Material							SPONTANEOUS SPLENIC RUPTURE; EPSTEIN-BARR-VIRUS; INFECTIOUS-MONONUCLEOSIS; MANAGEMENT		Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough PE3 6DA, Cambs, England		Wallis, S (corresponding author), Peterborough & Stamford Hosp NHS Fdn Trust, Thorpe Rd, Peterborough PE3 6DA, Cambs, England.	stephen.wallis@pbh-tr.nhs.uk						Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; Khoo SG, 2007, ENT-EAR NOSE THROAT, V86, P300, DOI 10.1177/014556130708600518; MAKI DG, 1982, AM J SPORT MED, V10, P162, DOI 10.1177/036354658201000308; Papesch M, 2001, CLIN OTOLARYNGOL, V26, P3, DOI 10.1046/j.1365-2273.2001.00431.x; Stephenson JT, 2007, PEDIATRICS, V120, pE432, DOI 10.1542/peds.2006-3071	5	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 15	2007	370	9604					2068	2068		10.1016/S0140-6736(07)61868-6	http://dx.doi.org/10.1016/S0140-6736(07)61868-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083406				2022-12-28	WOS:000251698600034
J	Lipscombe, LL; Gomes, T; Levesque, LE; Hux, JE; Juurlink, DN; Alter, DA				Lipscombe, Lorraine L.; Gomes, Tara; Levesque, Linda E.; Hux, Janet E.; Juurlink, David N.; Alter, David A.			Thiazolidinediones and cardiovascular outcomes in older patients with diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; ROSIGLITAZONE; RISK; PIOGLITAZONE; DISEASE; METAANALYSIS; HOSPITALIZATION; MELLITUS; EVENTS; WOMEN	Context Thiazolidinediones ( TZDs), used to treat type 2 diabetes, are associated with an excess risk of congestive heart failure and possibly acute myocardial infarction. However, the association between TZD use and cardiovascular events has not been adequately evaluated on a population level. Objective To explore the association between TZD therapy and congestive heart failure, acute myocardial infarction, and mortality compared with treatment with other oral hypoglycemic agents. Design, Setting, and Patients Nested case- control analysis of a retrospective cohort study using health care databases in Ontario. We included diabetes patients aged 66 years or older treated with at least 1 oral hypoglycemic agent between 2002 and 2005 ( N= 159 026) and followed them up until March 31, 2006. Main Outcome Measures The primary outcome consisted of an emergency department visit or hospitalization for congestive heart failure; secondary outcomes were an emergency department visit or hospitalization for acute myocardial infarction and all- cause mortality. The risks of these events were compared between persons treated with TZDs ( rosiglitazone and pioglitazone) and other oral hypoglycemic agent combinations, after matching and adjusting for prognostic factors. Results During a median follow- up of 3.8 years, 12 491 patients ( 7.9%) had a hospital visit for congestive heart failure, 12 578 ( 7.9%) had a visit for acute myocardial infarction, and 30 265 ( 19%) died. Current treatment with TZD monotherapy was associated with a significantly increased risk of congestive heart failure ( 78 cases; adjusted rate ratio [ RR], 1.60; 95% confidence interval [ Cl], 1.21- 2.10; P <. 001), acute myocardial infarction ( 65 cases; RR, 1.40; 95% Cl, 1.05- 1.86; P=. 02), and death ( 102 cases; RR, 1.29; 95% Cl, 1.02- 1.62; P=. 03) compared with other oral hypoglycemic agent combination therapies ( 3478 congestive heart failure cases, 3695 acute myocardial infarction cases, and 5529 deaths). The increased risk of congestive heart failure, acute myocardial infarction, and mortality associated with TZD use appeared limited to rosiglitazone. Conclusion In this population- based study of older patients with diabetes, TZD treatment, primarily with rosiglitazone, was associated with an increased risk of congestive heart failure, acute myocardial infarction, and mortality when compared with other combination oral hypoglycemic agent treatments.	Univ Toronto, Womens Coll Hosp, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Womens Coll Hosp, Dept Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Womens Coll Hosp, Dept Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Toronto Rehabil Inst, Toronto, ON, Canada; Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; Kingston Lennox Frontenac & Addington Publ Hlth, Kingston, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Queens University - Canada	Lipscombe, LL (corresponding author), Univ Toronto, Womens Coll Hosp, Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	lorraine.lipscombe@ices.on.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875; Gomes, Tara/0000-0002-1468-1965; Lipscombe, Lorraine/0000-0001-7412-7993				Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Berlie HD, 2007, DIABETES RES CLIN PR, V76, P279, DOI 10.1016/j.diabres.2006.09.010; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; Collet D, 1999, MODELLING BINARY DAT, P223; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Delea TE, 2003, DIABETES CARE, V26, P2983, DOI 10.2337/diacare.26.11.2983; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; END SOC, FDA ADV PAN VOT KEEP; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hartung DM, 2005, PHARMACOTHERAPY, V25, P1329, DOI 10.1592/phco.2005.25.10.1329; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LIDDELL FDK, 1977, J R STAT SOC A STAT, V140, P469, DOI 10.2307/2345280; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2005, ARCH INTERN MED, V165, P2090, DOI 10.1001/archinte.165.18.2090; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Rajagopalan R, 2004, CLIN THER, V26, P1400, DOI 10.1016/j.clinthera.2004.09.016; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK PROSP DIAB STU, 1998, LANCET, V352, P1557; *US FDA, 2007, SAF LAB CHANG APPR F; US Food and Drug Administration, FDA BRIEF DOC JOINT	46	252	261	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2634	2643		10.1001/jama.298.22.2634	http://dx.doi.org/10.1001/jama.298.22.2634			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073359	Bronze			2022-12-28	WOS:000251546100015
J	Buist, M; Harrison, J; Abaloz, E; Van Dyke, S				Buist, Michael; Harrison, Julia; Abaloz, Ellie; Van Dyke, Susan			Quality improvement report - Six year audit of cardiac arrests and medical emergency team calls in an Australian outer metropolitan teaching hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE; ANTECEDENTS; RESPONSES; SURVIVAL	Problem In-hospitai cardiac arrest often represents failure of optimal clinical care. The use of medical emergency teams to prevent such events is controversial. In-hospitat cardiac arrests have been reduced in several single centre historical control studies, but the only randomised prospective study showed no such benefit. In our hospital an important problem was failure to call the medical emergency team or cardiac arrest team when, before in-hospital cardiac arrest, patients had fulfilled the criteria for calling the team. Design Single centre, prospective audit of cardiac arrests and data on use of the medical emergency team during 2000 to 2005. Setting 400 bed general outer suburban metropolitan teaching hospital. Strategies for change Three initiatives in the hospital to improve use of the medical emergency team: orientation programme for first year doctors, professional development course for medical registrars, and the evolving role of liaison intensive care unit nurses. Key measures for improvement Incidence of cardiac arrests. Effects of the change Incidence of cardiac arrests reduced 24% per year, from 2.4/1000 admissions in 2000 to 0.66/ 1000 admissions in 2005. Lessons learnt Medical emergency teams can be efficacious when supported with a multidisciplinary, multifaceted education system for clinical staff.	Dandenong Hosp, Intens Care Unit, Dandenong, Vic 3175, Australia		Buist, M (corresponding author), Dandenong Hosp, Intens Care Unit, POB 478, Dandenong, Vic 3175, Australia.	mbuist@patientrack.com						BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; BULST M, 2004, CRIT CARE RESUSC, V6, P83; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Esmonde L, 2006, INTENS CARE MED, V32, P1713, DOI 10.1007/s00134-006-0380-6; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; PEATFIELD RC, 1977, LANCET, V1, P1223; Russell S, 2000, Prof Nurse, V15, P497; Russell S, 1999, HEART LUNG, V28, P365, DOI 10.1053/hl.1999.v28.a101055; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68	17	141	148	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1210	1212		10.1136/bmj.39385.534236.47	http://dx.doi.org/10.1136/bmj.39385.534236.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18048504	Green Published			2022-12-28	WOS:000251707800037
J	Malone, P; Steinbrecher, H				Malone, Padraig; Steinbrecher, Henrik			Medical aspects of male circumcision	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BALANITIS-XEROTICA-OBLITERANS; PENILE CANCER; FORESKIN; ASSOCIATION; COMPLICATIONS; DISEASE; RISK		Southampton Univ Hosp, Dept Paediat Urol, Southampton SO16 6YD, Hants, England	University of Southampton	Malone, P (corresponding author), Southampton Univ Hosp, Dept Paediat Urol, Southampton SO16 6YD, Hants, England.	pat.malone@suht.swest.nhs.uk						Ben Chaim J, 2005, ISR MED ASSOC J, V7, P368; Ceylan Kadir, 2007, J Pediatr Urol, V3, P32, DOI 10.1016/j.jpurol.2006.02.009; Choe JM, 2000, AM FAM PHYSICIAN, V62, P2623; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; ESCALA JM, 1989, BRIT J UROL, V63, P196, DOI 10.1111/j.1464-410X.1989.tb05164.x; Gargollo PC, 2005, J UROLOGY, V174, P1409, DOI 10.1097/01.ju.0000173126.63094.b3; GINSBURG CM, 1982, PEDIATRICS, V69, P409; Hammann C, 1999, CLIN RHEUMATOL, V18, P85, DOI 10.1007/s100670050062; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hsieh TF, 2006, INT J UROL, V13, P968, DOI 10.1111/j.1442-2042.2006.01449.x; Kayaba H, 1996, J UROLOGY, V156, P1813, DOI 10.1016/S0022-5347(01)65544-7; Kwak C, 2004, BJU INT, V94, P627, DOI 10.1111/j.1464-410X.2004.05014.x; Lannon CM, 1999, PEDIATRICS, V103, P686; MADEN C, 1993, JNCI-J NATL CANCER I, V85, P19, DOI 10.1093/jnci/85.1.19; O'Hara K, 1999, BJU INT, V83, P79, DOI 10.1046/j.1464-410x.1999.0830s1079.x; OSTER J, 1968, ARCH DIS CHILD, V43, P200, DOI 10.1136/adc.43.228.200; Pietrzak P, 2006, BJU INT, V98, P74, DOI 10.1111/j.1464-410X.2006.06213.x; Rickwood AMK, 1999, BJU INT, V83, P45, DOI 10.1046/j.1464-410x.1999.0830s1045.x; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Snodgrass WT, 2006, J UROLOGY, V176, P711, DOI 10.1016/j.juro.2006.03.082; Svare EI, 2002, SEX TRANSM INFECT, V78, P215, DOI 10.1136/sti.78.3.215; Velazquez EF, 2003, AM J SURG PATHOL, V27, P994, DOI 10.1097/00000478-200307000-00015; Yegane RA, 2006, PEDIATR SURG INT, V22, P442, DOI 10.1007/s00383-006-1672-1	24	35	36	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1206	1209		10.1136/bmj.39385.382708.AD	http://dx.doi.org/10.1136/bmj.39385.382708.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063645	Green Published			2022-12-28	WOS:000251707800036
J	Nishtar, S				Nishtar, Sania			Time for a global partnership on non-communicable diseases	LANCET			English	Editorial Material									Heartfile, Islamabad 44000, Pakistan		Nishtar, S (corresponding author), Heartfile, Islamabad 44000, Pakistan.	sania@heartfile.org						Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2005, PREV CHRON DIS VIT I; Buse K., 2004, BROWN J WORLD AFFAIR, VX, P225; *GLOB PREV ALL, 2006, GLOB PREV ALL B; Nishtar Sania, 2004, Health Res Policy Syst, V2, P5, DOI 10.1186/1478-4505-2-5; Widdus R, 2003, B WORLD HEALTH ORGAN, V81, P235	6	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1887	1888		10.1016/S0140-6736(07)61791-7	http://dx.doi.org/10.1016/S0140-6736(07)61791-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18068498				2022-12-28	WOS:000251517600008
J	Aulanier, G; Golub, L; DeLuca, EE; Cirtain, JW; Kano, R; Lundquist, LL; Narukage, N; Sakao, T; Weber, MA				Aulanier, Guillaume; Golub, Leon; DeLuca, Edward E.; Cirtain, Jonathan W.; Kano, Ryouhei; Lundquist, Loraine L.; Narukage, Noriyuki; Sakao, Taro; Weber, Mark A.			Slipping magnetic reconnection in coronal loops	SCIENCE			English	Article							REGION; WAVES; FLUX	The heating of the solar chromosphere and corona is a long-standing puzzle in solar physics. Hinode observations show the ubiquitous presence of chromospheric anemone jets outside sunspots in active regions. They are typically 3 to 7 arc seconds = 2000 to 5000 kilometers long and 0.2 to 0.4 arc second = 150 to 300 kilometers wide, and their velocity is 10 to 20 kilometers per second. These small jets have an inverted Y-shape, similar to the shape of x-ray anemone jets in the corona. These features imply that magnetic reconnection similar to that in the corona is occurring at a much smaller spatial scale throughout the chromosphere and suggest that the heating of the solar chromosphere and corona may be related to small-scale ubiquitous reconnection.	Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, F-92190 Meudon, France; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Natl Astron Observ Japan, Tokyo 1818588, Japan; Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University; Kyoto University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Aulanier, G (corresponding author), Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, 5 Pl Jules Janssen, F-92190 Meudon, France.	guillaume.aulanier@obspm.fr	DeLuca, Edward E/L-7534-2013	DeLuca, Edward E/0000-0001-7416-2895; Golub, Leon/0000-0001-9638-3082	STFC [PP/D002907/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aulanier G, 2006, SOL PHYS, V238, P347, DOI 10.1007/s11207-006-0230-2; Berger TE, 1999, SOL PHYS, V190, P409, DOI 10.1023/A:1005286503963; De Moortel I, 2006, ASTRON ASTROPHYS, V451, P1101, DOI 10.1051/0004-6361:20054587; Demoulin P, 2006, ADV SPACE RES-SERIES, V37, P1269, DOI 10.1016/j.asr.2005.03.085; Demoulin P, 1997, SOL PHYS, V175, P123, DOI 10.1023/A:1004986503291; Demoulin P, 1996, ASTRON ASTROPHYS, V308, P643; Fletcher L, 2002, SOL PHYS, V210, P307, DOI 10.1023/A:1022479610710; Gibson SE, 2002, ASTROPHYS J, V574, P1021, DOI 10.1086/341090; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; Handy BN, 1999, SOL PHYS, V187, P229, DOI 10.1023/A:1005166902804; Karpen JT, 1998, ASTROPHYS J, V495, P491, DOI 10.1086/305252; Krucker S, 2003, ASTROPHYS J, V595, pL103, DOI 10.1086/378840; LEROY B, 1980, ASTRON ASTROPHYS, V91, P136; MA ZW, 1995, PHYS PLASMAS, V2, P3184, DOI 10.1063/1.871150; Ofman L, 2002, ASTROPHYS J, V568, pL135, DOI 10.1086/340329; Pontin DI, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1891005; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Schmieder B, 2004, ASTROPHYS J, V601, P530, DOI 10.1086/380199; Sweet P. A., 1958, ELECTROMAGNETIC PHEN, P123; Titov VS, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000278; Winebarger AR, 2005, ASTROPHYS J, V626, P543, DOI 10.1086/429817; YOKOYAMA T, 1994, ASTROPHYS J, V436, pL197, DOI 10.1086/187666	22	83	84	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1588	1591		10.1126/science.1146143	http://dx.doi.org/10.1126/science.1146143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063789				2022-12-28	WOS:000251421700035
J	Ichimoto, K; Suematsu, Y; Tsuneta, S; Katsukawa, Y; Shimizu, T; Shine, RA; Tarbell, TD; Title, AM; Lites, BW; Kubo, M; Nagata, S				Ichimoto, K.; Suematsu, Y.; Tsuneta, S.; Katsukawa, Y.; Shimizu, T.; Shine, R. A.; Tarbell, T. D.; Title, A. M.; Lites, B. W.; Kubo, M.; Nagata, S.			Twisting motions of sunspot penumbral filaments	SCIENCE			English	Article							DARK-CORED FILAMENTS; FINE-STRUCTURE; MAGNETIC-FIELDS; EVERSHED FLOW; SPECTROSCOPY; RESOLUTION; INTENSITY	The penumbra of a sunspot is composed of numerous thin, radially extended, bright and dark filaments carrying outward gas flows (the Evershed flow). Using high-resolution images obtained by the Solar Optical Telescope aboard the solar physics satellite Hinode, we discovered a number of penumbral bright filaments revealing twisting motions about their axes. These twisting motions are observed only in penumbrae located in the direction perpendicular to the symmetry line connecting the sunspot center and the solar disk center, and the direction of the twist (that is, lateral motions of intensity fluctuation across filaments) is always from limb side to disk-center side. Thus, the twisting feature is not an actual twist or turn of filaments but a manifestation of dynamics of penumbral filaments with three-dimensional radiative transfer effects.	Natl Astron Observ Japan, Tokyo 1818588, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; Kyoto Univ, Kwasan Observ, Kyoto 6078471, Japan; Kyoto Univ, Hida Observ, Kyoto 6078471, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Lockheed Martin; National Center Atmospheric Research (NCAR) - USA; Kyoto University; Kyoto University	Ichimoto, K (corresponding author), Natl Astron Observ Japan, 2-21-1 Osawa, Tokyo 1818588, Japan.	ichimoto@solar.mtk.nao.ac.jp		Shimizu, Toshifumi/0000-0003-4764-6856; Kubo, Masahito/0000-0001-5616-2808	Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish; STFC [PP/D002907/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BECKERS JM, 1969, SOL PHYS, V10, P384, DOI 10.1007/BF00145526; Evershed J., 1909, MNRAS, V69, P454, DOI [10.1093/mnras/69.5.454, DOI 10.1093/MNRAS/69.5.454]; Ichimoto K, 2007, PUBL ASTRON SOC JPN, V59, pS593, DOI 10.1093/pasj/59.sp3.S593; ICHIMOTO KIYOSHI, 2005, Journal of the Korean Astronomical Society, V38, P307; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Langhans K, 2007, ASTRON ASTROPHYS, V464, P763, DOI 10.1051/0004-6361:20065215; Langhans K, 2005, ASTRON ASTROPHYS, V436, P1087, DOI 10.1051/0004-6361:20052678; LITES BW, 1993, ASTROPHYS J, V418, P928, DOI 10.1086/173450; MULLER R, 1976, SOL PHYS, V48, P101, DOI 10.1007/BF00153335; Rimmele T, 2006, ASTROPHYS J, V646, P593, DOI 10.1086/504794; Rubio LRB, 2006, ASTRON ASTROPHYS, V453, P1117, DOI 10.1051/0004-6361:20054768; Rubio LRB, 2005, ASTRON ASTROPHYS, V443, pL7, DOI 10.1051/0004-6361:200500179; Rubio LRB, 2004, ASTRON ASTROPHYS, V427, P319, DOI 10.1051/0004-6361:20041277; Scharmer GB, 2006, ASTRON ASTROPHYS, V460, P605, DOI 10.1051/0004-6361:20066019; Scharmer GRB, 2002, NATURE, V420, P151, DOI 10.1038/nature01173; Schlichenmaier R, 1998, ASTRON ASTROPHYS, V337, P897; Schlichenmaier R, 2005, ASTRON NACHR, V326, P301, DOI 10.1002/asna.200410394; SCHMIDT W, 1992, ASTRON ASTROPHYS, V264, pL27; Schussler M, 2006, ASTROPHYS J, V641, pL73, DOI 10.1086/503772; SHINE RA, 1994, ASTROPHYS J, V430, P413, DOI 10.1086/174416; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; SOLANKI SK, 1993, ASTRON ASTROPHYS, V275, P283; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Sutterlin P, 2004, ASTRON ASTROPHYS, V424, P1049, DOI 10.1051/0004-6361:20041380; Thomas JH, 2004, ANNU REV ASTRON ASTR, V42, P517, DOI 10.1146/annurev.astro.42.010803.115226; TITLE A, 1993, ASTROPHYS J, V4103, P780; Weiss NO, 2006, ASTR SOC P, V354, P213; WEISS NO, 1990, MON NOT R ASTRON SOC, V245, P434	28	57	58	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1597	1599		10.1126/science.1146337	http://dx.doi.org/10.1126/science.1146337			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063792				2022-12-28	WOS:000251421700038
J	Yeates, TO; Clubb, RT				Yeates, Todd O.; Clubb, Robert T.			Biochemistry - How some pili pull	SCIENCE			English	Editorial Material							GRAM-POSITIVE BACTERIA		Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.			Yeates, Todd/0000-0001-5709-9839	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI052217] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129	10	20	20	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1558	1559		10.1126/science.1151398	http://dx.doi.org/10.1126/science.1151398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063774				2022-12-28	WOS:000251421700020
J	Bibbins-Domingo, K; Coxson, P; Pletcher, MJ; Lightwood, J; Goldman, L				Bibbins-Domingo, Kirsten; Coxson, Pamela; Pletcher, Mark J.; Lightwood, James; Goldman, Lee			Adolescent overweight and future adult coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; RISK-FACTORS; MYOCARDIAL-INFARCTION; US ADULTS; PROSPECTIVE COHORT; PREDICTIVE-VALUE; OBESE CHILDREN; SECULAR TRENDS; CARDIAC-ARREST; MORTALITY	Background: The effect of adolescent overweight on future adult coronary heart disease (CHD) is not known. Methods: We estimated the prevalence of obese 35-year-olds in 2020 on the basis of adolescent overweight in 2000 and historical trends regarding overweight adolescents who become obese adults. We then used the CHD Policy Model, a state-transition computer simulation of U.S. residents who are 35 years of age or older, to project the annual excess incidence and prevalence of CHD, the total number of excess CHD events, and excess deaths from both CHD and other causes attributable to obesity from 2020 to 2035. We also modeled the effect of treating obesity-related increases in blood pressure and dyslipidemia. Results: Adolescent overweight is projected to increase the prevalence of obese 35-year-olds in 2020 to a range of 30 to 37% in men and 34 to 44% in women. As a consequence of this increased obesity, an increase in the incidence of CHD and in the total number of CHD events and deaths is projected to occur in young adulthood. The increase is projected to continue in both absolute and relative terms as the population reaches middle age. By 2035, it is estimated that the prevalence of CHD will increase by a range of 5 to 16%, with more than 100,000 excess cases of CHD attributable to the increased obesity. Aggressive treatment with currently available therapies to reverse modifiable obesity-related risk factors would reduce, but not eliminate, the projected increase in the number of CHD events. Conclusions: Although projections 25 or more years into the future are subject to innumerable uncertainties, extrapolation from current data suggests that adolescent overweight will increase rates of CHD among future young and middle-aged adults, resulting in substantial morbidity and mortality.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharm, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu						Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; *CA OFF STAT HLTH, 2000, CAL PAT DISCH DAT; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; *DEP HLTH HUM SERV, 2005, FRAM HEART STUD CD R; Dietz WH, 1998, PEDIATRICS, V101, P518; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gregg EW, 2005, JAMA-J AM MED ASSOC, V294, P182; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Groeneveld PW, 2003, CIRCULATION, V108, P286, DOI 10.1161/01.CIR.0000079164.95019.5A; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; KUCZ, 2002, VITAL HLTH STAT 11, V246; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; MALLORY GB, 1989, J PEDIATR-US, V115, P892, DOI 10.1016/S0022-3476(89)80738-3; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Must Aviva, 2003, Nutr Clin Care, V6, P4; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV DA; *NAT CTR HLTH STAT, 2003, PREV OV CHILDR AD; *NAT CTR HLTH STAT, DEATHS 358 SEL CAUS; National Center for Health Statistics, NAT HOSP DISCH SURV; National Center for Health Statistics, 2004, ICD10 COD; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Packer M, 1999, AM J CARDIOL, V83, p1A; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; PEDERSEN TR, 1994, LANCET, V344, P1383; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; United States Census Bureau, 2004, US INT PROJ AG SEX R; *US BUR CENS, 2000, US CENS SUMM FIL 1; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilsgaard T, 2004, ANN EPIDEMIOL, V14, P265, DOI 10.1016/j.annepidem.2003.08.004; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	47	344	369	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2371	2379		10.1056/NEJMsa073166	http://dx.doi.org/10.1056/NEJMsa073166			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057339				2022-12-28	WOS:000251389200007
J	Rezza, G; Nicoletti, L; Angelini, R; Romi, R; Finarelli, AC; Panning, M; Cordioli, P; Fortuna, C; Boros, S; Magurano, F; Silvi, G; Angelini, P; Dottori, M; Ciufolini, MG; Majori, GC; Cassone, A				Rezza, G.; Nicoletti, L.; Angelini, R.; Romi, R.; Finarelli, A. C.; Panning, M.; Cordioli, P.; Fortuna, C.; Boros, S.; Magurano, F.; Silvi, G.; Angelini, P.; Dottori, M.; Ciufolini, M. G.; Majori, G. C.; Cassone, A.		CHIKV Study Grp	Infection with chikungunya virus in Italy: an outbreak in a temperate region	LANCET			English	Article							AEDES-ALBOPICTUS; TRAVELERS	Background Chikungunya virus (CHIKV), which is transmitted by Aedes spp mosquitoes, has recently caused several outbreaks on islands in the Indian Ocean and on the Indian subcontinent. We report on an outbreak in Italy. Methods After reports of a large number of cases of febrile illness of unknown origin in two contiguous villages in northeastern Italy, an outbreak investigation was done to identify the primary source of infection and modes of transmission. An active surveillance system was also implemented. The clinical case definition was presentation with fever and joint pain. Blood samples were gathered and analysed by PCR and serological assays to identify the causal agent. Locally captured mosquitoes were also tested by PCR. Phylogenetic analysis of the CHIKV E1 region was done. Findings Analysis of samples from human beings and from mosquitoes showed that the outbreak was caused by CHIKV. We identified 205 cases of infection with CHIKV between July 4 and Sept 27, 2007. The presumed index case was a man from India who developed symptoms while visiting relatives in one of the villages. Phylogenetic analysis showed a high similarity between the strains found in Italy and those identified during an earlier outbreak on islands in the Indian Ocean. The disease was fairly mild in nearly all cases, with only one reported death. Interpretation This outbreak of CHIKV disease in a non-tropical area was to some extent unexpected and emphasises the need for preparedness and response to emerging infectious threats in the era of globalisation.	Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; Local Hlth Unit, Ravenna, Italy; Reg Hlth Author, Emilia Romagna, Italy; Bernhard Nocht Inst Trop Med, Hamburg, Germany; Ist Zooprofilatt, Brescia, Italy	Istituto Superiore di Sanita (ISS); Bernhard Nocht Institut fur Tropenmedizin	Cassone, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	cassone@iss.it	VENTURI, GIULIETTA/O-8123-2015; Cassone, Antonio/J-4666-2019; dottori, michele/AAB-3815-2019; FORTUNA, CLAUDIA/O-9446-2015; Nicoletti, Loredana/B-9973-2016; rezza, giovanni/D-4393-2016; Panning, Marcus/I-7889-2016; MAGURANO, FABIO/B-9975-2016	VENTURI, GIULIETTA/0000-0002-9078-8350; FORTUNA, CLAUDIA/0000-0001-8878-4505; Nicoletti, Loredana/0000-0002-5887-6940; rezza, giovanni/0000-0003-0268-6790; MAGURANO, FABIO/0000-0002-0394-7043; Boros, Stefano/0000-0003-2521-0883; Dottori, Michele/0000-0002-9975-0367				Angelini R, 2007, Euro Surveill, V12; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Peragallo MS, 2003, EMERG INFECT DIS, V9, P876; Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Romi R., 1995, Parassitologia (Rome), V37, P99; Romi R, 1999, J AM MOSQUITO CONTR, V15, P425; ROSS R. W., 1956, JOUR HYG, V54, P177; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; WHO, 2006, WKLY EPIDEMIOL REC, V81, P105; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	26	1028	1086	1	156	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1840	1846		10.1016/S0140-6736(07)61779-6	http://dx.doi.org/10.1016/S0140-6736(07)61779-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061059				2022-12-28	WOS:000251588700030
J	Rapoport, TA				Rapoport, Tom A.			Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes	NATURE			English	Review							SIGNAL RECOGNITION PARTICLE; DIMERIC SECA ATPASE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; ER MEMBRANE; PLUG DOMAIN; PREPROTEIN TRANSLOCATION; PERMEABILITY BARRIER; MOLECULAR-DYNAMICS; HALOFERAX-VOLCANII	A decisive step in the biosynthesis of many proteins is their partial or complete translocation across the eukaryotic endoplasmic reticulum membrane or the prokaryotic plasma membrane. Most of these proteins are translocated through a protein-conducting channel that is formed by a conserved, heterotrimeric membrane-protein complex, the Sec61 or SecY complex. Depending on channel binding partners, polypeptides are moved by different mechanisms: the polypeptide chain is transferred directly into the channel by the translating ribosome, a ratcheting mechanism is used by the endoplasmic reticulum chaperone BiP, and a pushing mechanism is used by the bacterial ATPase SecA. Structural, genetic and biochemical data show how the channel opens across the membrane, releases hydrophobic segments of membrane proteins laterally into lipid, and maintains the membrane barrier for small molecules.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu						Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Blobel G., 1971, BIOMEMBRANE, P193; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; Haider S, 2006, BIOCHEMISTRY-US, V45, P13018, DOI 10.1021/bi061013d; HALEGOUA S, 1977, J BIOL CHEM, V252, P2324; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; INOUYE H, 1977, P NATL ACAD SCI USA, V74, P1440, DOI 10.1073/pnas.74.4.1440; Irihimovitch V, 2003, J BIOL CHEM, V278, P12881, DOI 10.1074/jbc.M210762200; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Johnson AE, 2003, BIOCHEM SOC T, V31, P1227; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KURZCHALIA TV, 1988, EUR J BIOCHEM, V172, P663, DOI 10.1111/j.1432-1033.1988.tb13940.x; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; MENETRET JF, IN PRESS MOL CELL; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Musial-Siwek M, 2007, J MOL BIOL, V365, P637, DOI 10.1016/j.jmb.2006.10.027; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Ortenberg R, 2000, J BIOL CHEM, V275, P22839, DOI 10.1074/jbc.M908916199; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; SCHIEBEL E, 1992, J BIOL CHEM, V267, P7505; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Tian P, 2006, BIOPHYS J, V90, P2718, DOI 10.1529/biophysj.105.073304; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2	99	665	692	6	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					663	669		10.1038/nature06384	http://dx.doi.org/10.1038/nature06384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046402				2022-12-28	WOS:000251209700042
J	MacLean, C; Newberry, S; Maglione, M; McMahon, M; Ranganath, V; Suttorp, M; Mojica, W; Timmer, M; Alexander, A; McNamara, M; Desai, SB; Zhou, A; Chen, S; Carter, J; Tringale, C; Valentine, D; Johnsen, B; Grossman, J				MacLean, Catherine; Newberry, Sydne; Maglione, Margaret; McMahon, Maureen; Ranganath, Veena; Suttorp, Marika; Mojica, Walter; Timmer, Martha; Alexander, Alicia; McNamara, Melissa; Desai, Sheetal B.; Zhou, Annie; Chen, Susan; Carter, Jason; Tringale, Carlo; Valentine, Di; Johnsen, Breanne; Grossman, Jennifer			Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Review							CYCLICAL ETIDRONATE THERAPY; RANDOMIZED CONTROLLED-TRIAL; EARLY POSTMENOPAUSAL WOMEN; CORTICOSTEROID-INDUCED OSTEOPOROSIS; HORMONE REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; ONCE-WEEKLY ALENDRONATE; VITAMIN-D SUPPLEMENTATION; PRIMARY BILIARY-CIRRHOSIS; PLACEBO-CONTROLLED TRIAL	Background: Although several agents are available to treat osteoporosis, the relative efficacy and toxicity of these agents when used to prevent fractures has not been well described. Purpose: To compare the benefits in fracture reduction and the harms from adverse events of various therapies for osteoporosis. Data Sources: MEDLINE (1966 to November 2007) and other selected databases were searched for English-language studies. Study Selection: For the efficacy analysis, investigators selected studies that reported the rate of or risk for fractures. For the adverse event analysis, they selected studies that reported the relationship between an agent and cardiovascular, thromboembolic, or upper gastrointestinal events; malignant conditions; and osteonecrosis. Data Extraction: Using a standardized protocol, investigators abstracted data on fractures and adverse events, agents and comparators, study design, and variables of methodological quality. Data Synthesis: Good evidence suggests that alendronate, etidronate, ibandronate, risedronate, zoledronic acid, estrogen, parathyroid hormone (1-34), and raloxifene prevent vertebral fractures more than placebo; the evidence for calcitonin was fair. Good evidence suggests that alendronate, risedronate, and estrogen prevent hip fractures more than placebo; the evidence for zoledronic acid was fair. The effects of vitamin D varied with dose, analogue, and study population for both vertebral and hip fractures. Raloxifene, estrogen, and estrogen-progestin increased the risk for thromboembolic events, and etidronate increased the risk for esophageal ulcerations and gastrointestinal perforations, ulcerations, and bleeding. Limitation: Few studies have directly compared different agents or classes of agents used to treat osteoporosis. Conclusion: Although good evidence suggests that many agents are effective in preventing osteoporotic fractures, the data are insufficient to determine the relative efficacy or safety of these agents.	[Maglione, Margaret] RAND Corp, MPP, So California Evidence Based Practice Ctr, Santa Monica, CA 90401 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; Univ Calif Los Angeles, Greater Los Angeles Vet Adm Healthcare Syst, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Maglione, M (corresponding author), RAND Corp, MPP, So California Evidence Based Practice Ctr, 1776 Main St, Santa Monica, CA 90401 USA.	maglione@rand.org			PHS HHS [290-02-003] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adachi JD, 1997, NEW ENGL J MED, V337, P382, DOI 10.1056/NEJM199708073370603; Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Adami S, 2000, J ENDOCRINOL INVEST, V23, P310, DOI 10.1007/BF03343728; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Aris RM, 2000, AM J RESP CRIT CARE, V162, P941, DOI 10.1164/ajrccm.162.3.2002051; AVENELL A, 2005, COCHRANE DB SYST REV; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Blair MM, 2000, J FAM PRACTICE, V49, P839; Body JJ, 2002, J CLIN ENDOCR METAB, V87, P4528, DOI 10.1210/jc.2002-020334; Bone HG, 2000, J CLIN ENDOCR METAB, V85, P720, DOI 10.1210/jc.85.2.720; Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602; Boonen S, 2005, OSTEOPOROSIS INT, V16, P1291, DOI 10.1007/s00198-005-1945-x; Boutsen Y, 1997, CALCIFIED TISSUE INT, V61, P266, DOI 10.1007/s002239900334; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brumsen C, 2002, J BONE MINER RES, V17, P1057, DOI 10.1359/jbmr.2002.17.6.1057; Campbell IA, 2004, THORAX, V59, P761, DOI 10.1136/thx.2003.013839; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cherry N, 2002, LANCET, V360, P2001; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; Coco M, 2003, J AM SOC NEPHROL, V14, P2669, DOI 10.1097/01.ASN.0000087092.53894.80; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Cortet B, 1999, REV RHUM, V66, P214; Cranney A, 2000, Cochrane Database Syst Rev, pCD001983; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cranney A, 2002, ENDOCR REV, V23, P540, DOI 10.1210/er.2001-6002; Cranney A, 2001, COCHRANE DB SYST REV; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Draper MW, 1996, J BONE MINER RES, V11, P835; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fukunaga M, 2002, OSTEOPOROSIS INT, V13, P971, DOI 10.1007/s001980200135; Gallagher JC, 2005, J CLIN ENDOCR METAB, V90, P1583, DOI 10.1210/jc.2004-0826; GarciaDelgado I, 1997, CALCIFIED TISSUE INT, V60, P155, DOI 10.1007/s002239900206; Geusens P, 1998, ANN RHEUM DIS, V57, P724, DOI 10.1136/ard.57.12.724; Geusens P., 1997, Bone (New York), V20, p9S; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Greenspan SL, 2003, JAMA-J AM MED ASSOC, V289, P2525, DOI 10.1001/jama.289.19.2525; Greenspan SL, 2007, J CLIN ENDOCR METAB, V92, P131, DOI 10.1210/jc.2006-1272; Grotz W, 2001, J AM SOC NEPHROL, V12, P1530, DOI 10.1681/ASN.V1271530; Guanabens N, 2003, AM J GASTROENTEROL, V98, P2268, DOI 10.1016/S0002-9270(03)00550-1; Hay JE, 2001, J HEPATOL, V34, P292, DOI 10.1016/S0168-8278(00)00093-3; Heath DA, 2000, J CLIN DENSITOM, V3, P27, DOI 10.1385/JCD:3:1:027; Herd RJM, 1997, AM J MED, V103, P92, DOI 10.1016/S0002-9343(97)00019-3; Homik JE, 1999, J RHEUMATOL, V26, P1148; Hooper MJ, 2005, CLIMACTERIC, V8, P251, DOI 10.1080/13697130500118126; HORMIK J, 2000, COCHRANE DB SYST REV; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Hosking D, 2003, CURR MED RES OPIN, V19, P383, DOI 10.1185/030079903125002009; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ishida Y, 2004, AM J MED, V117, P549, DOI 10.1016/j.amjmed.2004.05.019; Iwamoto Jun, 2003, Keio Journal of Medicine, V52, P230; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamal SA, 2007, J BONE MINER RES, V22, P503, DOI 10.1359/JBMR.070112; Jenkins EA, 1999, SCAND J RHEUMATOL, V28, P152; JENSEN D, 1998, 2 JOINT M AM SOC BON; Johnell O, 2002, J CLIN ENDOCR METAB, V87, P985, DOI 10.1210/jc.87.3.985; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A; Kanaji A, 2006, LEPROSY REV, V77, P147; Kananen K, 2005, J CLIN ENDOCR METAB, V90, P3877, DOI 10.1210/jc.2004-2161; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 1999, QJM-MON J ASSOC PHYS, V92, P143, DOI 10.1093/qjmed/92.3.143; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kaufman JM, 2005, OSTEOPOROSIS INT, V16, P510, DOI 10.1007/s00198-004-1713-3; Keen Richard W, 2003, Curr Osteoporos Rep, V1, P66, DOI 10.1007/s11914-003-0011-x; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kim SH, 2004, AM J MED, V116, P524, DOI 10.1016/j.amjmed.2003.12.019; Kung AWC, 2003, J CLIN ENDOCR METAB, V88, P3130, DOI 10.1210/jc.2002-021855; Kushida K, 2004, J BONE MINER METAB, V22, P469, DOI 10.1007/s00774-004-0509-z; Lees B, 1996, OSTEOPOROSIS INT, V6, P480, DOI 10.1007/BF01629581; LINDSAY R, 1992, OSTEOPOROSIS GUIDE D; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; MacLean C, 2007, COMP EFFECTIVENESS R, V12; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McClung MR, 2004, J BONE MINER RES, V19, P11, DOI 10.1359/JBMR.0301202; Meunier PJ, 1999, OSTEOPOROSIS INT, V10, P330, DOI 10.1007/s001980050236; Meunier PJ, 1997, J CLIN ENDOCR METAB, V82, P2784, DOI 10.1210/jc.82.9.2784; Michalska D, 2006, J CLIN ENDOCR METAB, V91, P870, DOI 10.1210/jc.2004-2212; Milgrom C, 2004, BONE, V35, P418, DOI 10.1016/j.bone.2004.04.016; Miller PD, 2005, J BONE MINER RES, V20, P2105, DOI 10.1359/JBMR.050817; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mosekilde L, 2000, MATURITAS, V36, P181, DOI 10.1016/S0378-5122(00)00158-4; Muscoso E, 2004, Eur Rev Med Pharmacol Sci, V8, P97; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nguyen ND, 2006, J BONE MINER RES, V21, P340, DOI 10.1359/JBMR.050903; Ninkovic M, 2002, J HEPATOL, V37, P93, DOI 10.1016/S0168-8278(02)00100-9; Notelovitz M, 2002, MENOPAUSE, V9, P343, DOI 10.1097/00042192-200209000-00007; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Palmer SC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005015.pub2; Palomba S, 2005, OSTEOPOROSIS INT, V16, P1141, DOI 10.1007/s00198-005-1927-z; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z; PECK WA, 1993, AM J MED, V94, P646; Pitt P, 1998, THORAX, V53, P351, DOI 10.1136/thx.53.5.351; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Pouilles JM, 1997, OSTEOPOROSIS INT, V7, P213, DOI 10.1007/BF01622291; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Ravn P, 1996, BONE, V19, P527, DOI 10.1016/S8756-3282(96)00229-3; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Recker R, 2004, BONE, V34, P890, DOI 10.1016/j.bone.2004.01.008; Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Reid IR, 2004, ARCH INTERN MED, V164, P871, DOI 10.1001/archinte.164.8.871; REID IR, 1988, LANCET, V1, P143; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; REID IR, 1994, J CLIN ENDOCR METAB, V79, P1595, DOI 10.1210/jc.79.6.1595; Richy F, 2004, OSTEOPOROSIS INT, V15, P301, DOI 10.1007/s00198-003-1570-5; Richy F, 2005, CALCIFIED TISSUE INT, V76, P176, DOI 10.1007/s00223-004-0005-4; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roux C, 1998, J CLIN ENDOCR METAB, V83, P1128, DOI 10.1210/jc.83.4.1128; Rubin MR, 2003, J CLIN ENDOCR METAB, V88, P1174, DOI 10.1210/jc.2002-020667; Ryan PJ, 2000, OSTEOPOROSIS INT, V11, P171, DOI 10.1007/PL00004179; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sasser AC, 2005, WOMEN HEALTH ISS, V15, P97, DOI 10.1016/j.whi.2004.11.006; Sato S, 2003, J RHEUMATOL, V30, P2673; Sato Y, 2000, J BONE MINER RES, V15, P2487, DOI 10.1359/jbmr.2000.15.12.2487; Sato Y, 2005, ARCH INTERN MED, V165, P1737, DOI 10.1001/archinte.165.15.1737; Sato Y, 2005, NEUROLOGY, V64, P811, DOI 10.1212/01.WNL.0000152871.65027.76; Sato Y, 2005, CEREBROVASC DIS, V20, P187, DOI 10.1159/000087203; Sato Y, 2005, ARCH INTERN MED, V165, P1743, DOI 10.1001/archinte.165.15.1743; Sato Y, 2004, AM J PHYS MED REHAB, V83, P298, DOI 10.1097/01.PHM.0000122877.28631.23; Sato Y, 2006, BONE, V39, P1080, DOI 10.1016/j.bone.2006.04.025; Sato Y, 2006, MOVEMENT DISORD, V21, P924, DOI 10.1002/mds.20825; Sawka AM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-39; SCHACHTER HM, 2005, RALOXIFENE PRIMARY 2; Seeman E, 2006, OSTEOPOROSIS INT, V17, P313, DOI 10.1007/s00198-005-2030-1; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; SILBERSTEIN EB, 1992, J NUCL MED, V33, P1; Skingle SJ, 1997, INT J CLIN PRACT, V51, P364; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Sorensen OH, 2003, BONE, V32, P120, DOI 10.1016/S8756-3282(02)00946-8; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Tauchmanova L, 2006, BONE MARROW TRANSPL, V37, P81, DOI 10.1038/sj.bmt.1705196; Torgerson D J, 2001, BMC Musculoskelet Disord, V2, P7, DOI 10.1186/1471-2474-2-7; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Toth E, 2005, BONE, V36, P47, DOI 10.1016/j.bone.2004.09.003; Trovas GP, 2002, J BONE MINER RES, V17, P521, DOI 10.1359/jbmr.2002.17.3.521; Uchida S, 2005, J BONE MINER METAB, V23, P382, DOI 10.1007/s00774-005-0616-5; Ushiroyama T, 2001, MATURITAS, V40, P229, DOI 10.1016/S0378-5122(01)00243-2; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002; Wimalawansa SJ, 1998, AM J MED, V104, P219, DOI 10.1016/S0002-9343(98)00029-1; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zein CO, 2005, HEPATOLOGY, V42, P762, DOI 10.1002/hep.20866; Zheng SR, 2003, CHINESE MED J-PEKING, V116, P1127	162	374	420	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					197	213		10.7326/0003-4819-148-3-200802050-00198	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00198			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18087050				2022-12-28	WOS:000252849700004
J	Malhi, Y; Roberts, JT; Betts, RA; Killeen, TJ; Li, WH; Nobre, CA				Malhi, Yadvinder; Roberts, J. Timmons; Betts, Richard A.; Killeen, Timothy J.; Li, Wenhong; Nobre, Carlos A.			Climate change, deforestation, and the fate of the Amazon	SCIENCE			English	Review							TROPICAL FORESTS; RAIN-FOREST; BIOMASS; FIRE; BIODIVERSITY; CIRCULATION; RESPONSES; NORTHERN; TRENDS; STATE	The forest biome of Amazonia is one of Earth's greatest biological treasures and a major component of the Earth system. This century, it faces the dual threats of deforestation and stress from climate change. Here, we summarize some of the latest findings and thinking on these threats, explore the consequences for the forest ecosystem and its human residents, and outline options for the future of Amazonia. We also discuss the implications of new proposals to finance preservation of Amazonian forests.	[Malhi, Yadvinder; Roberts, J. Timmons] Univ Oxford, Ctr Environm, Environm Change Inst, Oxford OX1 3QY, England; [Roberts, J. Timmons] Coll William & Mary, Williamsburg, VA 23187 USA; [Betts, Richard A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Killeen, Timothy J.] Conservat Int, Washington, DC 20036 USA; [Li, Wenhong] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Nobre, Carlos A.] Inst Nacl Pesquisas Espaciais, BR-12201 Sao Jose Dos Campos, SP, Brazil	University of Oxford; William & Mary; Met Office - UK; Hadley Centre; Conservation International; University System of Georgia; Georgia Institute of Technology; Instituto Nacional de Pesquisas Espaciais (INPE)	Malhi, Y (corresponding author), Univ Oxford, Ctr Environm, Environm Change Inst, S Parks Rd, Oxford OX1 3QY, England.	yadvinder.malhi@ouce.ox.ac.uk	Betts, Richard A/P-8976-2015; Li, Wenhong/AAK-9940-2020	Betts, Richard A/0000-0002-4929-0307; Li, Wenhong/0000-0002-5990-2004				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alencar AAC, 2004, ECOL APPL, V14, pS139; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Barlow J, 2004, PHILOS T R SOC B, V359, P367, DOI 10.1098/rstb.2003.1423; Barreto P., 2006, HUMAN PRESSURE BRAZI; Betts RA, 2004, THEOR APPL CLIMATOL, V78, P157, DOI 10.1007/s00704-004-0050-y; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chang P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016119; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dong BW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015229; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fisher RA, 2007, GLOBAL CHANGE BIOL, V13, P2361, DOI 10.1111/j.1365-2486.2007.01417.x; Foster P, 2001, EARTH-SCI REV, V55, P73, DOI 10.1016/S0012-8252(01)00056-3; GARSTANG M, 1994, MON WEATHER REV, V122, P608, DOI 10.1175/1520-0493(1994)122<0608:ACSLPI>2.0.CO;2; Gedney N, 2000, GEOPHYS RES LETT, V27, P3053, DOI 10.1029/2000GL011794; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Holmes KW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002507; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; KILLEEN T. J., 2007, ADV APPL BIODIVERSIT; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; Maslin M, 2005, T I BRIT GEOGR, V30, P477, DOI 10.1111/j.1475-5661.2005.00181.x; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Moutinho P., 2005, TROPICAL DEFORESTATI; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira RS, 2005, OECOLOGIA, V145, P354, DOI 10.1007/s00442-005-0108-2; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Roy SB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000266; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Santilli M, 2005, CLIMATIC CHANGE, V71, P267, DOI 10.1007/s10584-005-8074-6; SHARKEY TD, 2004, PHYSL MOL ECOLOGY ST, P101; Shprits YY, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011758; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	48	1093	1133	21	853	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					169	172		10.1126/science.1146961	http://dx.doi.org/10.1126/science.1146961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18048654	Green Submitted			2022-12-28	WOS:000252246400030
J	Cunningham, D; Starling, N				Cunningham, David; Starling, Naureen			Adjuvant chemotherapy of colorectal cancer	LANCET			English	Editorial Material							COLON-CANCER; POOLED ANALYSIS; STAGE-II; FLUOROURACIL; LEUCOVORIN; SURVIVAL; OXALIPLATIN; THERAPY		Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Cunningham, D (corresponding author), Royal Marsden Hosp, Dept Med, Downs Rd, Sutton SM2 5PT, Surrey, England.	david.cunningham@rmh.nhs.uk		Cunningham, David/0000-0001-5158-1069; Starling, Naureen/0000-0002-1496-6792				Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; de Gramont A, 2007, J CLIN ONCOL, V25, P3224, DOI 10.1200/JCO.2006.10.4380; Goldberg RM, 2006, J CLIN ONCOL, V24, P4085, DOI 10.1200/JCO.2006.06.9039; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Heald RJ, 2006, BMJ-BRIT MED J, V333, P808, DOI 10.1136/bmj.333.7572.808; HEALD RJ, 1986, LANCET, V1, P1479; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; OConnell MJ, 1997, J CLIN ONCOL, V15, P246, DOI 10.1200/JCO.1997.15.1.246; Sargent DJ, 2007, J CLIN ONCOL, V25, P4569, DOI 10.1200/JCO.2006.10.4323; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603	16	10	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1980	1981		10.1016/S0140-6736(07)61841-8	http://dx.doi.org/10.1016/S0140-6736(07)61841-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083386				2022-12-28	WOS:000251698600006
J	Becker, CG; Fonseca, CR; Haddad, CFB; Batista, RF; Prado, PI				Becker, Carlos Guilherme; Fonseca, Carlos Roberto; Baptista Haddad, Celio Fernando; Batista, Romulo Fernandes; Prado, Paulo Inacio			Habitat split and the global decline of amphibians	SCIENCE			English	Article							ECOLOGICAL TRAITS; BIODIVERSITY; CONSERVATION; POPULATIONS; EXTINCTIONS; LANDSCAPE; DISEASE; BRAZIL	The worldwide decline in amphibians has been attributed to several causes, especially habitat loss and disease. We identified a further factor, namely "habitat split"- defined as human- induced disconnection between habitats used by different life history stages of a species- which forces forest- associated amphibians with aquatic larvae to make risky breeding migrations between suitable aquatic and terrestrial habitats. In the Brazilian Atlantic Forest, we found that habitat split negatively affects the richness of species with aquatic larvae but not the richness of species with terrestrial development ( the latter can complete their life cycle inside forest remnants). This mechanism helps to explain why species with aquatic larvae have the highest incidence of population decline. These findings reinforce the need for the conservation and restoration of riparian vegetation.	Univ Vale Rio dos Sinos, Lab Interacao Anim Planta, BR-93022970 Sao Leopoldo, RS, Brazil; Univ Estadual Campinas, Dept Zool, BR-13083970 Campinas, SP, Brazil; Univ Estadual Paulista, Dept Zool, BR-13506900 Rio Claro, SP, Brazil; Secretaria Estadual Meio Ambiente & Desenvolvimen, BR-69050030 Manaus, Amazonas, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508900 Sao Paulo, Brazil	Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo	Fonseca, CR (corresponding author), Univ Vale Rio dos Sinos, Lab Interacao Anim Planta, BR-93022970 Sao Leopoldo, RS, Brazil.	cfonseca@unisinos.br	Fonseca, Carlos Roberto/A-9273-2013; Haddad, Célio F. B./C-4267-2012; Fonseca, Carlos Roberto/V-5869-2017; Becker, C. Guilherme/B-9887-2014; Prado, Paulo Inácio/AAN-6512-2021; Prado, Paulo I/G-3353-2012	Haddad, Célio F. B./0000-0002-7044-5764; Fonseca, Carlos Roberto/0000-0003-0292-0399; Prado, Paulo Inácio/0000-0002-7174-5005; 				Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Amezaga JM, 2002, ACTA OECOL, V23, P213, DOI 10.1016/S1146-609X(02)01152-9; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Bustarnante MR, 2005, BIOTROPICA, V37, P180, DOI 10.1111/j.1744-7429.2005.00025.x; CAROLSFELD J, 2004, MIGRATORY FISHES S A; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; *IUCN, CONS INT NATURESERVE; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; MAC ARTHUR ROBERT H., 1967; Mazerolle MJ, 2005, CAN J ZOOL, V83, P455, DOI 10.1139/Z05-032; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mendelson JR, 2006, SCIENCE, V314, P1541; Mittermeier R, 2005, HOTSPOTS REVISITED E; Pounds JA, 2006, SCIENCE, V314, P1541, DOI 10.1126/science.314.5805.1541; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Silvano DL, 2005, CONSERV BIOL, V19, P653, DOI 10.1111/j.1523-1739.2005.00681.x; VIANA V.M., 1997, TROPICAL FOREST REMN, P347; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070	29	408	444	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1775	1777		10.1126/science.1149374	http://dx.doi.org/10.1126/science.1149374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079402				2022-12-28	WOS:000251616800041
J	O'Neill, LAJ				O'Neill, Luke A. J.			TAMpering with toll-like receptor signaling	CELL			English	Editorial Material							CYTOKINE SIGNALING-1; TYROSINE KINASE; SUPPRESSOR; SYSTEM; FAMILY	Toll-like receptors (TLRs) provoke a profound inflammatory response during host defense and must be controlled in order to avoid autoimmune and inflammatory diseases. In this issue, Rothlin et al. (2007) uncover a complex negative feedback mechanism to limit TLR signaling involving the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases, which induce expression of the inhibitory proteins SOCS1 and SOCS3.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Camenisch TD, 1999, J IMMUNOL, V162, P3498; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Pyz E, 2006, ANN MED, V38, P242, DOI 10.1080/07853890600608985; ROTHLIN CV, 2007, CELL	10	27	31	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1039	1041		10.1016/j.cell.2007.11.032	http://dx.doi.org/10.1016/j.cell.2007.11.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083093	Bronze			2022-12-28	WOS:000252217100011
J	Rikova, K; Guo, A; Zeng, Q; Possemato, A; Yu, J; Haack, H; Nardone, J; Lee, K; Reeves, C; Li, Y; Hu, Y; Tan, ZP; Stokes, M; Sullivan, L; Mitchell, J; Wetzel, R; MacNeill, J; Ren, JM; Yuan, J; Bakalarski, CE; Villen, J; Kornhauser, JM; Smith, B; Li, D; Zhou, X; Gygi, SP; Gu, TL; Polakiewicz, RD; Rush, J; Comb, MJ				Rikova, Klarisa; Guo, Ailan; Zeng, Qingfu; Possemato, Anthony; Yu, Jian; Haack, Herbert; Nardone, Julie; Lee, Kimberly; Reeves, Cynthia; Li, Yu; Hu, Yerong; Tan, Zhiping; Stokes, Matthew; Sullivan, Laura; Mitchell, Jeffrey; Wetzel, Randy; MacNeill, Joan; Ren, Jian Min; Yuan, Jin; Bakalarski, Corey E.; Villen, Judit; Kornhauser, Jon M.; Smith, Bradley; Li, Daiqiang; Zhou, Xinmin; Gygi, Steven P.; Gu, Ting-Lei; Polakiewicz, Roberto D.; Rush, John; Comb, Michael J.			Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; ABL TYROSINE KINASE; CELL-LINES; PROSTATE-CANCER; SHOTGUN PROTEOMICS; MYELOID-LEUKEMIA; MUTATIONS; GEFITINIB; FUSION; GENE	Despite the success of tyrosine kinase-based cancer therapeutics, for most solid tumors the tyrosine kinases that drive disease remain unknown, limiting our ability to identify drug targets and predict response. Here we present the first large-scale survey of tyrosine kinase activity in lung cancer. Using a phosphoproteomic approach, we characterize tyrosine kinase signaling across 41 non-small cell lung cancer (NSCLC) cell lines and over 150 NSCLC tumors. Profiles of phosphotyrosine signaling are generated and analyzed to identify known oncogenic kinases such as EGFR and c-Met as well as novel ALK and ROS fusion proteins. Other activated tyrosine kinases such as PDGFR alpha and DDR1 not previously implicated in the genesis of NSCLC are also identified. By focusing on activated cell circuitry, the approach outlined here provides insight into cancer biology not available at the chromosomal and transcriptional levels and can be applied broadly across all human cancers.	[Rikova, Klarisa; Guo, Ailan; Zeng, Qingfu; Possemato, Anthony; Yu, Jian; Haack, Herbert; Nardone, Julie; Lee, Kimberly; Reeves, Cynthia; Li, Yu; Stokes, Matthew; Sullivan, Laura; Mitchell, Jeffrey; Wetzel, Randy; MacNeill, Joan; Ren, Jian Min; Yuan, Jin; Kornhauser, Jon M.; Smith, Bradley; Li, Daiqiang; Gu, Ting-Lei; Polakiewicz, Roberto D.; Rush, John; Comb, Michael J.] Cell Signaling Technol, Danvers, MA 01923 USA; [Bakalarski, Corey E.; Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hu, Yerong; Tan, Zhiping; Zhou, Xinmin] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha 410011, Hunan, Peoples R China; [Li, Daiqiang] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China	Harvard University; Harvard Medical School; Central South University; Central South University	Comb, MJ (corresponding author), Cell Signaling Technol, 3 Trask Lane, Danvers, MA 01923 USA.	mcomb@cellsignal.com		Villen, Judit/0000-0002-1005-1739; Bakalarski, Corey/0000-0003-1085-7828				Amann J, 2005, CANCER RES, V65, P226; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dowell JE, 2005, NEW ENGL J MED, V352, P830, DOI 10.1056/NEJMe058033; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu TL, 2006, BLOOD, V108, P4202, DOI 10.1182/blood-2006-06-026666; Hernandez L, 1999, BLOOD, V94, P3265; Hernandez L, 2002, AM J PATHOL, V160, P1487, DOI 10.1016/S0002-9440(10)62574-6; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Minami Y, 2007, ONCOGENE, V26, P5023, DOI 10.1038/sj.onc.1210292; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	54	1732	1886	4	224	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1190	1203		10.1016/j.cell.2007.11.025	http://dx.doi.org/10.1016/j.cell.2007.11.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083107	Bronze			2022-12-28	WOS:000252217100025
J	Schmidt, AR; Dorfelt, H; Perrichot, V				Schmidt, Alexander R.; Doerfelt, Heinrich; Perrichot, Vincent			Carnivorous fungi from Cretaceous amber	SCIENCE			English	Article							EVOLUTION		Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; Univ Halle Wittenberg, Inst Geobot, D-06108 Halle, Germany; Univ Halle Wittenberg, Bot Garten, D-06108 Halle, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schmidt, AR (corresponding author), Humboldt Univ, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	alexander.schmidt@museum.hu-berlin.de	Perrichot, Vincent/I-4134-2019	Perrichot, Vincent/0000-0002-7973-0430				Ahren D, 2003, J NEMATOL, V35, P194; Barron G.L., 1977, NEMATODE DESTROYING, VI, P144; Hao Y, 2005, AQUAT MICROB ECOL, V40, P175, DOI 10.3354/ame040175; JANSSON HB, 1986, T BRIT MYCOL SOC, V87, P471, DOI 10.1016/S0007-1536(86)80227-3; Perrichot V, 2007, AFR INVERTEBR, V48, P213; Yang Y, 2007, P NATL ACAD SCI USA, V104, P8379, DOI 10.1073/pnas.0702770104	6	41	43	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1743	1743		10.1126/science.1149947	http://dx.doi.org/10.1126/science.1149947			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079393				2022-12-28	WOS:000251616800030
J	Daily, JP; Scanfeld, D; Pochet, N; Le Roch, K; Plouffe, D; Kamal, M; Sarr, O; Mboup, S; Ndir, O; Wypij, D; Levasseur, K; Thomas, E; Tamayo, P; Dong, C; Zhou, Y; Lander, ES; Ndiaye, D; Wirth, D; Winzeler, EA; Mesirov, JP; Regev, A				Daily, J. P.; Scanfeld, D.; Pochet, N.; Le Roch, K.; Plouffe, D.; Kamal, M.; Sarr, O.; Mboup, S.; Ndir, O.; Wypij, D.; Levasseur, K.; Thomas, E.; Tamayo, P.; Dong, C.; Zhou, Y.; Lander, E. S.; Ndiaye, D.; Wirth, D.; Winzeler, E. A.; Mesirov, J. P.; Regev, A.			Distinct physiological states of Plasmodium falciparum in malaria-infected patients	NATURE			English	Article							GENE-FUNCTION; TRANSCRIPTOME; CHILDREN; PARASITE; STAGE; AQUAGLYCEROPORIN; MITOCHONDRIA; ANNOTATION; DISCOVERY; DATABASE	Infection with the malaria parasite Plasmodium falciparum leads to widely different clinical conditions in children, ranging from mild flu- like symptoms to coma and death(1). Despite the immense medical implications, the genetic and molecular basis of this diversity remains largely unknown(2). Studies of in vitro gene expression have found few transcriptional differences between different parasite strains(3). Here we present a large study of in vivo expression profiles of parasites derived directly from blood samples from infected patients. The in vivo expression profiles define three distinct transcriptional states. The biological basis of these states can be interpreted by comparison with an extensive compendium of expression data in the yeast Saccharomyces cerevisiae. The three states in vivo closely resemble, first, active growth based on glycolytic metabolism, second, a starvation response accompanied by metabolism of alternative carbon sources, and third, an environmental stress response. The glycolytic state is highly similar to the known profile of the ring stage in vitro, but the other states have not been observed in vitro. The results reveal a previously unknown physiological diversity in the in vivo biology of the malaria parasite, in particular evidence for a functional mitochondrion in the asexual- stage parasite, and indicate in vivo and in vitro studies to determine how this variation may affect disease manifestations and treatment.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Cheikh Anta Diop Univ, Dantec Hosp, Lab Bacteriol & Virol, Dakar, Senegal; Cheikh Anta Diop Univ, Dantec Hosp, Dept Parasitol & Mycol, Dakar, Senegal; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of California System; University of California Riverside; Novartis; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute	Mesirov, JP (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mesirov@broad.mit.edu; aregev@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Pochet, Nathalie/Q-1322-2017; Winzeler, Elizabeth/AAP-6752-2020	Pochet, Nathalie/0000-0003-1820-5656; Winzeler, Elizabeth/0000-0002-4049-2113; Wypij, David/0000-0001-8367-8711	NIAID NIH HHS [K23 AI054518] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054518] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashburner M, 2003, COLD SPRING HARB SYM, V68, P227, DOI 10.1101/sqb.2003.68.227; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Daily JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Faye O, 1995, Dakar Med, V40, P201; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Happi CT, 2004, AM J TROP MED HYG, V70, P20, DOI 10.4269/ajtmh.2004.70.20; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Planche T, 2006, CURR MOL MED, V6, P141, DOI 10.2174/156652406776055177; Promeneur D, 2007, P NATL ACAD SCI USA, V104, P2211, DOI 10.1073/pnas.0610843104; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Uyemura SA, 2004, J BIOL CHEM, V279, P385, DOI 10.1074/jbc.M307264200; White NJ, 2002, MANSONS TROPICAL DIS, P1205; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	41	177	179	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1091	U15		10.1038/nature06311	http://dx.doi.org/10.1038/nature06311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18046333	Bronze			2022-12-28	WOS:000251579900089
J	Solli, DR; Ropers, C; Koonath, P; Jalali, B				Solli, D. R.; Ropers, C.; Koonath, P.; Jalali, B.			Optical rogue waves	NATURE			English	Article							SUPERCONTINUUM GENERATION; CONTINUUM GENERATION; FREAK WAVES; SEA; DISPERSION; FREQUENCY	Recent observations show that the probability of encountering an extremely large rogue wave in the open ocean is much larger than expected from ordinary wave- amplitude statistics(1-3). Although considerable effort has been directed towards understanding the physics behind these mysterious and potentially destructive events, the complete picture remains uncertain. Furthermore, rogue waves have not yet been observed in other physical systems. Here, we introduce the concept of optical rogue waves, a counterpart of the infamous rare water waves. Using a new real- time detection technique, we study a system that exposes extremely steep, large waves as rare outcomes from an almost identically prepared initial population of waves. Specifically, we report the observation of rogue waves in an optical system, based on a microstructured optical fibre, near the threshold of soliton- fission supercontinuum generation(4,5) - a noise- sensitive(5-7) nonlinear process in which extremely broadband radiation is generated from a narrowband input(8). We model the generation of these rogue waves using the generalized nonlinear Schrodinger equation(9) and demonstrate that they arise infrequently from initially smooth pulses owing to power transfer seeded by a small noise perturbation.	Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; Max Born Inst Nonlinear Opt & Short Pulse Spect, D-12489 Berlin, Germany	University of California System; University of California Los Angeles; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Solli, DR (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	solli@ucla.edu	jalali, bahram/AFK-2299-2022; Ropers, Claus/D-4843-2015	Ropers, Claus/0000-0002-9539-3817				Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Alfano RR, 2006, SCI AM, V295, P86, DOI 10.1038/scientificamerican1206-86; Boyraz O, 2000, J LIGHTWAVE TECHNOL, V18, P2167, DOI 10.1109/50.908829; BROAD WJ, 2006, NY TIMES        0711; Corwin KL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113904; DEAN RG, 1990, NATO ADV SCI I E-APP, V178, P609; Dudley JM, 2006, REV MOD PHYS, V78, P1135, DOI 10.1103/RevModPhys.78.1135; DYSTHE K, 2005, ROGUE WAVES, P91; Gaeta AL, 2002, OPT LETT, V27, P924, DOI 10.1364/OL.27.000924; Gu X, 2002, OPT LETT, V27, P1174, DOI 10.1364/OL.27.001174; Han Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2142087; Henderson KL, 1999, WAVE MOTION, V29, P341, DOI 10.1016/S0165-2125(98)00045-6; Herrmann J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173901; Hopkin M, 2004, NATURE, V430, P492, DOI 10.1038/430492b; ISLAM MN, 1989, J OPT SOC AM B, V6, P1149, DOI 10.1364/JOSAB.6.001149; Janssen PAEM, 2003, J PHYS OCEANOGR, V33, P863, DOI 10.1175/1520-0485(2003)33<863:NFIAFW>2.0.CO;2; Kutz JN, 2005, OPT EXPRESS, V13, P3989, DOI 10.1364/OPEX.13.003989; Nakazawa M, 1999, OPT LETT, V24, P318, DOI 10.1364/OL.24.000318; OLIU PC, 2006, P OMAE2006, P1; Onorato M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.014503; Onorato M, 2001, PHYS REV LETT, V86, P5831, DOI 10.1103/PhysRevLett.86.5831; Perkins S., 2006, SCI NEWS, V170, P328; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Shukla PK, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094501; Trulsen K, 1996, WAVE MOTION, V24, P281, DOI 10.1016/S0165-2125(96)00020-0; Walker DAG, 2004, APPL OCEAN RES, V26, P73, DOI 10.1016/j.apor.2005.02.001; White BS, 1998, J FLUID MECH, V355, P113, DOI 10.1017/S0022112097007751	29	1826	1846	15	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1054	U7		10.1038/nature06402	http://dx.doi.org/10.1038/nature06402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075587				2022-12-28	WOS:000251579900080
J	Hudis, C; Modi, S				Hudis, Clifford; Modi, Shanu			Preoperative chemotherapy for breast cancer - Miracle or mirage?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEOADJUVANT CHEMOTHERAPY; NODE BIOPSY; ADJUVANT; RECURRENCE; THERAPY; MASTECTOMY; PREDICT; WOMEN		Cornell Univ, Weill Coll Med, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10024 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Hudis, C (corresponding author), Cornell Univ, Weill Coll Med, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, 1275 York Ave,Box 206, New York, NY 10024 USA.	hudisc@mskcc.org	Hudis, Clifford/AAW-9482-2021	Hudis, Clifford/0000-0001-7144-8791; Modi, Shanu/0000-0001-6427-7373				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Brito RA, 2001, J CLIN ONCOL, V19, P628, DOI 10.1200/JCO.2001.19.3.628; Buchholz TA, 2002, INT J RADIAT ONCOL, V53, P880, DOI 10.1016/S0360-3016(02)02850-X; Buchholz TA, 2002, J CLIN ONCOL, V20, P17, DOI 10.1200/JCO.20.1.17; Charfare H, 2005, BRIT J SURG, V92, P14, DOI 10.1002/bjs.4840; Colozzaa M, 2006, ONCOLOGIST, V11, P111, DOI 10.1634/theoncologist.11-2-111; EAR HD, 2003, J CLIN ONCOL, V21, P4165; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; HENDERSON IC, 1985, J CLIN ONCOL, V3, P140, DOI 10.1200/JCO.1985.3.2.140; Honkoop AH, 1998, ONCOLOGY-BASEL, V55, P218, DOI 10.1159/000011861; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hunt KK, 1996, SURG CLIN N AM, V76, P393, DOI 10.1016/S0039-6109(05)70446-1; Jones JL, 2005, AM J SURG, V190, P517, DOI 10.1016/j.amjsurg.2005.06.004; Kuerer HM., 2002, SEMIN BREAST DIS, V5, P80; Newman EA, 2007, SURG CLIN N AM, V87, P353, DOI 10.1016/j.suc.2007.01.013; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pectasides D, 2005, EUR UROL, V48, P60, DOI 10.1016/j.eururo.2005.03.025; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Smith IC, 2002, J CLIN ONCOL, V20, P1456, DOI 10.1200/JCO.20.6.1456; Valero Vicente, 2002, Clin Breast Cancer, V3 Suppl 2, pS63, DOI 10.3816/CBC.2002.s.014; von Minckwitz G, 2005, ANN ONCOL, V16, P56, DOI 10.1093/annonc/mdi001; Vyzula R, 2004, NEOPLASMA, V51, P471; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	25	11	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2665	2667		10.1001/jama.298.22.2665	http://dx.doi.org/10.1001/jama.298.22.2665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073362				2022-12-28	WOS:000251546100018
J	Rodrigues, ASL				Rodrigues, Ana S. L.			Effective global conservation strategies	NATURE			English	Letter									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Rodrigues, ASL (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	aslr2@cam.ac.uk	Rodrigues, Ana/GYQ-6273-2022; Rodrigues, Ana S.L./A-5914-2009	Rodrigues, Ana S.L./0000-0003-4775-0127				[Anonymous], 2004, HOTSPOTS REVISITED E; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; *IUCN, 2006, GLOB AMPH ASS; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; SECHREST WW, 2003, THESIS U VIRGINIA; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538	9	10	10	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					E19	E19		10.1038/nature06374	http://dx.doi.org/10.1038/nature06374			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063950	Bronze			2022-12-28	WOS:000251394900041
J	Chretien, JP; Linthicum, KJ				Chretien, Jean-Paul; Linthicum, Kenneth J.			Chikungunya in Europe: what's next?	LANCET			English	Editorial Material							EMERGENCE; DENGUE; FEVER		US Dept Def, Global Emerging Infect Surveillance & Response Sy, Silver Spring, MD 20910 USA; ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	United States Department of Defense; United States Department of Agriculture (USDA)	Chretien, JP (corresponding author), US Dept Def, Global Emerging Infect Surveillance & Response Sy, Silver Spring, MD 20910 USA.	Jean-Paul.Chretien@na.amedd.army.mil		Chretien, Jean-Paul/0000-0001-8143-6823				Anyamba Assaf, 2006, Int J Health Geogr, V5, P60, DOI 10.1186/1476-072X-5-60; Callaway E, 2007, NATURE, V448, P734, DOI 10.1038/448734a; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Linthicum Kenneth J, 2007, Vet Ital, V43, P663; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; *PROMED MAIL SERV, 2007, CHIK IMP RISK TRANSM; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Smolinsky M.S., 2003, MICROBIAL THREATS HL	12	29	29	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1805	1806		10.1016/S0140-6736(07)61752-8	http://dx.doi.org/10.1016/S0140-6736(07)61752-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061039				2022-12-28	WOS:000251588700005
J	Lowe, S				Lowe, Siri			A patient's journey - Pemphigus vulgaris	BRITISH MEDICAL JOURNAL			English	Editorial Material									Pemphigus Vulgaris Network, London, England		Lowe, S (corresponding author), Pemphigus Vulgaris Network, London, England.	siri.lowe@btopenworld.com							0	0	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1152	1154		10.1136/bmj.39374.504884.BE	http://dx.doi.org/10.1136/bmj.39374.504884.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048542	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000251596100038
J	Taylor, DR; Hall, IP				Taylor, D. Robin; Hall, Ian P.			ADRB2 polymorphisms and beta(2) agonists	LANCET			English	Editorial Material							ASTHMA; SALMETEROL; RECEPTOR; GENOTYPE; EXACERBATIONS		[Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand; [Hall, Ian P.] Univ Nottingham, Fac Med, Nottingham NG7 2RD, England	University of Otago; University of Nottingham	Taylor, DR (corresponding author), Univ Otago, Dunedin Sch Med, Dunedin, New Zealand.	robin.taylor@stonebow.otago.ac.nz		Hall, Ian/0000-0001-9933-3216				Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bleecker ER, 2006, J ALLERGY CLIN IMMUN, V118, P809, DOI 10.1016/j.jaci.2006.06.036; Hall IP, 2006, LANCET, V368, P771, DOI 10.1016/S0140-6736(06)69287-8; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; O'Byrne PM, 2006, CHEST, V129, P3, DOI 10.1378/chest.129.1.3; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; Shore Stephanie A., 2002, Journal of Allergy and Clinical Immunology, V110, pS255, DOI 10.1067/mai.2002.129947; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Wechsler ME, 2006, AM J RESP CRIT CARE, V173, P519, DOI 10.1164/rccm.200509-1519OC	11	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2075	2076		10.1016/S0140-6736(07)61876-5	http://dx.doi.org/10.1016/S0140-6736(07)61876-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156014				2022-12-28	WOS:000252058600006
J	Cunningham, JT; Rodgers, JT; Arlow, DH; Vazquez, F; Mootha, VK; Puigserver, P				Cunningham, John T.; Rodgers, Joseph T.; Arlow, Daniel H.; Vazquez, Francisca; Mootha, Vamsi K.; Puigserver, Pere			mTOR controls mitochondrial oxidative function through a YY1-PGC-1 alpha transcriptional complex	NATURE			English	Article							INSULIN-RESISTANCE; AMINO-ACID; ERR-ALPHA; METABOLISM; GENES; CELL; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; SIROLIMUS	Transcriptional complexes that contain peroxisome-proliferator-activated receptor coactivator (PGC)-1 alpha control mitochondrial oxidative function to maintain energy homeostasis in response to nutrient and hormonal signals(1,2). An important component in the energy and nutrient pathways is mammalian target of rapamycin (mTOR), a kinase that regulates cell growth, size and survival(3-5). However, it is unknown whether and how mTOR controls mitochondrial oxidative activities. Here we show that mTOR is necessary for the maintenance of mitochondrial oxidative function. In skeletal muscle tissues and cells, the mTOR inhibitor rapamycin decreased the gene expression of the mitochondrial transcriptional regulators PGC-1 alpha, oestrogen-related receptor a and nuclear respiratory factors, resulting in a decrease in mitochondrial gene expression and oxygen consumption. Using computational genomics, we identified the transcription factor yin-yang 1 (YY1) as a common target of mTOR and PGC-1 alpha. Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and raptor interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1 alpha. We have therefore identified a mechanism by which a nutrient sensor (mTOR) balances energy metabolism by means of the transcriptional control of mitochondrial oxidative function. These results have important implications for our understanding of how these pathways might be altered in metabolic diseases and cancer.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Puigserver, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	vamsi@hms.harvard.edu; pere_puigserver@dfci.harvard.edu	Cunningham, John T./AAS-5008-2021; Vazquez, Francisca/ABC-4620-2020	Cunningham, John T./0000-0001-6490-4533; Rodgers, Joseph/0000-0002-6598-5520				Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ribes D, 2005, TRANSPL P, V37, P2813, DOI 10.1016/j.transproceed.2005.05.029; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	30	1025	1061	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					736	U12		10.1038/nature06322	http://dx.doi.org/10.1038/nature06322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046414				2022-12-28	WOS:000251209700057
J	Drossart, P; Piccioni, G; Gerard, JC; Lopez-Valverde, MA; Sanchez-Lavega, A; Zasova, L; Hueso, R; Taylor, FW; Bezard, B; Adriani, A; Angrilli, F; Arnold, G; Baines, KH; Bellucci, G; Benkhoff, J; Bibring, JP; Blanco, A; Blecka, MI; Carlson, RW; Coradini, A; Di Lellis, A; Encrenaz, T; Erard, S; Fonti, S; Formisano, V; Fouchet, T; Garcia, R; Haus, R; Helbert, J; Ignatiev, NI; Irwin, P; Langevin, Y; Lebonnois, S; Luz, D; Marinangeli, L; Orofino, V; Rodin, AV; Roos-Serote, MC; Saggin, B; Stam, DM; Titov, D; Visconti, G; Zambelli, M; Tsang, C				Drossart, P.; Piccioni, G.; Gerard, J. C.; Lopez-Valverde, M. A.; Sanchez-Lavega, A.; Zasova, L.; Hueso, R.; Taylor, F. W.; Bezard, B.; Adriani, A.; Angrilli, F.; Arnold, G.; Baines, K. H.; Bellucci, G.; Benkhoff, J.; Bibring, J. P.; Blanco, A.; Blecka, M. I.; Carlson, R. W.; Coradini, A.; Di Lellis, A.; Encrenaz, T.; Erard, S.; Fonti, S.; Formisano, V.; Fouchet, T.; Garcia, R.; Haus, R.; Helbert, J.; Ignatiev, N. I.; Irwin, P.; Langevin, Y.; Lebonnois, S.; Luz, D.; Marinangeli, L.; Orofino, V.; Rodin, A. V.; Roos-Serote, M. C.; Saggin, B.; Stam, D. M.; Titov, D.; Visconti, G.; Zambelli, M.; Tsang, C.		VIRTIS-Venus Express Tech Te	A dynamic upper atmosphere of Venus as revealed by VIRTIS on Venus Express	NATURE			English	Article							INFRARED EMISSIONS; AIRGLOW; MARS	The upper atmosphere of a planet is a transition region in which energy is transferred between the deeper atmosphere and outer space. Molecular emissions from the upper atmosphere (90-120 km altitude) of Venus can be used to investigate the energetics and to trace the circulation of this hitherto little-studied region. Previous spacecraft(1) and ground-based(2-4) observations of infrared emission from CO2, O-2 and NO have established that photochemical and dynamic activity controls the structure of the upper atmosphere of Venus. These data, however, have left unresolved the precise altitude of the emission(1) owing to a lack of data and of an adequate observing geometry(5,6). Here we report measurements of day-side CO2 non-local thermodynamic equilibrium emission at 4.3 mu m, extending from 90 to 120 km altitude, and of night-side O-2 emission extending from 95 to 100 km. The CO2 emission peak occurs at similar to 115 km and varies with solar zenith angle over a range of similar to 10 km. This confirms previous modelling(7), and permits the beginning of a systematic study of the variability of the emission. The O-2 peak emission happens at 96 km +/- 1 km, which is consistent with three-body recombination of oxygen atoms transported from the day side by a global thermospheric sub-solar to anti-solar circulation, as previously predicted(8).	Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, F-92195 Meudon, France; INAF IASF, I-00133 Rome, Italy; INAF IFSI, I-00133 Rome, Italy; Univ Liege, LPAP, B-4000 Liege, Belgium; CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; Univ Basque Country, Escuela Super Ingn Fis Aplicada 1, Bilbao 48013, Spain; Space Res Inst, IKI, Moscow, Russia; Clarendon Lab, Oxford OX1 3PU, England; Univ Padua, CISAS, I-35131 Padua, Italy; German Aerosp Ctr, DLR, D-12489 Berlin, Germany; Jet Propuls Lab, Pasadena, CA 91109 USA; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Lecce, Dipartimento Fis, I-73100 Lecce, Italy; Ctr Badan Kosmicznych Pan, PL-00716 Warsaw, Poland; AMDLSPACE, I-00149 Rome, Italy; Observ Midi Pyrenees, CNRS, UMR5562, F-31400 Toulouse, France; UPMC, Meteorol Dynam Lab, F-75252 Paris 05, France; Univ G DAnnunzio, I-65127 Pescara, Italy; Lisbon Astron Observ, P-1349018 Lisbon, Portugal; Politecn Milan, I-20133 Milan, Italy; Univ Amsterdam, NL-1098 SJ Amsterdam, Netherlands; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Aquila, Dipartimento Fis, I-67010 Laquila, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Liege; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Basque Country; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Oxford; University of Padua; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Salento; Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite; G d'Annunzio University of Chieti-Pescara; Universidade de Lisboa; Polytechnic University of Milan; University of Amsterdam; Max Planck Society; University of L'Aquila	Drossart, P (corresponding author), Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, 5 Pl Jules Janssen, F-92195 Meudon, France.		Hueso, Ricardo/Z-3277-2019; Tosi, Federico/F-2321-2018; Piccioni, Giuseppe/T-9272-2017; Rodin, Alexander V./L-1904-2013; Filacchione, Gianrico/S-2320-2017; Fouchet, Thierry/C-6374-2017; Garcia, Raphael F./B-2612-2012; Rodin, Alexander/M-8693-2019; Bellucci, Giancarlo/ABA-9201-2020; Cardesin-Moinelo, Alejandro/AAF-2783-2021; saggin, bortolino/G-2831-2018; Sanchez-Lavega, Agustin/Z-3639-2019; Drossart, Pierre/H-8670-2013; Luz, David/J-4588-2013; Helbert, Jorn/P-1570-2019	Hueso, Ricardo/0000-0003-0169-123X; Tosi, Federico/0000-0003-4002-2434; Piccioni, Giuseppe/0000-0002-7893-6808; Rodin, Alexander V./0000-0002-3601-7790; Filacchione, Gianrico/0000-0001-9567-0055; Fouchet, Thierry/0000-0001-9040-8285; Garcia, Raphael F./0000-0003-1460-6663; Rodin, Alexander/0000-0002-3601-7790; Bellucci, Giancarlo/0000-0003-0867-8679; Cardesin-Moinelo, Alejandro/0000-0001-8932-9694; saggin, bortolino/0000-0002-4033-3585; Luz, David/0000-0002-9473-8035; Helbert, Jorn/0000-0001-5346-9505; De Nino, Maurizio/0000-0002-1171-7272; Adriani, Alberto/0000-0003-4998-8008; BETTANINI FECIA DI COSSATO, Carlo/0000-0001-5457-9108; LEBONNOIS, SEBASTIEN/0000-0002-2390-8164; Blecka, Maria/0000-0002-6473-1211; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Sanchez-Lavega, Agustin/0000-0001-7234-7634; GERARD, Jean-Claude/0000-0002-8565-8746; Ignatiev, Nikolay/0000-0002-6358-7094; Erard, Stephane/0000-0002-9099-8366; Capaccioni, Fabrizio/0000-0003-1631-4314; Bezard, Bruno/0000-0002-5433-5661; Taylor, Fred/0000-0002-0675-9769; Knoll, Ralph/0000-0001-8871-112X; MARINANGELI, Lucia/0000-0001-5417-6122; Lopez-Valverde, M. A./0000-0002-7989-4267; Sanchez-Lavega, Agustin/0000-0001-7355-1522				Bougher S. W., 1997, VENUS 2, P259; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; Crisp D, 1996, J GEOPHYS RES-PLANET, V101, P4577, DOI 10.1029/95JE03136; Crovisier J, 2006, PLANET SPACE SCI, V54, P1398, DOI 10.1016/j.pss.2006.04.027; DROSSART P, IN PRESS PLANET SPAC, DOI DOI 10.1016/J.PSS.2007.01.03; Formisano V, 2006, ICARUS, V182, P51, DOI 10.1016/j.icarus.2005.12.022; Keating G.M., 1985, ADV SPACE RES, V5, P117, DOI [10.1016/0273-1177(85)90200-5, DOI 10.1016/0273-1177(85)90200-5]; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; LELLOUCH E, 1997, VENUS 2, P295; Lopez-Valverde MA, 2007, PLANET SPACE SCI, V55, P1757, DOI 10.1016/j.pss.2007.01.008; LOPEZVALVERDE MA, 1994, J GEOPHYS RES-PLANET, V99, P13093, DOI 10.1029/94JE00635; Ohtsuki S, 2005, ADV SPACE RES-SERIES, V36, P2038, DOI 10.1016/j.asr.2005.05.078; Picard RH, 1998, GEOPHYS RES LETT, V25, P2809, DOI 10.1029/98GL01701; Roldan C, 2000, ICARUS, V147, P11, DOI 10.1006/icar.2000.6432; Titov DV, 2006, PLANET SPACE SCI, V54, P1279, DOI 10.1016/j.pss.2006.04.017	15	79	80	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					641	645		10.1038/nature06140	http://dx.doi.org/10.1038/nature06140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046396	Green Published			2022-12-28	WOS:000251209700036
J	Mashchenko, S; Wadsley, J; Couchman, HMP				Mashchenko, Sergey; Wadsley, James; Couchman, H. M. P.			Stellar feedback in dwarf galaxy formation	SCIENCE			English	Article							DARK-MATTER; STAR-FORMATION; SPHEROIDAL GALAXIES; SIMULATIONS; PROFILES; CUSPS; CORES; HALOS	Dwarf galaxies pose substantial challenges for cosmological models. In particular, current models predict a dark- matter density that is divergent at the center, which is in sharp contrast with observations that indicate a core of roughly constant density. Energy feedback, from supernova explosions and stellar winds, has been proposed as a major factor shaping the evolution of dwarf galaxies. We present detailed cosmological simulations with sufficient resolution both to model the relevant physical processes and to directly assess the impact of stellar feedback on observable properties of dwarf galaxies. We show that feedback drives large- scale, bulk motions of the interstellar gas, resulting in substantial gravitational potential fluctuations and a consequent reduction in the central matter density, bringing the theoretical predictions in agreement with observations.	[Mashchenko, Sergey; Wadsley, James; Couchman, H. M. P.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University	Mashchenko, S (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	syam@physics.mcmaster.ca						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Battaglia G, 2006, ASTRON ASTROPHYS, V459, P423, DOI 10.1051/0004-6361:20065720; de Avillez MA, 2005, ASTRON ASTROPHYS, V436, P585, DOI 10.1051/0004-6361:20042146; El-Zant A, 2001, ASTROPHYS J, V560, P636, DOI 10.1086/322516; Gentile G, 2005, ASTROPHYS J, V634, pL145, DOI 10.1086/498939; Gilmore G, 2007, ASTROPHYS J, V663, P948, DOI 10.1086/518025; Gnedin OY, 2002, MON NOT R ASTRON SOC, V333, P299, DOI 10.1046/j.1365-8711.2002.05361.x; Goerdt T, 2006, MON NOT R ASTRON SOC, V368, P1073, DOI 10.1111/j.1365-2966.2006.10182.x; Kazantzidis S, 2006, ASTROPHYS J, V641, P647, DOI 10.1086/500579; Kleyna JT, 2003, ASTROPHYS J, V588, pL21, DOI 10.1086/375522; Lotz JM, 2001, ASTROPHYS J, V552, P572, DOI 10.1086/320545; Marcolini A, 2006, MON NOT R ASTRON SOC, V371, P643, DOI 10.1111/j.1365-2966.2006.10671.x; Mashchenko S, 2006, NATURE, V442, P539, DOI 10.1038/nature04944; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; Mayer L, 2007, NATURE, V445, P738, DOI 10.1038/nature05552; Navarro JF, 2004, MON NOT R ASTRON SOC, V349, P1039, DOI 10.1111/j.1365-2966.2004.07586.x; Navarro JF, 1996, MON NOT R ASTRON SOC, V283, pL72, DOI 10.1093/mnras/283.3.L72; Pelupessy FI, 2006, ASTROPHYS J, V645, P1024, DOI 10.1086/504366; Pelupessy FI, 2004, ASTRON ASTROPHYS, V422, P55, DOI 10.1051/0004-6361:20047071; Read JI, 2006, MON NOT R ASTRON SOC, V371, P885, DOI 10.1111/j.1365-2966.2006.10720.x; Read JI, 2005, MON NOT R ASTRON SOC, V356, P107, DOI 10.1111/j.1365-2966.2004.08424.x; Ricotti M, 2005, ASTROPHYS J, V629, P259, DOI 10.1086/431415; Slyz AD, 2005, MON NOT R ASTRON SOC, V356, P737, DOI 10.1111/j.1365-2966.2004.08494.x; Stinson G, 2006, MON NOT R ASTRON SOC, V373, P1074, DOI 10.1111/j.1365-2966.2006.11097.x; Tolstoy E, 2004, ASTROPHYS J, V617, pL119, DOI 10.1086/427388; Tonini C, 2006, ASTROPHYS J, V649, P591, DOI 10.1086/506431; Wadsley JW, 2004, NEW ASTRON, V9, P137, DOI 10.1016/j.newast.2003.08.004; Yoshida N, 2003, ASTROPHYS J, V592, P645, DOI 10.1086/375810	29	280	281	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					174	177		10.1126/science.1148666	http://dx.doi.org/10.1126/science.1148666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18048653	Green Submitted			2022-12-28	WOS:000252246400032
J	Jones, P; Jones, S; Stone, D				Jones, Phil; Jones, Sarah; Stone, Debbie			Accuracy of comparing bone quality to chocolate bars for patient information purposes: observational study	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To test whether standard information for patients using Crunchie and Aero chocolate bars to explain bone health and risk of fracture is robust. Design observational study. Setting Domestic kitchen in rural west Wales. Participants 10 Crunchie bars and 10 Aero bars. Main outcome measure Fracture after falls from varying heights. Results Both Crunchie and Aero bars exhibited the same T and Z scores for bone density. Crunchie bars had a lower chocolate mass index than the Aero bars. Crunchie bars are more liable to fracture. Conclusions Using Crunchie and Aero chocolate bars to explain bone structure to patients may be visually attractive but oversimplifies the situation.	[Jones, Phil; Jones, Sarah; Stone, Debbie] Bronglais Gen Hosp, Aberystwyth SY23 1ER, Dyfed, Wales		Jones, P (corresponding author), Bronglais Gen Hosp, Aberystwyth SY23 1ER, Dyfed, Wales.	phil.jones@ceredigion-tr.wales.nhs.uk						NICHOLLS C, 2004, TODAYS THERAP    MAR; 2004, EXTENNDICARE CANADA	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1285	1287		10.1136/bmj.39413.798472.BE	http://dx.doi.org/10.1136/bmj.39413.798472.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156229	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000252182700009
J	Egloff, S; O'Reilly, D; Chapman, RD; Taylor, A; Tanzhaus, K; Pitts, L; Eick, D; Murphy, S				Egloff, Sylvain; O'Reilly, Dawn; Chapman, Rob D.; Taylor, Alice; Tanzhaus, Katrin; Pitts, Laura; Eick, Dirk; Murphy, Shona			Serine-7 of the RNA polymerase IICTD is specifically required for snRNA gene expression	SCIENCE			English	Article							C-TERMINAL DOMAIN; HUMAN U2 SNRNA; POL-II; TRANSCRIPTION; CTD; STABILITY; PROTEIN	RNA polymerase II ( Pol II) transcribes genes that encode proteins and noncoding small nuclear RNAs ( snRNAs). The carboxyl- terminal repeat domain ( CTD) of the largest subunit of mammalian RNA Pol II, comprising tandem repeats of the heptapeptide consensus Tyr(1)-Ser(2)-Pro(3)Thr(4)- Ser(5)-Pro(6)-Ser(7), is required for expression of both gene types. We show that mutation of serine-7 to alanine causes a specific defect in snRNA gene expression. We also present evidence that phosphorylation of serine-7 facilitates interaction with the snRNA gene- specific Integrator complex. These findings assign a biological function to this amino acid and highlight a gene type-specific requirement for a residue within the CTD heptapeptide, supporting the existence of a CTD code.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, D-81377 Munich, Germany	University of Oxford; University of Munich	Murphy, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	shona.murphy@path.ox.ac.uk		Murphy, Shona/0000-0001-5276-9645; EGLOFF, Sylvain/0000-0002-9798-125X	Medical Research Council [G9826944, G0400653, G0400653(71330)] Funding Source: Medline; Wellcome Trust [072107, 081312] Funding Source: Medline; MRC [G0400653, G9826944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cuello P, 1999, EMBO J, V18, P2867, DOI 10.1093/emboj/18.10.2867; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Fong N, 2003, EMBO J, V22, P4274, DOI 10.1093/emboj/cdg396; Fury MG, 1996, EXP CELL RES, V228, P160, DOI 10.1006/excr.1996.0311; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; YOON JB, 1995, MOL CELL BIOL, V15, P2019	18	200	200	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1777	1779		10.1126/science.1145989	http://dx.doi.org/10.1126/science.1145989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079403	Green Accepted			2022-12-28	WOS:000251616800042
J	Hartmann, DL; Hendon, HH				Hartmann, Dennis L.; Hendon, Harry H.			Atmospheric science - Resolving an atmospheric enigma	SCIENCE			English	Editorial Material							MADDEN-JULIAN OSCILLATION; WESTERN PACIFIC; MODELS		Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3001, Australia	University of Washington; University of Washington Seattle; Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hartmann, DL (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	dennis@atmos.washington.edu; h.hendon@bom.gov.au						LIEBMANN B, 1994, J METEOROL SOC JPN, V72, P401, DOI 10.2151/jmsj1965.72.3_401; Lin JL, 2006, J CLIMATE, V19, P2665, DOI 10.1175/JCLI3735.1; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Maloney ED, 2000, SCIENCE, V287, P2002, DOI 10.1126/science.287.5460.2002; Matthews AJ, 2007, SCIENCE, V318, P1765, DOI 10.1126/science.1147312; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Miura H, 2007, SCIENCE, V318, P1763, DOI 10.1126/science.1148443; NAKAZAWA T, 1988, J METEOROL SOC JPN, V66, P823, DOI 10.2151/jmsj1965.66.6_823; Randall D, 2003, B AM METEOROL SOC, V84, P1547, DOI 10.1175/BAMS-84-11-1547; SPILLANE MC, 1987, J PHYS OCEANOGR, V17, P313, DOI 10.1175/1520-0485(1987)017<0313:IOISLA>2.0.CO;2; Zhang CD, 2006, CLIM DYNAM, V27, P573, DOI 10.1007/s00382-006-0148-2	11	14	14	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1731	1732		10.1126/science.1152502	http://dx.doi.org/10.1126/science.1152502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079387				2022-12-28	WOS:000251616800024
J	Janse, CJ; Waters, AP				Janse, Chris J.; Waters, Andrew P.			The exoneme helps malaria parasites to break out of blood cells	CELL			English	Editorial Material							PARASITOPHOROUS VACUOLE; PROTEASE; EGRESS	Malaria parasites must invade the erythrocytes of its host, to be able to grow and multiply. Having depleted the host cell of its nutrients, the parasites break out to invade new erythrocytes. In this issue of Cell, Yeoh et al. (2007) discover a new organelle, the exoneme, that contains a protease SUB1, which helps the parasite to escape from old erythrocytes and invade new ones.	[Janse, Chris J.; Waters, Andrew P.] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	waters@lumc.nl	Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205				Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; MILLER SK, 2003, J BIOL CHEM, V278, P48169; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; YEOH S, 2007, CELL	11	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1036	1038		10.1016/j.cell.2007.11.026	http://dx.doi.org/10.1016/j.cell.2007.11.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083092	Bronze			2022-12-28	WOS:000252217100010
J	Knottnerus, JA; ten Velden, GHM				Knottnerus, J. Andre; ten Velden, Gabriel H. M.			Dutch doctors and their patients - Effects of health care reform in the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maastricht, Maastricht, Netherlands; Hlth Council Netherlands, The Hague, Netherlands	Maastricht University	Knottnerus, JA (corresponding author), Univ Maastricht, Maastricht, Netherlands.		Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009					*HLTH COUNC NET, 2003, PUBL HLTH COUNC NETH; *MIN HLTH WELF SPO, 2007, NIET LAT ZORG; *RVZ, 2007, PUBL RVZ; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; te Brake H., 2007, BEKOSTIGING HUISARTS	5	21	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2424	2426		10.1056/NEJMp0707383	http://dx.doi.org/10.1056/NEJMp0707383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240CK	18077806				2022-12-28	WOS:000251564400002
J	McVary, KT				McVary, Kevin T.			Erectile dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY-TRACT SYMPTOMS; SILDENAFIL CITRATE; SEXUAL DYSFUNCTION; UROLOGIC COMPLICATIONS; CARDIOVASCULAR-DISEASE; CONTROLLED-TRIAL; DOUBLE-BLIND; LONG-TERM; MEN; EFFICACY	A 65- year- old man presents to an outpatient clinic, reporting that he can no longer maintain an erection sufficient for intercourse. His medical history includes well-controlled hypertension and stable coronary artery disease. He smokes a pack of cigarettes daily. His medications include atenolol and low- dose aspirin ( 81 mg daily). On physical examination, his body- mass index ( the weight in kilograms divided by the square of the height in meters) is 31; the examination is otherwise unremarkable, with normal external genitalia and no loss of body hair. How should he be evaluated and treated?	Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	McVary, KT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Tarry 16-749,303 E Chicago Ave, Chicago, IL 60611 USA.	k-mcvary@northwestern.edu						Aytac IA, 1999, BJU INT, V84, P50; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Bechara A, 1997, J UROLOGY, V157, P2132, DOI 10.1016/S0022-5347(01)64694-9; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P2688; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Billups KL, 2005, AM J CARDIOL, V96, p57M, DOI 10.1016/j.amjcard.2005.10.007; Brown JS, 2005, DIABETES CARE, V28, P177, DOI 10.2337/diacare.28.1.177; Cappelleri JC, 2005, INT J IMPOT RES, V17, P307, DOI 10.1038/sj.ijir.3901327; Carson CC, 2004, BJU INT, V93, P1276, DOI 10.1111/j.1464-410X.2004.04819.x; Carson CC, 2000, J UROLOGY, V164, P376, DOI 10.1016/S0022-5347(05)67364-8; Carter JE, 2007, J NEUROL SCI, V262, P89, DOI 10.1016/j.jns.2007.06.018; Crowe SM, 2004, ANN PHARMACOTHER, V38, P77, DOI 10.1345/aph.1D019; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Dutta TC, 1999, UROLOGY, V54, P891, DOI 10.1016/S0090-4295(99)00264-2; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fink HA, 2002, ARCH INTERN MED, V162, P1349, DOI 10.1001/archinte.162.12.1349; Guay Andre T, 2003, Endocr Pract, V9, P77; Jackson G, 2006, J SEX MED, V3, P28, DOI 10.1111/j.1743-6109.2005.00196.x; Jaffe JS, 2004, UROLOGY, V63, P951, DOI 10.1016/j.urology.2003.11.039; Jain P, 2000, J UROLOGY, V164, P371, DOI 10.1016/S0022-5347(05)67363-6; Kupelian V, 2006, J UROLOGY, V176, P222, DOI 10.1016/S0022-5347(06)00503-9; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; Lue TF, 2004, J SEX MED, V1, P6, DOI 10.1111/j.1743-6109.2004.10104.x; McCullough AR, 2002, UROLOGY, V60, P28, DOI 10.1016/S0090-4295(02)01688-6; MCMAHON CG, 1991, INT J IMPOT RES, V3, P113; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; McVary KT, 2005, EUR UROL, V47, P838, DOI 10.1016/j.eururo.2005.02.001; Montague DK, 2005, J UROLOGY, V174, P230, DOI 10.1097/01.ju.0000164463.19239.19; O'Leary MP, 2006, J UROLOGY, V175, P1058, DOI 10.1016/S0022-5347(05)00418-0; Padma-Nathan H, 2003, UROLOGY, V62, P400, DOI 10.1016/S0090-4295(03)00567-3; PRICE SC, 1981, ARCH SEX BEHAV, V180, P253; Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; Stravynski A, 1997, BRIT J PSYCHIAT, V170, P338, DOI 10.1192/bjp.170.4.338; Thomas A, 2003, UROL CLIN N AM, V30, P123, DOI 10.1016/S0094-0143(02)00111-8; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; URCIUOLI R, 2000, COCHRANE DB SYST REV, V2, DOI UNSP CD001784	39	122	133	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2472	2481		10.1056/NEJMcp067261	http://dx.doi.org/10.1056/NEJMcp067261			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077811				2022-12-28	WOS:000251564400008
J	Samb, B; Celletti, F; Holloway, J; Van Damme, W; De Cock, KM; Dybul, M				Samb, Badara; Celletti, Francesca; Holloway, Joan; Van Damme, Wim; De Cock, Kevin M.; Dybul, Mark			Rapid expansion of the health workforce in response to the HIV epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NURSE-PRACTITIONERS; PRIMARY-CARE; THERAPY		WHO, CH-1211 Geneva, Switzerland; US Dept State, Off US Global AIDS Coordinator, Washington, DC 20520 USA; Inst Trop Med, B-2000 Antwerp, Belgium	World Health Organization; Institute of Tropical Medicine (ITM)	Samb, B (corresponding author), WHO, CH-1211 Geneva, Switzerland.		Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Abbatt F., 2005, SCALING HLTH ED WORK; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; Bell D, 2001, B WORLD HEALTH ORGAN, V79, P933; CLARKE M, 2005, COST EFFECTIVE TUBER; *DEP STAT, 2006, PRES EM PLAN AIDS RE; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; DUALE S, 1992, INT J GYNECOL OBSTET, V38, pS33, DOI 10.1016/0020-7292(92)90027-G; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; *INT LAB OFF, 2004, HIV AIDS WORK GLOB E; LANKSHEAR A, 2005, HLTH POLICY MATT JUL, P1; LEHMANN U, 2004, 41 JLI; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Marston Barbara J, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P106, DOI 10.1177/1545109707300688; *MED SANS FRONT, 2006, ACH SUST UN ACC ANT; Miles K, 2006, INT NURS REV, V53, P290, DOI 10.1111/j.1466-7657.2006.00491.x; Pienaar D, 2006, MODELS CARE ANTIRETR; SHERWOOD GD, 1997, INTERNET J ADV NURS, V1; *STOP TB DEP, 2003, COMM CONTR TB CAR PR; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Yong CS, 2006, MED J AUSTRALIA, V185, P27, DOI 10.5694/j.1326-5377.2006.tb00446.x; 1981, ANN SOC BELG MED T S, V60, P5	23	136	136	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2510	2514		10.1056/NEJMsb071889	http://dx.doi.org/10.1056/NEJMsb071889			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240CK	18077816				2022-12-28	WOS:000251564400016
J	Duriez, P				Duriez, Patrick			CETP inhibition	LANCET			English	Editorial Material							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CHOLESTEROL LEVELS; TORCETRAPIB; ATHEROSCLEROSIS; INDIVIDUALS; EFFICACY; SAFETY		INSERM, U545, F-59045 Lille, France; Univ Law & Hlth, Fac Pharm, Physiol Lab, F-59006 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Duriez, P (corresponding author), INSERM, U545, F-59045 Lille, France.	Patrick.Duriez@univ-lille2.fr						Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; COBAIN MR, 2007, AM J CARDIOL, V7, P623; Davidson MH, 2006, J AM COLL CARDIOL, V48, P1774, DOI 10.1016/j.jacc.2006.06.067; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Krishna R, 2007, LANCET, V370, P1907, DOI 10.1016/S0140-6736(07)61813-3; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347	11	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1882	1883		10.1016/S0140-6736(07)61788-7	http://dx.doi.org/10.1016/S0140-6736(07)61788-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068495				2022-12-28	WOS:000251517600005
J	Gostin, LO				Gostin, Lawrence O.			The "tobacco wars" - Global litigation strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Daynard RA, 2000, BRIT MED J, V320, P111, DOI 10.1136/bmj.320.7227.111; Department of Health and Human Services (US), 2006, HLTH CONS INV EXP TO; DOYLE L, 2007, INDEPENDENT LON 0406; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P2057, DOI 10.1001/jama.298.17.2057; HANAI K, 2006, JAPAN TIMES     0522; SIRGELITZKOVICK J, 2000, BRIT MED J, V321, P1306; 2007, GLOBE MAIL      0531, pB11	7	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2537	2539		10.1001/jama.298.21.2537	http://dx.doi.org/10.1001/jama.298.21.2537			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056907	Green Published			2022-12-28	WOS:000251361900020
J	Calonge, N; Petitti, DB; DeWitt, TG; Gordis, L; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Siu, AL; Teutsch, SM; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.		US Prevent Serv Task Force	Screening for high blood pressure: U. S. preventive services task force reaffirmation recommendation statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Reaffirmation of the 2003 U. S. Preventive Services Task Force statement about screening for high blood pressure. Methods: The U. S. Preventive Services Task Force did a targeted literature search for evidence on the benefits and harms of screening for high blood pressure. Recommendation: Screen for high blood pressure in adults age 18 years or older. (Grade A recommendation)	Colorado Dept Publ Hlth & Environm, Denver, CO USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Sierra Madre, CA USA; Childrens Hosp, Med Ctr, Cincinnati, OH USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Cedars Sinai Med Ctr, Los Angeles, CA USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; HealthPartners, Minneapolis, MN USA; Univ Missouri, Sch Med, Columbia, MO USA; Univ Michigan, Sch Nursing, Ann Arbor, MI USA; Med Coll Georgia, Augusta, GA USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Univ Calif San Francisco, San Francisco, CA USA; Mt Sinai Med Ctr, New York, NY USA; Merck & Co Inc, West Point, PA USA; Olmsted Res Ctr, Rochester, MN USA	Colorado Department of Public Health & Environment; University of Southern California; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Merck & Company	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.							ACOG Committee on Gynecologic Practice, 2006, Obstet Gynecol, V108, P1615; American Academy of family physicians, 2005, SUMM REC CLIN PREV S; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Sheridan S, 2003, AM J PREV MED, V25, P151, DOI 10.1016/S0749-3797(03)00121-1; Wolff T, 2007, ANN INTERN MED, V147, P787, DOI 10.7326/0003-4819-147-11-200712040-00010	6	96	96	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					783	231		10.7326/0003-4819-147-11-200712040-00009	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056662				2022-12-28	WOS:000251539100005
J	Fischer, M; Casey, C; Chen, RT				Fischer, Marc; Casey, Christine; Chen, Robert T.			Promise of new Japanese encephalitis vaccines	LANCET			English	Editorial Material							CHILDREN		Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Ft Collins, CO 80521 USA; Ctr Dis Control & Prevent, Off Chief Sci Officer, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD & TB, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fischer, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Ft Collins, CO 80521 USA.	mxf2@cdc.gov	Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367				Artenstein AW, 2005, VACCINE, V23, P3301, DOI 10.1016/j.vaccine.2005.01.079; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; FERGUSON M, 2007, BIOLOGICALS     0924, DOI DOI 10.1016/J.BIOLOGICALS.2007.07.002; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Monath TP, 2002, CURR TOP MICROBIOL, V267, P105; Plesner AM, 2003, IMMUNOL ALLERGY CLIN, V23, P665, DOI 10.1016/S0889-8561(03)00102-4; Sakaguchi M, 2001, ALLERGY, V56, P536, DOI 10.1034/j.1398-9995.2001.056006536.x; Takahashi H, 2000, VACCINE, V18, P2963, DOI 10.1016/S0264-410X(00)00111-0; Tandan JB, 2007, VACCINE, V25, P5041, DOI 10.1016/j.vaccine.2007.04.052; Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2; World Health O, 2006, JAPANESE ENCEPHALITI, P331; World Health Organization, 2005, WKLY EPIDEMIOL REC, V80, P241; [No title captured]	14	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1806	1808		10.1016/S0140-6736(07)61753-X	http://dx.doi.org/10.1016/S0140-6736(07)61753-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061040				2022-12-28	WOS:000251588700006
J	Irino, T; Kawase, T; Miki, K				Irino, Tadayoshi; Kawase, Takeshi; Miki, Kenji			Arson, an attractive monk, and our vertigo clinic	LANCET			English	Editorial Material									[Irino, Tadayoshi] Inst Neurosci, Div Vertigo, Irino Clin, Naniwa Ku, Osaka 5580016, Japan; [Kawase, Takeshi] Keio Univ, Dept Neurosurg, Tokyo, Japan; [Miki, Kenji] Kyoto Univ, Sch Publ Hlth, Kyoto, Japan	Keio University; Kyoto University	Irino, T (corresponding author), Inst Neurosci, Div Vertigo, Irino Clin, Naniwa Ku, 2-1-16 Motomachi, Osaka 5580016, Japan.	irinohinoeuma@irino.jp							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2126	2126		10.1016/S0140-6736(07)61907-2	http://dx.doi.org/10.1016/S0140-6736(07)61907-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156034				2022-12-28	WOS:000252058600033
J	Jack, A				Jack, Andrew			Bitter pills	BRITISH MEDICAL JOURNAL			English	Article									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*AEG, BELG EXP; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; European Commission Tax And Customs Union, 2006, SUMM COMM CUST ACT C; JACK A, 2007, FINANCIAL TIMES 1122; JACK A, 2007, FINANCIAL TIMES 0514; Organisation for Economic Co-operation and Development, 2007, EC IMP COUNT PIR; *US FDA, FDA COUNT DRUG TASK; *WHO, 2007, IMPACT M; *WHO INT MED PROD, 2007, IMPACT TECHN SUBGR M; World Health Organization (WHO), 2006, COUNT MED	10	18	18	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1120	1121		10.1136/bmj.39412.431655.AD	http://dx.doi.org/10.1136/bmj.39412.431655.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048535	Green Published			2022-12-28	WOS:000251596100027
J	Nallagatla, SR; Hwang, J; Toroney, R; Zheng, XF; Cameron, CE; Bevilacqua, PC				Nallagatla, Subba Rao; Hwang, Jungwook; Toroney, Rebecca; Zheng, Xiaofeng; Cameron, Craig E.; Bevilacqua, Philip C.			5 '-triphosphate-dependent activation of PKR by RNAs with short stem-loops	SCIENCE			English	Article							PROTEIN-KINASE PKR; DOUBLE-STRANDED-RNA; MESSENGER-RNA; RIG-I; BINDING; CELLS; RECOGNITION; POLYMERASE; VIRUSES	Molecular patterns in pathogenic RNAs can be recognized by the innate immune system, and a component of this response is the interferon-induced enzyme RNA-activated protein kinase (PKR). The major activators of PKR have been proposed to be long double-stranded RNAs. We report that RNAs with very limited secondary structures activate PKR in a 5'-triphosphate-dependent fashion in vitro and in vivo. Activation of PKR by 5'-triphosphate RNA is independent of RIG-I and is enhanced by treatment with type 1 interferon (IFN-alpha). Surveillance of molecular features at the 5' end of transcripts by PKR presents a means of allowing pathogenic RNA to be distinguished from self-RNA. The evidence presented here suggests that this form of RNA-based discrimination may be a critical step in mounting an early immune response.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Peking Univ, Life Sci Coll, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	cec9@psu.edu; pcb@chem.psu.edu	Hwang, Jungwook/P-1614-2015	Hwang, Jungwook/0000-0002-2290-1649; Bevilacqua, Philip/0000-0001-8074-3434	NIGMS NIH HHS [GM58709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Knipe DM, 2007, FIELDS VIROLOGY; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Robertson HD, 1996, J VIROL, V70, P5611, DOI 10.1128/JVI.70.8.5611-5617.1996; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	22	185	189	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1455	1458		10.1126/science.1147347	http://dx.doi.org/10.1126/science.1147347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048689				2022-12-28	WOS:000251246100047
J	Terry, LJ; Shows, EB; Wente, SR				Terry, Laura J.; Shows, Eric B.; Wente, Susan R.			Crossing the nuclear envelope: Hierarchical regulation of nucleocytoplasmic transport	SCIENCE			English	Review							MESSENGER-RNA EXPORT; BOX PROTEIN DBP5; KAPPA-B COMPLEX; PORE COMPLEX; IMPORTIN-ALPHA; LOCALIZATION SIGNAL; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; IN-VIVO; NUCLEOPORINS	Transport of macromolecules between the nucleus and cytoplasm is a critical cellular process for eukaryotes, and the machinery that mediates nucleocytoplasmic exchange is subject to multiple levels of control. Regulation is achieved by modulating the expression or function of single cargoes, transport receptors, or the transport channel. Each of these mechanisms has increasingly broad impacts on transport patterns and capacity, and this hierarchy of control directly affects gene expression, signal transduction, development, and disease.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			NCI NIH HHS [5T32-CA009385] Funding Source: Medline; NIGMS NIH HHS [R01-GM57438, R01-GM51219, 5T32-GM008554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051219, R01GM057438, T32GM008554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Goldberg MW, 1996, J MOL BIOL, V257, P848, DOI 10.1006/jmbi.1996.0206; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kay RA, 2005, CANCER RES, V65, P10742, DOI 10.1158/0008-5472.CAN-05-2038; Kiseleva E, 1998, J CELL SCI, V111, P223; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Olsson M, 2004, EXP CELL RES, V292, P359, DOI 10.1016/j.yexcr.2003.09.014; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160; Rollenhagen C, 2007, EUKARYOT CELL, V6, P505, DOI 10.1128/EC.00317-06; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Uv AE, 2000, GENE DEV, V14, P1945; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	80	406	427	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1412	1416		10.1126/science.1142204	http://dx.doi.org/10.1126/science.1142204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048681				2022-12-28	WOS:000251246100035
J	Zurner, A; Kirstein, J; Doblinger, M; Brauchle, C; Bein, T				Zuerner, Andreas; Kirstein, Johanna; Doeblinger, Markus; Braeuchle, Christoph; Bein, Thomas			Visualizing single-molecule diffusion in mesoporous materials	NATURE			English	Article							SILICA; DYNAMICS; TRACKING; PORES; FILMS	Periodic mesoporous materials formed through the cooperative self-assembly of surfactants and framework building blocks can assume a variety of structures(1-3), and their widely tuneable properties make them attractive hosts for numerous applications(4-7). Because the molecular movement in the pore system is the most important and defining characteristic of porous materials(8), it is of interest to learn about this behaviour as a function of local structure. Generally, individual fluorescent dye molecules can be used as molecular beacons with which to explore the structure of-and the dynamics within-these porous hosts(9-13), and single-molecule fluorescence techniques provide detailed insights into the dynamics of various processes, ranging from biology(14,15) to heterogeneous catalysis(16). However, optical microscopy methods cannot directly image the mesoporous structure of the host system accommodating the diffusing molecules, whereas transmission electron microscopy provides detailed images of the porous structure(17), but no dynamic information. It has therefore not been possible to 'see' how molecules diffuse in a real nanoscale pore structure. Here we present a combination of electron microscopic mapping and optical single-molecule tracking experiments to reveal how a single luminescent dye molecule travels through linear or strongly curved sections of a mesoporous channel system. In our approach we directly correlate porous structures detected by transmission electron microscopy with the diffusion dynamics of single molecules detected by optical microscopy. This opens up new ways of understanding the interactions of host and guest.	Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Univ Munich, Ctr NanoSci, D-81377 Munich, Germany	University of Munich; University of Munich	Zurner, A (corresponding author), Univ Munich, Dept Chem & Biochem, Butenandtstr 5-13 E, D-81377 Munich, Germany.	bein@lmu.de	Bein, Thomas/G-7686-2014	Bein, Thomas/0000-0001-7248-5906				BECK JS, 1992, J AM CHEM SOC, V114, P10843; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; Dag O, 1999, ADV MATER, V11, P474, DOI 10.1002/(SICI)1521-4095(199904)11:6<474::AID-ADMA474>3.0.CO;2-I; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Hellriegel C, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/023; Holtrup FO, 1997, CHEM-EUR J, V3, P219, DOI 10.1002/chem.19970030209; Jung C, 2006, J AM CHEM SOC, V128, P5283, DOI 10.1021/ja0588104; Jung C, 2007, ADV MATER, V19, P956, DOI 10.1002/adma.200602173; Kirstein J, 2007, NAT MATER, V6, P303, DOI 10.1038/nmat1861; Kukla V, 1996, SCIENCE, V272, P702, DOI 10.1126/science.272.5262.702; McCain KS, 2003, ANAL CHEM, V75, P4351, DOI 10.1021/ac0345289; Roeffaers MBJ, 2006, NATURE, V439, P572, DOI 10.1038/nature04502; Sakamoto Y, 2000, NATURE, V408, P449, DOI 10.1038/35044040; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sen T, 2004, CHEM MATER, V16, P2044, DOI 10.1021/cm034946u; Shen JL, 2003, MICROPOR MESOPOR MAT, V64, P135, DOI 10.1016/j.micromeso.2003.08.001; Werley CA, 2006, J PHYS CHEM B, V110, P18939, DOI 10.1021/jp057570b; Yang CM, 2001, ADV MATER, V13, P1099, DOI 10.1002/1521-4095(200107)13:14<1099::AID-ADMA1099>3.0.CO;2-0; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	21	189	193	2	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					705	+		10.1038/nature06398	http://dx.doi.org/10.1038/nature06398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046407				2022-12-28	WOS:000251209700050
J	Jeremias, A; Kirtane, A				Jeremias, Allen; Kirtane, Ajay			Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention	ANNALS OF INTERNAL MEDICINE			English	Article							BARE-METAL STENTS; RANDOMIZED CONTROLLED-TRIAL; ARTERY-DISEASE; CLINICAL-PRACTICE; SLOW-RELEASE; DOUBLE-BLIND; LESIONS; IMPLANTATION; THROMBOSIS; OUTCOMES	Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent target vessel revascularization compared with bare-metal stents. However, the safety of drug-eluting stents has been called into question because of an apparent increase in late stent thrombosis, a frequently fatal event. A substantial body of research has focused on determining the magnitude of these competing events, often reaching contradictory results even with analyses of the same data. Although larger, adequately powered, randomized trials are needed to fully assess the net clinical effects of drug-eluting stents compared with bare-metal stents, the evidence seems to suggest that the net clinical benefit of drug-eluting stents may outweigh their risks. The evidence is clearer that premature discontinuation of antiplatelet therapy is an important trigger for stent thrombosis; therefore, patients who are candidates for implantation of drug-eluting stents should be screened for their ability to receive and tolerate uninterrupted antiplatelet therapy longer than is necessary with bare-metal stents. The evidence suggests that drug-eluting stents relieve obstructive coronary artery disease, provide durable mechanical results, and do more good than harm, but all patients also should be given antiplatelet and other optimal medical therapies to achieve the best outcomes.	[Jeremias, Allen] SUNY Stony Brook, Med Ctr, Div Cardiovasc Med, Hlth Sci Ctr, Stony Brook, NY 11794 USA; Columbia Univ, Med Ctr, New York, NY 10027 USA; Cardiovasc Res Fdn, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Cardiovascular Research Foundation (CRF)	Jeremias, A (corresponding author), SUNY Stony Brook, Med Ctr, Div Cardiovasc Med, Hlth Sci Ctr, T16-080, Stony Brook, NY 11794 USA.	allen.jeremias@stonybrook.edu			PHS HHS [290-02-0024] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bavry AA, 2007, ANN INTERN MED, V146, P230, DOI 10.7326/0003-4819-146-3-200702060-00146; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Hodgson JM, 2007, CATHETER CARDIO INTE, V69, P327, DOI 10.1002/ccd.21093; Jeremias A, 2004, CIRCULATION, V109, P1930, DOI 10.1161/01.CIR.0000127105.99982.21; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; MUELLER C, 2006, J AM COLL CARDIOL, V48, P2584; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tung R, 2006, ANN INTERN MED, V144, P913, DOI 10.7326/0003-4819-144-12-200606200-00009; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242	27	44	46	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					234	238		10.7326/0003-4819-148-3-200802050-00199	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18087049				2022-12-28	WOS:000252849700007
J	Underwood, M; Ashby, D; Cross, P; Hennessy, E; Letley, L; Martin, J; Mt-Isa, S; Parsons, S; Vickers, M; Whyte, K				Underwood, Martin; Ashby, Deborah; Cross, Pamela; Hennessy, Enid; Letley, Louise; Martin, Jeannett; Mt-Isa, Shahrul; Parsons, Suzanne; Vickers, Madge; Whyte, Ken		TOIB Study Team	Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; PRIMARY-CARE; HIP OSTEOARTHRITIS; HEALTH SURVEY; RELIABILITY; OUTCOMES; THERAPY; QUESTIONNAIRE; METAANALYSIS; PREVALENCE	Objective To determine whether older patients with chronic knee pain should be advised to use topical or oral non-steroidal anti-inflammatory drugs (NSAIDs). Design Randomised controlled trial and parallel patient preference study. Setting 26 general practices. Participants People aged >= 50 with knee pain: 282 in randomised trial and 303 in preference study. Interventions Advice to use topical or oral ibuprofen. Primary outcome measures WOMAC (Western Ontario and McMaster Universities) osteoarthritis index, major and minor adverse effects. Results Changes in global WOMAC scores at 12 months were equivalent. In the randomised trial the difference (topical minus oral) was two points (95% confidence interval -2 to 6); in the preference study, it was one point (-4 to 6). There were no differences in major adverse effects in the trial or study. The only significant differences in secondary outcomes were in the randomised trial. The oral group had more respiratory adverse effects (17% v 7%, 95% confidence interval for difference -17% to -20/6), the change in serum creatinine was 3.7 mu mol/l less favourable (0.9 mu mol/l to 6.5 mu mol/l); and more participants changed treatments because of adverse effects (16% v 1%, -16% to -5%). In the topical group more participants had chronic pain grade III or IV at three months, and more participants changed treatment because of ineffectiveness. Conclusions Advice to use oral or topical preparations has an equivalent effect on knee pain over one year, and there are more minor side effects with oral NSAIDs. Topical NSAIDs may be a useful alternative to oral NSAIDs.	[Underwood, Martin; Cross, Pamela; Parsons, Suzanne; Whyte, Ken] Univ London, Queen Mary, Barts & The London, Ctr Hlth Sci, London E1 2AT, England; [Ashby, Deborah; Hennessy, Enid; Mt-Isa, Shahrul] Univ London, Queen Mary, Barts & The London, Wolfson Inst Prevent Med, London EC1M 6BQ, England; [Letley, Louise] MRC, Gen Practice Res Framework, London NW1 2ND, England; [Martin, Jeannett] London S Bank Univ, Dept Primary & Social Care, London SE1 6EN, England; [Vickers, Madge] Univ Hertfordshire, Clin Trials Coordinating Ctr, Hatfield AL10 9LB, Herts, England	University of London; Queen Mary University London; University of London; Queen Mary University London; London South Bank University; University of Hertfordshire	Underwood, M (corresponding author), Univ London, Queen Mary, Barts & The London, Ctr Hlth Sci, London E1 2AT, England.	m.underwood@warwick.ac.uk	Parsons, Suzanne/E-7805-2010; Underwood, Martin/D-6364-2015; Mt-Isa, Shahrul/F-1275-2010	Underwood, Martin/0000-0002-0309-1708; Mt-Isa, Shahrul/0000-0002-7163-8402	MRC [MC_U122785831] Funding Source: UKRI; National Institute for Health Research [01/09/02] Funding Source: researchfish; Medical Research Council [MC_U122785831, MC_U122797165] Funding Source: Medline; Department of Health [01/09/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Carnes D, 2008, BRIT MED J, V336, P142, DOI 10.1136/bmj.39401.699063.BE; Cross PL, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-55; Fransen M, 1999, RHEUMATOLOGY, V38, P807, DOI 10.1093/rheumatology/38.9.807; Gabriel Sherine E., 1996, Current Opinion in Rheumatology, V8, P96, DOI 10.1097/00002281-199603000-00002; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Jinks C, 2001, RHEUMATOLOGY, V40, P528, DOI 10.1093/rheumatology/40.5.528; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Lin FY, 2004, BMJ-BRIT MED J, V329, P324, DOI 10.1136/bmj.38159.639028.7C; Mason L, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-28; *MRC, GEN PRACT RES FRAM; *OFF NAT STAT, 2007, STAND OCC CLASS 2000; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; Parsons S, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-34; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; Rannou F, 2007, OSTEOARTHR CARTILAGE, V15, P1013, DOI 10.1016/j.joca.2007.02.012; Salaffi F, 2005, CLIN RHEUMATOL, V24, P29, DOI 10.1007/s10067-004-0965-9; Shlipak MG, 2004, AM J KIDNEY DIS, V43, P37, DOI 10.1053/j.ajkd.2003.08.044; Smith BH, 1997, PAIN, V71, P141, DOI 10.1016/S0304-3959(97)03347-2; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Towheed TE, 2006, J RHEUMATOL, V33, P567; Towheed TE, 1997, SEMIN ARTHRITIS RHEU, V26, P755, DOI 10.1016/S0049-0172(97)80043-1; Tubach F, 2005, ANN RHEUM DIS, V64, P34, DOI 10.1136/ard.2004.023028; UNDERWOOD MR, IN PRESS HLTH TECHNO; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD SYST	30	70	77	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					138	142		10.1136/bmj.39399.656331.25	http://dx.doi.org/10.1136/bmj.39399.656331.25			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18056743	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252819400032
J	Gilbert, CE; Shah, SP; Jadoon, MZ; Bourne, R; Dineen, B; Khan, MA; Johnson, GJ; Khan, MD				Gilbert, Clare E.; Shah, S. P.; Jadoon, M. Z.; Bourne, R.; Dineen, B.; Khan, M. A.; Johnson, G. J.; Khan, M. D.		Pakistan Natl Eye Survey Study Grp	Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL SERVICES; VISION IMPAIRMENT; EYE SURVEY; PREVALENCE; BURDEN; DEPRIVATION; POPULATION; ADULTS; COST; LIFE	Objective To explore the association between blindness and deprivation in a nationally representative sample of adults in Pakistan. Design Cross sectional population based survey. Setting 221 rural and urban clusters selected randomly throughout Pakistan. Participants Nationally representative sample of 16 507 adults aged 30 or above (95.3% response rate). Main outcome measures Associations between visual impairment and poverty assessed by a cluster level deprivation index and a household level poverty indicator; prevalence and causes of blindness; measures of the rate of uptake and quality of eye care services. Results561 blind participants (<3/60 in the better eye) were identified during the survey. Clusters in urban Sindh province were the most affluent, whereas rural areas in Balochistan were the poorest. The prevalence of blindness in adults living in affluent clusters was 2.2%, compared with 3.7% in medium clusters and 3.9% in poor clusters (P<0.001). The highest prevalence of blindness was found in rural Balochistan (5.2%). The prevalence of total blindness (bilateral no light perception) was more than three times higher in poor clusters than in affluent clusters (0.24% v 0.07%, P<0.001). The prevalences of blindness caused by cataract, glaucoma, and corneal opacity were tower in affluent clusters and households. Reflecting access to eye care services, cataract surgical coverage was higher in affluent clusters (80.6%) than in medium (76.8%) and poor areas (75.1%). Intraocular tens implantation rates were significantly lower in participants from poorer households. 10.2% of adults living in affluent clusters presented to the examination station wearing spectacles, compared with 6.7% in medium clusters and 4.4% in poor cluster areas. Spectacle coverage in affluent areas was more than double that in poor clusters (23.5% v 11.1%, P<0.001). Conclusion Blindness is associated with poverty in Pakistan; lower access to eye care services was one contributory factor. To reduce blindness, strategies targeting poor people will be needed. These interventions may have an impact on deprivation in Pakistan.	[Gilbert, Clare E.; Shah, S. P.; Dineen, B.; Johnson, G. J.] Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1E 7HT, England; [Jadoon, M. Z.; Khan, M. A.; Khan, M. D.] Pakistan Inst Community Ophthalmol, Peshawar, Pakistan; [Bourne, R.] Hinchingbrooke Hosp, Dept Ophthalmol, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine	Gilbert, CE (corresponding author), Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Keppel St, London WC1E 7HT, England.	clare.gilbert@lshtm.ac.uk		Dineen, Brendan/0000-0002-9619-8044				Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Bourne R, 2005, OPHTHAL EPIDEMIOL, V12, P321, DOI 10.1080/09286580500230948; Bourne RRA, 2004, INVEST OPHTH VIS SCI, V45, P410, DOI 10.1167/iovs.03-0129; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Dineen BP, 2003, BRIT J OPHTHALMOL, V87, P820, DOI 10.1136/bjo.87.7.820; Elwan A., 1999, 9932 WORLD BANK; Fletcher AE, 1997, ARCH OPHTHALMOL-CHIC, V115, P767, DOI 10.1001/archopht.1997.01100150769013; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Frick KD, 2005, ARCH OPHTHALMOL-CHIC, V123, P239, DOI 10.1001/archopht.123.2.239; GOODING K, 2006, POVERTY BLINDNESS SU; *GOV PAK MIN EC AF, 1998, POP CENS OGR; *GOV PAK MIN EC AF, 1998, POP CENS ORG; HUSSEIN A, 2003, PAKISTAN NATL HUMAN; Jadoon MZ, 2006, INVEST OPHTH VIS SCI, V47, P4749, DOI 10.1167/iovs.06-0374; Jadoon Z, 2007, BRIT J OPHTHALMOL, V91, P1269, DOI 10.1136/bjo.2006.106914; JAVITT J, 1983, ACTA 24 INT C OPHTH, P1308; Johnson GJ, 1998, EP EYE DIS, P8; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; McCarty CA, 2001, BRIT J OPHTHALMOL, V85, P322, DOI 10.1136/bjo.85.3.322; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Narayan D., 2000, VOICES POOR CAN ANYO, DOI DOI 10.1002/JID.793; *NAT TASK FORC TRA, 2002, REP TRACH RAP ASS PA; Nirmalan PK, 2003, BRIT J OPHTHALMOL, V87, P847, DOI 10.1136/bjo.87.7.847; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SMITH LK, 1994, J PUBLIC HEALTH MED, V16, P348; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; VALE D, 2004, UNSEEN NEGLECT ISOLA; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; *WHO, 2004, 282 WO; *WHO, 2004, 282 WHO; *WHO, 1988, COD INSTR WHO PBL EY; *WHO, 2005, GLO DAT BOD MASS IND; 2001, PROFILE REGIONAL INE, P80	39	72	74	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					29	32B		10.1136/bmj.39395.500046.AE	http://dx.doi.org/10.1136/bmj.39395.500046.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18087076	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000252327500032
J	Yapici, N; Kim, YJ; Ribeiro, C; Dickson, BJ				Yapici, Nilay; Kim, Young-Joon; Ribeiro, Carlos; Dickson, Barry J.			A receptor that mediates the post-mating switch in Drosophila reproductive behaviour	NATURE			English	Article							MELANOGASTER SEX-PEPTIDE; MALE COURTSHIP BEHAVIOR; FUNCTIONAL EXPRESSION; HELICOVERPA-ARMIGERA; FMRFAMIDE RECEPTOR; MOLECULAR-CLONING; SEMINAL PEPTIDES; NEURAL CIRCUITRY; FEMALE; IDENTIFICATION	Mating in many species induces a dramatic switch in female reproductive behaviour. In most insects, this switch is triggered by factors present in the male's seminal fluid. How these factors exert such profound effects in females is unknown. Here we identify a receptor for the Drosophila melanogaster sex peptide (SP, also known as Acp70A), the primary trigger of post- mating responses in this species. Females that lack the sex peptide receptor (SPR, also known as CG16752), either entirely or only in the nervous system, fail to respond to SP and continue to show virgin behaviours even after mating. SPR is expressed in the female's reproductive tract and central nervous system. The behavioural functions of SPR map to the subset of neurons that also express the fruitless gene, a key determinant of sex- specific reproductive behaviour. SPR is highly conserved across insects, opening up the prospect of new strategies to control the reproductive and host- seeking behaviours of agricultural pests and human disease vectors.	[Yapici, Nilay; Kim, Young-Joon; Ribeiro, Carlos; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Ribeiro, Carlos/0000-0002-9542-7335; Kim, Young-Joon/0000-0002-7990-754X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 1996, J INSECT PHYSIOL, V42, P1007, DOI 10.1016/S0022-1910(96)00070-4; Cheng CC, 1998, APPL ACOUST, V54, P291, DOI 10.1016/S0003-682X(97)00093-5; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fan YL, 1999, J INSECT PHYSIOL, V45, P127, DOI 10.1016/S0022-1910(98)00106-1; Fan YL, 2000, INSECT BIOCHEM MOLEC, V30, P805, DOI 10.1016/S0965-1748(00)00052-7; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harshman LG, 1999, J INSECT PHYSIOL, V45, P571, DOI 10.1016/S0022-1910(99)00038-4; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; Le Poul E, 2002, J BIOMOL SCREEN, V7, P57, DOI 10.1089/108705702753520341; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ottiger M, 2000, J NEUROBIOL, V44, P57; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; Schlote, 1984, DROS INFORM SERV, V60, P210; SCHMIDT T, 1993, J INSECT PHYSIOL, V39, P361, DOI 10.1016/0022-1910(93)90023-K; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Vernon WI, 2002, BIOTECHNIQUES, V33, P730, DOI 10.2144/02334bm02	45	340	355	6	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					33	U1		10.1038/nature06483	http://dx.doi.org/10.1038/nature06483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18066048				2022-12-28	WOS:000252079300026
J	Vasudevan, S; Tong, YC; Steitz, JA				Vasudevan, Shobha; Tong, Yingchun; Steitz, Joan A.			Switching from repression to activation: MicroRNAs can up-regulate translation	SCIENCE			English	Article							MESSENGER-RNA DEGRADATION; SIRNAS; MIRNAS	AU- rich elements ( AREs) and microRNA target sites are conserved sequences in messenger RNA ( mRNA) 3' untranslated regions ( 3' UTRs) that control gene expression posttranscriptionally. Upon cell cycle arrest, the ARE in tumor necrosis factor-alpha ( TNF alpha) mRNA is transformed into a translation activation signal, recruiting Argonaute ( AGO) and fragile X mental retardation- related protein 1 ( FXR1), factors associated with micro- ribonucleoproteins ( microRNPs). We show that human microRNA miR369-3 directs association of these proteins with the AREs to activate translation. Furthermore, we document that two well- studied microRNAs- Let- 7 and the synthetic microRNA miRcxcr4- likewise induce translation up-regulation of target mRNAs on cell cycle arrest, yet they repress translation in proliferating cells. Thus, activation is a common function of microRNPs on cell cycle arrest. We propose that translation regulation by microRNPs oscillates between repression and activation during the cell cycle.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Huang, H/E-9490-2010					Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Khabar KSA, 2005, GENOMICS, V85, P165, DOI 10.1016/j.ygeno.2004.10.004; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	13	2041	2205	6	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1931	1934		10.1126/science.1149460	http://dx.doi.org/10.1126/science.1149460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18048652				2022-12-28	WOS:000251786600061
J	Del'Haye, P; Schliesser, A; Arcizet, O; Wilken, T; Holzwarth, R; Kippenberg, TJ				Del'Haye, P.; Schliesser, A.; Arcizet, O.; Wilken, T.; Holzwarth, R.; Kippenberg, T. J.			Optical frequency comb generation from a monolithic microresonator	NATURE			English	Article							LASER; MICROCAVITY; ULTRAVIOLET; LIGHT; CHIP	Optical frequency combs(1-3) provide equidistant frequency markers in the infrared, visible and ultraviolet(4,5), and can be used to link an unknown optical frequency to a radio or microwave frequency reference(6,7). Since their inception, frequency combs have triggered substantial advances in optical frequency metrology and precision measurements(6,7) and in applications such as broadband laser- based gas sensing(8) and molecular fingerprinting(9). Early work generated frequency combs by intra- cavity phase modulation(10,11); subsequently, frequency combs have been generated using the comb- like mode structure of mode- locked lasers, whose repetition rate and carrier envelope phase can be stabilized(12). Here we report a substantially different approach to comb generation, in which equally spaced frequency markers are produced by the interaction between a continuous- wave pump laser of a known frequency with the modes of a monolithic ultra- high- Q microresonator(13) via the Kerr nonlinearity(14,15). The intrinsically broadband nature of parametric gain makes it possible to generate discrete comb modes over a 500- nm- wide span (similar to 70 THz) around 1,550 nm without relying on any external spectral broadening. Optical- heterodyne- based measurements reveal that cascaded parametric interactions give rise to an optical frequency comb, overcoming passive cavity dispersion. The uniformity of the mode spacing has been verified to within a relative experimental precision of 7.3 x 10(-18). In contrast to femtosecond mode- locked lasers(16), this work represents a step towards a monolithic optical frequency comb generator, allowing considerable reduction in size, complexity and power consumption. Moreover, the approach can operate at previously unattainable repetition rates(17), exceeding 100 GHz, which are useful in applications where access to individual comb modes is required, such as optical waveform synthesis(18), high capacity telecommunications or astrophysical spectrometer calibration(19).	Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Kippenberg, TJ (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	tobias.kippenberg@mpq.mpg.de	Schliesser, Albert/C-5619-2014; Kippenberg, T. J./B-3133-2013; Del'Haye, Pascal/G-2588-2016	Schliesser, Albert/0000-0003-4317-5030; Kippenberg, T. J./0000-0002-3408-886X; Del'Haye, Pascal/0000-0002-6517-6942				Agha IH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043837; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Carmon T, 2007, NAT PHYS, V3, P430, DOI 10.1038/nphys601; CHANG RK, 1996, OPTICAL PROCESSES MI; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Diddams SA, 2007, NATURE, V445, P627, DOI 10.1038/nature05524; Dunn MH, 1999, SCIENCE, V286, P1513, DOI 10.1126/science.286.5444.1513; Foster MA, 2006, NATURE, V441, P960, DOI 10.1038/nature04932; Gohle C, 2005, NATURE, V436, P234, DOI 10.1038/nature03851; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Jones RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.193201; Keller U, 2003, NATURE, V424, P831, DOI 10.1038/nature01938; Kippenberg TJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083904; KOUROGI M, 1993, IEEE J QUANTUM ELECT, V29, P2693, DOI 10.1109/3.250392; Kubina P, 2005, OPT EXPRESS, V13, P904, DOI 10.1364/OPEX.13.000904; Murphy MT, 2007, MON NOT R ASTRON SOC, V380, P839, DOI 10.1111/j.1365-2966.2007.12147.x; Reichert J, 2000, PHYS REV LETT, V84, P3232, DOI 10.1103/PhysRevLett.84.3232; Savchenkov AA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243905; Schliesser A, 2005, OPT EXPRESS, V13, P9029, DOI 10.1364/OPEX.13.009029; Spillane SM, 2002, NATURE, V415, P621, DOI 10.1038/415621a; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; STOLEN RH, 1982, IEEE J QUANTUM ELECT, V18, P1062, DOI 10.1109/JQE.1982.1071660; Thorpe MJ, 2006, SCIENCE, V311, P1595, DOI 10.1126/science.1123921; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Ye J, 1997, OPT LETT, V22, P301, DOI 10.1364/OL.22.000301; Ye J., 2005, FEMTOSECOND OPTICAL	30	1448	1487	43	652	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1214	1217		10.1038/nature06401	http://dx.doi.org/10.1038/nature06401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097405	Green Submitted			2022-12-28	WOS:000251786200046
J	Lindenauer, PK; Rothberg, MB; Pekow, PS; Kenwood, C; Benjamin, EM; Auerbach, AD				Lindenauer, Peter K.; Rothberg, Michael B.; Pekow, Penelope S.; Kenwood, Christopher; Benjamin, Evan M.; Auerbach, Andrew D.			Outcomes of care by hospitalists, general internists, and family physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH-OF-STAY; HEALTH-CARE; PATIENT SATISFACTION; RESOURCE UTILIZATION; MEDICINE; SERVICE; QUALITY; IMPACT; COST; IMPLEMENTATION	Background: The hospitalist model is rapidly altering the landscape for inpatient care in the United States, yet evidence about the clinical and economic outcomes of care by hospitalists is derived from a small number of single-hospital studies examining the practices of a few physicians. Methods: We conducted a retrospective cohort study of 76,926 patients 18 years of age or older who were hospitalized between September 2002 and June 2005 for pneumonia, heart failure, chest pain, ischemic stroke, urinary tract infection, acute exacerbation of chronic obstructive pulmonary disease, or acute myocardial infarction at 45 hospitals throughout the United States. We used multivariable models to compare the outcomes of care by 284 hospitalists, 993 general internists, and 971 family physicians. Results: As compared with patients cared for by general internists, patients cared for by hospitalists had a modestly shorter hospital stay (adjusted difference, 0.4 day; P<0.001) and lower costs (adjusted difference, $268; P=0.02) but a similar inpatient rate of death (odds ratio, 0.95; 95% confidence interval [CI], 0.85 to 1.05) and 14-day readmission rate (odds ratio, 0.98; 95% CI, 0.91 to 1.05). As compared with patients cared for by family physicians, patients cared for by hospitalists had a shorter length of stay (adjusted difference, 0.4 day; P<0.001), and the costs (adjusted difference, $125; P=0.33), rate of death (odds ratio, 0.95; 95% CI, 0.83 to 1.07), and 14-day readmission rate (odds ratio, 0.95; 95% CI, 0.87 to 1.04) were similar. Conclusions: For common inpatient diagnoses, the hospitalist model is associated with a small reduction in the length of stay without an adverse effect on rates of death or readmission. Hospitalist care appears to be modestly less expensive than that provided by general internists, but it offers no significant savings as compared with the care provided by family physicians.	Baystate Med Ctr, Ctr Qual & Safety Res, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California San Francisco	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual & Safety Res, 759 Chestnut St,P-5928, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Auerbach, Andrew/0000-0001-8440-0527	AHRQ HHS [K08 HS11416-02] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS011416] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Auerbach AD, 2003, ARCH INTERN MED, V163, P2330, DOI 10.1001/archinte.163.19.2330; Auerbach AD, 2006, J GEN INTERN MED, V21, P1079, DOI 10.1111/j.1525-1497.2006.00558.x; Coffman J, 2005, MED CARE RES REV, V62, P379, DOI 10.1177/1077558705277379; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Davis KM, 2000, AM J MED, V108, P621, DOI 10.1016/S0002-9343(00)00362-4; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fernandez A, 2000, ARCH INTERN MED, V160, P2902, DOI 10.1001/archinte.160.19.2902; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Goldman Lee, 2001, American Journal of Medicine, V111, p36S; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Halasyamani LK, 2005, AM J MED, V118, P536, DOI 10.1016/j.amjmed.2005.01.027; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Kaboli PJ, 2004, AM J MANAG CARE, V10, P561; Kralovec PD, 2006, J HOSP MED, V1, P75, DOI 10.1002/jhm.82; LANDRY L, 2004, WALL STREET J   0727, pD1; Lindenauer PK, 2002, ARCH INTERN MED, V162, P1251, DOI 10.1001/archinte.162.11.1251; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Lurie JD, 1999, AM J MED, V106, P441, DOI 10.1016/S0002-9343(99)00045-5; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Myers JS, 2006, ACAD MED, V81, P432, DOI 10.1097/01.ACM.0000222278.28824.bc; Pham HH, 2005, J GEN INTERN MED, V20, P101, DOI 10.1111/j.1525-1497.2005.40184.x; Phy MP, 2005, ARCH INTERN MED, V165, P796, DOI 10.1001/archinte.165.7.796; Rifkin WD, 2004, J GEN INTERN MED, V19, P1127, DOI 10.1111/j.1525-1497.2004.1930415.x; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1999, ANN INTERN MED, V130, P338, DOI 10.7326/0003-4819-130-4-199902161-00002; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713	31	169	169	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2589	2600		10.1056/NEJMsa067735	http://dx.doi.org/10.1056/NEJMsa067735			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094379	Green Published			2022-12-28	WOS:000251728900009
J	Fourgeaud, L; Boulanger, LM				Fourgeaud, Lawrence; Boulanger, Lisa M.			Synapse remodeling, compliments of the complement system	CELL			English	Editorial Material							MHC CLASS-I; PLASTICITY; MOLECULES; CELLS	A growing body of evidence indicates that some proteins known for their immune functions also have distinct nonimmune functions in the normal uninjured central nervous system. In this issue, Stevens et al. (2007) demonstrate an unexpected requirement for molecules of the complement cascade in the remodeling of synaptic connections in the developing visual system.	[Fourgeaud, Lawrence; Boulanger, Lisa M.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Boulanger, LM (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lboulanger@ucsd.edu		Boulanger, Lisa/0000-0002-6578-7890				Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Gasque P, 1998, J IMMUNOL, V160, P3543; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Maslinska D, 1998, FOLIA NEUROPATHOL, V36, P145; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; STEVENS B, 2007, CELL; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315	10	50	54	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1034	1036		10.1016/j.cell.2007.11.031	http://dx.doi.org/10.1016/j.cell.2007.11.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083091	Bronze			2022-12-28	WOS:000252217100009
J	Qazilbash, MM; Brehm, M; Chae, BG; Ho, PC; Andreev, GO; Kim, BJ; Yun, SJ; Balatsky, AV; Maple, MB; Keilmann, F; Kim, HT; Basov, DN				Qazilbash, M. M.; Brehm, M.; Chae, Byung-Gyu; Ho, P. -C.; Andreev, G. O.; Kim, Bong-Jun; Yun, Sun Jin; Balatsky, A. V.; Maple, M. B.; Keilmann, F.; Kim, Hyun-Tak; Basov, D. N.			Mott transition in VO2 revealed by infrared spectroscopy and nano-imaging	SCIENCE			English	Article							METAL-INSULATOR-TRANSITION; BAND THEORY; BI2SR2CACU2O8+DELTA; SUPERCONDUCTIVITY; MICROSCOPY; PEIERLS; HUBBARD; PHASE; VIEW; FILM	Electrons in correlated insulators are prevented from conducting by Coulomb repulsion between them. When an insulator- to- metal transition is induced in a correlated insulator by doping or heating, the resulting conducting state can be radically different from that characterized by free electrons in conventional metals. We report on the electronic properties of a prototypical correlated insulator vanadium dioxide in which the metallic state can be induced by increasing temperature. Scanning near- field infrared microscopy allows us to directly image nanoscale metallic puddles that appear at the onset of the insulator- to- metal transition. In combination with far- field infrared spectroscopy, the data reveal the Mott transition with divergent quasi- particle mass in the metallic puddles. The experimental approach used sets the stage for investigations of charge dynamics on the nanoscale in other inhomogeneous correlated electron systems.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Max Planck Inst Biochem, Abt Mol Strukturbiol, D-82152 Munich, Germany; Ctr Nanosci, D-82152 Munich, Germany; Elect & Telecommun Res Inst, IT Convergence & Components Lab, Taejon 305350, South Korea; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA	University of California System; University of California San Diego; Max Planck Society; University of Munich; Electronics & Telecommunications Research Institute - Korea (ETRI); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Qazilbash, MM (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	mumtaz@physics.ucsd.edu		Kim, Hyun Tak/0000-0002-4315-1701; Chae, Byung Gyu/0000-0001-5721-3064; Andreev, Gregory/0000-0001-9908-2162				ALLEN PB, 1993, PHYS REV B, V48, P4359, DOI 10.1103/PhysRevB.48.4359; Arcangeletti E, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196406; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; Basov DN, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.054516; Biermann S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026404; Brinkman WF, 1970, PHYS REV B-SOLID ST, V2, P4302, DOI 10.1103/PhysRevB.2.4302; Carr G. L., 1985, INFRARED MILLIMETER, V13; Chae BG, 2006, ELECTROCHEM SOLID ST, V9, pC12, DOI 10.1149/1.2135430; Chang YJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075118; Choi HS, 1996, PHYS REV B, V54, P4621, DOI 10.1103/PhysRevB.54.4621; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; EMERY VJ, 1995, PHYS REV LETT, V74, P3253, DOI 10.1103/PhysRevLett.74.3253; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Keilmann F, 2004, PHILOS T R SOC A, V362, P787, DOI 10.1098/rsta.2003.1347; Kim HT, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/052; Kim HT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266401; Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154; Koethe TC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116402; Lee J, 2006, NATURE, V442, P546, DOI 10.1038/nature04973; Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781; Padilla WJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060511; Qazilbash MM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.205118; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Sun Z, 2007, NAT PHYS, V3, P248, DOI 10.1038/nphys517; Tu JJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.017402; Uehara M, 1999, NATURE, V399, P560, DOI 10.1038/21142; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Zhang LW, 2002, SCIENCE, V298, P805, DOI 10.1126/science.1077346	31	1101	1119	23	851	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1750	1753		10.1126/science.1150124	http://dx.doi.org/10.1126/science.1150124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079396	Green Submitted			2022-12-28	WOS:000251616800033
J	Dubernard, JM; Lengele, B; Morelon, E; Testelin, S; Badet, L; Moure, C; Beziat, JL; Dakpe, S; Kanitakis, J; D'Hauthuille, C; El Jaafari, A; Petruzzo, P; Lefrancois, N; Taha, F; Sirigu, A; Di Marco, G; Carmi, E; Bachmann, D; Cremades, S; Giraux, P; Burloux, G; Hequet, O; Parquet, N; Frances, C; Michallet, M; Martin, X; Devauchelle, B				Dubernard, Jean-Michel; Lengele, Benoit; Morelon, Emmanuel; Testelin, Sylvie; Badet, Lionel; Moure, Christophe; Beziat, Jean-Luc; Dakpe, Stephanie; Kanitakis, Jean; D'Hauthuille, Cedric; El Jaafari, Assia; Petruzzo, Palmina; Lefrancois, Nicole; Taha, Farid; Sirigu, Angela; Di Marco, Giovanni; Carmi, Esther; Bachmann, Danielle; Cremades, Sophie; Giraux, Pascal; Burloux, Gabriel; Hequet, Olivier; Parquet, Nathalie; Frances, Camille; Michallet, Mauricette; Martin, Xavier; Devauchelle, Bernard			Outcomes 18 months after the first human partial face transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DONOR BONE-MARROW; COMPOSITE TISSUE ALLOTRANSPLANTATION; HUMAN HAND-ALLOGRAFT; EXTRACORPOREAL PHOTOCHEMOTHERAPY; RECIPIENTS; CHIMERISM; REJECTION; MICROCHIMERISM; PANCREAS; INFUSION	Background: We performed the first human partial face allograft on November 27, 2005. Here we report outcomes up to 18 months after transplantation. Methods: The postsurgical induction immunosuppression protocol included thymoglobulins combined with tacrolimus, mycophenolate mofetil, and prednisone. Donor hematopoietic stem cells were infused on postoperative days 4 and 11. Sequential biopsy specimens were taken from a sentinel skin graft, the facial skin, and the oral mucosa. Functional progress was assessed by tests of sensory and motor function performed monthly. Psychological support was provided before and after transplantation. Results: Sensitivity to light touch, as assessed with the use of static monofilaments, and sensitivity to heat and cold had returned to normal at 6 months after transplantation. Motor recovery was slower, and labial contact allowing complete mouth closure was achieved at 10 months. Psychological acceptance of the graft progressed as function improved. Rejection episodes occurred on days 18 and 214 after transplantation and were reversed. A decrease in inulin clearance led to a change in immunosuppressive regimen from tacrolimus to sirolimus at 14 months. Extracorporeal photochemotherapy was introduced at 10 months to prevent recurrence of rejection. There have been no subsequent rejection episodes. At 18 months, the patient is satisfied with the aesthetic result. Conclusions: In this patient who underwent the first partial face transplantation, the functional and aesthetic results 18 months after transplantation are satisfactory.	Univ Lyon 1, Hop Edouard Herriot, Dept Transplantol, Centaure Network, F-69437 Lyon, France; Catholic Univ Louvain, Brussels, Belgium; Univ Hosp, Amiens, France; Hop St Louis, Paris, France; Hop Tenon, F-75970 Paris, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Dubernard, JM (corresponding author), Univ Lyon 1, Hop Edouard Herriot, Dept Transplantol, Centaure Network, 5 Pl Arsonval,Pavillon V, F-69437 Lyon, France.	jean-michel.dubernard@chu-lyon.fr	; Giraux, Pascal/D-8105-2018	Kanitakis, Jean/0000-0003-0469-257X; HEQUET, Olivier/0000-0001-5650-5786; Giraux, Pascal/0000-0002-8581-1472; Petruzzo, Palmina/0000-0002-7933-0525				Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; ANDREU G, 1994, TRANSFUS SCI, V15, P443, DOI 10.1016/0955-3886(94)90178-3; BARBER WH, 1991, TRANSPLANTATION, V51, P70, DOI 10.1097/00007890-199101000-00011; Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; CAILLATZUCMAN S, 1994, HUM IMMUNOL, V41, P91, DOI 10.1016/0198-8859(94)90091-4; Ciancio G, 2002, TRANSPLANTATION, V74, P488, DOI 10.1097/00007890-200208270-00010; Ciancio G, 2001, TRANSPLANTATION, V71, P827, DOI 10.1097/00007890-200104150-00002; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; Couriel DR, 2006, BLOOD, V107, P3074, DOI 10.1182/blood-2005-09-3907; Delis S, 2006, PANCREAS, V32, P1, DOI 10.1097/01.mpa.0000188307.67420.46; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 2003, ANN SURG, V238, P128, DOI 10.1097/01.SLA.0000078945.70869.82; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Dubernard JM, 2000, TRANSPL INT, V13, P521; Eljaafari A, 2006, TRANSPLANTATION, V82, P1764, DOI 10.1097/01.tp.0000250937.46187.ca; Gordon CR, 2006, MICROSURG, V26, P566, DOI 10.1002/micr.20296; HOFFMANN GO, 1995, TX MED, V8, P46; Hu WL, 2006, EUR UROL, V50, P851, DOI 10.1016/j.eururo.2006.07.026; Kanitakis J, 2005, EUR J DERMATOL, V15, P235; Kanitakis J, 2006, TRANSPLANTATION, V82, P1610, DOI 10.1097/01.tp.0000248780.55263.33; Levi DM, 2003, LANCET, V361, P2173, DOI 10.1016/S0140-6736(03)13769-5; Mathew JM, 2001, BONE MARROW TRANSPL, V28, P115, DOI 10.1038/sj.bmt.1703110; Pham SM, 2000, J THORAC CARDIOV SUR, V119, P673, DOI 10.1016/S0022-5223(00)70001-8; Sivasai, 1997, TRANSPLANTATION, V64, P1636; Sivasai KSR, 1997, TRANSPLANTATION, V64, P427, DOI 10.1097/00007890-199708150-00010; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204	26	300	310	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2451	2460		10.1056/NEJMoa072828	http://dx.doi.org/10.1056/NEJMoa072828			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077810	Bronze			2022-12-28	WOS:000251564400006
J	Garbutt, JC; Flannery, B				Garbutt, James C.; Flannery, Barbara			Baclofen for alcoholism	LANCET			English	Editorial Material							COMORBIDITY; DISORDERS; ABUSE		Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; RTI Int, Transdisciplinary Behav Sci Program, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Garbutt, JC (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.	jc_garbutt@med.unc.edu						Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683	6	15	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1884	1885		10.1016/S0140-6736(07)61789-9	http://dx.doi.org/10.1016/S0140-6736(07)61789-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068496				2022-12-28	WOS:000251517600006
J	Krishna, R; Anderson, MS; Bergman, AJ; Jin, B; Fallon, M; Cote, J; Rosko, K; Chavez-Eng, C; Lutz, R; Bloomfield, DM; Gutierrez, M; Doherty, J; Bieberdorf, F; Chodakewitz, J; Gottesdiener, KM; Wagner, JA				Krishna, Rajesh; Anderson, Matt S.; Bergman, Arthur J.; Jin, Bo; Fallon, Marissa; Cote, Josee; Rosko, Kim; Chavez-Eng, Cynthia; Lutz, Ryan; Bloomfield, Daniel M.; Gutierrez, Maria; Doherty, James; Bieberdorf, Fredrick; Chodakewitz, Jeffrey; Gottesdiener, Keith M.; Wagner, John A.			Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies	LANCET			English	Article							HIGH-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; CORONARY ATHEROSCLEROSIS; TORCETRAPIB; PLASMA; HDL; DEFICIENCY; EFFICACY; SAFETY; ATORVASTATIN	Background The inhibition of cholesteryl ester transfer protein (CETP) is considered a potential new mechanism for treatment of dyslipidaemia. Anacetrapib (MK-0859) is a CETP inhibitor currently under development. We aimed to assess anacetrapib's effects as monotherapy on low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) and on 24-h ambulatory blood pressure. Methods We did two double-blind, randomised, placebo-controlled phase I studies. In the first study, 50 patients with dyslipidaemia (LDL-C 100-190 mg/dL; 40 active, 10 placebo) aged 18-75 years received anacetrapib doses of 0, 10, 40, 150, or 300 mg orally once a day with a meal for 28 days. Standard lipid and lipoprotein monitoring, safety monitoring, and anacetrapib concentrations for pharmacokinetics were done. In the second study, 22 healthy participants aged 45-75 years received either 150 mg of anacetrapib once a day or matching placebo with a meal for 10 days in each crossover period, in a randomised sequence, with at least a 14-day washout between the treatment periods. Continuous 24-h ambulatory blood pressure monitoring was done on day -1 and day 10 of each treatment period in this study. The primary or secondary endpoints of safety and tolerability were assessed in both studies by monitoring clinical adverse experiences, physical examinations, vital signs, 12-lead electrocardiogram, and laboratory safety. Analysis was per protocol. These trials are registered with ClinicalTrials.gov, numbers NCT00565292 and NCT00565006. Findings In the dyslipidaemia study, one patient withdrew consent and one was excluded from the data analysis for HDL-C and LDL-C because complete pre-dose measurements were not available. Anacetrapib produced dose-dependent lipid-altering effects with peak lipid-altering effects of 129% (mean 51.1 [SD 3.8]-114.9 [7.-9] mg/dL) increase in HDL-C and a 38% (138.2 [11.4]-77.6 [7.9] mg/dL) decrease in LDL-C in patients with dyslipidaemia. In the 24-h ambulatory blood pressure study in healthy individuals, least squares difference between anacetrapib and placebo groups on day 10 were 0 . 60 (90% CI -1 . 54 to 2.74; p=0 . 634) mm Hg for systolic blood pressure and 0 . 47 (90% CI -0 . 90 to 1 . 84; p=0 . 561) mm Hg for diastolic blood pressure. Interpretation Anacetrapib seems to exhibit HDL-C increases greater than those seen with other investigational drugs in this class and LDL-C lowering effects similar to statins. Despite greater lipid-altering effects relative to other members of this class, anacetrapib seems not to increase blood pressure, suggesting that potent CETP inhibition by itself might not lead to increased blood pressure.	Merck Res Labs, Rahway, NJ 07065 USA; Merck & Co Inc, Whitehouse Stn, NJ USA; Comprehens Phase One, Miramar, FL USA; CEDRA Clin Res LLC, San Antonio, TX USA; CEDRA Clin Res LLC, Austin, TX USA	Merck & Company; Merck & Company	Krishna, R (corresponding author), Merck Res Labs, Mailstop RY34-A500, Rahway, NJ 07065 USA.	rajesh-krishna@merck.com						Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/14656566.4.11.1901; BLOOMFIELD DM, 2007, EFFICACY SAFETY CETP; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Davidson MH, 2006, J AM COLL CARDIOL, V48, P1774, DOI 10.1016/j.jacc.2006.06.067; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gibaldi M, 1982, PHARMACOKINETICS; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HESLER CB, 1987, J BIOL CHEM, V262, P2275; Hirano K, 2000, CURR OPIN LIPIDOL, V11, P589, DOI 10.1097/00041433-200012000-00004; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kastelein JJP, 2007, CURR MED RES OPIN, V23, P885, DOI 10.1185/030079907X182121; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; KRISHNA R, 2007, EUR HEART J S1, V28, P18; Kuivenhoven JA, 2005, AM J CARDIOL, V95, P1085, DOI 10.1016/j.amjcard.2004.12.064; Lindgren F., 1972, BLOOD LIPIDS LIPOPRO, P181; Mandema JW, 2005, AAPS J, V7, pE513, DOI 10.1208/aapsj070352; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Moriyama Y, 1998, PREV MED, V27, P659, DOI 10.1006/pmed.1998.0340; NICHOLLS SJ, 2007, AM HEART ASS ANN M; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; ONEILL E, 2007, IDENTIFICATION CHARA; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; ROBINS SJ, 2006, BRIT MED J, V333, P1237; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; TALL AR, 1993, J LIPID RES, V34, P1255; THUREN T, 2005, AM HEART ASS ANN M; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	36	249	260	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1907	1914		10.1016/S0140-6736(07)61813-3	http://dx.doi.org/10.1016/S0140-6736(07)61813-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068514				2022-12-28	WOS:000251517600028
J	Englund, D; Faraon, A; Fushman, I; Stoltz, N; Petroff, P; Vuckovic, J				Englund, Dirk; Faraon, Andrei; Fushman, Ilya; Stoltz, Nick; Petroff, Pierre; Vuckovic, Jelena			Controlling cavity reflectivity with a single quantum dot	NATURE			English	Article							PHOTONIC CRYSTAL; GENERATION; NANOCAVITY; NUMBER; LIGHT	Solid-state cavity quantum electrodynamics ( QED) systems offer a robust and scalable platform for quantum optics experiments and the development of quantum information processing devices. In particular, systems based on photonic crystal nanocavities and semiconductor quantum dots have seen rapid progress. Recent experiments have allowed the observation of weak(1) and strong coupling(2,3) regimes of interaction between the photonic crystal cavity and a single quantum dot in photoluminescence. In the weak coupling regime(1), the quantum dot radiative lifetime is modified; in the strong coupling regime(3), the coupled quantum dot also modifies the cavity spectrum. Several proposals for scalable quantum information networks and quantum computation rely on direct probing of the cavity-quantum dot coupling, by means of resonant light scattering from strongly or weakly coupled quantum dots(4-9). Such experiments have recently been performed in atomic systems(10-12) and superconducting circuit QED systems(13), but not in solid-state quantum dot-cavity QED systems. Here we present experimental evidence that this interaction can be probed in solid-state systems, and show that, as expected from theory, the quantum dot strongly modifies the cavity transmission and reflection spectra. We show that when the quantum dot is coupled to the cavity, photons that are resonant with its transition are prohibited from entering the cavity. We observe this effect as the quantum dot is tuned through the cavity and the coupling strength between them changes. At high intensity of the probe beam, we observe rapid saturation of the transmission dip. These measurements provide both a method for probing the cavity-quantum dot system and a step towards the realization of quantum devices based on coherent light scattering and large optical nonlinearities from quantum dots in photonic crystal cavities.	Stanford Univ, Ginzton Lab, Stanford, CA 94305 USA; Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Vuckovic, J (corresponding author), Stanford Univ, Ginzton Lab, Stanford, CA 94305 USA.	jela@stanford.edu	Petroff, Pierre/M-9840-2019; Vuckovic, Jelena/A-7335-2019; Englund, Dirk Robert/GNH-1681-2022	Vuckovic, Jelena/0000-0002-4603-9686; Englund, Dirk Robert/0000-0002-1043-3489				Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; Auffeves-Garnier A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.053823; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Childress L, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052330; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Englund D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013904; Englund D, 2007, OPT EXPRESS, V15, P5550, DOI 10.1364/OE.15.005550; Faraon A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742789; Faraon A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2472534; Gerardot BD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743750; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hood CJ, 1998, PHYS REV LETT, V80, P4157, DOI 10.1103/PhysRevLett.80.4157; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; IMOTO N, 1985, PHYS REV A, V32, P2287, DOI 10.1103/PhysRevA.32.2287; KIMBLE HJ, 1994, CAVITY QUANTUM ELECT, P213; Ladd TD, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/184; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; Reiner JE, 2001, J OPT SOC AM B, V18, P1911, DOI 10.1364/JOSAB.18.001911; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Tan SM, 1999, J OPT B-QUANTUM S O, V1, P424, DOI 10.1088/1464-4266/1/4/312; Vuckovic J, 2006, PHYSICA E, V32, P466, DOI 10.1016/j.physe.2005.12.135; Waks E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.153601; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119	25	512	520	4	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					857	861		10.1038/nature06234	http://dx.doi.org/10.1038/nature06234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064008				2022-12-28	WOS:000251394900051
J	Campbell, EG; Regan, S; Gruen, RL; Ferris, TG; Rao, SR; Cleary, PD; Blumenthal, D				Campbell, Eric G.; Regan, Susan; Gruen, Russell L.; Ferris, Timothy G.; Rao, Sowmya R.; Cleary, Paul D.; Blumenthal, David			Professionalism in medicine: Results of a national survey of physicians	ANNALS OF INTERNAL MEDICINE			English	Article							EXPERIENCE; QUALITY	Background: The prospect of improving care through increasing professionalism has been gaining momentum among physician organizations. Although there have been efforts to define and promote professionalism, few data are available on physician attitudes toward and conformance with professional norms. Objective: To ascertain the extent to which practicing physicians agree with and act consistently with norms of professionalism. Design: National survey using a stratified random sample. Setting: Medical care in the United States. Participants: 3504 practicing physicians in internal medicine, family practice, pediatrics, surgery, anesthesiology, and cardiology. Measurements: Attitudes and behaviors were assessed by using indicators for each domain of professionalism developed by the American College of Physicians and the American Board of Internal Medicine. Of the eligible sampled physicians, 1662 responded, yielding a 58% weighted response rate ( adjusting for noneligible physicians). Results: Ninety percent or more of the respondents agreed with specific statements about principles of fair distribution of finite resources, improving access to and quality of care, managing conflicts of interest, and professional self-regulation. Twenty-four percent disagreed that periodic recertification was desirable. Physician behavior did not always reflect the standards they endorsed. For example, although 96% of respondents agreed that physicians should report impaired or incompetent colleagues to relevant authorities, 45% of respondents who encountered such colleagues had not reported them. Limitations: Our measures of behavior did not capture all activities that may reflect on the norms in question. Furthermore, behaviors were self-reported, and the results may not be generalizable to physicians in specialties not included in the study. Conclusion: Physicians agreed with standards of professional behavior promulgated by professional societies. Reported behavior, however, did not always conform to those norms.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Yale Univ, Sch Publ Hlth, New Haven, CT USA; Univ Melbourne, Royal Melbourne Hosp, Med Res Ctr, Parkville, Vic, Australia	Harvard University; Massachusetts General Hospital; Yale University; Royal Melbourne Hospital; University of Melbourne	Campbell, EG (corresponding author), Inst Hlth Policy, 50 Staniford St, 9th Fl, Boston, MA 02114 USA.	ecampbell@partners.org	Cleary, Paul/AAF-7048-2019					*AM AC NEUR ETH LA, 2001, NEUROLOGY, V56, P1; [Anonymous], STAND DEF FIN DISP C; Arnold EL, 1998, ACAD MED, V73, P1119, DOI 10.1097/00001888-199810000-00025; Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Blumenthal D, 2002, MILBANK Q, V80, P525, DOI 10.1111/1468-0009.00021; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; EMANUEL LL, 1997, JAMA-J AM MED ASSOC, V227, P1004; Enthoven AC, 2004, HEALTH AFFAIR, V23, P136, DOI 10.1377/hlthaff.23.6.136; ENTHOVEN AC, 2005, HLTH AFFARIS WE 0907; Finkel MA, 1999, EMERG MED CLIN N AM, V17, P443, DOI 10.1016/S0733-8627(05)70070-5; Fowler F.J, 1995, IMPROVING SURVEY QUE; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kim CS, 1999, AM J MED, V107, P556, DOI 10.1016/S0002-9343(99)00293-4; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; PETERSDORF RG, 1993, JAMA-J AM MED ASSOC, V269, P1681, DOI 10.1001/jama.269.13.1681; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; ROTHMAN DJ, 2003, NEW ENGL J MED, V342, P1284; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Starr Paul., 1984, SOCIAL TRANSFORMATIO; *STATACORP, 2003, STAT STAT SOFTW REL; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010	23	182	184	2	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					795	U60		10.7326/0003-4819-147-11-200712040-00012	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239SX	18056665				2022-12-28	WOS:000251539100008
J	Bertaux, JL; Vandaele, AC; Korablev, O; Villard, E; Fedorova, A; Fussen, D; Quemerais, E; Belyaev, D; Mahieux, A; Montmessin, F; Muller, C; Neefs, E; Nevejans, D; Wilquet, V; Dubois, JP; Hauchecorne, A; Stepanov, A; Vinogradov, I; Rodin, A				Bertaux, Jean-Loup; Vandaele, Ann-Carine; Korablev, Oleg; Villard, E.; Fedorova, A.; Fussen, D.; Quemerais, E.; Belyaev, D.; Mahieux, A.; Montmessin, F.; Muller, C.; Neefs, E.; Nevejans, D.; Wilquet, V.; Dubois, J. P.; Hauchecorne, A.; Stepanov, A.; Vinogradov, I.; Rodin, A.		SPICAV SOIR Team	A warm layer in Venus' cryosphere and high-altitude measurements of HF, HCl, H2O and HDO	NATURE			English	Article							WATER-VAPOR; NIGHT AIRGLOW; ATMOSPHERE; MESOSPHERE; DEUTERIUM; SPECTRA; FRACTIONATION; CIRCULATION	Venus has thick clouds of H2SO4 aerosol particles extending from altitudes of 40 to 60 km. The 60-100 km region (the mesosphere) is a transition region between the 4 day retrograde superrotation at the top of the thick clouds and the solar-antisolar circulation in the thermosphere (above 100 km), which has upwelling over the subsolar point and transport to the nightside(1,2). The mesosphere has a light haze of variable optical thickness, with CO, SO2, HCl, HF, H2O and HDO as the most important minor gaseous constituents, but the vertical distribution of the haze and molecules is poorly known because previous descent probes began their measurements at or below 60 km. Here we report the detection of an extensive layer of warm air at altitudes 90-120 km on the night side that we interpret as the result of adiabatic heating during air subsidence. Such a strong temperature inversion was not expected, because the night side of Venus was otherwise so cold that it was named the 'cryosphere' above 100 km. We also measured the mesospheric distributions of HF, HCl, H2O and HDO. HCl is less abundant than reported 40 years ago(3). HDO/H2O is enhanced by a factor of similar to 2.5 with respect to the lower atmosphere, and there is a general depletion of H2O around 80-90 km for which we have no explanation.	CNRS, IPSL, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Paris 06, F-75252 Paris, France; Belgian Inst Space Aeron, B-1180 Brussels, Belgium; Space Res Inst, IKI, Moscow 117810, Russia; Univ Versailles St Quentin, Inst Pierre Simon Laplace, F-78280 Guyancourt, France; Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119992, Russia; Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; UDICE-French Research Universities; Universite Paris Saclay; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Bertaux, JL (corresponding author), CNRS, IPSL, Serv Aeron, F-91371 Verrieres Le Buisson, France.	bertaux@aerov.jussieu.fr	Rodin, Alexander V./L-1904-2013; Belyaev, Denis/A-5404-2015; Korablev, Oleg I/K-6770-2017; Rodin, Alexander/M-8693-2019; Fedorova, Anna A/L-5116-2013; Hauchecorne, Alain/A-8489-2013; Korablev, Oleg/L-5083-2013; Vandaele, Ann C/D-7167-2016; Mahieux, Arnaud/R-2991-2017	Rodin, Alexander V./0000-0002-3601-7790; Belyaev, Denis/0000-0003-1123-5983; Korablev, Oleg I/0000-0003-1115-0656; Rodin, Alexander/0000-0002-3601-7790; Korablev, Oleg/0000-0003-1115-0656; Vandaele, Ann C/0000-0001-8940-9301; Mahieux, Arnaud/0000-0001-5359-7179; LEBONNOIS, SEBASTIEN/0000-0002-2390-8164; Hauchecorne, Alain/0000-0001-9888-6994; Fedorova, Anna/0000-0002-4176-2955; Montmessin, Franck/0000-0002-4187-1457; RANNOU, pascal/0000-0003-0836-723X; GERARD, Jean-Claude/0000-0002-8565-8746				Bertaux JL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002690; Bertaux JL, 2001, J GEOPHYS RES-PLANET, V106, P32879, DOI 10.1029/2000JE001358; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; Bjoraker G. L., 1992, B AM ASTRON SOC, V24, P995; Bougher S. W., 1997, VENUS 2, P259; BOUGHER SW, 1990, J GEOPHYS RES-SPACE, V95, P6271, DOI 10.1029/JA095iA05p06271; Cheng BM, 1999, GEOPHYS RES LETT, V26, P3657, DOI 10.1029/1999GL008367; Clancy RT, 2003, ICARUS, V161, P1, DOI 10.1016/S0019-1035(02)00022-2; CONNES P, 1967, ASTROPHYS J, V147, P1230, DOI 10.1086/149124; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; DEBERGH C, 1991, SCIENCE, V251, P547, DOI 10.1126/science.251.4993.547; DICKINSON RE, 1977, ICARUS, V30, P163, DOI 10.1016/0019-1035(77)90130-0; Donahue T. M., 1997, VENUS 2 GEOLOGY GEOP, P385; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; GERARD JC, 1981, GEOPHYS RES LETT, V8, P633, DOI 10.1029/GL008i006p00633; Gurwell MA, 2007, ICARUS, V188, P288, DOI 10.1016/j.icarus.2006.12.004; JENKINS JM, 1994, ICARUS, V110, P79, DOI 10.1006/icar.1994.1108; Keating G.M., 1985, ADV SPACE RES, V5, P117, DOI [10.1016/0273-1177(85)90200-5, DOI 10.1016/0273-1177(85)90200-5]; LELLOUCH E, 1994, ICARUS, V110, P315, DOI 10.1006/icar.1994.1125; Nevejans D, 2006, APPL OPTICS, V45, P5191, DOI 10.1364/AO.45.005191; Quemerais E, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002604; Sandor BJ, 2005, ICARUS, V177, P129, DOI 10.1016/j.icarus.2005.03.020; Stewart AIF, 1980, J GEOPHYS RES-SPACE, V85, P7861, DOI 10.1029/JA085iA13p07861; VANDAELE AC, 2006, ESA ATM SCI C FRASC; YOUNG LDG, 1972, ICARUS, V17, P632, DOI 10.1016/0019-1035(72)90029-2; YUNG YL, 1982, ICARUS, V51, P199, DOI 10.1016/0019-1035(82)90080-X; Zasova LV, 2006, COSMIC RES+, V44, P364, DOI 10.1134/S0010952506040095	27	142	144	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					646	649		10.1038/nature05974	http://dx.doi.org/10.1038/nature05974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046397	Green Published			2022-12-28	WOS:000251209700037
J	Loncarek, J; Kisurina-Evgenieva, O; Vinogradova, T; Hergert, P; La Terra, S; Kapoor, TM; Khodjakov, A				Loncarek, Jadranka; Kisurina-Evgenieva, Olga; Vinogradova, Tatiana; Hergert, Polla; La Terra, Sabrina; Kapoor, Tarun M.; Khodjakov, Alexey			The centromere geometry essential for keeping mitosis error free is controlled by spindle forces	NATURE			English	Article							KINETOCHORE FIBERS CONTRIBUTES; SMALL-MOLECULE INHIBITOR; CELL-CYCLE PROGRESSION; CHROMOSOME CONGRESSION; MITOTIC CHROMOSOMES; MICROTUBULE; TENSION; CHECKPOINT; ATTACHMENT; VERTEBRATES	Accurate segregation of chromosomes, essential for the stability of the genome, depends on 'bi-orientation'-simultaneous attachment of each individual chromosome to both poles of the mitotic spindle(1). On bi-oriented chromosomes, kinetochores (macromolecular complexes that attach the chromosome to the spindle) reside on the opposite sides of the chromosome's centromere(2). In contrast, sister kinetochores shift towards one side of the centromere on 'syntelic' chromosomes that erroneously attach to one spindle pole with both sister kinetochores. Syntelic attachments often arise during spindle assembly and must be corrected to prevent chromosome loss(3). It is assumed that restoration of proper centromere architecture occurs automatically owing to elastic properties of the centromere(1,2). Here we test this assumption by combining laser microsurgery and chemical biology assays in cultured mammalian cells. We find that kinetochores of syntelic chromosomes remain juxtaposed on detachment from spindle microtubules. These findings reveal that correction of syntelic attachments involves an extra step that has previously been overlooked: external forces must be applied to move sister kinetochores to the opposite sides of the centromere. Furthermore, we demonstrate that the shape of the centromere is important for spindle assembly, because bipolar spindles do not form in cells lacking centrosomes when multiple chromosomes with juxtaposed kinetochores are present. Thus, proper architecture of the centromere makes an important contribution to achieving high fidelity of chromosome segregation.	New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rockefeller University	Khodjakov, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Albany, NY 12201 USA.	kapoor@rockefeller.edu; khodj@wadsworth.org	Kisurina-Evgenieva, Olga/ABC-4520-2020	Loncarek, Jadranka/0000-0003-1879-5473	NIGMS NIH HHS [R01 GM065933, R01 GM059363-09, R01 GM059363] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363, R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; CASSIMERIS L, 1994, J CELL SCI, V107, P285; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Compton DA, 1998, J CELL SCI, V111, P1477; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sullivan KF, 1999, METHOD CELL BIOL, V58, P183; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	31	77	77	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					745	U14		10.1038/nature06344	http://dx.doi.org/10.1038/nature06344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046416	Green Accepted			2022-12-28	WOS:000251209700059
J	Milne, JC; Lambert, PD; Schenk, S; Carney, DP; Smith, JJ; Gagne, DJ; Jin, L; Boss, O; Perni, RB; Vu, CB; Bemis, JE; Xie, R; Disch, JS; Ng, PY; Nunes, JJ; Lynch, AV; Yang, HY; Galonek, H; Israelian, K; Choy, W; Iffland, A; Lavu, S; Medvedik, O; Sinclair, DA; Olefsky, JM; Jirousek, MR; Elliott, PJ; Westphal, CH				Milne, Jill C.; Lambert, Philip D.; Schenk, Simon; Carney, David P.; Smith, Jesse J.; Gagne, David J.; Jin, Lei; Boss, Olivier; Perni, Robert B.; Vu, Chi B.; Bemis, Jean E.; Xie, Roger; Disch, Jeremy S.; Ng, Pui Yee; Nunes, Joseph J.; Lynch, Amy V.; Yang, Hongying; Galonek, Heidi; Israelian, Kristine; Choy, Wendy; Iffland, Andre; Lavu, Siva; Medvedik, Oliver; Sinclair, David A.; Olefsky, Jerrold M.; Jirousek, Michael R.; Elliott, Peter J.; Westphal, Christoph H.			Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes	NATURE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; SIR2-LIKE PROTEINS; INSULIN-RESISTANCE; CELL-SURVIVAL; LONGEVITY; NAD; DEACETYLASE; GLUCOSE	Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes(1,2). SIRT1, an NAD(+)-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity(3-9). Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival10-14. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.	Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School	Westphal, CH (corresponding author), Sirtris Pharmaceut Inc, 790 Mem Dr, Cambridge, MA 02139 USA.	cwestphal@sirtrispharma.com		Sinclair, David/0000-0002-9936-436X; Disch, Jeremy/0000-0002-0357-1672; Schenk, Simon/0000-0002-8224-3203	NIA NIH HHS [P01 AG027916-030003, R01 AG028730-03, P01 AG027916, R01 AG019719, P01 AG027916-040003, R01 AG028730-02, R01 AG019719-07, R01 AG028730] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG028730, R01AG019719] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; BANKS A, 2007, DIABETES, V56; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sarabu R, 2005, CURR OPIN DRUG DISC, V8, P631; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	28	1348	1431	11	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					712	716		10.1038/nature06261	http://dx.doi.org/10.1038/nature06261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	235BY	18046409	Green Accepted			2022-12-28	WOS:000251209700052
J	Froggatt, P				Froggatt, Peter			Life after retirement	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1323	1324		10.1136/bmj.39419.431944.AD	http://dx.doi.org/10.1136/bmj.39419.431944.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	248UO	18156249	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252182700033
J	Williams, G; Dharmaraj, P				Williams, Gareth; Dharmaraj, Poonam			Dissent of the testis	BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBERTY		[Williams, Gareth] Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England; [Dharmaraj, Poonam] Royal Victoria Infirm, Dept Paediat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Bristol; Newcastle University - UK	Williams, G (corresponding author), Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England.							Bhalla P, 2001, BRIT MED J, V323, P1486, DOI 10.1136/bmj.323.7327.1486; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1287	1287		10.1136/bmj.39415.755752.AD	http://dx.doi.org/10.1136/bmj.39415.755752.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156230	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000252182700010
J	Falk, ML				Falk, Michael L.			Materials science - The flow of glass	SCIENCE			English	Editorial Material							METALLIC-GLASS; AMORPHOUS-ALLOYS; BUBBLE RAFT; DEFORMATION; TRANSITION; DYNAMICS; MODEL		Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Falk, ML (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.	mfalk@umich.edu	Falk, Michael L/A-8478-2008	Falk, Michael L/0000-0002-8383-4259				ARGON AS, 1979, MATER SCI ENG, V39, P101, DOI 10.1016/0025-5416(79)90174-5; ARGON AS, 1979, ACTA METALL MATER, V27, P47, DOI 10.1016/0001-6160(79)90055-5; DENG D, 1989, PHILOS T R SOC A, V329, P549, DOI 10.1098/rsta.1989.0089; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; INOUE A, 1990, MATER T JIM, V31, P177, DOI 10.2320/matertrans1989.31.177; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; OHR SM, 1980, PHILOS MAG A, V41, P81, DOI 10.1080/01418618008241832; PEKER A, 1993, APPL PHYS LETT, V63, P2342, DOI 10.1063/1.110520; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Schuh CA, 2003, NAT MATER, V2, P449, DOI 10.1038/nmat918; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Sheng HW, 2007, NAT MATER, V6, P192, DOI 10.1038/nmat1839; SIMPSON AW, 1972, NATURE, V237, P320, DOI 10.1038/237320a0; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2	14	20	21	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1880	1881		10.1126/science.1150919	http://dx.doi.org/10.1126/science.1150919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HE	18096797				2022-12-28	WOS:000251786600046
J	Lai, CL; Gane, E; Liaw, YF; Hsu, CW; Thongsawat, S; Wang, YM; Chen, YG; Heathcote, EJ; Rasenack, J; Bzowej, N; Naoumov, NV; Di Bisceglie, AM; Zeuzem, S; Moon, YM; Goodman, Z; Chao, G; Constance, BF; Brown, NA				Lai, Ching-Lung; Gane, Edward; Liaw, Yun-Fan; Hsu, Chao-Wei; Thongsawat, Satawat; Wang, Yuming; Chen, Yagang; Heathcote, E. Jenny; Rasenack, Jens; Bzowej, Natalie; Naoumov, Nikolai V.; Di Bisceglie, Adrian M.; Zeuzem, Stefan; Moon, Young Myoung; Goodman, Zachary; Chao, George; Constance, Barbara Fielman; Brown, Nathaniel A.		Globe Study Grp	Telbivudine versus lamivudine in patients with chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; ADEFOVIR DIPIVOXIL; YMDD VARIANTS; VIRAL LOAD; HBV-DNA; COMBINATION; MANAGEMENT; RESISTANCE; ENTECAVIR	Background: Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a key therapeutic goal for chronic hepatitis B. Methods: In this double-blind, phase 3 trial, 1370 patients with chronic hepatitis B were randomly assigned to receive 600 mg of telbivudine or 100 mg of lamivudine once daily. The primary efficacy end point was noninferiority of telbivudine to lamivudine for therapeutic response (i.e., a reduction in serum HBV DNA levels to fewer than 5 log(10) copies per milliliter, along with loss of hepatitis B e antigen [HBeAg] or normalization of alanine aminotransferase levels). Secondary efficacy measures included histologic response, changes in serum HBV DNA levels, and HBeAg responses. Results: At week 52, a significantly higher proportion of HBeAg-positive patients receiving telbivudine than of those receiving lamivudine had a therapeutic response (75.3% vs. 67.0%, P=0.005) or a histologic response (64.7% vs. 56.3%, P=0.01); telbivudine also was not inferior to lamivudine for these end points in HBeAg-negative patients. In HBeAg-positive and HBeAg-negative patients, telbivudine was superior to lamivudine with respect to the mean reduction in the number of copies of HBV DNA from baseline, the proportion of patients with a reduction in HBV DNA to levels undetectable by polymerase-chain-reaction assay, and development of resistance to the drug. Elevated creatine kinase levels were more common in patients who received telbivudine, whereas elevated alanine aminotransferase and aspartate aminotransferase levels were more common in those who received lamivudine. Conclusions: Among patients with HBeAg-positive chronic hepatitis B, the rates of therapeutic and histologic response at 1 year were significantly higher in patients treated with telbivudine than in patients treated with lamivudine. In both the HBeAg-negative and the HBeAg-positive groups, telbivudine demonstrated greater HBV DNA suppression with less resistance than did lamivudine. (ClinicalTrials.gov number, NCT00057265.).	Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; Middlemore Hosp, Auckland 6, New Zealand; Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Taipei, Taiwan; Chiang Mai Univ, Chiang Mai 50000, Thailand; Third Mil Med Univ, Xi Nan Hosp, Chongqing, Peoples R China; Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310027, Peoples R China; Univ Toronto, Toronto, ON, Canada; Univ Freiburg, Freiburg, Germany; Sutter Hlth, San Francisco, CA USA; UCL, London, England; St Louis Univ, St Louis, MO 63103 USA; Saarland Univ Hosp, Homburg, Germany; Yonsei Univ, Coll Med, Seoul, South Korea; Armed Forces Inst Pathol, Washington, DC 20306 USA; Idenix Pharmaceut, Cambridge, MA USA	University of Hong Kong; Chang Gung Memorial Hospital; Chang Gung University; Chiang Mai University; Army Medical University; Zhejiang University; University of Toronto; University of Freiburg; University of London; University College London; Saint Louis University; Universitatsklinikum des Saarlandes; Yonsei University; Yonsei University Health System; United States Department of Defense	Lai, CL (corresponding author), Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China.	hrmelcl@hkucc.hku.hk	Liaw, Yun-Fan/B-4305-2009; Zeuzem, Stefan/AAE-7435-2019; Lai, Ching Lung/C-4298-2009	Lai, Ching-Lung/0000-0002-5927-2436; Thongsawat, Satawat/0000-0003-3302-3930				Bridges E, 2006, J HEPATOL, V44, pS147, DOI 10.1016/S0168-8278(06)80388-0; CHAN HLY, IN PRESS ANN INTERN; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen G, 2006, AM J GASTROENTEROL, V101, P1797, DOI 10.1111/j.1572-0241.2006.00647.x; *CHMP, 2006, GUID CLIN EV MED PRO; Colonno RJ, 2006, HEPATOLOGY, V44, p229A; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Gauthier J, 1999, J INFECT DIS, V180, P1757, DOI 10.1086/315147; *GIL SCI, 2006, HEPS AD DIP PRESCR I; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2004, HEPATOLOGY, V40, P719, DOI 10.1002/hep.20374; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lai CL, 2006, NEW ENGL J MED, V354, P1863; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lampertico P, 2003, HEPATOLOGY, V37, P756, DOI 10.1053/jhep.2003.50148; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Leung N, 2007, J HEPATOL, V46, pS24, DOI 10.1016/S0168-8278(07)61647-X; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Locarnini S, 2004, ANTIVIR THER, V9, P679; Lok ASF, 2007, HEPATOLOGY, V45, P1347, DOI 10.1002/hep.21738; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Lu HL, 2001, BIOMETRICAL J, V43, P909; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; *NAT I ALL INF DIS, 1992, DIV AIDS TABL GRAD S; Ohata K, 2004, J GASTROEN HEPATOL, V19, P670, DOI 10.1111/j.1440-1746.2004.03360.x; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; Standring DN, 2006, J HEPATOL, V44, pS191, DOI 10.1016/S0168-8278(06)80514-3; Standring David N., 2001, Antiviral Chemistry and Chemotherapy, V12, P119; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Yuan HJ, 2005, J VIRAL HEPATITIS, V12, P373, DOI 10.1111/j.1365-2893.2005.00603.x; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; 2007, MED LETT DRUGS THER, V49, P11	48	571	656	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2576	2588		10.1056/NEJMoa066422	http://dx.doi.org/10.1056/NEJMoa066422			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094378				2022-12-28	WOS:000251728900008
J	Sanjuan, MA; Dillon, CP; Tait, SWG; Moshiach, S; Dorsey, F; Connell, S; Komatsu, M; Tanaka, K; Cleveland, JL; Withoff, S; Green, DR				Sanjuan, Miguel A.; Dillon, Christopher P.; Tait, Stephen W. G.; Moshiach, Simon; Dorsey, Frank; Connell, Samuel; Komatsu, Masaaki; Tanaka, Keiji; Cleveland, John L.; Withoff, Sebo; Green, Douglas R.			Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis	NATURE			English	Article							PHAGOSOME MATURATION; LEGIONELLA-PNEUMOPHILA; CLASS-I; INNATE; IMMUNITY; DEFENSE; SYSTEM; ROLES	Phagocytosis and autophagy are two ancient, highly conserved processes involved, respectively, in the removal of extracellular organisms and the destruction of organisms in the cytosol(1-3). Autophagy, for either metabolic regulation or defence, involves the formation of a double membrane called the autophagosome, which then fuses with lysosomes to degrade the contents(4), a process that has similarities with phagosome maturation. Toll-like-receptor ( TLR) engagement activates a variety of defence mechanisms within phagocytes(5), including facilitation of phagosome maturation(6), and also engages autophagy(7). Therefore we speculated that TLR signalling might link these processes to enhance the function of conventional phagosomes. Here we show that a particle that engages TLRs on a murine macrophage while it is phagocytosed triggers the autophagosome marker LC3 to be rapidly recruited to the phagosome in a manner that depends on the autophagy pathway proteins ATG5 and ATG7; this process is preceded by recruitment of beclin 1 and phosphoinositide-3-OH kinase activity. Translocation of beclin 1 and LC3 to the phagosome was not associated with observable double- membrane structures characteristic of conventional autophagosomes, but was associated with phagosome fusion with lysosomes, leading to rapid acidification and enhanced killing of the ingested organism.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Tokyo Metropolitan Institute of Medical Science; Scripps Research Institute	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Dillon, Christopher/P-4457-2014; Sanjuán, Miguel Ángel/I-6896-2019; Green, Douglas R/N-8083-2018; Komatsu, Masaaki/B-8321-2011	Dillon, Christopher/0000-0002-9458-0266; Sanjuán, Miguel Ángel/0000-0001-6694-0634; Green, Douglas R/0000-0002-7332-1417; Komatsu, Masaaki/0000-0001-7672-7722; Tait, Stephen/0000-0001-7697-132X				Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Blander JM, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217b; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tilney LG, 2001, J CELL SCI, V114, P4637; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	30	968	997	3	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1253	1257		10.1038/nature06421	http://dx.doi.org/10.1038/nature06421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097414				2022-12-28	WOS:000251786200055
J	Touboul, M; Kleine, T; Bourdon, B; Palme, H; Wieler, R				Touboul, M.; Kleine, T.; Bourdon, B.; Palme, H.; Wieler, R.			Late formation and prolonged differentiation of the Moon inferred from W isotopes in lunar metals	NATURE			English	Article							COSMIC-RAY PRODUCTION; BULK SILICATE EARTH; CORE FORMATION; IMPACT HISTORY; GIANT IMPACT; ORIGIN; CONSTRAINTS; AGE; HF; ACCRETION	The Moon is thought to have formed from debris ejected by a giant impact with the early 'proto'-Earth(1) and, as a result of the high energies involved, the Moon would have melted to form a magma ocean. The timescales for formation and solidification of the Moon can be quantified by using Hf-182-W-182 and Sm-146-Nd-142 chronometry(2-4), but these methods have yielded contradicting results. In earlier studies(3,5-7), W-182 anomalies in lunar rocks were attributed to decay of Hf-182 within the lunar mantle and were used to infer that the Moon solidified within the first, 60 million years of the Solar System. However, the dominant W-182 component in most lunar rocks reflects cosmogenic production mainly by neutron capture of Ta-181 during cosmic- ray exposure of the lunar surface(3,7), compromising a reliable interpretation in terms of Hf-182-W-182 chronometry. Here we present tungsten isotope data for lunar metals that do not contain any measurable Ta- derived W-182. All metals have identical W-182/W-184 ratios, indicating that the lunar magma ocean did not crystallize within the first, 60 Myr of the Solar System, which is no longer inconsistent with Sm - Nd chronometry(8-11). Our new data reveal that the lunar and terrestrial mantles have identical W-182/W-184. This, in conjunction with Sm-147-Nd-143 ages for the oldest lunar rocks(8-11), constrains the age of the Moon and Earth to 62(-10)(+90) Myr after formation of the Solar System. The identical W-182/W-184 ratios of the lunar and terrestrial mantles require either that the Moon is derived mainly from terrestrial material or that tungsten isotopes in the Moon and Earth's mantle equilibrated in the aftermath of the giant impact, as has been proposed to account for identical oxygen isotope compositions of the Earth and Moon(12).	ETH, Inst Isotope Geochem & Mineral Resources, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Cologne, Inst Mineral & Geochem, D-50674 Cologne, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne	Touboul, M (corresponding author), ETH, Inst Isotope Geochem & Mineral Resources, Dept Earth Sci, Clausiusstr 25, CH-8092 Zurich, Switzerland.	touboul@erdw.ethz.ch	Bourdon, Bernard/A-3303-2008; Kleine, Thorsten/S-2792-2017; Wieler, Rainer/A-1355-2010	Kleine, Thorsten/0000-0003-4657-5961; Wieler, Rainer/0000-0001-5666-7494				ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; ALLEGRE CJ, 1986, CHEM GEOL, V56, P219, DOI 10.1016/0009-2541(86)90005-7; Borg L, 1999, GEOCHIM COSMOCHIM AC, V63, P2679, DOI 10.1016/S0016-7037(99)00130-1; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; Kleine T, 2005, EARTH PLANET SC LETT, V231, P41, DOI 10.1016/j.epsl.2004.12.016; Kleine T, 2004, EARTH PLANET SC LETT, V228, P109, DOI 10.1016/j.epsl.2004.09.023; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; Lee DC, 2002, EARTH PLANET SC LETT, V198, P267, DOI 10.1016/S0012-821X(02)00533-2; Leya I, 2000, EARTH PLANET SC LETT, V175, P1, DOI 10.1016/S0012-821X(99)00295-2; Leya I, 2003, GEOCHIM COSMOCHIM AC, V67, P529, DOI 10.1016/S0016-7037(02)01091-8; Newsom HE, 1996, GEOCHIM COSMOCHIM AC, V60, P1155, DOI 10.1016/0016-7037(96)00029-4; Nimmo F, 2006, EARTH PLANET SC LETT, V243, P26, DOI 10.1016/j.epsl.2005.12.009; Norman MD, 2003, METEORIT PLANET SCI, V38, P645, DOI 10.1111/j.1945-5100.2003.tb00031.x; Nyquist L, 2006, GEOCHIM COSMOCHIM AC, V70, P5990, DOI 10.1016/j.gca.2006.07.042; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; PALME H, 1975, P LUNAR PLANET SCI C, P1179; PALME H, 1981, P LUN PLAN SCI 12, P949; Palme H., 1981, P LUNAR PLANET SCI, V12B, P949; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Righter K, 2003, GEOCHIM COSMOCHIM AC, V67, P2497, DOI 10.1016/S0016-7037(02)01349-2; ROCHOLL A, 1993, EARTH PLANET SC LETT, V117, P265, DOI 10.1016/0012-821X(93)90132-S; Shearer CK, 2000, GEOCHIM COSMOCHIM AC, V64, P3599, DOI 10.1016/S0016-7037(00)00442-7; Shearer CK, 1999, AM MINERAL, V84, P1469; Solomatov V.S., 2000, ORIGIN EARTH MOON, P323; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037	31	314	323	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1206	1209		10.1038/nature06428	http://dx.doi.org/10.1038/nature06428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097403				2022-12-28	WOS:000251786200044
J	Morpeth, S; Murdoch, D; Cabell, CH; Karchmer, AW; Pappas, P; Levine, D; Nacinovich, F; Tattevin, P; Fernandez-Hidalgo, N; Dickerman, S; Bouza, E; Del Rio, A; Lejko-Zupanc, T; Ramos, ADO; Larussi, D; Klein, J; Chirouze, C; Bedimo, R; Corey, GR; Fowler, VG				Morpeth, Susan; Murdoch, David; Cabell, Christopher H.; Karchmer, Adolf W.; Pappas, Paul; Levine, Donald; Nacinovich, Francisco; Tattevin, Pierre; Fernandez-Hidalgo, Nuria; Dickerman, Stuart; Bouza, Emilio; Del Rio, Ana; Lejko-Zupanc, Tatjana; Ramos, Auristela De Oliveira; Larussi, Diana; Klein, John; Chirouze, Catherine; Bedimo, Roger; Corey, G. Ralph; Fowler, Vance G., Jr.			Non-HACEK gram-negative bacillus endocarditis	ANNALS OF INTERNAL MEDICINE			English	Article							PROSTHETIC VALVE ENDOCARDITIS; LEFT-SIDED ENDOCARDITIS; DETROIT-MEDICAL-CENTER; INFECTIVE ENDOCARDITIS; INTERNATIONAL-COLLABORATION; PSEUDOMONAS-AERUGINOSA; BACTEREMIA; DIAGNOSIS; MANAGEMENT; PROGRESS	Background: Infective endocarditis caused by non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, or Kingella species) gram-negative bacilli is rare, is poorly characterized, and is commonly considered to be primarily a disease of injection drug users. Objective: To describe the clinical characteristics and outcomes of patients with non-HACEK gram-negative bacillus endocarditis in a large, international, contemporary cohort of patients. Design: Observations from the International Collaboration on Infective Endocarditis Prospective Cohort Study (ICE-PCS) database. Setting: 61 hospitals in 28 countries. Patients: Hospitalized patients with definite endocarditis. Measurements: Characteristics of non-HACEK gram-negative bacillus endocarditis cases were described and compared with those due to other pathogens. Results: Among the 2761 case-patients with definite endocarditis enrolled in ICE-PCS, 49 (1.8%) had endocarditis (20 native valve, 29 prosthetic valve or device) due to non-HACEK, gram-negative bacilli. Escherichia coli (14 patients [29%]) and Pseudomonas aeruginosa (11 patients [22%]) were the most common pathogens. Most patients (57%) with non-HACEK gram-negative bacillus endocarditis had health care-associated infection, whereas injection drug use was rare (4%). Implanted endovascular devices were frequently associated with non-HACEK gram-negative bacillus endocarditis compared with other causes of endlocarditis (29% vs. 11%; P < 0.001). The in-hospital mortality rate of patients with enclocarditis due to non-HACEK gram-negative bacilli was high (24%) despite high rates of cardiac surgery (51%). Limitations: Because of the small number of patients with non-HACEK gram-negative bacillus endocarditis in each treatment group and the lack of long-term follow-up, strong treatment recommendations are difficult to make. Conclusion: in this large, prospective, multinational cohort, more than one half of all cases of non-HACEK gram-negative bacillus enclocarditis were associated with health care contact. Non-HACEK gram-negative bacillus enclocarditis is not primarily a disease of injection drug users.	Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Univ Otago, Christchurch, New Zealand; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Wayne State Univ, Ctr Hlth, Detroit, MI USA; Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina; Pontchaillou Univ Hosp, Rennes, France; Hosp Univ Vall Hebron, Barcelona, Spain; NYU, Med Ctr, Sch Med, New York, NY 10016 USA; Univ Gregorio Maranon, Gen Hosp, Madrid, Spain; Univ Barcelona, Hosp Clin & Prov Clin, Inst Invest Biomed August Pi Sunyer, Barcelona, Spain; Med Ctr, Ljubljana, Slovenia; Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; Univ Naples 2, Naples, Italy; St Thomas Hosp, London, England; Univ Besancon, Med Ctr, F-25030 Besancon, France; Univ Texas Southwester Med Ctr Dallas, Vet Hlth Affairs N Texas, Dallas, TX USA	Duke University; Duke University; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; Wayne State University; Instituto Cardiovascular de Buenos Aires (ICBA); CHU Rennes; Hospital Universitari Vall d'Hebron; New York University; General University Gregorio Maranon Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto Dante Pazzanese de Cardiologia; Universita della Campania Vanvitelli; Guy's & St Thomas' NHS Foundation Trust; Universite de Franche-Comte; CHU Besancon	Fowler, VG (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Box 3281, Durham, NC 27710 USA.	vance.fowler@duke.edu	DE ROSA, Francesco Giuseppe/AAC-7275-2022; ntsekhe, mpiko/AAI-8001-2021; Benito, Natividad/D-1855-2010; Toniolo, Antonio Q./B-4103-2015; Bouza, Emilio/D-8661-2014; Murdoch, David/A-2012-2009; Fowler, Vance/AAW-2017-2021; Vincelj, Josip/ABE-3053-2021; Francis, Johnson/N-3588-2015; McBryde, Emma/D-2220-2018; Vandenesch, Francois/C-7209-2014	DE ROSA, Francesco Giuseppe/0000-0001-8338-0130; ntsekhe, mpiko/0000-0002-0851-7675; Benito, Natividad/0000-0001-6410-013X; Toniolo, Antonio Q./0000-0003-3008-2126; Bouza, Emilio/0000-0001-6967-9267; Vincelj, Josip/0000-0003-0064-9128; Francis, Johnson/0000-0003-1084-8075; McBryde, Emma/0000-0002-9570-9172; Vandenesch, Francois/0000-0001-9412-7106; Lambert, Peter/0000-0002-8243-2741; Durante-Mangoni, Emanuele/0000-0002-5381-3537; Fernandez-Hidalgo, Nuria/0000-0002-2115-344X; Post, Jeffrey/0000-0003-1475-9272; Gordon, David/0000-0003-3276-9685; Giamarellou, Helen/0000-0002-7387-5065; GIANNITSIOTI, EFTHYMIA/0000-0003-2715-7457; Athan, Eugene/0000-0001-9838-6471; Tan, Ru San/0000-0003-2086-6517; Kanafani, Zeina/0000-0001-8814-1286; Chambers, Stephen/0000-0002-0698-3285; Querido Fortes, Claudio/0000-0002-9700-9743; Eisen, Damon/0000-0002-8987-4358; Almirante, Benito/0000-0002-1189-2361; Sexton, Daniel J/0000-0001-9604-5948; Henry, Assoc Prof Margaret J/0000-0002-1233-6754; Imazio, Massimo/0000-0002-5722-0245; Wang, Andrew/0000-0001-8729-0933	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI068804] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47; Cabell CH, 2005, AM HEART J, V150, P1092, DOI 10.1016/j.ahj.2005.03.057; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011; COHEN PS, 1980, PROG CARDIOVASC DIS, V22, P205, DOI 10.1016/0033-0620(80)90010-9; COOPER R, 1980, ARCH INTERN MED, V140, P199, DOI 10.1001/archinte.140.2.199; DISMUKES WE, 1973, CIRCULATION, V48, P365, DOI 10.1161/01.CIR.48.2.365; FANG GD, 1993, ANN INTERN MED, V119, P560, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00003; Fowler V, 2005, PRINCIPLES PRACTICE, P975; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GABELL CH, 2004, AM HEART J, V147, P582; GERACI JE, 1982, MAYO CLIN PROC, V57, P145; Jauhar S, 2004, NEW ENGL J MED, V351, P2542, DOI 10.1056/NEJMe048303; KOMSHIAN SV, 1990, REV INFECT DIS, V12, P693; LEVINE DP, 1986, REV INFECT DIS, V8, P374; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Micol R, 2006, CLIN MICROBIOL INFEC, V12, P401, DOI 10.1111/j.1469-0691.2006.01375.x; MILLS J, 1976, ANN INTERN MED, V84, P29, DOI 10.7326/0003-4819-84-1-29; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; Uslan DZ, 2006, CLIN INFECT DIS, V43, P731, DOI 10.1086/506942; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; WIELAND M, 1986, MEDICINE, V65, P180, DOI 10.1097/00005792-198605000-00006; WITCHITZ S, 1982, PATHOL BIOL, V30, P569	27	158	163	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					829	835		10.7326/0003-4819-147-12-200712180-00002	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243HO	18087053				2022-12-28	WOS:000251787600002
J	Davies, JC; Alton, EWFW; Bush, A				Davies, Jane C.; Alton, Eric W. F. W.; Bush, Andrew			Cystic fibrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DISEASE		Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London, England; Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6LY, England; Royal Brompton Hosp, Dept Adult Resp Med, London SW3 6LY, England	Imperial College London; Royal Brompton Hospital; Royal Brompton Hospital	Davies, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London, England.	j.c.davies@ic.ac.uk		Davies, Jane/0000-0003-3506-1199				[Anonymous], COCHRANE DATABASE SY, DOI [10.1002/14651858.CD002203.pub2, DOI 10.1002/14651858.CD002203.PUB2]; Colombo C, 2006, J PEDIATR GASTR NUTR, V43, pS49, DOI 10.1097/01.mpg.0000226390.02355.52; Davies JC, 2005, ADV GENET, V54, P291, DOI 10.1016/S0065-2660(05)54012-4; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Daviskas E, 2006, J AEROSOL MED, V19, P100, DOI 10.1089/jam.2006.19.100; Deterding R, 2005, PEDIATR PULM, V39, P339, DOI 10.1002/ppul.20192; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GLASSCOE CA, 2003, COCHRANE DB SYST REV, P3148; Jones A. P., 2003, COCHRANE DB SYST REV, V3; LANDS LC, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001505; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MIDDLETON PG, 1994, EUR RESPIR J, V7, P2050; Onady GM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004730.pub2; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Smyth A, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd001912, DOI 10.1002/14651858.CD001912]; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Wicks E, 2007, BRIT MED J, V334, P1270, DOI 10.1136/bmj.39188.741944.47; Wood DM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004197.pub2; Yung MW, 2002, ANN OTO RHINOL LARYN, V111, P1081, DOI 10.1177/000348940211101204	23	219	223	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2007	335	7632					1255	1259		10.1136/bmj.39391.713229.AD	http://dx.doi.org/10.1136/bmj.39391.713229.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079549	Green Published			2022-12-28	WOS:000251832200037
J	Frihagen, F; Nordsletten, L; Madsen, JE				Frihagen, Frede; Nordsletten, Lars; Madsen, Jan Erik			Hemiarthroplasty or internal fixation for intracapsular displaced femoral neck fractures: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL HIP-ARTHROPLASTY; FEMUR; METAANALYSIS	Objective To compare the functional results after displaced fractures of the femoral neck treated with internal fixation or hemiarthroplasty. Design Randomised trial with blinding of assessments of functional results. Setting University hospital. Participants 222 patients; 165 (74%) women, mean age 83 years. Inclusion criteria were age above 60, ability to walk before the fracture, and no major hip pathology, regardless of cognitive function. Interventions Closed reduction and two parallel screws (112 patients) and-bipolar cemented hemiarthroplasty (110 patients). Follow-up at 4, 12, and 24 months. Main outcome measures Hip function (Harris hip score), health related quality of life (Eq-5d), activities of daily living (Barthel index). In all cases high scores indicate better function. Results Mean Harris hip score in the hemiarthroplasty group was 8.2 points higher (95% confidence interval 2.8 to 13.5 points, P=0.003) at four months and 6.7 points (1.5 to 11.9 points,P=0.01) higher at 12 months. Mean Eq-5d index score at 24 months was 0.13 higher in the hemiarthroplasty group (0.01 to 0.25, P=0.03). The Eq-5d visual analogue scale was 8.7 points higher in the hemiarthroplasty group after 4 months (1.9 to 15.6, P=0.01). After 12 and 24 months the percentage scoring 95 or 100 on the Barthel index was higher in the hemiarthroplasty group (relative risk 0.67, 0.47 to 0.95, P=0.02. and 0.63, 0.42 to 0.94, P=0.02, respectively). Complications occurred in 56 (50%) patients in the internal fixation group and 16 (15%) in the hemiarthroplasty group (3.44, 2.11 to 5.60, P<0.001). In each group 39 patients (35%) died within 24 months (0.98, 0.69 to 1.40, P=0.92). Conclusions Hemiarthroplasty is associated with better functional outcome than internal fixation in treatment of displaced fractures of the femoral neck in elderly patients.	Ullevaal Univ Hosp, Orthopaed Ctr, Oslo, Norway; Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo	Frihagen, F (corresponding author), Ullevaal Univ Hosp, Orthopaed Ctr, Oslo, Norway.	j.f.frihagen@medisin.uio.no		Frihagen, Frede/0000-0002-4811-669X				Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Blomfeldt R, 2005, J BONE JOINT SURG AM, V87A, P1680, DOI 10.2106/JBJS.D.02655; Blomfeldt R, 2005, J BONE JOINT SURG BR, V87B, P523, DOI 10.1302/0301-620X.87B4; BRAEKHUS A, 1992, J AM GERIATR SOC, V40, P1139, DOI 10.1111/j.1532-5415.1992.tb01804.x; Davison JNS, 2001, J BONE JOINT SURG BR, V83B, P206, DOI 10.1302/0301-620X.83B2.11128; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hoeksma HL, 2003, ANN RHEUM DIS, V62, P935, DOI 10.1136/ard.62.10.935; Johansson T, 2000, ACTA ORTHOP SCAND, V71, P597, DOI 10.1080/000164700317362235; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; MAHONEY F I, 1965, Md State Med J, V14, P61; MASSON M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001708; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; Ravikumar KJ, 2000, INJURY, V31, P793, DOI 10.1016/S0020-1383(00)00125-X; Roden M, 2003, ACTA ORTHOP SCAND, V74, P42, DOI 10.1080/00016470310013635; Rogmark C, 2002, J BONE JOINT SURG BR, V84B, P183, DOI 10.1302/0301-620X.84B2.11923; Rogmark C, 2006, ACTA ORTHOP, V77, P359, DOI 10.1080/17453670610046262; Shepherd SM, 1996, J ROY COLL PHYS LOND, V30, P335; Soderman P, 2001, CLIN ORTHOP RELAT R, P189; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	21	176	203	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2007	335	7632					1251	1254		10.1136/bmj.39399.456551.25	http://dx.doi.org/10.1136/bmj.39399.456551.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18056740	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000251832200036
J	Pechlaner, C; Marschang, P				Pechlaner, Christoph; Marschang, Peter			Dabigatran versus enoxaparin after total hip replacement	LANCET			English	Letter							VENOUS THROMBOEMBOLISM; PREVENTION		Innsbruck Med Univ, Dept Internal Med, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Pechlaner, C (corresponding author), Innsbruck Med Univ, Dept Internal Med, A-6020 Innsbruck, Austria.	christoph.pechlaner@i-med.ac.at		Marschang, Peter/0000-0002-8239-3447				Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Norrie J, 2007, LANCET, V370, P915, DOI 10.1016/S0140-6736(07)61425-1; O'Brien J, 2000, LANCET, V355, P1295; WELLS PS, 1994, ARCH INTERN MED, V154, P67, DOI 10.1001/archinte.154.1.67	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2002	2002		10.1016/S0140-6736(07)61858-3	http://dx.doi.org/10.1016/S0140-6736(07)61858-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083398				2022-12-28	WOS:000251698600021
J	Whitehouse, I; Rando, OJ; Delrow, J; Tsukiyama, T				Whitehouse, Iestyn; Rando, Oliver J.; Delrow, Jeff; Tsukiyama, Toshio			Chromatin remodelling at promoters suppresses antisense transcription	NATURE			English	Article							RNA-QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NUCLEOSOME POSITIONS; POLY(A) POLYMERASE; NUCLEAR EXOSOME; DNA-REPLICATION; BUDDING YEAST; COMPLEX; GENOME	Chromatin allows the eukaryotic cell to package its DNA efficiently. To understand how chromatin structure is controlled across the Saccharomyces cerevisiae genome, we have investigated the role of the ATP- dependent chromatin remodelling complex Isw2 in positioning nucleosomes. We find that Isw2 functions adjacent to promoter regions where it repositions nucleosomes at the interface between genic and intergenic sequences. Nucleosome repositioning by Isw2 is directional and results in increased nucleosome occupancy of the intergenic region. Loss of Isw2 activity leads to inappropriate transcription, resulting in the generation of both coding and noncoding transcripts. Here we show that Isw2 repositions nucleosomes to enforce directionality on transcription by preventing transcription initiation from cryptic sites. Our analyses reveal how chromatin is organized on a global scale and advance our understanding of how transcription is regulated.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	Fred Hutchinson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Tsukiyama, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	ttsukiya@fhcrc.org		Rando, Oliver/0000-0003-1516-9397; Whitehouse, Iestyn/0000-0003-0385-3116				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; BEHE MJ, 1995, NUCLEIC ACIDS RES, V23, P689, DOI 10.1093/nar/23.4.689; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; KUNKEL GR, 1981, NUCLEIC ACIDS RES, V9, P6869, DOI 10.1093/nar/9.24.6869; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	48	325	329	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1031	U3		10.1038/nature06391	http://dx.doi.org/10.1038/nature06391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075583				2022-12-28	WOS:000251579900076
J	Mills, E; Nachega, JB				Mills, Edward; Nachega, Jean B.			A wake-up call for global access to salvage HIV drug regimens	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; ADHERENCE; INDIVIDUALS; RESISTANCE		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Rhodes Univ, Fac Pharm, ZA-6140 Grahamstown, Eastern Cape, South Africa; Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, Western Cape, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; B.C. Centre for Excellence in HIV/AIDS; Rhodes University; University of Cape Town	Nachega, JB (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	jnachega@jhsph.edu		Nachega, Jean/0000-0002-2862-4443	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI068582, R01AI055359] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 5535901, K23 AI068582-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Boulle A, 2007, ANTIVIR THER, V12, P753; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Orrell C, 2007, ANTIVIR THER, V12, P83; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Phillips AN, 2007, LANCET, V370, P1923, DOI 10.1016/S0140-6736(07)61815-7; VANCUTSEM G, 2007, C RETR OPP INF LOS A, P535	13	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1885	1887		10.1016/S0140-6736(07)61790-5	http://dx.doi.org/10.1016/S0140-6736(07)61790-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18068497				2022-12-28	WOS:000251517600007
J	Sokol, DK				Sokol, Daniel K.			A perforated education	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, St Georges, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, St Georges, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1186	1186		10.1136/bmj.39420.480995.34	http://dx.doi.org/10.1136/bmj.39420.480995.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063644	Green Published			2022-12-28	WOS:000251707800030
J	Augui, S; Filion, GJ; Huart, S; Nora, E; Guggiari, M; Maresca, M; Stewart, AF; Heard, E				Augui, S.; Filion, G. J.; Huart, S.; Nora, E.; Guggiari, M.; Maresca, M.; Stewart, A. F.; Heard, E.			Sensing X chromosome pairs before X inactivation via a novel X-pairing region of the Xic	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; XIST LOCUS; HISTONE H3; TSIX; TRANSCRIPTION; METHYLATION; CENTERS; CHOICE; LYS-9	Mammalian dosage compensation involves silencing of one of the two X chromosomes in females and is controlled by the X-inactivation center (Xic). The Xic, which includes Xist and its antisense transcription unit Tsix/Xite, somehow senses the number of X chromosomes and triggers Xist up-regulation from one of the two X chromosomes in females. We found that a segment of the mouse Xic lying several hundred kilobases upstream of Xist brings the two Xics together before the onset of X inactivation. This region can autonomously drive Xic trans-interactions even as an ectopic single-copy transgene. Its introduction into male embryonic stem cells is strongly selected against, consistent with a possible role in trans-activating Xist. We propose that homologous associations driven by this novel X-pairing region (Xpr) of the Xic enable a cell to sense that more than one X chromosome is present and coordinate reciprocal Xist/Tsix expression.	Inst Curie, CNRS, UMR218, F-75005 Paris, France; Tech Univ Dresden, BioInnovat Zentrum, D-01307 Dresden, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Technische Universitat Dresden	Heard, E (corresponding author), Inst Curie, CNRS, UMR218, 26 Rue Ulm, F-75005 Paris, France.	edith.heard@curie.fr	Filion, Guillaume/G-9619-2015; Stewart, A. Francis/E-7789-2010; Nora, Elphège/AAW-9646-2021; Heard, Edith/D-7197-2017	Filion, Guillaume/0000-0002-3473-1632; Nora, Elphège/0000-0002-8347-4396; Heard, Edith/0000-0001-8052-7117				Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heard E, 1999, MOL CELL BIOL, V19, P3156; HEARD E, 1994, HUM MOL GENET, V3, P1481, DOI 10.1093/hmg/3.suppl_1.1481; Henikoff S, 1998, CELL, V93, P329, DOI 10.1016/S0092-8674(00)81161-7; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	19	147	149	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1632	1636		10.1126/science.1149420	http://dx.doi.org/10.1126/science.1149420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063799				2022-12-28	WOS:000251421700048
J	Berg, P; Lehman, IR				Berg, Paul; Lehman, I. R.			Retrospective - Arthur Kornberg (1918-2007)	SCIENCE			English	Biographical-Item									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Berg, P (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	pberg@cmgm.stanford.edu							0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1564	1564		10.1126/science.1152989	http://dx.doi.org/10.1126/science.1152989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063778				2022-12-28	WOS:000251421700025
J	Hanson, B; Voss, D				Hanson, Brooks; Voss, David			Sunrise - Introduction	SCIENCE			English	Editorial Material																			0	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1571	1571		10.1126/science.318.5856.1571	http://dx.doi.org/10.1126/science.318.5856.1571			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063782				2022-12-28	WOS:000251421700028
J	Sakao, T; Kano, R; Narukage, N; Kotoku, J; Bando, T; DeLuca, EE; Lundquist, LL; Tsuneta, S; Harra, LK; Katsukawa, Y; Kubo, M; Hara, H; Matsuzaki, K; Shimojo, M; Bookbinder, JA; Golub, L; Korreck, KE; Su, YN; Shibasaki, K; Shimizu, T; Nakatani, I				Sakao, Taro; Kano, Ryouhei; Narukage, Noriyuki; Kotoku, Jun'ichi; Bando, Takamasa; DeLuca, Edward E.; Lundquist, Loraine L.; Tsuneta, Saku; Harra, Louise K.; Katsukawa, Yukio; Kubo, Masahito; Hara, Hirohisa; Matsuzaki, Keiichi; Shimojo, Masumi; Bookbinder, Jay A.; Golub, Leon; Korreck, Kelly E.; Su, Yingna; Shibasaki, Kiyoto; Shimizu, Toshifumi; Nakatani, Ichiro			Continuous plasma outflows from the edge of a solar active region as a possible source of solar wind	SCIENCE			English	Article							TRANSITION REGION; CORONAL EXPLORER; TELESCOPE; MISSION; HINODE; ORIGIN; LOOPS; VICINITY; FLOWS; EIT	The Sun continuously expels a huge amount of ionized material into interplanetary space as the solar wind. Despite its influence on the heliospheric environment, the origin of the solar wind has yet to be well identified. In this paper, we report Hinode X-ray Telescope observations of a solar active region. At the edge of the active region, located adjacent to a coronal hole, a pattern of continuous outflow of soft-x-ray-emitting plasmas was identified emanating along apparently open magnetic field lines and into the upper corona. Estimates of temperature and density for the outflowing plasmas suggest a mass loss rate that amounts to similar to 1/4 of the total mass loss rate of the solar wind. These outflows may be indicative of one of the solar wind sources at the Sun.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; NAOJ, Nobeyama Radio Observ, Minamisa Ku, Nagano 3841305, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of London; University College London; National Center Atmospheric Research (NCAR) - USA; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Sakao, T (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	sakao@solar.isas.jaxa.jp	DeLuca, Edward E/L-7534-2013; Shibasaki, Kiyoto/AAG-5951-2020; Shimojo, Masumi/J-2605-2016	DeLuca, Edward E/0000-0001-7416-2895; Shibasaki, Kiyoto/0000-0003-4707-5897; Shimojo, Masumi/0000-0002-2350-3749; Narukage, Noriyuki/0000-0002-6330-3944; Hara, Hirohisa/0000-0001-5686-3081; Harra, Louise/0000-0001-9457-6200; Shimizu, Toshifumi/0000-0003-4764-6856; Kubo, Masahito/0000-0001-5616-2808; Golub, Leon/0000-0001-9638-3082	STFC [PP/D002907/1, PP/E001173/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1, PP/E001173/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		[Anonymous], 1943, Z ASTROPHYS; BELL B, 1976, J GEOPHYS RES-SPACE, V81, P4508, DOI 10.1029/JA081i025p04508; BIERMANN L, 1951, Z ASTROPHYS, V29, P274; Chapman S., 1957, SMITHSONIAN CONTRIB, V2, P1, DOI DOI 10.5479/SI.00810231.2-1.1; Culhane JL, 2007, SOL PHYS, V243, P19, DOI 10.1007/s01007-007-0293-1; De Moortel I, 2000, ASTRON ASTROPHYS, V355, pL23; Delaboudiniere JP, 1995, SOL PHYS, V162, P291, DOI 10.1007/BF00733432; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; GOSLING JT, 1981, J GEOPHYS RES-SPACE, V86, P5438, DOI 10.1029/JA086iA07p05438; Handy BN, 1999, SOL PHYS, V187, P229, DOI 10.1023/A:1005166902804; HARA H, 1992, PUBL ASTRON SOC JPN, V44, pL135; Hassler DM, 1999, SCIENCE, V283, P810, DOI 10.1126/science.283.5403.810; ICHIMOTO KIYOSHI, 2005, Journal of the Korean Astronomical Society, V38, P307; Ko YK, 2006, ASTROPHYS J, V646, P1275, DOI 10.1086/505021; Kojima M, 1999, J GEOPHYS RES-SPACE, V104, P16993, DOI 10.1029/1999JA900177; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; NOCI G, 1973, SOL PHYS, V28, P403, DOI 10.1007/BF00152311; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Robbrecht E, 2001, ASTRON ASTROPHYS, V370, P591, DOI 10.1051/0004-6361:20010226; Shimizu T, 2004, ASTR SOC P, V325, P3; Tu CY, 2005, SCIENCE, V308, P519, DOI 10.1126/science.1109447; Wang YM, 1998, ASTROPHYS J, V498, pL165, DOI 10.1086/311321; Winebarger AR, 2002, ASTROPHYS J, V567, pL89, DOI 10.1086/339796; Winebarger AR, 2001, ASTROPHYS J, V553, pL81, DOI 10.1086/320496	24	170	171	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1585	1588		10.1126/science.1147292	http://dx.doi.org/10.1126/science.1147292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063788				2022-12-28	WOS:000251421700034
J	Shojaei, F; Wu, XM; Zhong, CL; Yu, LL; Liang, XH; Yao, J; Blanchard, D; Bais, C; Peale, FV; van Bruggen, N; Ho, C; Ross, J; Tan, M; Carano, RAD; Meng, YG; Ferrara, N				Shojaei, Farbod; Wu, Xiumin; Zhong, Cuiling; Yu, Lanlan; Liang, Xiao-Huan; Yao, Jenny; Blanchard, Dominique; Bais, Carlos; Peale, Franklin V.; van Bruggen, Nicholas; Ho, Calvin; Ross, Jed; Tan, Martha; Carano, Richard A. D.; Meng, Y. Gloria; Ferrara, Napoleone			Bv8 regulates myeloid-cell-dependent tumour angiogenesis	NATURE			English	Article							COLONY-STIMULATING-FACTOR; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; HEMATOPOIETIC STEM-CELLS; GLAND-DERIVED VEGF; MICROCOMPUTED TOMOGRAPHY; PROGENITOR CELLS; IDENTIFICATION; NEOVASCULARIZATION; NEUTROPHILS	Bone- marrow- derived cells facilitate tumour angiogenesis, but the molecular mechanisms of this facilitation are incompletely understood. We have previously shown that the related EG- VEGF and Bv8 proteins, also known as prokineticin 1 ( Prok1) and prokineticin 2 ( Prok2), promote both tissue- specific angiogenesis and haematopoietic cell mobilization. Unlike EG- VEGF, Bv8 is expressed in the bone marrow. Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 in CD11b(+) Gr1(+) myeloid cells. We identified granulocyte colony- stimulating factor as a major positive regulator of Bv8 expression. Anti- Bv8 antibodies reduced CD11b(+) Gr1(+) cell mobilization elicited by granulocyte colony- stimulating factor. Adenoviral delivery of Bv8 into tumours was shown to promote angiogenesis. Anti- Bv8 antibodies inhibited growth of several tumours in mice and suppressed angiogenesis. Anti- Bv8 treatment also reduced CD11b(+) Gr1(+) cells, both in peripheral blood and in tumours. The effects of anti- Bv8 antibodies were additive to those of anti- Vegf antibodies or cytotoxic chemotherapy. Thus, Bv8 modulates mobilization of CD11b(+) Gr1(+) cells from the bone marrow during tumour development and also promotes angiogenesis locally.	Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	nf@gene.com						Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Garcia-Sanz A, 1998, HYPERTENSION, V31, P440, DOI 10.1161/01.HYP.31.1.440; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; Kavgaci H, 2002, J EXP CLIN CANC RES, V21, P475; Kwon HM, 1998, J CLIN INVEST, V101, P1551, DOI 10.1172/JCI1568; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2002, NAT MED, V8, P913, DOI 10.1038/nm0902-913; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Maehara N, 2003, EUR RADIOL, V13, P1559, DOI 10.1007/s00330-002-1729-z; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; NEBEN S, 1993, BLOOD, V81, P1960; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	45	485	508	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					825	U6		10.1038/nature06348	http://dx.doi.org/10.1038/nature06348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064003				2022-12-28	WOS:000251394900045
J	Satcher, D; Friel, S; Bell, R				Satcher, David; Friel, Sharon; Bell, Ruth			Natural and manmade disasters and mental health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; EXPOSURE; VIOLENCE		Morehouse Sch Med, Natl Ctr Primary Care, Ctr Excellence Hlth Disparities, Atlanta, GA 30310 USA; UCL, Commiss Social Determinants Hlth, Dept Epidemiol & Publ Hlth, London, England	Morehouse School of Medicine; University of London; University College London	Satcher, D (corresponding author), Morehouse Sch Med, Natl Ctr Primary Care, Ctr Excellence Hlth Disparities, 720 Westview Dr SW, Atlanta, GA 30310 USA.	dsatcher@msm.edu		Friel, Sharon/0000-0002-8345-5435	National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER; NIMHD NIH HHS [U54 MD008173] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Ajdukovic Dean, 2004, Med Confl Surviv, V20, P120, DOI 10.1080/1362369042000234717; Bingenheimer JB, 2005, SCIENCE, V308, P1323, DOI 10.1126/science.1110096; Coghlan B, 2006, LANCET, V367, P568; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Coker Ann L, 2006, Disaster Manag Response, V4, P88, DOI 10.1016/j.dmr.2006.06.001; *EM DIS DAT BAS, 2007, OFDA CRED INT DIS DA; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Giacaman R, 2007, PUBLIC HEALTH, V121, P563, DOI 10.1016/j.puhe.2006.10.021; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Gorman-Smith D, 2004, J CLIN CHILD ADOLESC, V33, P439, DOI 10.1207/s15374424jccp3303_2; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Mollica RF, 2004, LANCET, V364, P2058, DOI 10.1016/S0140-6736(04)17519-3; MURTHY R, 2001, WORLD HLTH REPORT 20, P1; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Neuner F, 2006, J TRAUMA STRESS, V19, P339, DOI 10.1002/jts.20121; Nicholls RJ, 2006, PHILOS T R SOC A, V364, P1073, DOI 10.1098/rsta.2006.1754; NICHOLLS RJ, 2006, PHILOS T A, V364, P3539; Norris FH, 2004, J TRAUMA STRESS, V17, P283, DOI 10.1023/B:JOTS.0000038476.87634.9b; Norris FH., RANGE MAGNITUDE DURA; PANCH T, 2004, MEDACT CHALLENGING B; *US DHHS, 1999, MENT HLTH REP SURG G; *US DHHS SUBST AB, 2000, YOUTH VIOL REP SURG; van Ommeren M, 2005, BRIT MED J, V330, P1160, DOI 10.1136/bmj.330.7501.1160; Watts Susan Sameen Siddiqi, 2007, SOCIAL DETERMINANTS; World Health Organization, 2005, WHO MULT STUD WOM HL; World Health Organization, 2007, 3 MIL GLOB CAMP VIOL	27	38	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2540	2542		10.1001/jama.298.21.2540	http://dx.doi.org/10.1001/jama.298.21.2540			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237GJ	18056908				2022-12-28	WOS:000251361900021
J	Stone, GW; Ware, JH; Bertrand, ME; Lincoff, AM; Moses, JW; Ohman, EM; White, HD; Feit, F; Colombo, A; McLaurin, BT; Cox, DA; Manoukian, SV; Fahy, M; Clayton, TC; Mehran, R; Pocock, SJ				Stone, Gregg W.; Ware, James H.; Bertrand, Michel E.; Lincoff, A. Michael; Moses, Jeffrey W.; Ohman, E. Magnus; White, Harvey D.; Feit, Frederick; Colombo, Antonio; McLaurin, Brent T.; Cox, David A.; Manoukian, Steven V.; Fahy, Martin; Clayton, Tim C.; Mehran, Roxana; Pocock, Stuart J.		ACUITY Investigators	Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management - One-year results from the ACUITY trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; AMERICAN-COLLEGE; INTERVENTION; ELEVATION; IMPACT; PREDICTORS; REVASCULARIZATION	Context At 30-day follow-up, patients with moderate-and high-risk acute coronary syndromes (ACS) undergoing early invasive treatment in the ACUITY trial with bivalirudin monotherapy vs heparin plus glycoprotein ( GP) IIb/IIIa inhibitors had noninferior rates of adverse ischemic events with reduced rates of major bleeding. Deferred upstream use of GP IIb/IIIa inhibitors for selective administration to patients undergoing percutaneous coronary intervention (PCI) resulted in a significant reduction in major bleeding, although a small increase in composite ischemia could not be excluded. Objective To determine 1-year ischemic outcomes for patients in the ACUITY trial. Design, Setting, and Patients A prospective, randomized, open-label trial with 1-year clinical follow-up at 450 academic and community-based institutions in 17 countries. A total of 13 819 patients with moderate- and high-risk ACS undergoing invasive treatment were enrolled between August 23, 2003, and December 5, 2005. Interventions Patients were assigned to heparin plus GP IIb/IIIa inhibitors (n= 4603), bivalirudin plus GP IIb/IIIa inhibitors ( n= 4604), or bivalirudin monotherapy ( n= 4612). Of these patients, 4605 were assigned to routine upstream GP IIb/IIIa administration and 4602 were deferred to selective GP IIb/IIIa inhibitor administration. Main Outcome Measure Composite ischemia ( death, myocardial infarction, or unplanned revascularization for ischemia) at 1 year. Results Composite ischemia at 1 year occurred in 15.4% of patients assigned to heparin plus GP IIb/IIIa inhibitors and 16.0% assigned to bivalirudin plus GP IIb/ IIIa inhibitors ( compared with heparin plus GP IIb/ IIIa inhibitors, HR, 1.05; 95% Cl, 0.951.16; P=.35), and 16.2% assigned to bivalirudin monotherapy (HR, 1.06; 95% Cl, 0.95-1.17; P=.29). Mortality at 1 year occurred in an estimated 3.9% of patients assigned to heparin plus GP IIb/ IIIa inhibitors, 3.9% assigned to bivalirudin plus GP IIb/ IIIa inhibitors ( HR, 0.99; 95% Cl, 0.80-1.22; P=.92), and 3.8% assigned to bivalirudin monotherapy ( HR, 0.96; 95% Cl, 0.77-1.18; P=.67). Composite ischemia occurred in 16.3% of patients assigned to deferred use compared with 15.2% of patients assigned to upstream administration ( HR, 1.08; 95% Cl, 0.97-1.20; P=.15). Conclusions At 1 year, no statistically significant difference in rates of composite ischemia or mortality among patients with moderate- and high-risk ACS undergoing invasive treatment with the 3 therapies was found. There was no statistically significant difference in the rates of composite ischemia between patients receiving routine upstream administration of GP IIb/ IIIa inhibitors vs deferring their use for patients undergoing PCI. Trial Registration clinicaltrials. gov Identifier: NCT00093158.	Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; Harvard Univ, Boston, MA 02115 USA; Hop Cardiol, F-59037 Lille, France; Cleveland Clin, Cleveland, OH 44106 USA; Duke Univ, Med Ctr, Durham, NC USA; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; NYU, Sch Med, New York, NY USA; Osped San Raphael, Milan, Italy; AnMed Hlth, Anderson, SC USA; Mid Carolina Cardiol, Charlotte, NC USA; Emory Univ, Sch Med, Atlanta, GA USA; London Sch Hyg & Trop Med, London WC1, England	Cardiovascular Research Foundation (CRF); Columbia University; Harvard University; Universite de Lille - ISITE; CHU Lille; Cleveland Clinic Foundation; Duke University; Auckland City Hospital; New York University; Emory University; University of London; London School of Hygiene & Tropical Medicine	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Floor, New York, NY 10022 USA.	gs2184@columbia.edu	Mehran, Roxana/ABF-4160-2021; Colombo, Antonio/N-2960-2015	Colombo, Antonio/0000-0002-2940-2455; Clayton, Tim/0000-0002-1266-3288				Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; ANTMAN EM, 1997, HEART DIS TXB CARDIO, P1184; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2003, EUR HEART J, V24, P1174, DOI 10.1016/S0195-668X(03)00231-8; Bertrand ME, 2003, EUR HEART J, V24, P485, DOI 10.1016/S0195-668X(03)00080-0; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Ellis SG, 2002, CIRCULATION, V106, P1205, DOI 10.1161/01.CIR.0000028146.71416.2E; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Rothman MT, 2005, NAT CLIN PRACT CARD, V2, P465, DOI 10.1038/ncpcardio0311; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone Gregg W, 2004, J Invasive Cardiol, V16 Suppl G, P12; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Stone GW, 2001, CIRCULATION, V104, P642, DOI 10.1161/hc3101.093902; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610	24	192	206	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2497	2506		10.1001/jama.298.21.2497	http://dx.doi.org/10.1001/jama.298.21.2497			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056903	Green Accepted			2022-12-28	WOS:000251361900015
J	Archer, JRH; Wood, DM; Tizzard, Z; Jones, AL; Dargan, PI				Archer, John R. H.; Wood, David M.; Tizzard, Zoe; Jones, Alison L.; Dargan, Paul I.			Lesson of the week - Alcohol hand rubs: hygiene and hazard	BRITISH MEDICAL JOURNAL			English	Review							BLOOD-ALCOHOL		Guys & St Thomas NHS Fdn Trust, Guys & St Thomas Poisons Unit, London SE14 5ER, England; Univ Newcastle, Newcastle, NSW 2300, Australia	Guy's & St Thomas' NHS Foundation Trust; University of Newcastle	Archer, JRH (corresponding author), Guys & St Thomas NHS Fdn Trust, Guys & St Thomas Poisons Unit, London SE14 5ER, England.			Wood, David/0000-0002-7826-7237				*AM C GOV IND HYG, 2001, DOC THRESH LIM VAL B; Bartzokas CA, 1995, STUDIES HLTH HUMAN S; BERILD D, 1981, LANCET, V2, P363; Cookson B, 1999, BRIT MED J, V318, P686; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Gould D, 1996, Nurs Times, V92, P42; HEATLEY MK, 1990, MED SCI LAW, V30, P101, DOI 10.1177/002580249003000203; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Lewis RJ., 2000, SAXS DANGEROUS PROPE; Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; *NAT PAT SAF AG, 2004, PAT SAF AL CLEAN HAN; PERPER JA, 1986, J FORENSIC SCI, V31, P212; Pirson M, 2005, J HOSP INFECT, V59, P33, DOI 10.1016/j.jhin.2004.07.006; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Roche KM, 2006, CLIN TOXICOL, V44, P633	15	13	13	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1154	1155		10.1136/bmj.39274.583472.AE	http://dx.doi.org/10.1136/bmj.39274.583472.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048543	Green Published			2022-12-28	WOS:000251596100040
J	Gupta, R; Warren, T; Wald, A				Gupta, Rachna; Warren, Terri; Wald, Anna			Genital herpes	LANCET			English	Review							SIMPLEX-VIRUS TYPE-2; FEMALE SEX WORKERS; SEXUALLY-TRANSMITTED INFECTIONS; PLACEBO-CONTROLLED TRIAL; VARICELLA-ZOSTER-VIRUS; CD8(+) T-CELLS; RISK-FACTORS; PREGNANT-WOMEN; UNITED-STATES; DOUBLE-BLIND	Genital herpes is the main cause of genital ulcers worldwide; the prevalence of herpes simplex virus (HSV) type 2 infections in the general population ranges from 10% to 60%. Most genital herpes is caused by HSV-2, although HSV-1 accounts for about half of new cases in developed countries. The risk of HIV acquisition is three times higher in people with HSV-2. Neonatal herpes is an uncommon but serious complication of genital herpes. Most genital HSV-2 infections are unrecognised and undiagnosed; infected individuals, even with mild symptoms, shed HSV, and can infect sexual partners. Since clinical diagnosis is neither sensitive nor specific, virological and type-specific serological tests should be used routinely. Oral antiviral drugs for HSV infections are safe and effective and can be used both to treat episodes and to prevent recurrences. Antiviral treatment of the infected partners and condom use reduce the risk of sexual transmission of HSV-2.	[Gupta, Rachna; Wald, Anna] Univ Washington, Dept Med, Seattle, WA USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Warren, Terri] Westover Hts Clin, Portland, OR USA; [Wald, Anna] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Gupta, R (corresponding author), ID Care, 765 Route 10 E, Randolph, NJ 07869 USA.	Rachnabanner@aol.com	Warren, Terri/AAJ-1650-2021; Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30731] Funding Source: Medline; PHS HHS [K24AIO71113] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*ACOG, 2004, OBSTET GYNECOL, V104, P111; Alanen A, 2005, BJOG-INT J OBSTET GY, V112, P50, DOI 10.1111/j.1471-0528.2004.00320.x; Andreoletti L, 2005, J CLIN MICROBIOL, V43, P4215, DOI 10.1128/JCM.43.8.4215-4217.2005; [Anonymous], 2007, FIELDS VIROLOGY; Aoki FY, 2006, CLIN INFECT DIS, V42, P8, DOI 10.1086/498521; *ASHA, 2006, HERP SUPP GROUPS AM; Ashley Rhoda L, 2002, Herpes, V9, P38; Ashley RL, 1999, CLIN MICROBIOL REV, V12, P1; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Bacon TH, 2003, CLIN MICROBIOL REV, V16, P114, DOI 10.1128/CMR.16.1.114-128.2003; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; BERNSTEIN DI, 1984, AM J MED, V77, P1055, DOI 10.1016/0002-9343(84)90188-8; Bodeus M, 2004, SEX TRANSM DIS, V31, P297, DOI 10.1097/01.OLQ.0000124454.51844.E7; BROCK BV, 1990, JAMA-J AM MED ASSOC, V263, P418, DOI 10.1001/jama.263.3.418; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Buxbaum S, 2003, MED MICROBIOL IMMUN, V192, P177, DOI 10.1007/s00430-003-0183-0; Carvalho M, 1998, Int J Infect Dis, V3, P94; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P12; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Cherpes TL, 2005, SEX TRANSM DIS, V32, P84, DOI 10.1097/01.olq.0000151414.64297.46; COLACO S, 2003, DERMATOLOGY GLOSSARY; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; Corey L, 1999, SEX TRANSM DIS, V3rd, P285; Cowan FF, 2006, AIDS, V20, P261, DOI 10.1097/01.aids.0000198086.39831.4a; Cowan FM, 2003, SEX TRANSM INFECT, V79, P286, DOI 10.1136/sti.79.4.286; Coyle PV, 2003, J CLIN VIROL, V27, P22, DOI 10.1016/S1386-6532(02)00105-1; Crosby Richard A, 2003, J Pediatr Adolesc Gynecol, V16, P39, DOI 10.1016/S1083-3188(02)00204-8; Dada AJ, 1998, SEX TRANSM DIS, V25, P237, DOI 10.1097/00007435-199805000-00004; Dan M, 2003, SEX TRANSM DIS, V30, P835, DOI 10.1097/01.OLQ.0000086608.07893.1A; DaRosaSantos OL, 1996, INT J DERMATOL, V35, P794; Diamond C, 1999, SEX TRANSM DIS, V26, P221, DOI 10.1097/00007435-199904000-00007; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Edmiston N, 2003, AUST NZ J OBSTET GYN, V43, P351, DOI 10.1046/j.0004-8666.2003.00096.x; Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015; FIFE KH, 1994, J INFECT DIS, V169, P1338, DOI 10.1093/infdis/169.6.1338; Filen F, 2004, SEX TRANSM DIS, V31, P331, DOI 10.1097/00007435-200406000-00002; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gadkari DA, 1998, J ACQ IMMUN DEF SYND, V18, P277, DOI 10.1097/00042560-199807010-00012; Gaytant MA, 2002, SEX TRANSM DIS, V29, P710, DOI 10.1097/00007435-200211000-00015; Ghebrekidan H, 1999, J CLIN VIROL, V12, P53, DOI 10.1016/S0928-0197(98)00064-6; GOLDBERG LH, 1993, ARCH DERMATOL, V129, P582, DOI 10.1001/archderm.129.5.582; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; GOODELL S, 1983, NEW ENGL J MED, V309, P868; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Gupta R, 2005, J INFECT DIS, V192, P1102, DOI 10.1086/432766; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Halpern-Felsher BL, 2005, PEDIATRICS, V115, P845, DOI 10.1542/peds.2004-2108; Hashido M, 1998, EPIDEMIOL INFECT, V120, P179, DOI 10.1017/S095026889700856X; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Jerome KR, 1998, J VIROL, V72, P436, DOI 10.1128/JVI.72.1.436-441.1998; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Keller MJ, 2005, J ANTIMICROB CHEMOTH, V55, P420, DOI 10.1093/jac/dki056; Kim O, 2003, INT J STD AIDS, V14, P46, DOI 10.1258/095646203321043264; Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Koelle DM, 1998, J VIROL, V72, P7476, DOI 10.1128/JVI.72.9.7476-7483.1998; KOELLE DM, 1993, J CLIN INVEST, V91, P961, DOI 10.1172/JCI116317; Koelle DM, 2001, J IMMUNOL, V166, P4049, DOI 10.4049/jimmunol.166.6.4049; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1539; Krantz I, 2004, BRIT MED J, V329, P618, DOI 10.1136/bmj.329.7466.618; Lafferty WE, 2000, J INFECT DIS, V181, P1454, DOI 10.1086/315395; LAFFERTY WE, 1987, NEW ENGL J MED, V316, P1444, DOI 10.1056/NEJM198706043162304; LAFFERTY WE, 1987, J CLIN MICROBIOL, V25, P323, DOI 10.1128/JCM.25.2.323-326.1987; Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919; LANGENBERG A, 1989, ANN INTERN MED, V110, P882, DOI 10.7326/0003-4819-110-11-882; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; Leone P, 2004, SEX TRANSM DIS, V31, P311, DOI 10.1097/01.OLQ.0000123651.84697.D6; Leone PA, 2002, CLIN INFECT DIS, V34, P958, DOI 10.1086/339326; Levett PN, 2005, MED MICROBIOL IMMUN, V194, P105, DOI 10.1007/s00430-004-0222-5; Limpakarnjanarat K, 1999, SEX TRANSM INFECT, V75, P30, DOI 10.1136/sti.75.1.30; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Lo JYC, 1999, SEX TRANSM INFECT, V75, P123; Looker KJ, 2005, SEX TRANSM INFECT, V81, P103, DOI 10.1136/sti.2004.012039; Manavi K, 2004, SEX TRANSM DIS, V31, P322, DOI 10.1097/01.OLQ.0000123652.88904.9B; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; MCADAM AJ, 2005, PATHOLOGIC BASIS DIS, P343; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Meyer JL, 2005, SEX TRANSM INFECT, V81, P309, DOI 10.1136/sti.2004.012146; Mindel A, 1996, SCAND J INFECT DIS, P27; Miyai T, 2004, SEX TRANSM DIS, V31, P517, DOI 10.1097/01.olq.0000137901.71284.6b; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; Nahmias A J, 1990, Scand J Infect Dis Suppl, V69, P19; NAHMIAS AJ, 1971, AM J OBSTET GYNECOL, V110, P825, DOI 10.1016/0002-9378(71)90580-1; Nilsen A, 2005, EPIDEMIOL INFECT, V133, P915, DOI 10.1017/S095026880500395X; Patel R, 1999, SEX TRANSM INFECT, V75, P398, DOI 10.1136/sti.75.6.398; Patrick DM, 2001, SEX TRANSM DIS, V28, P424, DOI 10.1097/00007435-200107000-00011; Qutub M, 2003, EUR J EPIDEMIOL, V18, P903, DOI 10.1023/A:1025607913408; Rabenau HF, 2002, MED MICROBIOL IMMUN, V190, P153, DOI 10.1007/s00430-001-0102-1; Ramaswamy M, 2006, SEX TRANSM DIS, V33, P96, DOI 10.1097/01.olq.0000187211.61052.c7; Ramaswamy M, 2004, SEX TRANSM INFECT, V80, P406, DOI 10.1136/sti.2003.008201; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roest RW, 2004, J MED VIROL, V73, P601, DOI 10.1002/jmv.20132; Romanowski B, 2000, AIDS, V14, P1211, DOI 10.1097/00002030-200006160-00019; Russell DB, 2001, J CLIN VIROL, V22, P305, DOI 10.1016/S1386-6532(01)00203-7; Sacks SL, 2004, J INFECT DIS, V189, P1341, DOI 10.1086/383038; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015; Sizemore JM, 2006, J INFECT DIS, V193, P905, DOI 10.1086/500841; Sizemore JM, 2005, SEX TRANSM INFECT, V81, P303, DOI 10.1136/sti.2004.011957; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; Sucato G, 1998, J INFECT DIS, V177, P1069, DOI 10.1086/515261; Suligoi B, 2002, SEX TRANSM DIS, V29, P665, DOI 10.1097/00007435-200211000-00008; Tideman RL, 2001, SEX TRANSM INFECT, V77, P413, DOI 10.1136/sti.77.6.413; Uribe-Salas F, 2003, EPIDEMIOL INFECT, V131, P859, DOI 10.1017/S0950268803008860; Uuskula A, 2004, SCAND J INFECT DIS, V36, P727, DOI 10.1080/00365540410020992; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Vonau B, 1997, BRIT J OBSTET GYNAEC, V104, P347, DOI 10.1111/j.1471-0528.1997.tb11466.x; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 2002, J INFECT DIS, V186, pS34, DOI 10.1086/342969; Wald A, 2002, CLIN INFECT DIS, V34, P944, DOI 10.1086/339325; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; Whitley RJ, 1996, FIELDS VIROLOGY, P2297; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zimet GD, 2004, SEX TRANSM DIS, V31, P665, DOI 10.1097/01.olq.0000143089.77493.c2	127	386	407	2	66	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2127	2137		10.1016/S0140-6736(07)61908-4	http://dx.doi.org/10.1016/S0140-6736(07)61908-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156035				2022-12-28	WOS:000252058600034
J	Lester, H; Roland, M				Lester, Helen; Roland, Martin			Future of quality measurement	BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-KINGDOM; HEALTH; CARE; ENGLAND; PAY		Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Lester, H (corresponding author), Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	helen.lester@manchester.ac.uk		Roland, Martin/0000-0002-8533-3060				Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Down S, 1998, PERS REV, V27, P143, DOI 10.1108/00483489810369287; Elwyn G, 2007, BRIT MED J, V335, P1021, DOI 10.1136/bmj.39339.490301.AD; Ganz DA, 2007, MED CARE, V45, P8, DOI 10.1097/01.mlr.0000241115.31531.15; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	9	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1130	1131		10.1136/bmj.39385.406192.AD	http://dx.doi.org/10.1136/bmj.39385.406192.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240OE	18048540	Green Published			2022-12-28	WOS:000251596100032
J	Vollmar, C; Feddersen, B; Beckmann, BM; Kaab, S; Noachtar, S				Vollmar, Christian; Feddersen, Berend; Beckmann, Britt Maria; Kaeaeb, Stefan; Noachtar, Soheyl			Seizures on hearing the alarm clock	LANCET			English	Editorial Material							LONG-QT SYNDROME		[Vollmar, Christian; Feddersen, Berend; Noachtar, Soheyl] Univ Munich, Klinikum Grosshadern, Neurol Klin, Dept Neurol, D-81377 Munich, Germany; [Beckmann, Britt Maria; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Internal Med, D-81377 Munich, Germany	University of Munich; University of Munich	Feddersen, B (corresponding author), Univ Munich, Klinikum Grosshadern, Neurol Klin, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	berend.feddersen@med.uni-muenchen.de	Vollmar, Christian/D-5130-2012	Environmental Science and Management, Global Journal of/0000-0003-0365-1696; Vollmar, Christian/0000-0002-4630-7484				Khan IA, 2002, AM J MED, V112, P58, DOI 10.1016/S0002-9343(01)01011-7; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; Schwartz PJ, 2001, CIRCULATION, V103, P89	5	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2172	2172		10.1016/S0140-6736(07)61913-8	http://dx.doi.org/10.1016/S0140-6736(07)61913-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156040				2022-12-28	WOS:000252058600041
J	Markiewicz, WJ; Titov, DV; Limaye, SS; Keller, HU; Ignatiev, N; Jaumann, R; Thomas, N; Michalik, H; Moissl, R; Russo, P				Markiewicz, W. J.; Titov, D. V.; Limaye, S. S.; Keller, H. U.; Ignatiev, N.; Jaumann, R.; Thomas, N.; Michalik, H.; Moissl, R.; Russo, P.			Morphology and dynamics of the upper cloud layer of Venus	NATURE			English	Article							COMPRESSIBLE CONVECTION; ATMOSPHERE; GALILEO; IMAGES; WINDS	Venus is completely covered by a thick cloud layer, of which the upper part is composed of sulphuric acid and some unknown aerosols(1). The cloud tops are in fast retrograde rotation (super-rotation), but the factors responsible for this super-rotation are unknown(2). Here we report observations of Venus with the Venus Monitoring Camera(3) on board the Venus Express spacecraft. We investigate both global and small-scale properties of the clouds, their temporal and latitudinal variations, and derive wind velocities. The southern polar region is highly variable and can change dramatically on timescales as short as one day, perhaps arising from the injection of SO2 into the mesosphere. The convective cells in the vicinity of the subsolar point are much smaller than previously inferred(4-6), which we interpret as indicating that they are confined to the upper cloud layer, contrary to previous conclusions(7,8), but consistent with more recent study(9).	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Space Res Inst, IKI, Moscow 117997, Russia; Univ Wisconsin, Ctr Space Sci & Engn, Madison, WI 53706 USA; Inst Planetenforsch, D-12489 Berlin, Germany; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; TU Braunschweig, IDA, D-38106 Braunschweig, Germany	Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Wisconsin System; University of Wisconsin Madison; University of Bern; Braunschweig University of Technology	Markiewicz, WJ (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany.	markiewicz@mps.mpg.de	Jaumann, Ralf/N-1001-2018; Thomas, Nicolas/G-4693-2015	Jaumann, Ralf/0000-0002-9759-6597; Thomas, Nicolas/0000-0002-0146-0071; Ignatiev, Nikolay/0000-0002-6358-7094; Russo, Pedro/0000-0002-8589-7800				Baker RD, 1999, J GEOPHYS RES-PLANET, V104, P3815, DOI 10.1029/1998JE900029; Baker RD, 1998, J ATMOS SCI, V55, P3, DOI 10.1175/1520-0469(1998)055<0003:CLPCCI>2.0.CO;2; BAKER RD, 1992, NATURE, V355, P710, DOI 10.1038/355710a0; BELTON MJS, 1976, J ATMOS SCI, V33, P1394, DOI 10.1175/1520-0469(1976)033<1394:CPWACI>2.0.CO;2; BELTON MJS, 1991, SCIENCE, V253, P1531, DOI 10.1126/science.253.5027.1531; COVEY CC, 1981, NATURE, V290, P17, DOI 10.1038/290017a0; Esposito L. W., 1983, Venus, P484; Limaye SS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002814; Markiewicz WJ, 2007, PLANET SPACE SCI, V55, P1701, DOI 10.1016/j.pss.2007.01.004; MURRAY BC, 1974, SCIENCE, V183, P1307, DOI 10.1126/science.183.4131.1307; NEWMAN M, 1984, J ATMOS SCI, V41, P1901, DOI 10.1175/1520-0469(1984)041<1901:ZWITMA>2.0.CO;2; ROSSOW WB, 1990, J ATMOS SCI, V47, P2053, DOI 10.1175/1520-0469(1990)047<2053:CTWFVO>2.0.CO;2; Rossow WB, 1980, J GEOPHYS RES-SPACE, V85, P8107, DOI 10.1029/JA085iA13p08107; SATO M, 1996, ICARUS, V124, P596; Taylor FW, 1980, J GEOPHYS RES-SPACE, V85, P7963, DOI 10.1029/JA085iA13p07963; TOIGO A, 1994, ICARUS, V109, P318, DOI 10.1006/icar.1994.1097; Zasova LV, 2007, PLANET SPACE SCI, V55, P1712, DOI 10.1016/j.pss.2007.01.011	17	94	96	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					633	636		10.1038/nature06320	http://dx.doi.org/10.1038/nature06320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046394				2022-12-28	WOS:000251209700034
J	Warnock, M				Warnock, Mary			The ethical regulation of science	NATURE			English	Editorial Material									House Lords, London SW1A 0PW, England		Warnock, M (corresponding author), House Lords, London SW1A 0PW, England.								0	5	5	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					615	615		10.1038/450615a	http://dx.doi.org/10.1038/450615a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	235BY	18046384	Bronze			2022-12-28	WOS:000251209700025
J	Trotzky, S; Cheinet, P; Folling, S; Feld, M; Schnorrberger, U; Rey, AM; Polkovnikov, A; Demler, EA; Lukin, MD; Bloch, I				Trotzky, S.; Cheinet, P.; Foelling, S.; Feld, M.; Schnorrberger, U.; Rey, A. M.; Polkovnikov, A.; Demler, E. A.; Lukin, M. D.; Bloch, I.			Time-resolved observation and control of superexchange interactions with ultracold atoms in optical lattices	SCIENCE			English	Article							QUANTUM; ENTANGLEMENT; DYNAMICS	Quantum mechanical superexchange interactions form the basis of quantum magnetism in strongly correlated electronic media. We report on the direct measurement of superexchange interactions with ultracold atoms in optical lattices. After preparing a spin- mixture of ultracold atoms in an antiferromagnetically ordered state, we measured coherent superexchange- mediated spin dynamics with coupling energies from 5 hertz up to 1 kilohertz. By dynamically modifying the potential bias between neighboring lattice sites, the magnitude and sign of the superexchange interaction can be controlled, thus allowing the system to be switched between antiferromagnetic and ferromagnetic spin interactions. We compare our findings to predictions of a two- site Bose- Hubbard model and find very good agreement, but are also able to identify corrections that can be explained by the inclusion of direct nearest- neighbor interactions.	[Trotzky, S.; Cheinet, P.; Foelling, S.; Feld, M.; Schnorrberger, U.; Bloch, I.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Feld, M.] Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; [Rey, A. M.; Demler, E. A.; Lukin, M. D.] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys, Cambridge, MA 02138 USA; [Polkovnikov, A.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Demler, E. A.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Johannes Gutenberg University of Mainz; University of Kaiserslautern; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Boston University; Harvard University	Bloch, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.	bloch@uni-mainz.de	Demler, Eugene/ABG-1933-2021; Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010; Cheinet, Patrick/F-4942-2019; Polkovnikov, Anatoli/HDM-9329-2022	Demler, Eugene/0000-0002-2499-632X; Bloch, Immanuel/0000-0002-0679-4759; Cheinet, Patrick/0000-0002-9292-9735; Folling, Simon/0000-0002-6951-3651				Alet F, 2006, PHYSICA A, V369, P122, DOI 10.1016/j.physa.2006.04.003; Altman E, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/113; Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; ANDERSON PW, 1950, PHYS REV, V79, P350, DOI 10.1103/PhysRev.79.350; AUERBACH A, 2006, INTERACTING ELECT QU; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; Dirac PAM, 1926, P R SOC LOND A-CONTA, V112, P661, DOI 10.1098/rspa.1926.0133; Dirac PAM, 1929, P R SOC LOND A-CONTA, V123, P714, DOI 10.1098/rspa.1929.0094; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Gerbier F, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041602; Heisenberg W, 1928, Z PHYS, V49, P619, DOI 10.1007/BF01328601; Heisenberg W, 1926, Z PHYS, V38, P411, DOI 10.1007/BF01397160; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Jane E, 2003, QUANTUM INF COMPUT, V3, P15; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kramers HA, 1934, PHYSICA, V1, P182, DOI 10.1016/S0031-8914(34)90023-9; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; LIEB E, 1962, PHYS REV, V125, P164, DOI 10.1103/PhysRev.125.164; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Neel, 1936, ANN PHYS-PARIS, V5, P232; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Rey AM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140601; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Santos L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.030601; Sebby-Strabley J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200405; Sebby-Strabley J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033605; Sorensen A, 1999, PHYS REV LETT, V83, P2274, DOI 10.1103/PhysRevLett.83.2274; Verstraete F, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.060302; Widera A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190405; [No title captured]	37	515	519	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					295	299		10.1126/science.1150841	http://dx.doi.org/10.1126/science.1150841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18096767	Green Submitted			2022-12-28	WOS:000252436200028
J	Howes, OD; Weinstein, S; Tabraham, P; Valmaggia, L; Broome, M; McGuire, P				Howes, Oliver D.; Weinstein, Sara; Tabraham, Paul; Valmaggia, Lucia; Broome, Matthew; McGuire, Philip			Slang and schizophrenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THOUGHT		[Howes, Oliver D.; Weinstein, Sara; Tabraham, Paul; Valmaggia, Lucia; Broome, Matthew; McGuire, Philip] Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Howes, OD (corresponding author), Inst Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	o.howes@iop.kcl.ac.uk	Valmaggia, Lucia R./O-1377-2019; Broome, Matthew Richard/AAA-2265-2020; Howes, Oliver/E-7156-2010; Valmaggia, Lucia/E-9653-2012	Valmaggia, Lucia R./0000-0001-6099-8464; Broome, Matthew Richard/0000-0002-6963-8884; Howes, Oliver/0000-0002-2928-1972; Valmaggia, Lucia/0000-0001-6099-8464; McGuire, Philip/0000-0003-4381-0532	Medical Research Council [MC_U120097115] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Haroun N, 2006, SCHIZOPHRENIA BULL, V32, P166, DOI 10.1093/schbul/sbj007; Kuperberg GR, 2000, PSYCHOL MED, V30, P345, DOI 10.1017/S0033291700001744; Liddle PF, 2002, BRIT J PSYCHIAT, V181, P326, DOI 10.1192/bjp.181.4.326; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785	4	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1294	1294		10.1136/bmj.39419.647118.25	http://dx.doi.org/10.1136/bmj.39419.647118.25			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156234	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000252182700015
J	Sluijs, A; Brinkhuis, H; Schouten, S; Bohaty, SM; John, CM; Zachos, JC; Reichart, GJ; Damste, JSS; Crouch, EM; Dickens, GR				Sluijs, Appy; Brinkhuis, Henk; Schouten, Stefan; Bohaty, Steven M.; John, Cedric M.; Zachos, James C.; Reichart, Gert-Jan; Damste, Jaap S. Sinninghe; Crouch, Erica M.; Dickens, Gerald R.			Environmental precursors to rapid light carbon injection at the Palaeocene/Eocene boundary	NATURE			English	Article							EOCENE THERMAL MAXIMUM; METHANE HYDRATE; LATE PALEOCENE; ISOTOPE EXCURSION; MEMBRANE-LIPIDS; TEMPERATURES; MARINE; OCEAN; GAS; DISSOCIATION	The start of the Palaeocene/Eocene thermal maximum - a period of exceptional global warming about 55 million years ago - is marked by a prominent negative carbon isotope excursion that reflects a massive input of C-13-depleted (`light') carbon to the ocean - atmosphere system(1). It is often assumed(2) that this carbon injection initiated the rapid increase in global surface temperatures and environmental change that characterize the climate perturbation(3-7), but the exact sequence of events remains uncertain. Here we present chemical and biotic records of environmental change across the Palaeocene/Eocene boundary from two sediment sections in New Jersey that have high sediment accumulation rates. We show that the onsets of environmental change ( as recorded by the abundant occurrence ('acme') of the dinoflagellate cyst Apectodinium) and of surface- ocean warming ( as evidenced by the palaeothermometer TEX86) preceded the light carbon injection by several thousand years. The onset of the Apectodinium acme also precedes the carbon isotope excursion in sections from the southwest Pacific Ocean(8) and the North Sea, indicating that the early onset of environmental change was not confined to the New Jersey shelf. The lag of similar to 3,000 years between the onset of warming in New Jersey shelf waters and the carbon isotope excursion is consistent with the hypothesis that bottom water warming caused the injection of C-13-depleted carbon by triggering the dissociation of submarine methane hydrates(1,9,10), but the cause of the early warming remains uncertain.	Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95060 USA; Rice Univ, Dept Earth Sci, Houston, TX 77005 USA	Utrecht University; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of California System; University of California Santa Cruz; Rice University	Sluijs, A (corresponding author), Univ Utrecht, Palaeobot & Palynol Lab, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	A.Sluijs@uu.nl	Sluijs, Appy/B-3726-2009; Brinkhuis, Henk/B-4223-2009; John, Cedric/B-3292-2008; Reichart, Gert-Jan/N-6308-2018; Zachos, James C/A-7674-2008; Crouch, Erica/C-2820-2013; Damste, Jaap S Sinninghe/F-6128-2011; Dickens, Gerald R/G-1222-2011	Sluijs, Appy/0000-0003-2382-0215; John, Cedric/0000-0001-9711-1548; Reichart, Gert-Jan/0000-0002-7256-2243; Zachos, James C/0000-0001-8439-1886; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Brinkhuis, Henk/0000-0003-0253-6610; Dickens, Gerald/0000-0003-2869-4860				Bujak JP, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P277; Cramer BS, 1999, B SOC GEOL FR, V170, P883; Cramer BS, 2005, PALAEOGEOGR PALAEOCL, V224, P144, DOI 10.1016/j.palaeo.2005.03.040; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; MACDONALD GJ, 1990, CLIMATIC CHANGE, V16, P247, DOI 10.1007/BF00144504; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Sluijs A, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P323; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; STOLL HM, 2005, PALEOCEANOGRAPHY, V20; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas DJ, 2002, GEOLOGY, V30, P1067, DOI 10.1130/0091-7613(2002)030<1067:WTFFTF>2.0.CO;2; Thomas E., 1996, Geological Society Special Publication, V101, P401, DOI 10.1144/GSL.SP.1996.101.01.20; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; WUCHTER C, 2004, PALEOCEANOGRAPHY, V19; Xu WY, 2001, J GEOPHYS RES-SOL EA, V106, P26413, DOI 10.1029/2001JB000420; Zachos JC, 2006, GEOLOGY, V34, P737, DOI 10.1130/G22522.1; Zachos JC, 2007, PHILOS T R SOC A, V365, P1829, DOI 10.1098/rsta.2007.2045; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	30	244	250	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1218	U5		10.1038/nature06400	http://dx.doi.org/10.1038/nature06400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097406	Green Published			2022-12-28	WOS:000251786200047
J	Korenkov, M; Sauerland, S				Korenkov, Michael; Sauerland, Stefan			Clinical update: bariatric surgery	LANCET			English	Article							WEIGHT-LOSS; MORTALITY; OBESITY		Johannes Gutenberg Univ Mainz, Dept Abdominal Surg, D-55101 Mainz, Germany; Univ Witten Herdecke, Inst Res Operat Med, Witten, Germany	Johannes Gutenberg University of Mainz; Witten Herdecke University	Korenkov, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Abdominal Surg, D-55101 Mainz, Germany.	korenkov@ach.klinik.uni-mainz.de		Sauerland, Stefan/0000-0003-1048-796X				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Black DW, 2003, OBES SURG, V13, P746, DOI 10.1381/096089203322509327; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; De Luca M, 2004, OBES SURG, V14, pS33, DOI 10.1007/BF03342136; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Han SM, 2005, OBES SURG, V15, P1469; National Institutes of Health, 1991, OBES SURG, V1, P257, DOI DOI 10.1381/096089291765560962; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Puzziferri N, 2006, ANN SURG, V243, P181, DOI 10.1097/01.sla.0000197381.01214.76; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sauerland S, 2005, SURG ENDOSC, V19, P200, DOI 10.1007/s00464-004-9194-1; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Suter M, 2005, ANN SURG, V241, P55, DOI 10.1097/01.sla.0000150071.86934.36; Weiner Rudolph A, 2006, Surg Technol Int, V15, P63	20	24	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1988	1990		10.1016/S0140-6736(07)61844-3	http://dx.doi.org/10.1016/S0140-6736(07)61844-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083389				2022-12-28	WOS:000251698600011
J	Clapham, DE				Clapham, David E.			Calcium signaling	CELL			English	Review							KINESIN HEAVY-CHAIN; STORE DEPLETION; CRAC CHANNEL; AXONAL-TRANSPORT; PLASMA-MEMBRANE; ION CHANNELS; ADP-RIBOSE; CA2+; ACTIVATION; RECEPTOR	Calcium ions (Ca2+) impact nearly every aspect of cellular life. This review examines the principles of Ca2+ signaling, from changes in protein conformations driven by Ca2+ to the mechanisms that control Ca2+ levels in the cytoplasm and organelles. Also discussed is the highly localized nature of Ca2+- mediated signal transduction and its specific roles in excitability, exocytosis, motility, apoptosis, and transcription.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu		Clapham, David/0000-0002-4459-9428				Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Burgess HM, 2002, ENVIRON ST, V8, P193; Carafoli E, 2004, BIOCHEM BIOPH RES CO, V322, P1097, DOI 10.1016/j.bbrc.2004.08.049; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FLAVELL SW, 2007, IN PRESS ANN REV NEU; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Naraghi M, 1997, J NEUROSCI, V17, P6961; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Ringer S, 1883, J Physiol, V4, P29; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Waring P, 2005, ARCH BIOCHEM BIOPHYS, V434, P33, DOI 10.1016/j.abb.2004.08.001; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	73	2763	2834	19	471	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1047	1058		10.1016/j.cell.2007.11.028	http://dx.doi.org/10.1016/j.cell.2007.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083096	Bronze			2022-12-28	WOS:000252217100014
J	Krimigis, SM; Sergis, N; Mitchell, DG; Hamilton, DC; Krupp, N				Krimigis, S. M.; Sergis, N.; Mitchell, D. G.; Hamilton, D. C.; Krupp, N.			A dynamic, rotating ring current around Saturn	NATURE			English	Article							HOT PLASMA; MAGNETOSPHERE	The concept of an electrical current encircling the Earth at high altitudes was first proposed in 1917 to explain the depression of the horizontal component of the Earth's magnetic field during geomagnetic storms(1-4). In situ measurements of the extent and composition of this current were made some 50 years later(5) and an image was obtained in 2001 ( ref. 6). Ring currents of a different nature were observed at Jupiter(7,8) and their presence inferred at Saturn(9,10). Here we report images of the ring current at Saturn, together with a day - night pressure asymmetry and tilt of the planet's plasma sheet, based on measurements using the magnetospheric imaging instrument ( MIMI) on board Cassini. The ring current can be highly variable with strong longitudinal asymmetries that corotate nearly rigidly with the planet. This contrasts with the Earth's ring current, where there is no rotational modulation and initial asymmetries are organized by local time effects.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Acad Athens, Off Space Res & Technol, Athens 11527, Greece; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University System of Maryland; University of Maryland College Park; Max Planck Society	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Sergis, Nick/A-9881-2015; Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019	Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386; Hamilton, Douglas/0000-0001-6103-8019; Sergis, Nick/0000-0003-4144-8699				Chapman S, 1918, P R SOC LOND A-CONTA, V95, P61, DOI 10.1098/rspa.1918.0049; Chapman S., 1933, TERR MAGN ATMOS ELEC, V38, P79; CHAPMAN S, 1931, TERR MAGN ATMOS ELEC, V36, P171, DOI DOI 10.1029/TE036I003P00171; CONNERNEY JEP, 1981, NATURE, V292, P724, DOI 10.1038/292724a0; Hansen KC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022835; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; KRIMIGIS SM, 1985, GEOPHYS RES LETT, V12, P329, DOI 10.1029/GL012i005p00329; KRIMIGIS SM, 1983, J GEOPHYS RES-SPACE, V88, P8871, DOI 10.1029/JA088iA11p08871; KRIMIGIS SM, 1981, J GEOPHYS RES-SPACE, V86, P8227, DOI 10.1029/JA086iA10p08227; Krupp N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022829; Mauk BH, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010270; MAUK BH, 1985, J GEOPHYS RES-SPACE, V90, P8253, DOI 10.1029/JA090iA09p08253; Mitchell DG, 2001, GEOPHYS RES LETT, V28, P1151, DOI 10.1029/2000GL012395; MITCHELL DG, 2005, GEORL, V32, P20501, DOI DOI 10.1029/2005GL022647; SCHMIDT A, 1917, ENZYKLOPADIE MATH WI, V6; Sergis N, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029223; Sittler EC, 2006, PLANET SPACE SCI, V54, P1197, DOI 10.1016/j.pss.2006.05.038	17	81	81	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1050	1053		10.1038/nature06425	http://dx.doi.org/10.1038/nature06425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075586				2022-12-28	WOS:000251579900079
J	Scarborough, M; Gordon, SB; Whitty, CJM; French, N; Njalale, Y; Chitani, A; Peto, TEA; Lalloo, DG; Zijlstra, EE				Scarborough, Matthew; Gordon, Stephen B.; Whitty, Christopher J. M.; French, Neil; Njalale, Yasin; Chitani, Alex; Peto, Timothy E. A.; Lalloo, David G.; Zijlstra, Eduard E.			Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCOCCAL DISEASE; DEXAMETHASONE TREATMENT; HAEMOPHILUS-INFLUENZAE; ADJUNCTIVE THERAPY; MALAWIAN ADULTS; CEFTRIAXONE; MANAGEMENT; SEPTICEMIA; CHILDREN	Background: In sub-Saharan Africa, bacterial meningitis is common and is associated with a high mortality. Adjuvant therapy with corticosteroids reduces mortality among adults in the developed world, but it has not been adequately tested in developing countries or in the context of advanced human immunodeficiency virus (HIV) infection. Methods: We conducted a randomized, double-blind, placebo-controlled trial of dexamethasone (16 mg twice daily for 4 days) and an open-label trial of intramuscular versus intravenous ceftriaxone (2 g twice daily for 10 days) in adults with an admission diagnosis of bacterial meningitis in Blantyre, Malawi. The primary outcome was death at 40 days after randomization. Results: A total of 465 patients, 90% of whom were HIV-positive, were randomly assigned to receive dexamethasone (233 patients) or placebo (232 patients) plus intramuscular ceftriaxone (230 patients) or intravenous ceftriaxone (235 patients). There was no significant difference in mortality at 40 days in the corticosteroid group (129 of 231 patients) as compared with the placebo group (120 of 228 patients) by intention-to-treat analysis (odds ratio, 1.14; 95% confidence interval [CI], 0.79 to 1.64) or when the analysis was restricted to patients with proven pneumococcal meningitis (68 of 129 patients receiving corticosteroids vs. 72 of 143 patients receiving placebo) (odds ratio, 1.10; 95% CI, 0.68 to 1.77). There were no significant differences between groups in the outcomes of disability and death combined, hearing impairment, and adverse events. There was no difference in mortality with intravenous ceftriaxone (121 of 230 patients) as compared with intramuscular ceftriaxone (128 of 229 patients) (odds ratio, 0.88; 95% CI, 0.61 to 1.27). Conclusions: Adjuvant therapy with dexamethasone for bacterial meningitis in adults from an area with a high prevalence of HIV did not reduce mortality or morbidity. In this setting, intramuscular administration was not inferior to intravenous administration of ceftriaxone for bacterial meningitis. (Current Controlled Trials number, ISRCTN31371499.).	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; Univ Oxford, Nuffield Dept Med, Oxford OX3 9DU, England; Coll Med, Blantyre, Malawi; Malawi Liverpool Wellcome Programme Clin Trop Res, Blantyre, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; London Sch Hyg & Trop Med, London WC1, England	University of Oxford; University of Oxford; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine	Scarborough, M (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	matthew.scarborough@ndcls.ox.ac.uk	hlupeni, admire/M-1539-2018; Whitty, Christopher/C-7740-2012; French, Neil/A-2994-2012	Gordon, Stephen/0000-0001-6576-1116; French, Neil/0000-0003-4814-8293; Whitty, Christopher/0000-0002-6076-5027; peto, tim/0000-0003-3477-8307; Scarborough, Matthew/0000-0002-0455-0785; Lalloo, David/0000-0001-7680-2200	Wellcome Trust [061230, 061231] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahsan T, 2002, J Pak Med Assoc, V52, P233; Almirante B, 1998, CLIN INFECT DIS, V27, P176, DOI 10.1086/514611; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Bhaumik S, 1998, NEUROL INDIA, V46, P225; BRADLEY JS, 1994, PEDIATR INFECT DIS J, V13, P724, DOI 10.1097/00006454-199408000-00009; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; *DEP HLTH, HLTH SURV ENGL 1997; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Gijwani D, 2002, NEUROL INDIA, V50, P63; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; GIRGIS NI, 1989, PEDIATR INFECT DIS J, V8, P848, DOI 10.1097/00006454-198912000-00004; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Gupta A, 1996, J Assoc Physicians India, V44, P90; Heyderman RS, 2003, J INFECTION, V46, P75, DOI 10.1053/jinf.2002.1110; JENNETT B, 1975, LANCET, V1, P480; McCracken GH, 2002, LANCET, V360, P183, DOI 10.1016/S0140-6736(02)09499-0; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Msamati BC, 2000, E AFR MED J, V77, P364; Murray C. J. L., 1996, GLOBAL BURDEN DIS, VII; *NAT COMM CLIN LAB, 1993, M2A5 NAT COMM CLIN L; Ratka A, 2001, ANN PHARMACOTHER, V35, P36; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Tunkel AR, 2002, NEW ENGL J MED, V347, P1613, DOI 10.1056/NEJMe020131; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116	30	159	161	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2441	2450		10.1056/NEJMoa065711	http://dx.doi.org/10.1056/NEJMoa065711			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240CK	18077809	Bronze, Green Accepted			2022-12-28	WOS:000251564400005
J	Addolorato, G; Leggio, L; Ferrulli, A; Cardone, S; Vonghia, L; Mirijello, A; Abenavoli, L; D'Angelo, C; Caputo, F; Zambon, A; Haber, PS; Gasbarrini, G				Addolorato, Giovanni; Leggio, Lorenzo; Ferrulli, Anna; Cardone, Silvia; Vonghia, Luisa; Mirijello, Antonio; Abenavoli, Ludovico; D'Angelo, Cristina; Caputo, Fabio; Zambon, Antonella; Haber, Paul S.; Gasbarrini, Giovanni			Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study	LANCET			English	Article							CONTROLLED-TRIAL; HEPATIC-ENCEPHALOPATHY; CLINICAL-TRIALS; EFFICACY; RECEPTOR; RISK; DRUG	Background intervention to achieve alcohol abstinence represents the most effective treatment for alcohol-dependent patients with liver cirrhosis; however, anticraving drugs might worsen liver disease. We aimed to investigate the effectiveness and safety of baclofen in achieving and maintaining alcohol abstinence in patients with liver cirrhosis. Methods Between October, 2003, and November, 2006, 148 alcohol-dependent patients with liver cirrhosis were referred to the Institute of internal Medicine, Rome, Italy. 84 were randomly allocated either oral baclofen or placebo for 12 weeks. Primary outcome was proportion of patients achieving and maintaining alcohol abstinence. Measures of this outcome were total alcohol abstinence and cumulative abstinence duration, which were assessed at outpatient visits. Relapse was defined as alcohol intake of more than four drinks per day or overall consumption of 14 or more drinks per week over a period of at least 4 weeks. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00525252. Findings Of 42 patients allocated baclofen, 30 (71%) achieved and maintained abstinence compared with 12 (29%) of 42 assigned placebo (odds ratio 6.3 [95% CI 2.4-16. 1]; p=0 . 0001). The number of dropouts (termination of treatment) did not differ between the baclofen (6/42 [14%]) and placebo (13/42 [31%]) groups (p=0 . 12). Cumulative abstinence duration was about twofold higher in patients allocated baclofen than in those assigned placebo (mean 62.8 [SE 5.4] vs 30 . 8 [5.5] days; p=0 . 001). No hepatic side-effects were recorded. Interpretation Baclofen is effective at promoting alcohol abstinence in alcohol-dependent patients with liver cirrhosis. The drug is well tolerated and could have an important role in treatment of these individuals.	Univ Cattolica Sacro Cuore, Inst Internal Med, I-00168 Rome, Italy; Univ Bologna, Dept Internal Med Cardioangiol & Hepatol, G Fontana Ctr Study & Multidisciplinary Treatment, Bologna, Italy; Univ Milano Bicocca, Dept Stat, Unit Biostat & Epidemiol, Milan, Italy; Royal Prince Alfred Hosp, Drug Hlth Serv, Camperdown, NSW 2050, Australia; Univ Sydney, Sydney, NSW 2006, Australia	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bologna; University of Milano-Bicocca; University of Sydney; University of Sydney	Addolorato, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Internal Med, Largo A Gemelli 8, I-00168 Rome, Italy.	g.addolorato@rm.unicatt.it	Mirijello, Antonio/C-4103-2017; Ferrulli, Anna/AAA-5441-2019; Vonghia, Luisa/ABC-4169-2020; Leggio, Lorenzo/M-2972-2016; Abenavoli, Ludovico/J-4394-2019	Mirijello, Antonio/0000-0003-3932-3803; Vonghia, Luisa/0000-0002-3999-9259; Abenavoli, Ludovico/0000-0002-5922-1524; Zambon, Antonella/0000-0001-6443-3858; Ferrulli, Anna/0000-0002-8518-5547; Addolorato, Giovanni/0000-0002-1522-9946				Addolorato G, 2006, INT J CLIN PRACT, V60, P1003, DOI 10.1111/j.1742-1241.2006.01065.x; Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; Addolorato G, 2005, NEUROPSYCHOBIOLOGY, V51, P59, DOI 10.1159/000084161; Ahboucha S, 2004, METAB BRAIN DIS, V19, P241, DOI 10.1023/B:MEBR.0000043974.89820.22; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; ATKINSON RL, 1985, CLIN PHARMACOL THER, V384, P19; CHOUINARD G, 1994, J AFFECT DISORDERS, V32, P105, DOI 10.1016/0165-0327(94)90068-X; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Colombo G, 2004, NEUROTOX RES, V6, P403, DOI 10.1007/BF03033315; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; DELGRANGE T, 1992, GASTROEN CLIN BIOL, V16, P687; Flannery BA, 2004, ALCOHOL CLIN EXP RES, V28, P1517, DOI 10.1097/01.ALC.0000141640.48924.14; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Harden CL, 2000, EPILEPSIA, V41, pS37, DOI 10.1111/j.1528-1157.2000.tb02945.x; Heidelbaugh JJ, 2006, AM FAM PHYSICIAN, V74, P767; Kelly M, 2006, ALCOHOL ALCOHOLISM, V41, P278, DOI 10.1093/alcalc/agh257; Latour P, 2004, HUM PSYCHOPHARM CLIN, V19, P193, DOI 10.1002/hup.575; Lehert P, 1993, Alcohol Alcohol Suppl, V2, P157; Lindsey PJ, 2001, J APPL STAT, V28, P81, DOI 10.1080/02664760120011617; Mallinckrodt CH, 2003, BIOL PSYCHIAT, V53, P754, DOI 10.1016/S0006-3223(02)01867-X; Pessione F, 2003, LIVER INT, V23, P45, DOI 10.1034/j.1600-0676.2003.01804.x; Petkova E, 2002, PSYCHOSOM MED, V64, P531, DOI 10.1097/00006842-200205000-00018; Shoptaw S, 2003, J CLIN PSYCHIAT, V64, P1440, DOI 10.4088/JCP.v64n1207; Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683	25	459	470	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1915	1922		10.1016/S0140-6736(07)61814-5	http://dx.doi.org/10.1016/S0140-6736(07)61814-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068515				2022-12-28	WOS:000251517600029
J	Horton, R				Horton, Richard			Chronic diseases: the case for urgent global action	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2005, PREV CHRON DIS VIT I; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2	2	42	43	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1881	1882		10.1016/S0140-6736(07)61701-2	http://dx.doi.org/10.1016/S0140-6736(07)61701-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18063030				2022-12-28	WOS:000251517600004
J	Kenealy, T; Elley, CR; Arroll, B				Kenealy, Tim; Elley, C. Raina; Arroll, Bruce			Screening for diabetes and prediabetes	LANCET			English	Editorial Material							GLUCOSE; ASSOCIATION; MORTALITY; CRITERIA		Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1142, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1142, New Zealand.	b.arroll@auckland.ac.nz		Kenealy, Timothy/0000-0001-6002-4766				Borch-Johnsen K, 1999, LANCET, V354, P617; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Genuth S, 2003, DIABETES CARE, V26, P3160; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; WAUGH N, 2007, HEALTH TECHNOL ASSES, P11	10	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1888	1889		10.1016/S0140-6736(07)61792-9	http://dx.doi.org/10.1016/S0140-6736(07)61792-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068499				2022-12-28	WOS:000251517600009
J	Mahilum-Tapay, L; Laitila, V; Wawrzyniak, JJ; Lee, HH; Alexander, S; Ison, C; Swain, A; Barber, P; Ushiro-Lumb, I; Goh, BT				Mahilum-Tapay, Lourdes; Laitila, Vivian; Wawrzyniak, James J.; Lee, Helen H.; Alexander, Sarah; Ison, Catherine; Swain, Alison; Barber, Penelope; Ushiro-Lumb, Ines; Goh, Beng T.			New point of care Chlamydia Rapid Test - bridging the gap between diagnosis and treatment: performance evaluation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACID AMPLIFICATION TESTS; COST-SAVING STRATEGY; URINE SPECIMENS; SEX WORKERS; TRACHOMATIS INFECTIONS; NEISSERIA-GONORRHOEAE; VAGINAL SWABS; ASSAY; PCR	Objective To evaluate the performance of a new Chlamydia Rapid Test with vaginal swab specimens as a potential tool for chlamydia diagnosis and screening. Design Performance evaluation study. Settings A young people's sexual health centre (site 1) and two genitourinary medicine clinics (sites 2 and 3) in the United Kingdom. Participants 1349 women aged between 16 and 54 attending one of the three clinics. Main outcome measures Sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test versus polymerase chain reaction and strand displacement amplification assays; correlation between the Chlamydia Rapid Test visual signal and organism load; acceptability to participants of self collected vaginal swabs as the specimen type for Chlamydia testing. Results Polymerase chain reaction positivity rates for Chlamydia trachomatis infection were 8.4% (56/663) at site 1, 9.4% (36/385) at site 2, and 6.0% (18/301) at site 3. Compared with polymerase chain reaction assay, the resolved sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test were 83.5% (91/109), 98.9% (1224/1238), 86.7% (91/105), and 98.6% (1224/1242). Compared with strand displacement amplification assay, sensitivity and specificity of the Chlamydia Rapid Test were 81.6% (40/ 49) and 98.3% (578/588). Organism toad of self collected vaginal swabs ranged from 5.97x10(2) to 1.09x10(9) Chlamydia plasmids per swab, which correlated well with the Chlamydia Rapid Test's visual signal (r=0.6435, P<0.0001). Most (95.9%) surveyed participants felt comfortable about collecting their own swabs. Conclusions The performance of the Chlamydia Rapid Test with self collected vaginal swabs indicates that it would be an effective same day diagnostic and screening tool for Chlamydia infection in women. The availability of Chlamydia Rapid Test results within 30 minutes allows for immediate treatment and contact tracing, potentially reducing the risks of persistent infection and onward transmission. It could also provide a simple and reliable alternative to nucleic acid amplification tests in chlamydia screening programmes.	Univ Cambridge, Dept Haematol, Diagnost Dev Unit, Cambridge CB2 2PT, England; Diagnost Real World Europe Ltd, Cambridge CB4 0WG, England; Hlth Protect Agcy Ctr Infect, Sexually Transmitted Bacteria Reference Lab, London NW9 5HT, England; Brook Birmingham, Birmingham B1 1BL, W Midlands, England; Barts & London NHS Trust, London E1 1BB, England	University of Cambridge; Health Protection Agency; Barts Health NHS Trust	Lee, HH (corresponding author), Univ Cambridge, Dept Haematol, Diagnost Dev Unit, EABC Site,Long Rd, Cambridge CB2 2PT, England.	hl207@cam.ac.uk	Ushiro-Lumb, Ines/GXM-3502-2022	Ushiro-Lumb, Ines/0000-0003-0989-8091	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Currie MJ, 2004, J CLIN MICROBIOL, V42, P4866, DOI 10.1128/JCM.42.10.4866-4867.2004; Dallabetta GA, 1998, SEX TRANSM INFECT, V74, pS1; DALLABETTA GA, 1998, SEX TRANSM INFECT S1, V74, P1; Davies SC, 2003, SEX TRANSM DIS, V30, P671, DOI 10.1097/01.OLQ.0000075850.22166.DB; Gaydos CA, 2004, J CLIN MICROBIOL, V42, P3041, DOI 10.1128/JCM.42.7.3041-3045.2004; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; HOOK EW, 1994, JAMA-J AM MED ASSOC, V272, P867, DOI 10.1001/jama.272.11.867; Krepel J, 1999, SEX TRANSM DIS, V26, P504, DOI 10.1097/00007435-199910000-00004; Lauderdale TL, 1999, J CLIN MICROBIOL, V37, P2223, DOI 10.1128/JCM.37.7.2223-2229.1999; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; MOI H, 2007, INT J STD AIDS S, V18, P20; Moncada J, 2003, J CLIN MICROBIOL, V41, P4842, DOI 10.1128/JCM.41.10.4842-4843.2003; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; *NAT CHLAM SCREEN, NEW FRONT ANN REP NA; *NAT CHLAM SCREEN, 2006, NEW FRONT ANN REP NA; *NAT COMM CLIN LAB, 2002, EP12A NAT COMM CLIN, V22; *NAT COMM CLIN LAB, EP12A2002 NAT COMM C; Nessa K, 2005, SEX TRANSM DIS, V32, P13, DOI 10.1097/01.olq.0000148298.26228.74; Paavonen J, 1996, HUM REPROD UPDATE, V2, P519, DOI 10.1093/humupd/2.6.519; Pasternack R, 1996, J CLIN MICROBIOL, V34, P995, DOI 10.1128/JCM.34.4.995-998.1996; Pate MS, 1998, J CLIN MICROBIOL, V36, P2183, DOI 10.1128/JCM.36.8.2183-2186.1998; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Shafer MA, 2003, J CLIN MICROBIOL, V41, P4395, DOI 10.1128/JCM.41.9.4395-4399.2003; SHELTON JD, 1999, INT FAMILY PLANNING, V25, P127; Verkooyen RP, 2003, J CLIN MICROBIOL, V41, P3013, DOI 10.1128/JCM.41.7.3013-3016.2003; Vickerman P, 2003, SEX TRANSM INFECT, V79, P363, DOI 10.1136/sti.79.5.363; Wi T, 2006, SEX TRANSM INFECT, V82, P386, DOI 10.1136/sti.2005.018283; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	34	56	57	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1190	1194		10.1136/bmj.39402.463854.AE	http://dx.doi.org/10.1136/bmj.39402.463854.AE			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18055487	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000251707800032
J	Price, L; Parghi, C; Khan, R				Price, Lindsey; Parghi, Chirag; Khan, Rashid			Thunderclap headache - and a tender neck	LANCET			English	Editorial Material							VERTEBRAL ARTERY DISSECTIONS		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; George Washington Univ, Sch Med, Dept Radiol, Falls Church, VA USA	Baylor College of Medicine; George Washington University	Khan, R (corresponding author), 7675 Phoenix Dr,Apt 522, Houston, TX 77030 USA.	med_rhkhan@yahoo.com						Chang AJ, 1999, MAYO CLIN PROC, V74, P893, DOI 10.4065/74.9.893; Schievink WI, 2000, CURR OPIN CARDIOL, V15, P316, DOI 10.1097/00001573-200009000-00002; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Tzourio C, 2002, NEUROLOGY, V59, P435, DOI 10.1212/WNL.59.3.435	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1974	1974		10.1016/S0140-6736(07)61817-0	http://dx.doi.org/10.1016/S0140-6736(07)61817-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068518				2022-12-28	WOS:000251517600035
J	Erdelyi, R; Fedun, V				Erdelyi, R.; Fedun, V.			Are there Alfven waves in the solar atmosphere?	SCIENCE			English	Editorial Material							JETS		Univ Sheffield, Dept Appl Math, Solar Phys & Space Plasma Res Ctr, Sheffield S3 7RH, S Yorkshire, England	University of Sheffield	Erdelyi, R (corresponding author), Univ Sheffield, Dept Appl Math, Solar Phys & Space Plasma Res Ctr, Hicks Bldg,Hounsfield Rd, Sheffield S3 7RH, S Yorkshire, England.	robertus@sheffield.ac.uk	Fedun, Viktor/M-9244-2013; erdelyi, robertus/AAQ-3262-2020	erdelyi, robertus/0000-0003-3439-4127	STFC [PP/D002907/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D002907/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Banerjee D, 2007, SOL PHYS, V246, P3, DOI 10.1007/s11207-007-9029-z; Chapman S., 1957, SMITHSONIAN CONTRIB, V2, P1, DOI DOI 10.5479/SI.00810231.2-1.1; Cirtain JW, 2007, SCIENCE, V318, P1580, DOI 10.1126/science.1147050; Culhane JL, 2007, SOL PHYS, V243, P19, DOI 10.1007/s01007-007-0293-1; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; Katsukawa Y, 2007, SCIENCE, V318, P1594, DOI 10.1126/science.1146046; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Okamoto TJ, 2007, SCIENCE, V318, P1577, DOI 10.1126/science.1145447; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; Sakao T, 2007, SCIENCE, V318, P1585, DOI 10.1126/science.1147292; Shibata K, 2007, SCIENCE, V318, P1591, DOI 10.1126/science.1146708; YOKOYAMA T, 1995, NATURE, V375, P42, DOI 10.1038/375042a0	14	142	143	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1572	1574		10.1126/science.1153006	http://dx.doi.org/10.1126/science.1153006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063783				2022-12-28	WOS:000251421700029
J	Lewin, JS; Zinner, RG				Lewin, Jan S.; Zinner, Ralph G.			Reversal of laryngeal paresis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Lewin, JS (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Lewin, Jan/0000-0002-6743-9064					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					E25	E25		10.1056/NEJMicm062394	http://dx.doi.org/10.1056/NEJMicm062394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057332				2022-12-28	WOS:000251389200010
J	Roell, W; Lewalter, T; Sasse, P; Tallini, YN; Choi, BR; Breitbach, M; Doran, R; Becher, UM; Hwang, SM; Bostani, T; von Maltzahn, J; Hofmann, A; Reining, S; Eiberger, B; Gabris, B; Pfeifer, A; Welz, A; Willecke, K; Salama, G; Schrickel, JW; Kotlikoff, MI; Fleischmann, BK				Roell, Wilhelm; Lewalter, Thorsten; Sasse, Philipp; Tallini, Yvonne N.; Choi, Bum-Rak; Breitbach, Martin; Doran, Robert; Becher, Ulrich M.; Hwang, Seong-Min; Bostani, Toktam; von Maltzahn, Julia; Hofmann, Andreas; Reining, Shaun; Eiberger, Britta; Gabris, Bethann; Pfeifer, Alexander; Welz, Armin; Willecke, Klaus; Salama, Guy; Schrickel, Jan W.; Kotlikoff, Michael I.; Fleischmann, Bernd K.			Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia	NATURE			English	Article							ISCHEMIC-HEART FAILURE; MYOCARDIAL-INFARCTION; STEM-CELLS; CELLULAR CARDIOMYOPLASTY; VENTRICULAR-TACHYCARDIA; IN-VIVO; CARDIOMYOCYTES; TRANSDIFFERENTIATE; ELECTROPHYSIOLOGY; TRANSPLANTATION	Ventricular tachyarrhythmias are the main cause of sudden death in patients after myocardial infarction. Here we show that transplantation of embryonic cardiomyocytes ( eCMs) in myocardial infarcts protects against the induction of ventricular tachycardia ( VT) in mice. Engraftment of eCMs, but not skeletal myoblasts ( SMs), bone marrow cells or cardiac myofibroblasts, markedly decreased the incidence of VT induced by in vivo pacing. eCM engraftment results in improved electrical coupling between the surrounding myocardium and the infarct region, and Ca2(+) signals from engrafted eCMs expressing a genetically encoded Ca2(+) indicator could be entrained during sinoatrial cardiac activation in vivo. eCM grafts also increased conduction velocity and decreased the incidence of conduction block within the infarct. VT protection is critically dependent on expression of the gap- junction protein connexin 43 ( Cx43; also known as Gja1): SMs genetically engineered to express Cx43 conferred a similar protection to that of eCMs against induced VT. Thus, engraftment of Cx43- expressing myocytes has the potential to reduce life- threatening post- infarct arrhythmias through the augmentation of intercellular coupling, suggesting autologous strategies for cardiac cell- based therapy.	Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; Univ Bonn, Dept Cardiac Surg, D-53105 Bonn, Germany; Univ Bonn, Dept Internal Med 2, D-53105 Bonn, Germany; Univ Bonn, Inst Genet, D-53105 Bonn, Germany; Univ Bonn, Inst Pharmacol, D-53105 Bonn, Germany; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; Rhode Isl Hosp, Cardiovasc Res Ctr, Providence, RI 02903 USA; Brown Med Sch, Providence, RI 02903 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Cornell University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fleischmann, BK (corresponding author), Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany.	mik7@cornell.edu; bernd.fleischmann@uni-bonn.de	Salama, Guy/GWQ-9862-2022; Sasse, Philipp/G-9866-2013; von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017	Sasse, Philipp/0000-0002-8502-9472; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Roell, Wilhelm/0000-0002-2213-5024; Hwang, Seong-min/0000-0003-1282-8828				ALLESSIE MA, 1989, EUR HEART J, V10, P2, DOI 10.1093/eurheartj/10.suppl_E.2; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2; Fleischmann M, 1998, FEBS LETT, V440, P370, DOI 10.1016/S0014-5793(98)01476-8; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; GOTTLIEB GJ, 1981, AM J PATHOL, V103, P292; GRANT AO, 1978, J PHARMACOL EXP THER, V205, P193; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; Henkel DM, 2006, AM HEART J, V151, P806, DOI 10.1016/j.ahj.2005.05.015; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Makkar RR, 2003, J AM COLL CARDIOL, V42, P2070, DOI 10.1016/j.jacc.2003.09.018; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; MITCHELL GFF, 1998, BASIC RES CARDIOL, V274, pH747; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pouzet B, 2001, CIRCULATION, V104, pI223; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Roell W, 2002, TRANSPLANTATION, V73, P462, DOI 10.1097/00007890-200202150-00022; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; SALAMA G, 1994, CIRC RES, V74, P604, DOI 10.1161/01.RES.74.4.604; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Takahashi T, 2004, HEART RHYTHM, V1, P451, DOI 10.1016/j.hrthm.2004.05.005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TRAUB O, 1994, EUR J CELL BIOL, V64, P101; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	40	326	342	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					819	U3		10.1038/nature06321	http://dx.doi.org/10.1038/nature06321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064002				2022-12-28	WOS:000251394900044
J	Sutton, T; Baumann, U; Hayes, J; Collins, NC; Shi, BJ; Schnurbusch, T; Hay, A; Mayo, G; Pallotta, M; Tester, M; Langridge, P				Sutton, Tim; Baumann, Ute; Hayes, Julie; Collins, Nicholas C.; Shi, Bu-Jun; Schnurbusch, Thorsten; Hay, Alison; Mayo, Gwenda; Pallotta, Margaret; Tester, Mark; Langridge, Peter			Boron-toxicity tolerance in barley arising from efflux transporter amplification	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; FOLIAR ANALYSIS; BORIC-ACID; WHEAT	Both limiting and toxic soil concentrations of the essential micronutrient boron represent major limitations to crop production worldwide. We identified Bot1, a BOR1 ortholog, as the gene responsible for the superior boron-toxicity tolerance of the Algerian barley landrace Sahara 3771 (Sahara). Bot1 was located at the tolerance locus by high-resolution mapping. Compared to intolerant genotypes, Sahara contains about four times as many Bot1 gene copies, produces substantially more Bot1 transcript, and encodes a Bot1 protein with a higher capacity to provide tolerance in yeast. Bot1 transcript levels identified in barley tissues are consistent with a role in limiting the net entry of boron into the root and in the disposal of boron from leaves via hydathode guttation.	Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia	University of Adelaide	Sutton, T (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Private Mail Bag 1, Glen Osmond, SA 5064, Australia.	tim.sutton@acpfg.com.au	Tester, Mark/J-2368-2017; Schnurbusch, Thorsten/B-2249-2009; Sutton, Tim/ABC-8454-2020; Sutton, Tim/F-4824-2010; Hayes, Julie/B-9078-2009; Langridge, Peter/G-5864-2010	Tester, Mark/0000-0002-5085-8801; Schnurbusch, Thorsten/0000-0002-5267-0677; Langridge, Peter/0000-0001-9494-400X; Sutton, Timothy/0000-0002-9059-0774; Pallotta, Margaret/0000-0002-1642-5623; Hayes, Julie/0000-0001-8716-5024				Avci Muzaffer, 2005, Turkish Journal of Agriculture and Forestry, V29, P377; CARTWRIGHT B, 1984, AUST J SOIL RES, V22, P261, DOI 10.1071/SR9840261; Dixon J, 2006, J AGR SCI-CAMBRIDGE, V144, P489, DOI 10.1017/S0021859606006459; Dordas C, 2000, J MEMBRANE BIOL, V175, P95, DOI 10.1007/s002320001058; EGLINTON JK, 2004, CZECH J GENET PLANT, V40, P166; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Goldberg S, 1997, PLANT SOIL, V193, P35, DOI 10.1023/A:1004203723343; Gupta U.C., 1993, BORON ITS ROLE CROP; Hayes JE, 2004, PLANT PHYSIOL, V136, P3376, DOI 10.1104/pp.103.037028; Jefferies SP, 1999, THEOR APPL GENET, V98, P1293, DOI 10.1007/s001220051195; Matoh T, 1997, PLANT SOIL, V193, P59, DOI 10.1023/A:1004207824251; Miwa K, 2007, PLANT CELL PHYSIOL, V48, pS89; Nable R. O., 1991, Current Topics in Plant Biochemistry and Physiology, V10, P257; NABLE RO, 1992, PLANT SOIL, V140, P311, DOI 10.1007/BF00010608; NABLE RO, 1990, PLANT SOIL, V128, P225, DOI 10.1007/BF00011113; NABLE RO, 1990, ANN BOT-LONDON, V66, P83, DOI 10.1093/oxfordjournals.aob.a088003; NABLE RO, 1988, PLANT SOIL, V112, P45, DOI 10.1007/BF02181751; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; NABLE RO, 1990, ASPECTS PLANT MINERA, P243; OERTLI J. J., 1962, SOIL SCI, V94, P214, DOI 10.1097/00010694-196210000-00004; OERTLI JJ, 1969, AGROCHIMICA, V13, P212; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; YAU SK, 1996, BARLEY NEWSL, V40	26	294	302	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1446	1449		10.1126/science.1146853	http://dx.doi.org/10.1126/science.1146853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048688				2022-12-28	WOS:000251246100044
J	Alber, F; Dokudovskaya, S; Veenhoff, LM; Zhang, WH; Kipper, J; Devos, D; Suprapto, A; Karni-Schmidt, O; Williams, R; Chait, BT; Sali, A; Rout, MP				Alber, Frank; Dokudovskaya, Svetlana; Veenhoff, Liesbeth M.; Zhang, Wenzhu; Kipper, Julia; Devos, Damien; Suprapto, Adisetyantari; Karni-Schmidt, Orit; Williams, Rosemary; Chait, Brian T.; Sali, Andrej; Rout, Michael P.			The molecular architecture of the nuclear pore complex	NATURE			English	Article							FG-REPEAT DOMAINS; TERMINAL DOMAIN; TRANSPORT; NUCLEOPORINS; COMPONENTS; DYNAMICS; HOMOLOG; REGIONS; BINDING; IMPORT	Nuclear pore complexes (NPCs) are proteinaceous assemblies of approximately 50 MDa that selectively transport cargoes across the nuclear envelope. To determine the molecular architecture of the yeast NPC, we collected a diverse set of biophysical and proteomic data, and developed a method for using these data to localize the NPC's 456 constituent proteins (see the accompanying paper). Our structure reveals that half of the NPC is made up of a core scaffold, which is structurally analogous to vesicle-coating complexes. This scaffold forms an interlaced network that coats the entire curved surface of the nuclear envelope membrane within which the NPC is embedded. The selective barrier for transport is formed by large numbers of proteins with disordered regions that line the inner face of the scaffold. The NPC consists of only a few structural modules that resemble each other in terms of the configuration of their homologous constituents, the most striking of these being a 16-fold repetition of 'columns'. These findings provide clues to the evolutionary origins of the NPC.	Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Rockefeller University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University	Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA.	chait@rockefeller.edu; sali@salilab.org; rout@rockefeller.edu	devos, damien/ABH-5348-2020; Rout, Michael/Y-7090-2018; Li, Chia Cheng/D-9906-2015	Rout, Michael/0000-0003-2010-706X; Veenhoff, Liesbeth/0000-0002-0158-4728; Devos, Damien/0000-0002-9453-4753; Svetlana, Dokudovskaya/0000-0001-6032-622X	NCRR NIH HHS [U54 RR022220] Funding Source: Medline; NIGMS NIH HHS [R01 GM062427] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062427] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; Antonin W, 2005, NAT CELL BIOL, V7, P10, DOI 10.1038/ncb0105-10; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; SCANNELL DR, IN PRESS YEAST; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	56	768	783	3	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					695	701		10.1038/nature06405	http://dx.doi.org/10.1038/nature06405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046406				2022-12-28	WOS:000251209700048
J	Zhang, TL; Delva, M; Baumjohann, W; Auster, HU; Carr, C; Russell, CT; Barabash, S; Balikhin, M; Kudela, K; Berghofer, G; Biernat, HK; Lammer, H; Lichtenegger, H; Magnes, W; Nakamura, R; Schwingenschuh, K; Volwerk, M; Voros, Z; Zambelli, W; Fornacon, KH; Glassmeier, KH; Richter, I; Balogh, A; Schwarzl, H; Pope, SA; Shi, JK; Wang, C; Motschmann, U; Lebreton, JP				Zhang, T. L.; Delva, M.; Baumjohann, W.; Auster, H. -U.; Carr, C.; Russell, C. T.; Barabash, S.; Balikhin, M.; Kudela, K.; Berghofer, G.; Biernat, H. K.; Lammer, H.; Lichtenegger, H.; Magnes, W.; Nakamura, R.; Schwingenschuh, K.; Volwerk, M.; Voros, Z.; Zambelli, W.; Fornacon, K. -H.; Glassmeier, K. -H.; Richter, I.; Balogh, A.; Schwarzl, H.; Pope, S. A.; Shi, J. K.; Wang, C.; Motschmann, U.; Lebreton, J. -P.			Little or no solar wind enters Venus' atmosphere at solar minimum	NATURE			English	Article							MAGNETIC-FIELD; BOW SHOCK; EXPRESS; MARS; IONOSPHERE; LOCATION; PLANETS; PLASMA; FLOW	Venus has no significant internal magnetic field(1), which allows the solar wind to interact directly with its atmosphere(2,3). A field is induced in this interaction, which partially shields the atmosphere, but we have no knowledge of how effective that shield is at solar minimum. (Our current knowledge of the solar wind interaction with Venus is derived from measurements at solar maximum(4-7).) The bow shock is close to the planet, meaning that it is possible that some solar wind could be absorbed by the atmosphere and contribute to the evolution of the atmosphere(8,9). Here we report magnetic field measurements from the Venus Express spacecraft(4) in the plasma environment surrounding Venus. The bow shock under low solar activity conditions seems to be in the position that would be expected from a complete deflection by a magnetized ionosphere(10). Therefore little solar wind enters the Venus ionosphere even at solar minimum.	Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; TU Braunschweig, Inst Geophys & Extraterr Phys, D-3300 Braunschweig, Germany; TU Braunschweig, Inst Theoret Phys, D-3300 Braunschweig, Germany; Univ London Imperial Coll Sci & Technol, London SW7 2BZ, England; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Univ Sheffield, Sheffield S1 3JD, S Yorkshire, England; Slovak Acad Sci, Inst Expt Phys, Kosice 04353, Slovakia; Chinese Acad Sci, State Key Lab Space Weather, Beijing 100080, Peoples R China; RSSD ESTEC, NL-2000 AG Noordwijk, Netherlands	Austrian Academy of Sciences; Braunschweig University of Technology; Braunschweig University of Technology; Imperial College London; University of California System; University of California Los Angeles; University of Sheffield; Slovak Academy of Sciences; Chinese Academy of Sciences; European Space Agency	Zhang, TL (corresponding author), Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria.	tielong.zhang@oeaw.ac.at	Vörös, Zoltan/AAB-8745-2019; Balogh, Andre/GZK-2076-2022; Nakamura, Rumi/I-7712-2013; , Misha/U-9055-2019; Pope, Simon A/E-5855-2011; Russell, Christopher T/E-7745-2012; Baumjohann, Wolfgang/A-1012-2010	Vörös, Zoltan/0000-0001-7597-238X; Nakamura, Rumi/0000-0002-2620-9211; Pope, Simon A/0000-0001-8130-4222; Russell, Christopher T/0000-0003-1639-8298; Baumjohann, Wolfgang/0000-0001-6271-0110; Wang, Chi/0000-0001-6991-9398; Carr, Chris/0000-0002-6879-3970				Bertucci C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015713; BRACE LH, 1991, SPACE SCI REV, V55, P81, DOI 10.1007/BF00177136; LUHMANN JG, 1986, SPACE SCI REV, V44, P241, DOI 10.1007/BF00200818; Luhmann JG, 2004, ADV SPACE RES, V33, P1905, DOI 10.1016/j.asr.2003.03.031; NESS NF, 1971, J GEOPHYS RES, V76, P3565; PHILLIPS JL, 1987, J GEOPHYS RES, V92, P2253, DOI 10.1029/JA092iA03p02253; PHILLIPS JL, 1991, SPACE SCI REV, V55, P1, DOI 10.1007/BF00177135; RIEDLER W, 1989, NATURE, V341, P604, DOI 10.1038/341604a0; Russell CT, 2006, PLANET SPACE SCI, V54, P1482, DOI 10.1016/j.pss.2006.04.025; Russell CT, 2006, PLANET SPACE SCI, V54, P1344, DOI 10.1016/j.pss.2006.04.026; RUSSELL CT, 1988, J GEOPHYS RES, V93, P5461, DOI 10.1029/JA093iA06p05461; Slavin JA, 1980, J GEOPHYS RES-SPACE, V85, P7625, DOI 10.1029/JA085iA13p07625; SLAVIN JA, 1983, J GEOPHYS RES-SPACE, V88, P19, DOI 10.1029/JA088iA01p00019; SPREITER JR, 1970, PLANET SPACE SCI, V18, P1281, DOI 10.1016/0032-0633(70)90139-X; Titov DV, 2006, PLANET SPACE SCI, V54, P1279, DOI 10.1016/j.pss.2006.04.017; VERIGIN MI, 1978, J GEOPHYS RES-SPACE, V83, P3721, DOI 10.1029/JA083iA08p03721; ZHANG MHG, 1990, J GEOPHYS RES-SOLID, V95, P14829, DOI 10.1029/JB095iB09p14829; Zhang TL, 2006, PLANET SPACE SCI, V54, P1336, DOI 10.1016/j.pss.2006.04.018; ZHANG TL, 1991, J GEOPHYS RES-SPACE, V96, P11145, DOI 10.1029/91JA00088; ZHANG TL, 1990, J GEOPHYS RES-SPACE, V95, P14961, DOI 10.1029/JA095iA09p14961	20	66	66	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					654	656		10.1038/nature06026	http://dx.doi.org/10.1038/nature06026			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046399				2022-12-28	WOS:000251209700039
J	Goldston, D				Goldston, David			Small advances	NATURE			English	Editorial Material											Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.							Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a	1	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1141	1141		10.1038/4501141a	http://dx.doi.org/10.1038/4501141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243HA	18097369				2022-12-28	WOS:000251786200009
J	Bennett, VC; Brandon, AD; Nutman, AP				Bennett, Vickie C.; Brandon, Alan D.; Nutman, Allen P.			Coupled Nd-142-Nd-143 isotopic evidence for Hadean mantle dynamics	SCIENCE			English	Article							SOUTHERN WEST GREENLAND; EARLY DIFFERENTIATION; ND-142 EVIDENCE; NUUK REGION; EVOLUTION; NEODYMIUM; CRUST; EARTH; HETEROGENEITY; GEOCHEMISTRY	The oldest rocks-3.85 billion years old- from southwest Greenland have coupled neodymium- 142 excesses ( from decay of now- extinct samarium- 146; half- life, 103 million years) and neodymium- 143 excesses ( from decay of samarium- 147; half- life, 106 billion years), relative to chondritic meteorites, that directly date the formation of chemically distinct silicate reservoirs in the first 30 million to 75 million years of Earth history. The differences in Nd-142 signatures of coeval rocks from the two most extensive crustal relicts more than 3.6 billion years old, in Western Australia and southwest Greenland, reveal early-formed large- scale chemical heterogeneities in Earth's mantle that persisted for at least the first billion years of Earth history. Temporal variations in Nd-142 signatures track the subsequent incomplete remixing of very- early- formed mantle chemical domains.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China	Australian National University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Chinese Academy of Geological Sciences	Bennett, VC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	vickie.bennett@anu.edu.au		Nutman, Allen/0000-0002-8393-9456; Bennett, Vickie/0000-0003-0937-3471				Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; Amelin Y, 2005, GEOCHIM COSMOCHIM AC, V69, P505, DOI 10.1016/j.gca.2004.05.047; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; BORG L, 2003, METEORIT PLANET SCI, V34, P439; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; CHASE CG, 1988, EARTH PLANET SC LETT, V91, P66, DOI 10.1016/0012-821X(88)90151-3; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; Frei R, 2002, GEOCHIM COSMOCHIM AC, V66, P467, DOI 10.1016/S0016-7037(01)00781-5; Friend CRL, 2005, J GEOL SOC LONDON, V162, P147, DOI 10.1144/0016-764903-161; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Nutman AP, 2007, CONTRIB MINERAL PETR, V154, P385, DOI 10.1007/s00410-007-0199-3; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; NUTMAN AP, 1993, TECTONICS, V12, P971, DOI 10.1029/93TC00377; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; Polat A, 2003, PRECAMBRIAN RES, V126, P197, DOI 10.1016/S0301-9268(03)00095-0; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Sharma M, 2004, PRECAMBRIAN RES, V135, P315, DOI 10.1016/j.precamres.2004.09.003; Smithies RH, 2003, PRECAMBRIAN RES, V127, P89, DOI 10.1016/S0301-9268(03)00182-7; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726	29	203	208	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1907	1910		10.1126/science.1145928	http://dx.doi.org/10.1126/science.1145928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096803				2022-12-28	WOS:000251786600054
